data_6k2i_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6k2i _Structure_validation_residue.Date_analyzed 2019-05-31 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.968 0.414 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.19 106.3 16.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.65 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 93.1 mt -93.42 105.6 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.865 0.466 . . . . 0.0 109.862 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t -98.75 104.19 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.14 146.78 24.38 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.338 0.655 . . . . 0.0 111.376 -171.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 p -149.82 158.01 43.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.213 1.005 . . . . 0.0 109.877 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.71 -0.75 42.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.237 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.95 118.68 9.86 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-O 120.241 -0.2 . . . . 0.0 112.662 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.36 -167.12 29.47 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.3 tt -105.21 124.28 49.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.821 0.449 . . . . 0.0 110.513 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 19' ' ' LEU . 28.0 m -118.67 163.03 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.345 1.058 . . . . 0.0 108.744 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 5.7 pm0 -88.89 155.55 19.46 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.065 0.546 . . . . 0.0 109.979 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.87 111.7 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.866 0.866 . . . . 0.0 110.745 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.02 -14.17 23.91 Favored Glycine 0 N--CA 1.474 1.181 0 O-C-N 123.273 0.358 . . . . 0.0 113.042 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.37 170.99 51.29 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 120.111 -0.272 . . . . 0.0 112.457 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -105.57 138.85 41.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.512 0.725 . . . . 0.0 110.626 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.435 ' HB2' HG13 ' A' ' 13' ' ' VAL . 38.8 tp -132.51 130.94 41.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.683 1.193 . . . . 0.0 109.152 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -111.97 127.51 55.89 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.833 0.853 . . . . 0.0 109.573 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.7 mm? -99.61 149.31 23.41 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 108.957 170.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 p -138.26 124.05 19.9 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.65 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 49.2 t -116.77 101.96 9.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.895 0.878 . . . . 0.0 109.409 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.87 121.29 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.52 99.43 12.29 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.79 0.436 . . . . 0.0 110.374 -173.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.456 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 18.4 m 58.87 35.72 24.33 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.076 1.35 . . . . 0.0 112.108 173.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.79 -58.63 4.81 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.993 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 31.9 ttp-105 -173.47 77.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.668 1.187 . . . . 0.0 108.014 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.5 m -139.77 147.89 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.567 0.747 . . . . 0.0 110.293 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' A' ' 78' ' ' ASN . 11.6 p90 -128.18 136.95 51.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 0.0 110.103 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -169.67 12.93 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.0 0.92 . . . . 0.0 109.098 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.483 ' HG ' ' HG2' ' A' ' 35' ' ' MET . 20.8 t -108.79 108.6 19.47 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.398 0.679 . . . . 0.0 109.992 -172.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -88.83 -23.72 22.76 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.737 0.815 . . . . 0.0 110.66 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.43 123.47 29.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.005 0.922 . . . . 0.0 109.04 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.483 ' HG2' ' HG ' ' A' ' 32' ' ' SER . 40.0 mtm -132.28 166.18 22.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.233 1.013 . . . . 0.0 109.719 -177.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -154.6 179.81 30.42 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.288 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -138.38 130.31 28.26 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.549 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 64.9 m-85 -135.48 152.63 51.54 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 109.262 -173.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 13.7 ptp180 -107.39 141.51 38.66 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -132.5 145.43 51.16 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -176.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 44' ' ' LYS . . . -144.6 155.17 56.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.69 105.94 0.25 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.315 2.01 . . . . 0.0 111.83 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.05 -17.04 56.73 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.558 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 9.8 mmpt? -111.87 131.86 55.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.62 0.768 . . . . 0.0 110.326 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.68 170.64 14.09 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.009 0.924 . . . . 0.0 111.763 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -67.28 119.02 11.46 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.712 -177.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -103.68 136.85 42.61 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.961 0.904 . . . . 0.0 109.997 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -62.97 115.82 4.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.688 1.195 . . . . 0.0 111.539 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.4 t -102.46 -48.16 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.011 0.924 . . . . 0.0 109.281 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -153.11 168.45 25.89 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.434 0.694 . . . . 0.0 111.623 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.598 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -153.98 138.47 16.8 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.467 0.651 . . . . 0.0 111.423 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.652 HG23 ' HB2' ' A' ' 73' ' ' ARG . 72.3 mt -127.01 124.76 65.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.069 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 . . . . . 0 C--O 1.243 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 110.849 174.365 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.578 ' HB3' HG21 ' A' ' 52' ' ' ILE . 38.4 m . . . . . 0 CA--C 1.549 0.913 0 CA-C-O 121.271 0.557 . . . . 0.0 112.114 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.519 ' HA ' HD13 ' A' ' 71' ' ' ILE . 12.4 p -163.9 122.54 1.92 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.45 1.1 . . . . 0.0 109.704 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.529 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 93.8 m-85 -150.15 147.84 28.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.482 1.113 . . . . 0.0 108.603 174.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CD1' ' HA ' ' A' ' 66' ' ' LYS . 26.3 p90 -164.53 158.04 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.152 0.981 . . . . 0.0 109.649 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.0 157.63 28.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 110.631 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.43 -37.69 88.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.632 0.773 . . . . 0.0 110.985 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -70.2 -16.06 63.02 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.912 0.885 . . . . 0.0 112.635 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 62' ' ' ALA . 31.5 m -125.06 20.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.777 0.831 . . . . 0.0 110.551 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 4.3 ttmp? -48.92 113.55 0.81 Allowed 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.156 1.383 . . . . 0.0 113.072 -175.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.28 -28.91 4.97 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.275 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -71.49 -44.85 63.96 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.546 0.688 . . . . 0.0 109.546 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.62 121.88 28.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.563 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.2 m -134.94 149.8 50.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.388 1.475 . . . . 0.0 107.905 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.585 ' HB ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.12 152.65 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.636 -177.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 t -151.47 145.23 25.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.608 0.763 . . . . 0.0 110.024 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.652 ' HB2' HG23 ' A' ' 52' ' ' ILE . 28.7 ttt180 -110.57 122.93 48.97 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.5 86.96 2.59 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -79.82 -11.91 59.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.341 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -35.95 73.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.817 0.847 . . . . 0.0 111.831 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.02 1.39 11.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.921 0.488 . . . . 0.0 111.212 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 19.3 m120 57.74 67.49 0.96 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.772 1.229 . . . . 0.0 110.885 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.3 m -139.04 131.76 29.03 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.898 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.6 t -108.82 125.02 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.29 134.13 48.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.791 0.436 . . . . 0.0 111.359 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 57.1 tp -115.64 97.14 5.97 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -92.6 98.5 11.48 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.517 ' HE1' HD21 ' A' ' 87' ' ' LEU . 75.9 mtm -98.25 111.56 23.85 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -100.4 138.37 37.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.6 t 58.56 72.04 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.308 1.043 . . . . 0.0 110.572 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.517 HD21 ' HE1' ' A' ' 84' ' ' MET . 5.4 mp -77.88 144.68 36.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.605 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -87.0 153.87 54.76 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.24 -18.45 64.94 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.944 1.763 . . . . 0.0 112.654 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.16 3.68 41.78 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.733 0.813 . . . . 0.0 112.134 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.85 26.38 1.82 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.557 0.743 . . . . 0.0 109.971 167.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.497 HG22 HG23 ' A' ' 120' ' ' THR . 95.9 m -83.25 94.0 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 166.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.93 -169.29 2.33 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.71 0.804 . . . . 0.0 110.047 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 40' ' ' GLN . 3.0 p -114.84 110.7 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.441 0.697 . . . . 0.0 109.191 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -84.38 153.14 23.62 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.111 0.564 . . . . 0.0 109.683 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.41 147.5 31.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.368 0.667 . . . . 0.0 110.26 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.9 t -88.53 161.62 16.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.775 0.83 . . . . 0.0 109.244 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 110' ' ' PRO . . . -122.7 158.22 30.57 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.045 0.538 . . . . 0.0 109.586 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -152.44 167.2 29.52 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.2 1.0 . . . . 0.0 109.515 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.516 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.468 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 15.7 Cg_exo . . . . . 0 CA--C 1.545 1.029 0 N-CA-C 110.198 -0.732 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.47 -42.97 41.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.3 0.64 . . . . 0.0 110.075 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 96.8 m-85 -112.45 160.01 18.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.378 1.071 . . . . 0.0 110.453 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -137.1 165.36 26.24 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.562 1.145 . . . . 0.0 108.878 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.516 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -79.27 173.65 55.26 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.446 -175.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 11.7 mm100 -72.7 -19.55 61.38 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.244 0.618 . . . . 0.0 111.394 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.72 99.98 1.7 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 t -99.49 116.74 32.32 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.523 0.729 . . . . 0.0 110.104 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 112.27 8.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.901 0.881 . . . . 0.0 110.564 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.58 126.6 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.497 HG23 HG22 ' A' ' 92' ' ' THR . 57.1 m -120.5 104.37 9.92 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.69 98.08 7.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.7 t -71.29 146.46 48.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.826 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 m -71.92 86.41 0.99 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.158 0.583 . . . . 0.0 110.225 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 3.3 mm? . . . . . 0 N--CA 1.482 1.152 0 C-N-CA 124.656 1.183 . . . . 0.0 112.252 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -102.13 121.4 42.13 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.704 0.802 . . . . 0.0 110.322 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.687 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.4 mt -110.15 110.83 21.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.232 1.013 . . . . 0.0 109.878 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.3 104.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.691 0.797 . . . . 0.0 109.383 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.94 142.32 27.9 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.69 0.796 . . . . 0.0 111.427 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.8 m -154.62 145.85 22.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.401 1.48 . . . . 0.0 108.844 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.4 -32.91 2.28 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.958 -0.357 . . . . 0.0 112.4 175.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 127.05 43.94 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 123.977 0.457 . . . . 0.0 113.937 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.15 -175.78 36.16 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.302 0.477 . . . . 0.0 112.028 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 120' ' ' THR . 20.7 tp -91.46 120.11 32.01 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.956 0.503 . . . . 0.0 109.934 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.442 HG23 HD12 ' A' ' 87' ' ' LEU . 27.5 m -125.24 158.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 109.156 170.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.45 152.91 31.88 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -60.82 133.61 56.27 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.507 0.723 . . . . 0.0 110.469 173.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.95 -15.12 64.07 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 123.306 0.379 . . . . 0.0 112.387 -170.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.29 -173.82 49.26 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-O 121.078 0.265 . . . . 0.0 113.657 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.6 p -127.12 154.27 44.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.137 0.975 . . . . 0.0 110.318 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.1 tp -154.82 122.94 5.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -98.14 117.29 32.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 110.505 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -88.77 155.18 19.72 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.12 0.968 . . . . 0.0 109.209 172.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.8 p -151.39 133.95 15.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.987 0.915 . . . . 0.0 109.006 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 46.2 t -131.52 101.96 5.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.624 0.77 . . . . 0.0 109.158 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 t -87.66 127.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 109.68 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.1 96.93 10.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t 43.85 53.44 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.02 1.728 . . . . 0.0 112.69 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.37 -79.03 1.24 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.392 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.584 ' HG2' ' HA ' ' A' ' 77' ' ' LYS . 61.8 mtm-85 -150.37 86.0 1.4 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.046 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 t -141.22 145.16 35.26 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.83 117.51 21.98 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mtp85 -143.01 1.46 1.27 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.73 1.212 . . . . 0.0 109.439 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 91.87 6.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.905 0.882 . . . . 0.0 110.216 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -83.76 -26.24 29.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.31 1.044 . . . . 0.0 110.117 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.8 141.93 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.066 1.346 . . . . 0.0 108.076 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.507 ' HE3' ' HD3' ' A' ' 73' ' ' ARG . 20.9 mtm -151.89 162.06 41.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.121 0.968 . . . . 0.0 109.535 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -168.49 138.62 5.22 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.319 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -92.81 126.36 37.86 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -116.24 147.4 41.52 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 108.515 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.23 142.35 33.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.5 ' HB3' HG11 ' A' ' 94' ' ' VAL . 64.0 tt0 -141.41 128.38 20.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.83 160.78 31.85 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.391 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.73 112.39 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.095 2.53 . . . . 0.0 112.843 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.76 23.39 75.12 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.625 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -125.37 173.19 9.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.781 0.832 . . . . 0.0 110.679 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.18 163.8 26.72 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.481 1.112 . . . . 0.0 111.837 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.99 106.79 18.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.874 0.845 . . . . 0.0 109.024 170.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.73 135.84 33.76 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.346 1.059 . . . . 0.0 110.009 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -65.03 120.05 11.91 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.098 1.359 . . . . 0.0 111.31 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.96 -61.47 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.43 0.692 . . . . 0.0 109.162 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -146.65 159.36 43.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.958 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -132.19 141.41 49.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 0.0 111.021 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.7 mp -112.6 121.3 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.5 mtp-105 . . . . . 0 N--CA 1.472 0.644 0 C-N-CA 124.393 1.077 . . . . 0.0 109.417 -174.495 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 40.8 m . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.432 ' HA ' HD13 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -158.69 122.25 3.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.164 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.454 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 15.9 m-85 -159.16 125.62 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.599 1.56 . . . . 0.0 107.297 170.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -164.62 144.14 7.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.638 0.775 . . . . 0.0 109.649 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 158.46 28.63 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.332 165.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.41 -28.38 69.64 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.4 t -63.48 -34.69 78.32 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.04 0.936 . . . . 0.0 112.224 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.503 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 34.1 m -109.52 14.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.425 0.69 . . . . 0.0 111.035 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -71.25 134.31 46.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.868 0.867 . . . . 0.0 109.409 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.11 -0.14 63.82 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.697 0.623 . . . . 0.0 113.243 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 72.7 mtp180 -109.29 -73.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.525 1.13 . . . . 0.0 109.174 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.65 119.66 26.23 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -126.58 129.8 49.26 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.977 0.911 . . . . 0.0 108.801 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -113.37 138.82 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.272 0.558 . . . . 0.0 109.787 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -144.81 149.21 35.05 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.298 1.039 . . . . 0.0 108.775 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.58 ' HB2' HG23 ' A' ' 52' ' ' ILE . 57.7 ttp180 -124.6 129.29 50.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.15 130.01 45.44 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -87.44 -29.91 21.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 111.563 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.25 82.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.529 0.731 . . . . 0.0 112.064 -172.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.584 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.45 12.15 15.1 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.655 0.382 . . . . 0.0 111.839 175.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.7 m120 53.76 56.85 6.66 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.093 0.957 . . . . 0.0 112.052 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -126.03 130.63 51.54 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.626 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.09 121.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.856 0.862 . . . . 0.0 109.127 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -102.25 145.38 29.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.622 0.769 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 53.1 tp -125.36 98.03 5.45 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -83.22 101.43 11.23 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.462 ' SD ' HD22 ' A' ' 87' ' ' LEU . 61.4 mtt -84.53 123.75 30.64 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -121.67 146.14 47.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.9 t 57.24 63.14 1.96 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.586 0.708 . . . . 0.0 110.935 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.462 HD22 ' SD ' ' A' ' 84' ' ' MET . 35.3 mt -79.66 140.04 37.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.839 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.6 mmmp? -99.15 157.89 33.26 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 108.729 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.67 -22.76 74.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.459 2.106 . . . . 0.0 112.72 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.42 -17.2 64.35 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.705 1.202 . . . . 0.0 112.452 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -81.87 37.84 0.5 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.745 0.818 . . . . 0.0 111.048 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 120' ' ' THR . 90.1 m -91.27 90.86 7.93 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 164.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 40' ' ' GLN . . . -167.3 177.46 6.09 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 40' ' ' GLN . 4.7 p -107.32 112.85 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.71 0.804 . . . . 0.0 110.173 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -92.01 133.23 35.91 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -122.47 141.51 51.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.058 0.543 . . . . 0.0 109.969 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -91.23 149.47 21.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.75 158.94 43.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.409 0.684 . . . . 0.0 109.566 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.76 169.35 17.77 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 109.811 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.437 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.703 176.756 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 CA--C 1.546 1.102 0 CA-C-O 121.221 0.425 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.09 -30.55 55.43 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.36 0.6 . . . . 0.0 109.808 170.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -127.13 153.17 46.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.779 1.232 . . . . 0.0 108.567 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -131.38 157.64 42.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.475 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.7 -120.95 0.67 Allowed Glycine 0 C--N 1.336 0.57 0 O-C-N 123.244 0.34 . . . . 0.0 112.696 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -129.05 -15.14 4.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.8 109.97 0.14 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 123.332 0.395 . . . . 0.0 112.641 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.411 HG22 HD12 ' A' ' 21' ' ' LEU . 10.1 t -95.84 128.15 42.48 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.644 0.735 . . . . 0.0 110.798 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.416 ' NE2' ' HB ' ' A' ' 94' ' ' VAL . 8.4 mm-40 -79.36 108.86 13.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.47 136.27 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 31.3 m -133.9 129.34 36.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 87' ' ' LEU . 46.3 t -113.66 108.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.8 m -60.88 141.64 56.98 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.939 0.495 . . . . 0.0 111.934 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 m -74.66 90.74 2.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.464 0.705 . . . . 0.0 110.964 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.8 mm? . . . . . 0 N--CA 1.491 1.579 0 C-N-CA 124.486 1.114 . . . . 0.0 112.943 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -103.07 132.32 49.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.669 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 70.3 mt -121.86 120.22 33.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 52.4 t -95.76 99.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 51.9 mt-10 -95.34 123.92 39.11 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.678 -172.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 m -130.91 154.38 48.16 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.617 1.167 . . . . 0.0 109.769 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.23 11.67 35.87 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.015 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.57 74.65 1.5 Allowed Glycine 0 C--N 1.35 1.355 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.37 -164.17 13.68 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 120' ' ' THR . 6.5 tt -116.86 127.54 54.39 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 33.7 m -123.82 161.13 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.144 0.978 . . . . 0.0 109.007 168.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -80.67 158.27 25.66 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.212 0.605 . . . . 0.0 110.768 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.23 114.49 2.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.772 0.829 . . . . 0.0 110.539 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.99 -25.53 10.69 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.959 0.79 . . . . 0.0 112.01 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.67 164.63 54.82 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 113.725 0.25 . . . . 0.0 113.725 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.6 p -104.64 155.46 18.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.988 0.915 . . . . 0.0 110.38 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.2 tp -152.76 136.84 16.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.114 0.966 . . . . 0.0 108.464 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.062 0.545 . . . . 0.0 110.043 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -101.07 157.51 16.7 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.297 1.039 . . . . 0.0 108.899 174.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -144.89 127.27 15.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.669 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -127.79 105.37 8.39 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.542 0.737 . . . . 0.0 110.445 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.47 130.04 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.88 98.06 11.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.726 0.298 . . . . 0.0 110.374 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.524 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 5.6 m 56.9 29.12 15.66 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.329 1.451 . . . . 0.0 112.917 170.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.18 50.77 5.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -173.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 88.5 mtt180 69.68 24.42 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.629 1.172 . . . . 0.0 113.092 171.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 32.7 p -87.8 153.24 21.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.889 0.476 . . . . 0.0 110.271 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -110.67 123.16 49.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.791 0.836 . . . . 0.0 109.76 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -145.95 -50.27 0.23 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.672 1.189 . . . . 0.0 108.168 167.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -73.52 103.72 4.24 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.942 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -88.97 -13.96 37.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.794 0.838 . . . . 0.0 110.033 167.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.58 43.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.784 1.234 . . . . 0.0 108.3 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtm -148.9 167.15 26.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.007 . . . . 0.0 109.157 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.61 148.79 8.91 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.715 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.463 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 95.4 m95 -89.51 136.25 33.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.25 164.78 18.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.42 1.088 . . . . 0.0 108.447 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -128.47 148.02 50.71 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -155.07 144.67 21.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.533 ' HB1' ' HG3' ' A' ' 44' ' ' LYS . . . -108.82 152.56 42.38 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 171.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 110.71 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.706 2.27 . . . . 0.0 112.506 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.07 43.96 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.449 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HG3' ' HB1' ' A' ' 41' ' ' ALA . 9.1 mmpt? -119.78 170.62 9.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.086 0.955 . . . . 0.0 110.57 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.28 163.44 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.655 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.402 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.56 123.36 31.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.6 137.59 32.71 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 0.0 109.673 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 51' ' ' ALA . 80.7 t80 -69.09 119.72 13.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.13 0.972 . . . . 0.0 110.431 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.51 -54.68 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.293 0.637 . . . . 0.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' A' ' 37' ' ' TRP . . . -139.9 164.9 28.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.588 -171.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . . . -145.09 131.86 20.04 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.377 0.671 . . . . 0.0 110.846 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -110.79 127.24 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.767 1.227 . . . . 0.0 109.375 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 125.252 1.421 . . . . 0.0 109.408 -177.617 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.8 m . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 121.323 0.583 . . . . 0.0 112.236 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.497 ' HA ' HD12 ' A' ' 71' ' ' ILE . 2.5 p -150.59 122.2 8.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.261 1.025 . . . . 0.0 109.211 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.24 127.05 0.82 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -165.82 167.04 17.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.544 0.738 . . . . 0.0 110.086 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -79.34 145.56 33.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 168.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.77 -28.1 69.64 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.851 0.358 . . . . 0.0 110.966 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 m -70.92 -26.62 63.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.61 0.764 . . . . 0.0 112.214 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 62' ' ' ALA . 18.7 m -104.58 4.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 122.872 0.469 . . . . 0.0 111.43 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.76 116.05 3.2 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.463 1.105 . . . . 0.0 112.501 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.72 11.81 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.986 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -87.25 -57.24 3.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.516 0.726 . . . . 0.0 109.263 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -87.77 122.1 31.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -146.74 153.68 40.52 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.049 1.34 . . . . 0.0 108.63 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -124.92 156.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.59 0.756 . . . . 0.0 109.915 176.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -151.75 136.77 17.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.778 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.7 ttp85 -110.37 136.28 49.79 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -109.03 122.26 46.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -87.59 -23.85 24.18 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.053 0.541 . . . . 0.0 111.0 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.35 84.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.377 0.671 . . . . 0.0 111.875 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.0 17.1 12.53 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.51 0.324 . . . . 0.0 111.841 172.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.6 m120 48.72 56.37 7.74 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.237 1.015 . . . . 0.0 112.191 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.1 m -130.07 130.72 45.24 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -109.65 125.53 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.901 0.88 . . . . 0.0 109.89 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -102.45 146.59 27.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.739 0.815 . . . . 0.0 110.388 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.63 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.3 tp -124.53 101.48 7.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.111 0.964 . . . . 0.0 108.685 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -91.55 101.18 13.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.369 0.668 . . . . 0.0 109.995 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.467 ' HE3' HD22 ' A' ' 21' ' ' LEU . 55.7 mtm -107.84 107.61 18.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.376 0.67 . . . . 0.0 110.118 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -106.91 147.94 29.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.303 0.641 . . . . 0.0 109.908 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.4 t 61.71 60.63 1.57 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.117 0.967 . . . . 0.0 110.067 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 121' ' ' VAL . 42.9 mt -76.13 151.12 37.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.28 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.55 ' HZ1' ' HB2' ' A' ' 88' ' ' LYS . 8.4 mtmp? -110.7 157.11 39.36 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.392 1.077 . . . . 0.0 109.046 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 27.3 Cg_endo -59.14 -26.14 80.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.56 2.174 . . . . 0.0 113.145 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.14 -17.3 64.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.002 0.921 . . . . 0.0 112.326 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.06 15.65 1.44 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.643 0.777 . . . . 0.0 111.193 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.498 HG22 HG21 ' A' ' 120' ' ' THR . 85.6 m -81.4 89.95 6.15 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 163.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -167.05 -166.07 0.77 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.491 -172.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 p -115.23 112.93 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.195 0.598 . . . . 0.0 110.362 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -85.05 130.74 34.56 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.402 ' H ' HD22 ' A' ' 96' ' ' LEU . 1.6 pt? -130.3 125.04 33.77 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.504 0.721 . . . . 0.0 109.292 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.1 p -88.85 138.66 31.22 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 110' ' ' PRO . . . -111.88 152.04 28.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.295 1.038 . . . . 0.0 109.823 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.47 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -130.0 167.68 17.89 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.614 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.274 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.604 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HB2' ' HB3' ' A' ' 98' ' ' ALA . 84.6 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 N-CA-C 110.054 -0.787 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.2 -27.55 60.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.126 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -112.45 150.1 31.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 109.776 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -130.85 145.96 52.15 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -70.76 -79.39 0.37 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 123.527 0.517 . . . . 0.0 113.247 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -164.11 -40.31 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.771 0.828 . . . . 0.0 109.815 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.9 119.49 4.54 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.119 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 6.2 t -96.56 111.62 23.68 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.596 0.713 . . . . 0.0 109.622 174.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.45 98.56 1.45 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.513 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.02 132.79 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 10.8 m -128.1 106.21 8.91 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 87' ' ' LEU . 42.6 t -106.49 97.82 6.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 121.65 -0.656 . . . . 0.0 109.462 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.1 t -70.6 129.17 38.49 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.878 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.462 ' HB2' ' HB3' ' A' ' 89' ' ' PRO . 43.8 t -59.93 98.23 0.05 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.499 0.72 . . . . 0.0 110.743 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.486 1.361 0 C-N-CA 125.83 1.652 . . . . 0.0 113.288 177.319 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 37.8 mt-30 -104.02 121.66 43.63 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.317 0.647 . . . . 0.0 109.568 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.58 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.6 mt -120.08 107.17 12.73 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.66 102.56 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.69 146.69 23.98 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.453 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 p -159.18 177.77 10.72 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.169 0.988 . . . . 0.0 109.788 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.8 -0.28 87.86 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.858 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 142.86 29.65 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.968 0.384 . . . . 0.0 112.478 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.66 -168.76 39.0 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.1 tt -99.73 130.3 45.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.348 0.659 . . . . 0.0 109.631 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.72 149.83 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.742 0.817 . . . . 0.0 109.258 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' HD12 ' A' ' 124' ' ' LEU . 4.3 pm0 -70.17 146.92 50.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.827 0.451 . . . . 0.0 110.498 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -64.94 135.18 55.37 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.394 0.678 . . . . 0.0 110.868 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.08 6.2 72.06 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.068 -168.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.95 -169.83 27.36 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 122.896 0.284 . . . . 0.0 112.851 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 p -129.28 153.26 47.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.635 0.774 . . . . 0.0 110.57 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.5 tp -149.72 125.09 10.2 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -108.38 109.99 21.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.453 0.701 . . . . 0.0 110.216 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -87.55 153.8 21.12 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.209 1.004 . . . . 0.0 109.947 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 m -143.48 130.96 21.07 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.5 0.72 . . . . 0.0 109.407 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 47.8 t -124.78 105.93 9.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.19 0.996 . . . . 0.0 109.45 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.25 123.46 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.139 0.575 . . . . 0.0 109.464 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.44 97.39 11.15 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.026 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 21.4 t 55.7 33.36 21.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.827 1.251 . . . . 0.0 112.341 171.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.45 -88.92 0.61 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.436 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -125.81 -0.63 7.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.736 0.814 . . . . 0.0 111.532 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -77.3 126.09 30.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -105.32 124.87 50.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.066 0.946 . . . . 0.0 109.345 -170.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.1 mtt85 -165.11 175.55 9.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.116 0.967 . . . . 0.0 110.169 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t 66.25 104.89 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 O-C-N 125.176 1.547 . . . . 0.0 110.798 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.23 -28.98 67.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.708 0.803 . . . . 0.0 112.593 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . . . -126.21 149.55 48.96 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.582 0.753 . . . . 0.0 109.592 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.0 mtt -144.9 122.38 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -118.18 -173.87 16.2 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 123.487 0.492 . . . . 0.0 113.222 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -132.87 143.75 49.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.116 0.967 . . . . 0.0 109.26 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.09 172.07 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.69 1.596 . . . . 0.0 107.65 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -139.35 123.73 18.16 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.056 0.455 . . . . 0.0 110.367 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.475 ' HB3' HG13 ' A' ' 94' ' ' VAL . 65.0 tp60 -101.58 135.23 43.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.624 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 44' ' ' LYS . . . -122.58 137.83 28.43 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.048 0.939 . . . . 0.0 109.229 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -66.26 118.08 5.22 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.72 2.28 . . . . 0.0 111.717 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.73 0.4 59.11 Favored Glycine 0 N--CA 1.474 1.184 0 O-C-N 123.044 0.215 . . . . 0.0 112.656 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 5.5 mmpt? -135.61 172.89 12.36 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.155 . . . . 0.0 110.141 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.17 156.92 16.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.053 0.941 . . . . 0.0 109.922 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 125.92 28.16 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.456 0.646 . . . . 0.0 110.803 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -93.38 138.29 31.86 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.618 1.167 . . . . 0.0 109.29 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -69.18 115.24 8.24 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.742 0.652 . . . . 0.0 109.781 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.9 t -94.32 -53.1 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.409 0.683 . . . . 0.0 110.03 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -156.1 169.6 24.12 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -168.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.424 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -158.99 132.29 7.24 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 110.306 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -116.34 116.16 51.38 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.408 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 28.7 ttt-85 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 49.9 m . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.9 m -158.53 121.93 3.87 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.605 0.362 . . . . 0.0 111.274 -170.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.45 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 68.4 m-85 -156.52 135.53 11.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.876 1.67 . . . . 0.0 107.66 171.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -165.4 164.55 19.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.227 1.011 . . . . 0.0 110.263 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.16 160.89 30.58 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.705 0.402 . . . . 0.0 111.092 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.61 -36.05 81.66 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.425 0.69 . . . . 0.0 111.76 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.2 p -69.15 -36.09 77.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.294 0.638 . . . . 0.0 111.622 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.3 m -97.74 15.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.5 0.72 . . . . 0.0 111.634 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.15 114.23 2.51 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.325 1.05 . . . . 0.0 112.009 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.81 -19.75 35.85 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.588 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.402 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 15.1 mtm180 -80.84 -48.52 12.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -85.21 123.5 30.78 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.131 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -130.55 134.48 47.06 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -129.37 143.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 110.609 -176.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -150.05 169.5 21.08 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.279 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.475 ' HB3' HG23 ' A' ' 52' ' ' ILE . 77.0 ttt180 -147.76 131.44 16.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -122.47 106.14 10.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.293 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -72.51 -11.57 60.72 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.728 0.811 . . . . 0.0 110.844 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.18 79.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.419 1.087 . . . . 0.0 111.878 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.02 7.97 12.39 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.924 0.489 . . . . 0.0 111.406 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 53.59 67.28 1.03 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.448 1.099 . . . . 0.0 110.807 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -148.74 132.73 17.17 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.24 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.418 HG23 ' HG3' ' A' ' 73' ' ' ARG . 21.5 t -103.68 136.13 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.518 1.127 . . . . 0.0 108.072 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.41 146.11 44.69 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.977 0.418 . . . . 0.0 111.34 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.7 tp -127.86 98.61 5.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.691 1.197 . . . . 0.0 108.081 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -93.21 100.14 12.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 109.187 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.485 ' HE2' HD21 ' A' ' 21' ' ' LEU . 56.7 mtm -104.25 103.24 12.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.896 0.478 . . . . 0.0 110.082 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -102.54 153.35 20.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.637 0.775 . . . . 0.0 109.581 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 36.5 t 58.13 48.96 12.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.172 0.989 . . . . 0.0 110.698 -177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 84' ' ' MET . 29.3 mt -68.99 133.49 48.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.114 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . 37.7 mtmt -92.06 157.24 41.35 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.104 0.962 . . . . 0.0 109.059 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.06 -23.77 78.07 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.11 1.873 . . . . 0.0 112.608 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.92 -11.4 60.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.276 1.03 . . . . 0.0 112.385 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -84.67 33.28 0.52 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.634 0.773 . . . . 0.0 110.656 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.7 m -88.1 98.19 11.4 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.59 -166.66 1.39 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.649 0.78 . . . . 0.0 109.322 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.8 p -117.05 109.52 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.66 131.39 35.21 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.25 143.06 47.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.117 0.567 . . . . 0.0 110.529 -173.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -89.04 158.16 18.09 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.781 0.833 . . . . 0.0 109.75 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.02 152.48 49.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.968 0.907 . . . . 0.0 109.255 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -118.36 120.59 38.06 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 110' ' ' PRO . . . . . . . . 0 C--O 1.244 0.744 0 O-C-N 123.645 0.591 . . . . 0.0 111.918 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.457 ' HA ' ' HA2' ' A' ' 100' ' ' GLY . 1.9 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 N-CA-C 109.301 -1.077 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.35 -35.74 80.06 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.866 0.867 . . . . 0.0 111.661 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 80.8 m-85 -111.73 152.82 27.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.458 0.703 . . . . 0.0 110.131 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -134.13 160.05 38.97 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.342 1.057 . . . . 0.0 108.692 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.28 -151.97 6.6 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.877 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 6.72 28.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.235 0.614 . . . . 0.0 110.651 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.35 163.48 28.68 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 113.129 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 t -140.59 115.64 9.79 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -68.7 122.79 19.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.58 0.752 . . . . 0.0 111.011 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.93 136.16 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.9 m -134.04 103.58 5.86 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.5 t -87.95 101.16 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.403 ' HG ' ' HA ' ' A' ' 14' ' ' GLN . 69.6 p -56.9 141.41 45.15 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.425 0.69 . . . . 0.0 111.413 171.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.3 p -85.11 59.27 5.53 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.459 0.704 . . . . 0.0 110.65 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.435 HD12 ' HB2' ' A' ' 14' ' ' GLN . 3.2 mm? . . . . . 0 N--CA 1.489 1.509 0 C-N-CA 124.316 1.046 . . . . 0.0 110.957 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.562 HD12 ' HG ' ' A' ' 32' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -103.95 142.44 34.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.182 0.993 . . . . 0.0 109.924 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.613 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 82.6 mt -132.36 129.08 38.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.231 1.013 . . . . 0.0 109.336 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 68.0 t -119.5 102.39 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.195 0.598 . . . . 0.0 109.689 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.66 151.31 25.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.42 0.688 . . . . 0.0 110.669 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 p -155.19 146.45 22.82 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.241 1.016 . . . . 0.0 109.308 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.01 0.59 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.709 0.671 . . . . 0.0 111.504 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.39 121.79 7.29 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.387 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.02 -178.24 48.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 122' ' ' SER . 19.3 tp -94.21 128.26 40.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.93 166.34 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.992 . . . . 0.0 108.949 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -85.84 151.94 23.4 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.918 0.487 . . . . 0.0 111.206 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.48 113.05 2.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.902 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.22 0.02 28.22 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -178.43 46.37 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 113.805 0.282 . . . . 0.0 113.805 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 m -108.68 159.99 16.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.495 1.118 . . . . 0.0 109.233 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 tp -160.69 116.84 2.3 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -99.49 109.18 21.75 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 117' ' ' THR . 3.1 mm? -86.91 140.71 29.35 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 p -140.37 125.45 18.53 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.795 0.838 . . . . 0.0 109.336 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -124.54 115.47 20.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.053 0.941 . . . . 0.0 109.421 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.07 129.56 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.05 103.23 15.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.167 0.987 . . . . 0.0 110.53 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 p 51.8 53.24 12.97 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.098 1.759 . . . . 0.0 112.93 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.86 -74.3 1.83 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.893 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -165.61 39.01 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 122.27 1.033 . . . . 0.0 108.471 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.0 m -103.95 147.52 27.25 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.297 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -105.84 121.41 44.0 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -167.31 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.609 0.764 . . . . 0.0 110.291 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.562 ' HG ' HD12 ' A' ' 3' ' ' LEU . 6.0 m -65.98 95.61 0.28 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.391 0.676 . . . . 0.0 109.756 174.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.52 -35.08 25.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.297 0.639 . . . . 0.0 110.212 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.67 121.68 31.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.7 0.8 . . . . 0.0 109.219 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.431 ' HE3' ' HD3' ' A' ' 73' ' ' ARG . 2.9 mpp? -123.75 163.18 21.67 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.397 1.479 . . . . 0.0 108.682 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -157.57 135.92 4.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.56 121.8 36.48 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.5 160.96 24.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -139.67 133.47 30.64 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -98.23 128.74 44.85 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -94.33 141.56 23.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 122.765 0.426 . . . . 0.0 110.219 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.42 101.73 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.651 2.234 . . . . 0.0 111.462 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.95 2.74 60.89 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.93 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 7.5 mmpt? -139.51 152.49 46.98 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.708 0.803 . . . . 0.0 110.276 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.19 163.27 10.51 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.418 1.087 . . . . 0.0 111.531 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.58 149.74 43.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.205 0.526 . . . . 0.0 111.373 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -120.18 134.44 55.26 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.184 0.994 . . . . 0.0 109.501 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -72.31 111.14 7.25 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.291 1.036 . . . . 0.0 109.055 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.6 t -88.57 -53.67 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.467 0.707 . . . . 0.0 110.002 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.88 165.23 37.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.677 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.418 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -150.4 127.61 11.29 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 124.096 0.959 . . . . 0.0 109.823 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.726 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.9 mp -110.22 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.726 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 68.4 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -157.91 122.02 4.16 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.3 0.64 . . . . 0.0 110.16 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -152.83 122.87 7.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.07 1.348 . . . . 0.0 108.194 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -164.73 161.75 20.8 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.656 1.182 . . . . 0.0 109.126 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB1' HG21 ' A' ' 65' ' ' VAL . . . -81.53 151.74 27.61 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.21 -28.9 69.1 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.075 0.464 . . . . 0.0 110.75 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 p -66.85 -25.62 66.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.246 1.018 . . . . 0.0 111.887 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 22.9 m -114.45 13.78 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.332 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HZ1' ' HB3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -68.09 122.67 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.36 0.664 . . . . 0.0 110.476 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.17 -27.32 9.39 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.757 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.514 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 24.3 mtp180 -78.45 -52.67 8.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.78 1.232 . . . . 0.0 108.762 175.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -104.02 121.97 44.28 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.984 1.314 . . . . 0.0 107.787 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -135.72 151.39 50.11 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.442 1.097 . . . . 0.0 108.916 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.94 148.5 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.714 0.806 . . . . 0.0 110.206 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.8 m -153.03 172.2 17.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.13 0.972 . . . . 0.0 109.354 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.431 ' HD3' ' HE3' ' A' ' 35' ' ' MET . 55.4 ttp180 -148.3 139.72 23.51 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.12 100.13 6.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.852 1.261 . . . . 0.0 108.585 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -71.1 -13.22 61.89 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.753 0.821 . . . . 0.0 111.167 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.35 64.56 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.409 1.084 . . . . 0.0 111.744 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.26 1.33 10.23 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.704 0.802 . . . . 0.0 111.513 173.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m120 60.75 68.94 0.71 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.649 1.18 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -142.26 133.33 25.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.642 0.777 . . . . 0.0 109.769 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.414 HG21 ' HG2' ' A' ' 35' ' ' MET . 23.2 t -101.18 133.65 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 108.327 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.78 148.41 34.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.52 0.728 . . . . 0.0 111.659 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 47.8 tp -132.91 99.57 4.63 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -84.19 99.5 10.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.712 ' HB3' HD23 ' A' ' 87' ' ' LEU . 74.1 mtp -87.56 136.41 32.96 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.86 160.59 41.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.767 0.827 . . . . 0.0 108.81 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.2 t 58.46 48.25 12.42 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.517 1.135 . . . . 0.0 109.016 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.712 HD23 ' HB3' ' A' ' 84' ' ' MET . 70.4 mt -72.3 138.76 47.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.726 -166.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 14.1 mmmm -92.4 153.06 42.76 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 124.077 0.951 . . . . 0.0 108.904 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.473 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 19.5 Cg_endo -59.92 -20.79 61.67 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.644 2.229 . . . . 0.0 113.054 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -80.78 1.78 29.02 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.859 0.864 . . . . 0.0 112.151 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -87.98 24.95 1.66 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.631 0.772 . . . . 0.0 110.318 166.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.0 m -81.6 105.59 12.88 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 161.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.68 177.64 6.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.952 0.901 . . . . 0.0 110.494 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HB ' ' NE2' ' A' ' 118' ' ' GLN . 3.1 p -110.08 107.05 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -83.89 115.22 22.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.372 0.669 . . . . 0.0 109.207 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.14 143.79 36.42 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -91.62 144.6 25.37 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 170.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . . . -133.05 157.69 44.63 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.386 0.675 . . . . 0.0 109.445 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.55 12.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.529 0.731 . . . . 0.0 109.731 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.647 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -176.086 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 58.3 Cg_endo . . . . . 0 CA--C 1.545 1.057 0 CA-C-O 121.089 0.371 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.25 -34.26 14.33 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.034 0.934 . . . . 0.0 109.757 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -117.85 152.41 35.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.461 1.104 . . . . 0.0 109.339 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.09 157.35 47.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.22 1.008 . . . . 0.0 108.817 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.7 -147.73 15.39 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.829 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.424 HE21 ' HA ' ' A' ' 6' ' ' VAL . 48.1 mt-30 -94.05 -34.42 13.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.616 0.766 . . . . 0.0 111.541 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.22 116.04 1.27 Allowed Glycine 0 C--N 1.345 1.04 0 N-CA-C 111.879 -0.489 . . . . 0.0 111.879 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.485 HG22 HD13 ' A' ' 21' ' ' LEU . 7.0 t -99.79 118.39 36.16 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.632 0.773 . . . . 0.0 110.402 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.421 ' NE2' ' HB ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -74.16 106.43 5.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.008 0.923 . . . . 0.0 110.514 178.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.91 139.89 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 43.5 m -135.25 118.58 16.72 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.0 103.4 14.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.546 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.5 t -66.37 140.8 58.1 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 123.293 0.371 . . . . 0.0 110.684 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -70.63 101.26 2.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 109.799 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 125.785 1.634 . . . . 0.0 111.295 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 ' HE3' ' A' ' 35' ' ' MET . 1.6 tm? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -102.96 143.42 32.56 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.68 1.192 . . . . 0.0 109.337 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.677 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.8 mt -130.46 113.98 14.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.097 0.959 . . . . 0.0 109.069 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.46 104.72 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.48 ' HG2' ' HB ' ' A' ' 117' ' ' THR . 78.2 tt0 -104.69 135.65 45.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.304 -166.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 p -163.2 -177.37 5.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.101 0.96 . . . . 0.0 110.264 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.0 5.74 57.25 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 112.547 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.38 148.23 21.97 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.714 0.257 . . . . 0.0 112.719 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.91 -174.04 45.44 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.7 tt -93.29 129.57 39.32 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.45 157.25 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.956 0.903 . . . . 0.0 108.787 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.623 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -81.33 149.59 28.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.09 0.556 . . . . 0.0 110.286 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.62 123.57 19.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.678 1.191 . . . . 0.0 111.47 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.35 -25.94 11.77 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -172.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.34 -166.77 32.65 Favored Glycine 0 C--N 1.35 1.321 0 C-N-CA 123.194 0.426 . . . . 0.0 114.13 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -134.97 160.32 38.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.065 0.946 . . . . 0.0 110.438 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -154.29 131.29 10.95 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.63 0.772 . . . . 0.0 109.208 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -102.49 127.11 49.68 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.106 0.562 . . . . 0.0 110.531 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -98.65 157.56 16.18 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.462 1.105 . . . . 0.0 109.207 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.8 p -148.83 126.88 11.99 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.47 0.708 . . . . 0.0 109.405 -175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.677 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.2 t -128.05 106.13 8.86 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.81 0.844 . . . . 0.0 109.1 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.42 120.71 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.507 0.723 . . . . 0.0 109.301 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.08 100.76 13.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.937 0.495 . . . . 0.0 110.87 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 10.9 m 54.67 37.04 27.51 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.267 1.427 . . . . 0.0 112.183 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.66 -68.31 3.29 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.849 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 52.6 ttp180 -164.91 63.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 85.0 m -138.53 146.3 41.75 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.204 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -129.48 141.89 50.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 109.039 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -156.01 -50.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.926 0.89 . . . . 0.0 109.846 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -73.77 119.54 18.13 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.84 0.352 . . . . 0.0 110.101 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -78.63 -3.0 41.75 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.534 0.734 . . . . 0.0 111.028 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.98 41.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.383 0.673 . . . . 0.0 109.272 171.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.57 ' HE3' HD11 ' A' ' 3' ' ' LEU . 68.3 mtt -143.53 121.1 11.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.62 174.15 22.76 Favored Glycine 0 C--N 1.335 0.526 0 O-C-N 123.072 0.233 . . . . 0.0 113.341 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.438 ' HE1' HG12 ' A' ' 80' ' ' VAL . 85.7 m95 -110.98 133.68 53.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.857 0.863 . . . . 0.0 109.68 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -119.53 171.89 8.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.274 1.43 . . . . 0.0 107.486 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 40.1 ptt180 -143.42 127.76 17.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.044 0.449 . . . . 0.0 110.465 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -109.63 129.79 55.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -103.17 157.95 32.76 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.762 -0.637 . . . . 0.0 109.893 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.8 96.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.777 2.318 . . . . 0.0 113.326 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.69 -11.5 52.23 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.092 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 8.8 mmpt? -103.12 137.87 40.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.518 0.727 . . . . 0.0 109.496 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.25 149.92 23.04 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 146.27 22.09 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.38 1.072 . . . . 0.0 112.291 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -136.2 133.22 36.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 109.892 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.46 115.55 7.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.952 0.901 . . . . 0.0 110.781 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.54 -55.19 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.404 0.681 . . . . 0.0 109.417 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 71' ' ' ILE . . . -167.42 173.91 8.39 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.097 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.53 158.95 27.24 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 122.267 1.032 . . . . 0.0 112.467 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -117.7 116.48 51.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 113.472 -1.694 . . . . 0.0 106.968 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.405 ' HG2' ' HE2' ' A' ' 60' ' ' TYR . 29.2 mmt180 . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 72' ' ' SER . 22.8 t . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.546 ' HA ' HD11 ' A' ' 71' ' ' ILE . 3.8 p -158.01 123.89 4.63 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.917 0.487 . . . . 0.0 111.034 -170.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.405 ' HE2' ' HG2' ' A' ' 53' ' ' ARG . 69.6 m-85 -150.25 113.16 4.8 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 166.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.07 143.27 7.71 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.683 0.393 . . . . 0.0 110.71 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.28 159.0 31.0 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 168.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 31.2 t70 -60.9 -28.19 68.72 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.062 0.545 . . . . 0.0 111.147 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 m -65.98 -33.57 76.11 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.927 0.891 . . . . 0.0 112.087 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -109.22 -5.64 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.291 0.636 . . . . 0.0 111.877 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 25.5 ttpp -72.54 133.53 44.8 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 109.909 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.46 7.28 Favored Glycine 0 C--N 1.342 0.905 0 O-C-N 123.423 0.452 . . . . 0.0 112.053 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 69.7 mtp180 -80.64 -66.71 0.85 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -92.01 120.67 32.86 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.789 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 m -125.16 127.48 46.89 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.295 1.038 . . . . 0.0 108.213 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.546 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -125.07 140.97 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.122 0.569 . . . . 0.0 110.489 -174.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.433 ' HA ' ' OG ' ' A' ' 58' ' ' SER . 45.0 t -162.99 157.86 21.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.599 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -133.97 124.87 27.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.575 0.75 . . . . 0.0 109.364 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -103.37 122.02 43.98 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -76.8 -12.29 59.95 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.0 -48.78 67.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.618 1.167 . . . . 0.0 111.811 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 -0.06 11.0 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.13 175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 19.8 m120 53.37 68.12 0.89 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.396 1.079 . . . . 0.0 110.781 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.1 m -137.22 133.79 35.51 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.484 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.438 HG12 ' HE1' ' A' ' 37' ' ' TRP . 6.7 t -102.02 126.09 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -106.3 143.08 34.94 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.0 0.52 . . . . 0.0 110.82 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.6 tp -121.66 97.78 5.66 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 167.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -83.78 99.8 10.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.682 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.0 mtm -86.8 138.84 31.26 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -142.44 163.11 33.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.905 0.882 . . . . 0.0 109.068 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.516 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 26.9 t 54.3 42.24 31.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.014 0.926 . . . . 0.0 109.584 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.682 HD21 ' HB3' ' A' ' 84' ' ' MET . 51.6 mt -69.05 126.26 29.24 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.921 -171.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.1 mmmp? -87.83 149.99 47.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.661 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.61 -17.51 54.72 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.541 2.161 . . . . 0.0 113.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.434 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.8 pt-20 -69.46 -16.81 63.54 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.378 1.071 . . . . 0.0 112.029 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -84.43 32.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.962 0.905 . . . . 0.0 111.424 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.1 m -86.51 95.71 9.81 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -158.75 -174.25 4.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.422 0.689 . . . . 0.0 110.318 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -117.57 108.29 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 9.1 m-85 -82.28 137.02 34.94 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.421 HD13 ' HD1' ' A' ' 113' ' ' TRP . 4.1 pp -126.62 128.59 47.02 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -90.06 119.5 30.45 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.75 159.12 19.27 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.594 0.758 . . . . 0.0 109.821 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -130.97 169.07 16.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.052 0.941 . . . . 0.0 108.94 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.559 0 C-N-CA 121.737 -0.268 . . . . 0.0 112.644 178.35 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.546 1.095 0 N-CA-C 110.232 -0.718 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -84.31 -16.09 44.25 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.482 0.713 . . . . 0.0 111.236 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 72.7 m-85 -134.26 154.09 51.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 107.92 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.421 ' HD1' HD13 ' A' ' 96' ' ' LEU . 29.6 m-90 -135.48 155.9 49.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.528 0.731 . . . . 0.0 109.428 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -78.54 -103.53 0.2 Allowed Glycine 0 C--N 1.345 1.039 0 O-C-N 123.437 0.46 . . . . 0.0 112.305 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -154.02 -14.82 0.13 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.218 0.607 . . . . 0.0 111.74 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.32 110.84 1.45 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' A' ' 7' ' ' GLU . 12.6 t -96.33 123.71 40.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.467 0.651 . . . . 0.0 109.696 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.18 116.49 21.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.297 0.639 . . . . 0.0 110.836 -177.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.82 141.96 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.744 0.818 . . . . 0.0 108.968 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.4 m -134.38 105.2 6.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.86 97.78 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.2 t -73.61 147.66 43.6 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.428 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -75.68 77.27 2.65 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.509 0.724 . . . . 0.0 110.214 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.623 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 C-N-CA 125.445 1.498 . . . . 0.0 112.338 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 40.5 mt-30 -105.61 114.29 28.37 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.462 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 56.5 mt -105.08 118.29 36.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.82 102.81 14.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.66 150.03 25.42 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.049 0.94 . . . . 0.0 108.964 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 p -159.69 168.11 26.76 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.736 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.8 -5.46 61.9 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.95 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.83 146.83 45.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.679 0.24 . . . . 0.0 112.875 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.61 -176.73 47.4 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.6 tt -88.91 114.39 25.48 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 122.841 0.456 . . . . 0.0 110.148 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.76 163.31 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 165.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.487 ' HB2' HD11 ' A' ' 124' ' ' LEU . 5.4 pm0 -84.59 160.44 20.44 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -65.63 113.6 4.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.549 0.74 . . . . 0.0 109.618 174.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.01 -1.72 27.08 Favored Glycine 0 C--N 1.34 0.755 0 O-C-N 123.818 0.699 . . . . 0.0 111.737 -171.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.36 -166.18 41.69 Favored Glycine 0 C--N 1.344 1.006 0 C-N-CA 123.041 0.353 . . . . 0.0 113.044 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -144.1 138.01 27.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.644 0.778 . . . . 0.0 109.687 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.7 tp -140.58 128.06 21.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.535 0.734 . . . . 0.0 109.69 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -103.04 139.82 38.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.225 0.61 . . . . 0.0 110.07 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.544 HD22 ' HE3' ' A' ' 84' ' ' MET . 2.3 mm? -113.98 158.61 20.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.374 1.07 . . . . 0.0 109.419 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.8 m -146.7 127.54 14.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.625 ' SG ' ' HB ' ' A' ' 80' ' ' VAL . 27.1 p -124.8 115.72 21.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.248 0.619 . . . . 0.0 109.569 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.09 135.48 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.67 100.83 11.26 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.098 0.959 . . . . 0.0 109.992 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.58 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 20.2 m 64.32 33.02 11.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.684 1.594 . . . . 0.0 111.769 169.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.97 58.16 16.06 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.663 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.461 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 55.5 ttp180 62.67 68.63 0.64 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.277 1.031 . . . . 0.0 110.782 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.1 m -140.25 143.75 36.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.672 0.789 . . . . 0.0 109.133 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -105.45 120.82 42.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -145.9 -51.84 0.24 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.582 1.153 . . . . 0.0 108.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -83.53 163.72 20.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -146.95 9.35 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.509 1.124 . . . . 0.0 109.576 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.7 117.82 8.34 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.4 ttm -151.56 118.52 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -170.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -113.92 142.91 17.76 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.54 -173.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -88.41 135.57 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 92.7 m-85 -134.81 145.94 48.83 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.304 1.042 . . . . 0.0 109.063 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 12.9 ptp180 -104.14 145.24 30.48 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' O ' HG13 ' A' ' 94' ' ' VAL . 59.8 tt0 -151.02 129.08 11.79 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.92 0.782 . . . . 0.0 110.51 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.498 ' HB1' ' HG3' ' A' ' 44' ' ' LYS . . . -100.72 161.17 24.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.8 114.78 2.15 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.429 2.086 . . . . 0.0 111.598 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.288 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.498 ' HG3' ' HB1' ' A' ' 41' ' ' ALA . 9.3 mmpt? -128.02 153.93 46.21 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.285 1.034 . . . . 0.0 109.243 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.86 151.44 30.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.994 0.518 . . . . 0.0 110.664 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.07 113.42 13.57 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.647 0.592 . . . . 0.0 110.321 177.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -93.47 139.0 31.21 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.16 0.984 . . . . 0.0 110.104 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -64.94 110.24 2.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.23 1.412 . . . . 0.0 110.736 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.7 t -95.05 -48.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.318 0.647 . . . . 0.0 109.637 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.86 19.3 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.527 0.731 . . . . 0.0 110.815 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -155.69 130.43 9.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 0.0 110.564 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.04 111.47 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.335 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 p -165.73 149.73 8.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.984 1.314 . . . . 0.0 108.756 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.435 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -154.47 118.23 4.64 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.7 140.35 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.812 0.845 . . . . 0.0 110.196 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.94 167.9 12.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.68 0.792 . . . . 0.0 109.459 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.03 -31.41 72.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.859 0.464 . . . . 0.0 110.869 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.5 p -64.01 -27.1 68.89 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.607 1.163 . . . . 0.0 112.539 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.94 5.62 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.409 0.684 . . . . 0.0 111.516 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -67.42 113.76 5.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.899 0.879 . . . . 0.0 109.785 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.81 -27.72 17.71 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.238 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.08 -70.88 0.47 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.959 0.904 . . . . 0.0 109.631 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -90.49 120.87 31.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.9 m -135.01 138.42 43.95 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.163 0.985 . . . . 0.0 109.188 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.2 143.05 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.134 0.974 . . . . 0.0 109.46 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.7 t -138.45 142.45 39.46 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.487 1.115 . . . . 0.0 108.136 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -115.91 123.48 48.19 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.84 129.59 49.56 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -86.85 -35.93 18.76 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.907 0.883 . . . . 0.0 110.178 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.13 78.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.425 1.09 . . . . 0.0 112.749 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.46 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -118.05 14.79 14.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.413 0.285 . . . . 0.0 111.233 175.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 18.5 m120 51.71 59.0 4.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.598 1.159 . . . . 0.0 111.488 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -126.67 129.27 48.13 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.63 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.625 ' HB ' ' SG ' ' A' ' 23' ' ' CYS . 47.7 t -103.14 125.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -101.95 150.58 23.06 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.668 0.787 . . . . 0.0 110.39 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 tp -133.0 99.18 4.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.964 0.905 . . . . 0.0 108.814 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -86.58 102.17 13.9 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.544 ' HE3' HD22 ' A' ' 21' ' ' LEU . 47.8 mtm -95.08 119.22 33.21 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.591 0.756 . . . . 0.0 109.182 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -116.21 151.38 35.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.743 0.817 . . . . 0.0 108.953 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t 59.96 69.07 0.73 Allowed 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.291 0.994 . . . . 0.0 110.02 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 84' ' ' MET . 62.4 mt -88.16 155.82 19.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.384 -176.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 11.0 mmmm -116.65 155.66 48.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.709 1.204 . . . . 0.0 109.677 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.427 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 30.5 Cg_endo -61.08 -22.58 75.13 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.631 2.221 . . . . 0.0 112.919 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.27 -21.68 65.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.118 0.967 . . . . 0.0 112.07 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.66 17.43 0.7 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.999 0.92 . . . . 0.0 111.766 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.0 m -80.36 94.12 6.09 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 164.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.84 -178.82 6.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.875 0.87 . . . . 0.0 110.149 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 40' ' ' GLN . 11.4 p -100.09 114.95 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -85.83 109.96 19.05 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -115.15 145.81 42.0 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.493 0.717 . . . . 0.0 110.175 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 79.3 m -92.13 157.93 16.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 110' ' ' PRO . . . -141.69 115.76 9.32 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.67 132.06 55.35 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.426 0.691 . . . . 0.0 110.618 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.581 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.529 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HB2' ' HB3' ' A' ' 98' ' ' ALA . 67.8 Cg_endo . . . . . 0 CA--C 1.547 1.15 0 N-CA-C 109.774 -0.894 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.31 -28.55 63.15 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.35 0.66 . . . . 0.0 111.23 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -119.41 146.61 45.21 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.865 0.866 . . . . 0.0 108.869 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -121.17 159.45 25.83 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.44 178.54 47.59 Favored Glycine 0 C--O 1.24 0.497 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.191 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -20.89 58.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.909 0.483 . . . . 0.0 111.174 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.91 125.03 0.64 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.844 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -99.52 121.16 40.77 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.63 112.25 10.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.055 0.542 . . . . 0.0 110.03 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.8 m -103.09 143.19 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 96.7 m -133.46 102.84 5.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.51 94.23 4.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -53.53 147.66 10.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.944 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.3 m -83.73 55.3 3.18 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.945 0.898 . . . . 0.0 110.207 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 14' ' ' GLN . 3.4 mm? . . . . . 0 N--CA 1.491 1.592 0 C-N-CA 124.773 1.229 . . . . 0.0 112.136 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -92.59 136.71 32.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.123 0.969 . . . . 0.0 109.437 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.445 HD13 ' SG ' ' A' ' 97' ' ' CYS . 49.1 mt -113.42 127.29 56.06 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.406 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 59.5 t -115.48 103.18 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.35 147.88 26.93 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.706 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.2 p -157.91 173.39 16.86 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.602 1.161 . . . . 0.0 109.093 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.67 -17.78 57.86 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.18 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -67.14 124.96 23.84 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 122.784 0.23 . . . . 0.0 112.686 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.86 -167.28 26.25 Favored Glycine 0 C--O 1.245 0.81 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -91.27 119.13 31.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.967 0.507 . . . . 0.0 110.258 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -124.88 169.75 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.327 1.051 . . . . 0.0 109.082 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -87.51 152.2 22.4 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.15 0.58 . . . . 0.0 111.04 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.507 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -66.36 119.06 10.93 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.338 1.055 . . . . 0.0 110.176 175.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.35 -16.14 38.39 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.771 0.669 . . . . 0.0 111.612 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.95 178.62 43.75 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.097 0.38 . . . . 0.0 113.825 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.9 p -107.92 162.66 13.81 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.042 0.937 . . . . 0.0 111.54 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.12 126.21 4.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 0.0 108.203 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -106.21 123.35 47.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -89.42 157.39 18.16 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.593 1.157 . . . . 0.0 109.559 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.6 m -139.15 124.42 19.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.727 0.811 . . . . 0.0 108.984 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 25.8 t -116.64 102.87 9.83 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.1 0.96 . . . . 0.0 109.425 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.6 t -91.51 126.54 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.553 0.741 . . . . 0.0 109.168 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.91 100.02 12.86 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m 55.85 33.33 21.34 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.14 1.376 . . . . 0.0 112.089 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.8 -84.76 1.1 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -141.58 95.86 2.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.611 0.764 . . . . 0.0 109.284 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 t -135.26 168.19 19.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.195 0.998 . . . . 0.0 108.453 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -140.25 120.37 13.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.389 0.676 . . . . 0.0 109.557 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -171.81 -72.95 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 0.0 108.999 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -84.32 129.24 34.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.314 0.646 . . . . 0.0 109.263 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -121.3 16.14 11.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 109.876 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.96 118.4 32.82 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.019 0.928 . . . . 0.0 108.521 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -137.86 121.39 17.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.132 0.973 . . . . 0.0 109.104 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -99.27 136.14 12.52 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -86.94 132.11 33.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 109.921 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -132.97 171.71 13.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.044 1.338 . . . . 0.0 108.882 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -149.28 142.03 24.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.471 0.708 . . . . 0.0 109.848 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -133.27 131.95 40.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.98 0.512 . . . . 0.0 110.348 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.45 146.18 31.97 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 123.96 0.904 . . . . 0.0 109.101 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -54.9 118.71 5.44 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.957 2.438 . . . . 0.0 113.098 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.79 71.91 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 113.489 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -128.75 167.79 16.78 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 166.47 22.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.132 0.973 . . . . 0.0 110.037 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 122.92 31.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -93.5 142.13 27.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.9 0.88 . . . . 0.0 109.896 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -65.32 130.6 43.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.824 1.25 . . . . 0.0 110.336 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.38 -54.86 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.917 0.887 . . . . 0.0 108.774 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.46 170.39 20.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.561 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -160.98 128.61 4.27 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 121.284 0.564 . . . . 0.0 110.86 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.541 HD13 ' HB ' ' A' ' 71' ' ' ILE . 2.7 mp -110.59 113.49 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.538 ' H ' ' HA ' ' A' ' 58' ' ' SER . 73.2 mtp180 . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 122.709 0.404 . . . . 0.0 110.666 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.538 ' HA ' ' H ' ' A' ' 53' ' ' ARG . 77.5 p . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.486 HG23 HD12 ' A' ' 71' ' ' ILE . 21.2 p -160.55 123.99 3.45 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.483 1.113 . . . . 0.0 108.986 -172.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -147.39 137.17 22.91 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -165.68 157.83 14.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.873 1.269 . . . . 0.0 109.808 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 65' ' ' VAL . . . -85.59 149.63 25.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.15 -32.35 72.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.873 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 m -69.93 -38.0 76.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.165 0.586 . . . . 0.0 111.626 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' A' ' 62' ' ' ALA . 14.6 m -96.71 -2.16 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.009 0.524 . . . . 0.0 111.593 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -61.69 128.69 37.44 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.65 0.78 . . . . 0.0 109.231 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.66 -26.55 17.65 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.629 0.581 . . . . 0.0 112.602 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -89.77 -54.9 3.85 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -84.73 121.05 27.12 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.351 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 132.39 51.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.539 1.136 . . . . 0.0 108.018 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.541 ' HB ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -102.48 149.94 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.32 178.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 20.2 m -141.91 146.56 35.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 109.471 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.57 132.15 23.85 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.09 103.61 8.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.431 1.092 . . . . 0.0 108.42 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.43 -17.27 63.63 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.192 0.997 . . . . 0.0 111.962 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -46.39 75.07 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.964 0.905 . . . . 0.0 112.397 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.449 ' HE3' ' HB ' ' A' ' 79' ' ' THR . 0.3 OUTLIER -118.53 -0.74 11.32 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.62 0.768 . . . . 0.0 110.665 176.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 55.77 68.81 0.81 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.842 1.257 . . . . 0.0 111.32 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.449 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 98.7 m -132.71 131.58 41.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.396 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 125.8 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.418 1.087 . . . . 0.0 109.066 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.498 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 71.1 m-85 -106.52 155.57 19.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.56 0.744 . . . . 0.0 110.307 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 50.5 tp -133.92 98.43 4.15 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.47 0.708 . . . . 0.0 109.389 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.41 99.86 10.93 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.208 0.603 . . . . 0.0 109.423 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.736 ' HB3' HD21 ' A' ' 87' ' ' LEU . 75.0 mtp -100.66 101.06 11.86 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.753 0.821 . . . . 0.0 110.474 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.7 144.87 28.27 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.075 0.55 . . . . 0.0 111.082 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.1 t 60.97 72.95 0.5 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.854 1.261 . . . . 0.0 110.523 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' A' ' 84' ' ' MET . 67.5 mt -88.24 159.63 18.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.95 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -106.84 150.68 40.02 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.179 0.992 . . . . 0.0 108.657 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.98 -16.15 53.25 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.552 2.168 . . . . 0.0 112.958 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.77 -2.63 44.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.032 0.933 . . . . 0.0 112.142 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -90.76 37.38 0.92 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.604 0.762 . . . . 0.0 110.821 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.5 m -91.66 93.13 8.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.33 -177.23 5.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.759 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -104.55 109.83 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.031 0.532 . . . . 0.0 109.901 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.56 129.03 34.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.92 137.47 47.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 109.776 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.8 p -92.8 159.31 15.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 109.487 173.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 110' ' ' PRO . . . -133.12 145.04 50.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.62 123.69 50.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.873 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.632 179.421 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 36.2 Cg_exo . . . . . 0 CA--C 1.549 1.227 0 CA-C-O 120.778 0.241 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.1 -23.53 59.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.51 0.724 . . . . 0.0 110.983 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.537 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 79.8 m-85 -133.43 155.34 49.71 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.012 0.925 . . . . 0.0 109.079 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -127.28 158.86 36.08 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.97 -170.04 45.73 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.042 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' A' ' 6' ' ' VAL . 9.8 pt20 -86.64 -21.1 26.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.558 0.743 . . . . 0.0 110.715 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 158.55 32.2 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.559 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.1 t -138.93 118.22 12.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.775 0.83 . . . . 0.0 108.809 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.22 103.48 8.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.486 0.714 . . . . 0.0 110.719 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.443 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -93.23 143.77 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 93.6 m -134.33 102.06 5.22 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.05 97.02 5.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 t -68.55 145.99 53.5 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.999 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -74.07 84.9 1.81 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.239 0.616 . . . . 0.0 110.155 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 15' ' ' ALA . 3.9 mm? . . . . . 0 N--CA 1.486 1.355 0 C-N-CA 125.47 1.508 . . . . 0.0 112.327 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 CA--C 1.548 0.876 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.04 132.89 35.26 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.777 0.831 . . . . 0.0 110.155 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.5 mt -130.91 124.57 31.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.365 1.066 . . . . 0.0 108.579 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -121.32 101.25 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.209 0.604 . . . . 0.0 109.636 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.85 132.91 35.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.235 0.614 . . . . 0.0 109.635 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.3 m -144.35 163.77 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.147 0.979 . . . . 0.0 109.512 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.407 ' O ' HD11 ' A' ' 19' ' ' LEU . . . 117.73 -19.93 11.12 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.504 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.12 119.6 19.13 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 123.214 0.435 . . . . 0.0 112.871 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.23 -175.93 29.71 Favored Glycine 0 C--N 1.347 1.161 0 C-N-CA 123.431 0.538 . . . . 0.0 112.104 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 120' ' ' THR . 25.6 tp -89.85 114.46 26.21 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.354 0.662 . . . . 0.0 110.37 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.8 145.97 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 4.8 pm0 -75.22 154.65 37.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.126 0.421 . . . . 0.0 110.568 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' HB1' ' HD3' ' A' ' 89' ' ' PRO . . . -58.14 113.68 2.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.559 0.744 . . . . 0.0 111.36 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.98 -4.41 25.66 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.122 0.867 . . . . 0.0 111.511 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.44 -165.68 39.83 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 123.345 0.498 . . . . 0.0 112.839 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -141.46 150.47 42.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.749 0.82 . . . . 0.0 111.129 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 9' ' ' GLY . 31.2 tp -147.33 122.91 10.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.661 0.784 . . . . 0.0 109.072 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -103.13 119.26 38.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.047 0.539 . . . . 0.0 110.139 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.414 HD23 ' HE3' ' A' ' 84' ' ' MET . 2.4 mm? -87.47 157.46 19.19 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 m -143.22 127.34 17.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.941 0.896 . . . . 0.0 108.775 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.53 120.19 36.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.875 0.87 . . . . 0.0 109.81 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.66 115.18 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.541 0.736 . . . . 0.0 109.14 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -90.85 103.07 15.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.101 0.56 . . . . 0.0 110.633 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.1 p 52.75 57.68 6.13 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.999 1.72 . . . . 0.0 112.404 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.91 -82.84 0.4 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.407 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -160.54 41.79 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.594 1.187 . . . . 0.0 108.066 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -111.31 155.92 22.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.99 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -107.06 118.82 37.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -151.47 171.4 17.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.006 1.322 . . . . 0.0 107.759 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 t 65.69 114.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.807 1.243 . . . . 0.0 110.848 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -55.37 -32.36 62.52 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.887 0.875 . . . . 0.0 113.133 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.06 151.71 46.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 111.02 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.44 ' HE3' ' HB2' ' A' ' 25' ' ' ALA . 67.7 mtt -140.87 147.68 39.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 107.904 174.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.51 150.25 22.23 Favored Glycine 0 N--CA 1.467 0.723 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.858 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -91.23 149.4 21.78 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.2 152.14 49.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.222 1.409 . . . . 0.0 108.665 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -125.27 135.32 52.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.464 0.705 . . . . 0.0 109.181 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -147.56 130.95 16.62 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 123.313 0.645 . . . . 0.0 109.474 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HB1' ' HG3' ' A' ' 44' ' ' LYS . . . -88.96 154.22 49.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -53.59 105.56 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.643 2.229 . . . . 0.0 112.888 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.2 31.53 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.509 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HG3' ' HB1' ' A' ' 41' ' ' ALA . 6.6 mmpt? -126.33 174.5 8.53 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.966 0.907 . . . . 0.0 110.853 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -82.8 144.36 30.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.762 0.825 . . . . 0.0 110.208 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 116.34 24.4 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.046 0.45 . . . . 0.0 110.005 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -92.31 142.36 27.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.648 0.779 . . . . 0.0 109.904 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -73.61 107.77 6.07 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.717 0.807 . . . . 0.0 109.52 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -86.9 -54.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.714 0.806 . . . . 0.0 110.357 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -137.49 160.21 39.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -170.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.47 121.12 14.29 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 125.102 1.361 . . . . 0.0 108.873 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.5 mp -121.68 116.08 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 . . . . . 0 N--CA 1.48 1.031 0 CA-C-N 118.507 0.594 . . . . 0.0 110.022 175.585 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.1 m . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.445 ' HA ' HD12 ' A' ' 71' ' ' ILE . 17.8 p -146.57 120.84 9.56 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 12.3 t80 -171.38 131.94 0.77 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.56 134.99 9.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.06 150.47 33.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.923 0.489 . . . . 0.0 111.029 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 29.9 t70 -66.3 -18.86 65.61 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -72.97 -34.24 66.36 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.385 0.674 . . . . 0.0 111.219 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -106.96 15.97 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.788 0.835 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -65.93 121.17 14.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.36 1.064 . . . . 0.0 110.749 -176.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.52 -27.6 16.77 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.361 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.485 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 4.0 ptt180 -94.82 -28.08 15.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.394 0.597 . . . . 0.0 109.988 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.485 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -99.73 132.66 44.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.357 0.663 . . . . 0.0 109.282 173.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.9 m -137.99 145.23 41.67 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.889 1.276 . . . . 0.0 108.125 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -128.57 159.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.564 0.746 . . . . 0.0 109.884 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.8 t -156.78 139.69 15.29 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.74 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HD2' HG22 ' A' ' 52' ' ' ILE . 50.2 ttt85 -115.19 120.54 40.06 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.77 107.67 18.75 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 109.303 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.34 -34.49 75.36 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.4 1.062 . . . . 0.0 111.283 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.54 -44.68 69.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.336 1.054 . . . . 0.0 112.963 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.77 7.6 11.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.074 0.55 . . . . 0.0 111.729 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.6 m120 53.66 38.37 28.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.488 1.115 . . . . 0.0 111.784 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 32.2 m -114.43 130.99 56.74 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.705 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.482 HG22 ' HG3' ' A' ' 73' ' ' ARG . 39.8 t -104.63 121.31 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.749 0.82 . . . . 0.0 108.814 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -101.13 152.79 20.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.762 . . . . 0.0 111.261 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.7 tp -132.94 97.83 4.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.287 1.035 . . . . 0.0 108.374 171.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -80.51 101.35 9.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.606 ' HB3' HD21 ' A' ' 87' ' ' LEU . 34.3 mtm -92.71 135.63 33.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.49 170.09 16.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 t 58.61 33.45 23.1 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.859 0.864 . . . . 0.0 110.767 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -71.94 156.94 38.7 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.673 -173.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.613 ' HZ1' ' HB3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -132.06 158.3 75.89 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.848 1.259 . . . . 0.0 108.189 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.448 ' HD3' ' HB1' ' A' ' 15' ' ' ALA . 13.0 Cg_endo -53.68 -24.4 29.77 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 123.061 2.507 . . . . 0.0 114.522 -169.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.576 ' HG2' ' HG2' ' A' ' 88' ' ' LYS . 13.1 pt-20 -65.74 -18.76 65.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 0.0 112.589 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.408 ' HB2' HG23 ' A' ' 121' ' ' VAL . 65.3 m-20 -82.36 30.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.493 0.717 . . . . 0.0 110.959 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 120' ' ' THR . 95.9 m -83.14 93.56 7.66 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 164.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.6 27.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.431 0.692 . . . . 0.0 110.625 -172.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.53 120.89 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.009 0.524 . . . . 0.0 109.958 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -95.56 125.93 40.5 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -129.35 144.11 51.11 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 109.742 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -92.8 157.76 16.24 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.54 150.25 46.17 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.341 0.656 . . . . 0.0 109.518 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -113.4 132.03 55.77 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.661 0 CA-C-O 121.353 0.418 . . . . 0.0 113.459 -172.089 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.543 0.933 0 N-CA-C 110.648 -0.558 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -83.48 -22.59 32.49 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.115 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 21.9 m-85 -122.48 147.44 46.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.03 0.932 . . . . 0.0 108.525 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.8 m-90 -130.11 162.06 29.65 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 108.846 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.27 -142.93 7.78 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.438 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -102.34 -27.95 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 110.661 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.55 156.08 24.13 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.109 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.46 119.37 11.9 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.98 103.0 5.01 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -85.53 137.96 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 32.1 m -133.38 110.47 10.05 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 91' ' ' ASP . 48.0 t -91.89 103.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 35.5 t -45.35 143.0 1.9 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.387 1.075 . . . . 0.0 112.308 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.5 p -70.15 167.67 17.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.779 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 122.919 0.488 . . . . 0.0 111.476 -179.106 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.673 HD22 ' HB2' ' A' ' 26' ' ' SER . 2.0 tm? . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -103.12 150.32 23.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.571 1.149 . . . . 0.0 108.383 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.486 HD21 ' HG ' ' A' ' 23' ' ' CYS . 95.1 mt -131.27 108.76 9.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.092 0.557 . . . . 0.0 110.137 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.6 107.72 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.096 0.958 . . . . 0.0 108.821 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -99.22 155.24 17.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.1 m -153.56 155.63 36.52 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.836 1.654 . . . . 0.0 109.145 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.02 10.12 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 123.171 0.415 . . . . 0.0 112.887 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.544 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -71.05 90.13 0.41 Allowed Glycine 0 C--N 1.347 1.146 0 O-C-N 123.484 0.167 . . . . 0.0 113.206 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.31 -175.61 13.93 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -94.76 118.32 31.56 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.063 0.545 . . . . 0.0 110.041 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.63 167.36 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 109.271 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.468 ' NE2' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -84.24 152.83 23.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.797 0.839 . . . . 0.0 110.478 175.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' HB2' HD23 ' A' ' 124' ' ' LEU . . . -68.12 121.85 17.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.68 -22.39 14.92 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.077 0.846 . . . . 0.0 111.31 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.468 ' HA3' ' NE2' ' A' ' 14' ' ' GLN . . . -81.84 -166.99 38.41 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 121.225 0.347 . . . . 0.0 113.492 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 p -127.31 156.1 42.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.565 0.746 . . . . 0.0 110.891 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -152.66 133.24 13.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.006 0.922 . . . . 0.0 108.636 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -113.17 124.16 51.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.992 0.517 . . . . 0.0 109.706 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.37 157.12 19.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.906 0.882 . . . . 0.0 109.443 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.9 p -142.32 135.32 28.58 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.211 1.004 . . . . 0.0 108.725 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.486 ' HG ' HD21 ' A' ' 5' ' ' LEU . 53.8 t -140.06 116.83 10.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.24 0.616 . . . . 0.0 110.095 -177.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.53 122.86 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.58 102.57 15.31 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.037 0.935 . . . . 0.0 110.515 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.673 ' HB2' HD22 ' A' ' 3' ' ' LEU . 11.6 t 69.97 22.73 5.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.53 1.532 . . . . 0.0 111.906 168.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 56.97 10.24 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 86.6 mtm180 60.6 56.37 3.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.371 1.069 . . . . 0.0 110.948 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 47.2 m -137.3 150.33 47.7 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.817 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -103.14 127.42 50.43 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.595 ' HB3' HD21 ' A' ' 3' ' ' LEU . 44.3 ttm180 -170.51 -35.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.594 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 p -71.1 103.77 2.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.225 0.61 . . . . 0.0 110.52 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.8 OUTLIER -79.32 -34.65 42.09 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.7 0.8 . . . . 0.0 109.415 174.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.01 49.18 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.769 1.228 . . . . 0.0 108.948 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 50.2 mtm -150.54 168.43 24.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.932 1.693 . . . . 0.0 108.567 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.02 35.52 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -122.37 135.51 54.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 168.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -122.95 164.38 18.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.147 1.379 . . . . 0.0 108.326 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -138.11 151.18 47.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -153.94 150.41 28.29 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.42 145.34 30.61 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.95 104.53 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.371 2.714 . . . . 0.0 113.386 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.79 -12.58 50.02 Favored Glycine 0 C--N 1.352 1.469 0 C-N-CA 122.9 0.286 . . . . 0.0 113.349 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -97.99 173.53 7.01 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.0 0.92 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -78.13 170.06 17.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.909 0.883 . . . . 0.0 110.433 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.423 ' H ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -100.59 151.67 21.33 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.181 0.515 . . . . 0.0 110.681 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -115.75 139.53 50.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.668 1.587 . . . . 0.0 109.005 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.51 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 59.5 t80 -83.27 109.78 17.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.086 0.955 . . . . 0.0 109.155 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.7 t -90.09 -52.47 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.671 0.788 . . . . 0.0 110.288 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -148.83 169.83 19.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.112 -168.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.51 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -149.28 119.05 7.04 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.61 1.164 . . . . 0.0 109.512 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.673 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.0 mp -120.78 116.53 50.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 C-N-CA 123.801 0.84 . . . . 0.0 109.344 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' H ' ' HA ' ' A' ' 58' ' ' SER . 2.5 mpt_? . . . . . 0 C--O 1.244 0.782 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.7 m . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.532 ' HA ' HD13 ' A' ' 71' ' ' ILE . 19.3 p -151.33 126.11 9.66 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 6.0 t80 -166.47 130.2 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.73 150.73 12.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.616 1.566 . . . . 0.0 108.139 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.47 155.07 39.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.304 0.642 . . . . 0.0 110.729 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.88 -31.79 73.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.265 0.626 . . . . 0.0 111.42 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -69.37 -33.9 73.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.747 0.819 . . . . 0.0 111.77 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.501 ' HA ' HH21 ' A' ' 68' ' ' ARG . 31.1 m -102.53 -0.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.711 0.804 . . . . 0.0 111.722 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.16 134.94 56.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.052 1.341 . . . . 0.0 112.313 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.37 5.54 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.623 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.581 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 75.3 mtm180 -89.64 -51.78 5.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.008 0.908 . . . . 0.0 109.173 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -86.7 122.71 30.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.677 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -146.15 150.5 36.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.012 1.325 . . . . 0.0 108.037 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -121.42 155.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.959 0.904 . . . . 0.0 110.445 -177.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -146.78 134.07 20.63 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.957 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.601 ' HB2' HG21 ' A' ' 52' ' ' ILE . 32.3 ttt180 -112.21 130.8 55.8 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -116.42 116.06 26.98 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -87.51 -11.66 48.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.925 0.33 . . . . 0.0 111.642 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.33 94.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.135 0.574 . . . . 0.0 111.455 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -119.62 15.68 12.8 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 122.355 0.262 . . . . 0.0 110.957 169.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 16.9 m120 44.45 63.66 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.077 1.351 . . . . 0.0 111.982 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.5 m -131.29 132.61 44.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.394 0.677 . . . . 0.0 109.758 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.7 t -102.66 143.73 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.561 1.144 . . . . 0.0 108.623 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -125.78 142.22 51.62 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.585 0.754 . . . . 0.0 110.071 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.3 tp -126.85 96.8 4.75 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -89.98 107.75 19.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.6 mtm -107.96 119.08 38.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.959 0.904 . . . . 0.0 109.045 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -112.38 148.63 33.9 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.421 0.689 . . . . 0.0 110.229 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 41.6 t 56.47 68.86 0.8 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.434 1.093 . . . . 0.0 110.162 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -78.77 160.87 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.469 -1.242 . . . . 0.0 111.47 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.591 ' HB2' ' HZ2' ' A' ' 88' ' ' LYS . 8.0 mtmp? -127.61 147.39 62.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.425 -169.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -57.96 -29.35 86.3 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.34 2.694 . . . . 0.0 114.098 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 pm0 -78.67 -2.88 41.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.323 0.649 . . . . 0.0 111.843 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -86.67 25.68 1.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.0 0.92 . . . . 0.0 110.733 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 120' ' ' THR . 87.7 m -87.74 92.68 9.2 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.22 168.04 27.5 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.523 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.38 106.81 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-O 121.565 0.698 . . . . 0.0 109.765 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -89.9 114.41 26.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -111.74 146.97 36.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.175 0.59 . . . . 0.0 109.666 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -90.55 159.41 16.49 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.63 40.6 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.9 0.88 . . . . 0.0 109.089 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -152.97 170.0 21.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.607 0.763 . . . . 0.0 110.59 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.697 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 176.679 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 CA--C 1.552 1.419 0 CA-C-O 121.297 0.457 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.97 -18.73 64.11 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.013 0.925 . . . . 0.0 111.012 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -134.76 151.63 51.12 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 125.14 1.376 . . . . 0.0 108.459 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -126.14 162.23 25.84 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.961 0.904 . . . . 0.0 109.255 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -94.14 177.23 36.49 Favored Glycine 0 C--O 1.241 0.552 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.927 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.7 -25.89 65.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.562 0.745 . . . . 0.0 111.221 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.36 110.81 0.23 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.753 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -99.02 118.92 36.89 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.458 0.647 . . . . 0.0 110.044 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.25 103.92 6.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.099 0.96 . . . . 0.0 111.135 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.544 HG12 ' HA2' ' A' ' 10' ' ' GLY . 9.0 m -90.05 152.0 3.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 85.3 m -132.72 106.61 7.87 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.54 0.736 . . . . 0.0 109.026 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.2 96.2 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 t -68.44 144.06 54.83 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.649 0.38 . . . . 0.0 110.766 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -67.65 92.51 0.33 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.127 0.971 . . . . 0.0 111.813 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 15' ' ' ALA . 4.3 mm? . . . . . 0 N--CA 1.494 1.748 0 C-N-CA 124.565 1.146 . . . . 0.0 113.19 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.912 0.387 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 36.3 mt-30 -103.59 128.67 50.81 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.6 mp -127.12 122.88 35.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.2 t -114.39 101.87 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.94 144.59 26.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.408 0.683 . . . . 0.0 109.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -147.24 169.25 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 109.836 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.38 10.31 51.29 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.432 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.42 111.03 3.26 Favored Glycine 0 C--N 1.344 0.999 0 O-C-N 123.578 0.223 . . . . 0.0 112.649 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.85 -176.66 32.16 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 120' ' ' THR . 14.3 tp -92.07 125.87 36.93 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 19' ' ' LEU . 19.4 m -126.48 157.55 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -75.58 148.23 39.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.812 0.845 . . . . 0.0 110.358 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' HB3' HD21 ' A' ' 124' ' ' LEU . . . -64.56 111.9 2.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.345 0.658 . . . . 0.0 109.772 171.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.07 -21.7 17.4 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.561 0.538 . . . . 0.0 112.115 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.01 -178.53 34.94 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 116.555 0.178 . . . . 0.0 112.899 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 p -123.04 151.05 42.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.475 0.71 . . . . 0.0 110.553 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.538 ' HB2' HG12 ' A' ' 13' ' ' VAL . 56.5 tp -151.82 133.65 14.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.355 1.062 . . . . 0.0 108.961 -177.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -109.42 126.0 53.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.408 0.683 . . . . 0.0 109.843 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -96.19 158.94 15.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 109.217 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.6 p -147.89 124.36 11.01 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.217 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.3 t -116.89 109.54 17.2 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.828 0.851 . . . . 0.0 109.429 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.4 t -86.17 126.11 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.79 100.61 13.38 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.537 0.735 . . . . 0.0 110.693 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.579 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 22.7 t 60.9 40.15 15.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.071 1.348 . . . . 0.0 111.83 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.73 -62.33 4.62 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.973 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.501 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 25.5 ttt180 -160.86 4.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.741 0.816 . . . . 0.0 110.445 173.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 m -77.57 145.13 37.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.401 0.681 . . . . 0.0 110.608 -170.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -105.97 123.57 48.19 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.02 -18.11 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.519 1.128 . . . . 0.0 109.352 170.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -63.76 108.19 1.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.872 0.869 . . . . 0.0 109.666 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -82.32 -36.93 26.47 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.858 0.837 . . . . 0.0 109.47 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.18 41.48 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.742 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.432 ' HE2' ' SG ' ' A' ' 97' ' ' CYS . 97.8 mtp -141.93 118.98 11.29 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.12 142.83 17.32 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.24 123.06 32.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-85 -120.17 133.91 55.38 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.401 1.08 . . . . 0.0 108.193 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -103.29 124.09 48.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.319 0.58 . . . . 0.0 109.934 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 128.68 53.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -125.36 155.15 72.05 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 122.889 0.475 . . . . 0.0 110.444 -170.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -52.5 96.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.027 2.484 . . . . 0.0 112.781 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.28 58.78 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.075 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.583 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.2 mmpt? -105.56 138.27 42.03 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.505 0.722 . . . . 0.0 109.998 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.48 163.79 10.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 0.0 112.6 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 122.15 12.69 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 168.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.3 tt0 -115.7 128.7 56.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.428 0.691 . . . . 0.0 109.51 -172.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 46.6 t80 -66.57 107.45 2.1 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 124.121 0.888 . . . . 0.0 109.714 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.05 -55.61 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.075 0.95 . . . . 0.0 109.954 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.65 32.29 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.865 -172.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . . . -139.39 123.62 18.01 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.163 0.985 . . . . 0.0 109.92 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.769 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -108.68 119.36 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 . . . . . 0 C--O 1.238 0.497 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.678 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.769 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 50.6 m . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 p -149.52 121.59 8.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -170.59 126.83 0.76 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.403 ' HE2' ' HG3' ' A' ' 66' ' ' LYS . 25.1 p90 -163.66 144.07 8.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.154 0.982 . . . . 0.0 108.944 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -68.69 153.89 42.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.921 0.489 . . . . 0.0 110.378 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.45 -35.29 77.17 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.263 0.625 . . . . 0.0 110.54 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -63.41 -34.36 77.58 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 111.937 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' ' 62' ' ' ALA . 34.4 m -108.23 19.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.953 0.901 . . . . 0.0 111.124 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HG3' ' HE2' ' A' ' 61' ' ' TYR . 39.1 ttmt -57.34 116.84 3.56 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.169 0.988 . . . . 0.0 111.532 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.65 -27.91 6.81 Favored Glycine 0 C--N 1.342 0.876 0 O-C-N 123.733 0.646 . . . . 0.0 113.602 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -77.75 -60.25 2.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -84.69 122.11 28.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 p -143.58 153.82 42.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.28 154.39 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.747 0.819 . . . . 0.0 110.387 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.2 m -150.33 135.79 18.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.972 1.309 . . . . 0.0 107.932 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -110.05 123.42 49.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.02 128.32 36.79 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -87.25 -27.9 22.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.063 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.15 96.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.47 0.708 . . . . 0.0 112.403 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -116.34 4.28 13.41 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.135 0.425 . . . . 0.0 111.992 171.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 54.36 68.34 0.87 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.206 1.002 . . . . 0.0 111.183 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -134.99 130.67 36.11 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.25 120.43 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.031 0.932 . . . . 0.0 109.517 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.08 134.31 42.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.63 0.772 . . . . 0.0 110.297 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.5 tp -114.87 98.9 7.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -84.16 98.85 10.15 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.473 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 90.5 mtp -91.89 108.5 19.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 174.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -103.19 132.81 49.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t 61.17 70.33 0.61 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.203 1.001 . . . . 0.0 109.614 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp -71.24 135.88 47.71 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.382 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HZ3' ' HB3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -79.47 153.06 76.21 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.47 -19.7 68.31 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 121.946 1.764 . . . . 0.0 111.299 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -65.12 -20.51 66.5 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.861 2.064 . . . . 0.0 111.802 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.415 ' HB2' HG23 ' A' ' 121' ' ' VAL . 66.0 m-20 -84.9 31.61 0.54 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.814 0.846 . . . . 0.0 111.362 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.471 HG23 HG21 ' A' ' 120' ' ' THR . 98.7 m -82.23 92.28 6.88 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 161.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.5 -175.35 4.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.818 -168.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.93 109.14 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -85.06 109.25 18.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.62 147.51 31.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.432 ' SG ' ' HE2' ' A' ' 35' ' ' MET . 36.2 t -99.11 157.54 16.29 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 171.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -142.88 128.35 18.99 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.67 141.59 42.03 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.372 0.669 . . . . 0.0 110.345 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.825 0 O-C-N 123.982 0.801 . . . . 0.0 113.127 -177.841 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 CA--C 1.553 1.442 0 CA-C-O 120.565 0.152 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.76 -38.85 76.13 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.809 -176.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -136.86 123.92 21.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -87.25 162.91 17.17 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 109.668 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.34 -164.99 34.89 Favored Glycine 0 C--O 1.243 0.706 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.88 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -79.73 -37.53 35.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.431 0.692 . . . . 0.0 110.639 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.85 138.16 9.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.396 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.7 t -108.03 118.65 37.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.166 0.587 . . . . 0.0 109.51 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.12 107.44 11.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.795 0.838 . . . . 0.0 110.467 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.7 m -107.07 143.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.946 0.898 . . . . 0.0 109.501 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.471 HG21 HG23 ' A' ' 92' ' ' THR . 61.7 m -132.92 120.92 22.1 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.415 HG23 ' HB2' ' A' ' 91' ' ' ASP . 25.9 t -100.91 104.57 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 176.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.2 m -53.64 140.64 28.46 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.1 m -83.09 59.51 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.873 0.869 . . . . 0.0 110.255 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 15' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.485 1.32 0 C-N-CA 125.306 1.442 . . . . 0.0 112.74 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -88.92 114.45 25.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.5 mt -112.04 122.32 47.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.02 100.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -87.21 118.8 26.86 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m -129.46 135.0 48.1 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.186 0.995 . . . . 0.0 109.186 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.78 9.21 0.73 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.074 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.3 89.99 0.61 Allowed Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.921 0.361 . . . . 0.0 112.749 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.22 172.78 23.32 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 112.268 -0.333 . . . . 0.0 112.268 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.545 HD13 ' HB2' ' A' ' 122' ' ' SER . 15.9 tp -91.99 123.76 35.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.463 0.705 . . . . 0.0 109.132 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.1 m -126.81 151.15 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -77.89 153.75 32.35 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 122.574 0.35 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.7 114.15 2.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.672 0.789 . . . . 0.0 110.584 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.25 11.7 27.01 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.296 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.47 -167.01 24.61 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 122.555 0.121 . . . . 0.0 113.087 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -132.47 156.9 45.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.694 0.798 . . . . 0.0 110.011 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -159.32 119.71 3.13 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -100.18 126.45 46.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.994 0.518 . . . . 0.0 110.375 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.83 157.48 18.99 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.02 0.928 . . . . 0.0 109.865 170.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.3 p -141.12 148.81 40.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.66 1.184 . . . . 0.0 108.544 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.0 t -135.28 101.67 4.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.2 118.14 30.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.82 97.92 11.47 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m 51.97 49.35 20.89 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.334 1.453 . . . . 0.0 112.267 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.27 -78.1 2.04 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.333 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -172.28 85.1 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.406 1.082 . . . . 0.0 108.585 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -139.16 155.96 47.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.351 0.66 . . . . 0.0 110.222 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.17 117.87 35.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -173.08 160.91 4.26 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.757 1.223 . . . . 0.0 109.514 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m 64.95 177.52 0.19 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.422 1.089 . . . . 0.0 111.088 -171.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -147.33 19.68 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.807 0.443 . . . . 0.0 110.726 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.3 125.12 6.52 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.837 0.855 . . . . 0.0 109.78 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 65.9 mtt -139.91 119.86 13.55 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.31 177.13 16.85 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 123.125 0.393 . . . . 0.0 112.697 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -119.55 139.79 51.57 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.717 0.807 . . . . 0.0 110.656 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -127.28 166.86 16.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 107.527 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.24 139.22 19.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.316 0.246 . . . . 0.0 110.665 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -125.18 128.12 47.87 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.076 0.55 . . . . 0.0 109.697 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.33 158.69 31.77 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.393 0.677 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -55.08 115.68 2.61 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.919 2.413 . . . . 0.0 112.693 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -7.74 78.08 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 113.629 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -114.51 162.97 16.02 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.069 0.948 . . . . 0.0 110.596 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.24 175.18 9.09 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.668 0.787 . . . . 0.0 110.212 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 131.53 36.1 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -115.67 140.46 49.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 109.311 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.59 109.38 3.25 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.744 1.217 . . . . 0.0 110.263 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.48 -58.2 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -163.78 174.74 11.22 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.958 -173.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.74 130.69 23.12 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.573 1.149 . . . . 0.0 108.926 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.2 mp -112.84 116.27 52.15 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.1 mtm-85 . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.909 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 23.6 m . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.537 ' HA ' HD12 ' A' ' 71' ' ' ILE . 3.2 p -159.01 122.59 3.81 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.735 0.814 . . . . 0.0 110.157 -175.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.586 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 46.4 m-85 -160.56 111.81 1.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.364 1.466 . . . . 0.0 107.927 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -166.63 136.0 3.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.964 0.906 . . . . 0.0 110.414 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.24 168.13 16.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.093 0.957 . . . . 0.0 110.329 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -57.32 -33.94 68.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.461 0.704 . . . . 0.0 112.312 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 m -65.8 -31.01 71.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.319 0.648 . . . . 0.0 112.284 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.2 14.16 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.693 0.797 . . . . 0.0 111.053 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.9 124.2 27.7 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.556 0.743 . . . . 0.0 109.883 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.36 -28.54 6.19 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.177 -174.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 74.7 mtp180 -75.63 -78.1 0.12 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 124.11 0.964 . . . . 0.0 109.189 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -84.26 119.92 25.61 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.628 0.771 . . . . 0.0 108.932 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -137.87 133.0 33.34 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 108.289 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -112.66 140.09 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.682 0.793 . . . . 0.0 110.081 -175.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -148.67 174.9 11.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.52 1.128 . . . . 0.0 109.527 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -152.01 150.29 29.82 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.571 0.748 . . . . 0.0 109.247 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.85 100.31 5.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.556 1.143 . . . . 0.0 108.173 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -69.94 -13.4 62.22 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.03 0.932 . . . . 0.0 111.498 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.31 70.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.22 . . . . 0.0 111.508 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.09 9.0 15.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.068 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m120 53.66 64.72 1.74 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.585 1.154 . . . . 0.0 111.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.8 m -138.7 130.69 28.11 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.711 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.42 131.68 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.929 0.891 . . . . 0.0 108.626 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.53 150.54 29.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.101 0.56 . . . . 0.0 111.849 -174.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 37.8 tp -132.74 97.92 4.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -81.11 109.39 15.63 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.673 ' HB3' HD23 ' A' ' 87' ' ' LEU . 28.4 mtm -100.58 97.43 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -91.81 162.78 14.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.895 0.878 . . . . 0.0 110.615 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.464 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 20.5 t 42.92 63.72 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.3 1.44 . . . . 0.0 111.912 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.673 HD23 ' HB3' ' A' ' 84' ' ' MET . 50.7 mt -82.63 150.51 26.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.759 -168.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -106.2 153.07 40.56 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.117 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.15 -18.89 60.96 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.584 2.19 . . . . 0.0 112.922 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.48 -1.17 25.86 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -96.41 31.69 2.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.447 0.641 . . . . 0.0 110.377 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.6 m -82.81 98.96 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 164.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.58 156.18 25.31 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.976 0.417 . . . . 0.0 111.387 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.05 105.25 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 170.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.61 122.59 31.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 108.957 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.76 158.6 34.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.64 0.776 . . . . 0.0 110.012 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.81 159.24 17.37 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.235 1.014 . . . . 0.0 109.445 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 110' ' ' PRO . . . -141.67 138.82 32.74 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.545 0.738 . . . . 0.0 109.782 -176.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -114.1 124.63 52.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 0.0 110.081 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 C-N-CA 123.847 0.737 . . . . 0.0 111.536 176.507 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.492 ' HB2' ' HB2' ' A' ' 98' ' ' ALA . 73.2 Cg_endo . . . . . 0 CA--C 1.548 1.219 0 CA-C-O 121.176 0.407 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.24 -5.24 59.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.396 0.679 . . . . 0.0 111.351 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 89.9 m-85 -123.03 142.36 50.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.661 0.784 . . . . 0.0 109.414 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -132.09 150.71 52.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.995 1.318 . . . . 0.0 107.893 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.98 -142.09 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 123.212 0.32 . . . . 0.0 112.864 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -100.85 -29.88 11.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.904 0.882 . . . . 0.0 111.304 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.94 161.81 36.76 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.297 -173.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -144.62 126.03 14.88 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.054 0.454 . . . . 0.0 110.054 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 100.35 9.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 -175.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.469 HG22 ' HE3' ' A' ' 84' ' ' MET . 4.0 m -90.19 146.52 6.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 38.8 m -134.29 113.58 12.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.19 99.02 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.545 ' HB2' HD13 ' A' ' 12' ' ' LEU . 9.4 t -60.54 141.32 56.7 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.959 176.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.2 p -81.56 76.65 8.47 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.381 0.673 . . . . 0.0 109.822 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 125.232 1.413 . . . . 0.0 113.834 177.037 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.563 0.22 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.94 103.39 13.95 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 86.9 mt -100.28 112.89 25.25 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.58 102.44 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.16 128.38 36.34 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.2 m -128.11 165.92 19.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.859 1.263 . . . . 0.0 109.194 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.61 8.16 40.83 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -76.55 103.24 1.71 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.752 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -178.99 32.65 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.2 tt -91.67 119.41 31.52 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.54 163.07 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.063 0.945 . . . . 0.0 108.656 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.448 ' NE2' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -83.62 154.73 23.59 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.736 0.814 . . . . 0.0 110.666 177.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -71.52 127.13 31.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 109.462 174.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.18 -14.12 44.16 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.448 ' HA3' ' NE2' ' A' ' 14' ' ' GLN . . . -88.99 -177.84 46.21 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.628 0.251 . . . . 0.0 113.132 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 p -119.37 131.09 55.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.651 0.781 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.9 tp -128.99 131.47 47.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.849 0.86 . . . . 0.0 108.964 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -112.63 132.41 55.17 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.8 0.84 . . . . 0.0 110.108 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.97 158.65 16.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.475 1.11 . . . . 0.0 109.851 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 p -140.25 122.39 15.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.705 0.802 . . . . 0.0 109.847 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -112.31 108.92 18.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.233 1.013 . . . . 0.0 108.851 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.96 121.62 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.49 108.67 19.94 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.711 0.805 . . . . 0.0 109.729 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 p 48.08 45.35 19.46 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.986 1.714 . . . . 0.0 113.067 172.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.61 -61.41 4.7 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 69.0 ttt180 -165.48 14.97 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.936 0.894 . . . . 0.0 110.606 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -106.12 154.64 20.39 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.321 0.648 . . . . 0.0 109.855 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -108.9 116.86 32.8 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -131.55 16.27 4.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.104 0.962 . . . . 0.0 109.717 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 t -139.55 147.72 41.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.747 0.819 . . . . 0.0 109.556 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -43.6 19.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.827 0.851 . . . . 0.0 109.336 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.33 152.39 46.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.907 0.483 . . . . 0.0 111.252 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 2.1 mpt? -133.14 118.48 18.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.67 135.35 10.09 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -93.28 129.23 39.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.111 0.964 . . . . 0.0 109.971 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.21 135.87 39.46 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 23.5 ptt180 -103.55 118.15 36.07 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.307 0.575 . . . . 0.0 109.946 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.469 ' HB3' HG11 ' A' ' 94' ' ' VAL . 49.7 tp60 -100.71 129.13 46.57 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 44' ' ' LYS . . . -99.28 150.74 37.01 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 122.634 0.373 . . . . 0.0 110.408 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.21 98.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.688 2.259 . . . . 0.0 112.294 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.07 65.81 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.913 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 10.2 mmpt? -123.68 153.58 40.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.741 0.816 . . . . 0.0 110.182 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -68.39 172.65 5.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.174 0.989 . . . . 0.0 113.104 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -83.24 134.93 34.93 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.324 -177.11 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.0 142.86 29.19 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.069 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -71.05 122.02 19.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.979 0.912 . . . . 0.0 110.034 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.92 -53.47 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.97 173.6 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.807 0.443 . . . . 0.0 112.183 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.29 121.63 3.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.255 1.022 . . . . 0.0 110.313 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.14 115.47 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 . . . . . 0 N--CA 1.478 0.971 0 C-N-CA 122.582 0.353 . . . . 0.0 110.203 -179.1 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 p -170.01 145.64 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.105 1.762 . . . . 0.0 106.97 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.78 130.12 2.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.718 0.807 . . . . 0.0 109.189 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -164.25 147.84 9.51 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.633 0.773 . . . . 0.0 110.576 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.33 164.29 13.57 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.054 0.941 . . . . 0.0 109.832 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.8 -21.37 66.04 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.387 0.675 . . . . 0.0 111.588 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 m -67.9 -38.38 82.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.388 0.675 . . . . 0.0 111.192 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -105.75 -6.28 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.671 0.788 . . . . 0.0 111.846 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -57.59 131.13 49.29 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.315 1.046 . . . . 0.0 112.359 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.28 -26.5 6.95 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.69 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.409 HH21 ' HE1' ' A' ' 69' ' ' PHE . 3.6 mtm180 -96.88 -59.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.409 ' HE1' HH21 ' A' ' 68' ' ' ARG . 1.2 m-85 -84.99 120.63 26.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -139.34 143.66 37.9 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.297 1.039 . . . . 0.0 108.491 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.5 146.16 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.764 0.826 . . . . 0.0 111.03 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -151.75 140.49 20.86 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.344 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -107.96 123.48 48.7 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.68 131.0 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.907 170.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 -28.51 19.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.582 0.753 . . . . 0.0 111.177 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.19 -43.52 87.59 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.838 0.855 . . . . 0.0 112.141 -172.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -118.14 9.88 12.78 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.222 0.209 . . . . 0.0 111.506 172.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 47.48 67.35 0.82 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.886 1.274 . . . . 0.0 112.016 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.4 m -134.68 131.61 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.252 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.47 131.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.641 0.776 . . . . 0.0 109.267 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -111.87 137.76 49.4 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.506 0.722 . . . . 0.0 110.769 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.53 97.66 5.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -87.65 104.54 16.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.396 0.678 . . . . 0.0 109.548 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 35.4 mtm -103.09 103.21 13.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.752 0.821 . . . . 0.0 110.083 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -93.2 149.49 21.19 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.4 t 56.23 72.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.907 1.283 . . . . 0.0 110.968 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.4 mt -81.06 160.74 24.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.571 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 150.37 59.06 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.802 1.241 . . . . 0.0 108.358 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.43 -21.55 54.25 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.235 2.623 . . . . 0.0 114.18 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.74 -12.18 61.43 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.561 0.744 . . . . 0.0 112.43 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -79.11 13.82 1.67 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.206 0.602 . . . . 0.0 111.423 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.414 HG22 HG21 ' A' ' 120' ' ' THR . 83.2 m -73.46 89.38 1.65 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.6 -178.6 3.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 -166.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -110.44 111.73 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 109.781 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -83.61 109.39 17.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.12 154.62 21.45 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.335 0.654 . . . . 0.0 110.159 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -108.55 158.0 17.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.331 1.052 . . . . 0.0 108.6 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . . . -130.29 145.85 51.82 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.93 114.49 27.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.936 0 CA-C-O 121.23 0.35 . . . . 0.0 113.716 -167.903 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.501 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 12.1 Cg_exo . . . . . 0 CA--C 1.546 1.118 0 N-CA-C 110.176 -0.74 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.26 -37.27 74.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.015 0.926 . . . . 0.0 110.95 -173.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 67.8 m-85 -126.99 169.0 13.78 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.223 1.009 . . . . 0.0 109.238 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -133.94 164.35 27.49 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.49 1.116 . . . . 0.0 108.804 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -90.44 -172.99 44.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.236 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -75.27 -32.68 61.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.879 0.871 . . . . 0.0 110.128 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.2 124.96 1.67 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.627 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -97.96 118.52 34.73 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.493 0.663 . . . . 0.0 109.426 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.44 112.14 13.87 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.509 HG12 ' HA2' ' A' ' 10' ' ' GLY . 27.0 m -112.39 142.68 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.1 m -126.75 104.5 8.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.42 99.26 9.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -67.43 150.41 48.95 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.0 p -78.76 85.91 4.73 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.19 0.596 . . . . 0.0 110.291 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 15' ' ' ALA . 4.5 mm? . . . . . 0 N--CA 1.498 1.949 0 C-N-CA 125.223 1.409 . . . . 0.0 113.909 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -79.24 149.57 31.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.193 1.397 . . . . 0.0 110.567 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.7 mt -124.98 120.08 30.57 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.115 0.966 . . . . 0.0 108.738 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 65.4 t -119.47 101.45 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 23' ' ' CYS . 2.9 mp0 -90.56 153.04 20.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.442 0.697 . . . . 0.0 110.584 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.8 p -165.31 160.91 18.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.141 0.976 . . . . 0.0 109.582 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.87 -1.26 27.29 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 120.069 -0.295 . . . . 0.0 112.961 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -78.75 119.0 4.98 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.48 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.44 177.98 26.33 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.4 tt -82.52 117.1 22.28 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 m -118.22 160.18 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.006 0.922 . . . . 0.0 108.609 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.46 ' NE2' ' HA3' ' A' ' 17' ' ' GLY . 0.4 OUTLIER -78.12 159.14 28.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.531 0.732 . . . . 0.0 110.791 174.035 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.55 133.38 52.23 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.549 0.74 . . . . 0.0 110.224 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.28 80.34 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.276 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA3' ' NE2' ' A' ' 14' ' ' GLN . . . -90.67 -178.26 43.84 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 120.88 0.156 . . . . 0.0 113.264 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -128.97 156.66 43.43 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -176.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -159.59 130.63 5.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.606 0.762 . . . . 0.0 109.354 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -105.57 132.85 51.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.682 0.393 . . . . 0.0 110.061 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 159.19 15.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.046 0.938 . . . . 0.0 109.693 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 p -143.53 130.89 20.94 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 109.284 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 43.1 t -131.95 110.64 10.91 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.9 t -86.58 132.37 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.56 100.24 12.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.077 0.551 . . . . 0.0 109.827 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.583 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 7.4 m 59.31 20.2 8.4 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.144 1.378 . . . . 0.0 113.391 176.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 68.64 1.57 Allowed Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -174.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 55.0 ttp180 62.26 51.95 3.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.856 1.262 . . . . 0.0 111.507 176.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 30.3 m -118.26 141.16 48.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.641 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -104.37 119.47 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -170.75 171.73 6.03 Favored 'General case' 0 C--O 1.248 0.988 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 m 71.01 121.1 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.61 1.164 . . . . 0.0 111.825 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -106.61 7.12 30.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.844 0.858 . . . . 0.0 110.717 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.51 122.37 27.5 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.7 mtt -138.79 152.75 48.17 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.282 0.633 . . . . 0.0 110.015 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -159.56 175.12 36.47 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.45 -178.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.8 131.97 34.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.537 1.135 . . . . 0.0 108.28 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.601 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 85.1 m-85 -134.37 137.32 44.02 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.58 1.152 . . . . 0.0 108.231 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -103.98 130.32 51.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -133.73 143.35 48.42 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.557 0.743 . . . . 0.0 109.058 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.15 160.99 31.85 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.711 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.93 105.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.306 2.671 . . . . 0.0 113.773 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.97 23.26 61.97 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.455 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.7 mmpt? -126.41 172.89 9.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.796 0.838 . . . . 0.0 110.492 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.68 168.19 17.49 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.101 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -102.03 117.87 35.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.225 174.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -93.19 139.92 30.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.032 0.933 . . . . 0.0 109.564 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.08 111.06 3.67 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.417 0.687 . . . . 0.0 110.051 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.96 -56.96 4.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.535 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -161.44 173.39 14.96 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.848 -171.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.56 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -163.37 162.8 25.16 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.194 0.997 . . . . 0.0 113.265 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mt -129.3 128.08 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 108.693 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 123.343 0.657 . . . . 0.0 110.143 175.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.776 0.322 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 p -158.84 119.23 3.22 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 17.1 m-85 -169.73 119.46 0.64 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 167.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.73 151.53 20.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.055 0.542 . . . . 0.0 110.764 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 159.76 30.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.503 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.6 -32.39 71.51 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.65 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.3 m -60.77 -37.65 82.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.14 0.976 . . . . 0.0 112.029 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.98 4.33 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.387 0.675 . . . . 0.0 111.896 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.77 111.26 3.62 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.148 0.979 . . . . 0.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.58 44.78 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.201 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 60.3 mtm180 -103.01 -40.24 6.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.299 0.64 . . . . 0.0 110.358 176.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.3 123.03 48.18 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.676 0.79 . . . . 0.0 109.459 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -139.35 152.26 47.03 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.121 0.968 . . . . 0.0 108.98 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.574 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -128.48 156.13 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.733 0.813 . . . . 0.0 110.497 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -154.54 134.17 12.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.371 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -110.85 120.07 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -90.89 104.63 17.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -62.75 -26.66 68.81 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.925 0.765 . . . . 0.0 110.966 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.39 -53.79 33.09 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.838 1.255 . . . . 0.0 112.263 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.519 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.37 11.17 11.4 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 45.07 67.81 0.66 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.943 1.297 . . . . 0.0 112.503 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 m -130.75 131.11 44.54 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.748 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.83 127.97 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.37 1.068 . . . . 0.0 109.503 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -110.83 150.88 28.51 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.991 0.916 . . . . 0.0 110.502 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 tp -132.36 99.32 4.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -82.76 102.3 11.48 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.623 ' HB3' HD22 ' A' ' 87' ' ' LEU . 34.4 mtm -95.53 132.61 40.46 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 83.7 m-20 -128.98 149.77 50.68 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.444 0.698 . . . . 0.0 109.775 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 t 47.59 68.74 0.61 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.95 1.3 . . . . 0.0 111.15 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -81.59 157.58 24.69 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.577 -170.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.43 149.72 36.94 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.896 0.878 . . . . 0.0 108.632 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -58.84 -23.16 65.88 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 122.626 2.217 . . . . 0.0 113.182 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.01 -14.36 62.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.216 1.006 . . . . 0.0 112.348 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -81.22 27.52 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.657 0.783 . . . . 0.0 111.85 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 93.7 m -81.49 92.05 6.42 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 165.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.83 9.25 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.446 0.699 . . . . 0.0 110.794 -170.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.96 114.52 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.335 0.588 . . . . 0.0 109.877 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -86.23 113.59 22.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.25 148.3 40.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.713 0.805 . . . . 0.0 109.857 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 31.7 p -96.05 155.2 16.86 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.23 13.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.26 166.38 11.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.825 0.85 . . . . 0.0 110.462 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 112.301 -0.319 . . . . 0.0 112.301 -179.219 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 CA--C 1.546 1.115 0 CA-C-O 121.204 0.418 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.54 -29.03 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.391 1.076 . . . . 0.0 110.192 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -117.99 128.03 54.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 0.0 109.131 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -110.13 128.88 55.71 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 166.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.39 -178.36 47.71 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 123.703 0.627 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.12 -27.09 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.135 0.574 . . . . 0.0 110.79 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.97 170.12 38.02 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.922 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.66 124.72 16.28 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.199 0.6 . . . . 0.0 109.528 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 101.45 7.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.615 0.766 . . . . 0.0 111.275 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.532 HG12 ' HA2' ' A' ' 10' ' ' GLY . 17.3 m -88.11 147.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 87.2 m -135.07 103.28 5.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.9 t -90.12 96.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.2 t -69.92 150.34 46.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.797 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.6 m -73.34 85.8 1.46 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.739 0.816 . . . . 0.0 111.133 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.491 1.587 0 C-N-CA 125.568 1.547 . . . . 0.0 112.991 -178.252 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 3' ' ' LEU . 3.7 mm? . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 26' ' ' SER . 16.7 mt-30 -91.91 108.91 20.27 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.426 0.69 . . . . 0.0 109.447 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.748 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.9 mp -118.71 119.35 34.18 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.4 101.02 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -92.51 135.67 33.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.933 -174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 p -148.54 165.23 31.86 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.386 1.074 . . . . 0.0 109.72 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.84 -24.77 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.73 128.96 38.56 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.081 0.372 . . . . 0.0 113.175 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.84 -174.12 45.47 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.3 tp -78.03 116.98 18.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.06 0.544 . . . . 0.0 109.896 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.42 163.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.414 1.086 . . . . 0.0 109.611 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 145.34 24.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.787 0.435 . . . . 0.0 111.399 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 127.17 30.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.341 1.057 . . . . 0.0 110.998 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.53 62.06 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 123.604 0.565 . . . . 0.0 112.304 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.04 -166.34 39.54 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -141.46 130.41 23.15 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.53 122.47 29.29 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.027 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -93.46 117.74 30.46 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.6 151.32 23.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.973 0.909 . . . . 0.0 109.175 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.4 p -136.59 126.22 25.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.624 0.77 . . . . 0.0 109.365 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.748 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 50.0 t -120.27 102.85 8.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.977 1.311 . . . . 0.0 109.372 -174.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -95.3 118.39 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.565 1.146 . . . . 0.0 109.639 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.53 99.69 11.86 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.945 -0.472 . . . . 0.0 110.643 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 27.3 t 49.6 39.39 17.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.568 1.547 . . . . 0.0 111.506 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.27 -89.96 1.11 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -168.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' HG2' ' HB2' ' A' ' 77' ' ' LYS . 98.2 mtt180 -140.32 94.85 2.79 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 t -133.42 157.65 45.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.391 0.676 . . . . 0.0 110.013 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -112.42 119.76 39.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -154.38 -82.15 0.08 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.1 p -77.61 121.04 23.4 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.862 0.465 . . . . 0.0 111.275 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -92.84 10.36 31.35 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.267 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.57 122.79 15.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.653 1.181 . . . . 0.0 108.864 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.7 mtt -140.79 165.53 27.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.587 1.555 . . . . 0.0 108.546 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -166.36 156.17 27.88 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.612 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -108.14 133.67 52.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.387 1.075 . . . . 0.0 108.599 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -136.44 139.37 42.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.132 0.973 . . . . 0.0 108.829 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 33.4 ptt85 -103.68 137.98 40.97 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.492 0.717 . . . . 0.0 109.834 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 61.8 tt0 -143.83 130.72 20.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.059 0.544 . . . . 0.0 109.726 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.94 161.67 30.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.469 0.708 . . . . 0.0 109.563 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.35 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.59 2.193 . . . . 0.0 113.299 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.88 6.79 88.68 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -106.35 174.57 5.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.896 0.878 . . . . 0.0 110.549 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.45 166.37 22.07 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.833 0.853 . . . . 0.0 111.096 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -103.67 113.53 27.11 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 110.475 175.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -93.03 143.91 25.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.812 0.845 . . . . 0.0 110.382 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -62.76 118.12 7.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.751 0.821 . . . . 0.0 111.267 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -88.03 -47.16 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.15 176.47 8.45 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.785 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.57 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -156.98 127.24 6.43 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 123.886 0.874 . . . . 0.0 110.265 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.54 HD12 HG11 ' A' ' 80' ' ' VAL . 11.4 mt -118.92 118.06 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.35 1.06 . . . . 0.0 110.353 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 . . . . . 0 C--O 1.243 0.725 0 C-N-CA 124.218 1.007 . . . . 0.0 109.002 167.722 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 120.707 0.289 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -158.71 123.21 4.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.619 0.767 . . . . 0.0 110.031 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.412 ' HB3' ' N ' ' A' ' 51' ' ' ALA . 4.4 t80 -171.36 141.82 1.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.476 0.71 . . . . 0.0 109.675 172.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -165.86 156.75 13.4 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.624 0.77 . . . . 0.0 110.383 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.68 167.28 11.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.754 0.822 . . . . 0.0 110.078 167.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.32 -29.11 69.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 112.036 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -68.22 -33.39 74.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.208 0.603 . . . . 0.0 111.42 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 69' ' ' PHE . 26.4 m -105.83 9.39 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.635 0.774 . . . . 0.0 111.098 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.07 119.19 8.44 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.391 1.076 . . . . 0.0 110.84 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.24 -16.67 15.99 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -98.51 -45.8 5.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.212 0.605 . . . . 0.0 109.384 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.464 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.8 m-85 -98.12 120.04 37.83 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.2 m -124.99 144.8 50.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.492 ' HB ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -127.52 141.67 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.065 0.546 . . . . 0.0 110.826 -175.237 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -150.63 137.77 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.277 1.031 . . . . 0.0 109.694 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HB2' HG23 ' A' ' 52' ' ' ILE . 22.1 ttp85 -124.6 130.16 51.92 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.27 110.01 22.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.886 1.274 . . . . 0.0 111.794 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.93 68.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.137 0.975 . . . . 0.0 111.712 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HE3' ' HB ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -120.23 -3.91 10.0 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.455 176.106 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 52.92 67.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.43 1.092 . . . . 0.0 111.451 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.459 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 92.3 m -127.15 132.83 50.45 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.682 173.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.54 HG11 HD12 ' A' ' 52' ' ' ILE . 23.3 t -101.6 151.16 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.773 1.229 . . . . 0.0 108.607 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -133.04 141.36 48.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.462 0.705 . . . . 0.0 109.59 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 66.3 tp -128.48 99.55 5.43 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -83.3 98.04 9.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.437 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 72.6 mtp -90.74 107.74 19.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.143 0.977 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.9 153.45 23.02 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.946 0.498 . . . . 0.0 110.156 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.5 t 60.07 62.17 1.69 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.562 1.145 . . . . 0.0 109.936 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.13 152.73 45.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.088 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.585 ' HB2' ' HZ2' ' A' ' 88' ' ' LYS . 8.9 mtmp? -120.71 151.53 54.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.84 -15.2 45.61 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.15 1.9 . . . . 0.0 112.252 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.98 -25.1 66.16 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HB2' HG22 ' A' ' 121' ' ' VAL . 32.8 m-20 -82.2 24.15 0.68 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.661 0.784 . . . . 0.0 111.929 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.527 HG22 HG21 ' A' ' 120' ' ' THR . 64.4 m -79.66 90.44 5.18 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 159.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' GLN . . . -167.5 -174.31 2.48 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.446 -168.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.2 p -109.24 108.23 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.676 0.79 . . . . 0.0 109.807 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -85.04 116.3 23.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 167.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.449 HD13 ' HD1' ' A' ' 113' ' ' TRP . 2.5 pp -115.07 137.24 52.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 111.071 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.5 t -93.75 156.1 16.86 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.42 156.04 41.97 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.446 0.698 . . . . 0.0 109.713 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.64 158.61 37.33 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.906 0.482 . . . . 0.0 111.558 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.072 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 174.016 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.54 0.776 0 CA-C-O 120.847 0.27 . . . . 0.0 112.678 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.81 -40.23 6.65 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -121.94 164.35 17.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.162 0.985 . . . . 0.0 110.174 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.449 ' HD1' HD13 ' A' ' 96' ' ' LEU . 31.8 m-90 -119.7 157.53 28.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.695 1.198 . . . . 0.0 108.751 174.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -76.53 -76.43 0.83 Allowed Glycine 0 C--N 1.341 0.815 0 O-C-N 123.177 0.298 . . . . 0.0 112.987 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.92 -42.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 109.626 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.1 113.95 3.58 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.787 -172.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 t -96.41 108.67 21.25 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.832 0.825 . . . . 0.0 109.391 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 106.11 4.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.293 -175.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.47 125.28 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 26.0 m -120.04 104.42 10.12 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.409 HG22 ' HB2' ' A' ' 91' ' ' ASP . 57.8 t -89.23 105.79 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 121.862 -0.523 . . . . 0.0 110.365 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 m -58.74 139.27 56.44 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.46 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.9 m -72.54 91.14 1.38 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 125.668 1.587 . . . . 0.0 113.111 177.646 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.35 129.68 48.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.479 0.712 . . . . 0.0 109.667 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.429 HD22 ' SG ' ' A' ' 23' ' ' CYS . 89.7 mt -124.94 107.61 11.03 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.6 t -98.89 101.74 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 22' ' ' SER . 47.1 mt-10 -100.9 143.97 30.41 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.11 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.9 p -160.54 157.79 28.03 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.091 0.957 . . . . 0.0 109.792 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' O ' HD13 ' A' ' 19' ' ' LEU . . . 130.85 -32.27 3.05 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA2' HG13 ' A' ' 119' ' ' VAL . . . -59.09 127.96 46.43 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.27 -178.45 46.06 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 120' ' ' THR . 22.8 tp -88.18 109.51 19.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.86 0.464 . . . . 0.0 109.798 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.468 HG11 HD11 ' A' ' 19' ' ' LEU . 18.5 m -126.68 151.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.089 0.956 . . . . 0.0 109.373 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -75.64 151.11 37.83 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.438 0.563 . . . . 0.0 111.259 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB1' HD22 ' A' ' 124' ' ' LEU . . . -64.11 125.09 23.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.156 0.982 . . . . 0.0 110.407 175.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.18 -20.26 26.22 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 123.814 0.721 . . . . 0.0 111.35 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.62 -166.94 9.88 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 121.598 0.554 . . . . 0.0 113.618 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.4 p -133.01 132.73 42.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.013 0.925 . . . . 0.0 109.395 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.468 HD11 HG11 ' A' ' 13' ' ' VAL . 25.5 tp -134.95 118.76 17.22 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -97.65 120.8 38.69 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.128 0.571 . . . . 0.0 109.693 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.475 HD23 ' HE2' ' A' ' 84' ' ' MET . 2.5 mm? -86.9 157.26 19.55 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.199 0.6 . . . . 0.0 109.394 172.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 18.6 p -145.92 126.11 13.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.845 0.858 . . . . 0.0 109.191 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 52.5 t -123.19 107.54 11.83 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.468 1.107 . . . . 0.0 108.901 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 21.2 t -89.24 115.22 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.642 0.777 . . . . 0.0 109.023 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.19 103.23 15.87 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p 54.66 36.74 26.79 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.707 1.603 . . . . 0.0 112.381 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.94 -107.94 2.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.69 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -118.79 10.98 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.009 0.924 . . . . 0.0 110.288 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -81.78 146.99 29.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -104.21 115.75 30.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -151.35 10.76 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.883 1.673 . . . . 0.0 108.847 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 p -86.99 88.52 7.72 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.224 1.01 . . . . 0.0 110.453 -174.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.74 -48.7 53.07 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.555 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.86 126.95 1.03 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.338 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.418 ' HE1' ' NH1' ' A' ' 73' ' ' ARG . 1.8 mpp? -125.44 119.76 29.15 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.657 1.183 . . . . 0.0 108.337 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -103.49 140.39 14.87 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -87.71 125.26 34.3 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.61 148.55 49.78 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -126.56 139.09 53.47 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.81 130.0 53.07 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.92 154.53 83.0 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -53.73 102.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.448 2.099 . . . . 0.0 112.41 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.99 23.21 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.931 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 6.9 mmpt? -133.44 170.41 15.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.83 0.824 . . . . 0.0 112.453 -174.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.24 176.46 6.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.982 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.48 37.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.61 125.65 40.61 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.36 110.26 4.02 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.18 -51.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.348 0.659 . . . . 0.0 109.64 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.69 170.04 22.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.212 0.605 . . . . 0.0 111.706 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -154.59 120.2 5.14 Favored 'General case' 0 C--O 1.25 1.126 0 C-N-CA 124.053 0.941 . . . . 0.0 110.131 173.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.602 HG22 ' HB3' ' A' ' 58' ' ' SER . 4.0 mp -122.65 116.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.392 1.077 . . . . 0.0 109.045 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.578 0 C-N-CA 123.091 0.556 . . . . 0.0 109.636 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.602 ' HB3' HG22 ' A' ' 52' ' ' ILE . 20.3 m . . . . . 0 CA--C 1.55 0.944 0 CA-C-O 121.457 0.646 . . . . 0.0 112.166 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -157.21 123.49 4.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.954 0.901 . . . . 0.0 109.883 -166.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.44 ' CD2' ' HB1' ' A' ' 51' ' ' ALA . 25.8 m-85 -158.5 135.83 10.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.943 0.897 . . . . 0.0 109.167 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.55 153.9 11.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.554 1.542 . . . . 0.0 108.889 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.38 151.36 32.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.425 0.69 . . . . 0.0 109.789 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.2 -33.28 69.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.487 0.715 . . . . 0.0 111.498 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 m -66.82 -29.91 69.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.318 1.047 . . . . 0.0 112.208 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.48 -7.12 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.347 0.659 . . . . 0.0 111.869 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.05 122.48 17.49 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.603 0.761 . . . . 0.0 110.544 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.35 -28.54 14.05 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.666 0.604 . . . . 0.0 111.979 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.458 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 10.1 mtm180 -88.97 -52.89 4.85 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -91.39 131.6 36.77 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.722 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -140.9 150.21 42.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.458 1.103 . . . . 0.0 108.461 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.29 144.01 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.147 0.579 . . . . 0.0 110.491 178.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -144.13 134.4 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.101 0.96 . . . . 0.0 109.05 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.512 ' HB2' HG21 ' A' ' 52' ' ' ILE . 46.4 ttt180 -111.9 125.05 53.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.012 0.525 . . . . 0.0 110.363 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.51 ' HB3' ' HE3' ' A' ' 77' ' ' LYS . 60.6 m-20 -103.0 94.64 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.61 -26.07 67.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.824 0.85 . . . . 0.0 111.936 -173.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.58 73.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.678 0.791 . . . . 0.0 112.27 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -118.59 8.18 11.93 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.582 0.753 . . . . 0.0 110.528 176.229 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 55.82 30.73 16.32 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.843 1.257 . . . . 0.0 112.851 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.4 m -111.39 130.46 55.69 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.26 138.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 108.702 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -117.27 139.62 50.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.896 0.878 . . . . 0.0 110.055 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.1 tp -113.78 97.64 6.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -84.06 100.67 11.24 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.475 ' HE2' HD23 ' A' ' 21' ' ' LEU . 36.6 mtm -94.07 126.47 39.31 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -122.69 167.14 13.82 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 68' ' ' ARG . 13.5 m 57.65 40.2 26.82 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.622 0.769 . . . . 0.0 110.42 173.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.7 mt -56.85 142.99 38.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.653 -170.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.59 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -105.68 151.22 39.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.29 -14.19 40.48 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.199 1.933 . . . . 0.0 112.683 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.59 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.72 -22.02 66.58 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.453 0.701 . . . . 0.0 111.565 173.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -78.28 23.62 0.28 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.822 0.849 . . . . 0.0 111.647 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.508 HG21 HG22 ' A' ' 120' ' ' THR . 99.0 m -82.79 92.54 7.26 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 163.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.02 -174.74 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.312 0.645 . . . . 0.0 111.106 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.93 112.04 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -85.45 108.73 18.02 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -112.18 138.45 48.84 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.977 0.911 . . . . 0.0 109.435 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 52.1 m -91.29 139.07 31.08 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.71 116.86 16.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.592 0.757 . . . . 0.0 109.136 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.87 152.96 27.35 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.104 0.562 . . . . 0.0 110.362 -173.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.573 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.831 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 CA--C 1.548 1.185 0 CA-C-O 121.016 0.34 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -97.22 -47.93 5.55 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.363 0.602 . . . . 0.0 109.705 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.07 144.17 40.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.73 1.212 . . . . 0.0 108.438 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -120.97 137.92 54.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.335 0.654 . . . . 0.0 109.247 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.03 -137.04 1.05 Allowed Glycine 0 C--N 1.346 1.117 0 O-C-N 123.338 0.399 . . . . 0.0 113.151 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -94.92 -30.89 13.92 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.073 0.549 . . . . 0.0 110.599 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.22 116.95 0.13 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.249 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -99.37 123.35 43.57 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 117.229 0.514 . . . . 0.0 110.489 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.39 101.48 6.38 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.261 1.024 . . . . 0.0 110.707 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.549 HG13 ' HA2' ' A' ' 10' ' ' GLY . 20.0 m -93.01 137.5 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 70.2 m -134.17 105.03 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.3 t -87.77 98.22 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 t -50.43 131.2 24.54 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.382 1.073 . . . . 0.0 111.742 172.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.6 p -76.4 82.52 3.13 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.057 0.543 . . . . 0.0 110.616 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.475 HD22 ' HB1' ' A' ' 15' ' ' ALA . 3.5 mm? . . . . . 0 N--CA 1.491 1.581 0 C-N-CA 125.007 1.323 . . . . 0.0 114.071 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -117.68 133.9 55.46 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.51 1.124 . . . . 0.0 108.812 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 94.3 mt -131.68 120.8 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.915 0.886 . . . . 0.0 109.381 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.47 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 23.2 t -98.42 104.88 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 108.537 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -104.66 151.08 24.12 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.369 0.668 . . . . 0.0 111.19 -168.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 p -157.15 170.75 21.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.658 0.783 . . . . 0.0 111.079 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.09 32.28 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.26 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA2' HG11 ' A' ' 119' ' ' VAL . . . -69.34 120.34 10.21 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 113.957 0.343 . . . . 0.0 113.957 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.76 179.48 48.78 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 120' ' ' THR . 10.2 tt -88.02 128.55 35.4 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.411 0.284 . . . . 0.0 110.288 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.58 152.53 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.25 150.99 35.31 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HB1' HD21 ' A' ' 124' ' ' LEU . . . -59.7 127.6 32.82 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 0.0 110.552 174.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.15 18.13 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.2 -179.22 52.46 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 122.873 0.273 . . . . 0.0 113.292 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -121.0 164.64 16.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.042 0.937 . . . . 0.0 110.563 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.4 tp -159.47 123.65 3.87 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.579 0.752 . . . . 0.0 109.982 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -99.32 129.58 45.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.06 0.544 . . . . 0.0 109.576 173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.42 HD22 ' HE2' ' A' ' 84' ' ' MET . 2.9 mm? -96.42 154.32 17.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.325 1.05 . . . . 0.0 109.007 171.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -143.54 128.74 18.74 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 30.8 t -137.74 104.61 5.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.46 0.704 . . . . 0.0 110.065 -172.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -84.75 145.28 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.812 . . . . 0.0 110.25 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HA ' HD23 ' A' ' 5' ' ' LEU . . . -89.98 100.43 13.25 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.124 0.57 . . . . 0.0 110.063 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p 56.46 -75.38 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.85 2.06 . . . . 0.0 112.457 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.74 -64.38 0.06 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -161.66 39.32 0.13 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.06 0.933 . . . . 0.0 109.451 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -107.36 151.04 26.04 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.49 ' HB3' HD22 ' A' ' 78' ' ' ASN . 19.5 p90 -105.29 126.31 51.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.813 0.845 . . . . 0.0 108.878 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -150.66 146.68 26.64 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.832 0.853 . . . . 0.0 109.074 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t 66.07 115.34 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.212 1.405 . . . . 0.0 111.183 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -80.67 7.83 9.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.4 0.68 . . . . 0.0 111.299 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.86 119.92 21.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.561 0.744 . . . . 0.0 109.306 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.8 mtt -137.38 119.9 16.0 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -125.29 142.46 13.82 Favored Glycine 0 N--CA 1.468 0.832 0 CA-C-N 118.102 0.41 . . . . 0.0 112.92 -172.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -86.06 117.89 25.19 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -117.02 171.34 7.99 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.922 1.289 . . . . 0.0 108.595 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -150.83 130.93 13.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.924 0.49 . . . . 0.0 110.029 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -110.56 128.83 55.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.12 39.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.493 0.717 . . . . 0.0 109.658 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.74 107.72 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.778 2.318 . . . . 0.0 113.119 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.49 1.52 66.24 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.552 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.4 mmpt? -114.98 173.43 6.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.223 1.009 . . . . 0.0 110.203 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.59 176.48 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.024 0.93 . . . . 0.0 110.425 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 124.01 24.51 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.172 0.51 . . . . 0.0 111.141 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.15 134.63 36.39 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.358 1.063 . . . . 0.0 109.366 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -71.11 109.36 5.14 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.812 0.695 . . . . 0.0 109.305 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.57 -53.24 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.81 174.75 10.3 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.922 -172.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.565 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -159.85 142.07 13.31 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.15 0.976 . . . . 0.0 112.014 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.521 HD13 ' HB ' ' A' ' 71' ' ' ILE . 4.0 mp -109.78 114.06 45.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.139 174.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 . . . . . 0 C--O 1.243 0.711 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 168.453 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 13.5 p . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -154.08 121.18 5.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.472 0.709 . . . . 0.0 110.021 -166.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.426 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 32.3 m-85 -158.25 154.58 27.44 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.764 1.626 . . . . 0.0 107.028 170.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -166.49 148.4 6.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.04 0.536 . . . . 0.0 110.368 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.01 25.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.6 -34.1 76.34 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -66.81 -18.44 65.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.696 0.798 . . . . 0.0 112.617 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.13 5.27 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.974 0.51 . . . . 0.0 111.662 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.19 131.68 51.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.544 0.738 . . . . 0.0 111.54 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 -28.32 4.57 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.167 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 88.9 mtm180 -92.67 -47.85 6.88 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.509 0.723 . . . . 0.0 110.158 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -87.84 122.62 31.7 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 m -124.99 133.54 52.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 108.446 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.521 ' HB ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -120.77 146.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 122.766 0.426 . . . . 0.0 110.636 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 p -159.37 151.51 20.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.602 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.467 ' HB3' HG21 ' A' ' 52' ' ' ILE . 52.6 ttt180 -128.36 123.42 33.83 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -105.22 103.23 12.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -76.82 -11.83 59.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.218 0.607 . . . . 0.0 111.49 -173.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.59 92.34 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 122.549 0.34 . . . . 0.0 111.861 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.39 1.9 16.2 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 117.99 0.359 . . . . 0.0 110.905 169.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.49 HD22 ' HB3' ' A' ' 30' ' ' PHE . 18.5 m120 58.56 66.66 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.843 1.257 . . . . 0.0 110.807 176.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.8 m -141.8 132.36 25.39 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.088 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.5 t -111.17 130.0 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.381 1.072 . . . . 0.0 108.965 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -113.23 148.68 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.729 0.812 . . . . 0.0 111.308 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 65.5 tp -132.0 98.07 4.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -87.73 100.53 12.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.726 ' HB3' HD21 ' A' ' 87' ' ' LEU . 48.2 mtm -94.34 142.18 27.71 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.591 0.757 . . . . 0.0 108.99 175.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 18.1 m120 -136.81 150.15 48.16 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.45 0.7 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 t 52.31 59.91 4.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 173.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -79.66 161.08 26.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.4 -171.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.1 153.4 61.15 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.8 -15.66 39.31 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.862 2.375 . . . . 0.0 115.04 -168.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -72.56 -14.66 61.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.106 0.563 . . . . 0.0 111.983 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.401 ' HB2' HG23 ' A' ' 121' ' ' VAL . 26.0 m-20 -82.15 19.52 1.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.403 0.681 . . . . 0.0 111.019 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 96.7 m -75.31 92.44 2.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 165.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.4 164.05 27.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.449 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.27 107.45 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.414 174.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -84.66 138.02 32.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 113' ' ' TRP . 1.7 pt? -150.2 139.75 21.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.935 0.494 . . . . 0.0 110.889 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.7 m -87.74 114.69 24.59 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 110' ' ' PRO . . . -107.78 117.01 33.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 108.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.18 116.83 31.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.481 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.491 -174.659 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.52 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 2.6 Cg_exo . . . . . 0 CA--C 1.548 1.203 0 N-CA-C 110.433 -0.641 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -91.29 -47.01 7.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.432 0.693 . . . . 0.0 110.336 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -125.78 158.53 34.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.773 . . . . 0.0 109.945 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.421 ' HB3' HD11 ' A' ' 96' ' ' LEU . 22.7 m-90 -128.0 152.72 47.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.559 1.144 . . . . 0.0 108.534 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.21 46.52 3.4 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.965 -173.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.47 ' NE2' ' HA ' ' A' ' 6' ' ' VAL . 46.2 mt-30 73.26 -45.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.633 1.573 . . . . 0.0 111.857 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.36 112.06 3.13 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -97.75 123.16 41.57 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 121.885 0.85 . . . . 0.0 109.965 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -80.35 103.76 10.44 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.243 1.017 . . . . 0.0 110.567 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.553 HG11 ' HA2' ' A' ' 10' ' ' GLY . 3.5 m -105.26 150.56 7.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 89.8 m -134.85 114.6 12.75 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 91' ' ' ASP . 40.8 t -92.42 105.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB2' HD11 ' A' ' 12' ' ' LEU . 15.0 t -73.72 158.02 35.43 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 120.667 0.27 . . . . 0.0 111.036 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.7 p -84.85 73.14 10.68 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.686 0.795 . . . . 0.0 110.667 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.512 HD21 ' HB1' ' A' ' 15' ' ' ALA . 3.9 mm? . . . . . 0 N--CA 1.49 1.571 0 C-N-CA 125.521 1.528 . . . . 0.0 113.765 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 32' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -112.19 127.83 56.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.653 0.781 . . . . 0.0 109.535 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.653 HD13 ' HG2' ' A' ' 35' ' ' MET . 96.4 mt -132.84 122.77 24.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.616 1.166 . . . . 0.0 109.703 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -106.48 102.29 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.02 145.1 27.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 p -160.88 168.09 25.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.852 0.861 . . . . 0.0 110.257 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.06 17.82 21.63 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 119' ' ' VAL . . . -78.32 134.81 14.76 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.14 -178.54 47.67 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.6 tt -98.37 131.78 44.38 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.918 0.487 . . . . 0.0 109.889 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.68 170.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.926 1.291 . . . . 0.0 107.907 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -90.77 154.04 19.81 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.742 0.417 . . . . 0.0 109.964 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' A' ' 124' ' ' LEU . . . -66.45 124.97 24.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.761 0.824 . . . . 0.0 110.567 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.36 -23.35 24.97 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.03 174.81 48.79 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.774 0.338 . . . . 0.0 112.371 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.0 p -106.11 162.76 13.34 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.372 0.669 . . . . 0.0 110.566 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.6 tp -159.8 121.82 3.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.063 0.945 . . . . 0.0 108.613 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -98.53 122.41 41.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.062 0.458 . . . . 0.0 110.165 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 117' ' ' THR . 3.8 mm? -94.82 145.32 24.97 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.071 0.949 . . . . 0.0 108.966 172.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 p -131.89 126.15 33.46 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.508 0.723 . . . . 0.0 109.15 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 43.2 t -122.73 108.94 13.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.619 1.167 . . . . 0.0 108.623 -177.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.24 129.69 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.135 0.974 . . . . 0.0 109.088 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . . . -87.1 100.96 13.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.6 p 64.62 -75.51 0.04 OUTLIER 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.533 1.933 . . . . 0.0 111.713 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.06 -62.78 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -166.81 67.45 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -138.89 162.08 35.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.377 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -103.9 122.16 44.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.765 0.826 . . . . 0.0 109.227 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.22 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.51 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 5.5 m -71.84 85.03 0.94 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.565 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 73' ' ' ARG . 24.1 p-10 -93.59 -27.07 16.82 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.666 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.3 120.12 15.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.788 -171.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.653 ' HG2' HD13 ' A' ' 5' ' ' LEU . 4.5 mtm -150.82 141.84 23.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.222 1.409 . . . . 0.0 108.837 -175.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.64 136.44 11.06 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 76.2 m95 -86.72 130.12 34.6 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.532 0.666 . . . . 0.0 110.319 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -123.06 171.75 9.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.96 1.304 . . . . 0.0 108.261 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -143.23 131.37 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 168.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -102.5 130.9 49.46 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 44' ' ' LYS . . . -115.99 149.56 43.55 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.007 0.523 . . . . 0.0 110.054 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.27 100.6 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.385 2.056 . . . . 0.0 111.367 172.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.78 5.66 56.5 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.964 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.596 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 7.4 mmpt? -138.76 137.89 37.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.723 0.809 . . . . 0.0 109.623 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.32 171.6 5.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.766 0.826 . . . . 0.0 111.555 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.04 124.88 21.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.289 0.566 . . . . 0.0 111.317 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -93.83 126.47 39.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -76.0 106.63 7.7 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -94.95 -48.63 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.541 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . . . -151.19 164.14 37.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -170.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -152.68 134.9 14.98 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.923 0.868 . . . . 0.0 111.442 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.51 118.33 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 123.258 0.623 . . . . 0.0 109.47 -177.973 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -156.86 124.3 5.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -165.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.407 ' H ' HD12 ' A' ' 71' ' ' ILE . 5.5 t80 -169.52 117.28 0.61 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.512 ' HB2' HG23 ' A' ' 65' ' ' VAL . 4.8 p90 -164.87 151.92 11.0 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.935 0.894 . . . . 0.0 109.207 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.98 31.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.346 0.658 . . . . 0.0 110.885 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.58 -28.07 68.88 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.368 0.667 . . . . 0.0 110.439 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.8 p -68.32 -28.57 67.27 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.443 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 61' ' ' TYR . 29.3 m -116.37 19.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.615 0.766 . . . . 0.0 111.272 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -67.82 120.63 14.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.9 0.88 . . . . 0.0 110.483 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -20.83 26.27 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 68.6 mtp180 -85.68 -70.08 0.62 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 110.071 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -86.2 120.86 28.02 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 m -130.2 140.58 50.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.212 1.005 . . . . 0.0 108.615 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.421 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -122.53 147.06 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.535 0.734 . . . . 0.0 109.324 175.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -147.0 133.5 19.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.539 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 33' ' ' ASN . 51.2 ttt-85 -114.7 124.84 52.83 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -103.52 110.87 23.08 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -74.98 -20.18 59.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.556 0.742 . . . . 0.0 111.904 -175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.86 78.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.603 0.361 . . . . 0.0 111.727 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.93 -5.68 10.56 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.319 171.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 25' ' ' ALA . 11.4 m-80 60.75 70.37 0.62 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.007 0.923 . . . . 0.0 110.524 -174.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.0 m -138.17 131.68 30.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.36 135.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.745 0.818 . . . . 0.0 109.594 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -121.0 115.01 22.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.836 0.854 . . . . 0.0 109.508 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 tp -92.35 97.79 11.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -85.17 100.94 12.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.45 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.61 ' SD ' HD22 ' A' ' 87' ' ' LEU . 56.6 mtt -84.23 126.59 33.29 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -129.41 137.31 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 t 58.76 73.11 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.593 0.711 . . . . 0.0 110.304 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.61 HD22 ' SD ' ' A' ' 84' ' ' MET . 22.6 mt -75.53 162.5 28.25 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.287 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -125.99 149.16 65.43 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.524 1.129 . . . . 0.0 108.458 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.47 -13.7 40.08 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.956 2.437 . . . . 0.0 112.739 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.43 -28.63 69.81 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.591 1.157 . . . . 0.0 111.891 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -74.92 14.97 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.418 0.687 . . . . 0.0 112.375 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.487 HG21 HG21 ' A' ' 120' ' ' THR . 92.5 m -73.33 89.41 1.59 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 158.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.96 173.37 3.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.722 1.209 . . . . 0.0 109.389 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.26 115.8 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -83.62 133.23 34.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.494 0.718 . . . . 0.0 109.227 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -139.81 120.9 14.71 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.461 0.704 . . . . 0.0 109.891 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 35' ' ' MET . 46.8 t -89.37 116.14 27.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.75 158.67 23.49 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.13 0.972 . . . . 0.0 110.534 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -116.62 139.59 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.081 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.232 -178.466 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 N--CA 1.495 1.576 0 N-CA-C 114.028 0.742 . . . . 0.0 114.028 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.24 -47.95 22.06 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.201 0.524 . . . . 0.0 110.069 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.557 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 64.6 m-85 -111.84 147.24 36.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.27 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -126.13 146.23 50.02 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 167.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -70.42 -84.13 0.18 Allowed Glycine 0 C--N 1.339 0.744 0 O-C-N 123.664 0.602 . . . . 0.0 113.765 -176.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.26 -46.13 0.14 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -176.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.6 95.13 1.32 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.523 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.412 HG21 HD11 ' A' ' 21' ' ' LEU . 7.2 t -97.85 121.63 40.0 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.532 0.733 . . . . 0.0 110.409 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.36 117.88 20.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.845 0.858 . . . . 0.0 109.097 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.416 HG13 ' HA2' ' A' ' 10' ' ' GLY . 33.5 m -118.38 141.81 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.428 0.691 . . . . 0.0 109.23 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 33.6 m -129.23 104.34 7.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 87' ' ' LEU . 52.6 t -94.17 98.11 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.8 t -66.32 150.25 49.13 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.726 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.4 m -71.14 165.36 23.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.925 0.89 . . . . 0.0 111.463 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.404 HD22 ' HB1' ' A' ' 15' ' ' ALA . 2.8 mm? . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -119.89 108.38 14.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.586 HD22 ' HB2' ' A' ' 99' ' ' ALA . 2.9 mm? -96.38 109.02 21.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.01 104.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -76.96 155.83 32.39 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.512 0.673 . . . . 0.0 111.209 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 p -155.33 154.06 31.46 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 108.695 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.52 -2.63 56.09 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -69.57 105.49 1.54 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.55 27.2 Favored Glycine 0 C--O 1.245 0.8 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 122' ' ' SER . 9.8 tt -88.31 137.09 32.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 m -136.37 168.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.694 1.198 . . . . 0.0 109.213 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.5 151.58 22.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.575 0.75 . . . . 0.0 110.724 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.25 141.55 52.43 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 123.32 0.648 . . . . 0.0 110.384 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.49 13.72 Favored Glycine 0 N--CA 1.464 0.545 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.09 -172.25 46.04 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 112.161 -0.375 . . . . 0.0 112.161 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 p -123.18 164.08 19.38 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.301 0.64 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.4 tp -148.25 127.75 13.19 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -108.28 113.2 26.12 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.532 0.733 . . . . 0.0 109.336 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -84.27 153.39 23.59 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.5 p -142.14 122.06 13.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.889 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.4 ' SG ' HD11 ' A' ' 5' ' ' LEU . 43.7 t -105.71 111.89 24.75 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.97 0.908 . . . . 0.0 109.486 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.65 118.96 32.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.51 99.44 12.44 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.497 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 22.7 t 59.53 39.45 21.6 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.903 1.281 . . . . 0.0 111.355 173.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.18 -69.69 2.2 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -162.23 87.13 0.62 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.33 1.052 . . . . 0.0 108.491 166.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 50.1 m -140.37 139.91 35.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 109.227 175.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -106.35 141.29 37.91 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -157.41 -49.06 0.07 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -98.39 133.8 42.28 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.909 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -97.78 -0.02 46.03 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.134 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.47 51.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.472 1.109 . . . . 0.0 108.472 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.631 ' SD ' ' HD2' ' A' ' 73' ' ' ARG . 47.2 mtt -150.68 168.32 24.69 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.515 1.526 . . . . 0.0 109.689 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.89 -171.99 32.73 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -132.86 133.28 43.11 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.72 155.24 35.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.382 1.073 . . . . 0.0 108.718 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -123.45 136.33 54.55 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.206 0.526 . . . . 0.0 110.407 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.543 ' HB2' HG11 ' A' ' 94' ' ' VAL . 21.8 mm-40 -106.01 154.6 20.38 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.894 1.277 . . . . 0.0 108.254 172.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 44' ' ' LYS . . . -141.79 154.78 66.14 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.568 0.747 . . . . 0.0 109.235 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.12 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.384 2.722 . . . . 0.0 114.102 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.9 20.2 78.08 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.649 -0.705 . . . . 0.0 114.288 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 10.5 mmpt? -129.87 145.32 51.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.951 0.901 . . . . 0.0 109.904 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.2 168.83 18.81 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.347 1.059 . . . . 0.0 111.854 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 143.1 46.7 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.28 139.11 51.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.158 0.583 . . . . 0.0 109.701 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.503 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 92.1 t80 -71.95 110.08 6.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.247 1.019 . . . . 0.0 109.61 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.27 -40.43 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.737 -174.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.58 160.28 40.22 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -143.24 125.14 15.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.33 1.052 . . . . 0.0 110.228 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.58 121.16 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.158 1.383 . . . . 0.0 108.11 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 N--CA 1.475 0.818 0 C-N-CA 123.54 0.736 . . . . 0.0 110.579 -177.807 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.431 ' HA ' HD13 ' A' ' 71' ' ' ILE . 18.1 p -152.86 131.44 12.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.958 0.503 . . . . 0.0 110.672 -169.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.437 ' H ' HD13 ' A' ' 71' ' ' ILE . 11.0 t80 -160.7 132.82 6.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 168.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.407 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 20.1 p90 -159.57 157.88 30.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.178 0.991 . . . . 0.0 110.144 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.51 156.97 30.63 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.485 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 37.9 t70 -70.76 -20.82 62.58 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.731 0.301 . . . . 0.0 110.4 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.0 m -61.82 -36.7 81.91 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.528 0.731 . . . . 0.0 111.063 172.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.85 15.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -60.27 124.83 21.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.227 0.611 . . . . 0.0 109.83 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.77 -28.49 7.06 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 123.734 0.646 . . . . 0.0 112.597 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.583 HH21 ' HA ' ' A' ' 87' ' ' LEU . 66.3 mtp180 -76.36 -46.06 29.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.099 0.952 . . . . 0.0 109.326 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 61' ' ' TYR . 24.3 t80 -91.42 128.55 37.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.999 -166.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 42.1 m -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.35 1.06 . . . . 0.0 108.46 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -141.2 144.15 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.845 0.858 . . . . 0.0 109.131 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.9 m -151.97 142.07 22.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.617 0.767 . . . . 0.0 109.907 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.631 ' HD2' ' SD ' ' A' ' 35' ' ' MET . 18.2 ttt85 -110.17 127.45 54.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 170.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -103.08 132.39 49.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.472 0.709 . . . . 0.0 109.187 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.89 -27.05 21.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 112.69 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.89 94.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.705 0.802 . . . . 0.0 112.049 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.6 5.17 13.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.322 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 49.99 68.03 0.81 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.737 1.215 . . . . 0.0 111.67 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.1 m -136.16 133.44 37.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.129 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.44 147.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -126.99 141.19 51.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.023 0.529 . . . . 0.0 110.252 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.723 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.4 tp -127.25 96.28 4.54 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.485 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 24.9 tp60 -96.08 100.65 12.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.0 mtm -102.93 112.91 25.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.577 0.751 . . . . 0.0 109.017 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -102.79 165.58 10.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.128 0.971 . . . . 0.0 110.225 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.525 ' HB2' ' HG2' ' A' ' 68' ' ' ARG . 10.6 m 54.17 45.0 28.32 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 124.158 0.911 . . . . 0.0 111.384 171.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.583 ' HA ' HH21 ' A' ' 68' ' ' ARG . 82.2 mt -63.59 146.1 54.39 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.701 -168.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.465 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 29.4 mmmt -96.27 141.62 23.38 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.917 1.287 . . . . 0.0 108.6 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.85 -23.92 61.52 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.37 2.046 . . . . 0.0 113.216 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -72.24 -7.69 50.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.899 0.88 . . . . 0.0 112.316 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -84.77 38.2 0.69 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.802 0.841 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.2 m -90.84 100.52 13.36 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 171.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.76 -171.39 3.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.643 0.777 . . . . 0.0 110.273 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.543 HG11 ' HB2' ' A' ' 40' ' ' GLN . 1.5 p -123.77 106.03 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -90.98 146.84 23.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.626 0.77 . . . . 0.0 110.965 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 113' ' ' TRP . 2.0 pp -144.28 153.72 42.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.236 1.014 . . . . 0.0 109.41 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.8 148.21 22.53 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.05 148.49 31.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.106 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.586 ' HB2' HD22 ' A' ' 5' ' ' LEU . . . -155.85 135.76 12.76 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.394 0.678 . . . . 0.0 109.685 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 O-C-N 123.876 0.735 . . . . 0.0 111.441 171.004 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 CA--C 1.546 1.11 0 CA-C-O 121.231 0.43 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.34 -42.68 99.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.296 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -142.01 125.68 16.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.693 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.439 ' HB3' HD12 ' A' ' 96' ' ' LEU . 5.7 m-90 -94.03 155.11 17.29 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.85 171.55 52.02 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.191 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.22 -21.14 66.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.934 0.894 . . . . 0.0 112.059 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.05 127.79 1.22 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.451 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 11.1 t -125.61 138.47 53.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.127 0.571 . . . . 0.0 110.254 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.458 HE21 ' HB ' ' A' ' 94' ' ' VAL . 6.9 mm-40 -80.44 101.69 9.2 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.614 0.766 . . . . 0.0 111.449 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.0 m -99.25 130.57 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 170.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 82.9 m -135.11 110.7 9.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.7 104.61 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.939 -0.476 . . . . 0.0 109.779 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.499 ' HB2' HD22 ' A' ' 12' ' ' LEU . 35.2 t -61.88 155.43 23.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.584 0.754 . . . . 0.0 112.045 168.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 t -85.47 71.45 10.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.162 0.585 . . . . 0.0 109.644 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.494 1.732 0 C-N-CA 125.068 1.347 . . . . 0.0 114.26 173.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -107.58 146.18 32.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.346 1.058 . . . . 0.0 108.968 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.552 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 94.5 mt -125.63 108.17 11.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.67 107.52 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -102.98 154.84 18.83 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.691 0.619 . . . . 0.0 111.72 -170.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -157.68 158.8 36.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.4 1.08 . . . . 0.0 109.133 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.12 -2.99 29.91 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.827 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA2' HG13 ' A' ' 119' ' ' VAL . . . -72.24 83.33 0.53 Allowed Glycine 0 C--N 1.35 1.322 0 CA-C-N 117.173 0.486 . . . . 0.0 112.725 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.86 177.03 17.19 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.0 tt -92.54 114.14 26.61 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.424 HG23 HD11 ' A' ' 87' ' ' LEU . 35.9 m -113.34 171.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -94.4 158.07 15.73 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.15 0.58 . . . . 0.0 109.919 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB3' ' HD3' ' A' ' 89' ' ' PRO . . . -62.76 116.83 5.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.756 0.822 . . . . 0.0 110.571 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.43 22.8 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.602 0.564 . . . . 0.0 111.988 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.65 55.24 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 121.275 0.375 . . . . 0.0 113.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 p -109.4 165.7 11.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 110.685 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.7 tp -158.33 141.03 14.58 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -114.26 113.16 24.24 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.175 0.512 . . . . 0.0 110.15 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -87.72 149.17 24.39 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 109.332 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.2 p -145.22 126.79 15.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.798 0.839 . . . . 0.0 109.346 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 43.5 t -135.28 130.31 34.93 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 109.735 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.56 146.14 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.97 99.02 11.57 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t 53.37 40.65 31.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.297 1.439 . . . . 0.0 112.352 171.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.03 -61.08 4.36 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.027 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -168.54 33.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.03 1.332 . . . . 0.0 109.803 172.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -119.93 121.28 38.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.326 0.651 . . . . 0.0 109.945 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -133.43 150.67 51.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 110.371 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mtt85 -166.92 72.23 0.12 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 107.779 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.6 m -147.71 129.69 15.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.765 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.95 -43.71 21.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.88 0.472 . . . . 0.0 111.894 -171.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.39 169.5 9.26 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.569 0.347 . . . . 0.0 110.318 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.481 ' SD ' HG22 ' A' ' 80' ' ' VAL . 58.2 mtt -148.98 165.39 31.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.533 1.133 . . . . 0.0 109.006 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -155.8 -174.82 26.08 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-O 119.993 -0.337 . . . . 0.0 112.264 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -143.6 118.87 10.18 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.659 1.184 . . . . 0.0 108.455 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.52 162.87 14.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.411 1.084 . . . . 0.0 108.824 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -121.61 133.98 54.99 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.505 ' HB3' HG12 ' A' ' 94' ' ' VAL . 9.9 tm0? -107.84 128.97 55.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 44' ' ' LYS . . . -111.78 141.2 24.27 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.552 0.741 . . . . 0.0 109.015 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.82 114.1 2.01 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.597 2.198 . . . . 0.0 112.391 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.51 79.78 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.492 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -119.09 173.58 6.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.571 1.148 . . . . 0.0 108.943 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.49 166.46 15.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.843 0.354 . . . . 0.0 110.622 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.92 115.55 11.26 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.343 0.592 . . . . 0.0 109.746 170.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -92.63 141.57 28.34 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.082 0.953 . . . . 0.0 109.892 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -77.58 116.47 18.16 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.63 0.581 . . . . 0.0 109.535 -178.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.18 -59.59 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.584 0.754 . . . . 0.0 110.072 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB3' HD12 ' A' ' 71' ' ' ILE . . . -148.79 163.45 37.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.449 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -157.25 164.72 37.4 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.362 1.077 . . . . 0.0 112.226 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 96.4 mt -109.2 116.77 52.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.31 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 . . . . . 0 C--N 1.351 0.653 0 O-C-N 124.19 0.931 . . . . 0.0 108.992 176.38 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 9.5 t . . . . . 0 CA--C 1.549 0.939 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.39 117.68 1.15 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.713 0.805 . . . . 0.0 109.573 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -171.02 128.21 0.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.206 2.202 . . . . 0.0 105.924 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.15 146.21 7.43 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.041 0.936 . . . . 0.0 109.708 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.95 156.43 38.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.682 0.793 . . . . 0.0 109.981 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -60.32 -26.73 66.79 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.474 0.71 . . . . 0.0 112.135 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.2 t -65.55 -39.02 91.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.764 0.826 . . . . 0.0 111.089 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.09 12.33 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.878 0.871 . . . . 0.0 111.268 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -66.78 120.75 14.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.144 0.978 . . . . 0.0 110.799 -173.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.63 5.49 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.305 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -77.51 -55.36 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.14 120.3 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.2 m -129.44 138.13 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -116.23 142.49 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -137.17 133.07 34.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.556 ' HB2' HD11 ' A' ' 52' ' ' ILE . 78.3 ttt180 -115.27 122.41 45.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.46 90.65 3.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -69.93 -13.26 62.16 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.01 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.61 77.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.343 1.057 . . . . 0.0 111.988 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.19 11.86 12.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.884 0.474 . . . . 0.0 110.794 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.28 28.62 15.78 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.833 1.253 . . . . 0.0 112.091 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.5 m -114.37 131.75 56.45 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.306 0.642 . . . . 0.0 110.287 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.481 HG22 ' SD ' ' A' ' 35' ' ' MET . 79.0 t -108.58 150.05 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.41 1.484 . . . . 0.0 108.946 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -131.02 151.62 51.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.643 0.777 . . . . 0.0 110.745 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 55.7 tp -132.22 101.36 5.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 108.521 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -85.97 101.14 12.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.469 ' SD ' HD22 ' A' ' 87' ' ' LEU . 39.9 mtt -83.33 139.58 32.95 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.109 0.964 . . . . 0.0 109.2 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -138.23 138.11 38.18 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 t 58.4 72.34 0.53 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.629 1.172 . . . . 0.0 110.451 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.469 HD22 ' SD ' ' A' ' 84' ' ' MET . 42.3 mt -82.62 144.8 30.06 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.574 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -87.18 150.29 49.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.734 0.814 . . . . 0.0 109.38 -176.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 15' ' ' ALA . 29.1 Cg_endo -62.83 -23.63 74.36 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 C-N-CA 121.726 1.617 . . . . 0.0 110.891 169.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.04 -31.73 69.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.696 1.598 . . . . 0.0 111.775 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.37 22.43 0.84 Allowed 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.607 0.717 . . . . 0.0 111.632 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -77.85 92.28 4.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 161.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.53 169.97 21.87 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.023 0.929 . . . . 0.0 109.694 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -97.69 107.82 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -82.06 150.81 27.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.401 0.681 . . . . 0.0 109.445 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.78 140.26 21.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.354 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.578 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 14.7 p -89.7 149.92 22.55 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 110' ' ' PRO . . . -112.12 158.45 19.6 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.556 0.742 . . . . 0.0 109.71 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -139.33 137.71 36.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -176.839 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 17.4 Cg_exo . . . . . 0 CA--C 1.547 1.127 0 N-CA-C 111.318 -0.301 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -92.59 -12.05 32.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.312 0.645 . . . . 0.0 111.271 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 9.9 m-85 -128.55 149.25 50.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -138.92 163.98 30.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.623 0.769 . . . . 0.0 109.969 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.552 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -76.09 174.57 53.11 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.633 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -73.89 -28.11 61.39 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.987 0.515 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.06 100.81 2.66 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.378 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -96.2 106.81 19.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.078 0.942 . . . . 0.0 108.572 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -78.7 101.38 7.5 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.244 -172.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.515 HG13 ' HA2' ' A' ' 10' ' ' GLY . 19.8 m -91.04 137.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.0 m -124.46 102.98 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.32 94.73 4.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -64.43 142.43 58.42 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.0 p -70.48 88.58 0.67 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.75 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.492 1.657 0 C-N-CA 126.565 1.946 . . . . 0.0 113.361 174.57 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -75.39 144.4 42.28 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.126 0.571 . . . . 0.0 110.08 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.26 110.39 11.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.968 0.414 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.19 106.3 16.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.65 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 93.1 mt -93.42 105.6 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.865 0.466 . . . . 0.0 109.862 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t -98.75 104.19 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.14 146.78 24.38 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.338 0.655 . . . . 0.0 111.376 -171.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 p -149.82 158.01 43.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.213 1.005 . . . . 0.0 109.877 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.71 -0.75 42.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.237 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.95 118.68 9.86 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-O 120.241 -0.2 . . . . 0.0 112.662 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.36 -167.12 29.47 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.3 tt -105.21 124.28 49.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.821 0.449 . . . . 0.0 110.513 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 19' ' ' LEU . 28.0 m -118.67 163.03 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.345 1.058 . . . . 0.0 108.744 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 5.7 pm0 -88.89 155.55 19.46 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.065 0.546 . . . . 0.0 109.979 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.87 111.7 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.866 0.866 . . . . 0.0 110.745 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.02 -14.17 23.91 Favored Glycine 0 N--CA 1.474 1.181 0 O-C-N 123.273 0.358 . . . . 0.0 113.042 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.37 170.99 51.29 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 120.111 -0.272 . . . . 0.0 112.457 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -105.57 138.85 41.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.512 0.725 . . . . 0.0 110.626 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.435 ' HB2' HG13 ' A' ' 13' ' ' VAL . 38.8 tp -132.51 130.94 41.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.683 1.193 . . . . 0.0 109.152 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -111.97 127.51 55.89 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.833 0.853 . . . . 0.0 109.573 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.7 mm? -99.61 149.31 23.41 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 108.957 170.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 p -138.26 124.05 19.9 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.65 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 49.2 t -116.77 101.96 9.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.895 0.878 . . . . 0.0 109.409 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.87 121.29 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.52 99.43 12.29 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.79 0.436 . . . . 0.0 110.374 -173.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.456 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 18.4 m 58.87 35.72 24.33 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.076 1.35 . . . . 0.0 112.108 173.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.79 -58.63 4.81 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.993 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 31.9 ttp-105 -173.47 77.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.668 1.187 . . . . 0.0 108.014 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.5 m -139.77 147.89 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.567 0.747 . . . . 0.0 110.293 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' A' ' 78' ' ' ASN . 11.6 p90 -128.18 136.95 51.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 0.0 110.103 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -169.67 12.93 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.0 0.92 . . . . 0.0 109.098 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.483 ' HG ' ' HG2' ' A' ' 35' ' ' MET . 20.8 t -108.79 108.6 19.47 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.398 0.679 . . . . 0.0 109.992 -172.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -88.83 -23.72 22.76 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.737 0.815 . . . . 0.0 110.66 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.43 123.47 29.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.005 0.922 . . . . 0.0 109.04 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.483 ' HG2' ' HG ' ' A' ' 32' ' ' SER . 40.0 mtm -132.28 166.18 22.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.233 1.013 . . . . 0.0 109.719 -177.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -154.6 179.81 30.42 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.288 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -138.38 130.31 28.26 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.549 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 64.9 m-85 -135.48 152.63 51.54 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 109.262 -173.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 13.7 ptp180 -107.39 141.51 38.66 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB3' HG12 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -132.5 145.43 51.16 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -176.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 44' ' ' LYS . . . -144.6 155.17 56.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.69 105.94 0.25 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.315 2.01 . . . . 0.0 111.83 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.05 -17.04 56.73 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.558 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 9.8 mmpt? -111.87 131.86 55.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.62 0.768 . . . . 0.0 110.326 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.68 170.64 14.09 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.009 0.924 . . . . 0.0 111.763 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -67.28 119.02 11.46 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.712 -177.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -103.68 136.85 42.61 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.961 0.904 . . . . 0.0 109.997 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -62.97 115.82 4.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.688 1.195 . . . . 0.0 111.539 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.4 t -102.46 -48.16 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.011 0.924 . . . . 0.0 109.281 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -153.11 168.45 25.89 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.434 0.694 . . . . 0.0 111.623 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.598 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -153.98 138.47 16.8 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.467 0.651 . . . . 0.0 111.423 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.652 HG23 ' HB2' ' A' ' 73' ' ' ARG . 72.3 mt -127.01 124.76 65.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.069 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.423 HH21 ' HA ' ' A' ' 108' ' ' ASP . 63.1 mtt180 -113.86 178.3 4.33 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 110.849 174.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.0 t90 -67.39 95.36 0.44 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.074 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.8 t 63.01 -173.25 0.16 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.395 1.078 . . . . 0.0 111.869 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.09 -19.54 53.61 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 122.278 -0.264 . . . . 0.0 113.745 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.38 -63.62 0.46 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.578 ' HB3' HG21 ' A' ' 52' ' ' ILE . 38.4 m 62.9 69.77 0.58 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.182 0.993 . . . . 0.0 112.114 170.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.519 ' HA ' HD13 ' A' ' 71' ' ' ILE . 12.4 p -163.9 122.54 1.92 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.45 1.1 . . . . 0.0 109.704 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.529 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 93.8 m-85 -150.15 147.84 28.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.482 1.113 . . . . 0.0 108.603 174.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CD1' ' HA ' ' A' ' 66' ' ' LYS . 26.3 p90 -164.53 158.04 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.152 0.981 . . . . 0.0 109.649 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.0 157.63 28.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 110.631 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.43 -37.69 88.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.632 0.773 . . . . 0.0 110.985 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -70.2 -16.06 63.02 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.912 0.885 . . . . 0.0 112.635 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 62' ' ' ALA . 31.5 m -125.06 20.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.777 0.831 . . . . 0.0 110.551 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 4.3 ttmp? -48.92 113.55 0.81 Allowed 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.156 1.383 . . . . 0.0 113.072 -175.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.28 -28.91 4.97 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.275 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -71.49 -44.85 63.96 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.546 0.688 . . . . 0.0 109.546 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.62 121.88 28.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.563 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.2 m -134.94 149.8 50.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.388 1.475 . . . . 0.0 107.905 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.585 ' HB ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.12 152.65 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.636 -177.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 t -151.47 145.23 25.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.608 0.763 . . . . 0.0 110.024 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.652 ' HB2' HG23 ' A' ' 52' ' ' ILE . 28.7 ttt180 -110.57 122.93 48.97 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.5 86.96 2.59 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -79.82 -11.91 59.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.341 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -35.95 73.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.817 0.847 . . . . 0.0 111.831 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.02 1.39 11.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.921 0.488 . . . . 0.0 111.212 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 19.3 m120 57.74 67.49 0.96 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.772 1.229 . . . . 0.0 110.885 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.3 m -139.04 131.76 29.03 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.898 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.6 t -108.82 125.02 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.29 134.13 48.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.791 0.436 . . . . 0.0 111.359 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 57.1 tp -115.64 97.14 5.97 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -92.6 98.5 11.48 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.517 ' HE1' HD21 ' A' ' 87' ' ' LEU . 75.9 mtm -98.25 111.56 23.85 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -100.4 138.37 37.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.6 t 58.56 72.04 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.308 1.043 . . . . 0.0 110.572 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.517 HD21 ' HE1' ' A' ' 84' ' ' MET . 5.4 mp -77.88 144.68 36.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.605 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -87.0 153.87 54.76 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.24 -18.45 64.94 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.944 1.763 . . . . 0.0 112.654 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.16 3.68 41.78 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.733 0.813 . . . . 0.0 112.134 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.85 26.38 1.82 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.557 0.743 . . . . 0.0 109.971 167.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.497 HG22 HG23 ' A' ' 120' ' ' THR . 95.9 m -83.25 94.0 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 166.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.93 -169.29 2.33 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.71 0.804 . . . . 0.0 110.047 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 40' ' ' GLN . 3.0 p -114.84 110.7 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.441 0.697 . . . . 0.0 109.191 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -84.38 153.14 23.62 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.111 0.564 . . . . 0.0 109.683 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.41 147.5 31.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.368 0.667 . . . . 0.0 110.26 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.9 t -88.53 161.62 16.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.775 0.83 . . . . 0.0 109.244 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 110' ' ' PRO . . . -122.7 158.22 30.57 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.045 0.538 . . . . 0.0 109.586 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -152.44 167.2 29.52 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.2 1.0 . . . . 0.0 109.515 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.52 -159.91 28.19 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.0 m -124.08 167.73 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.474 0.71 . . . . 0.0 110.221 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -83.31 144.05 29.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.068 0.547 . . . . 0.0 110.47 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.427 ' HG3' ' H ' ' A' ' 105' ' ' SER . 19.2 tpt180 -90.35 143.01 27.16 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.411 0.684 . . . . 0.0 109.431 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 m -66.88 -20.26 65.88 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.307 0.643 . . . . 0.0 112.598 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.427 ' H ' ' HG3' ' A' ' 103' ' ' ARG . 47.3 t -71.17 -23.09 61.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.795 0.838 . . . . 0.0 111.381 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.28 -1.06 43.55 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.488 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -77.96 148.9 34.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.03 0.932 . . . . 0.0 110.286 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.423 ' HA ' HH21 ' A' ' 53' ' ' ARG . 23.2 t70 -95.07 123.32 38.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.077 0.551 . . . . 0.0 110.011 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.6 p -116.51 104.93 51.03 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 122.999 0.52 . . . . 0.0 110.515 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 15.7 Cg_exo -71.12 97.83 0.78 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.588 2.192 . . . . 0.0 110.198 164.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.47 -42.97 41.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.3 0.64 . . . . 0.0 110.075 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 96.8 m-85 -112.45 160.01 18.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.378 1.071 . . . . 0.0 110.453 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -137.1 165.36 26.24 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.562 1.145 . . . . 0.0 108.878 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.516 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -79.27 173.65 55.26 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.446 -175.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 11.7 mm100 -72.7 -19.55 61.38 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.244 0.618 . . . . 0.0 111.394 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.72 99.98 1.7 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 t -99.49 116.74 32.32 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.523 0.729 . . . . 0.0 110.104 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 112.27 8.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.901 0.881 . . . . 0.0 110.564 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.58 126.6 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.497 HG23 HG22 ' A' ' 92' ' ' THR . 57.1 m -120.5 104.37 9.92 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.69 98.08 7.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.7 t -71.29 146.46 48.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.826 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 m -71.92 86.41 0.99 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.158 0.583 . . . . 0.0 110.225 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 3.3 mm? 57.65 28.27 15.48 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.656 1.183 . . . . 0.0 112.252 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -126.23 165.72 18.41 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.825 0.85 . . . . 0.0 111.034 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -139.22 167.24 22.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.432 1.093 . . . . 0.0 108.808 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -131.69 128.6 39.32 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.117 0.567 . . . . 0.0 110.699 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -86.49 143.42 27.76 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.71 1.204 . . . . 0.0 109.668 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -139.44 99.92 3.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.445 0.698 . . . . 0.0 109.766 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -86.28 146.97 26.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.638 0.775 . . . . 0.0 110.381 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.8 m80 . . . . . 0 C--O 1.247 0.95 0 C-N-CA 123.522 0.729 . . . . 0.0 110.331 -176.95 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -81.78 82.38 7.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.467 0.707 . . . . 0.0 109.768 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.99 113.09 22.45 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -102.13 121.4 42.13 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.704 0.802 . . . . 0.0 110.322 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.687 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.4 mt -110.15 110.83 21.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.232 1.013 . . . . 0.0 109.878 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.3 104.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.691 0.797 . . . . 0.0 109.383 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.94 142.32 27.9 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.69 0.796 . . . . 0.0 111.427 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.8 m -154.62 145.85 22.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.401 1.48 . . . . 0.0 108.844 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.4 -32.91 2.28 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.958 -0.357 . . . . 0.0 112.4 175.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 127.05 43.94 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 123.977 0.457 . . . . 0.0 113.937 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.15 -175.78 36.16 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.302 0.477 . . . . 0.0 112.028 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 120' ' ' THR . 20.7 tp -91.46 120.11 32.01 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.956 0.503 . . . . 0.0 109.934 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.442 HG23 HD12 ' A' ' 87' ' ' LEU . 27.5 m -125.24 158.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 109.156 170.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.45 152.91 31.88 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -60.82 133.61 56.27 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.507 0.723 . . . . 0.0 110.469 173.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.95 -15.12 64.07 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 123.306 0.379 . . . . 0.0 112.387 -170.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.29 -173.82 49.26 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-O 121.078 0.265 . . . . 0.0 113.657 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.6 p -127.12 154.27 44.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.137 0.975 . . . . 0.0 110.318 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.1 tp -154.82 122.94 5.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -98.14 117.29 32.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 110.505 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -88.77 155.18 19.72 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.12 0.968 . . . . 0.0 109.209 172.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.8 p -151.39 133.95 15.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.987 0.915 . . . . 0.0 109.006 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 46.2 t -131.52 101.96 5.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.624 0.77 . . . . 0.0 109.158 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 t -87.66 127.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 109.68 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.1 96.93 10.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t 43.85 53.44 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.02 1.728 . . . . 0.0 112.69 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.37 -79.03 1.24 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.392 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.584 ' HG2' ' HA ' ' A' ' 77' ' ' LYS . 61.8 mtm-85 -150.37 86.0 1.4 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.046 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 t -141.22 145.16 35.26 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.83 117.51 21.98 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mtp85 -143.01 1.46 1.27 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.73 1.212 . . . . 0.0 109.439 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 91.87 6.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.905 0.882 . . . . 0.0 110.216 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.652 ' HB2' ' HA ' ' A' ' 101' ' ' VAL . 34.0 m-80 -83.76 -26.24 29.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.31 1.044 . . . . 0.0 110.117 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.8 141.93 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.066 1.346 . . . . 0.0 108.076 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.507 ' HE3' ' HD3' ' A' ' 73' ' ' ARG . 20.9 mtm -151.89 162.06 41.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.121 0.968 . . . . 0.0 109.535 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -168.49 138.62 5.22 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.319 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -92.81 126.36 37.86 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -116.24 147.4 41.52 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 108.515 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.23 142.35 33.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.5 ' HB3' HG11 ' A' ' 94' ' ' VAL . 64.0 tt0 -141.41 128.38 20.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.83 160.78 31.85 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.391 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.73 112.39 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.095 2.53 . . . . 0.0 112.843 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.76 23.39 75.12 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.625 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -125.37 173.19 9.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.781 0.832 . . . . 0.0 110.679 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.18 163.8 26.72 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.481 1.112 . . . . 0.0 111.837 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.99 106.79 18.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.874 0.845 . . . . 0.0 109.024 170.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.73 135.84 33.76 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.346 1.059 . . . . 0.0 110.009 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -65.03 120.05 11.91 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.098 1.359 . . . . 0.0 111.31 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.96 -61.47 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.43 0.692 . . . . 0.0 109.162 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -146.65 159.36 43.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.958 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -132.19 141.41 49.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 0.0 111.021 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.7 mp -112.6 121.3 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.5 mtp-105 -120.55 -175.42 3.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.393 1.077 . . . . 0.0 109.417 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -47.8 163.71 0.05 Allowed 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.48 0.712 . . . . 0.0 112.113 169.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -56.48 126.65 27.46 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.316 0.647 . . . . 0.0 110.202 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.32 -18.12 30.74 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.826 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.42 -128.88 6.01 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.547 -0.585 . . . . 0.0 111.926 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 40.8 m 62.06 52.6 3.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.068 0.947 . . . . 0.0 112.597 172.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.432 ' HA ' HD13 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -158.69 122.25 3.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.164 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.454 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 15.9 m-85 -159.16 125.62 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.599 1.56 . . . . 0.0 107.297 170.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -164.62 144.14 7.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.638 0.775 . . . . 0.0 109.649 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 158.46 28.63 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.332 165.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.41 -28.38 69.64 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.4 t -63.48 -34.69 78.32 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.04 0.936 . . . . 0.0 112.224 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.503 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 34.1 m -109.52 14.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.425 0.69 . . . . 0.0 111.035 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -71.25 134.31 46.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.868 0.867 . . . . 0.0 109.409 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.11 -0.14 63.82 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.697 0.623 . . . . 0.0 113.243 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 72.7 mtp180 -109.29 -73.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.525 1.13 . . . . 0.0 109.174 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.65 119.66 26.23 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -126.58 129.8 49.26 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.977 0.911 . . . . 0.0 108.801 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -113.37 138.82 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.272 0.558 . . . . 0.0 109.787 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -144.81 149.21 35.05 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.298 1.039 . . . . 0.0 108.775 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.58 ' HB2' HG23 ' A' ' 52' ' ' ILE . 57.7 ttp180 -124.6 129.29 50.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.15 130.01 45.44 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -87.44 -29.91 21.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 111.563 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.25 82.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.529 0.731 . . . . 0.0 112.064 -172.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.584 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.45 12.15 15.1 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.655 0.382 . . . . 0.0 111.839 175.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.7 m120 53.76 56.85 6.66 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.093 0.957 . . . . 0.0 112.052 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -126.03 130.63 51.54 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.626 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.09 121.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.856 0.862 . . . . 0.0 109.127 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -102.25 145.38 29.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.622 0.769 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 53.1 tp -125.36 98.03 5.45 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -83.22 101.43 11.23 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.462 ' SD ' HD22 ' A' ' 87' ' ' LEU . 61.4 mtt -84.53 123.75 30.64 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -121.67 146.14 47.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.9 t 57.24 63.14 1.96 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.586 0.708 . . . . 0.0 110.935 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.462 HD22 ' SD ' ' A' ' 84' ' ' MET . 35.3 mt -79.66 140.04 37.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.839 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.6 mmmp? -99.15 157.89 33.26 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 108.729 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.67 -22.76 74.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.459 2.106 . . . . 0.0 112.72 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.42 -17.2 64.35 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.705 1.202 . . . . 0.0 112.452 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -81.87 37.84 0.5 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.745 0.818 . . . . 0.0 111.048 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 120' ' ' THR . 90.1 m -91.27 90.86 7.93 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 164.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 40' ' ' GLN . . . -167.3 177.46 6.09 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 40' ' ' GLN . 4.7 p -107.32 112.85 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.71 0.804 . . . . 0.0 110.173 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -92.01 133.23 35.91 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -122.47 141.51 51.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.058 0.543 . . . . 0.0 109.969 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -91.23 149.47 21.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.75 158.94 43.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.409 0.684 . . . . 0.0 109.566 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.76 169.35 17.77 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 109.811 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.11 -154.97 25.92 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.703 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.652 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 30.5 m -130.98 179.72 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.298 1.039 . . . . 0.0 110.079 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -58.48 149.24 25.73 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.903 0.881 . . . . 0.0 111.079 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -119.7 147.62 44.36 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.557 0.343 . . . . 0.0 110.161 -175.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.0 m -65.28 -20.15 66.28 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.164 0.586 . . . . 0.0 111.153 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.5 m -72.84 -25.33 61.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.043 0.937 . . . . 0.0 111.963 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.94 -23.18 30.3 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 113.832 0.293 . . . . 0.0 113.832 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -79.34 152.66 30.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.106 0.562 . . . . 0.0 110.209 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.57 122.26 17.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.2 m -122.68 127.3 25.83 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 122.785 0.434 . . . . 0.0 111.284 -171.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.83 103.88 1.78 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.77 2.313 . . . . 0.0 112.015 172.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.09 -30.55 55.43 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.36 0.6 . . . . 0.0 109.808 170.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -127.13 153.17 46.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.779 1.232 . . . . 0.0 108.567 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -131.38 157.64 42.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.475 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.7 -120.95 0.67 Allowed Glycine 0 C--N 1.336 0.57 0 O-C-N 123.244 0.34 . . . . 0.0 112.696 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -129.05 -15.14 4.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.8 109.97 0.14 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 123.332 0.395 . . . . 0.0 112.641 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.411 HG22 HD12 ' A' ' 21' ' ' LEU . 10.1 t -95.84 128.15 42.48 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.644 0.735 . . . . 0.0 110.798 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.416 ' NE2' ' HB ' ' A' ' 94' ' ' VAL . 8.4 mm-40 -79.36 108.86 13.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.47 136.27 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 31.3 m -133.9 129.34 36.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 87' ' ' LEU . 46.3 t -113.66 108.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.559 ' HB3' ' HB2' ' A' ' 125' ' ' GLU . 20.8 m -60.88 141.64 56.98 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.939 0.495 . . . . 0.0 111.934 167.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 m -74.66 90.74 2.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.464 0.705 . . . . 0.0 110.964 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.8 mm? 61.16 15.44 6.33 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.486 1.114 . . . . 0.0 112.943 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 122' ' ' SER . 44.6 mt-10 -82.19 -91.82 0.07 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 117.865 0.302 . . . . 0.0 111.555 -174.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -148.37 152.4 36.95 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.23 0.612 . . . . 0.0 111.09 -170.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -96.8 153.52 17.83 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 160.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -73.21 128.97 36.99 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -67.26 103.39 1.24 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.734 0.414 . . . . 0.0 110.282 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.6 m80 60.27 -159.91 0.3 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.877 1.271 . . . . 0.0 111.443 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 . . . . . 0 CA--C 1.556 1.192 0 CA-C-O 118.959 -0.543 . . . . 0.0 111.093 175.011 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 63.43 -163.42 0.27 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.646 1.178 . . . . 0.0 111.707 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.73 111.04 7.51 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -103.07 132.32 49.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.669 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 70.3 mt -121.86 120.22 33.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 52.4 t -95.76 99.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 51.9 mt-10 -95.34 123.92 39.11 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.678 -172.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 m -130.91 154.38 48.16 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.617 1.167 . . . . 0.0 109.769 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.23 11.67 35.87 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.015 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.57 74.65 1.5 Allowed Glycine 0 C--N 1.35 1.355 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.37 -164.17 13.68 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 120' ' ' THR . 6.5 tt -116.86 127.54 54.39 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 33.7 m -123.82 161.13 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.144 0.978 . . . . 0.0 109.007 168.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -80.67 158.27 25.66 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.212 0.605 . . . . 0.0 110.768 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.23 114.49 2.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.772 0.829 . . . . 0.0 110.539 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.99 -25.53 10.69 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.959 0.79 . . . . 0.0 112.01 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.67 164.63 54.82 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 113.725 0.25 . . . . 0.0 113.725 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.6 p -104.64 155.46 18.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.988 0.915 . . . . 0.0 110.38 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.2 tp -152.76 136.84 16.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.114 0.966 . . . . 0.0 108.464 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.062 0.545 . . . . 0.0 110.043 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -101.07 157.51 16.7 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.297 1.039 . . . . 0.0 108.899 174.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -144.89 127.27 15.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.669 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -127.79 105.37 8.39 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.542 0.737 . . . . 0.0 110.445 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.47 130.04 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.88 98.06 11.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.726 0.298 . . . . 0.0 110.374 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.524 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 5.6 m 56.9 29.12 15.66 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.329 1.451 . . . . 0.0 112.917 170.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.18 50.77 5.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -173.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 88.5 mtt180 69.68 24.42 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.629 1.172 . . . . 0.0 113.092 171.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 32.7 p -87.8 153.24 21.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.889 0.476 . . . . 0.0 110.271 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -110.67 123.16 49.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.791 0.836 . . . . 0.0 109.76 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -145.95 -50.27 0.23 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.672 1.189 . . . . 0.0 108.168 167.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -73.52 103.72 4.24 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.942 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -88.97 -13.96 37.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.794 0.838 . . . . 0.0 110.033 167.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.58 43.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.784 1.234 . . . . 0.0 108.3 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtm -148.9 167.15 26.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.007 . . . . 0.0 109.157 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.61 148.79 8.91 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.715 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.463 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 95.4 m95 -89.51 136.25 33.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.25 164.78 18.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.42 1.088 . . . . 0.0 108.447 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -128.47 148.02 50.71 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -155.07 144.67 21.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.533 ' HB1' ' HG3' ' A' ' 44' ' ' LYS . . . -108.82 152.56 42.38 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 171.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 110.71 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.706 2.27 . . . . 0.0 112.506 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.07 43.96 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.449 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HG3' ' HB1' ' A' ' 41' ' ' ALA . 9.1 mmpt? -119.78 170.62 9.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.086 0.955 . . . . 0.0 110.57 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.28 163.44 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.655 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.402 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.56 123.36 31.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.6 137.59 32.71 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 0.0 109.673 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 51' ' ' ALA . 80.7 t80 -69.09 119.72 13.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.13 0.972 . . . . 0.0 110.431 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.51 -54.68 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.293 0.637 . . . . 0.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' A' ' 37' ' ' TRP . . . -139.9 164.9 28.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.588 -171.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . . . -145.09 131.86 20.04 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.377 0.671 . . . . 0.0 110.846 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -110.79 127.24 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.767 1.227 . . . . 0.0 109.375 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.451 ' HG3' ' HZ2' ' A' ' 102' ' ' TRP . 3.2 mpt_? -119.03 179.01 4.29 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.252 1.421 . . . . 0.0 109.408 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -66.02 -170.35 0.08 Allowed 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.994 0.918 . . . . 0.0 111.975 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.8 m -53.91 114.62 1.64 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.713 1.205 . . . . 0.0 112.439 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.48 16.78 28.4 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.465 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.6 -137.3 4.22 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.8 m 65.57 63.45 0.62 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.613 1.165 . . . . 0.0 112.236 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.497 ' HA ' HD12 ' A' ' 71' ' ' ILE . 2.5 p -150.59 122.2 8.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.261 1.025 . . . . 0.0 109.211 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.24 127.05 0.82 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -165.82 167.04 17.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.544 0.738 . . . . 0.0 110.086 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -79.34 145.56 33.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 168.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.77 -28.1 69.64 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.851 0.358 . . . . 0.0 110.966 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 m -70.92 -26.62 63.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.61 0.764 . . . . 0.0 112.214 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 62' ' ' ALA . 18.7 m -104.58 4.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 122.872 0.469 . . . . 0.0 111.43 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.76 116.05 3.2 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.463 1.105 . . . . 0.0 112.501 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.72 11.81 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.986 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -87.25 -57.24 3.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.516 0.726 . . . . 0.0 109.263 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -87.77 122.1 31.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -146.74 153.68 40.52 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.049 1.34 . . . . 0.0 108.63 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -124.92 156.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.59 0.756 . . . . 0.0 109.915 176.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -151.75 136.77 17.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.778 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.7 ttp85 -110.37 136.28 49.79 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -109.03 122.26 46.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -87.59 -23.85 24.18 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.053 0.541 . . . . 0.0 111.0 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.35 84.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.377 0.671 . . . . 0.0 111.875 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.0 17.1 12.53 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.51 0.324 . . . . 0.0 111.841 172.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.6 m120 48.72 56.37 7.74 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.237 1.015 . . . . 0.0 112.191 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.1 m -130.07 130.72 45.24 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -109.65 125.53 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.901 0.88 . . . . 0.0 109.89 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -102.45 146.59 27.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.739 0.815 . . . . 0.0 110.388 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.63 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.3 tp -124.53 101.48 7.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.111 0.964 . . . . 0.0 108.685 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -91.55 101.18 13.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.369 0.668 . . . . 0.0 109.995 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.467 ' HE3' HD22 ' A' ' 21' ' ' LEU . 55.7 mtm -107.84 107.61 18.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.376 0.67 . . . . 0.0 110.118 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -106.91 147.94 29.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.303 0.641 . . . . 0.0 109.908 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.4 t 61.71 60.63 1.57 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.117 0.967 . . . . 0.0 110.067 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 121' ' ' VAL . 42.9 mt -76.13 151.12 37.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.28 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.55 ' HZ1' ' HB2' ' A' ' 88' ' ' LYS . 8.4 mtmp? -110.7 157.11 39.36 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.392 1.077 . . . . 0.0 109.046 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 27.3 Cg_endo -59.14 -26.14 80.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.56 2.174 . . . . 0.0 113.145 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.14 -17.3 64.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.002 0.921 . . . . 0.0 112.326 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.06 15.65 1.44 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.643 0.777 . . . . 0.0 111.193 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.498 HG22 HG21 ' A' ' 120' ' ' THR . 85.6 m -81.4 89.95 6.15 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 163.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -167.05 -166.07 0.77 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.491 -172.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 p -115.23 112.93 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.195 0.598 . . . . 0.0 110.362 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -85.05 130.74 34.56 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.402 ' H ' HD22 ' A' ' 96' ' ' LEU . 1.6 pt? -130.3 125.04 33.77 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.504 0.721 . . . . 0.0 109.292 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.1 p -88.85 138.66 31.22 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 110' ' ' PRO . . . -111.88 152.04 28.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.295 1.038 . . . . 0.0 109.823 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.47 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -130.0 167.68 17.89 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.614 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.77 -168.88 39.85 Favored Glycine 0 C--O 1.236 0.274 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.6 145.74 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.602 0.761 . . . . 0.0 109.254 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.451 ' HZ2' ' HG3' ' A' ' 53' ' ' ARG . 83.1 m95 -59.61 117.03 4.45 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.618 0.767 . . . . 0.0 110.26 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.464 ' HD3' ' N ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -75.47 149.51 38.47 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 123.991 0.807 . . . . 0.0 108.943 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.464 ' N ' ' HD3' ' A' ' 103' ' ' ARG . 33.6 m -55.75 -19.92 12.89 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.539 1.135 . . . . 0.0 113.356 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.7 p -67.77 -24.2 65.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.305 1.042 . . . . 0.0 112.205 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.57 9.85 45.7 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.218 -174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -94.26 132.47 38.8 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.701 0.801 . . . . 0.0 110.531 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.41 92.25 2.81 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 166.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.9 p -95.48 107.05 30.53 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 123.286 0.634 . . . . 0.0 110.598 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HB2' ' HB3' ' A' ' 98' ' ' ALA . 84.6 Cg_endo -81.52 86.68 1.55 Allowed 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.701 2.267 . . . . 0.0 110.054 170.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.2 -27.55 60.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.126 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -112.45 150.1 31.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 109.776 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -130.85 145.96 52.15 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -70.76 -79.39 0.37 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 123.527 0.517 . . . . 0.0 113.247 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -164.11 -40.31 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.771 0.828 . . . . 0.0 109.815 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.9 119.49 4.54 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.119 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 6.2 t -96.56 111.62 23.68 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.596 0.713 . . . . 0.0 109.622 174.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.45 98.56 1.45 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.513 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.02 132.79 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 10.8 m -128.1 106.21 8.91 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 87' ' ' LEU . 42.6 t -106.49 97.82 6.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 121.65 -0.656 . . . . 0.0 109.462 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.1 t -70.6 129.17 38.49 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.878 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.462 ' HB2' ' HB3' ' A' ' 89' ' ' PRO . 43.8 t -59.93 98.23 0.05 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.499 0.72 . . . . 0.0 110.743 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 77.94 -43.24 0.38 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.83 1.652 . . . . 0.0 113.288 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.66 152.33 43.98 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.869 0.468 . . . . 0.0 110.995 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -92.11 -164.42 1.18 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.621 0.768 . . . . 0.0 110.345 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.474 ' HA ' HD21 ' A' ' 12' ' ' LEU . 57.8 t60 -47.5 -58.0 4.72 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.261 1.025 . . . . 0.0 113.673 -168.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 64.59 121.76 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.856 1.262 . . . . 0.0 112.329 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -78.23 155.23 30.42 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.823 0.449 . . . . 0.0 110.762 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -135.71 170.92 15.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.075 0.95 . . . . 0.0 109.286 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.7 t60 . . . . . 0 CA--C 1.562 1.411 0 C-N-CA 124.772 1.229 . . . . 0.0 110.578 -176.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtm . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -134.18 112.39 11.06 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.14 112.63 17.64 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 37.8 mt-30 -104.02 121.66 43.63 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.317 0.647 . . . . 0.0 109.568 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.58 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.6 mt -120.08 107.17 12.73 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.66 102.56 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.69 146.69 23.98 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.453 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 p -159.18 177.77 10.72 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.169 0.988 . . . . 0.0 109.788 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.8 -0.28 87.86 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.858 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 142.86 29.65 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.968 0.384 . . . . 0.0 112.478 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.66 -168.76 39.0 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.1 tt -99.73 130.3 45.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.348 0.659 . . . . 0.0 109.631 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.72 149.83 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.742 0.817 . . . . 0.0 109.258 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' HD12 ' A' ' 124' ' ' LEU . 4.3 pm0 -70.17 146.92 50.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.827 0.451 . . . . 0.0 110.498 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -64.94 135.18 55.37 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.394 0.678 . . . . 0.0 110.868 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.08 6.2 72.06 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.068 -168.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.95 -169.83 27.36 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 122.896 0.284 . . . . 0.0 112.851 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 p -129.28 153.26 47.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.635 0.774 . . . . 0.0 110.57 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.5 tp -149.72 125.09 10.2 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -108.38 109.99 21.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.453 0.701 . . . . 0.0 110.216 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -87.55 153.8 21.12 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.209 1.004 . . . . 0.0 109.947 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 m -143.48 130.96 21.07 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.5 0.72 . . . . 0.0 109.407 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 47.8 t -124.78 105.93 9.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.19 0.996 . . . . 0.0 109.45 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.25 123.46 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.139 0.575 . . . . 0.0 109.464 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.44 97.39 11.15 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.026 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 21.4 t 55.7 33.36 21.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.827 1.251 . . . . 0.0 112.341 171.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.45 -88.92 0.61 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.436 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -125.81 -0.63 7.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.736 0.814 . . . . 0.0 111.532 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -77.3 126.09 30.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -105.32 124.87 50.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.066 0.946 . . . . 0.0 109.345 -170.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.1 mtt85 -165.11 175.55 9.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.116 0.967 . . . . 0.0 110.169 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t 66.25 104.89 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 O-C-N 125.176 1.547 . . . . 0.0 110.798 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.23 -28.98 67.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.708 0.803 . . . . 0.0 112.593 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HB3' ' HG3' ' A' ' 53' ' ' ARG . . . -126.21 149.55 48.96 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.582 0.753 . . . . 0.0 109.592 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.0 mtt -144.9 122.38 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -118.18 -173.87 16.2 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 123.487 0.492 . . . . 0.0 113.222 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -132.87 143.75 49.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.116 0.967 . . . . 0.0 109.26 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.09 172.07 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.69 1.596 . . . . 0.0 107.65 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -139.35 123.73 18.16 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.056 0.455 . . . . 0.0 110.367 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.475 ' HB3' HG13 ' A' ' 94' ' ' VAL . 65.0 tp60 -101.58 135.23 43.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.624 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 44' ' ' LYS . . . -122.58 137.83 28.43 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.048 0.939 . . . . 0.0 109.229 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -66.26 118.08 5.22 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.72 2.28 . . . . 0.0 111.717 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.73 0.4 59.11 Favored Glycine 0 N--CA 1.474 1.184 0 O-C-N 123.044 0.215 . . . . 0.0 112.656 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 5.5 mmpt? -135.61 172.89 12.36 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.155 . . . . 0.0 110.141 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.17 156.92 16.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.053 0.941 . . . . 0.0 109.922 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 125.92 28.16 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.456 0.646 . . . . 0.0 110.803 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -93.38 138.29 31.86 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.618 1.167 . . . . 0.0 109.29 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -69.18 115.24 8.24 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.742 0.652 . . . . 0.0 109.781 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.9 t -94.32 -53.1 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.409 0.683 . . . . 0.0 110.03 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -156.1 169.6 24.12 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -168.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.424 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -158.99 132.29 7.24 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 110.306 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -116.34 116.16 51.38 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.408 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 28.7 ttt-85 -117.47 144.71 44.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -65.21 -13.66 58.79 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.624 0.769 . . . . 0.0 111.509 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 m -74.56 -2.61 26.66 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.7 0.8 . . . . 0.0 112.151 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.09 -16.89 32.49 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.694 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.26 72.54 1.65 Allowed Glycine 0 C--N 1.351 1.4 0 C-N-CA 122.885 0.278 . . . . 0.0 112.465 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 49.9 m -106.4 29.72 6.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.314 1.046 . . . . 0.0 111.97 -169.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.9 m -158.53 121.93 3.87 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.605 0.362 . . . . 0.0 111.274 -170.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.45 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 68.4 m-85 -156.52 135.53 11.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.876 1.67 . . . . 0.0 107.66 171.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -165.4 164.55 19.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.227 1.011 . . . . 0.0 110.263 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.16 160.89 30.58 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.705 0.402 . . . . 0.0 111.092 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.61 -36.05 81.66 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.425 0.69 . . . . 0.0 111.76 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.2 p -69.15 -36.09 77.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.294 0.638 . . . . 0.0 111.622 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.3 m -97.74 15.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.5 0.72 . . . . 0.0 111.634 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.15 114.23 2.51 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.325 1.05 . . . . 0.0 112.009 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.81 -19.75 35.85 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.588 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.402 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 15.1 mtm180 -80.84 -48.52 12.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -85.21 123.5 30.78 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.131 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -130.55 134.48 47.06 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -129.37 143.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 110.609 -176.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -150.05 169.5 21.08 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.279 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.475 ' HB3' HG23 ' A' ' 52' ' ' ILE . 77.0 ttt180 -147.76 131.44 16.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -122.47 106.14 10.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.293 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -72.51 -11.57 60.72 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.728 0.811 . . . . 0.0 110.844 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.18 79.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.419 1.087 . . . . 0.0 111.878 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.02 7.97 12.39 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.924 0.489 . . . . 0.0 111.406 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 53.59 67.28 1.03 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.448 1.099 . . . . 0.0 110.807 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -148.74 132.73 17.17 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.24 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.418 HG23 ' HG3' ' A' ' 73' ' ' ARG . 21.5 t -103.68 136.13 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.518 1.127 . . . . 0.0 108.072 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.41 146.11 44.69 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.977 0.418 . . . . 0.0 111.34 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.7 tp -127.86 98.61 5.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.691 1.197 . . . . 0.0 108.081 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -93.21 100.14 12.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 109.187 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.485 ' HE2' HD21 ' A' ' 21' ' ' LEU . 56.7 mtm -104.25 103.24 12.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.896 0.478 . . . . 0.0 110.082 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -102.54 153.35 20.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.637 0.775 . . . . 0.0 109.581 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 36.5 t 58.13 48.96 12.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.172 0.989 . . . . 0.0 110.698 -177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 84' ' ' MET . 29.3 mt -68.99 133.49 48.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.114 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . 37.7 mtmt -92.06 157.24 41.35 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.104 0.962 . . . . 0.0 109.059 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.06 -23.77 78.07 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.11 1.873 . . . . 0.0 112.608 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.92 -11.4 60.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.276 1.03 . . . . 0.0 112.385 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -84.67 33.28 0.52 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.634 0.773 . . . . 0.0 110.656 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.7 m -88.1 98.19 11.4 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.59 -166.66 1.39 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.649 0.78 . . . . 0.0 109.322 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.8 p -117.05 109.52 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.66 131.39 35.21 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.25 143.06 47.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.117 0.567 . . . . 0.0 110.529 -173.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -89.04 158.16 18.09 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.781 0.833 . . . . 0.0 109.75 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.02 152.48 49.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.968 0.907 . . . . 0.0 109.255 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -118.36 120.59 38.06 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 110' ' ' PRO . . . -116.65 147.0 18.92 Favored Glycine 0 C--O 1.244 0.744 0 O-C-N 123.645 0.591 . . . . 0.0 111.918 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.0 m -136.99 140.16 43.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.749 1.219 . . . . 0.0 109.01 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -63.18 117.55 6.7 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HD3' ' H ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -102.17 153.29 20.09 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.044 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.485 ' H ' ' HD3' ' A' ' 103' ' ' ARG . 54.6 p -65.99 -13.16 59.36 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.991 0.916 . . . . 0.0 111.984 174.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.7 m -67.19 -24.45 65.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.75 0.82 . . . . 0.0 111.075 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.07 -30.2 8.54 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.515 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 22.7 m-90 -83.81 146.4 28.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.082 0.553 . . . . 0.0 109.877 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.44 92.34 7.55 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 35.7 p -77.25 121.08 84.0 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.116 -170.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.457 ' HA ' ' HA2' ' A' ' 100' ' ' GLY . 1.9 Cg_endo -77.35 72.71 5.85 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.033 2.489 . . . . 0.0 109.301 175.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.35 -35.74 80.06 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.866 0.867 . . . . 0.0 111.661 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 80.8 m-85 -111.73 152.82 27.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.458 0.703 . . . . 0.0 110.131 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -134.13 160.05 38.97 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.342 1.057 . . . . 0.0 108.692 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.28 -151.97 6.6 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.877 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 6.72 28.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.235 0.614 . . . . 0.0 110.651 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.35 163.48 28.68 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 113.129 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 t -140.59 115.64 9.79 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -68.7 122.79 19.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.58 0.752 . . . . 0.0 111.011 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.93 136.16 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.9 m -134.04 103.58 5.86 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.5 t -87.95 101.16 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.403 ' HG ' ' HA ' ' A' ' 14' ' ' GLN . 69.6 p -56.9 141.41 45.15 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.425 0.69 . . . . 0.0 111.413 171.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.3 p -85.11 59.27 5.53 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.459 0.704 . . . . 0.0 110.65 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.435 HD12 ' HB2' ' A' ' 14' ' ' GLN . 3.2 mm? 58.59 34.82 24.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.316 1.046 . . . . 0.0 110.957 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -76.67 -87.52 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.154 0.582 . . . . 0.0 111.769 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -139.31 26.91 2.35 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.975 0.51 . . . . 0.0 111.368 -171.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -75.87 97.99 4.08 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -56.89 109.88 0.71 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.04 0.838 . . . . 0.0 111.195 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -82.92 168.89 16.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.777 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -141.48 140.26 33.5 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.534 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 175.077 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.6 mtp . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 121.168 0.509 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -107.78 125.22 51.15 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.562 HD12 ' HG ' ' A' ' 32' ' ' SER . 0.9 OUTLIER -77.22 113.69 15.24 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -103.95 142.44 34.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.182 0.993 . . . . 0.0 109.924 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.613 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 82.6 mt -132.36 129.08 38.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.231 1.013 . . . . 0.0 109.336 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 68.0 t -119.5 102.39 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.195 0.598 . . . . 0.0 109.689 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.66 151.31 25.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.42 0.688 . . . . 0.0 110.669 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 p -155.19 146.45 22.82 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.241 1.016 . . . . 0.0 109.308 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.01 0.59 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.709 0.671 . . . . 0.0 111.504 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.39 121.79 7.29 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.387 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.02 -178.24 48.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 122' ' ' SER . 19.3 tp -94.21 128.26 40.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.93 166.34 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.992 . . . . 0.0 108.949 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -85.84 151.94 23.4 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.918 0.487 . . . . 0.0 111.206 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.48 113.05 2.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.902 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.22 0.02 28.22 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -178.43 46.37 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 113.805 0.282 . . . . 0.0 113.805 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 m -108.68 159.99 16.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.495 1.118 . . . . 0.0 109.233 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 tp -160.69 116.84 2.3 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -99.49 109.18 21.75 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 117' ' ' THR . 3.1 mm? -86.91 140.71 29.35 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 p -140.37 125.45 18.53 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.795 0.838 . . . . 0.0 109.336 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -124.54 115.47 20.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.053 0.941 . . . . 0.0 109.421 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.07 129.56 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.05 103.23 15.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.167 0.987 . . . . 0.0 110.53 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 p 51.8 53.24 12.97 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.098 1.759 . . . . 0.0 112.93 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.86 -74.3 1.83 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.893 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -165.61 39.01 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 122.27 1.033 . . . . 0.0 108.471 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.0 m -103.95 147.52 27.25 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.297 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -105.84 121.41 44.0 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -167.31 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.609 0.764 . . . . 0.0 110.291 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.562 ' HG ' HD12 ' A' ' 3' ' ' LEU . 6.0 m -65.98 95.61 0.28 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.391 0.676 . . . . 0.0 109.756 174.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.52 -35.08 25.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.297 0.639 . . . . 0.0 110.212 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.67 121.68 31.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.7 0.8 . . . . 0.0 109.219 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.431 ' HE3' ' HD3' ' A' ' 73' ' ' ARG . 2.9 mpp? -123.75 163.18 21.67 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.397 1.479 . . . . 0.0 108.682 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -157.57 135.92 4.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.56 121.8 36.48 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.5 160.96 24.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -139.67 133.47 30.64 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -98.23 128.74 44.85 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -94.33 141.56 23.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 122.765 0.426 . . . . 0.0 110.219 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.42 101.73 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.651 2.234 . . . . 0.0 111.462 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.95 2.74 60.89 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.93 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 7.5 mmpt? -139.51 152.49 46.98 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.708 0.803 . . . . 0.0 110.276 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.19 163.27 10.51 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.418 1.087 . . . . 0.0 111.531 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.58 149.74 43.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.205 0.526 . . . . 0.0 111.373 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -120.18 134.44 55.26 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.184 0.994 . . . . 0.0 109.501 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -72.31 111.14 7.25 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.291 1.036 . . . . 0.0 109.055 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.6 t -88.57 -53.67 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.467 0.707 . . . . 0.0 110.002 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.88 165.23 37.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.677 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.418 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -150.4 127.61 11.29 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 124.096 0.959 . . . . 0.0 109.823 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.726 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.9 mp -110.22 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.31 127.81 53.55 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -72.82 82.46 1.18 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 t -162.77 21.14 0.09 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.34 1.056 . . . . 0.0 109.817 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.88 32.34 33.04 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.649 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.87 -91.56 0.78 Allowed Glycine 0 C--N 1.355 1.604 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.726 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 68.4 m 63.16 35.21 12.94 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.684 1.194 . . . . 0.0 113.999 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -157.91 122.02 4.16 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.3 0.64 . . . . 0.0 110.16 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -152.83 122.87 7.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.07 1.348 . . . . 0.0 108.194 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -164.73 161.75 20.8 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.656 1.182 . . . . 0.0 109.126 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB1' HG21 ' A' ' 65' ' ' VAL . . . -81.53 151.74 27.61 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.21 -28.9 69.1 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.075 0.464 . . . . 0.0 110.75 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 p -66.85 -25.62 66.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.246 1.018 . . . . 0.0 111.887 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 22.9 m -114.45 13.78 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.332 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HZ1' ' HB3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -68.09 122.67 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.36 0.664 . . . . 0.0 110.476 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.17 -27.32 9.39 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.757 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.514 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 24.3 mtp180 -78.45 -52.67 8.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.78 1.232 . . . . 0.0 108.762 175.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -104.02 121.97 44.28 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.984 1.314 . . . . 0.0 107.787 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -135.72 151.39 50.11 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.442 1.097 . . . . 0.0 108.916 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.94 148.5 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.714 0.806 . . . . 0.0 110.206 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.8 m -153.03 172.2 17.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.13 0.972 . . . . 0.0 109.354 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.431 ' HD3' ' HE3' ' A' ' 35' ' ' MET . 55.4 ttp180 -148.3 139.72 23.51 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.12 100.13 6.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.852 1.261 . . . . 0.0 108.585 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -71.1 -13.22 61.89 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.753 0.821 . . . . 0.0 111.167 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.35 64.56 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.409 1.084 . . . . 0.0 111.744 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.26 1.33 10.23 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.704 0.802 . . . . 0.0 111.513 173.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m120 60.75 68.94 0.71 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.649 1.18 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -142.26 133.33 25.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.642 0.777 . . . . 0.0 109.769 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.414 HG21 ' HG2' ' A' ' 35' ' ' MET . 23.2 t -101.18 133.65 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 108.327 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.78 148.41 34.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.52 0.728 . . . . 0.0 111.659 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 47.8 tp -132.91 99.57 4.63 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -84.19 99.5 10.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.712 ' HB3' HD23 ' A' ' 87' ' ' LEU . 74.1 mtp -87.56 136.41 32.96 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.86 160.59 41.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.767 0.827 . . . . 0.0 108.81 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.2 t 58.46 48.25 12.42 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.517 1.135 . . . . 0.0 109.016 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.712 HD23 ' HB3' ' A' ' 84' ' ' MET . 70.4 mt -72.3 138.76 47.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.726 -166.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 14.1 mmmm -92.4 153.06 42.76 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 124.077 0.951 . . . . 0.0 108.904 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.473 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 19.5 Cg_endo -59.92 -20.79 61.67 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.644 2.229 . . . . 0.0 113.054 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -80.78 1.78 29.02 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.859 0.864 . . . . 0.0 112.151 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -87.98 24.95 1.66 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.631 0.772 . . . . 0.0 110.318 166.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.0 m -81.6 105.59 12.88 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 161.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.68 177.64 6.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.952 0.901 . . . . 0.0 110.494 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HB ' ' NE2' ' A' ' 118' ' ' GLN . 3.1 p -110.08 107.05 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -83.89 115.22 22.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.372 0.669 . . . . 0.0 109.207 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.14 143.79 36.42 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -91.62 144.6 25.37 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 170.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . . . -133.05 157.69 44.63 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.386 0.675 . . . . 0.0 109.445 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.55 12.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.529 0.731 . . . . 0.0 109.731 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.85 -151.13 5.43 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.94 146.85 14.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 C-N-CA 123.388 0.675 . . . . 0.0 110.044 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.457 ' HE3' ' HB2' ' A' ' 108' ' ' ASP . 42.7 t-105 -68.21 107.27 2.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -76.39 169.31 18.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.109 0.564 . . . . 0.0 111.922 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.5 m -65.77 -26.36 67.68 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.679 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.7 p -69.99 -15.17 62.99 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.056 0.942 . . . . 0.0 111.53 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.36 2.67 67.85 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.801 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -95.24 110.99 22.9 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.334 0.654 . . . . 0.0 110.183 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.457 ' HB2' ' HE3' ' A' ' 102' ' ' TRP . 27.6 t70 -79.43 105.6 10.86 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 168.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.4 p -136.67 139.03 28.02 Favored Pre-proline 0 C--O 1.244 0.775 0 C-N-CA 123.614 0.766 . . . . 0.0 110.064 -171.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 58.3 Cg_endo -69.72 128.78 16.55 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.802 2.335 . . . . 0.0 112.779 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.25 -34.26 14.33 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.034 0.934 . . . . 0.0 109.757 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -117.85 152.41 35.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.461 1.104 . . . . 0.0 109.339 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.09 157.35 47.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.22 1.008 . . . . 0.0 108.817 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.7 -147.73 15.39 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.829 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.424 HE21 ' HA ' ' A' ' 6' ' ' VAL . 48.1 mt-30 -94.05 -34.42 13.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.616 0.766 . . . . 0.0 111.541 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.22 116.04 1.27 Allowed Glycine 0 C--N 1.345 1.04 0 N-CA-C 111.879 -0.489 . . . . 0.0 111.879 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.485 HG22 HD13 ' A' ' 21' ' ' LEU . 7.0 t -99.79 118.39 36.16 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.632 0.773 . . . . 0.0 110.402 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.421 ' NE2' ' HB ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -74.16 106.43 5.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.008 0.923 . . . . 0.0 110.514 178.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.91 139.89 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 43.5 m -135.25 118.58 16.72 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.0 103.4 14.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.546 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.5 t -66.37 140.8 58.1 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 123.293 0.371 . . . . 0.0 110.684 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -70.63 101.26 2.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 109.799 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 79.35 -51.87 0.42 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.785 1.634 . . . . 0.0 111.295 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -75.3 171.05 14.89 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.997 0.919 . . . . 0.0 111.808 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -168.16 42.38 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.223 1.409 . . . . 0.0 107.974 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -62.71 -44.89 95.06 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.448 -172.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -84.33 141.18 31.09 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 162.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -163.23 144.26 9.43 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.94 0.896 . . . . 0.0 108.855 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 58.48 41.85 22.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -167.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.556 1.185 0 C-N-CA 125.184 1.394 . . . . 0.0 109.834 -169.087 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 ttm . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -128.34 149.31 50.57 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.836 0.854 . . . . 0.0 109.121 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 ' HE3' ' A' ' 35' ' ' MET . 1.6 tm? -75.59 109.94 9.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -102.96 143.42 32.56 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.68 1.192 . . . . 0.0 109.337 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.677 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.8 mt -130.46 113.98 14.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.097 0.959 . . . . 0.0 109.069 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.46 104.72 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.48 ' HG2' ' HB ' ' A' ' 117' ' ' THR . 78.2 tt0 -104.69 135.65 45.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.304 -166.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 p -163.2 -177.37 5.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.101 0.96 . . . . 0.0 110.264 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.0 5.74 57.25 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 112.547 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.38 148.23 21.97 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.714 0.257 . . . . 0.0 112.719 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.91 -174.04 45.44 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.7 tt -93.29 129.57 39.32 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.45 157.25 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.956 0.903 . . . . 0.0 108.787 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.623 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -81.33 149.59 28.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.09 0.556 . . . . 0.0 110.286 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.62 123.57 19.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.678 1.191 . . . . 0.0 111.47 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.35 -25.94 11.77 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -172.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.34 -166.77 32.65 Favored Glycine 0 C--N 1.35 1.321 0 C-N-CA 123.194 0.426 . . . . 0.0 114.13 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -134.97 160.32 38.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.065 0.946 . . . . 0.0 110.438 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -154.29 131.29 10.95 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.63 0.772 . . . . 0.0 109.208 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -102.49 127.11 49.68 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.106 0.562 . . . . 0.0 110.531 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -98.65 157.56 16.18 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.462 1.105 . . . . 0.0 109.207 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.8 p -148.83 126.88 11.99 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.47 0.708 . . . . 0.0 109.405 -175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.677 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.2 t -128.05 106.13 8.86 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.81 0.844 . . . . 0.0 109.1 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.42 120.71 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.507 0.723 . . . . 0.0 109.301 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.08 100.76 13.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.937 0.495 . . . . 0.0 110.87 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 10.9 m 54.67 37.04 27.51 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.267 1.427 . . . . 0.0 112.183 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.66 -68.31 3.29 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.849 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 52.6 ttp180 -164.91 63.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 85.0 m -138.53 146.3 41.75 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.204 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -129.48 141.89 50.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 109.039 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -156.01 -50.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.926 0.89 . . . . 0.0 109.846 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -73.77 119.54 18.13 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.84 0.352 . . . . 0.0 110.101 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -78.63 -3.0 41.75 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.534 0.734 . . . . 0.0 111.028 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.98 41.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.383 0.673 . . . . 0.0 109.272 171.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.57 ' HE3' HD11 ' A' ' 3' ' ' LEU . 68.3 mtt -143.53 121.1 11.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.62 174.15 22.76 Favored Glycine 0 C--N 1.335 0.526 0 O-C-N 123.072 0.233 . . . . 0.0 113.341 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.438 ' HE1' HG12 ' A' ' 80' ' ' VAL . 85.7 m95 -110.98 133.68 53.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.857 0.863 . . . . 0.0 109.68 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -119.53 171.89 8.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.274 1.43 . . . . 0.0 107.486 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 40.1 ptt180 -143.42 127.76 17.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.044 0.449 . . . . 0.0 110.465 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -109.63 129.79 55.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -103.17 157.95 32.76 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.762 -0.637 . . . . 0.0 109.893 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.8 96.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.777 2.318 . . . . 0.0 113.326 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.69 -11.5 52.23 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.092 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 8.8 mmpt? -103.12 137.87 40.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.518 0.727 . . . . 0.0 109.496 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.25 149.92 23.04 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 146.27 22.09 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.38 1.072 . . . . 0.0 112.291 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -136.2 133.22 36.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 109.892 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.46 115.55 7.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.952 0.901 . . . . 0.0 110.781 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.54 -55.19 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.404 0.681 . . . . 0.0 109.417 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 71' ' ' ILE . . . -167.42 173.91 8.39 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.097 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.53 158.95 27.24 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 122.267 1.032 . . . . 0.0 112.467 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -117.7 116.48 51.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 113.472 -1.694 . . . . 0.0 106.968 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.405 ' HG2' ' HE2' ' A' ' 60' ' ' TYR . 29.2 mmt180 -93.97 88.59 5.76 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 23.9 t90 63.95 -82.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.673 1.189 . . . . 0.0 110.478 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.2 p -165.29 166.29 18.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.286 1.034 . . . . 0.0 109.954 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.92 29.36 61.02 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.11 0.256 . . . . 0.0 113.599 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.04 -80.33 0.04 OUTLIER Glycine 0 C--N 1.348 1.197 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 72' ' ' SER . 22.8 t 60.2 40.74 17.72 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.386 1.074 . . . . 0.0 111.91 169.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.546 ' HA ' HD11 ' A' ' 71' ' ' ILE . 3.8 p -158.01 123.89 4.63 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.917 0.487 . . . . 0.0 111.034 -170.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.405 ' HE2' ' HG2' ' A' ' 53' ' ' ARG . 69.6 m-85 -150.25 113.16 4.8 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 166.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.07 143.27 7.71 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.683 0.393 . . . . 0.0 110.71 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.28 159.0 31.0 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 168.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 31.2 t70 -60.9 -28.19 68.72 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.062 0.545 . . . . 0.0 111.147 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 m -65.98 -33.57 76.11 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.927 0.891 . . . . 0.0 112.087 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -109.22 -5.64 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.291 0.636 . . . . 0.0 111.877 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 25.5 ttpp -72.54 133.53 44.8 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 109.909 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.46 7.28 Favored Glycine 0 C--N 1.342 0.905 0 O-C-N 123.423 0.452 . . . . 0.0 112.053 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 69.7 mtp180 -80.64 -66.71 0.85 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -92.01 120.67 32.86 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.789 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 m -125.16 127.48 46.89 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.295 1.038 . . . . 0.0 108.213 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.546 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -125.07 140.97 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.122 0.569 . . . . 0.0 110.489 -174.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.433 ' HA ' ' OG ' ' A' ' 58' ' ' SER . 45.0 t -162.99 157.86 21.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.599 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -133.97 124.87 27.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.575 0.75 . . . . 0.0 109.364 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -103.37 122.02 43.98 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -76.8 -12.29 59.95 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.0 -48.78 67.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.618 1.167 . . . . 0.0 111.811 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 -0.06 11.0 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.13 175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 19.8 m120 53.37 68.12 0.89 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.396 1.079 . . . . 0.0 110.781 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.1 m -137.22 133.79 35.51 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.484 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.438 HG12 ' HE1' ' A' ' 37' ' ' TRP . 6.7 t -102.02 126.09 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -106.3 143.08 34.94 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.0 0.52 . . . . 0.0 110.82 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.6 tp -121.66 97.78 5.66 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 167.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -83.78 99.8 10.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.682 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.0 mtm -86.8 138.84 31.26 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -142.44 163.11 33.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.905 0.882 . . . . 0.0 109.068 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.516 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 26.9 t 54.3 42.24 31.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.014 0.926 . . . . 0.0 109.584 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.682 HD21 ' HB3' ' A' ' 84' ' ' MET . 51.6 mt -69.05 126.26 29.24 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.921 -171.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.1 mmmp? -87.83 149.99 47.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.661 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.61 -17.51 54.72 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.541 2.161 . . . . 0.0 113.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.434 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.8 pt-20 -69.46 -16.81 63.54 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.378 1.071 . . . . 0.0 112.029 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -84.43 32.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.962 0.905 . . . . 0.0 111.424 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.1 m -86.51 95.71 9.81 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -158.75 -174.25 4.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.422 0.689 . . . . 0.0 110.318 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -117.57 108.29 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 9.1 m-85 -82.28 137.02 34.94 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD13 ' HD1' ' A' ' 113' ' ' TRP . 4.1 pp -126.62 128.59 47.02 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -90.06 119.5 30.45 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.75 159.12 19.27 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.594 0.758 . . . . 0.0 109.821 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -130.97 169.07 16.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.052 0.941 . . . . 0.0 108.94 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -174.72 -178.76 44.85 Favored Glycine 0 CA--C 1.505 -0.559 0 C-N-CA 121.737 -0.268 . . . . 0.0 112.644 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.47 133.49 50.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -67.9 123.22 19.97 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -92.94 154.28 18.27 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.46 0.704 . . . . 0.0 110.788 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.0 p -69.41 -16.17 63.44 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.454 0.702 . . . . 0.0 111.754 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.2 p -67.91 -25.48 65.51 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.725 0.81 . . . . 0.0 110.919 170.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.53 -23.76 32.39 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 -173.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 35.6 t-105 -78.55 109.84 13.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.492 1.117 . . . . 0.0 108.427 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -86.49 147.67 25.87 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.021 0.529 . . . . 0.0 110.341 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 39.6 p -132.9 144.05 51.21 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.287 0.635 . . . . 0.0 110.155 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.87 91.81 0.62 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.073 1.849 . . . . 0.0 110.232 169.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -84.31 -16.09 44.25 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.482 0.713 . . . . 0.0 111.236 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 72.7 m-85 -134.26 154.09 51.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 107.92 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.421 ' HD1' HD13 ' A' ' 96' ' ' LEU . 29.6 m-90 -135.48 155.9 49.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.528 0.731 . . . . 0.0 109.428 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -78.54 -103.53 0.2 Allowed Glycine 0 C--N 1.345 1.039 0 O-C-N 123.437 0.46 . . . . 0.0 112.305 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -154.02 -14.82 0.13 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.218 0.607 . . . . 0.0 111.74 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.32 110.84 1.45 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' A' ' 7' ' ' GLU . 12.6 t -96.33 123.71 40.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.467 0.651 . . . . 0.0 109.696 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.18 116.49 21.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.297 0.639 . . . . 0.0 110.836 -177.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.82 141.96 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.744 0.818 . . . . 0.0 108.968 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.4 m -134.38 105.2 6.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.86 97.78 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.2 t -73.61 147.66 43.6 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.428 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -75.68 77.27 2.65 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.509 0.724 . . . . 0.0 110.214 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.623 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER 75.58 -30.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.445 1.498 . . . . 0.0 112.338 178.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.38 109.21 2.21 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.323 1.049 . . . . 0.0 111.376 -171.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -83.99 171.93 12.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.45 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -65.95 87.71 0.1 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.077 0.941 . . . . 0.0 111.087 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -96.95 1.38 50.3 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.888 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -110.96 121.05 44.37 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 124.983 1.313 . . . . 0.0 108.568 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -74.86 152.34 38.92 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.387 0.43 . . . . 0.0 110.185 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 . . . . . 0 CA--C 1.563 1.443 0 C-N-CA 123.242 0.617 . . . . 0.0 110.01 175.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 62.32 -168.25 0.19 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.422 1.089 . . . . 0.0 111.643 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.62 116.07 28.68 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 40.5 mt-30 -105.61 114.29 28.37 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.462 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 56.5 mt -105.08 118.29 36.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.82 102.81 14.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.66 150.03 25.42 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.049 0.94 . . . . 0.0 108.964 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 p -159.69 168.11 26.76 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.736 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.8 -5.46 61.9 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.95 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.83 146.83 45.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.679 0.24 . . . . 0.0 112.875 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.61 -176.73 47.4 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.6 tt -88.91 114.39 25.48 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 122.841 0.456 . . . . 0.0 110.148 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.76 163.31 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 165.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.487 ' HB2' HD11 ' A' ' 124' ' ' LEU . 5.4 pm0 -84.59 160.44 20.44 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -65.63 113.6 4.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.549 0.74 . . . . 0.0 109.618 174.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.01 -1.72 27.08 Favored Glycine 0 C--N 1.34 0.755 0 O-C-N 123.818 0.699 . . . . 0.0 111.737 -171.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.36 -166.18 41.69 Favored Glycine 0 C--N 1.344 1.006 0 C-N-CA 123.041 0.353 . . . . 0.0 113.044 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -144.1 138.01 27.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.644 0.778 . . . . 0.0 109.687 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.7 tp -140.58 128.06 21.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.535 0.734 . . . . 0.0 109.69 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -103.04 139.82 38.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.225 0.61 . . . . 0.0 110.07 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.544 HD22 ' HE3' ' A' ' 84' ' ' MET . 2.3 mm? -113.98 158.61 20.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.374 1.07 . . . . 0.0 109.419 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.8 m -146.7 127.54 14.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.625 ' SG ' ' HB ' ' A' ' 80' ' ' VAL . 27.1 p -124.8 115.72 21.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.248 0.619 . . . . 0.0 109.569 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.09 135.48 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.67 100.83 11.26 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.098 0.959 . . . . 0.0 109.992 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.58 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 20.2 m 64.32 33.02 11.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.684 1.594 . . . . 0.0 111.769 169.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.97 58.16 16.06 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.663 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.461 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 55.5 ttp180 62.67 68.63 0.64 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.277 1.031 . . . . 0.0 110.782 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.1 m -140.25 143.75 36.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.672 0.789 . . . . 0.0 109.133 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -105.45 120.82 42.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -145.9 -51.84 0.24 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.582 1.153 . . . . 0.0 108.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -83.53 163.72 20.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -146.95 9.35 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.509 1.124 . . . . 0.0 109.576 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.7 117.82 8.34 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.4 ttm -151.56 118.52 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -170.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -113.92 142.91 17.76 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.54 -173.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -88.41 135.57 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 92.7 m-85 -134.81 145.94 48.83 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.304 1.042 . . . . 0.0 109.063 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 12.9 ptp180 -104.14 145.24 30.48 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' O ' HG13 ' A' ' 94' ' ' VAL . 59.8 tt0 -151.02 129.08 11.79 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.92 0.782 . . . . 0.0 110.51 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.498 ' HB1' ' HG3' ' A' ' 44' ' ' LYS . . . -100.72 161.17 24.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.8 114.78 2.15 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.429 2.086 . . . . 0.0 111.598 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.288 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.498 ' HG3' ' HB1' ' A' ' 41' ' ' ALA . 9.3 mmpt? -128.02 153.93 46.21 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.285 1.034 . . . . 0.0 109.243 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.86 151.44 30.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.994 0.518 . . . . 0.0 110.664 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.07 113.42 13.57 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.647 0.592 . . . . 0.0 110.321 177.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -93.47 139.0 31.21 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.16 0.984 . . . . 0.0 110.104 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -64.94 110.24 2.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.23 1.412 . . . . 0.0 110.736 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.7 t -95.05 -48.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.318 0.647 . . . . 0.0 109.637 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.86 19.3 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.527 0.731 . . . . 0.0 110.815 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -155.69 130.43 9.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 0.0 110.564 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.04 111.47 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -119.77 126.09 50.19 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.558 ' HA ' ' NH1' ' A' ' 73' ' ' ARG . 18.1 t90 -52.31 -55.13 23.45 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.332 1.02 . . . . 0.0 111.458 -165.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.0 p -112.91 118.35 34.63 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.891 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.42 23.42 7.27 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-O 119.676 -0.513 . . . . 0.0 114.125 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.22 -80.81 0.09 OUTLIER Glycine 0 C--N 1.348 1.208 0 CA-C-N 117.398 0.599 . . . . 0.0 112.598 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.9 m 63.48 9.87 4.48 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.013 1.325 . . . . 0.0 113.144 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 p -165.73 149.73 8.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.984 1.314 . . . . 0.0 108.756 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.435 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -154.47 118.23 4.64 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.7 140.35 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.812 0.845 . . . . 0.0 110.196 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.94 167.9 12.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.68 0.792 . . . . 0.0 109.459 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.03 -31.41 72.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.859 0.464 . . . . 0.0 110.869 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.5 p -64.01 -27.1 68.89 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.607 1.163 . . . . 0.0 112.539 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.94 5.62 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.409 0.684 . . . . 0.0 111.516 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -67.42 113.76 5.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.899 0.879 . . . . 0.0 109.785 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.81 -27.72 17.71 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.238 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.08 -70.88 0.47 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.959 0.904 . . . . 0.0 109.631 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -90.49 120.87 31.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.9 m -135.01 138.42 43.95 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.163 0.985 . . . . 0.0 109.188 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.2 143.05 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.134 0.974 . . . . 0.0 109.46 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.7 t -138.45 142.45 39.46 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.487 1.115 . . . . 0.0 108.136 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.558 ' NH1' ' HA ' ' A' ' 54' ' ' TRP . 42.4 ttp180 -115.91 123.48 48.19 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.84 129.59 49.56 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -86.85 -35.93 18.76 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.907 0.883 . . . . 0.0 110.178 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.13 78.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.425 1.09 . . . . 0.0 112.749 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -118.05 14.79 14.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.413 0.285 . . . . 0.0 111.233 175.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 18.5 m120 51.71 59.0 4.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.598 1.159 . . . . 0.0 111.488 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -126.67 129.27 48.13 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.63 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.625 ' HB ' ' SG ' ' A' ' 23' ' ' CYS . 47.7 t -103.14 125.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -101.95 150.58 23.06 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.668 0.787 . . . . 0.0 110.39 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 tp -133.0 99.18 4.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.964 0.905 . . . . 0.0 108.814 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -86.58 102.17 13.9 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.544 ' HE3' HD22 ' A' ' 21' ' ' LEU . 47.8 mtm -95.08 119.22 33.21 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.591 0.756 . . . . 0.0 109.182 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -116.21 151.38 35.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.743 0.817 . . . . 0.0 108.953 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t 59.96 69.07 0.73 Allowed 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.291 0.994 . . . . 0.0 110.02 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 84' ' ' MET . 62.4 mt -88.16 155.82 19.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.384 -176.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 11.0 mmmm -116.65 155.66 48.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.709 1.204 . . . . 0.0 109.677 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.427 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 30.5 Cg_endo -61.08 -22.58 75.13 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.631 2.221 . . . . 0.0 112.919 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.27 -21.68 65.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.118 0.967 . . . . 0.0 112.07 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.66 17.43 0.7 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.999 0.92 . . . . 0.0 111.766 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.0 m -80.36 94.12 6.09 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 164.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.84 -178.82 6.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.875 0.87 . . . . 0.0 110.149 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 40' ' ' GLN . 11.4 p -100.09 114.95 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -85.83 109.96 19.05 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -115.15 145.81 42.0 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.493 0.717 . . . . 0.0 110.175 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 79.3 m -92.13 157.93 16.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 110' ' ' PRO . . . -141.69 115.76 9.32 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.67 132.06 55.35 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.426 0.691 . . . . 0.0 110.618 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.97 -153.43 7.21 Favored Glycine 0 C--O 1.241 0.581 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.0 m -138.91 150.46 23.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 123.318 0.647 . . . . 0.0 110.088 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 108' ' ' ASP . 30.4 p-90 -74.11 80.95 1.75 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 164.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.405 ' HE ' ' HB2' ' A' ' 107' ' ' TRP . 28.3 ptt180 -65.42 165.13 12.49 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.167 -171.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.8 m -63.17 -17.21 62.14 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.218 1.007 . . . . 0.0 112.478 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.0 t -64.82 -24.9 67.69 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.06 0.944 . . . . 0.0 111.58 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.32 -18.56 23.11 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.144 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.405 ' HB2' ' HE ' ' A' ' 103' ' ' ARG . 74.8 m95 -85.16 132.56 34.28 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.613 0.765 . . . . 0.0 110.581 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 102' ' ' TRP . 25.7 t70 -86.85 95.33 9.83 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 168.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -108.05 114.51 59.72 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.627 0.771 . . . . 0.0 111.264 -171.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HB2' ' HB3' ' A' ' 98' ' ' ALA . 67.8 Cg_endo -72.26 96.08 0.79 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.521 2.147 . . . . 0.0 109.774 167.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.31 -28.55 63.15 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.35 0.66 . . . . 0.0 111.23 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -119.41 146.61 45.21 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.865 0.866 . . . . 0.0 108.869 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -121.17 159.45 25.83 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.44 178.54 47.59 Favored Glycine 0 C--O 1.24 0.497 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.191 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -20.89 58.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.909 0.483 . . . . 0.0 111.174 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.91 125.03 0.64 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.844 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -99.52 121.16 40.77 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.63 112.25 10.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.055 0.542 . . . . 0.0 110.03 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.8 m -103.09 143.19 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 96.7 m -133.46 102.84 5.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.51 94.23 4.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -53.53 147.66 10.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.944 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.3 m -83.73 55.3 3.18 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.945 0.898 . . . . 0.0 110.207 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 14' ' ' GLN . 3.4 mm? 59.87 20.24 9.17 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.773 1.229 . . . . 0.0 112.136 -174.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -80.42 -64.45 1.19 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.209 0.604 . . . . 0.0 109.453 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.5 t60 71.78 -17.59 0.34 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.107 1.763 . . . . 0.0 113.656 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -71.56 171.6 11.12 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 123.796 0.839 . . . . 0.0 112.429 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -57.31 151.37 16.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.91 0.884 . . . . 0.0 111.732 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -153.7 129.21 9.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.293 1.037 . . . . 0.0 108.854 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -85.04 105.21 15.62 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.414 0.685 . . . . 0.0 109.346 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 . . . . . 0 C--O 1.251 1.174 0 C-N-CA 123.465 0.706 . . . . 0.0 109.179 174.724 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.1 mtp . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -113.69 117.99 33.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.539 0.736 . . . . 0.0 109.016 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.2 111.66 9.59 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -92.59 136.71 32.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.123 0.969 . . . . 0.0 109.437 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD13 ' SG ' ' A' ' 97' ' ' CYS . 49.1 mt -113.42 127.29 56.06 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.406 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 59.5 t -115.48 103.18 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.35 147.88 26.93 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.706 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.2 p -157.91 173.39 16.86 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.602 1.161 . . . . 0.0 109.093 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.67 -17.78 57.86 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.18 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -67.14 124.96 23.84 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 122.784 0.23 . . . . 0.0 112.686 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.86 -167.28 26.25 Favored Glycine 0 C--O 1.245 0.81 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -91.27 119.13 31.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.967 0.507 . . . . 0.0 110.258 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -124.88 169.75 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.327 1.051 . . . . 0.0 109.082 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -87.51 152.2 22.4 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.15 0.58 . . . . 0.0 111.04 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.507 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -66.36 119.06 10.93 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.338 1.055 . . . . 0.0 110.176 175.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.35 -16.14 38.39 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.771 0.669 . . . . 0.0 111.612 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.95 178.62 43.75 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.097 0.38 . . . . 0.0 113.825 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.9 p -107.92 162.66 13.81 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.042 0.937 . . . . 0.0 111.54 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.12 126.21 4.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 0.0 108.203 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -106.21 123.35 47.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -89.42 157.39 18.16 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.593 1.157 . . . . 0.0 109.559 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.6 m -139.15 124.42 19.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.727 0.811 . . . . 0.0 108.984 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 25.8 t -116.64 102.87 9.83 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.1 0.96 . . . . 0.0 109.425 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.6 t -91.51 126.54 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.553 0.741 . . . . 0.0 109.168 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.91 100.02 12.86 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m 55.85 33.33 21.34 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.14 1.376 . . . . 0.0 112.089 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.8 -84.76 1.1 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -141.58 95.86 2.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.611 0.764 . . . . 0.0 109.284 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 t -135.26 168.19 19.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.195 0.998 . . . . 0.0 108.453 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -140.25 120.37 13.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.389 0.676 . . . . 0.0 109.557 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -171.81 -72.95 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 0.0 108.999 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -84.32 129.24 34.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.314 0.646 . . . . 0.0 109.263 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.418 ' HB2' ' HD1' ' A' ' 54' ' ' TRP . 13.6 m120 -121.3 16.14 11.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 109.876 176.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.96 118.4 32.82 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.019 0.928 . . . . 0.0 108.521 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -137.86 121.39 17.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.132 0.973 . . . . 0.0 109.104 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -99.27 136.14 12.52 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -86.94 132.11 33.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 109.921 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -132.97 171.71 13.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.044 1.338 . . . . 0.0 108.882 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -149.28 142.03 24.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.471 0.708 . . . . 0.0 109.848 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -133.27 131.95 40.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.98 0.512 . . . . 0.0 110.348 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.45 146.18 31.97 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 123.96 0.904 . . . . 0.0 109.101 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -54.9 118.71 5.44 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.957 2.438 . . . . 0.0 113.098 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.79 71.91 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 113.489 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -128.75 167.79 16.78 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 166.47 22.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.132 0.973 . . . . 0.0 110.037 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 122.92 31.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -93.5 142.13 27.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.9 0.88 . . . . 0.0 109.896 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -65.32 130.6 43.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.824 1.25 . . . . 0.0 110.336 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.38 -54.86 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.917 0.887 . . . . 0.0 108.774 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.46 170.39 20.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.561 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -160.98 128.61 4.27 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 121.284 0.564 . . . . 0.0 110.86 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.541 HD13 ' HB ' ' A' ' 71' ' ' ILE . 2.7 mp -110.59 113.49 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.538 ' H ' ' HA ' ' A' ' 58' ' ' SER . 73.2 mtp180 -94.12 175.27 6.77 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.709 0.404 . . . . 0.0 110.666 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.418 ' HD1' ' HB2' ' A' ' 33' ' ' ASN . 65.7 t90 -54.44 -44.34 72.39 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.885 0.741 . . . . 0.0 109.86 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.5 p -166.65 -178.96 4.6 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.418 1.087 . . . . 0.0 109.827 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.77 31.54 53.34 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.425 0.453 . . . . 0.0 113.722 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.56 -75.18 0.21 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.538 ' HA ' ' H ' ' A' ' 53' ' ' ARG . 77.5 p 54.92 24.7 6.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.239 1.416 . . . . 0.0 114.094 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.486 HG23 HD12 ' A' ' 71' ' ' ILE . 21.2 p -160.55 123.99 3.45 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.483 1.113 . . . . 0.0 108.986 -172.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -147.39 137.17 22.91 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -165.68 157.83 14.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.873 1.269 . . . . 0.0 109.808 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 65' ' ' VAL . . . -85.59 149.63 25.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.15 -32.35 72.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.873 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 m -69.93 -38.0 76.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.165 0.586 . . . . 0.0 111.626 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' A' ' 62' ' ' ALA . 14.6 m -96.71 -2.16 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.009 0.524 . . . . 0.0 111.593 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -61.69 128.69 37.44 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.65 0.78 . . . . 0.0 109.231 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.66 -26.55 17.65 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.629 0.581 . . . . 0.0 112.602 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -89.77 -54.9 3.85 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -84.73 121.05 27.12 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.351 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 132.39 51.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.539 1.136 . . . . 0.0 108.018 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.541 ' HB ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -102.48 149.94 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.32 178.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 20.2 m -141.91 146.56 35.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 109.471 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.57 132.15 23.85 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.09 103.61 8.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.431 1.092 . . . . 0.0 108.42 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.43 -17.27 63.63 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.192 0.997 . . . . 0.0 111.962 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -46.39 75.07 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.964 0.905 . . . . 0.0 112.397 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.449 ' HE3' ' HB ' ' A' ' 79' ' ' THR . 0.3 OUTLIER -118.53 -0.74 11.32 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.62 0.768 . . . . 0.0 110.665 176.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 55.77 68.81 0.81 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.842 1.257 . . . . 0.0 111.32 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.449 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 98.7 m -132.71 131.58 41.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.396 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 125.8 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.418 1.087 . . . . 0.0 109.066 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.498 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 71.1 m-85 -106.52 155.57 19.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.56 0.744 . . . . 0.0 110.307 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 50.5 tp -133.92 98.43 4.15 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.47 0.708 . . . . 0.0 109.389 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.41 99.86 10.93 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.208 0.603 . . . . 0.0 109.423 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.736 ' HB3' HD21 ' A' ' 87' ' ' LEU . 75.0 mtp -100.66 101.06 11.86 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.753 0.821 . . . . 0.0 110.474 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.7 144.87 28.27 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.075 0.55 . . . . 0.0 111.082 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.1 t 60.97 72.95 0.5 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.854 1.261 . . . . 0.0 110.523 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' A' ' 84' ' ' MET . 67.5 mt -88.24 159.63 18.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.95 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -106.84 150.68 40.02 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.179 0.992 . . . . 0.0 108.657 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.98 -16.15 53.25 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.552 2.168 . . . . 0.0 112.958 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.77 -2.63 44.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.032 0.933 . . . . 0.0 112.142 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -90.76 37.38 0.92 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.604 0.762 . . . . 0.0 110.821 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.5 m -91.66 93.13 8.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.33 -177.23 5.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.759 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -104.55 109.83 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.031 0.532 . . . . 0.0 109.901 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.56 129.03 34.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.92 137.47 47.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 109.776 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.8 p -92.8 159.31 15.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 109.487 173.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 110' ' ' PRO . . . -133.12 145.04 50.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.62 123.69 50.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.21 178.55 16.86 Favored Glycine 0 C--O 1.246 0.873 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.632 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.18 160.34 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.041 0.937 . . . . 0.0 110.019 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -74.86 85.11 2.21 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -74.48 150.77 39.72 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.445 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.9 m -59.39 -37.14 77.21 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.48 1.112 . . . . 0.0 112.15 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 t -64.18 -25.17 67.96 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.566 0.746 . . . . 0.0 111.635 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.55 -29.72 8.11 Favored Glycine 0 C--N 1.346 1.138 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -69.91 117.99 12.19 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.702 0.801 . . . . 0.0 108.944 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -76.25 139.69 41.25 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.4 p -128.69 125.27 23.0 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 123.505 0.722 . . . . 0.0 110.332 -173.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 36.2 Cg_exo -62.38 91.04 0.12 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.707 2.272 . . . . 0.0 111.819 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.1 -23.53 59.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.51 0.724 . . . . 0.0 110.983 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.537 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 79.8 m-85 -133.43 155.34 49.71 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.012 0.925 . . . . 0.0 109.079 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -127.28 158.86 36.08 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.97 -170.04 45.73 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.042 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' A' ' 6' ' ' VAL . 9.8 pt20 -86.64 -21.1 26.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.558 0.743 . . . . 0.0 110.715 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 158.55 32.2 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.559 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.1 t -138.93 118.22 12.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.775 0.83 . . . . 0.0 108.809 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.22 103.48 8.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.486 0.714 . . . . 0.0 110.719 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.443 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -93.23 143.77 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 93.6 m -134.33 102.06 5.22 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.05 97.02 5.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 t -68.55 145.99 53.5 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.999 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -74.07 84.9 1.81 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.239 0.616 . . . . 0.0 110.155 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 15' ' ' ALA . 3.9 mm? 70.24 -65.48 0.32 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.47 1.508 . . . . 0.0 112.327 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.45 106.11 2.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.015 0.926 . . . . 0.0 111.477 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -73.29 126.35 29.92 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -149.9 107.29 3.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.497 0.319 . . . . 0.0 110.188 -175.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -158.98 79.22 0.77 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.409 1.083 . . . . 0.0 108.677 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -97.61 109.08 21.9 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.949 -174.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -66.16 -36.25 82.62 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.996 0.918 . . . . 0.0 112.307 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.254 1.312 0 C-N-CA 123.598 0.759 . . . . 0.0 108.964 179.365 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -72.04 90.44 1.17 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.988 0.915 . . . . 0.0 109.994 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -94.0 114.62 26.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.707 0.803 . . . . 0.0 109.501 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.04 132.89 35.26 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.777 0.831 . . . . 0.0 110.155 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.5 mt -130.91 124.57 31.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.365 1.066 . . . . 0.0 108.579 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -121.32 101.25 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.209 0.604 . . . . 0.0 109.636 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.85 132.91 35.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.235 0.614 . . . . 0.0 109.635 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.3 m -144.35 163.77 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.147 0.979 . . . . 0.0 109.512 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.407 ' O ' HD11 ' A' ' 19' ' ' LEU . . . 117.73 -19.93 11.12 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.504 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.12 119.6 19.13 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 123.214 0.435 . . . . 0.0 112.871 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.23 -175.93 29.71 Favored Glycine 0 C--N 1.347 1.161 0 C-N-CA 123.431 0.538 . . . . 0.0 112.104 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 120' ' ' THR . 25.6 tp -89.85 114.46 26.21 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.354 0.662 . . . . 0.0 110.37 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.8 145.97 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 4.8 pm0 -75.22 154.65 37.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.126 0.421 . . . . 0.0 110.568 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' HB1' ' HD3' ' A' ' 89' ' ' PRO . . . -58.14 113.68 2.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.559 0.744 . . . . 0.0 111.36 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.98 -4.41 25.66 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.122 0.867 . . . . 0.0 111.511 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.44 -165.68 39.83 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 123.345 0.498 . . . . 0.0 112.839 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -141.46 150.47 42.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.749 0.82 . . . . 0.0 111.129 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 9' ' ' GLY . 31.2 tp -147.33 122.91 10.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.661 0.784 . . . . 0.0 109.072 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -103.13 119.26 38.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.047 0.539 . . . . 0.0 110.139 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.414 HD23 ' HE3' ' A' ' 84' ' ' MET . 2.4 mm? -87.47 157.46 19.19 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 m -143.22 127.34 17.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.941 0.896 . . . . 0.0 108.775 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.53 120.19 36.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.875 0.87 . . . . 0.0 109.81 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.66 115.18 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.541 0.736 . . . . 0.0 109.14 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HB2' ' HE3' ' A' ' 35' ' ' MET . . . -90.85 103.07 15.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.101 0.56 . . . . 0.0 110.633 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.1 p 52.75 57.68 6.13 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.999 1.72 . . . . 0.0 112.404 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.91 -82.84 0.4 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.407 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -160.54 41.79 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.594 1.187 . . . . 0.0 108.066 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -111.31 155.92 22.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.99 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -107.06 118.82 37.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -151.47 171.4 17.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.006 1.322 . . . . 0.0 107.759 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 t 65.69 114.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.807 1.243 . . . . 0.0 110.848 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.455 ' ND2' ' HB2' ' A' ' 102' ' ' TRP . 2.2 p-10 -55.37 -32.36 62.52 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.887 0.875 . . . . 0.0 113.133 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.06 151.71 46.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 111.02 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.44 ' HE3' ' HB2' ' A' ' 25' ' ' ALA . 67.7 mtt -140.87 147.68 39.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 107.904 174.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.51 150.25 22.23 Favored Glycine 0 N--CA 1.467 0.723 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.858 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -91.23 149.4 21.78 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.2 152.14 49.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.222 1.409 . . . . 0.0 108.665 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -125.27 135.32 52.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.464 0.705 . . . . 0.0 109.181 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -147.56 130.95 16.62 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 123.313 0.645 . . . . 0.0 109.474 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HB1' ' HG3' ' A' ' 44' ' ' LYS . . . -88.96 154.22 49.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -53.59 105.56 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.643 2.229 . . . . 0.0 112.888 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.2 31.53 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.509 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HG3' ' HB1' ' A' ' 41' ' ' ALA . 6.6 mmpt? -126.33 174.5 8.53 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.966 0.907 . . . . 0.0 110.853 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -82.8 144.36 30.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.762 0.825 . . . . 0.0 110.208 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.29 116.34 24.4 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.046 0.45 . . . . 0.0 110.005 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -92.31 142.36 27.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.648 0.779 . . . . 0.0 109.904 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -73.61 107.77 6.07 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.717 0.807 . . . . 0.0 109.52 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -86.9 -54.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.714 0.806 . . . . 0.0 110.357 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -137.49 160.21 39.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -170.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.47 121.12 14.29 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 125.102 1.361 . . . . 0.0 108.873 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.5 mp -121.68 116.08 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -107.13 90.53 3.33 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.507 0.594 . . . . 0.0 110.022 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 63.85 -75.99 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.117 1.767 . . . . 0.0 111.726 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.8 p -163.25 145.3 9.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.244 1.017 . . . . 0.0 109.69 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.71 -19.26 34.09 Favored Glycine 0 N--CA 1.475 1.267 0 CA-C-O 120.081 -0.289 . . . . 0.0 113.815 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.62 44.72 1.28 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.1 m -101.99 60.73 0.86 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.961 0.905 . . . . 0.0 110.017 -175.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.445 ' HA ' HD12 ' A' ' 71' ' ' ILE . 17.8 p -146.57 120.84 9.56 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 12.3 t80 -171.38 131.94 0.77 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.56 134.99 9.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.06 150.47 33.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.923 0.489 . . . . 0.0 111.029 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 29.9 t70 -66.3 -18.86 65.61 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -72.97 -34.24 66.36 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.385 0.674 . . . . 0.0 111.219 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -106.96 15.97 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.788 0.835 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -65.93 121.17 14.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.36 1.064 . . . . 0.0 110.749 -176.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.52 -27.6 16.77 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.361 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.485 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 4.0 ptt180 -94.82 -28.08 15.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.394 0.597 . . . . 0.0 109.988 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.485 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -99.73 132.66 44.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.357 0.663 . . . . 0.0 109.282 173.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.9 m -137.99 145.23 41.67 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.889 1.276 . . . . 0.0 108.125 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -128.57 159.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.564 0.746 . . . . 0.0 109.884 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.8 t -156.78 139.69 15.29 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.74 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HD2' HG22 ' A' ' 52' ' ' ILE . 50.2 ttt85 -115.19 120.54 40.06 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.77 107.67 18.75 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 109.303 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.34 -34.49 75.36 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.4 1.062 . . . . 0.0 111.283 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.54 -44.68 69.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.336 1.054 . . . . 0.0 112.963 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.77 7.6 11.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.074 0.55 . . . . 0.0 111.729 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.6 m120 53.66 38.37 28.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.488 1.115 . . . . 0.0 111.784 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 32.2 m -114.43 130.99 56.74 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.705 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG22 ' HG3' ' A' ' 73' ' ' ARG . 39.8 t -104.63 121.31 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.749 0.82 . . . . 0.0 108.814 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -101.13 152.79 20.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.762 . . . . 0.0 111.261 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.7 tp -132.94 97.83 4.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.287 1.035 . . . . 0.0 108.374 171.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -80.51 101.35 9.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.606 ' HB3' HD21 ' A' ' 87' ' ' LEU . 34.3 mtm -92.71 135.63 33.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.49 170.09 16.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 t 58.61 33.45 23.1 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.859 0.864 . . . . 0.0 110.767 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -71.94 156.94 38.7 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.673 -173.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.613 ' HZ1' ' HB3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -132.06 158.3 75.89 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.848 1.259 . . . . 0.0 108.189 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.448 ' HD3' ' HB1' ' A' ' 15' ' ' ALA . 13.0 Cg_endo -53.68 -24.4 29.77 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 123.061 2.507 . . . . 0.0 114.522 -169.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.576 ' HG2' ' HG2' ' A' ' 88' ' ' LYS . 13.1 pt-20 -65.74 -18.76 65.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 0.0 112.589 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.408 ' HB2' HG23 ' A' ' 121' ' ' VAL . 65.3 m-20 -82.36 30.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.493 0.717 . . . . 0.0 110.959 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 120' ' ' THR . 95.9 m -83.14 93.56 7.66 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 164.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.6 27.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.431 0.692 . . . . 0.0 110.625 -172.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.53 120.89 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.009 0.524 . . . . 0.0 109.958 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -95.56 125.93 40.5 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -129.35 144.11 51.11 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 109.742 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -92.8 157.76 16.24 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.54 150.25 46.17 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.341 0.656 . . . . 0.0 109.518 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -113.4 132.03 55.77 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.71 178.84 16.43 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 121.353 0.418 . . . . 0.0 113.459 -172.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 p -139.47 115.74 9.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 124.035 0.934 . . . . 0.0 108.633 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.455 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 14.6 t90 -79.61 141.7 36.3 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.196 -171.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -105.52 153.84 21.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.567 1.147 . . . . 0.0 110.133 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 t -67.3 -21.09 65.7 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.878 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.5 p -68.66 -25.29 64.74 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.385 0.674 . . . . 0.0 110.634 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.59 -9.11 24.02 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 116.71 -0.223 . . . . 0.0 113.508 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -89.93 159.7 16.8 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.483 0.713 . . . . 0.0 109.897 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -116.35 141.69 47.83 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.8 p -116.84 109.51 43.06 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.146 0.578 . . . . 0.0 109.998 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.57 91.74 0.35 Allowed 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.738 2.292 . . . . 0.0 110.648 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -83.48 -22.59 32.49 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.115 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 21.9 m-85 -122.48 147.44 46.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.03 0.932 . . . . 0.0 108.525 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.8 m-90 -130.11 162.06 29.65 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 108.846 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.27 -142.93 7.78 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.438 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -102.34 -27.95 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 110.661 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.55 156.08 24.13 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.109 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.46 119.37 11.9 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.98 103.0 5.01 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -85.53 137.96 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 32.1 m -133.38 110.47 10.05 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 91' ' ' ASP . 48.0 t -91.89 103.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 35.5 t -45.35 143.0 1.9 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.387 1.075 . . . . 0.0 112.308 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.5 p -70.15 167.67 17.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.779 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.25 -41.22 88.25 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.919 0.488 . . . . 0.0 111.476 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -146.86 122.03 10.16 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 122.66 0.384 . . . . 0.0 110.438 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -147.6 107.61 4.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.945 0.898 . . . . 0.0 108.74 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -84.92 19.67 2.05 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.588 0.755 . . . . 0.0 111.637 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -122.16 166.58 14.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.632 0.773 . . . . 0.0 109.958 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -115.22 -77.54 0.57 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -179.19 -55.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.013 0.925 . . . . 0.0 111.085 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.0 m80 . . . . . 0 C--O 1.257 1.486 0 C-N-CA 124.523 1.129 . . . . 0.0 109.388 -160.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 62.25 -170.06 0.17 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.989 0.916 . . . . 0.0 111.709 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.673 HD22 ' HB2' ' A' ' 26' ' ' SER . 2.0 tm? -75.35 115.89 15.48 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -103.12 150.32 23.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.571 1.149 . . . . 0.0 108.383 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.486 HD21 ' HG ' ' A' ' 23' ' ' CYS . 95.1 mt -131.27 108.76 9.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.092 0.557 . . . . 0.0 110.137 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.6 107.72 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.096 0.958 . . . . 0.0 108.821 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -99.22 155.24 17.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.1 m -153.56 155.63 36.52 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.836 1.654 . . . . 0.0 109.145 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.02 10.12 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 123.171 0.415 . . . . 0.0 112.887 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -71.05 90.13 0.41 Allowed Glycine 0 C--N 1.347 1.146 0 O-C-N 123.484 0.167 . . . . 0.0 113.206 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.31 -175.61 13.93 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -94.76 118.32 31.56 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.063 0.545 . . . . 0.0 110.041 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.63 167.36 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 109.271 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.468 ' NE2' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -84.24 152.83 23.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.797 0.839 . . . . 0.0 110.478 175.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' HB2' HD23 ' A' ' 124' ' ' LEU . . . -68.12 121.85 17.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.68 -22.39 14.92 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.077 0.846 . . . . 0.0 111.31 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.468 ' HA3' ' NE2' ' A' ' 14' ' ' GLN . . . -81.84 -166.99 38.41 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 121.225 0.347 . . . . 0.0 113.492 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 p -127.31 156.1 42.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.565 0.746 . . . . 0.0 110.891 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -152.66 133.24 13.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.006 0.922 . . . . 0.0 108.636 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -113.17 124.16 51.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.992 0.517 . . . . 0.0 109.706 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.37 157.12 19.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.906 0.882 . . . . 0.0 109.443 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.9 p -142.32 135.32 28.58 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.211 1.004 . . . . 0.0 108.725 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.486 ' HG ' HD21 ' A' ' 5' ' ' LEU . 53.8 t -140.06 116.83 10.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.24 0.616 . . . . 0.0 110.095 -177.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.53 122.86 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.58 102.57 15.31 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.037 0.935 . . . . 0.0 110.515 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.673 ' HB2' HD22 ' A' ' 3' ' ' LEU . 11.6 t 69.97 22.73 5.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.53 1.532 . . . . 0.0 111.906 168.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 56.97 10.24 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 86.6 mtm180 60.6 56.37 3.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.371 1.069 . . . . 0.0 110.948 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 47.2 m -137.3 150.33 47.7 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.817 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -103.14 127.42 50.43 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.595 ' HB3' HD21 ' A' ' 3' ' ' LEU . 44.3 ttm180 -170.51 -35.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.594 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 p -71.1 103.77 2.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.225 0.61 . . . . 0.0 110.52 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.8 OUTLIER -79.32 -34.65 42.09 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.7 0.8 . . . . 0.0 109.415 174.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.01 49.18 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.769 1.228 . . . . 0.0 108.948 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 50.2 mtm -150.54 168.43 24.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.932 1.693 . . . . 0.0 108.567 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.02 35.52 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -122.37 135.51 54.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 168.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -122.95 164.38 18.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.147 1.379 . . . . 0.0 108.326 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -138.11 151.18 47.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -153.94 150.41 28.29 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.42 145.34 30.61 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.95 104.53 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.371 2.714 . . . . 0.0 113.386 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.79 -12.58 50.02 Favored Glycine 0 C--N 1.352 1.469 0 C-N-CA 122.9 0.286 . . . . 0.0 113.349 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -97.99 173.53 7.01 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.0 0.92 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -78.13 170.06 17.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.909 0.883 . . . . 0.0 110.433 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.423 ' H ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -100.59 151.67 21.33 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.181 0.515 . . . . 0.0 110.681 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -115.75 139.53 50.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.668 1.587 . . . . 0.0 109.005 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.51 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 59.5 t80 -83.27 109.78 17.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.086 0.955 . . . . 0.0 109.155 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.7 t -90.09 -52.47 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.671 0.788 . . . . 0.0 110.288 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -148.83 169.83 19.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.112 -168.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.51 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -149.28 119.05 7.04 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.61 1.164 . . . . 0.0 109.512 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.673 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.0 mp -120.78 116.53 50.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 C-N-CA 123.801 0.84 . . . . 0.0 109.344 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' H ' ' HA ' ' A' ' 58' ' ' SER . 2.5 mpt_? -95.74 177.63 5.72 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -80.43 -30.88 37.63 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 165.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 p -164.18 149.73 10.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.721 1.208 . . . . 0.0 109.693 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.09 -9.78 33.8 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.239 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.21 -81.36 0.05 OUTLIER Glycine 0 C--N 1.349 1.298 0 CA-C-N 117.903 0.852 . . . . 0.0 111.434 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.7 m 64.06 21.1 12.47 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.676 1.19 . . . . 0.0 113.617 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.532 ' HA ' HD13 ' A' ' 71' ' ' ILE . 19.3 p -151.33 126.11 9.66 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 6.0 t80 -166.47 130.2 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.73 150.73 12.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.616 1.566 . . . . 0.0 108.139 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.47 155.07 39.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.304 0.642 . . . . 0.0 110.729 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.88 -31.79 73.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.265 0.626 . . . . 0.0 111.42 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -69.37 -33.9 73.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.747 0.819 . . . . 0.0 111.77 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' HA ' HH21 ' A' ' 68' ' ' ARG . 31.1 m -102.53 -0.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.711 0.804 . . . . 0.0 111.722 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.16 134.94 56.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.052 1.341 . . . . 0.0 112.313 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.37 5.54 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.623 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.581 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 75.3 mtm180 -89.64 -51.78 5.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.008 0.908 . . . . 0.0 109.173 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -86.7 122.71 30.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.677 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -146.15 150.5 36.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.012 1.325 . . . . 0.0 108.037 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -121.42 155.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.959 0.904 . . . . 0.0 110.445 -177.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -146.78 134.07 20.63 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.957 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.601 ' HB2' HG21 ' A' ' 52' ' ' ILE . 32.3 ttt180 -112.21 130.8 55.8 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -116.42 116.06 26.98 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -87.51 -11.66 48.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.925 0.33 . . . . 0.0 111.642 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.33 94.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.135 0.574 . . . . 0.0 111.455 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -119.62 15.68 12.8 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 122.355 0.262 . . . . 0.0 110.957 169.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 16.9 m120 44.45 63.66 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.077 1.351 . . . . 0.0 111.982 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.5 m -131.29 132.61 44.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.394 0.677 . . . . 0.0 109.758 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.7 t -102.66 143.73 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.561 1.144 . . . . 0.0 108.623 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -125.78 142.22 51.62 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.585 0.754 . . . . 0.0 110.071 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.3 tp -126.85 96.8 4.75 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -89.98 107.75 19.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.6 mtm -107.96 119.08 38.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.959 0.904 . . . . 0.0 109.045 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -112.38 148.63 33.9 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.421 0.689 . . . . 0.0 110.229 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 41.6 t 56.47 68.86 0.8 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.434 1.093 . . . . 0.0 110.162 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -78.77 160.87 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.469 -1.242 . . . . 0.0 111.47 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.591 ' HB2' ' HZ2' ' A' ' 88' ' ' LYS . 8.0 mtmp? -127.61 147.39 62.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.425 -169.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -57.96 -29.35 86.3 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.34 2.694 . . . . 0.0 114.098 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 pm0 -78.67 -2.88 41.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.323 0.649 . . . . 0.0 111.843 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -86.67 25.68 1.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.0 0.92 . . . . 0.0 110.733 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 120' ' ' THR . 87.7 m -87.74 92.68 9.2 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.22 168.04 27.5 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.523 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.38 106.81 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-O 121.565 0.698 . . . . 0.0 109.765 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -89.9 114.41 26.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -111.74 146.97 36.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.175 0.59 . . . . 0.0 109.666 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -90.55 159.41 16.49 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.63 40.6 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.9 0.88 . . . . 0.0 109.089 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -152.97 170.0 21.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.607 0.763 . . . . 0.0 110.59 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.63 -154.8 25.83 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.96 140.01 46.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -66.51 148.85 51.3 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.388 0.43 . . . . 0.0 109.953 173.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.56 173.12 9.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.181 0.992 . . . . 0.0 112.279 -173.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -65.57 -24.34 67.07 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.623 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.2 t -70.46 -24.01 62.8 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.937 0.895 . . . . 0.0 111.164 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.58 -13.39 61.16 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.166 -174.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -66.42 114.81 5.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.911 0.884 . . . . 0.0 110.026 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.66 144.33 49.42 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 123.501 0.501 . . . . 0.0 109.843 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.8 t -146.79 131.96 9.06 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.187 0.595 . . . . 0.0 110.247 -172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.3 83.63 1.22 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.426 2.084 . . . . 0.0 111.305 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.97 -18.73 64.11 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.013 0.925 . . . . 0.0 111.012 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -134.76 151.63 51.12 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 125.14 1.376 . . . . 0.0 108.459 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -126.14 162.23 25.84 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.961 0.904 . . . . 0.0 109.255 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -94.14 177.23 36.49 Favored Glycine 0 C--O 1.241 0.552 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.927 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.7 -25.89 65.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.562 0.745 . . . . 0.0 111.221 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.36 110.81 0.23 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.753 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -99.02 118.92 36.89 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.458 0.647 . . . . 0.0 110.044 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.25 103.92 6.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.099 0.96 . . . . 0.0 111.135 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.544 HG12 ' HA2' ' A' ' 10' ' ' GLY . 9.0 m -90.05 152.0 3.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 85.3 m -132.72 106.61 7.87 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.54 0.736 . . . . 0.0 109.026 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.2 96.2 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 t -68.44 144.06 54.83 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.649 0.38 . . . . 0.0 110.766 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -67.65 92.51 0.33 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.127 0.971 . . . . 0.0 111.813 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 15' ' ' ALA . 4.3 mm? 61.56 13.16 4.96 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.565 1.146 . . . . 0.0 113.19 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -92.28 99.72 12.44 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 120.943 0.401 . . . . 0.0 110.312 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -76.57 78.79 3.25 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -70.33 -43.46 70.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.892 -173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 61.52 94.02 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 O-C-N 124.621 1.201 . . . . 0.0 112.344 171.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -156.09 119.32 4.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.186 0.595 . . . . 0.0 109.398 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -95.51 120.63 36.11 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.49 0.716 . . . . 0.0 109.376 175.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 CA--C 1.562 1.422 0 C-N-CA 124.806 1.242 . . . . 0.0 111.433 -177.933 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -67.71 177.64 1.98 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.822 0.849 . . . . 0.0 112.967 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.4 117.11 5.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.799 0.839 . . . . 0.0 111.902 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 36.3 mt-30 -103.59 128.67 50.81 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.6 mp -127.12 122.88 35.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.2 t -114.39 101.87 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.94 144.59 26.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.408 0.683 . . . . 0.0 109.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -147.24 169.25 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 109.836 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.38 10.31 51.29 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.432 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.42 111.03 3.26 Favored Glycine 0 C--N 1.344 0.999 0 O-C-N 123.578 0.223 . . . . 0.0 112.649 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.85 -176.66 32.16 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 129' ' ' HIS . 14.3 tp -92.07 125.87 36.93 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 19' ' ' LEU . 19.4 m -126.48 157.55 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -75.58 148.23 39.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.812 0.845 . . . . 0.0 110.358 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' HB3' HD21 ' A' ' 124' ' ' LEU . . . -64.56 111.9 2.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.345 0.658 . . . . 0.0 109.772 171.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.07 -21.7 17.4 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.561 0.538 . . . . 0.0 112.115 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.01 -178.53 34.94 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 116.555 0.178 . . . . 0.0 112.899 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 p -123.04 151.05 42.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.475 0.71 . . . . 0.0 110.553 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.538 ' HB2' HG12 ' A' ' 13' ' ' VAL . 56.5 tp -151.82 133.65 14.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.355 1.062 . . . . 0.0 108.961 -177.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -109.42 126.0 53.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.408 0.683 . . . . 0.0 109.843 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -96.19 158.94 15.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 109.217 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.6 p -147.89 124.36 11.01 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.217 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.3 t -116.89 109.54 17.2 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.828 0.851 . . . . 0.0 109.429 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.4 t -86.17 126.11 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.79 100.61 13.38 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.537 0.735 . . . . 0.0 110.693 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.579 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 22.7 t 60.9 40.15 15.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.071 1.348 . . . . 0.0 111.83 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.73 -62.33 4.62 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.973 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.501 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 25.5 ttt180 -160.86 4.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.741 0.816 . . . . 0.0 110.445 173.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 m -77.57 145.13 37.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.401 0.681 . . . . 0.0 110.608 -170.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -105.97 123.57 48.19 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.02 -18.11 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.519 1.128 . . . . 0.0 109.352 170.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -63.76 108.19 1.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.872 0.869 . . . . 0.0 109.666 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -82.32 -36.93 26.47 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.858 0.837 . . . . 0.0 109.47 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.18 41.48 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.742 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.432 ' HE2' ' SG ' ' A' ' 97' ' ' CYS . 97.8 mtp -141.93 118.98 11.29 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.12 142.83 17.32 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.24 123.06 32.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-85 -120.17 133.91 55.38 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.401 1.08 . . . . 0.0 108.193 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -103.29 124.09 48.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.319 0.58 . . . . 0.0 109.934 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 128.68 53.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -125.36 155.15 72.05 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 122.889 0.475 . . . . 0.0 110.444 -170.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -52.5 96.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.027 2.484 . . . . 0.0 112.781 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.28 58.78 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.075 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.583 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.2 mmpt? -105.56 138.27 42.03 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.505 0.722 . . . . 0.0 109.998 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.48 163.79 10.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 0.0 112.6 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 122.15 12.69 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 168.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.3 tt0 -115.7 128.7 56.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.428 0.691 . . . . 0.0 109.51 -172.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 46.6 t80 -66.57 107.45 2.1 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 124.121 0.888 . . . . 0.0 109.714 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.05 -55.61 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.075 0.95 . . . . 0.0 109.954 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.65 32.29 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.865 -172.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . . . -139.39 123.62 18.01 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.163 0.985 . . . . 0.0 109.92 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.769 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -108.68 119.36 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.435 HH22 ' HB2' ' A' ' 108' ' ' ASP . 16.1 tpp180 -120.19 107.69 13.31 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -68.58 -7.75 35.58 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.146 0.498 . . . . 0.0 111.205 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 m -68.49 -2.38 8.64 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.553 1.141 . . . . 0.0 112.825 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.74 17.18 9.95 Favored Glycine 0 C--N 1.353 1.484 0 C-N-CA 122.91 0.291 . . . . 0.0 112.402 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.17 -93.97 1.71 Allowed Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.769 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 50.6 m 61.68 39.36 14.42 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.378 1.071 . . . . 0.0 113.091 173.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 p -149.52 121.59 8.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -170.59 126.83 0.76 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.403 ' HE2' ' HG3' ' A' ' 66' ' ' LYS . 25.1 p90 -163.66 144.07 8.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.154 0.982 . . . . 0.0 108.944 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -68.69 153.89 42.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.921 0.489 . . . . 0.0 110.378 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.45 -35.29 77.17 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.263 0.625 . . . . 0.0 110.54 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -63.41 -34.36 77.58 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 111.937 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' ' 62' ' ' ALA . 34.4 m -108.23 19.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.953 0.901 . . . . 0.0 111.124 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HG3' ' HE2' ' A' ' 61' ' ' TYR . 39.1 ttmt -57.34 116.84 3.56 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.169 0.988 . . . . 0.0 111.532 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.65 -27.91 6.81 Favored Glycine 0 C--N 1.342 0.876 0 O-C-N 123.733 0.646 . . . . 0.0 113.602 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -77.75 -60.25 2.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -84.69 122.11 28.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 p -143.58 153.82 42.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.28 154.39 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.747 0.819 . . . . 0.0 110.387 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.2 m -150.33 135.79 18.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.972 1.309 . . . . 0.0 107.932 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -110.05 123.42 49.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.02 128.32 36.79 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -87.25 -27.9 22.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.063 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.15 96.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.47 0.708 . . . . 0.0 112.403 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -116.34 4.28 13.41 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.135 0.425 . . . . 0.0 111.992 171.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 54.36 68.34 0.87 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.206 1.002 . . . . 0.0 111.183 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -134.99 130.67 36.11 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.25 120.43 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.031 0.932 . . . . 0.0 109.517 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.08 134.31 42.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.63 0.772 . . . . 0.0 110.297 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.5 tp -114.87 98.9 7.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -84.16 98.85 10.15 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.473 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 90.5 mtp -91.89 108.5 19.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 174.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -103.19 132.81 49.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t 61.17 70.33 0.61 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.203 1.001 . . . . 0.0 109.614 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp -71.24 135.88 47.71 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.382 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HZ3' ' HB3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -79.47 153.06 76.21 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.47 -19.7 68.31 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 121.946 1.764 . . . . 0.0 111.299 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -65.12 -20.51 66.5 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.861 2.064 . . . . 0.0 111.802 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.415 ' HB2' HG23 ' A' ' 121' ' ' VAL . 66.0 m-20 -84.9 31.61 0.54 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.814 0.846 . . . . 0.0 111.362 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.471 HG23 HG21 ' A' ' 120' ' ' THR . 98.7 m -82.23 92.28 6.88 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 161.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.5 -175.35 4.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.818 -168.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.93 109.14 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -85.06 109.25 18.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.62 147.51 31.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.432 ' SG ' ' HE2' ' A' ' 35' ' ' MET . 36.2 t -99.11 157.54 16.29 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 171.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -142.88 128.35 18.99 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.67 141.59 42.03 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.372 0.669 . . . . 0.0 110.345 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -159.75 -158.84 9.39 Favored Glycine 0 C--N 1.341 0.825 0 O-C-N 123.982 0.801 . . . . 0.0 113.127 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.9 m -119.25 -170.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.275 1.03 . . . . 0.0 110.746 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -97.2 123.77 41.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.686 0.794 . . . . 0.0 109.176 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -78.23 162.87 26.24 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.544 0.338 . . . . 0.0 111.165 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.7 m -72.25 -22.6 61.21 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.768 0.827 . . . . 0.0 110.946 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.9 t -73.81 -22.35 59.83 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.837 0.855 . . . . 0.0 110.506 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.55 -3.24 78.56 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.29 -174.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -79.1 151.95 31.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.119 0.968 . . . . 0.0 110.612 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.435 ' HB2' HH22 ' A' ' 53' ' ' ARG . 26.5 t70 -76.45 149.29 36.84 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.827 0.851 . . . . 0.0 110.408 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -138.94 113.71 8.39 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.209 0.604 . . . . 0.0 110.541 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.86 70.58 6.48 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.983 2.456 . . . . 0.0 111.762 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.76 -38.85 76.13 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.809 -176.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -136.86 123.92 21.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -87.25 162.91 17.17 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 109.668 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.34 -164.99 34.89 Favored Glycine 0 C--O 1.243 0.706 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.88 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -79.73 -37.53 35.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.431 0.692 . . . . 0.0 110.639 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.85 138.16 9.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.396 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.7 t -108.03 118.65 37.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.166 0.587 . . . . 0.0 109.51 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.12 107.44 11.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.795 0.838 . . . . 0.0 110.467 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.7 m -107.07 143.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.946 0.898 . . . . 0.0 109.501 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.471 HG21 HG23 ' A' ' 92' ' ' THR . 61.7 m -132.92 120.92 22.1 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.415 HG23 ' HB2' ' A' ' 91' ' ' ASP . 25.9 t -100.91 104.57 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 176.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.2 m -53.64 140.64 28.46 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.1 m -83.09 59.51 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.873 0.869 . . . . 0.0 110.255 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 15' ' ' ALA . 3.7 mm? 69.3 23.36 6.27 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.306 1.442 . . . . 0.0 112.74 -171.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -86.0 87.04 7.35 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 166.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -75.6 84.4 2.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -146.95 114.61 6.41 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -169.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -73.07 90.02 1.5 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.113 0.482 . . . . 0.0 111.301 -172.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.568 ' HB2' HD21 ' A' ' 12' ' ' LEU . 26.7 m-70 -82.27 89.66 6.56 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.691 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -76.79 -17.4 59.06 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 165.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.3 m80 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.871 1.269 . . . . 0.0 108.262 166.019 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.728 0.299 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -68.18 141.76 55.9 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.515 0.726 . . . . 0.0 110.785 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.04 111.06 8.84 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -88.92 114.45 25.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.5 mt -112.04 122.32 47.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.02 100.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -87.21 118.8 26.86 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m -129.46 135.0 48.1 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.186 0.995 . . . . 0.0 109.186 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.78 9.21 0.73 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.074 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.3 89.99 0.61 Allowed Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.921 0.361 . . . . 0.0 112.749 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.22 172.78 23.32 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 112.268 -0.333 . . . . 0.0 112.268 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.545 HD13 ' HB2' ' A' ' 122' ' ' SER . 15.9 tp -91.99 123.76 35.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.463 0.705 . . . . 0.0 109.132 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.1 m -126.81 151.15 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -77.89 153.75 32.35 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 122.574 0.35 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.7 114.15 2.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.672 0.789 . . . . 0.0 110.584 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.25 11.7 27.01 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.296 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.47 -167.01 24.61 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 122.555 0.121 . . . . 0.0 113.087 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -132.47 156.9 45.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.694 0.798 . . . . 0.0 110.011 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -159.32 119.71 3.13 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -100.18 126.45 46.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.994 0.518 . . . . 0.0 110.375 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.83 157.48 18.99 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.02 0.928 . . . . 0.0 109.865 170.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.3 p -141.12 148.81 40.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.66 1.184 . . . . 0.0 108.544 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.0 t -135.28 101.67 4.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.2 118.14 30.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.82 97.92 11.47 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m 51.97 49.35 20.89 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.334 1.453 . . . . 0.0 112.267 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.27 -78.1 2.04 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.333 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -172.28 85.1 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.406 1.082 . . . . 0.0 108.585 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -139.16 155.96 47.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.351 0.66 . . . . 0.0 110.222 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.17 117.87 35.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -173.08 160.91 4.26 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.757 1.223 . . . . 0.0 109.514 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m 64.95 177.52 0.19 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.422 1.089 . . . . 0.0 111.088 -171.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -147.33 19.68 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.807 0.443 . . . . 0.0 110.726 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.3 125.12 6.52 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.837 0.855 . . . . 0.0 109.78 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 65.9 mtt -139.91 119.86 13.55 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.31 177.13 16.85 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 123.125 0.393 . . . . 0.0 112.697 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -119.55 139.79 51.57 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.717 0.807 . . . . 0.0 110.656 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -127.28 166.86 16.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 107.527 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.24 139.22 19.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.316 0.246 . . . . 0.0 110.665 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -125.18 128.12 47.87 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.076 0.55 . . . . 0.0 109.697 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.33 158.69 31.77 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.393 0.677 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -55.08 115.68 2.61 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.919 2.413 . . . . 0.0 112.693 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -7.74 78.08 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 113.629 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -114.51 162.97 16.02 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.069 0.948 . . . . 0.0 110.596 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.24 175.18 9.09 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.668 0.787 . . . . 0.0 110.212 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 131.53 36.1 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -115.67 140.46 49.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 109.311 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.59 109.38 3.25 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.744 1.217 . . . . 0.0 110.263 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.48 -58.2 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -163.78 174.74 11.22 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.958 -173.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.74 130.69 23.12 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.573 1.149 . . . . 0.0 108.926 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.2 mp -112.84 116.27 52.15 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.1 mtm-85 -114.17 169.11 9.26 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -59.32 -39.09 81.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -158.99 146.27 17.42 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.521 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.41 30.95 32.0 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 114.129 0.412 . . . . 0.0 114.129 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.28 -124.52 0.74 Allowed Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 23.6 m 65.92 8.99 5.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 170.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.537 ' HA ' HD12 ' A' ' 71' ' ' ILE . 3.2 p -159.01 122.59 3.81 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.735 0.814 . . . . 0.0 110.157 -175.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.586 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 46.4 m-85 -160.56 111.81 1.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.364 1.466 . . . . 0.0 107.927 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -166.63 136.0 3.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.964 0.906 . . . . 0.0 110.414 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.24 168.13 16.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.093 0.957 . . . . 0.0 110.329 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -57.32 -33.94 68.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.461 0.704 . . . . 0.0 112.312 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 m -65.8 -31.01 71.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.319 0.648 . . . . 0.0 112.284 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.2 14.16 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.693 0.797 . . . . 0.0 111.053 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.9 124.2 27.7 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.556 0.743 . . . . 0.0 109.883 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.36 -28.54 6.19 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.177 -174.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 74.7 mtp180 -75.63 -78.1 0.12 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 124.11 0.964 . . . . 0.0 109.189 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -84.26 119.92 25.61 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.628 0.771 . . . . 0.0 108.932 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -137.87 133.0 33.34 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 108.289 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -112.66 140.09 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.682 0.793 . . . . 0.0 110.081 -175.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -148.67 174.9 11.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.52 1.128 . . . . 0.0 109.527 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -152.01 150.29 29.82 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.571 0.748 . . . . 0.0 109.247 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.85 100.31 5.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.556 1.143 . . . . 0.0 108.173 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -69.94 -13.4 62.22 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.03 0.932 . . . . 0.0 111.498 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.31 70.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.22 . . . . 0.0 111.508 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.09 9.0 15.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.068 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m120 53.66 64.72 1.74 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.585 1.154 . . . . 0.0 111.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.8 m -138.7 130.69 28.11 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.711 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.42 131.68 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.929 0.891 . . . . 0.0 108.626 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.53 150.54 29.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.101 0.56 . . . . 0.0 111.849 -174.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 37.8 tp -132.74 97.92 4.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -81.11 109.39 15.63 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.673 ' HB3' HD23 ' A' ' 87' ' ' LEU . 28.4 mtm -100.58 97.43 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -91.81 162.78 14.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.895 0.878 . . . . 0.0 110.615 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.464 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 20.5 t 42.92 63.72 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.3 1.44 . . . . 0.0 111.912 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.673 HD23 ' HB3' ' A' ' 84' ' ' MET . 50.7 mt -82.63 150.51 26.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.759 -168.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -106.2 153.07 40.56 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.117 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.15 -18.89 60.96 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.584 2.19 . . . . 0.0 112.922 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.48 -1.17 25.86 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -96.41 31.69 2.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.447 0.641 . . . . 0.0 110.377 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.6 m -82.81 98.96 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 164.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.58 156.18 25.31 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.976 0.417 . . . . 0.0 111.387 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.05 105.25 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 170.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.61 122.59 31.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 108.957 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.76 158.6 34.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.64 0.776 . . . . 0.0 110.012 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.81 159.24 17.37 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.235 1.014 . . . . 0.0 109.445 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 110' ' ' PRO . . . -141.67 138.82 32.74 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.545 0.738 . . . . 0.0 109.782 -176.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -114.1 124.63 52.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 0.0 110.081 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.08 -172.7 12.94 Favored Glycine 0 C--O 1.248 0.974 0 C-N-CA 123.847 0.737 . . . . 0.0 111.536 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.57 158.91 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.02 0.928 . . . . 0.0 109.956 -176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -59.82 102.37 0.15 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 168.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -91.07 149.69 21.71 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.293 -172.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.6 m -68.89 -15.32 63.46 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.807 0.843 . . . . 0.0 112.441 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.8 p -69.03 -25.41 64.46 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.438 0.695 . . . . 0.0 110.967 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.56 -27.03 14.38 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.241 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -94.67 118.73 32.19 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.49 0.716 . . . . 0.0 110.45 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.48 120.35 12.14 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.3 p -123.74 126.08 25.81 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 123.334 0.654 . . . . 0.0 109.653 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.492 ' HB2' ' HB2' ' A' ' 98' ' ' ALA . 73.2 Cg_endo -74.23 95.76 0.93 Allowed 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.136 1.891 . . . . 0.0 111.302 173.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.24 -5.24 59.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.396 0.679 . . . . 0.0 111.351 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 89.9 m-85 -123.03 142.36 50.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.661 0.784 . . . . 0.0 109.414 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -132.09 150.71 52.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.995 1.318 . . . . 0.0 107.893 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.98 -142.09 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 123.212 0.32 . . . . 0.0 112.864 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -100.85 -29.88 11.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.904 0.882 . . . . 0.0 111.304 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.94 161.81 36.76 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.297 -173.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -144.62 126.03 14.88 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.054 0.454 . . . . 0.0 110.054 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 100.35 9.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 -175.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.469 HG22 ' HE3' ' A' ' 84' ' ' MET . 4.0 m -90.19 146.52 6.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 38.8 m -134.29 113.58 12.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.19 99.02 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.545 ' HB2' HD13 ' A' ' 12' ' ' LEU . 9.4 t -60.54 141.32 56.7 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.959 176.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.2 p -81.56 76.65 8.47 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.381 0.673 . . . . 0.0 109.822 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 71.44 -8.77 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.232 1.413 . . . . 0.0 113.834 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.482 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 7.1 tm-20 -75.71 140.45 42.47 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -154.32 96.9 1.97 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.283 0.633 . . . . 0.0 110.508 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -135.65 143.23 45.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.113 0.965 . . . . 0.0 109.615 173.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -81.0 84.47 6.46 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.921 0.867 . . . . 0.0 109.596 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -72.17 -28.23 63.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.309 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -109.01 117.56 34.53 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.393 1.077 . . . . 0.0 108.275 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 . . . . . 0 CA--C 1.559 1.291 0 C-N-CA 125.132 1.373 . . . . 0.0 110.97 -179.885 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mtm . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 119.006 -0.521 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 63.98 81.31 0.21 Allowed 'General case' 0 C--N 1.368 1.376 0 C-N-CA 124.591 1.156 . . . . 0.0 110.569 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.58 112.61 4.23 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.827 0.451 . . . . 0.0 110.901 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.94 103.39 13.95 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 86.9 mt -100.28 112.89 25.25 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.58 102.44 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.16 128.38 36.34 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.2 m -128.11 165.92 19.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.859 1.263 . . . . 0.0 109.194 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.61 8.16 40.83 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -76.55 103.24 1.71 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.752 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -178.99 32.65 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.2 tt -91.67 119.41 31.52 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.54 163.07 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.063 0.945 . . . . 0.0 108.656 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.448 ' NE2' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -83.62 154.73 23.59 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.736 0.814 . . . . 0.0 110.666 177.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -71.52 127.13 31.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 109.462 174.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.18 -14.12 44.16 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.448 ' HA3' ' NE2' ' A' ' 14' ' ' GLN . . . -88.99 -177.84 46.21 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.628 0.251 . . . . 0.0 113.132 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 p -119.37 131.09 55.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.651 0.781 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.9 tp -128.99 131.47 47.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.849 0.86 . . . . 0.0 108.964 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -112.63 132.41 55.17 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.8 0.84 . . . . 0.0 110.108 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.97 158.65 16.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.475 1.11 . . . . 0.0 109.851 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 p -140.25 122.39 15.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.705 0.802 . . . . 0.0 109.847 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -112.31 108.92 18.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.233 1.013 . . . . 0.0 108.851 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.96 121.62 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.49 108.67 19.94 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.711 0.805 . . . . 0.0 109.729 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 p 48.08 45.35 19.46 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.986 1.714 . . . . 0.0 113.067 172.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.61 -61.41 4.7 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 69.0 ttt180 -165.48 14.97 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.936 0.894 . . . . 0.0 110.606 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -106.12 154.64 20.39 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.321 0.648 . . . . 0.0 109.855 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -108.9 116.86 32.8 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -131.55 16.27 4.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.104 0.962 . . . . 0.0 109.717 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 t -139.55 147.72 41.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.747 0.819 . . . . 0.0 109.556 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -43.6 19.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.827 0.851 . . . . 0.0 109.336 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.33 152.39 46.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.907 0.483 . . . . 0.0 111.252 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 2.1 mpt? -133.14 118.48 18.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.67 135.35 10.09 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -93.28 129.23 39.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.111 0.964 . . . . 0.0 109.971 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.21 135.87 39.46 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 23.5 ptt180 -103.55 118.15 36.07 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.307 0.575 . . . . 0.0 109.946 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.469 ' HB3' HG11 ' A' ' 94' ' ' VAL . 49.7 tp60 -100.71 129.13 46.57 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 44' ' ' LYS . . . -99.28 150.74 37.01 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 122.634 0.373 . . . . 0.0 110.408 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.21 98.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.688 2.259 . . . . 0.0 112.294 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.07 65.81 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.913 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 10.2 mmpt? -123.68 153.58 40.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.741 0.816 . . . . 0.0 110.182 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -68.39 172.65 5.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.174 0.989 . . . . 0.0 113.104 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -83.24 134.93 34.93 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.324 -177.11 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.0 142.86 29.19 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.069 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -71.05 122.02 19.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.979 0.912 . . . . 0.0 110.034 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.92 -53.47 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.97 173.6 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.807 0.443 . . . . 0.0 112.183 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.29 121.63 3.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.255 1.022 . . . . 0.0 110.313 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.14 115.47 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -109.37 166.47 10.85 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.582 0.353 . . . . 0.0 110.203 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -60.08 -45.26 93.48 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.751 0.821 . . . . 0.0 109.273 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -151.82 162.17 41.47 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.823 170.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.47 32.72 41.36 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.39 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.61 -85.47 0.08 OUTLIER Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m 65.63 5.56 3.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.725 1.21 . . . . 0.0 113.504 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 p -170.01 145.64 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.105 1.762 . . . . 0.0 106.97 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.78 130.12 2.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.718 0.807 . . . . 0.0 109.189 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -164.25 147.84 9.51 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.633 0.773 . . . . 0.0 110.576 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.33 164.29 13.57 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.054 0.941 . . . . 0.0 109.832 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.8 -21.37 66.04 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.387 0.675 . . . . 0.0 111.588 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 m -67.9 -38.38 82.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.388 0.675 . . . . 0.0 111.192 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -105.75 -6.28 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.671 0.788 . . . . 0.0 111.846 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -57.59 131.13 49.29 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.315 1.046 . . . . 0.0 112.359 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.28 -26.5 6.95 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.69 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.409 HH21 ' HE1' ' A' ' 69' ' ' PHE . 3.6 mtm180 -96.88 -59.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.409 ' HE1' HH21 ' A' ' 68' ' ' ARG . 1.2 m-85 -84.99 120.63 26.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -139.34 143.66 37.9 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.297 1.039 . . . . 0.0 108.491 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.5 146.16 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.764 0.826 . . . . 0.0 111.03 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -151.75 140.49 20.86 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.344 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -107.96 123.48 48.7 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.68 131.0 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.907 170.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 -28.51 19.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.582 0.753 . . . . 0.0 111.177 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.19 -43.52 87.59 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.838 0.855 . . . . 0.0 112.141 -172.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -118.14 9.88 12.78 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.222 0.209 . . . . 0.0 111.506 172.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 47.48 67.35 0.82 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.886 1.274 . . . . 0.0 112.016 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.4 m -134.68 131.61 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.252 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.47 131.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.641 0.776 . . . . 0.0 109.267 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -111.87 137.76 49.4 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.506 0.722 . . . . 0.0 110.769 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.53 97.66 5.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -87.65 104.54 16.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.396 0.678 . . . . 0.0 109.548 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 35.4 mtm -103.09 103.21 13.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.752 0.821 . . . . 0.0 110.083 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -93.2 149.49 21.19 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.4 t 56.23 72.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.907 1.283 . . . . 0.0 110.968 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.4 mt -81.06 160.74 24.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.571 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 150.37 59.06 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.802 1.241 . . . . 0.0 108.358 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.43 -21.55 54.25 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.235 2.623 . . . . 0.0 114.18 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.74 -12.18 61.43 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.561 0.744 . . . . 0.0 112.43 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -79.11 13.82 1.67 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.206 0.602 . . . . 0.0 111.423 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.414 HG22 HG21 ' A' ' 120' ' ' THR . 83.2 m -73.46 89.38 1.65 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.6 -178.6 3.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 -166.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -110.44 111.73 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 109.781 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -83.61 109.39 17.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.12 154.62 21.45 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.335 0.654 . . . . 0.0 110.159 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -108.55 158.0 17.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.331 1.052 . . . . 0.0 108.6 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . . . -130.29 145.85 51.82 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.93 114.49 27.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.37 164.57 13.3 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 121.23 0.35 . . . . 0.0 113.716 -167.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.49 130.34 70.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 C-N-CA 125.187 1.395 . . . . 0.0 107.248 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 24.1 p-90 -69.28 139.23 54.36 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.579 0.55 . . . . 0.0 110.461 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -104.13 147.72 27.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 166.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.9 t -70.15 -17.22 63.17 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.013 0.525 . . . . 0.0 110.202 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.0 t -66.87 -19.42 65.73 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.442 1.097 . . . . 0.0 111.133 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.66 -28.88 11.27 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.88 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -73.77 109.96 7.69 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.333 0.653 . . . . 0.0 109.899 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.28 103.35 11.8 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.2 t -79.43 117.22 65.93 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 123.237 0.615 . . . . 0.0 111.287 -173.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.501 ' HB3' ' HB3' ' A' ' 98' ' ' ALA . 12.1 Cg_exo -69.5 95.53 0.53 Allowed 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.679 2.252 . . . . 0.0 110.176 176.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.26 -37.27 74.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.015 0.926 . . . . 0.0 110.95 -173.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 67.8 m-85 -126.99 169.0 13.78 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.223 1.009 . . . . 0.0 109.238 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -133.94 164.35 27.49 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.49 1.116 . . . . 0.0 108.804 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -90.44 -172.99 44.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.236 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -75.27 -32.68 61.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.879 0.871 . . . . 0.0 110.128 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.2 124.96 1.67 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.627 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -97.96 118.52 34.73 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.493 0.663 . . . . 0.0 109.426 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.44 112.14 13.87 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.509 HG12 ' HA2' ' A' ' 10' ' ' GLY . 27.0 m -112.39 142.68 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.1 m -126.75 104.5 8.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.42 99.26 9.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -67.43 150.41 48.95 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.0 p -78.76 85.91 4.73 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.19 0.596 . . . . 0.0 110.291 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 15' ' ' ALA . 4.5 mm? 69.44 -19.15 0.18 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.223 1.409 . . . . 0.0 113.909 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.93 127.48 32.61 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.094 0.558 . . . . 0.0 110.883 -170.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -97.17 89.09 4.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.234 1.014 . . . . 0.0 109.679 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -144.85 126.75 15.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.475 0.71 . . . . 0.0 110.012 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -77.65 109.58 11.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.107 0.963 . . . . 0.0 109.517 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -53.28 121.22 7.14 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.315 1.046 . . . . 0.0 111.272 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -81.89 102.39 10.85 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.806 0.843 . . . . 0.0 109.948 177.501 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -74.33 99.29 3.45 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.519 0.327 . . . . 0.0 110.201 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -71.13 108.13 4.51 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -79.24 149.57 31.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.193 1.397 . . . . 0.0 110.567 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.7 mt -124.98 120.08 30.57 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.115 0.966 . . . . 0.0 108.738 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 65.4 t -119.47 101.45 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 23' ' ' CYS . 2.9 mp0 -90.56 153.04 20.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.442 0.697 . . . . 0.0 110.584 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.8 p -165.31 160.91 18.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.141 0.976 . . . . 0.0 109.582 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.87 -1.26 27.29 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 120.069 -0.295 . . . . 0.0 112.961 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -78.75 119.0 4.98 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.48 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.44 177.98 26.33 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.4 tt -82.52 117.1 22.28 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 m -118.22 160.18 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.006 0.922 . . . . 0.0 108.609 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.46 ' NE2' ' HA3' ' A' ' 17' ' ' GLY . 0.4 OUTLIER -78.12 159.14 28.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.531 0.732 . . . . 0.0 110.791 174.035 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.55 133.38 52.23 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.549 0.74 . . . . 0.0 110.224 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.28 80.34 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.276 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA3' ' NE2' ' A' ' 14' ' ' GLN . . . -90.67 -178.26 43.84 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 120.88 0.156 . . . . 0.0 113.264 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -128.97 156.66 43.43 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -176.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -159.59 130.63 5.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.606 0.762 . . . . 0.0 109.354 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -105.57 132.85 51.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.682 0.393 . . . . 0.0 110.061 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 159.19 15.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.046 0.938 . . . . 0.0 109.693 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 p -143.53 130.89 20.94 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 109.284 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 43.1 t -131.95 110.64 10.91 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.9 t -86.58 132.37 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.56 100.24 12.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.077 0.551 . . . . 0.0 109.827 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.583 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 7.4 m 59.31 20.2 8.4 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.144 1.378 . . . . 0.0 113.391 176.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 68.64 1.57 Allowed Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -174.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 55.0 ttp180 62.26 51.95 3.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.856 1.262 . . . . 0.0 111.507 176.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.583 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 30.3 m -118.26 141.16 48.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.641 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -104.37 119.47 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -170.75 171.73 6.03 Favored 'General case' 0 C--O 1.248 0.988 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 m 71.01 121.1 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.61 1.164 . . . . 0.0 111.825 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.458 HD22 ' HB3' ' A' ' 102' ' ' TRP . 3.6 p-10 -106.61 7.12 30.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.844 0.858 . . . . 0.0 110.717 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.51 122.37 27.5 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.7 mtt -138.79 152.75 48.17 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.282 0.633 . . . . 0.0 110.015 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -159.56 175.12 36.47 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.45 -178.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.8 131.97 34.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.537 1.135 . . . . 0.0 108.28 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.601 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 85.1 m-85 -134.37 137.32 44.02 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.58 1.152 . . . . 0.0 108.231 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -103.98 130.32 51.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -133.73 143.35 48.42 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.557 0.743 . . . . 0.0 109.058 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.15 160.99 31.85 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.711 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.93 105.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.306 2.671 . . . . 0.0 113.773 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.97 23.26 61.97 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.455 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.7 mmpt? -126.41 172.89 9.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.796 0.838 . . . . 0.0 110.492 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.68 168.19 17.49 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.101 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -102.03 117.87 35.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.225 174.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -93.19 139.92 30.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.032 0.933 . . . . 0.0 109.564 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.08 111.06 3.67 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.417 0.687 . . . . 0.0 110.051 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.96 -56.96 4.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.535 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.574 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -161.44 173.39 14.96 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.848 -171.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.56 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -163.37 162.8 25.16 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.194 0.997 . . . . 0.0 113.265 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mt -129.3 128.08 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 108.693 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -98.78 123.41 43.0 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.343 0.657 . . . . 0.0 110.143 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 22.5 t90 59.62 -89.82 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.708 1.603 . . . . 0.0 110.767 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -171.55 130.82 0.71 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.73 -18.89 48.16 Favored Glycine 0 N--CA 1.471 1.031 0 N-CA-C 112.596 -0.201 . . . . 0.0 112.596 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.66 50.4 2.61 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 174.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.8 m -83.64 69.56 10.16 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.59 0.756 . . . . 0.0 111.085 -172.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 p -158.84 119.23 3.22 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 17.1 m-85 -169.73 119.46 0.64 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 167.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.73 151.53 20.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.055 0.542 . . . . 0.0 110.764 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 159.76 30.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.503 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.6 -32.39 71.51 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.65 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.3 m -60.77 -37.65 82.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.14 0.976 . . . . 0.0 112.029 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.98 4.33 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.387 0.675 . . . . 0.0 111.896 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.77 111.26 3.62 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.148 0.979 . . . . 0.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.58 44.78 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.201 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 60.3 mtm180 -103.01 -40.24 6.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.299 0.64 . . . . 0.0 110.358 176.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.3 123.03 48.18 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.676 0.79 . . . . 0.0 109.459 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -139.35 152.26 47.03 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.121 0.968 . . . . 0.0 108.98 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.574 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -128.48 156.13 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.733 0.813 . . . . 0.0 110.497 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -154.54 134.17 12.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.371 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -110.85 120.07 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -90.89 104.63 17.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -62.75 -26.66 68.81 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.925 0.765 . . . . 0.0 110.966 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.39 -53.79 33.09 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.838 1.255 . . . . 0.0 112.263 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.519 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.37 11.17 11.4 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 45.07 67.81 0.66 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.943 1.297 . . . . 0.0 112.503 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 m -130.75 131.11 44.54 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.748 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.83 127.97 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.37 1.068 . . . . 0.0 109.503 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -110.83 150.88 28.51 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.991 0.916 . . . . 0.0 110.502 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 tp -132.36 99.32 4.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -82.76 102.3 11.48 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.623 ' HB3' HD22 ' A' ' 87' ' ' LEU . 34.4 mtm -95.53 132.61 40.46 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 83.7 m-20 -128.98 149.77 50.68 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.444 0.698 . . . . 0.0 109.775 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 t 47.59 68.74 0.61 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.95 1.3 . . . . 0.0 111.15 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.623 HD22 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -81.59 157.58 24.69 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.577 -170.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.43 149.72 36.94 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.896 0.878 . . . . 0.0 108.632 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -58.84 -23.16 65.88 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 122.626 2.217 . . . . 0.0 113.182 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.01 -14.36 62.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.216 1.006 . . . . 0.0 112.348 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -81.22 27.52 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.657 0.783 . . . . 0.0 111.85 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 93.7 m -81.49 92.05 6.42 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 165.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.83 9.25 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.446 0.699 . . . . 0.0 110.794 -170.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.96 114.52 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.335 0.588 . . . . 0.0 109.877 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -86.23 113.59 22.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.25 148.3 40.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.713 0.805 . . . . 0.0 109.857 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 31.7 p -96.05 155.2 16.86 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.23 13.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.26 166.38 11.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.825 0.85 . . . . 0.0 110.462 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.83 -166.94 40.11 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 112.301 -0.319 . . . . 0.0 112.301 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.32 170.19 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.411 0.684 . . . . 0.0 111.465 -174.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.458 ' HB3' HD22 ' A' ' 33' ' ' ASN . 64.8 p-90 -66.04 155.81 35.62 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.944 0.897 . . . . 0.0 110.889 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 -134.8 142.34 46.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.422 0.689 . . . . 0.0 110.765 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.6 m -80.75 -11.64 59.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.07 0.948 . . . . 0.0 111.0 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 m -64.57 -23.41 67.26 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.564 0.746 . . . . 0.0 111.073 171.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.83 -30.55 9.16 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.405 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -76.94 117.99 19.09 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.998 0.519 . . . . 0.0 110.005 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.54 119.84 11.21 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.8 m -139.48 128.25 13.67 Favored Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -175.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.42 146.57 27.88 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.501 2.134 . . . . 0.0 112.109 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.54 -29.03 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.391 1.076 . . . . 0.0 110.192 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -117.99 128.03 54.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 0.0 109.131 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -110.13 128.88 55.71 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 166.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.39 -178.36 47.71 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 123.703 0.627 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.12 -27.09 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.135 0.574 . . . . 0.0 110.79 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.97 170.12 38.02 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.922 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.66 124.72 16.28 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.199 0.6 . . . . 0.0 109.528 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 101.45 7.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.615 0.766 . . . . 0.0 111.275 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.532 HG12 ' HA2' ' A' ' 10' ' ' GLY . 17.3 m -88.11 147.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 87.2 m -135.07 103.28 5.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.9 t -90.12 96.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' A' ' 125' ' ' GLU . 12.2 t -69.92 150.34 46.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.797 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.6 m -73.34 85.8 1.46 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.739 0.816 . . . . 0.0 111.133 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 67.45 2.13 2.79 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.568 1.547 . . . . 0.0 112.991 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.418 ' HB2' ' OG ' ' A' ' 122' ' ' SER . 9.8 mm-40 -90.36 89.38 7.58 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.026 0.531 . . . . 0.0 110.279 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -75.27 -18.74 60.0 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.427 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -78.4 116.93 19.16 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -160.5 173.14 16.0 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.045 0.938 . . . . 0.0 109.796 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.89 141.07 37.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -105.55 118.52 36.79 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.416 173.78 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -81.03 158.7 25.02 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.142 0.577 . . . . 0.0 109.768 169.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 3' ' ' LEU . 3.7 mm? -73.45 116.7 14.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.168 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 26' ' ' SER . 16.7 mt-30 -91.91 108.91 20.27 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.426 0.69 . . . . 0.0 109.447 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.748 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.9 mp -118.71 119.35 34.18 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.4 101.02 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -92.51 135.67 33.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.933 -174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 p -148.54 165.23 31.86 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.386 1.074 . . . . 0.0 109.72 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.84 -24.77 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.73 128.96 38.56 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.081 0.372 . . . . 0.0 113.175 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.84 -174.12 45.47 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.3 tp -78.03 116.98 18.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.06 0.544 . . . . 0.0 109.896 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.42 163.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.414 1.086 . . . . 0.0 109.611 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 145.34 24.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.787 0.435 . . . . 0.0 111.399 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 127.17 30.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.341 1.057 . . . . 0.0 110.998 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.53 62.06 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 123.604 0.565 . . . . 0.0 112.304 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.04 -166.34 39.54 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -141.46 130.41 23.15 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.53 122.47 29.29 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.027 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -93.46 117.74 30.46 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.6 151.32 23.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.973 0.909 . . . . 0.0 109.175 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.4 p -136.59 126.22 25.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.624 0.77 . . . . 0.0 109.365 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.748 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 50.0 t -120.27 102.85 8.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.977 1.311 . . . . 0.0 109.372 -174.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -95.3 118.39 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.565 1.146 . . . . 0.0 109.639 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.53 99.69 11.86 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.945 -0.472 . . . . 0.0 110.643 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 27.3 t 49.6 39.39 17.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.568 1.547 . . . . 0.0 111.506 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.27 -89.96 1.11 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -168.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.411 ' HG2' ' HB2' ' A' ' 77' ' ' LYS . 98.2 mtt180 -140.32 94.85 2.79 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 t -133.42 157.65 45.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.391 0.676 . . . . 0.0 110.013 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -112.42 119.76 39.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -154.38 -82.15 0.08 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.1 p -77.61 121.04 23.4 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.862 0.465 . . . . 0.0 111.275 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.565 ' HB3' ' HD1' ' A' ' 54' ' ' TRP . 40.6 m-80 -92.84 10.36 31.35 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.267 173.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.57 122.79 15.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.653 1.181 . . . . 0.0 108.864 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.7 mtt -140.79 165.53 27.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.587 1.555 . . . . 0.0 108.546 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -166.36 156.17 27.88 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.612 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -108.14 133.67 52.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.387 1.075 . . . . 0.0 108.599 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -136.44 139.37 42.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.132 0.973 . . . . 0.0 108.829 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 33.4 ptt85 -103.68 137.98 40.97 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.492 0.717 . . . . 0.0 109.834 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 61.8 tt0 -143.83 130.72 20.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.059 0.544 . . . . 0.0 109.726 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.94 161.67 30.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.469 0.708 . . . . 0.0 109.563 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.35 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.59 2.193 . . . . 0.0 113.299 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.88 6.79 88.68 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -106.35 174.57 5.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.896 0.878 . . . . 0.0 110.549 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.45 166.37 22.07 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.833 0.853 . . . . 0.0 111.096 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -103.67 113.53 27.11 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 110.475 175.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -93.03 143.91 25.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.812 0.845 . . . . 0.0 110.382 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -62.76 118.12 7.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.751 0.821 . . . . 0.0 111.267 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -88.03 -47.16 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.15 176.47 8.45 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.785 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.57 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -156.98 127.24 6.43 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 123.886 0.874 . . . . 0.0 110.265 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.54 HD12 HG11 ' A' ' 80' ' ' VAL . 11.4 mt -118.92 118.06 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.35 1.06 . . . . 0.0 110.353 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -96.12 -175.84 3.5 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.218 1.007 . . . . 0.0 109.002 167.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.565 ' HD1' ' HB3' ' A' ' 33' ' ' ASN . 46.5 p-90 -43.61 160.29 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 123.426 0.69 . . . . 0.0 112.375 165.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -60.79 120.13 9.53 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.578 0.751 . . . . 0.0 111.639 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.51 -18.06 25.4 Favored Glycine 0 C--N 1.351 1.377 0 C-N-CA 123.434 0.54 . . . . 0.0 112.582 -172.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.94 12.3 8.18 Favored Glycine 0 N--CA 1.477 1.38 0 C-N-CA 123.248 0.451 . . . . 0.0 112.184 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 p -90.55 74.5 6.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.183 0.993 . . . . 0.0 110.362 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -158.71 123.21 4.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.619 0.767 . . . . 0.0 110.031 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.412 ' HB3' ' N ' ' A' ' 51' ' ' ALA . 4.4 t80 -171.36 141.82 1.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.476 0.71 . . . . 0.0 109.675 172.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -165.86 156.75 13.4 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.624 0.77 . . . . 0.0 110.383 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.68 167.28 11.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.754 0.822 . . . . 0.0 110.078 167.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.32 -29.11 69.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 112.036 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -68.22 -33.39 74.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.208 0.603 . . . . 0.0 111.42 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 69' ' ' PHE . 26.4 m -105.83 9.39 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.635 0.774 . . . . 0.0 111.098 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.07 119.19 8.44 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.391 1.076 . . . . 0.0 110.84 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.24 -16.67 15.99 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -98.51 -45.8 5.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.212 0.605 . . . . 0.0 109.384 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.464 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.8 m-85 -98.12 120.04 37.83 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.2 m -124.99 144.8 50.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.492 ' HB ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -127.52 141.67 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.065 0.546 . . . . 0.0 110.826 -175.237 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -150.63 137.77 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.277 1.031 . . . . 0.0 109.694 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HB2' HG23 ' A' ' 52' ' ' ILE . 22.1 ttp85 -124.6 130.16 51.92 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.27 110.01 22.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.886 1.274 . . . . 0.0 111.794 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.93 68.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.137 0.975 . . . . 0.0 111.712 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HE3' ' HB ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -120.23 -3.91 10.0 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.455 176.106 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 52.92 67.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.43 1.092 . . . . 0.0 111.451 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.459 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 92.3 m -127.15 132.83 50.45 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.682 173.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.54 HG11 HD12 ' A' ' 52' ' ' ILE . 23.3 t -101.6 151.16 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.773 1.229 . . . . 0.0 108.607 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -133.04 141.36 48.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.462 0.705 . . . . 0.0 109.59 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 66.3 tp -128.48 99.55 5.43 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -83.3 98.04 9.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.437 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 72.6 mtp -90.74 107.74 19.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.143 0.977 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.9 153.45 23.02 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.946 0.498 . . . . 0.0 110.156 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.5 t 60.07 62.17 1.69 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.562 1.145 . . . . 0.0 109.936 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.13 152.73 45.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.088 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.585 ' HB2' ' HZ2' ' A' ' 88' ' ' LYS . 8.9 mtmp? -120.71 151.53 54.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.84 -15.2 45.61 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.15 1.9 . . . . 0.0 112.252 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.98 -25.1 66.16 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HB2' HG22 ' A' ' 121' ' ' VAL . 32.8 m-20 -82.2 24.15 0.68 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.661 0.784 . . . . 0.0 111.929 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.527 HG22 HG21 ' A' ' 120' ' ' THR . 64.4 m -79.66 90.44 5.18 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 159.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' GLN . . . -167.5 -174.31 2.48 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.446 -168.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.2 p -109.24 108.23 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.676 0.79 . . . . 0.0 109.807 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -85.04 116.3 23.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 167.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.449 HD13 ' HD1' ' A' ' 113' ' ' TRP . 2.5 pp -115.07 137.24 52.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 111.071 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.5 t -93.75 156.1 16.86 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.42 156.04 41.97 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.446 0.698 . . . . 0.0 109.713 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.64 158.61 37.33 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.906 0.482 . . . . 0.0 111.558 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.96 149.15 5.26 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 t -111.45 19.34 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.062 0.934 . . . . 0.0 109.572 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -114.66 104.79 12.33 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -126.37 138.94 53.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.1 m -89.36 -41.85 11.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.486 0.714 . . . . 0.0 111.164 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.2 t -78.34 -24.95 46.3 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.001 0.92 . . . . 0.0 111.723 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.23 -28.77 11.69 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -174.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -67.37 143.35 56.38 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.49 0.716 . . . . 0.0 109.758 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.47 99.22 0.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 O-C-N 123.878 0.736 . . . . 0.0 110.478 -174.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.9 p -134.5 149.58 71.4 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.959 1.304 . . . . 0.0 109.389 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.14 154.63 29.09 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.441 2.094 . . . . 0.0 112.678 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.81 -40.23 6.65 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -121.94 164.35 17.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.162 0.985 . . . . 0.0 110.174 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.449 ' HD1' HD13 ' A' ' 96' ' ' LEU . 31.8 m-90 -119.7 157.53 28.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.695 1.198 . . . . 0.0 108.751 174.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -76.53 -76.43 0.83 Allowed Glycine 0 C--N 1.341 0.815 0 O-C-N 123.177 0.298 . . . . 0.0 112.987 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.92 -42.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 109.626 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.1 113.95 3.58 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.787 -172.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 t -96.41 108.67 21.25 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.832 0.825 . . . . 0.0 109.391 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 106.11 4.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.293 -175.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.47 125.28 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 26.0 m -120.04 104.42 10.12 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.409 HG22 ' HB2' ' A' ' 91' ' ' ASP . 57.8 t -89.23 105.79 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 121.862 -0.523 . . . . 0.0 110.365 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 m -58.74 139.27 56.44 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.46 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.9 m -72.54 91.14 1.38 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 73.81 -22.94 0.23 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.668 1.587 . . . . 0.0 113.111 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.58 145.39 36.88 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.123 0.969 . . . . 0.0 110.693 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -99.9 145.83 27.35 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.496 0.718 . . . . 0.0 110.657 -174.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -83.05 96.65 8.42 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.796 0.838 . . . . 0.0 110.159 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -76.15 111.1 11.21 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -68.78 133.82 48.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.688 0.795 . . . . 0.0 111.05 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -131.09 131.96 44.54 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.006 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 ttm . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -99.18 85.56 3.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.933 0.893 . . . . 0.0 109.152 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.33 111.64 9.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.35 129.68 48.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.479 0.712 . . . . 0.0 109.667 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.429 HD22 ' SG ' ' A' ' 23' ' ' CYS . 89.7 mt -124.94 107.61 11.03 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.6 t -98.89 101.74 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 22' ' ' SER . 47.1 mt-10 -100.9 143.97 30.41 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.11 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.9 p -160.54 157.79 28.03 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.091 0.957 . . . . 0.0 109.792 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' O ' HD13 ' A' ' 19' ' ' LEU . . . 130.85 -32.27 3.05 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA2' HG13 ' A' ' 119' ' ' VAL . . . -59.09 127.96 46.43 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.27 -178.45 46.06 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 120' ' ' THR . 22.8 tp -88.18 109.51 19.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.86 0.464 . . . . 0.0 109.798 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.468 HG11 HD11 ' A' ' 19' ' ' LEU . 18.5 m -126.68 151.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.089 0.956 . . . . 0.0 109.373 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -75.64 151.11 37.83 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.438 0.563 . . . . 0.0 111.259 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB1' HD22 ' A' ' 124' ' ' LEU . . . -64.11 125.09 23.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.156 0.982 . . . . 0.0 110.407 175.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.18 -20.26 26.22 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 123.814 0.721 . . . . 0.0 111.35 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.62 -166.94 9.88 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 121.598 0.554 . . . . 0.0 113.618 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.4 p -133.01 132.73 42.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.013 0.925 . . . . 0.0 109.395 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.468 HD11 HG11 ' A' ' 13' ' ' VAL . 25.5 tp -134.95 118.76 17.22 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -97.65 120.8 38.69 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.128 0.571 . . . . 0.0 109.693 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.475 HD23 ' HE2' ' A' ' 84' ' ' MET . 2.5 mm? -86.9 157.26 19.55 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.199 0.6 . . . . 0.0 109.394 172.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 18.6 p -145.92 126.11 13.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.845 0.858 . . . . 0.0 109.191 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 52.5 t -123.19 107.54 11.83 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.468 1.107 . . . . 0.0 108.901 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 21.2 t -89.24 115.22 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.642 0.777 . . . . 0.0 109.023 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.19 103.23 15.87 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p 54.66 36.74 26.79 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.707 1.603 . . . . 0.0 112.381 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.94 -107.94 2.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.69 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -118.79 10.98 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.009 0.924 . . . . 0.0 110.288 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -81.78 146.99 29.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -104.21 115.75 30.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -151.35 10.76 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.883 1.673 . . . . 0.0 108.847 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 p -86.99 88.52 7.72 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.224 1.01 . . . . 0.0 110.453 -174.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.74 -48.7 53.07 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.555 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.86 126.95 1.03 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.338 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.418 ' HE1' ' NH1' ' A' ' 73' ' ' ARG . 1.8 mpp? -125.44 119.76 29.15 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.657 1.183 . . . . 0.0 108.337 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -103.49 140.39 14.87 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -87.71 125.26 34.3 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.61 148.55 49.78 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -126.56 139.09 53.47 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.81 130.0 53.07 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.92 154.53 83.0 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -53.73 102.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.448 2.099 . . . . 0.0 112.41 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.99 23.21 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.931 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 6.9 mmpt? -133.44 170.41 15.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.83 0.824 . . . . 0.0 112.453 -174.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.24 176.46 6.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.982 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.48 37.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.61 125.65 40.61 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.36 110.26 4.02 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.18 -51.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.348 0.659 . . . . 0.0 109.64 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.69 170.04 22.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.212 0.605 . . . . 0.0 111.706 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -154.59 120.2 5.14 Favored 'General case' 0 C--O 1.25 1.126 0 C-N-CA 124.053 0.941 . . . . 0.0 110.131 173.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.602 HG22 ' HB3' ' A' ' 58' ' ' SER . 4.0 mp -122.65 116.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.392 1.077 . . . . 0.0 109.045 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.87 178.33 5.47 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.091 0.556 . . . . 0.0 109.636 172.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.403 ' HE1' ' ND2' ' A' ' 75' ' ' ASN . 28.0 t90 -71.89 -28.45 63.53 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 120.982 0.42 . . . . 0.0 110.22 171.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.2 t -153.0 160.98 43.07 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.73 0.812 . . . . 0.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.93 11.7 25.7 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.848 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.83 -52.33 0.65 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.602 ' HB3' HG22 ' A' ' 52' ' ' ILE . 20.3 m 61.25 64.59 1.07 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.632 0.773 . . . . 0.0 112.166 168.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -157.21 123.49 4.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.954 0.901 . . . . 0.0 109.883 -166.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.44 ' CD2' ' HB1' ' A' ' 51' ' ' ALA . 25.8 m-85 -158.5 135.83 10.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.943 0.897 . . . . 0.0 109.167 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.55 153.9 11.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.554 1.542 . . . . 0.0 108.889 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.38 151.36 32.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.425 0.69 . . . . 0.0 109.789 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.2 -33.28 69.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.487 0.715 . . . . 0.0 111.498 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 m -66.82 -29.91 69.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.318 1.047 . . . . 0.0 112.208 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.48 -7.12 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.347 0.659 . . . . 0.0 111.869 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.05 122.48 17.49 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.603 0.761 . . . . 0.0 110.544 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.35 -28.54 14.05 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.666 0.604 . . . . 0.0 111.979 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.458 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 10.1 mtm180 -88.97 -52.89 4.85 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -91.39 131.6 36.77 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.722 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -140.9 150.21 42.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.458 1.103 . . . . 0.0 108.461 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.29 144.01 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.147 0.579 . . . . 0.0 110.491 178.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -144.13 134.4 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.101 0.96 . . . . 0.0 109.05 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.512 ' HB2' HG21 ' A' ' 52' ' ' ILE . 46.4 ttt180 -111.9 125.05 53.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.012 0.525 . . . . 0.0 110.363 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.51 ' HB3' ' HE3' ' A' ' 77' ' ' LYS . 60.6 m-20 -103.0 94.64 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.403 ' ND2' ' HE1' ' A' ' 54' ' ' TRP . 63.9 t30 -65.61 -26.07 67.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.824 0.85 . . . . 0.0 111.936 -173.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.58 73.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.678 0.791 . . . . 0.0 112.27 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -118.59 8.18 11.93 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.582 0.753 . . . . 0.0 110.528 176.229 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 55.82 30.73 16.32 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.843 1.257 . . . . 0.0 112.851 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.4 m -111.39 130.46 55.69 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.26 138.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 108.702 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -117.27 139.62 50.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.896 0.878 . . . . 0.0 110.055 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.1 tp -113.78 97.64 6.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -84.06 100.67 11.24 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.475 ' HE2' HD23 ' A' ' 21' ' ' LEU . 36.6 mtm -94.07 126.47 39.31 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -122.69 167.14 13.82 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 68' ' ' ARG . 13.5 m 57.65 40.2 26.82 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.622 0.769 . . . . 0.0 110.42 173.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.7 mt -56.85 142.99 38.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.653 -170.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.59 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -105.68 151.22 39.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.29 -14.19 40.48 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.199 1.933 . . . . 0.0 112.683 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.59 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.72 -22.02 66.58 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.453 0.701 . . . . 0.0 111.565 173.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -78.28 23.62 0.28 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.822 0.849 . . . . 0.0 111.647 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.508 HG21 HG22 ' A' ' 120' ' ' THR . 99.0 m -82.79 92.54 7.26 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 163.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.02 -174.74 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.312 0.645 . . . . 0.0 111.106 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.93 112.04 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -85.45 108.73 18.02 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -112.18 138.45 48.84 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.977 0.911 . . . . 0.0 109.435 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 52.1 m -91.29 139.07 31.08 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.71 116.86 16.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.592 0.757 . . . . 0.0 109.136 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.87 152.96 27.35 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.104 0.562 . . . . 0.0 110.362 -173.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -135.99 149.68 20.14 Favored Glycine 0 C--O 1.241 0.573 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.9 m -72.11 166.91 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.095 0.558 . . . . 0.0 110.267 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -53.85 133.75 42.65 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.8 0.84 . . . . 0.0 112.096 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.694 ' NH2' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -136.31 155.96 49.33 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.673 0.789 . . . . 0.0 110.347 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.5 m -77.2 -22.25 52.65 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.976 0.91 . . . . 0.0 111.257 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.2 p -74.04 -26.24 60.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.574 0.75 . . . . 0.0 112.232 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.14 -31.24 3.17 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.104 0.802 . . . . 0.0 115.104 173.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -73.94 153.57 39.73 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.071 0.935 . . . . 0.0 111.044 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.694 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 25.5 t70 -75.71 125.44 29.07 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.099 -174.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.9 t -125.15 114.9 26.06 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.699 -173.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.39 95.04 0.37 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.783 2.322 . . . . 0.0 111.441 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -97.22 -47.93 5.55 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.363 0.602 . . . . 0.0 109.705 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.07 144.17 40.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.73 1.212 . . . . 0.0 108.438 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -120.97 137.92 54.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.335 0.654 . . . . 0.0 109.247 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.03 -137.04 1.05 Allowed Glycine 0 C--N 1.346 1.117 0 O-C-N 123.338 0.399 . . . . 0.0 113.151 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -94.92 -30.89 13.92 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.073 0.549 . . . . 0.0 110.599 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.22 116.95 0.13 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.249 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -99.37 123.35 43.57 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 117.229 0.514 . . . . 0.0 110.489 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.39 101.48 6.38 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.261 1.024 . . . . 0.0 110.707 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.549 HG13 ' HA2' ' A' ' 10' ' ' GLY . 20.0 m -93.01 137.5 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 70.2 m -134.17 105.03 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.3 t -87.77 98.22 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 t -50.43 131.2 24.54 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.382 1.073 . . . . 0.0 111.742 172.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.6 p -76.4 82.52 3.13 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.057 0.543 . . . . 0.0 110.616 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.475 HD22 ' HB1' ' A' ' 15' ' ' ALA . 3.5 mm? 63.26 7.41 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.007 1.323 . . . . 0.0 114.071 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -88.55 143.34 27.02 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -85.38 109.1 18.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.745 0.818 . . . . 0.0 110.776 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -80.95 140.5 35.22 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -122.78 115.05 21.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -79.64 -27.24 40.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.18 0.992 . . . . 0.0 111.468 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 72.09 -77.44 0.06 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.626 1.17 . . . . 0.0 111.068 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.6 t60 . . . . . 0 C--O 1.246 0.911 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.333 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' N ' ' SD ' ' A' ' 1' ' ' MET . 96.6 mt-30 67.99 -175.22 0.2 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.221 1.008 . . . . 0.0 110.806 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.88 113.47 22.04 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 168.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -117.68 133.9 55.46 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.51 1.124 . . . . 0.0 108.812 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 94.3 mt -131.68 120.8 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.915 0.886 . . . . 0.0 109.381 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.47 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 23.2 t -98.42 104.88 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 108.537 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -104.66 151.08 24.12 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.369 0.668 . . . . 0.0 111.19 -168.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 p -157.15 170.75 21.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.658 0.783 . . . . 0.0 111.079 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.09 32.28 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.26 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA2' HG11 ' A' ' 119' ' ' VAL . . . -69.34 120.34 10.21 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 113.957 0.343 . . . . 0.0 113.957 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.76 179.48 48.78 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 120' ' ' THR . 10.2 tt -88.02 128.55 35.4 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.411 0.284 . . . . 0.0 110.288 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.58 152.53 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.25 150.99 35.31 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HB1' HD21 ' A' ' 124' ' ' LEU . . . -59.7 127.6 32.82 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 0.0 110.552 174.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.15 18.13 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.2 -179.22 52.46 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 122.873 0.273 . . . . 0.0 113.292 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -121.0 164.64 16.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.042 0.937 . . . . 0.0 110.563 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.4 tp -159.47 123.65 3.87 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.579 0.752 . . . . 0.0 109.982 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -99.32 129.58 45.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.06 0.544 . . . . 0.0 109.576 173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.42 HD22 ' HE2' ' A' ' 84' ' ' MET . 2.9 mm? -96.42 154.32 17.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.325 1.05 . . . . 0.0 109.007 171.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -143.54 128.74 18.74 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 30.8 t -137.74 104.61 5.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.46 0.704 . . . . 0.0 110.065 -172.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -84.75 145.28 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.812 . . . . 0.0 110.25 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HA ' HD23 ' A' ' 5' ' ' LEU . . . -89.98 100.43 13.25 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.124 0.57 . . . . 0.0 110.063 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p 56.46 -75.38 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.85 2.06 . . . . 0.0 112.457 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.74 -64.38 0.06 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -161.66 39.32 0.13 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.06 0.933 . . . . 0.0 109.451 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -107.36 151.04 26.04 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.49 ' HB3' HD22 ' A' ' 78' ' ' ASN . 19.5 p90 -105.29 126.31 51.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.813 0.845 . . . . 0.0 108.878 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -150.66 146.68 26.64 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.832 0.853 . . . . 0.0 109.074 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t 66.07 115.34 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.212 1.405 . . . . 0.0 111.183 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -80.67 7.83 9.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.4 0.68 . . . . 0.0 111.299 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.86 119.92 21.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.561 0.744 . . . . 0.0 109.306 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.8 mtt -137.38 119.9 16.0 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -125.29 142.46 13.82 Favored Glycine 0 N--CA 1.468 0.832 0 CA-C-N 118.102 0.41 . . . . 0.0 112.92 -172.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -86.06 117.89 25.19 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -117.02 171.34 7.99 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.922 1.289 . . . . 0.0 108.595 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -150.83 130.93 13.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.924 0.49 . . . . 0.0 110.029 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -110.56 128.83 55.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.12 39.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.493 0.717 . . . . 0.0 109.658 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.74 107.72 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.778 2.318 . . . . 0.0 113.119 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.49 1.52 66.24 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.552 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.4 mmpt? -114.98 173.43 6.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.223 1.009 . . . . 0.0 110.203 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.59 176.48 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.024 0.93 . . . . 0.0 110.425 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 124.01 24.51 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.172 0.51 . . . . 0.0 111.141 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.15 134.63 36.39 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.358 1.063 . . . . 0.0 109.366 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -71.11 109.36 5.14 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.812 0.695 . . . . 0.0 109.305 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.57 -53.24 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.81 174.75 10.3 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.922 -172.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.565 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -159.85 142.07 13.31 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.15 0.976 . . . . 0.0 112.014 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.521 HD13 ' HB ' ' A' ' 71' ' ' ILE . 4.0 mp -109.78 114.06 45.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.139 174.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -98.11 109.22 22.01 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 168.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -71.05 81.12 0.67 Allowed 'General case' 0 C--N 1.35 0.589 0 C-N-CA 123.386 0.674 . . . . 0.0 109.225 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.5 t 179.09 8.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.641 1.576 . . . . 0.0 109.924 -175.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.16 -18.44 28.35 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 119.928 -0.374 . . . . 0.0 113.218 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.87 44.65 2.69 Favored Glycine 0 N--CA 1.478 1.461 0 CA-C-N 117.387 0.593 . . . . 0.0 112.463 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 13.5 p -85.79 39.83 0.82 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.643 1.177 . . . . 0.0 112.445 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -154.08 121.18 5.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.472 0.709 . . . . 0.0 110.021 -166.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.426 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 32.3 m-85 -158.25 154.58 27.44 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.764 1.626 . . . . 0.0 107.028 170.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -166.49 148.4 6.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.04 0.536 . . . . 0.0 110.368 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.01 25.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.6 -34.1 76.34 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -66.81 -18.44 65.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.696 0.798 . . . . 0.0 112.617 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.13 5.27 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.974 0.51 . . . . 0.0 111.662 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.19 131.68 51.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.544 0.738 . . . . 0.0 111.54 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 -28.32 4.57 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.167 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 88.9 mtm180 -92.67 -47.85 6.88 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.509 0.723 . . . . 0.0 110.158 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -87.84 122.62 31.7 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 m -124.99 133.54 52.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 108.446 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.521 ' HB ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -120.77 146.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 122.766 0.426 . . . . 0.0 110.636 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 p -159.37 151.51 20.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.602 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.467 ' HB3' HG21 ' A' ' 52' ' ' ILE . 52.6 ttt180 -128.36 123.42 33.83 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -105.22 103.23 12.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -76.82 -11.83 59.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.218 0.607 . . . . 0.0 111.49 -173.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.59 92.34 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 122.549 0.34 . . . . 0.0 111.861 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.39 1.9 16.2 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 117.99 0.359 . . . . 0.0 110.905 169.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.49 HD22 ' HB3' ' A' ' 30' ' ' PHE . 18.5 m120 58.56 66.66 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.843 1.257 . . . . 0.0 110.807 176.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.8 m -141.8 132.36 25.39 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.088 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.5 t -111.17 130.0 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.381 1.072 . . . . 0.0 108.965 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -113.23 148.68 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.729 0.812 . . . . 0.0 111.308 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 65.5 tp -132.0 98.07 4.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -87.73 100.53 12.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.726 ' HB3' HD21 ' A' ' 87' ' ' LEU . 48.2 mtm -94.34 142.18 27.71 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.591 0.757 . . . . 0.0 108.99 175.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 18.1 m120 -136.81 150.15 48.16 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.45 0.7 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 t 52.31 59.91 4.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 173.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -79.66 161.08 26.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.4 -171.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.1 153.4 61.15 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.8 -15.66 39.31 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.862 2.375 . . . . 0.0 115.04 -168.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -72.56 -14.66 61.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.106 0.563 . . . . 0.0 111.983 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.401 ' HB2' HG23 ' A' ' 121' ' ' VAL . 26.0 m-20 -82.15 19.52 1.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.403 0.681 . . . . 0.0 111.019 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 96.7 m -75.31 92.44 2.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 165.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.4 164.05 27.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.449 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.27 107.45 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.414 174.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -84.66 138.02 32.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 113' ' ' TRP . 1.7 pt? -150.2 139.75 21.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.935 0.494 . . . . 0.0 110.889 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.7 m -87.74 114.69 24.59 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 110' ' ' PRO . . . -107.78 117.01 33.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 108.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.18 116.83 31.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.29 159.29 29.31 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.491 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.24 118.66 43.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.572 ' HD1' ' HA ' ' A' ' 108' ' ' ASP . 6.3 m-90 -61.86 141.17 58.12 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -63.17 162.84 11.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.767 0.427 . . . . 0.0 111.55 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.0 t -65.81 -25.15 67.1 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.235 0.614 . . . . 0.0 110.745 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 p -73.13 -24.57 60.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.411 0.684 . . . . 0.0 111.051 172.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.18 -7.38 28.89 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.096 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -64.94 137.6 57.84 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.253 0.621 . . . . 0.0 110.481 -175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.572 ' HA ' ' HD1' ' A' ' 102' ' ' TRP . 21.9 t70 -72.21 126.87 30.88 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.238 0.615 . . . . 0.0 110.489 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.94 107.35 4.27 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.616 0.766 . . . . 0.0 111.006 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.52 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 2.6 Cg_exo -77.39 123.4 6.53 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.13 2.553 . . . . 0.0 110.433 167.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -91.29 -47.01 7.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.432 0.693 . . . . 0.0 110.336 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -125.78 158.53 34.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.773 . . . . 0.0 109.945 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.421 ' HB3' HD11 ' A' ' 96' ' ' LEU . 22.7 m-90 -128.0 152.72 47.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.559 1.144 . . . . 0.0 108.534 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.21 46.52 3.4 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.965 -173.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.47 ' NE2' ' HA ' ' A' ' 6' ' ' VAL . 46.2 mt-30 73.26 -45.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.633 1.573 . . . . 0.0 111.857 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.36 112.06 3.13 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -97.75 123.16 41.57 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 121.885 0.85 . . . . 0.0 109.965 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -80.35 103.76 10.44 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.243 1.017 . . . . 0.0 110.567 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.553 HG11 ' HA2' ' A' ' 10' ' ' GLY . 3.5 m -105.26 150.56 7.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 89.8 m -134.85 114.6 12.75 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 91' ' ' ASP . 40.8 t -92.42 105.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.518 ' HB2' HD11 ' A' ' 12' ' ' LEU . 15.0 t -73.72 158.02 35.43 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 120.667 0.27 . . . . 0.0 111.036 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.7 p -84.85 73.14 10.68 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.686 0.795 . . . . 0.0 110.667 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.512 HD21 ' HB1' ' A' ' 15' ' ' ALA . 3.9 mm? 71.89 -14.67 0.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.521 1.528 . . . . 0.0 113.765 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.449 ' HB2' ' OG ' ' A' ' 122' ' ' SER . 2.4 mp0 -63.12 106.9 0.93 Allowed 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.97 0.805 . . . . 0.0 109.739 173.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -74.22 -10.32 59.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.944 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -63.9 98.62 0.21 Allowed 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.68 0.792 . . . . 0.0 108.924 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.506 ' HA ' HD23 ' A' ' 12' ' ' LEU . 57.6 m80 -67.8 133.46 49.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.84 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.2 t60 58.57 87.55 0.07 Allowed 'General case' 0 CA--C 1.55 0.962 0 O-C-N 124.587 1.179 . . . . 0.0 108.652 -169.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -50.67 -40.25 53.1 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.518 1.127 . . . . 0.0 113.369 -165.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 . . . . . 0 C--O 1.244 0.784 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -63.85 144.61 56.92 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.081 0.552 . . . . 0.0 110.679 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -72.25 108.79 5.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -112.19 127.83 56.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.653 0.781 . . . . 0.0 109.535 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.653 HD13 ' HG2' ' A' ' 35' ' ' MET . 96.4 mt -132.84 122.77 24.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.616 1.166 . . . . 0.0 109.703 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -106.48 102.29 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.02 145.1 27.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 p -160.88 168.09 25.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.852 0.861 . . . . 0.0 110.257 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.06 17.82 21.63 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 119' ' ' VAL . . . -78.32 134.81 14.76 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.14 -178.54 47.67 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.6 tt -98.37 131.78 44.38 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.918 0.487 . . . . 0.0 109.889 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.68 170.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.926 1.291 . . . . 0.0 107.907 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -90.77 154.04 19.81 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.742 0.417 . . . . 0.0 109.964 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' A' ' 124' ' ' LEU . . . -66.45 124.97 24.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.761 0.824 . . . . 0.0 110.567 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.36 -23.35 24.97 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.03 174.81 48.79 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.774 0.338 . . . . 0.0 112.371 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.0 p -106.11 162.76 13.34 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.372 0.669 . . . . 0.0 110.566 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.6 tp -159.8 121.82 3.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.063 0.945 . . . . 0.0 108.613 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -98.53 122.41 41.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.062 0.458 . . . . 0.0 110.165 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 117' ' ' THR . 3.8 mm? -94.82 145.32 24.97 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.071 0.949 . . . . 0.0 108.966 172.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 p -131.89 126.15 33.46 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.508 0.723 . . . . 0.0 109.15 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 43.2 t -122.73 108.94 13.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.619 1.167 . . . . 0.0 108.623 -177.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.24 129.69 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.135 0.974 . . . . 0.0 109.088 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . . . -87.1 100.96 13.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.6 p 64.62 -75.51 0.04 OUTLIER 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.533 1.933 . . . . 0.0 111.713 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.06 -62.78 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -166.81 67.45 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -138.89 162.08 35.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.377 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -103.9 122.16 44.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.765 0.826 . . . . 0.0 109.227 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.22 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.51 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 5.5 m -71.84 85.03 0.94 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.565 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 73' ' ' ARG . 24.1 p-10 -93.59 -27.07 16.82 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.666 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.3 120.12 15.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.788 -171.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.653 ' HG2' HD13 ' A' ' 5' ' ' LEU . 4.5 mtm -150.82 141.84 23.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.222 1.409 . . . . 0.0 108.837 -175.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.64 136.44 11.06 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 76.2 m95 -86.72 130.12 34.6 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.532 0.666 . . . . 0.0 110.319 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -123.06 171.75 9.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.96 1.304 . . . . 0.0 108.261 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -143.23 131.37 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 168.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -102.5 130.9 49.46 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 44' ' ' LYS . . . -115.99 149.56 43.55 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.007 0.523 . . . . 0.0 110.054 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.27 100.6 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.385 2.056 . . . . 0.0 111.367 172.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.78 5.66 56.5 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.964 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.596 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 7.4 mmpt? -138.76 137.89 37.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.723 0.809 . . . . 0.0 109.623 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.32 171.6 5.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.766 0.826 . . . . 0.0 111.555 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.04 124.88 21.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.289 0.566 . . . . 0.0 111.317 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -93.83 126.47 39.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -76.0 106.63 7.7 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -94.95 -48.63 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.541 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . . . -151.19 164.14 37.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -170.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -152.68 134.9 14.98 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.923 0.868 . . . . 0.0 111.442 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.51 118.33 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -121.28 97.43 5.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.258 0.623 . . . . 0.0 109.47 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 67.98 -71.21 0.11 Allowed 'General case' 0 C--N 1.368 1.399 0 C-N-CA 125.278 1.431 . . . . 0.0 108.566 -172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 t -146.45 -78.79 0.17 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 164.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.03 22.27 70.43 Favored Glycine 0 C--N 1.356 1.648 0 C-N-CA 123.12 0.391 . . . . 0.0 114.054 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.85 -20.58 41.44 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-O 119.334 -0.704 . . . . 0.0 112.797 -172.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.7 t 56.52 66.94 1.07 Allowed 'General case' 0 C--N 1.367 1.331 0 C-N-CA 124.468 1.107 . . . . 0.0 109.602 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -156.86 124.3 5.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -165.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.407 ' H ' HD12 ' A' ' 71' ' ' ILE . 5.5 t80 -169.52 117.28 0.61 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.512 ' HB2' HG23 ' A' ' 65' ' ' VAL . 4.8 p90 -164.87 151.92 11.0 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.935 0.894 . . . . 0.0 109.207 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.98 31.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.346 0.658 . . . . 0.0 110.885 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.58 -28.07 68.88 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.368 0.667 . . . . 0.0 110.439 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.8 p -68.32 -28.57 67.27 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.443 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 61' ' ' TYR . 29.3 m -116.37 19.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.615 0.766 . . . . 0.0 111.272 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -67.82 120.63 14.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.9 0.88 . . . . 0.0 110.483 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -20.83 26.27 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 68.6 mtp180 -85.68 -70.08 0.62 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 110.071 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -86.2 120.86 28.02 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 m -130.2 140.58 50.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.212 1.005 . . . . 0.0 108.615 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.421 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -122.53 147.06 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.535 0.734 . . . . 0.0 109.324 175.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -147.0 133.5 19.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.539 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 33' ' ' ASN . 51.2 ttt-85 -114.7 124.84 52.83 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -103.52 110.87 23.08 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -74.98 -20.18 59.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.556 0.742 . . . . 0.0 111.904 -175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.86 78.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.603 0.361 . . . . 0.0 111.727 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.93 -5.68 10.56 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.319 171.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 25' ' ' ALA . 11.4 m-80 60.75 70.37 0.62 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.007 0.923 . . . . 0.0 110.524 -174.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.0 m -138.17 131.68 30.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.36 135.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.745 0.818 . . . . 0.0 109.594 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -121.0 115.01 22.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.836 0.854 . . . . 0.0 109.508 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 tp -92.35 97.79 11.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -85.17 100.94 12.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.45 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.61 ' SD ' HD22 ' A' ' 87' ' ' LEU . 56.6 mtt -84.23 126.59 33.29 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -129.41 137.31 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 t 58.76 73.11 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.593 0.711 . . . . 0.0 110.304 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.61 HD22 ' SD ' ' A' ' 84' ' ' MET . 22.6 mt -75.53 162.5 28.25 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.287 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -125.99 149.16 65.43 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.524 1.129 . . . . 0.0 108.458 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.47 -13.7 40.08 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.956 2.437 . . . . 0.0 112.739 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.43 -28.63 69.81 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.591 1.157 . . . . 0.0 111.891 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -74.92 14.97 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.418 0.687 . . . . 0.0 112.375 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.487 HG21 HG21 ' A' ' 120' ' ' THR . 92.5 m -73.33 89.41 1.59 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 158.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.96 173.37 3.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.722 1.209 . . . . 0.0 109.389 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.26 115.8 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -83.62 133.23 34.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.494 0.718 . . . . 0.0 109.227 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -139.81 120.9 14.71 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.461 0.704 . . . . 0.0 109.891 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 35' ' ' MET . 46.8 t -89.37 116.14 27.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.75 158.67 23.49 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.13 0.972 . . . . 0.0 110.534 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -116.62 139.59 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.4 -153.49 23.33 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.232 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 m -99.3 82.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-O 122.122 0.963 . . . . 0.0 109.896 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -69.48 117.33 10.96 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.101 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -136.77 159.03 43.05 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.6 m -85.17 -2.26 57.82 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.198 0.599 . . . . 0.0 111.671 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.3 t -80.99 14.3 2.31 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.956 0.903 . . . . 0.0 112.656 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.32 19.02 61.31 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.343 -0.698 . . . . 0.0 114.117 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -51.79 158.59 0.96 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.606 1.162 . . . . 0.0 113.79 -170.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.83 162.95 22.94 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.018 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.402 ' HB ' ' HZ2' ' A' ' 113' ' ' TRP . 59.1 p -40.91 127.23 1.97 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 125.948 1.699 . . . . 0.0 113.661 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.32 165.41 5.67 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.813 3.009 . . . . 0.0 114.028 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.24 -47.95 22.06 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.201 0.524 . . . . 0.0 110.069 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.557 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 64.6 m-85 -111.84 147.24 36.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.27 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.402 ' HZ2' ' HB ' ' A' ' 109' ' ' THR . 21.6 m-90 -126.13 146.23 50.02 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 167.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -70.42 -84.13 0.18 Allowed Glycine 0 C--N 1.339 0.744 0 O-C-N 123.664 0.602 . . . . 0.0 113.765 -176.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.26 -46.13 0.14 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -176.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.6 95.13 1.32 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.523 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.412 HG21 HD11 ' A' ' 21' ' ' LEU . 7.2 t -97.85 121.63 40.0 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.532 0.733 . . . . 0.0 110.409 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.36 117.88 20.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.845 0.858 . . . . 0.0 109.097 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.416 HG13 ' HA2' ' A' ' 10' ' ' GLY . 33.5 m -118.38 141.81 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.428 0.691 . . . . 0.0 109.23 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 33.6 m -129.23 104.34 7.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 87' ' ' LEU . 52.6 t -94.17 98.11 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.8 t -66.32 150.25 49.13 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.726 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.4 m -71.14 165.36 23.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.925 0.89 . . . . 0.0 111.463 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.404 HD22 ' HB1' ' A' ' 15' ' ' ALA . 2.8 mm? -68.55 -42.79 77.88 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -71.65 -92.97 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.136 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 176.54 107.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.892 0.877 . . . . 0.0 108.692 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -148.9 153.16 37.63 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.882 1.273 . . . . 0.0 110.034 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -159.81 138.23 10.44 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 62.18 -177.53 0.13 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.403 1.081 . . . . 0.0 111.932 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -122.23 115.94 23.26 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 17.1 p80 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 124.269 1.028 . . . . 0.0 111.47 -176.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 57.11 -156.49 0.3 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.104 0.962 . . . . 0.0 111.536 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.09 111.26 21.37 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -119.89 108.38 14.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.586 HD22 ' HB2' ' A' ' 99' ' ' ALA . 2.9 mm? -96.38 109.02 21.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.01 104.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -76.96 155.83 32.39 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.512 0.673 . . . . 0.0 111.209 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 p -155.33 154.06 31.46 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 108.695 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.52 -2.63 56.09 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -69.57 105.49 1.54 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.55 27.2 Favored Glycine 0 C--O 1.245 0.8 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 122' ' ' SER . 9.8 tt -88.31 137.09 32.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 m -136.37 168.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.694 1.198 . . . . 0.0 109.213 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.5 151.58 22.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.575 0.75 . . . . 0.0 110.724 177.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.25 141.55 52.43 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 123.32 0.648 . . . . 0.0 110.384 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.49 13.72 Favored Glycine 0 N--CA 1.464 0.545 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.09 -172.25 46.04 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 112.161 -0.375 . . . . 0.0 112.161 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 p -123.18 164.08 19.38 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.301 0.64 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.4 tp -148.25 127.75 13.19 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -108.28 113.2 26.12 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.532 0.733 . . . . 0.0 109.336 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -84.27 153.39 23.59 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.5 p -142.14 122.06 13.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.889 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' SG ' HD11 ' A' ' 5' ' ' LEU . 43.7 t -105.71 111.89 24.75 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.97 0.908 . . . . 0.0 109.486 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.65 118.96 32.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.51 99.44 12.44 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.497 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 22.7 t 59.53 39.45 21.6 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.903 1.281 . . . . 0.0 111.355 173.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.18 -69.69 2.2 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -162.23 87.13 0.62 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.33 1.052 . . . . 0.0 108.491 166.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 50.1 m -140.37 139.91 35.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 109.227 175.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -106.35 141.29 37.91 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -157.41 -49.06 0.07 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -98.39 133.8 42.28 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.909 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -97.78 -0.02 46.03 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.134 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.47 51.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.472 1.109 . . . . 0.0 108.472 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.631 ' SD ' ' HD2' ' A' ' 73' ' ' ARG . 47.2 mtt -150.68 168.32 24.69 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.515 1.526 . . . . 0.0 109.689 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.89 -171.99 32.73 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -132.86 133.28 43.11 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.72 155.24 35.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.382 1.073 . . . . 0.0 108.718 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -123.45 136.33 54.55 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.206 0.526 . . . . 0.0 110.407 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.543 ' HB2' HG11 ' A' ' 94' ' ' VAL . 21.8 mm-40 -106.01 154.6 20.38 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.894 1.277 . . . . 0.0 108.254 172.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 44' ' ' LYS . . . -141.79 154.78 66.14 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.568 0.747 . . . . 0.0 109.235 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.12 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.384 2.722 . . . . 0.0 114.102 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.9 20.2 78.08 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.649 -0.705 . . . . 0.0 114.288 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 10.5 mmpt? -129.87 145.32 51.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.951 0.901 . . . . 0.0 109.904 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.2 168.83 18.81 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.347 1.059 . . . . 0.0 111.854 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 143.1 46.7 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.28 139.11 51.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.158 0.583 . . . . 0.0 109.701 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.503 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 92.1 t80 -71.95 110.08 6.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.247 1.019 . . . . 0.0 109.61 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.27 -40.43 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.737 -174.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.58 160.28 40.22 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -143.24 125.14 15.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.33 1.052 . . . . 0.0 110.228 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.58 121.16 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.158 1.383 . . . . 0.0 108.11 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -110.53 179.03 4.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.54 0.736 . . . . 0.0 110.579 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -59.48 162.9 4.48 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.081 0.952 . . . . 0.0 110.911 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -37.69 120.1 0.79 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.692 1.597 . . . . 0.0 112.691 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.2 32.05 3.13 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.188 -171.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.71 145.37 4.15 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.307 173.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 t -167.85 43.09 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.61 0.764 . . . . 0.0 109.331 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.431 ' HA ' HD13 ' A' ' 71' ' ' ILE . 18.1 p -152.86 131.44 12.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.958 0.503 . . . . 0.0 110.672 -169.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.437 ' H ' HD13 ' A' ' 71' ' ' ILE . 11.0 t80 -160.7 132.82 6.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 168.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.407 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 20.1 p90 -159.57 157.88 30.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.178 0.991 . . . . 0.0 110.144 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.51 156.97 30.63 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.485 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 37.9 t70 -70.76 -20.82 62.58 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.731 0.301 . . . . 0.0 110.4 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.0 m -61.82 -36.7 81.91 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.528 0.731 . . . . 0.0 111.063 172.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.85 15.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -60.27 124.83 21.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.227 0.611 . . . . 0.0 109.83 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.77 -28.49 7.06 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 123.734 0.646 . . . . 0.0 112.597 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.583 HH21 ' HA ' ' A' ' 87' ' ' LEU . 66.3 mtp180 -76.36 -46.06 29.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.099 0.952 . . . . 0.0 109.326 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 61' ' ' TYR . 24.3 t80 -91.42 128.55 37.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.999 -166.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 42.1 m -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.35 1.06 . . . . 0.0 108.46 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -141.2 144.15 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.845 0.858 . . . . 0.0 109.131 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.9 m -151.97 142.07 22.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.617 0.767 . . . . 0.0 109.907 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.631 ' HD2' ' SD ' ' A' ' 35' ' ' MET . 18.2 ttt85 -110.17 127.45 54.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 170.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -103.08 132.39 49.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.472 0.709 . . . . 0.0 109.187 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.89 -27.05 21.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 112.69 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.89 94.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.705 0.802 . . . . 0.0 112.049 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.6 5.17 13.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.322 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 49.99 68.03 0.81 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.737 1.215 . . . . 0.0 111.67 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.1 m -136.16 133.44 37.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.129 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.44 147.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -126.99 141.19 51.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.023 0.529 . . . . 0.0 110.252 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.723 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.4 tp -127.25 96.28 4.54 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.485 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 24.9 tp60 -96.08 100.65 12.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.0 mtm -102.93 112.91 25.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.577 0.751 . . . . 0.0 109.017 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -102.79 165.58 10.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.128 0.971 . . . . 0.0 110.225 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.525 ' HB2' ' HG2' ' A' ' 68' ' ' ARG . 10.6 m 54.17 45.0 28.32 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 124.158 0.911 . . . . 0.0 111.384 171.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.583 ' HA ' HH21 ' A' ' 68' ' ' ARG . 82.2 mt -63.59 146.1 54.39 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.701 -168.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.465 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 29.4 mmmt -96.27 141.62 23.38 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.917 1.287 . . . . 0.0 108.6 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.85 -23.92 61.52 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.37 2.046 . . . . 0.0 113.216 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -72.24 -7.69 50.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.899 0.88 . . . . 0.0 112.316 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -84.77 38.2 0.69 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.802 0.841 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.2 m -90.84 100.52 13.36 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 171.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.76 -171.39 3.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.643 0.777 . . . . 0.0 110.273 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.543 HG11 ' HB2' ' A' ' 40' ' ' GLN . 1.5 p -123.77 106.03 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -90.98 146.84 23.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.626 0.77 . . . . 0.0 110.965 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 113' ' ' TRP . 2.0 pp -144.28 153.72 42.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.236 1.014 . . . . 0.0 109.41 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.8 148.21 22.53 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.05 148.49 31.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.106 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.586 ' HB2' HD22 ' A' ' 5' ' ' LEU . . . -155.85 135.76 12.76 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.394 0.678 . . . . 0.0 109.685 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.05 166.59 34.11 Favored Glycine 0 N--CA 1.449 -0.447 0 O-C-N 123.876 0.735 . . . . 0.0 111.441 171.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 m -62.75 147.22 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 122.642 0.377 . . . . 0.0 111.57 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -57.59 108.83 0.6 Allowed 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.069 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.598 ' HD2' ' HB ' ' A' ' 109' ' ' THR . 66.8 ttt180 -73.7 150.89 40.93 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.354 -176.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.2 m -64.9 -22.57 67.02 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.695 0.798 . . . . 0.0 111.814 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 t -74.0 -17.4 60.99 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.699 0.8 . . . . 0.0 111.533 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.85 -28.68 14.87 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.652 -0.249 . . . . 0.0 112.833 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -78.81 161.26 26.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.692 0.797 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.88 125.82 27.88 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 171.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 103' ' ' ARG . 8.1 t -96.13 109.5 47.37 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.85 88.59 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 121.91 1.74 . . . . 0.0 111.056 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.34 -42.68 99.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.296 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -142.01 125.68 16.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.693 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.439 ' HB3' HD12 ' A' ' 96' ' ' LEU . 5.7 m-90 -94.03 155.11 17.29 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.85 171.55 52.02 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.191 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.22 -21.14 66.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.934 0.894 . . . . 0.0 112.059 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.05 127.79 1.22 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.451 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 11.1 t -125.61 138.47 53.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.127 0.571 . . . . 0.0 110.254 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.458 HE21 ' HB ' ' A' ' 94' ' ' VAL . 6.9 mm-40 -80.44 101.69 9.2 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.614 0.766 . . . . 0.0 111.449 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.0 m -99.25 130.57 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 170.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 82.9 m -135.11 110.7 9.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.7 104.61 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.939 -0.476 . . . . 0.0 109.779 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.499 ' HB2' HD22 ' A' ' 12' ' ' LEU . 35.2 t -61.88 155.43 23.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.584 0.754 . . . . 0.0 112.045 168.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 t -85.47 71.45 10.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.162 0.585 . . . . 0.0 109.644 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 68.25 -2.04 1.66 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.068 1.347 . . . . 0.0 114.26 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -73.31 -57.52 3.95 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.495 0.589 . . . . 0.0 111.165 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -129.63 178.21 6.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.39 0.614 . . . . 0.0 110.837 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -144.35 42.47 1.39 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.417 1.487 . . . . 0.0 107.606 172.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.455 ' H ' HD21 ' A' ' 12' ' ' LEU . 69.0 t60 -62.09 113.05 2.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.875 -168.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -100.68 163.93 12.11 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -74.34 -48.81 25.82 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.098 0.475 . . . . 0.0 110.304 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 . . . . . 0 C--O 1.248 1.017 0 C-N-CA 123.972 0.909 . . . . 0.0 109.118 -176.589 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 mtm . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -87.37 71.84 9.87 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.837 0.855 . . . . 0.0 108.886 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -72.31 112.2 8.17 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -107.58 146.18 32.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.346 1.058 . . . . 0.0 108.968 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.552 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 94.5 mt -125.63 108.17 11.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.67 107.52 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -102.98 154.84 18.83 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.691 0.619 . . . . 0.0 111.72 -170.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -157.68 158.8 36.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.4 1.08 . . . . 0.0 109.133 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.12 -2.99 29.91 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.827 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA2' HG13 ' A' ' 119' ' ' VAL . . . -72.24 83.33 0.53 Allowed Glycine 0 C--N 1.35 1.322 0 CA-C-N 117.173 0.486 . . . . 0.0 112.725 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.86 177.03 17.19 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.0 tt -92.54 114.14 26.61 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.424 HG23 HD11 ' A' ' 87' ' ' LEU . 35.9 m -113.34 171.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -94.4 158.07 15.73 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.15 0.58 . . . . 0.0 109.919 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB3' ' HD3' ' A' ' 89' ' ' PRO . . . -62.76 116.83 5.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.756 0.822 . . . . 0.0 110.571 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.43 22.8 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.602 0.564 . . . . 0.0 111.988 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.65 55.24 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 121.275 0.375 . . . . 0.0 113.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 p -109.4 165.7 11.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 110.685 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.7 tp -158.33 141.03 14.58 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -114.26 113.16 24.24 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.175 0.512 . . . . 0.0 110.15 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -87.72 149.17 24.39 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 109.332 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.2 p -145.22 126.79 15.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.798 0.839 . . . . 0.0 109.346 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.578 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 43.5 t -135.28 130.31 34.93 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 109.735 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.56 146.14 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.97 99.02 11.57 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t 53.37 40.65 31.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.297 1.439 . . . . 0.0 112.352 171.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.03 -61.08 4.36 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.027 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -168.54 33.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.03 1.332 . . . . 0.0 109.803 172.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -119.93 121.28 38.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.326 0.651 . . . . 0.0 109.945 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -133.43 150.67 51.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 110.371 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mtt85 -166.92 72.23 0.12 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 107.779 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.6 m -147.71 129.69 15.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.765 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.421 ' HB3' ' NE1' ' A' ' 54' ' ' TRP . 18.5 m120 -79.95 -43.71 21.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.88 0.472 . . . . 0.0 111.894 -171.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 54' ' ' TRP . . . -116.39 169.5 9.26 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.569 0.347 . . . . 0.0 110.318 173.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.481 ' SD ' HG22 ' A' ' 80' ' ' VAL . 58.2 mtt -148.98 165.39 31.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.533 1.133 . . . . 0.0 109.006 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -155.8 -174.82 26.08 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-O 119.993 -0.337 . . . . 0.0 112.264 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -143.6 118.87 10.18 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.659 1.184 . . . . 0.0 108.455 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.52 162.87 14.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.411 1.084 . . . . 0.0 108.824 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -121.61 133.98 54.99 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.505 ' HB3' HG12 ' A' ' 94' ' ' VAL . 9.9 tm0? -107.84 128.97 55.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 44' ' ' LYS . . . -111.78 141.2 24.27 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.552 0.741 . . . . 0.0 109.015 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.82 114.1 2.01 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.597 2.198 . . . . 0.0 112.391 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.51 79.78 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.492 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -119.09 173.58 6.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.571 1.148 . . . . 0.0 108.943 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.49 166.46 15.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.843 0.354 . . . . 0.0 110.622 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.92 115.55 11.26 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.343 0.592 . . . . 0.0 109.746 170.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -92.63 141.57 28.34 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.082 0.953 . . . . 0.0 109.892 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -77.58 116.47 18.16 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.63 0.581 . . . . 0.0 109.535 -178.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.18 -59.59 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.584 0.754 . . . . 0.0 110.072 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB3' HD12 ' A' ' 71' ' ' ILE . . . -148.79 163.45 37.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.449 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -157.25 164.72 37.4 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.362 1.077 . . . . 0.0 112.226 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 96.4 mt -109.2 116.77 52.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.31 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.465 ' HB3' ' HA3' ' A' ' 57' ' ' GLY . 16.5 tpt180 -63.28 95.0 0.08 Allowed 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.19 0.931 . . . . 0.0 108.992 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.45 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.6 t90 53.21 -100.63 0.1 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 125.446 1.498 . . . . 0.0 110.511 -176.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.0 t -151.89 106.78 3.25 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.77 -20.46 29.31 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.364 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 53' ' ' ARG . . . -72.77 -62.12 3.31 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 9.5 t 55.47 60.14 3.52 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.689 1.196 . . . . 0.0 113.501 167.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.39 117.68 1.15 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.713 0.805 . . . . 0.0 109.573 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -171.02 128.21 0.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.206 2.202 . . . . 0.0 105.924 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.15 146.21 7.43 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.041 0.936 . . . . 0.0 109.708 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.95 156.43 38.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.682 0.793 . . . . 0.0 109.981 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -60.32 -26.73 66.79 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.474 0.71 . . . . 0.0 112.135 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.2 t -65.55 -39.02 91.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.764 0.826 . . . . 0.0 111.089 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.09 12.33 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.878 0.871 . . . . 0.0 111.268 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -66.78 120.75 14.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.144 0.978 . . . . 0.0 110.799 -173.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.63 5.49 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.305 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -77.51 -55.36 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.14 120.3 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.2 m -129.44 138.13 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -116.23 142.49 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -137.17 133.07 34.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.556 ' HB2' HD11 ' A' ' 52' ' ' ILE . 78.3 ttt180 -115.27 122.41 45.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.46 90.65 3.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -69.93 -13.26 62.16 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.01 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.61 77.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.343 1.057 . . . . 0.0 111.988 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.19 11.86 12.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.884 0.474 . . . . 0.0 110.794 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.28 28.62 15.78 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.833 1.253 . . . . 0.0 112.091 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.5 m -114.37 131.75 56.45 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.306 0.642 . . . . 0.0 110.287 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.481 HG22 ' SD ' ' A' ' 35' ' ' MET . 79.0 t -108.58 150.05 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.41 1.484 . . . . 0.0 108.946 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -131.02 151.62 51.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.643 0.777 . . . . 0.0 110.745 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 55.7 tp -132.22 101.36 5.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 108.521 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -85.97 101.14 12.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.469 ' SD ' HD22 ' A' ' 87' ' ' LEU . 39.9 mtt -83.33 139.58 32.95 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.109 0.964 . . . . 0.0 109.2 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -138.23 138.11 38.18 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 t 58.4 72.34 0.53 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.629 1.172 . . . . 0.0 110.451 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.469 HD22 ' SD ' ' A' ' 84' ' ' MET . 42.3 mt -82.62 144.8 30.06 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.574 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -87.18 150.29 49.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.734 0.814 . . . . 0.0 109.38 -176.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 15' ' ' ALA . 29.1 Cg_endo -62.83 -23.63 74.36 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 C-N-CA 121.726 1.617 . . . . 0.0 110.891 169.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.04 -31.73 69.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.696 1.598 . . . . 0.0 111.775 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.37 22.43 0.84 Allowed 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.607 0.717 . . . . 0.0 111.632 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -77.85 92.28 4.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 161.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.53 169.97 21.87 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.023 0.929 . . . . 0.0 109.694 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -97.69 107.82 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -82.06 150.81 27.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.401 0.681 . . . . 0.0 109.445 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.78 140.26 21.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.354 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.578 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 14.7 p -89.7 149.92 22.55 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 110' ' ' PRO . . . -112.12 158.45 19.6 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.556 0.742 . . . . 0.0 109.71 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -139.33 137.71 36.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.31 157.83 25.16 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.5 m -114.23 149.54 16.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 123.459 0.703 . . . . 0.0 109.98 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -69.7 84.96 0.46 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -70.94 152.6 43.47 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.116 -167.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.6 m -66.73 -17.58 64.93 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.252 0.621 . . . . 0.0 111.821 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.1 t -67.05 -22.87 65.84 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.988 0.915 . . . . 0.0 111.421 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.58 -29.37 11.53 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -88.0 117.69 27.04 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.564 0.745 . . . . 0.0 110.024 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -76.24 101.4 5.41 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.1 t -110.67 142.68 26.64 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 123.327 0.651 . . . . 0.0 110.577 -171.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 17.4 Cg_exo -64.66 99.82 0.32 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.68 2.253 . . . . 0.0 111.318 177.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -92.59 -12.05 32.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.312 0.645 . . . . 0.0 111.271 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 9.9 m-85 -128.55 149.25 50.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -138.92 163.98 30.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.623 0.769 . . . . 0.0 109.969 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.552 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -76.09 174.57 53.11 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.633 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -73.89 -28.11 61.39 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.987 0.515 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.06 100.81 2.66 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.378 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -96.2 106.81 19.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.078 0.942 . . . . 0.0 108.572 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -78.7 101.38 7.5 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.244 -172.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.515 HG13 ' HA2' ' A' ' 10' ' ' GLY . 19.8 m -91.04 137.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.0 m -124.46 102.98 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.32 94.73 4.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -64.43 142.43 58.42 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.0 p -70.48 88.58 0.67 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.75 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 73.98 -46.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.565 1.946 . . . . 0.0 113.361 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.77 110.61 5.66 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.107 0.963 . . . . 0.0 110.344 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -77.82 81.75 4.23 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -71.77 152.79 42.44 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.199 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 45.7 m170 -111.73 -167.04 1.13 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.283 1.033 . . . . 0.0 109.104 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -150.86 176.19 11.31 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.047 0.939 . . . . 0.0 109.218 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -69.76 113.08 6.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.958 0.503 . . . . 0.0 109.882 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 . . . . . 0 C--O 1.247 0.969 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.609 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.968 0.414 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.19 106.3 16.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 93.1 mt -93.42 105.6 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.865 0.466 . . . . 0.0 109.862 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t -98.75 104.19 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.14 146.78 24.38 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.338 0.655 . . . . 0.0 111.376 -171.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 p -149.82 158.01 43.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.213 1.005 . . . . 0.0 109.877 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.71 -0.75 42.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.237 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.95 118.68 9.86 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-O 120.241 -0.2 . . . . 0.0 112.662 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.36 -167.12 29.47 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.3 tt -105.21 124.28 49.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.821 0.449 . . . . 0.0 110.513 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 19' ' ' LEU . 28.0 m -118.67 163.03 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.345 1.058 . . . . 0.0 108.744 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 5.7 pm0 -88.89 155.55 19.46 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.065 0.546 . . . . 0.0 109.979 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.87 111.7 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.866 0.866 . . . . 0.0 110.745 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.02 -14.17 23.91 Favored Glycine 0 N--CA 1.474 1.181 0 O-C-N 123.273 0.358 . . . . 0.0 113.042 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.37 170.99 51.29 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 120.111 -0.272 . . . . 0.0 112.457 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -105.57 138.85 41.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.512 0.725 . . . . 0.0 110.626 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HB2' HG11 ' A' ' 13' ' ' VAL . 38.8 tp -132.51 130.94 41.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.683 1.193 . . . . 0.0 109.152 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -111.97 127.51 55.89 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.833 0.853 . . . . 0.0 109.573 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.7 mm? -99.61 149.31 23.41 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 108.957 170.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 p -138.26 124.05 19.9 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 49.2 t -116.77 101.96 9.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.895 0.878 . . . . 0.0 109.409 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.87 121.29 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.52 99.43 12.29 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.79 0.436 . . . . 0.0 110.374 -173.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 18.4 m 58.87 35.72 24.33 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.076 1.35 . . . . 0.0 112.108 173.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.79 -58.63 4.81 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.993 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 31.9 ttp-105 -173.47 77.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.668 1.187 . . . . 0.0 108.014 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.5 m -139.77 147.89 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.567 0.747 . . . . 0.0 110.293 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.471 ' HB3' HD21 ' A' ' 78' ' ' ASN . 11.6 p90 -128.18 136.95 51.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 0.0 110.103 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -169.67 12.93 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.0 0.92 . . . . 0.0 109.098 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 t -108.79 108.6 19.47 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.398 0.679 . . . . 0.0 109.992 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -88.83 -23.72 22.76 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.737 0.815 . . . . 0.0 110.66 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . . . -130.43 123.47 29.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.005 0.922 . . . . 0.0 109.04 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.0 mtm -132.28 166.18 22.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.233 1.013 . . . . 0.0 109.719 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -154.6 179.81 30.42 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.288 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 93.2 m95 -138.38 130.31 28.26 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 170.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.556 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 64.9 m-85 -135.48 152.63 51.54 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 109.262 -173.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 13.7 ptp180 -107.39 141.51 38.66 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -132.5 145.43 51.16 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -176.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -144.6 155.17 56.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.69 105.94 0.25 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.315 2.01 . . . . 0.0 111.83 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.05 -17.04 56.73 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.558 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 9.8 mmpt? -111.87 131.86 55.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.62 0.768 . . . . 0.0 110.326 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.68 170.64 14.09 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.009 0.924 . . . . 0.0 111.763 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -67.28 119.02 11.46 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.712 -177.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -103.68 136.85 42.61 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.961 0.904 . . . . 0.0 109.997 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -62.97 115.82 4.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.688 1.195 . . . . 0.0 111.539 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.4 t -102.46 -48.16 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.011 0.924 . . . . 0.0 109.281 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -153.11 168.45 25.89 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.434 0.694 . . . . 0.0 111.623 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.626 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -153.98 138.47 16.8 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.467 0.651 . . . . 0.0 111.423 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.658 HG21 ' HB2' ' A' ' 73' ' ' ARG . 72.3 mt -127.01 124.76 65.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.069 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 34' ' ' ALA . 63.1 mtt180 . . . . . 0 C--O 1.243 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 110.849 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB3' HG23 ' A' ' 52' ' ' ILE . 38.4 m . . . . . 0 CA--C 1.549 0.913 0 CA-C-O 121.271 0.557 . . . . 0.0 112.114 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.499 ' HA ' HD11 ' A' ' 71' ' ' ILE . 12.4 p -163.9 122.54 1.92 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.45 1.1 . . . . 0.0 109.704 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.553 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 93.8 m-85 -150.15 147.84 28.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.482 1.113 . . . . 0.0 108.603 174.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' CD1' ' HA ' ' A' ' 66' ' ' LYS . 26.3 p90 -164.53 158.04 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.152 0.981 . . . . 0.0 109.649 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.0 157.63 28.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 110.631 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.43 -37.69 88.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.632 0.773 . . . . 0.0 110.985 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -70.2 -16.06 63.02 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.912 0.885 . . . . 0.0 112.635 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 62' ' ' ALA . 31.5 m -125.06 20.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.777 0.831 . . . . 0.0 110.551 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 4.3 ttmp? -48.92 113.55 0.81 Allowed 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.156 1.383 . . . . 0.0 113.072 -175.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.28 -28.91 4.97 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.275 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -71.49 -44.85 63.96 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.546 0.688 . . . . 0.0 109.546 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.62 121.88 28.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.563 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.2 m -134.94 149.8 50.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.388 1.475 . . . . 0.0 107.905 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.632 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.12 152.65 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.636 -177.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 t -151.47 145.23 25.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.608 0.763 . . . . 0.0 110.024 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.658 ' HB2' HG21 ' A' ' 52' ' ' ILE . 28.7 ttt180 -110.57 122.93 48.97 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.5 86.96 2.59 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -79.82 -11.91 59.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.341 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -35.95 73.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.817 0.847 . . . . 0.0 111.831 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.02 1.39 11.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.921 0.488 . . . . 0.0 111.212 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.471 HD21 ' HB3' ' A' ' 30' ' ' PHE . 19.3 m120 57.74 67.49 0.96 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.772 1.229 . . . . 0.0 110.885 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.3 m -139.04 131.76 29.03 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.898 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.4 HG12 ' HE1' ' A' ' 37' ' ' TRP . 20.6 t -108.82 125.02 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.29 134.13 48.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.791 0.436 . . . . 0.0 111.359 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 57.1 tp -115.64 97.14 5.97 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -92.6 98.5 11.48 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.498 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 75.9 mtm -98.25 111.56 23.85 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -100.4 138.37 37.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.6 t 58.56 72.04 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.308 1.043 . . . . 0.0 110.572 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.88 144.68 36.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.605 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -87.0 153.87 54.76 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.24 -18.45 64.94 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.944 1.763 . . . . 0.0 112.654 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.16 3.68 41.78 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.733 0.813 . . . . 0.0 112.134 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.85 26.38 1.82 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.557 0.743 . . . . 0.0 109.971 167.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.524 HG23 HG23 ' A' ' 120' ' ' THR . 95.9 m -83.25 94.0 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 166.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.93 -169.29 2.33 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.71 0.804 . . . . 0.0 110.047 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.0 p -114.84 110.7 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.441 0.697 . . . . 0.0 109.191 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -84.38 153.14 23.62 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.111 0.564 . . . . 0.0 109.683 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.41 147.5 31.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.368 0.667 . . . . 0.0 110.26 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.9 t -88.53 161.62 16.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.775 0.83 . . . . 0.0 109.244 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -122.7 158.22 30.57 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.045 0.538 . . . . 0.0 109.586 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -152.44 167.2 29.52 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.2 1.0 . . . . 0.0 109.515 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.516 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.468 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 15.7 Cg_exo . . . . . 0 CA--C 1.545 1.029 0 N-CA-C 110.198 -0.732 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.47 -42.97 41.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.3 0.64 . . . . 0.0 110.075 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 96.8 m-85 -112.45 160.01 18.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.378 1.071 . . . . 0.0 110.453 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -137.1 165.36 26.24 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.562 1.145 . . . . 0.0 108.878 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -79.27 173.65 55.26 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.446 -175.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 11.7 mm100 -72.7 -19.55 61.38 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.244 0.618 . . . . 0.0 111.394 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.72 99.98 1.7 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 t -99.49 116.74 32.32 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.523 0.729 . . . . 0.0 110.104 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -72.27 112.27 8.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.901 0.881 . . . . 0.0 110.564 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.58 126.6 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.524 HG23 HG23 ' A' ' 92' ' ' THR . 57.1 m -120.5 104.37 9.92 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.69 98.08 7.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.7 t -71.29 146.46 48.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.826 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 m -71.92 86.41 0.99 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.158 0.583 . . . . 0.0 110.225 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 3.3 mm? . . . . . 0 N--CA 1.482 1.152 0 C-N-CA 124.656 1.183 . . . . 0.0 112.252 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -102.13 121.4 42.13 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.704 0.802 . . . . 0.0 110.322 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.691 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.4 mt -110.15 110.83 21.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.232 1.013 . . . . 0.0 109.878 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.3 104.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.691 0.797 . . . . 0.0 109.383 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.94 142.32 27.9 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.69 0.796 . . . . 0.0 111.427 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.8 m -154.62 145.85 22.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.401 1.48 . . . . 0.0 108.844 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.4 -32.91 2.28 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.958 -0.357 . . . . 0.0 112.4 175.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 127.05 43.94 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 123.977 0.457 . . . . 0.0 113.937 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.15 -175.78 36.16 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.302 0.477 . . . . 0.0 112.028 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 120' ' ' THR . 20.7 tp -91.46 120.11 32.01 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.956 0.503 . . . . 0.0 109.934 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 87' ' ' LEU . 27.5 m -125.24 158.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 109.156 170.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.45 152.91 31.88 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -60.82 133.61 56.27 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.507 0.723 . . . . 0.0 110.469 173.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.95 -15.12 64.07 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 123.306 0.379 . . . . 0.0 112.387 -170.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.29 -173.82 49.26 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-O 121.078 0.265 . . . . 0.0 113.657 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.6 p -127.12 154.27 44.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.137 0.975 . . . . 0.0 110.318 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.1 tp -154.82 122.94 5.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -98.14 117.29 32.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 110.505 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -88.77 155.18 19.72 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.12 0.968 . . . . 0.0 109.209 172.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.8 p -151.39 133.95 15.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.987 0.915 . . . . 0.0 109.006 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 46.2 t -131.52 101.96 5.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.624 0.77 . . . . 0.0 109.158 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 t -87.66 127.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 109.68 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.1 96.93 10.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t 43.85 53.44 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.02 1.728 . . . . 0.0 112.69 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.37 -79.03 1.24 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.392 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.565 ' HG2' ' HA ' ' A' ' 77' ' ' LYS . 61.8 mtm-85 -150.37 86.0 1.4 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.046 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 t -141.22 145.16 35.26 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.83 117.51 21.98 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mtp85 -143.01 1.46 1.27 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.73 1.212 . . . . 0.0 109.439 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 91.87 6.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.905 0.882 . . . . 0.0 110.216 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -83.76 -26.24 29.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.31 1.044 . . . . 0.0 110.117 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.8 141.93 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.066 1.346 . . . . 0.0 108.076 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.487 ' HE3' HG22 ' A' ' 52' ' ' ILE . 20.9 mtm -151.89 162.06 41.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.121 0.968 . . . . 0.0 109.535 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -168.49 138.62 5.22 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.319 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -92.81 126.36 37.86 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -116.24 147.4 41.52 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 108.515 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.23 142.35 33.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.51 ' HB3' HG13 ' A' ' 94' ' ' VAL . 64.0 tt0 -141.41 128.38 20.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.83 160.78 31.85 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.391 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.73 112.39 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.095 2.53 . . . . 0.0 112.843 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.76 23.39 75.12 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.625 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -125.37 173.19 9.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.781 0.832 . . . . 0.0 110.679 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.18 163.8 26.72 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.481 1.112 . . . . 0.0 111.837 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -92.99 106.79 18.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.874 0.845 . . . . 0.0 109.024 170.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.73 135.84 33.76 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.346 1.059 . . . . 0.0 110.009 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -65.03 120.05 11.91 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.098 1.359 . . . . 0.0 111.31 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.96 -61.47 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.43 0.692 . . . . 0.0 109.162 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -146.65 159.36 43.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.958 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -132.19 141.41 49.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 0.0 111.021 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 73' ' ' ARG . 3.7 mp -112.6 121.3 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.5 mtp-105 . . . . . 0 N--CA 1.472 0.644 0 C-N-CA 124.393 1.077 . . . . 0.0 109.417 -174.495 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 40.8 m . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.437 ' HA ' HD11 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -158.69 122.25 3.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.164 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 15.9 m-85 -159.16 125.62 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.599 1.56 . . . . 0.0 107.297 170.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -164.62 144.14 7.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.638 0.775 . . . . 0.0 109.649 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 158.46 28.63 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.332 165.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.41 -28.38 69.64 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.4 t -63.48 -34.69 78.32 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.04 0.936 . . . . 0.0 112.224 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 34.1 m -109.52 14.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.425 0.69 . . . . 0.0 111.035 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -71.25 134.31 46.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.868 0.867 . . . . 0.0 109.409 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.11 -0.14 63.82 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.697 0.623 . . . . 0.0 113.243 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 72.7 mtp180 -109.29 -73.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.525 1.13 . . . . 0.0 109.174 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.65 119.66 26.23 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -126.58 129.8 49.26 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.977 0.911 . . . . 0.0 108.801 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -113.37 138.82 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.272 0.558 . . . . 0.0 109.787 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -144.81 149.21 35.05 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.298 1.039 . . . . 0.0 108.775 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.599 ' HB2' HG21 ' A' ' 52' ' ' ILE . 57.7 ttp180 -124.6 129.29 50.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.15 130.01 45.44 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -87.44 -29.91 21.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 111.563 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.25 82.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.529 0.731 . . . . 0.0 112.064 -172.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.45 12.15 15.1 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.655 0.382 . . . . 0.0 111.839 175.083 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 53.76 56.85 6.66 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.093 0.957 . . . . 0.0 112.052 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -126.03 130.63 51.54 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.626 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.09 121.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.856 0.862 . . . . 0.0 109.127 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -102.25 145.38 29.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.622 0.769 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 53.1 tp -125.36 98.03 5.45 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -83.22 101.43 11.23 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.472 ' SD ' HD21 ' A' ' 87' ' ' LEU . 61.4 mtt -84.53 123.75 30.64 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -121.67 146.14 47.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.9 t 57.24 63.14 1.96 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.586 0.708 . . . . 0.0 110.935 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HB3' HG21 ' A' ' 121' ' ' VAL . 35.3 mt -79.66 140.04 37.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.839 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.6 mmmp? -99.15 157.89 33.26 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 108.729 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.67 -22.76 74.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.459 2.106 . . . . 0.0 112.72 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.42 -17.2 64.35 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.705 1.202 . . . . 0.0 112.452 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -81.87 37.84 0.5 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.745 0.818 . . . . 0.0 111.048 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 120' ' ' THR . 90.1 m -91.27 90.86 7.93 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 164.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.3 177.46 6.09 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.51 HG13 ' HB3' ' A' ' 40' ' ' GLN . 4.7 p -107.32 112.85 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.71 0.804 . . . . 0.0 110.173 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -92.01 133.23 35.91 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -122.47 141.51 51.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.058 0.543 . . . . 0.0 109.969 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -91.23 149.47 21.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.75 158.94 43.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.409 0.684 . . . . 0.0 109.566 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.76 169.35 17.77 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 109.811 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.437 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.703 176.756 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 CA--C 1.546 1.102 0 CA-C-O 121.221 0.425 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.09 -30.55 55.43 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.36 0.6 . . . . 0.0 109.808 170.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -127.13 153.17 46.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.779 1.232 . . . . 0.0 108.567 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -131.38 157.64 42.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.7 -120.95 0.67 Allowed Glycine 0 C--N 1.336 0.57 0 O-C-N 123.244 0.34 . . . . 0.0 112.696 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -129.05 -15.14 4.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.8 109.97 0.14 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 123.332 0.395 . . . . 0.0 112.641 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.454 HG21 HD12 ' A' ' 21' ' ' LEU . 10.1 t -95.84 128.15 42.48 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.644 0.735 . . . . 0.0 110.798 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -79.36 108.86 13.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.47 136.27 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 92' ' ' THR . 31.3 m -133.9 129.34 36.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 87' ' ' LEU . 46.3 t -113.66 108.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.8 m -60.88 141.64 56.98 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.939 0.495 . . . . 0.0 111.934 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 m -74.66 90.74 2.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.464 0.705 . . . . 0.0 110.964 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.8 mm? . . . . . 0 N--CA 1.491 1.579 0 C-N-CA 124.486 1.114 . . . . 0.0 112.943 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -103.07 132.32 49.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.672 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 70.3 mt -121.86 120.22 33.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 52.4 t -95.76 99.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 51.9 mt-10 -95.34 123.92 39.11 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.678 -172.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 m -130.91 154.38 48.16 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.617 1.167 . . . . 0.0 109.769 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.23 11.67 35.87 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.015 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.57 74.65 1.5 Allowed Glycine 0 C--N 1.35 1.355 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.37 -164.17 13.68 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 120' ' ' THR . 6.5 tt -116.86 127.54 54.39 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.82 161.13 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.144 0.978 . . . . 0.0 109.007 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -80.67 158.27 25.66 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.212 0.605 . . . . 0.0 110.768 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.23 114.49 2.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.772 0.829 . . . . 0.0 110.539 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.99 -25.53 10.69 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.959 0.79 . . . . 0.0 112.01 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.67 164.63 54.82 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 113.725 0.25 . . . . 0.0 113.725 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.6 p -104.64 155.46 18.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.988 0.915 . . . . 0.0 110.38 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.2 tp -152.76 136.84 16.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.114 0.966 . . . . 0.0 108.464 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.062 0.545 . . . . 0.0 110.043 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -101.07 157.51 16.7 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.297 1.039 . . . . 0.0 108.899 174.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -144.89 127.27 15.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -127.79 105.37 8.39 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.542 0.737 . . . . 0.0 110.445 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.47 130.04 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.88 98.06 11.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.726 0.298 . . . . 0.0 110.374 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 5.6 m 56.9 29.12 15.66 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.329 1.451 . . . . 0.0 112.917 170.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.18 50.77 5.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -173.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 69.68 24.42 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.629 1.172 . . . . 0.0 113.092 171.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 32.7 p -87.8 153.24 21.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.889 0.476 . . . . 0.0 110.271 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -110.67 123.16 49.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.791 0.836 . . . . 0.0 109.76 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -145.95 -50.27 0.23 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.672 1.189 . . . . 0.0 108.168 167.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -73.52 103.72 4.24 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.942 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -88.97 -13.96 37.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.794 0.838 . . . . 0.0 110.033 167.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.58 43.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.784 1.234 . . . . 0.0 108.3 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtm -148.9 167.15 26.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.007 . . . . 0.0 109.157 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.61 148.79 8.91 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.715 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 95.4 m95 -89.51 136.25 33.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.25 164.78 18.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.42 1.088 . . . . 0.0 108.447 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -128.47 148.02 50.71 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.41 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 35.5 tt0 -155.07 144.67 21.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.546 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -108.82 152.56 42.38 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 171.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 110.71 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.706 2.27 . . . . 0.0 112.506 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.07 43.96 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.449 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 9.1 mmpt? -119.78 170.62 9.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.086 0.955 . . . . 0.0 110.57 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.28 163.44 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.655 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.499 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.56 123.36 31.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.6 137.59 32.71 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 0.0 109.673 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 80.7 t80 -69.09 119.72 13.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.13 0.972 . . . . 0.0 110.431 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.51 -54.68 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.293 0.637 . . . . 0.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . . . -139.9 164.9 28.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.588 -171.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . . . -145.09 131.86 20.04 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.377 0.671 . . . . 0.0 110.846 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -110.79 127.24 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.767 1.227 . . . . 0.0 109.375 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.41 ' CZ ' ' HB1' ' A' ' 51' ' ' ALA . 3.2 mpt_? . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 125.252 1.421 . . . . 0.0 109.408 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.8 m . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 121.323 0.583 . . . . 0.0 112.236 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.467 ' HA ' HD11 ' A' ' 71' ' ' ILE . 2.5 p -150.59 122.2 8.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.261 1.025 . . . . 0.0 109.211 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.24 127.05 0.82 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -165.82 167.04 17.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.544 0.738 . . . . 0.0 110.086 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.34 145.56 33.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 168.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.77 -28.1 69.64 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.851 0.358 . . . . 0.0 110.966 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 m -70.92 -26.62 63.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.61 0.764 . . . . 0.0 112.214 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 62' ' ' ALA . 18.7 m -104.58 4.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 122.872 0.469 . . . . 0.0 111.43 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.76 116.05 3.2 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.463 1.105 . . . . 0.0 112.501 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.72 11.81 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.986 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -87.25 -57.24 3.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.516 0.726 . . . . 0.0 109.263 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -87.77 122.1 31.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -146.74 153.68 40.52 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.049 1.34 . . . . 0.0 108.63 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -124.92 156.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.59 0.756 . . . . 0.0 109.915 176.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -151.75 136.77 17.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.778 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.7 ttp85 -110.37 136.28 49.79 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -109.03 122.26 46.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -87.59 -23.85 24.18 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.053 0.541 . . . . 0.0 111.0 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.35 84.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.377 0.671 . . . . 0.0 111.875 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 17.1 12.53 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.51 0.324 . . . . 0.0 111.841 172.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 48.72 56.37 7.74 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.237 1.015 . . . . 0.0 112.191 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.1 m -130.07 130.72 45.24 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.422 HG12 ' HE1' ' A' ' 37' ' ' TRP . 86.9 t -109.65 125.53 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.901 0.88 . . . . 0.0 109.89 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -102.45 146.59 27.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.739 0.815 . . . . 0.0 110.388 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.3 tp -124.53 101.48 7.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.111 0.964 . . . . 0.0 108.685 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -91.55 101.18 13.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.369 0.668 . . . . 0.0 109.995 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.419 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 55.7 mtm -107.84 107.61 18.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.376 0.67 . . . . 0.0 110.118 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -106.91 147.94 29.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.303 0.641 . . . . 0.0 109.908 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.4 t 61.71 60.63 1.57 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.117 0.967 . . . . 0.0 110.067 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' A' ' 121' ' ' VAL . 42.9 mt -76.13 151.12 37.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.28 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -110.7 157.11 39.36 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.392 1.077 . . . . 0.0 109.046 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 27.3 Cg_endo -59.14 -26.14 80.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.56 2.174 . . . . 0.0 113.145 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.14 -17.3 64.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.002 0.921 . . . . 0.0 112.326 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.06 15.65 1.44 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.643 0.777 . . . . 0.0 111.193 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.52 HG23 HG23 ' A' ' 120' ' ' THR . 85.6 m -81.4 89.95 6.15 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 163.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.05 -166.07 0.77 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.491 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 p -115.23 112.93 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.195 0.598 . . . . 0.0 110.362 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -85.05 130.74 34.56 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 96' ' ' LEU . 1.6 pt? -130.3 125.04 33.77 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.504 0.721 . . . . 0.0 109.292 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.1 p -88.85 138.66 31.22 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -111.88 152.04 28.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.295 1.038 . . . . 0.0 109.823 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 5' ' ' LEU . . . -130.0 167.68 17.89 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.614 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.274 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.604 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 84.6 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 N-CA-C 110.054 -0.787 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.2 -27.55 60.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.126 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -112.45 150.1 31.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 109.776 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -130.85 145.96 52.15 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -70.76 -79.39 0.37 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 123.527 0.517 . . . . 0.0 113.247 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -164.11 -40.31 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.771 0.828 . . . . 0.0 109.815 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.9 119.49 4.54 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.119 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 6.2 t -96.56 111.62 23.68 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.596 0.713 . . . . 0.0 109.622 174.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -70.45 98.56 1.45 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.513 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.02 132.79 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 10.8 m -128.1 106.21 8.91 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 87' ' ' LEU . 42.6 t -106.49 97.82 6.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 121.65 -0.656 . . . . 0.0 109.462 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.412 ' CB ' HD21 ' A' ' 12' ' ' LEU . 28.1 t -70.6 129.17 38.49 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.878 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 89' ' ' PRO . 43.8 t -59.93 98.23 0.05 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.499 0.72 . . . . 0.0 110.743 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.486 1.361 0 C-N-CA 125.83 1.652 . . . . 0.0 113.288 177.319 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 37.8 mt-30 -104.02 121.66 43.63 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.317 0.647 . . . . 0.0 109.568 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.582 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.6 mt -120.08 107.17 12.73 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.66 102.56 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.69 146.69 23.98 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.453 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 p -159.18 177.77 10.72 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.169 0.988 . . . . 0.0 109.788 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.8 -0.28 87.86 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.858 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 142.86 29.65 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.968 0.384 . . . . 0.0 112.478 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.66 -168.76 39.0 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.1 tt -99.73 130.3 45.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.348 0.659 . . . . 0.0 109.631 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.72 149.83 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.742 0.817 . . . . 0.0 109.258 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HB2' HD13 ' A' ' 124' ' ' LEU . 4.3 pm0 -70.17 146.92 50.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.827 0.451 . . . . 0.0 110.498 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.94 135.18 55.37 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.394 0.678 . . . . 0.0 110.868 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.08 6.2 72.06 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.068 -168.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.95 -169.83 27.36 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 122.896 0.284 . . . . 0.0 112.851 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 p -129.28 153.26 47.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.635 0.774 . . . . 0.0 110.57 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.5 tp -149.72 125.09 10.2 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -108.38 109.99 21.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.453 0.701 . . . . 0.0 110.216 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -87.55 153.8 21.12 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.209 1.004 . . . . 0.0 109.947 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 m -143.48 130.96 21.07 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.5 0.72 . . . . 0.0 109.407 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 47.8 t -124.78 105.93 9.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.19 0.996 . . . . 0.0 109.45 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.25 123.46 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.139 0.575 . . . . 0.0 109.464 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.44 97.39 11.15 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.026 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.454 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 21.4 t 55.7 33.36 21.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.827 1.251 . . . . 0.0 112.341 171.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.45 -88.92 0.61 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.436 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -125.81 -0.63 7.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.736 0.814 . . . . 0.0 111.532 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -77.3 126.09 30.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -105.32 124.87 50.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.066 0.946 . . . . 0.0 109.345 -170.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.1 mtt85 -165.11 175.55 9.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.116 0.967 . . . . 0.0 110.169 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t 66.25 104.89 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 O-C-N 125.176 1.547 . . . . 0.0 110.798 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.23 -28.98 67.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.708 0.803 . . . . 0.0 112.593 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB2' ' HG3' ' A' ' 53' ' ' ARG . . . -126.21 149.55 48.96 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.582 0.753 . . . . 0.0 109.592 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.0 mtt -144.9 122.38 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -118.18 -173.87 16.2 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 123.487 0.492 . . . . 0.0 113.222 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -132.87 143.75 49.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.116 0.967 . . . . 0.0 109.26 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.09 172.07 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.69 1.596 . . . . 0.0 107.65 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -139.35 123.73 18.16 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.056 0.455 . . . . 0.0 110.367 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.494 ' HB3' HG13 ' A' ' 94' ' ' VAL . 65.0 tp60 -101.58 135.23 43.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.624 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -122.58 137.83 28.43 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.048 0.939 . . . . 0.0 109.229 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -66.26 118.08 5.22 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.72 2.28 . . . . 0.0 111.717 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.73 0.4 59.11 Favored Glycine 0 N--CA 1.474 1.184 0 O-C-N 123.044 0.215 . . . . 0.0 112.656 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 5.5 mmpt? -135.61 172.89 12.36 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.155 . . . . 0.0 110.141 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.17 156.92 16.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.053 0.941 . . . . 0.0 109.922 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 125.92 28.16 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.456 0.646 . . . . 0.0 110.803 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -93.38 138.29 31.86 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.618 1.167 . . . . 0.0 109.29 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -69.18 115.24 8.24 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.742 0.652 . . . . 0.0 109.781 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.9 t -94.32 -53.1 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.409 0.683 . . . . 0.0 110.03 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -156.1 169.6 24.12 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -168.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.426 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -158.99 132.29 7.24 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 110.306 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -116.34 116.16 51.38 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HG3' ' HB2' ' A' ' 34' ' ' ALA . 28.7 ttt-85 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 49.9 m . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.9 m -158.53 121.93 3.87 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.605 0.362 . . . . 0.0 111.274 -170.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.478 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 68.4 m-85 -156.52 135.53 11.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.876 1.67 . . . . 0.0 107.66 171.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -165.4 164.55 19.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.227 1.011 . . . . 0.0 110.263 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.16 160.89 30.58 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.705 0.402 . . . . 0.0 111.092 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.61 -36.05 81.66 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.425 0.69 . . . . 0.0 111.76 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.2 p -69.15 -36.09 77.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.294 0.638 . . . . 0.0 111.622 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.401 HG12 HH21 ' A' ' 68' ' ' ARG . 20.3 m -97.74 15.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.5 0.72 . . . . 0.0 111.634 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.15 114.23 2.51 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.325 1.05 . . . . 0.0 112.009 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.81 -19.75 35.85 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.588 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.401 HH21 HG12 ' A' ' 65' ' ' VAL . 15.1 mtm180 -80.84 -48.52 12.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -85.21 123.5 30.78 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.131 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -130.55 134.48 47.06 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.579 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -129.37 143.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 110.609 -176.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -150.05 169.5 21.08 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.279 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.482 ' HB3' HG21 ' A' ' 52' ' ' ILE . 77.0 ttt180 -147.76 131.44 16.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -122.47 106.14 10.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.293 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -72.51 -11.57 60.72 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.728 0.811 . . . . 0.0 110.844 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.18 79.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.419 1.087 . . . . 0.0 111.878 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.02 7.97 12.39 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.924 0.489 . . . . 0.0 111.406 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 53.59 67.28 1.03 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.448 1.099 . . . . 0.0 110.807 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -148.74 132.73 17.17 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.24 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 73' ' ' ARG . 21.5 t -103.68 136.13 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.518 1.127 . . . . 0.0 108.072 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.41 146.11 44.69 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.977 0.418 . . . . 0.0 111.34 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.7 tp -127.86 98.61 5.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.691 1.197 . . . . 0.0 108.081 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -93.21 100.14 12.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 109.187 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.436 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 56.7 mtm -104.25 103.24 12.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.896 0.478 . . . . 0.0 110.082 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -102.54 153.35 20.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.637 0.775 . . . . 0.0 109.581 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.5 t 58.13 48.96 12.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.172 0.989 . . . . 0.0 110.698 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 84' ' ' MET . 29.3 mt -68.99 133.49 48.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.114 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . 37.7 mtmt -92.06 157.24 41.35 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.104 0.962 . . . . 0.0 109.059 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.06 -23.77 78.07 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.11 1.873 . . . . 0.0 112.608 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.92 -11.4 60.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.276 1.03 . . . . 0.0 112.385 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -84.67 33.28 0.52 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.634 0.773 . . . . 0.0 110.656 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.7 m -88.1 98.19 11.4 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.59 -166.66 1.39 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.649 0.78 . . . . 0.0 109.322 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.8 p -117.05 109.52 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.66 131.39 35.21 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.25 143.06 47.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.117 0.567 . . . . 0.0 110.529 -173.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -89.04 158.16 18.09 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.781 0.833 . . . . 0.0 109.75 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.02 152.48 49.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.968 0.907 . . . . 0.0 109.255 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -118.36 120.59 38.06 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 110' ' ' PRO . . . . . . . . 0 C--O 1.244 0.744 0 O-C-N 123.645 0.591 . . . . 0.0 111.918 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.438 ' HA ' ' HA2' ' A' ' 100' ' ' GLY . 1.9 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 N-CA-C 109.301 -1.077 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.35 -35.74 80.06 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.866 0.867 . . . . 0.0 111.661 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.557 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 80.8 m-85 -111.73 152.82 27.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.458 0.703 . . . . 0.0 110.131 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -134.13 160.05 38.97 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.342 1.057 . . . . 0.0 108.692 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.28 -151.97 6.6 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.877 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 6.72 28.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.235 0.614 . . . . 0.0 110.651 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.35 163.48 28.68 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 113.129 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 t -140.59 115.64 9.79 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -68.7 122.79 19.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.58 0.752 . . . . 0.0 111.011 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.93 136.16 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.9 m -134.04 103.58 5.86 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 87' ' ' LEU . 25.5 t -87.95 101.16 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.6 p -56.9 141.41 45.15 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.425 0.69 . . . . 0.0 111.413 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.3 p -85.11 59.27 5.53 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.459 0.704 . . . . 0.0 110.65 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 14' ' ' GLN . 3.2 mm? . . . . . 0 N--CA 1.489 1.509 0 C-N-CA 124.316 1.046 . . . . 0.0 110.957 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -103.95 142.44 34.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.182 0.993 . . . . 0.0 109.924 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.617 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 82.6 mt -132.36 129.08 38.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.231 1.013 . . . . 0.0 109.336 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 68.0 t -119.5 102.39 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.195 0.598 . . . . 0.0 109.689 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.66 151.31 25.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.42 0.688 . . . . 0.0 110.669 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 p -155.19 146.45 22.82 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.241 1.016 . . . . 0.0 109.308 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.01 0.59 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.709 0.671 . . . . 0.0 111.504 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.39 121.79 7.29 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.387 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.02 -178.24 48.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 122' ' ' SER . 19.3 tp -94.21 128.26 40.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.93 166.34 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.992 . . . . 0.0 108.949 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -85.84 151.94 23.4 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.918 0.487 . . . . 0.0 111.206 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.48 113.05 2.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.902 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.22 0.02 28.22 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -178.43 46.37 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 113.805 0.282 . . . . 0.0 113.805 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 m -108.68 159.99 16.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.495 1.118 . . . . 0.0 109.233 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 tp -160.69 116.84 2.3 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -99.49 109.18 21.75 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 117' ' ' THR . 3.1 mm? -86.91 140.71 29.35 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 p -140.37 125.45 18.53 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.795 0.838 . . . . 0.0 109.336 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -124.54 115.47 20.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.053 0.941 . . . . 0.0 109.421 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.07 129.56 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.05 103.23 15.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.167 0.987 . . . . 0.0 110.53 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 p 51.8 53.24 12.97 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.098 1.759 . . . . 0.0 112.93 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.86 -74.3 1.83 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.893 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -165.61 39.01 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 122.27 1.033 . . . . 0.0 108.471 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.0 m -103.95 147.52 27.25 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.297 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -105.84 121.41 44.0 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -167.31 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.609 0.764 . . . . 0.0 110.291 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -65.98 95.61 0.28 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.391 0.676 . . . . 0.0 109.756 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.52 -35.08 25.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.297 0.639 . . . . 0.0 110.212 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.67 121.68 31.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.7 0.8 . . . . 0.0 109.219 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.431 ' HG2' HG21 ' A' ' 80' ' ' VAL . 2.9 mpp? -123.75 163.18 21.67 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.397 1.479 . . . . 0.0 108.682 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -157.57 135.92 4.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.56 121.8 36.48 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.5 160.96 24.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -139.67 133.47 30.64 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -98.23 128.74 44.85 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -94.33 141.56 23.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 122.765 0.426 . . . . 0.0 110.219 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.42 101.73 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.651 2.234 . . . . 0.0 111.462 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.95 2.74 60.89 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.93 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 7.5 mmpt? -139.51 152.49 46.98 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.708 0.803 . . . . 0.0 110.276 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.19 163.27 10.51 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.418 1.087 . . . . 0.0 111.531 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.58 149.74 43.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.205 0.526 . . . . 0.0 111.373 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -120.18 134.44 55.26 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.184 0.994 . . . . 0.0 109.501 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -72.31 111.14 7.25 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.291 1.036 . . . . 0.0 109.055 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.6 t -88.57 -53.67 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.467 0.707 . . . . 0.0 110.002 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.88 165.23 37.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.677 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.419 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -150.4 127.61 11.29 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 124.096 0.959 . . . . 0.0 109.823 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.9 mp -110.22 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 68.4 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -157.91 122.02 4.16 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.3 0.64 . . . . 0.0 110.16 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -152.83 122.87 7.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.07 1.348 . . . . 0.0 108.194 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -164.73 161.75 20.8 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.656 1.182 . . . . 0.0 109.126 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -81.53 151.74 27.61 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.21 -28.9 69.1 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.075 0.464 . . . . 0.0 110.75 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 p -66.85 -25.62 66.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.246 1.018 . . . . 0.0 111.887 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.518 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 22.9 m -114.45 13.78 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.332 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 122.67 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.36 0.664 . . . . 0.0 110.476 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.17 -27.32 9.39 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.757 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.518 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 24.3 mtp180 -78.45 -52.67 8.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.78 1.232 . . . . 0.0 108.762 175.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -104.02 121.97 44.28 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.984 1.314 . . . . 0.0 107.787 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -135.72 151.39 50.11 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.442 1.097 . . . . 0.0 108.916 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.94 148.5 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.714 0.806 . . . . 0.0 110.206 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.8 m -153.03 172.2 17.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.13 0.972 . . . . 0.0 109.354 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -148.3 139.72 23.51 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.12 100.13 6.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.852 1.261 . . . . 0.0 108.585 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -71.1 -13.22 61.89 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.753 0.821 . . . . 0.0 111.167 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.35 64.56 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.409 1.084 . . . . 0.0 111.744 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -121.26 1.33 10.23 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.704 0.802 . . . . 0.0 111.513 173.032 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 60.75 68.94 0.71 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.649 1.18 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -142.26 133.33 25.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.642 0.777 . . . . 0.0 109.769 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.431 HG21 ' HG2' ' A' ' 35' ' ' MET . 23.2 t -101.18 133.65 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 108.327 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.78 148.41 34.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.52 0.728 . . . . 0.0 111.659 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 47.8 tp -132.91 99.57 4.63 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -84.19 99.5 10.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.744 ' HB3' HD21 ' A' ' 87' ' ' LEU . 74.1 mtp -87.56 136.41 32.96 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.86 160.59 41.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.767 0.827 . . . . 0.0 108.81 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.2 t 58.46 48.25 12.42 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.517 1.135 . . . . 0.0 109.016 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 84' ' ' MET . 70.4 mt -72.3 138.76 47.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.726 -166.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.494 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 14.1 mmmm -92.4 153.06 42.76 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 124.077 0.951 . . . . 0.0 108.904 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.494 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 19.5 Cg_endo -59.92 -20.79 61.67 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.644 2.229 . . . . 0.0 113.054 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -80.78 1.78 29.02 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.859 0.864 . . . . 0.0 112.151 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -87.98 24.95 1.66 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.631 0.772 . . . . 0.0 110.318 166.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 120' ' ' THR . 52.0 m -81.6 105.59 12.88 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 161.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.68 177.64 6.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.952 0.901 . . . . 0.0 110.494 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.08 107.05 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -83.89 115.22 22.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.372 0.669 . . . . 0.0 109.207 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.14 143.79 36.42 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -91.62 144.6 25.37 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 170.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -133.05 157.69 44.63 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.386 0.675 . . . . 0.0 109.445 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.55 12.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.529 0.731 . . . . 0.0 109.731 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.647 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -176.086 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.477 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 58.3 Cg_endo . . . . . 0 CA--C 1.545 1.057 0 CA-C-O 121.089 0.371 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.25 -34.26 14.33 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.034 0.934 . . . . 0.0 109.757 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -117.85 152.41 35.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.461 1.104 . . . . 0.0 109.339 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.09 157.35 47.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.22 1.008 . . . . 0.0 108.817 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.7 -147.73 15.39 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.829 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -94.05 -34.42 13.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.616 0.766 . . . . 0.0 111.541 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.22 116.04 1.27 Allowed Glycine 0 C--N 1.345 1.04 0 N-CA-C 111.879 -0.489 . . . . 0.0 111.879 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.525 HG21 HD12 ' A' ' 21' ' ' LEU . 7.0 t -99.79 118.39 36.16 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.632 0.773 . . . . 0.0 110.402 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.16 106.43 5.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.008 0.923 . . . . 0.0 110.514 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.91 139.89 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 92' ' ' THR . 43.5 m -135.25 118.58 16.72 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.0 103.4 14.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.571 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.5 t -66.37 140.8 58.1 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 123.293 0.371 . . . . 0.0 110.684 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -70.63 101.26 2.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 109.799 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 125.785 1.634 . . . . 0.0 111.295 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -102.96 143.42 32.56 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.68 1.192 . . . . 0.0 109.337 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.681 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.8 mt -130.46 113.98 14.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.097 0.959 . . . . 0.0 109.069 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.46 104.72 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' HG2' ' HB ' ' A' ' 117' ' ' THR . 78.2 tt0 -104.69 135.65 45.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.304 -166.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 p -163.2 -177.37 5.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.101 0.96 . . . . 0.0 110.264 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.0 5.74 57.25 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 112.547 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.38 148.23 21.97 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.714 0.257 . . . . 0.0 112.719 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.91 -174.04 45.44 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.7 tt -93.29 129.57 39.32 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.45 157.25 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.956 0.903 . . . . 0.0 108.787 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.619 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -81.33 149.59 28.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.09 0.556 . . . . 0.0 110.286 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.62 123.57 19.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.678 1.191 . . . . 0.0 111.47 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.35 -25.94 11.77 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -172.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.34 -166.77 32.65 Favored Glycine 0 C--N 1.35 1.321 0 C-N-CA 123.194 0.426 . . . . 0.0 114.13 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -134.97 160.32 38.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.065 0.946 . . . . 0.0 110.438 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -154.29 131.29 10.95 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.63 0.772 . . . . 0.0 109.208 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -102.49 127.11 49.68 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.106 0.562 . . . . 0.0 110.531 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -98.65 157.56 16.18 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.462 1.105 . . . . 0.0 109.207 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.8 p -148.83 126.88 11.99 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.47 0.708 . . . . 0.0 109.405 -175.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.2 t -128.05 106.13 8.86 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.81 0.844 . . . . 0.0 109.1 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.42 120.71 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.507 0.723 . . . . 0.0 109.301 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.08 100.76 13.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.937 0.495 . . . . 0.0 110.87 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.639 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 10.9 m 54.67 37.04 27.51 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.267 1.427 . . . . 0.0 112.183 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.66 -68.31 3.29 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.849 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 52.6 ttp180 -164.91 63.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 85.0 m -138.53 146.3 41.75 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.204 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -129.48 141.89 50.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 109.039 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -156.01 -50.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.926 0.89 . . . . 0.0 109.846 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -73.77 119.54 18.13 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.84 0.352 . . . . 0.0 110.101 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -78.63 -3.0 41.75 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.534 0.734 . . . . 0.0 111.028 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.98 41.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.383 0.673 . . . . 0.0 109.272 171.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 68.3 mtt -143.53 121.1 11.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.62 174.15 22.76 Favored Glycine 0 C--N 1.335 0.526 0 O-C-N 123.072 0.233 . . . . 0.0 113.341 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.505 ' HE1' HG12 ' A' ' 80' ' ' VAL . 85.7 m95 -110.98 133.68 53.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.857 0.863 . . . . 0.0 109.68 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -119.53 171.89 8.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.274 1.43 . . . . 0.0 107.486 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 40.1 ptt180 -143.42 127.76 17.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.044 0.449 . . . . 0.0 110.465 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -109.63 129.79 55.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -103.17 157.95 32.76 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.762 -0.637 . . . . 0.0 109.893 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.8 96.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.777 2.318 . . . . 0.0 113.326 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.69 -11.5 52.23 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.092 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 8.8 mmpt? -103.12 137.87 40.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.518 0.727 . . . . 0.0 109.496 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.25 149.92 23.04 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 146.27 22.09 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.38 1.072 . . . . 0.0 112.291 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -136.2 133.22 36.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 109.892 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.46 115.55 7.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.952 0.901 . . . . 0.0 110.781 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.54 -55.19 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.404 0.681 . . . . 0.0 109.417 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB3' HG21 ' A' ' 71' ' ' ILE . . . -167.42 173.91 8.39 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.097 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.53 158.95 27.24 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 122.267 1.032 . . . . 0.0 112.467 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -117.7 116.48 51.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 113.472 -1.694 . . . . 0.0 106.968 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.413 ' HG2' ' HE2' ' A' ' 60' ' ' TYR . 29.2 mmt180 . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 22.8 t . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.6 ' HA ' HD11 ' A' ' 71' ' ' ILE . 3.8 p -158.01 123.89 4.63 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.917 0.487 . . . . 0.0 111.034 -170.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HE2' ' HG2' ' A' ' 53' ' ' ARG . 69.6 m-85 -150.25 113.16 4.8 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 166.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.07 143.27 7.71 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.683 0.393 . . . . 0.0 110.71 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.28 159.0 31.0 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 168.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 31.2 t70 -60.9 -28.19 68.72 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.062 0.545 . . . . 0.0 111.147 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 m -65.98 -33.57 76.11 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.927 0.891 . . . . 0.0 112.087 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -109.22 -5.64 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.291 0.636 . . . . 0.0 111.877 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 25.5 ttpp -72.54 133.53 44.8 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 109.909 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.46 7.28 Favored Glycine 0 C--N 1.342 0.905 0 O-C-N 123.423 0.452 . . . . 0.0 112.053 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 69.7 mtp180 -80.64 -66.71 0.85 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -92.01 120.67 32.86 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.789 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 m -125.16 127.48 46.89 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.295 1.038 . . . . 0.0 108.213 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.6 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -125.07 140.97 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.122 0.569 . . . . 0.0 110.489 -174.345 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.444 ' HA ' ' OG ' ' A' ' 58' ' ' SER . 45.0 t -162.99 157.86 21.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.599 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -133.97 124.87 27.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.575 0.75 . . . . 0.0 109.364 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -103.37 122.02 43.98 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -76.8 -12.29 59.95 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.0 -48.78 67.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.618 1.167 . . . . 0.0 111.811 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 -0.06 11.0 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.13 175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 19.8 m120 53.37 68.12 0.89 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.396 1.079 . . . . 0.0 110.781 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.1 m -137.22 133.79 35.51 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.484 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.505 HG12 ' HE1' ' A' ' 37' ' ' TRP . 6.7 t -102.02 126.09 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -106.3 143.08 34.94 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.0 0.52 . . . . 0.0 110.82 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.6 tp -121.66 97.78 5.66 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 167.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -83.78 99.8 10.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.701 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.0 mtm -86.8 138.84 31.26 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -142.44 163.11 33.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.905 0.882 . . . . 0.0 109.068 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 26.9 t 54.3 42.24 31.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.014 0.926 . . . . 0.0 109.584 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.701 HD21 ' HB3' ' A' ' 84' ' ' MET . 51.6 mt -69.05 126.26 29.24 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.921 -171.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.1 mmmp? -87.83 149.99 47.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.661 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.61 -17.51 54.72 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.541 2.161 . . . . 0.0 113.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.8 pt-20 -69.46 -16.81 63.54 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.378 1.071 . . . . 0.0 112.029 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -84.43 32.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.962 0.905 . . . . 0.0 111.424 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.1 m -86.51 95.71 9.81 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -158.75 -174.25 4.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.422 0.689 . . . . 0.0 110.318 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -117.57 108.29 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 9.1 m-85 -82.28 137.02 34.94 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.416 HD13 ' HD1' ' A' ' 113' ' ' TRP . 4.1 pp -126.62 128.59 47.02 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -90.06 119.5 30.45 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.75 159.12 19.27 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.594 0.758 . . . . 0.0 109.821 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -130.97 169.07 16.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.052 0.941 . . . . 0.0 108.94 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.559 0 C-N-CA 121.737 -0.268 . . . . 0.0 112.644 178.35 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.546 1.095 0 N-CA-C 110.232 -0.718 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -84.31 -16.09 44.25 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.482 0.713 . . . . 0.0 111.236 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 72.7 m-85 -134.26 154.09 51.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 107.92 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.416 ' HD1' HD13 ' A' ' 96' ' ' LEU . 29.6 m-90 -135.48 155.9 49.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.528 0.731 . . . . 0.0 109.428 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -78.54 -103.53 0.2 Allowed Glycine 0 C--N 1.345 1.039 0 O-C-N 123.437 0.46 . . . . 0.0 112.305 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -154.02 -14.82 0.13 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.218 0.607 . . . . 0.0 111.74 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.32 110.84 1.45 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.508 ' HB ' ' HG2' ' A' ' 7' ' ' GLU . 12.6 t -96.33 123.71 40.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.467 0.651 . . . . 0.0 109.696 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -81.18 116.49 21.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.297 0.639 . . . . 0.0 110.836 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.82 141.96 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.744 0.818 . . . . 0.0 108.968 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.4 m -134.38 105.2 6.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.86 97.78 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.2 t -73.61 147.66 43.6 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.428 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -75.68 77.27 2.65 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.509 0.724 . . . . 0.0 110.214 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 C-N-CA 125.445 1.498 . . . . 0.0 112.338 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 3' ' ' LEU . 4.0 mm? . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 40.5 mt-30 -105.61 114.29 28.37 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 56.5 mt -105.08 118.29 36.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.82 102.81 14.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 23' ' ' CYS . 1.7 mp0 -84.66 150.03 25.42 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.049 0.94 . . . . 0.0 108.964 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 p -159.69 168.11 26.76 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.736 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.8 -5.46 61.9 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.95 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.83 146.83 45.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.679 0.24 . . . . 0.0 112.875 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.61 -176.73 47.4 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.6 tt -88.91 114.39 25.48 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 122.841 0.456 . . . . 0.0 110.148 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.76 163.31 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 165.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HB2' HD13 ' A' ' 124' ' ' LEU . 5.4 pm0 -84.59 160.44 20.44 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -65.63 113.6 4.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.549 0.74 . . . . 0.0 109.618 174.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.01 -1.72 27.08 Favored Glycine 0 C--N 1.34 0.755 0 O-C-N 123.818 0.699 . . . . 0.0 111.737 -171.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.36 -166.18 41.69 Favored Glycine 0 C--N 1.344 1.006 0 C-N-CA 123.041 0.353 . . . . 0.0 113.044 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -144.1 138.01 27.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.644 0.778 . . . . 0.0 109.687 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.7 tp -140.58 128.06 21.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.535 0.734 . . . . 0.0 109.69 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -103.04 139.82 38.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.225 0.61 . . . . 0.0 110.07 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -113.98 158.61 20.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.374 1.07 . . . . 0.0 109.419 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.8 m -146.7 127.54 14.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.626 ' SG ' ' HB ' ' A' ' 80' ' ' VAL . 27.1 p -124.8 115.72 21.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.248 0.619 . . . . 0.0 109.569 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.09 135.48 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.67 100.83 11.26 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.098 0.959 . . . . 0.0 109.992 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.598 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 20.2 m 64.32 33.02 11.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.684 1.594 . . . . 0.0 111.769 169.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.97 58.16 16.06 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.663 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 55.5 ttp180 62.67 68.63 0.64 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.277 1.031 . . . . 0.0 110.782 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.1 m -140.25 143.75 36.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.672 0.789 . . . . 0.0 109.133 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -105.45 120.82 42.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -145.9 -51.84 0.24 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.582 1.153 . . . . 0.0 108.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -83.53 163.72 20.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -146.95 9.35 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.509 1.124 . . . . 0.0 109.576 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.7 117.82 8.34 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.4 ttm -151.56 118.52 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -170.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -113.92 142.91 17.76 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.54 -173.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -88.41 135.57 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 92.7 m-85 -134.81 145.94 48.83 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.304 1.042 . . . . 0.0 109.063 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 12.9 ptp180 -104.14 145.24 30.48 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -151.02 129.08 11.79 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.92 0.782 . . . . 0.0 110.51 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -100.72 161.17 24.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.8 114.78 2.15 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.429 2.086 . . . . 0.0 111.598 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.288 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 9.3 mmpt? -128.02 153.93 46.21 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.285 1.034 . . . . 0.0 109.243 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.86 151.44 30.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.994 0.518 . . . . 0.0 110.664 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.07 113.42 13.57 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.647 0.592 . . . . 0.0 110.321 177.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -93.47 139.0 31.21 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.16 0.984 . . . . 0.0 110.104 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -64.94 110.24 2.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.23 1.412 . . . . 0.0 110.736 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.7 t -95.05 -48.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.318 0.647 . . . . 0.0 109.637 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.86 19.3 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.527 0.731 . . . . 0.0 110.815 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.475 ' H ' ' HB2' ' A' ' 60' ' ' TYR . . . -155.69 130.43 9.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 0.0 110.564 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.04 111.47 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.335 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 p -165.73 149.73 8.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.984 1.314 . . . . 0.0 108.756 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.475 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -154.47 118.23 4.64 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.244 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.7 140.35 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.812 0.845 . . . . 0.0 110.196 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.94 167.9 12.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.68 0.792 . . . . 0.0 109.459 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.03 -31.41 72.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.859 0.464 . . . . 0.0 110.869 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.5 p -64.01 -27.1 68.89 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.607 1.163 . . . . 0.0 112.539 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.94 5.62 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.409 0.684 . . . . 0.0 111.516 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -67.42 113.76 5.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.899 0.879 . . . . 0.0 109.785 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.81 -27.72 17.71 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.238 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.08 -70.88 0.47 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.959 0.904 . . . . 0.0 109.631 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -90.49 120.87 31.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.9 m -135.01 138.42 43.95 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.163 0.985 . . . . 0.0 109.188 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -119.2 143.05 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.134 0.974 . . . . 0.0 109.46 178.299 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.7 t -138.45 142.45 39.46 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.487 1.115 . . . . 0.0 108.136 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -115.91 123.48 48.19 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.84 129.59 49.56 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -86.85 -35.93 18.76 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.907 0.883 . . . . 0.0 110.178 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.13 78.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.425 1.09 . . . . 0.0 112.749 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -118.05 14.79 14.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.413 0.285 . . . . 0.0 111.233 175.029 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 18.5 m120 51.71 59.0 4.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.598 1.159 . . . . 0.0 111.488 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -126.67 129.27 48.13 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.63 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.626 ' HB ' ' SG ' ' A' ' 23' ' ' CYS . 47.7 t -103.14 125.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -101.95 150.58 23.06 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.668 0.787 . . . . 0.0 110.39 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 tp -133.0 99.18 4.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.964 0.905 . . . . 0.0 108.814 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -86.58 102.17 13.9 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.557 ' HB3' HD21 ' A' ' 87' ' ' LEU . 47.8 mtm -95.08 119.22 33.21 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.591 0.756 . . . . 0.0 109.182 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -116.21 151.38 35.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.743 0.817 . . . . 0.0 108.953 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t 59.96 69.07 0.73 Allowed 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.291 0.994 . . . . 0.0 110.02 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 84' ' ' MET . 62.4 mt -88.16 155.82 19.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.384 -176.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 11.0 mmmm -116.65 155.66 48.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.709 1.204 . . . . 0.0 109.677 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.441 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 30.5 Cg_endo -61.08 -22.58 75.13 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.631 2.221 . . . . 0.0 112.919 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.27 -21.68 65.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.118 0.967 . . . . 0.0 112.07 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.66 17.43 0.7 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.999 0.92 . . . . 0.0 111.766 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.0 m -80.36 94.12 6.09 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 164.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.84 -178.82 6.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.875 0.87 . . . . 0.0 110.149 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.4 p -100.09 114.95 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -85.83 109.96 19.05 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -115.15 145.81 42.0 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.493 0.717 . . . . 0.0 110.175 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 79.3 m -92.13 157.93 16.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -141.69 115.76 9.32 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.67 132.06 55.35 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.426 0.691 . . . . 0.0 110.618 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.581 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.529 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.55 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 67.8 Cg_endo . . . . . 0 CA--C 1.547 1.15 0 N-CA-C 109.774 -0.894 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.31 -28.55 63.15 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.35 0.66 . . . . 0.0 111.23 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -119.41 146.61 45.21 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.865 0.866 . . . . 0.0 108.869 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -121.17 159.45 25.83 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.44 178.54 47.59 Favored Glycine 0 C--O 1.24 0.497 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.191 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -20.89 58.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.909 0.483 . . . . 0.0 111.174 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.91 125.03 0.64 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.844 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -99.52 121.16 40.77 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -74.63 112.25 10.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.055 0.542 . . . . 0.0 110.03 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.8 m -103.09 143.19 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 96.7 m -133.46 102.84 5.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.51 94.23 4.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -53.53 147.66 10.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.944 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.3 m -83.73 55.3 3.18 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.945 0.898 . . . . 0.0 110.207 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 14' ' ' GLN . 3.4 mm? . . . . . 0 N--CA 1.491 1.592 0 C-N-CA 124.773 1.229 . . . . 0.0 112.136 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -92.59 136.71 32.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.123 0.969 . . . . 0.0 109.437 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.462 HD13 ' SG ' ' A' ' 97' ' ' CYS . 49.1 mt -113.42 127.29 56.06 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.48 103.18 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.35 147.88 26.93 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.706 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.2 p -157.91 173.39 16.86 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.602 1.161 . . . . 0.0 109.093 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.67 -17.78 57.86 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.18 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -67.14 124.96 23.84 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 122.784 0.23 . . . . 0.0 112.686 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.86 -167.28 26.25 Favored Glycine 0 C--O 1.245 0.81 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -91.27 119.13 31.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.967 0.507 . . . . 0.0 110.258 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -124.88 169.75 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.327 1.051 . . . . 0.0 109.082 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -87.51 152.2 22.4 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.15 0.58 . . . . 0.0 111.04 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -66.36 119.06 10.93 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.338 1.055 . . . . 0.0 110.176 175.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.35 -16.14 38.39 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.771 0.669 . . . . 0.0 111.612 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.95 178.62 43.75 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.097 0.38 . . . . 0.0 113.825 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.9 p -107.92 162.66 13.81 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.042 0.937 . . . . 0.0 111.54 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.12 126.21 4.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 0.0 108.203 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -106.21 123.35 47.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -89.42 157.39 18.16 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.593 1.157 . . . . 0.0 109.559 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.6 m -139.15 124.42 19.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.727 0.811 . . . . 0.0 108.984 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 25.8 t -116.64 102.87 9.83 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.1 0.96 . . . . 0.0 109.425 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.6 t -91.51 126.54 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.553 0.741 . . . . 0.0 109.168 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.91 100.02 12.86 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m 55.85 33.33 21.34 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.14 1.376 . . . . 0.0 112.089 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.8 -84.76 1.1 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -141.58 95.86 2.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.611 0.764 . . . . 0.0 109.284 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 t -135.26 168.19 19.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.195 0.998 . . . . 0.0 108.453 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -140.25 120.37 13.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.389 0.676 . . . . 0.0 109.557 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -171.81 -72.95 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 0.0 108.999 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -84.32 129.24 34.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.314 0.646 . . . . 0.0 109.263 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -121.3 16.14 11.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 109.876 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.96 118.4 32.82 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.019 0.928 . . . . 0.0 108.521 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -137.86 121.39 17.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.132 0.973 . . . . 0.0 109.104 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -99.27 136.14 12.52 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -86.94 132.11 33.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 109.921 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -132.97 171.71 13.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.044 1.338 . . . . 0.0 108.882 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -149.28 142.03 24.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.471 0.708 . . . . 0.0 109.848 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -133.27 131.95 40.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.98 0.512 . . . . 0.0 110.348 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.45 146.18 31.97 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 123.96 0.904 . . . . 0.0 109.101 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -54.9 118.71 5.44 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.957 2.438 . . . . 0.0 113.098 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.79 71.91 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 113.489 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -128.75 167.79 16.78 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 166.47 22.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.132 0.973 . . . . 0.0 110.037 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 122.92 31.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -93.5 142.13 27.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.9 0.88 . . . . 0.0 109.896 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -65.32 130.6 43.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.824 1.25 . . . . 0.0 110.336 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.38 -54.86 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.917 0.887 . . . . 0.0 108.774 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.46 170.39 20.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -160.98 128.61 4.27 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 121.284 0.564 . . . . 0.0 110.86 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.53 HD11 ' HB ' ' A' ' 71' ' ' ILE . 2.7 mp -110.59 113.49 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.538 ' H ' ' HA ' ' A' ' 58' ' ' SER . 73.2 mtp180 . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 122.709 0.404 . . . . 0.0 110.666 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.538 ' HA ' ' H ' ' A' ' 53' ' ' ARG . 77.5 p . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.525 HG22 HD11 ' A' ' 71' ' ' ILE . 21.2 p -160.55 123.99 3.45 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.483 1.113 . . . . 0.0 108.986 -172.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 51' ' ' ALA . 59.7 m-85 -147.39 137.17 22.91 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -165.68 157.83 14.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.873 1.269 . . . . 0.0 109.808 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -85.59 149.63 25.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.15 -32.35 72.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.873 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 m -69.93 -38.0 76.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.165 0.586 . . . . 0.0 111.626 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 62' ' ' ALA . 14.6 m -96.71 -2.16 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.009 0.524 . . . . 0.0 111.593 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -61.69 128.69 37.44 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.65 0.78 . . . . 0.0 109.231 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.66 -26.55 17.65 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.629 0.581 . . . . 0.0 112.602 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -89.77 -54.9 3.85 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -84.73 121.05 27.12 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.351 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 132.39 51.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.539 1.136 . . . . 0.0 108.018 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.6 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -102.48 149.94 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.32 178.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 20.2 m -141.91 146.56 35.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 109.471 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.57 132.15 23.85 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.09 103.61 8.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.431 1.092 . . . . 0.0 108.42 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.43 -17.27 63.63 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.192 0.997 . . . . 0.0 111.962 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -46.39 75.07 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.964 0.905 . . . . 0.0 112.397 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -118.53 -0.74 11.32 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.62 0.768 . . . . 0.0 110.665 176.431 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 55.77 68.81 0.81 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.842 1.257 . . . . 0.0 111.32 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.449 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 98.7 m -132.71 131.58 41.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.396 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 125.8 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.418 1.087 . . . . 0.0 109.066 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 71.1 m-85 -106.52 155.57 19.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.56 0.744 . . . . 0.0 110.307 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 50.5 tp -133.92 98.43 4.15 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.47 0.708 . . . . 0.0 109.389 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.41 99.86 10.93 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.208 0.603 . . . . 0.0 109.423 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.76 ' HB3' HD21 ' A' ' 87' ' ' LEU . 75.0 mtp -100.66 101.06 11.86 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.753 0.821 . . . . 0.0 110.474 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.7 144.87 28.27 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.075 0.55 . . . . 0.0 111.082 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.1 t 60.97 72.95 0.5 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.854 1.261 . . . . 0.0 110.523 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' ' 84' ' ' MET . 67.5 mt -88.24 159.63 18.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.95 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -106.84 150.68 40.02 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.179 0.992 . . . . 0.0 108.657 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.98 -16.15 53.25 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.552 2.168 . . . . 0.0 112.958 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.77 -2.63 44.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.032 0.933 . . . . 0.0 112.142 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -90.76 37.38 0.92 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.604 0.762 . . . . 0.0 110.821 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.5 m -91.66 93.13 8.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.33 -177.23 5.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.759 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -104.55 109.83 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.031 0.532 . . . . 0.0 109.901 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.56 129.03 34.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.92 137.47 47.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 109.776 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.8 p -92.8 159.31 15.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 109.487 173.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -133.12 145.04 50.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.62 123.69 50.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.873 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.632 179.421 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.587 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 36.2 Cg_exo . . . . . 0 CA--C 1.549 1.227 0 CA-C-O 120.778 0.241 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.1 -23.53 59.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.51 0.724 . . . . 0.0 110.983 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 79.8 m-85 -133.43 155.34 49.71 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.012 0.925 . . . . 0.0 109.079 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -127.28 158.86 36.08 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.97 -170.04 45.73 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.042 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -86.64 -21.1 26.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.558 0.743 . . . . 0.0 110.715 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 158.55 32.2 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.559 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.421 HG21 HD12 ' A' ' 21' ' ' LEU . 9.1 t -138.93 118.22 12.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.775 0.83 . . . . 0.0 108.809 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -78.22 103.48 8.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.486 0.714 . . . . 0.0 110.719 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.447 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -93.23 143.77 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 93.6 m -134.33 102.06 5.22 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.05 97.02 5.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 t -68.55 145.99 53.5 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.999 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -74.07 84.9 1.81 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.239 0.616 . . . . 0.0 110.155 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.9 mm? . . . . . 0 N--CA 1.486 1.355 0 C-N-CA 125.47 1.508 . . . . 0.0 112.327 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 CA--C 1.548 0.876 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.04 132.89 35.26 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.777 0.831 . . . . 0.0 110.155 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.5 mt -130.91 124.57 31.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.365 1.066 . . . . 0.0 108.579 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -121.32 101.25 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.209 0.604 . . . . 0.0 109.636 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.85 132.91 35.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.235 0.614 . . . . 0.0 109.635 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.3 m -144.35 163.77 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.147 0.979 . . . . 0.0 109.512 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.415 ' O ' HD11 ' A' ' 19' ' ' LEU . . . 117.73 -19.93 11.12 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.504 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.12 119.6 19.13 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 123.214 0.435 . . . . 0.0 112.871 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.23 -175.93 29.71 Favored Glycine 0 C--N 1.347 1.161 0 C-N-CA 123.431 0.538 . . . . 0.0 112.104 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 120' ' ' THR . 25.6 tp -89.85 114.46 26.21 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.354 0.662 . . . . 0.0 110.37 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.8 145.97 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 4.8 pm0 -75.22 154.65 37.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.126 0.421 . . . . 0.0 110.568 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . . . -58.14 113.68 2.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.559 0.744 . . . . 0.0 111.36 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.98 -4.41 25.66 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.122 0.867 . . . . 0.0 111.511 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.44 -165.68 39.83 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 123.345 0.498 . . . . 0.0 112.839 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -141.46 150.47 42.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.749 0.82 . . . . 0.0 111.129 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 9' ' ' GLY . 31.2 tp -147.33 122.91 10.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.661 0.784 . . . . 0.0 109.072 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -103.13 119.26 38.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.047 0.539 . . . . 0.0 110.139 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.47 157.46 19.19 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 m -143.22 127.34 17.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.941 0.896 . . . . 0.0 108.775 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.53 120.19 36.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.875 0.87 . . . . 0.0 109.81 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.66 115.18 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.541 0.736 . . . . 0.0 109.14 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.85 103.07 15.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.101 0.56 . . . . 0.0 110.633 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.1 p 52.75 57.68 6.13 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.999 1.72 . . . . 0.0 112.404 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.91 -82.84 0.4 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.407 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -160.54 41.79 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.594 1.187 . . . . 0.0 108.066 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -111.31 155.92 22.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.99 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -107.06 118.82 37.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -151.47 171.4 17.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.006 1.322 . . . . 0.0 107.759 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 t 65.69 114.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.807 1.243 . . . . 0.0 110.848 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -55.37 -32.36 62.52 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.887 0.875 . . . . 0.0 113.133 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.06 151.71 46.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 111.02 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 67.7 mtt -140.87 147.68 39.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 107.904 174.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.51 150.25 22.23 Favored Glycine 0 N--CA 1.467 0.723 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.858 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -91.23 149.4 21.78 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.2 152.14 49.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.222 1.409 . . . . 0.0 108.665 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -125.27 135.32 52.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.464 0.705 . . . . 0.0 109.181 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -147.56 130.95 16.62 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 123.313 0.645 . . . . 0.0 109.474 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -88.96 154.22 49.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -53.59 105.56 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.643 2.229 . . . . 0.0 112.888 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.2 31.53 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.509 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 6.6 mmpt? -126.33 174.5 8.53 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.966 0.907 . . . . 0.0 110.853 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -82.8 144.36 30.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.762 0.825 . . . . 0.0 110.208 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.29 116.34 24.4 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.046 0.45 . . . . 0.0 110.005 176.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -92.31 142.36 27.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.648 0.779 . . . . 0.0 109.904 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -73.61 107.77 6.07 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.717 0.807 . . . . 0.0 109.52 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -86.9 -54.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.714 0.806 . . . . 0.0 110.357 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -137.49 160.21 39.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -170.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.47 121.12 14.29 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 125.102 1.361 . . . . 0.0 108.873 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.5 mp -121.68 116.08 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 . . . . . 0 N--CA 1.48 1.031 0 CA-C-N 118.507 0.594 . . . . 0.0 110.022 175.585 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.1 m . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.442 ' HA ' HD11 ' A' ' 71' ' ' ILE . 17.8 p -146.57 120.84 9.56 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 12.3 t80 -171.38 131.94 0.77 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.56 134.99 9.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.06 150.47 33.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.923 0.489 . . . . 0.0 111.029 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.561 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 29.9 t70 -66.3 -18.86 65.61 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -72.97 -34.24 66.36 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.385 0.674 . . . . 0.0 111.219 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -106.96 15.97 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.788 0.835 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -65.93 121.17 14.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.36 1.064 . . . . 0.0 110.749 -176.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.52 -27.6 16.77 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.361 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 4.0 ptt180 -94.82 -28.08 15.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.394 0.597 . . . . 0.0 109.988 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -99.73 132.66 44.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.357 0.663 . . . . 0.0 109.282 173.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.9 m -137.99 145.23 41.67 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.889 1.276 . . . . 0.0 108.125 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -128.57 159.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.564 0.746 . . . . 0.0 109.884 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.8 t -156.78 139.69 15.29 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.74 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.546 ' HD2' HG21 ' A' ' 52' ' ' ILE . 50.2 ttt85 -115.19 120.54 40.06 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.77 107.67 18.75 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 109.303 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.34 -34.49 75.36 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.4 1.062 . . . . 0.0 111.283 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.54 -44.68 69.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.336 1.054 . . . . 0.0 112.963 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.77 7.6 11.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.074 0.55 . . . . 0.0 111.729 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.6 m120 53.66 38.37 28.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.488 1.115 . . . . 0.0 111.784 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 32.2 m -114.43 130.99 56.74 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.705 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 73' ' ' ARG . 39.8 t -104.63 121.31 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.749 0.82 . . . . 0.0 108.814 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -101.13 152.79 20.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.762 . . . . 0.0 111.261 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.7 tp -132.94 97.83 4.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.287 1.035 . . . . 0.0 108.374 171.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -80.51 101.35 9.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.624 ' HB3' HD21 ' A' ' 87' ' ' LEU . 34.3 mtm -92.71 135.63 33.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.49 170.09 16.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 t 58.61 33.45 23.1 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.859 0.864 . . . . 0.0 110.767 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -71.94 156.94 38.7 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.673 -173.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.608 ' HG2' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -132.06 158.3 75.89 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.848 1.259 . . . . 0.0 108.189 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' A' ' 15' ' ' ALA . 13.0 Cg_endo -53.68 -24.4 29.77 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 123.061 2.507 . . . . 0.0 114.522 -169.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.608 ' HG2' ' HG2' ' A' ' 88' ' ' LYS . 13.1 pt-20 -65.74 -18.76 65.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 0.0 112.589 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 121' ' ' VAL . 65.3 m-20 -82.36 30.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.493 0.717 . . . . 0.0 110.959 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.472 HG23 HG23 ' A' ' 120' ' ' THR . 95.9 m -83.14 93.56 7.66 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 164.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.6 27.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.431 0.692 . . . . 0.0 110.625 -172.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.53 120.89 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.009 0.524 . . . . 0.0 109.958 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -95.56 125.93 40.5 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -129.35 144.11 51.11 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 109.742 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -92.8 157.76 16.24 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.54 150.25 46.17 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.341 0.656 . . . . 0.0 109.518 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -113.4 132.03 55.77 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.661 0 CA-C-O 121.353 0.418 . . . . 0.0 113.459 -172.089 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.543 0.933 0 N-CA-C 110.648 -0.558 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -83.48 -22.59 32.49 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.115 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 21.9 m-85 -122.48 147.44 46.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.03 0.932 . . . . 0.0 108.525 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.8 m-90 -130.11 162.06 29.65 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 108.846 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.27 -142.93 7.78 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.438 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -102.34 -27.95 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 110.661 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.55 156.08 24.13 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.109 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.46 119.37 11.9 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -74.98 103.0 5.01 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -85.53 137.96 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 32.1 m -133.38 110.47 10.05 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 91' ' ' ASP . 48.0 t -91.89 103.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 35.5 t -45.35 143.0 1.9 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.387 1.075 . . . . 0.0 112.308 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.5 p -70.15 167.67 17.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.779 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 122.919 0.488 . . . . 0.0 111.476 -179.106 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 26' ' ' SER . 2.0 tm? . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -103.12 150.32 23.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.571 1.149 . . . . 0.0 108.383 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.468 HD22 ' SG ' ' A' ' 23' ' ' CYS . 95.1 mt -131.27 108.76 9.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.092 0.557 . . . . 0.0 110.137 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.6 107.72 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.096 0.958 . . . . 0.0 108.821 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -99.22 155.24 17.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.1 m -153.56 155.63 36.52 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.836 1.654 . . . . 0.0 109.145 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.02 10.12 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 123.171 0.415 . . . . 0.0 112.887 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -71.05 90.13 0.41 Allowed Glycine 0 C--N 1.347 1.146 0 O-C-N 123.484 0.167 . . . . 0.0 113.206 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.31 -175.61 13.93 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -94.76 118.32 31.56 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.063 0.545 . . . . 0.0 110.041 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.63 167.36 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 109.271 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.24 152.83 23.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.797 0.839 . . . . 0.0 110.478 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -68.12 121.85 17.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.68 -22.39 14.92 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.077 0.846 . . . . 0.0 111.31 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.84 -166.99 38.41 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 121.225 0.347 . . . . 0.0 113.492 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 p -127.31 156.1 42.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.565 0.746 . . . . 0.0 110.891 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -152.66 133.24 13.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.006 0.922 . . . . 0.0 108.636 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -113.17 124.16 51.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.992 0.517 . . . . 0.0 109.706 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.37 157.12 19.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.906 0.882 . . . . 0.0 109.443 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.9 p -142.32 135.32 28.58 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.211 1.004 . . . . 0.0 108.725 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' SG ' HD22 ' A' ' 5' ' ' LEU . 53.8 t -140.06 116.83 10.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.24 0.616 . . . . 0.0 110.095 -177.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.53 122.86 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.58 102.57 15.31 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.037 0.935 . . . . 0.0 110.515 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.686 ' HB2' HD22 ' A' ' 3' ' ' LEU . 11.6 t 69.97 22.73 5.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.53 1.532 . . . . 0.0 111.906 168.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 56.97 10.24 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 86.6 mtm180 60.6 56.37 3.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.371 1.069 . . . . 0.0 110.948 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 47.2 m -137.3 150.33 47.7 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.817 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -103.14 127.42 50.43 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.589 ' HB3' HD23 ' A' ' 3' ' ' LEU . 44.3 ttm180 -170.51 -35.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.594 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 p -71.1 103.77 2.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.225 0.61 . . . . 0.0 110.52 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -79.32 -34.65 42.09 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.7 0.8 . . . . 0.0 109.415 174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.01 49.18 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.769 1.228 . . . . 0.0 108.948 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 50.2 mtm -150.54 168.43 24.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.932 1.693 . . . . 0.0 108.567 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.02 35.52 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 96.9 m95 -122.37 135.51 54.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 168.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -122.95 164.38 18.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.147 1.379 . . . . 0.0 108.326 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -138.11 151.18 47.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -153.94 150.41 28.29 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.42 145.34 30.61 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.95 104.53 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.371 2.714 . . . . 0.0 113.386 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.79 -12.58 50.02 Favored Glycine 0 C--N 1.352 1.469 0 C-N-CA 122.9 0.286 . . . . 0.0 113.349 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -97.99 173.53 7.01 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.0 0.92 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -78.13 170.06 17.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.909 0.883 . . . . 0.0 110.433 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -100.59 151.67 21.33 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.181 0.515 . . . . 0.0 110.681 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -115.75 139.53 50.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.668 1.587 . . . . 0.0 109.005 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 59.5 t80 -83.27 109.78 17.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.086 0.955 . . . . 0.0 109.155 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.7 t -90.09 -52.47 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.671 0.788 . . . . 0.0 110.288 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -148.83 169.83 19.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.112 -168.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -149.28 119.05 7.04 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.61 1.164 . . . . 0.0 109.512 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.0 mp -120.78 116.53 50.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 C-N-CA 123.801 0.84 . . . . 0.0 109.344 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.438 ' H ' ' HA ' ' A' ' 58' ' ' SER . 2.5 mpt_? . . . . . 0 C--O 1.244 0.782 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.7 m . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.522 ' HA ' HD11 ' A' ' 71' ' ' ILE . 19.3 p -151.33 126.11 9.66 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 6.0 t80 -166.47 130.2 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.73 150.73 12.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.616 1.566 . . . . 0.0 108.139 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.47 155.07 39.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.304 0.642 . . . . 0.0 110.729 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.88 -31.79 73.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.265 0.626 . . . . 0.0 111.42 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -69.37 -33.9 73.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.747 0.819 . . . . 0.0 111.77 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.528 ' HA ' HH21 ' A' ' 68' ' ' ARG . 31.1 m -102.53 -0.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.711 0.804 . . . . 0.0 111.722 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.16 134.94 56.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.052 1.341 . . . . 0.0 112.313 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.37 5.54 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.623 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.612 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 75.3 mtm180 -89.64 -51.78 5.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.008 0.908 . . . . 0.0 109.173 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -86.7 122.71 30.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.677 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -146.15 150.5 36.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.012 1.325 . . . . 0.0 108.037 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -121.42 155.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.959 0.904 . . . . 0.0 110.445 -177.04 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -146.78 134.07 20.63 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.957 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.61 ' HB2' HG21 ' A' ' 52' ' ' ILE . 32.3 ttt180 -112.21 130.8 55.8 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -116.42 116.06 26.98 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -87.51 -11.66 48.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.925 0.33 . . . . 0.0 111.642 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.33 94.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.135 0.574 . . . . 0.0 111.455 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -119.62 15.68 12.8 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 122.355 0.262 . . . . 0.0 110.957 169.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 16.9 m120 44.45 63.66 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.077 1.351 . . . . 0.0 111.982 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.5 m -131.29 132.61 44.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.394 0.677 . . . . 0.0 109.758 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.7 t -102.66 143.73 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.561 1.144 . . . . 0.0 108.623 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -125.78 142.22 51.62 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.585 0.754 . . . . 0.0 110.071 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.3 tp -126.85 96.8 4.75 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -89.98 107.75 19.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.6 mtm -107.96 119.08 38.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.959 0.904 . . . . 0.0 109.045 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -112.38 148.63 33.9 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.421 0.689 . . . . 0.0 110.229 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.612 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 41.6 t 56.47 68.86 0.8 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.434 1.093 . . . . 0.0 110.162 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -78.77 160.87 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.469 -1.242 . . . . 0.0 111.47 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -127.61 147.39 62.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.425 -169.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -57.96 -29.35 86.3 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.34 2.694 . . . . 0.0 114.098 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 pm0 -78.67 -2.88 41.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.323 0.649 . . . . 0.0 111.843 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -86.67 25.68 1.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.0 0.92 . . . . 0.0 110.733 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.44 HG23 ' HA ' ' A' ' 120' ' ' THR . 87.7 m -87.74 92.68 9.2 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.22 168.04 27.5 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.523 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.38 106.81 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-O 121.565 0.698 . . . . 0.0 109.765 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -89.9 114.41 26.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -111.74 146.97 36.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.175 0.59 . . . . 0.0 109.666 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -90.55 159.41 16.49 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.63 40.6 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.9 0.88 . . . . 0.0 109.089 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -152.97 170.0 21.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.607 0.763 . . . . 0.0 110.59 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.697 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 176.679 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 CA--C 1.552 1.419 0 CA-C-O 121.297 0.457 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.97 -18.73 64.11 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.013 0.925 . . . . 0.0 111.012 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -134.76 151.63 51.12 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 125.14 1.376 . . . . 0.0 108.459 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -126.14 162.23 25.84 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.961 0.904 . . . . 0.0 109.255 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -94.14 177.23 36.49 Favored Glycine 0 C--O 1.241 0.552 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.927 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.7 -25.89 65.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.562 0.745 . . . . 0.0 111.221 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.36 110.81 0.23 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.753 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -99.02 118.92 36.89 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.458 0.647 . . . . 0.0 110.044 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -76.25 103.92 6.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.099 0.96 . . . . 0.0 111.135 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.553 HG12 ' HA2' ' A' ' 10' ' ' GLY . 9.0 m -90.05 152.0 3.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 85.3 m -132.72 106.61 7.87 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.54 0.736 . . . . 0.0 109.026 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.2 96.2 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 t -68.44 144.06 54.83 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.649 0.38 . . . . 0.0 110.766 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -67.65 92.51 0.33 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.127 0.971 . . . . 0.0 111.813 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 15' ' ' ALA . 4.3 mm? . . . . . 0 N--CA 1.494 1.748 0 C-N-CA 124.565 1.146 . . . . 0.0 113.19 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.912 0.387 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 36.3 mt-30 -103.59 128.67 50.81 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.6 mp -127.12 122.88 35.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.2 t -114.39 101.87 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.94 144.59 26.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.408 0.683 . . . . 0.0 109.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -147.24 169.25 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 109.836 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.38 10.31 51.29 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.432 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.42 111.03 3.26 Favored Glycine 0 C--N 1.344 0.999 0 O-C-N 123.578 0.223 . . . . 0.0 112.649 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.85 -176.66 32.16 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 120' ' ' THR . 14.3 tp -92.07 125.87 36.93 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 19' ' ' LEU . 19.4 m -126.48 157.55 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -75.58 148.23 39.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.812 0.845 . . . . 0.0 110.358 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.56 111.9 2.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.345 0.658 . . . . 0.0 109.772 171.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.07 -21.7 17.4 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.561 0.538 . . . . 0.0 112.115 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.01 -178.53 34.94 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 116.555 0.178 . . . . 0.0 112.899 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 p -123.04 151.05 42.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.475 0.71 . . . . 0.0 110.553 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 13' ' ' VAL . 56.5 tp -151.82 133.65 14.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.355 1.062 . . . . 0.0 108.961 -177.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -109.42 126.0 53.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.408 0.683 . . . . 0.0 109.843 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -96.19 158.94 15.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 109.217 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.6 p -147.89 124.36 11.01 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.217 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.3 t -116.89 109.54 17.2 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.828 0.851 . . . . 0.0 109.429 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.4 t -86.17 126.11 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.79 100.61 13.38 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.537 0.735 . . . . 0.0 110.693 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.591 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 22.7 t 60.9 40.15 15.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.071 1.348 . . . . 0.0 111.83 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.73 -62.33 4.62 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.973 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 25.5 ttt180 -160.86 4.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.741 0.816 . . . . 0.0 110.445 173.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 m -77.57 145.13 37.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.401 0.681 . . . . 0.0 110.608 -170.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -105.97 123.57 48.19 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.416 ' H ' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -163.02 -18.11 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.519 1.128 . . . . 0.0 109.352 170.019 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 31' ' ' ARG . 17.9 m -63.76 108.19 1.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.872 0.869 . . . . 0.0 109.666 174.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -82.32 -36.93 26.47 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.858 0.837 . . . . 0.0 109.47 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.18 41.48 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.742 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 97.8 mtp -141.93 118.98 11.29 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.12 142.83 17.32 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.24 123.06 32.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-85 -120.17 133.91 55.38 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.401 1.08 . . . . 0.0 108.193 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -103.29 124.09 48.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.319 0.58 . . . . 0.0 109.934 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 128.68 53.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.6 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -125.36 155.15 72.05 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 122.889 0.475 . . . . 0.0 110.444 -170.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -52.5 96.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.027 2.484 . . . . 0.0 112.781 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.28 58.78 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.075 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.2 mmpt? -105.56 138.27 42.03 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.505 0.722 . . . . 0.0 109.998 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.48 163.79 10.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 0.0 112.6 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -58.56 122.15 12.69 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 168.552 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.3 tt0 -115.7 128.7 56.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.428 0.691 . . . . 0.0 109.51 -172.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 46.6 t80 -66.57 107.45 2.1 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 124.121 0.888 . . . . 0.0 109.714 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.05 -55.61 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.075 0.95 . . . . 0.0 109.954 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.65 32.29 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.865 -172.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -139.39 123.62 18.01 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.163 0.985 . . . . 0.0 109.92 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.761 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -108.68 119.36 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 . . . . . 0 C--O 1.238 0.497 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.678 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 50.6 m . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 p -149.52 121.59 8.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.406 ' H ' HD11 ' A' ' 71' ' ' ILE . 12.3 t80 -170.59 126.83 0.76 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.405 ' HE2' ' HG3' ' A' ' 66' ' ' LYS . 25.1 p90 -163.66 144.07 8.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.154 0.982 . . . . 0.0 108.944 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -68.69 153.89 42.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.921 0.489 . . . . 0.0 110.378 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.45 -35.29 77.17 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.263 0.625 . . . . 0.0 110.54 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -63.41 -34.36 77.58 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 111.937 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 62' ' ' ALA . 34.4 m -108.23 19.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.953 0.901 . . . . 0.0 111.124 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' HG3' ' HE2' ' A' ' 61' ' ' TYR . 39.1 ttmt -57.34 116.84 3.56 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.169 0.988 . . . . 0.0 111.532 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.65 -27.91 6.81 Favored Glycine 0 C--N 1.342 0.876 0 O-C-N 123.733 0.646 . . . . 0.0 113.602 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -77.75 -60.25 2.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -84.69 122.11 28.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 p -143.58 153.82 42.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -130.28 154.39 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.747 0.819 . . . . 0.0 110.387 177.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.2 m -150.33 135.79 18.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.972 1.309 . . . . 0.0 107.932 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -110.05 123.42 49.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.02 128.32 36.79 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -87.25 -27.9 22.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.063 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.15 96.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.47 0.708 . . . . 0.0 112.403 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -116.34 4.28 13.41 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.135 0.425 . . . . 0.0 111.992 171.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 54.36 68.34 0.87 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.206 1.002 . . . . 0.0 111.183 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -134.99 130.67 36.11 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.25 120.43 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.031 0.932 . . . . 0.0 109.517 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.08 134.31 42.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.63 0.772 . . . . 0.0 110.297 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.5 tp -114.87 98.9 7.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -84.16 98.85 10.15 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.478 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 90.5 mtp -91.89 108.5 19.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 174.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -103.19 132.81 49.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t 61.17 70.33 0.61 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.203 1.001 . . . . 0.0 109.614 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 121' ' ' VAL . 5.5 mp -71.24 135.88 47.71 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.382 176.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.47 153.06 76.21 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.47 -19.7 68.31 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 121.946 1.764 . . . . 0.0 111.299 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -65.12 -20.51 66.5 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.861 2.064 . . . . 0.0 111.802 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.407 ' HB2' HG21 ' A' ' 121' ' ' VAL . 66.0 m-20 -84.9 31.61 0.54 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.814 0.846 . . . . 0.0 111.362 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 120' ' ' THR . 98.7 m -82.23 92.28 6.88 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 161.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.5 -175.35 4.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.818 -168.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.93 109.14 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -85.06 109.25 18.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.62 147.51 31.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 36.2 t -99.11 157.54 16.29 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 171.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -142.88 128.35 18.99 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.67 141.59 42.03 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.372 0.669 . . . . 0.0 110.345 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.825 0 O-C-N 123.982 0.801 . . . . 0.0 113.127 -177.841 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 CA--C 1.553 1.442 0 CA-C-O 120.565 0.152 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.76 -38.85 76.13 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.809 -176.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -136.86 123.92 21.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -87.25 162.91 17.17 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 109.668 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.34 -164.99 34.89 Favored Glycine 0 C--O 1.243 0.706 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.88 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -79.73 -37.53 35.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.431 0.692 . . . . 0.0 110.639 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.85 138.16 9.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.396 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.408 HG21 HD12 ' A' ' 21' ' ' LEU . 9.7 t -108.03 118.65 37.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.166 0.587 . . . . 0.0 109.51 173.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -79.12 107.44 11.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.795 0.838 . . . . 0.0 110.467 -177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.7 m -107.07 143.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.946 0.898 . . . . 0.0 109.501 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 92' ' ' THR . 61.7 m -132.92 120.92 22.1 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 87' ' ' LEU . 25.9 t -100.91 104.57 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 176.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.2 m -53.64 140.64 28.46 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.1 m -83.09 59.51 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.873 0.869 . . . . 0.0 110.255 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.485 1.32 0 C-N-CA 125.306 1.442 . . . . 0.0 112.74 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -88.92 114.45 25.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.5 mt -112.04 122.32 47.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.02 100.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -87.21 118.8 26.86 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m -129.46 135.0 48.1 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.186 0.995 . . . . 0.0 109.186 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.78 9.21 0.73 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.074 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.3 89.99 0.61 Allowed Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.921 0.361 . . . . 0.0 112.749 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.22 172.78 23.32 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 112.268 -0.333 . . . . 0.0 112.268 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 122' ' ' SER . 15.9 tp -91.99 123.76 35.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.463 0.705 . . . . 0.0 109.132 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.1 m -126.81 151.15 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -77.89 153.75 32.35 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 122.574 0.35 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.7 114.15 2.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.672 0.789 . . . . 0.0 110.584 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.25 11.7 27.01 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.296 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.47 -167.01 24.61 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 122.555 0.121 . . . . 0.0 113.087 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -132.47 156.9 45.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.694 0.798 . . . . 0.0 110.011 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -159.32 119.71 3.13 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -100.18 126.45 46.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.994 0.518 . . . . 0.0 110.375 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.83 157.48 18.99 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.02 0.928 . . . . 0.0 109.865 170.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.3 p -141.12 148.81 40.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.66 1.184 . . . . 0.0 108.544 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.0 t -135.28 101.67 4.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.2 118.14 30.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.82 97.92 11.47 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m 51.97 49.35 20.89 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.334 1.453 . . . . 0.0 112.267 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.27 -78.1 2.04 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.333 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -172.28 85.1 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.406 1.082 . . . . 0.0 108.585 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -139.16 155.96 47.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.351 0.66 . . . . 0.0 110.222 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.17 117.87 35.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -173.08 160.91 4.26 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.757 1.223 . . . . 0.0 109.514 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m 64.95 177.52 0.19 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.422 1.089 . . . . 0.0 111.088 -171.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -147.33 19.68 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.807 0.443 . . . . 0.0 110.726 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.3 125.12 6.52 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.837 0.855 . . . . 0.0 109.78 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 65.9 mtt -139.91 119.86 13.55 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.31 177.13 16.85 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 123.125 0.393 . . . . 0.0 112.697 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -119.55 139.79 51.57 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.717 0.807 . . . . 0.0 110.656 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -127.28 166.86 16.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 107.527 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.24 139.22 19.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.316 0.246 . . . . 0.0 110.665 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -125.18 128.12 47.87 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.076 0.55 . . . . 0.0 109.697 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.33 158.69 31.77 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.393 0.677 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -55.08 115.68 2.61 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.919 2.413 . . . . 0.0 112.693 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -7.74 78.08 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 113.629 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 9.2 mmpt? -114.51 162.97 16.02 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.069 0.948 . . . . 0.0 110.596 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.24 175.18 9.09 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.668 0.787 . . . . 0.0 110.212 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 131.53 36.1 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -115.67 140.46 49.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 109.311 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.59 109.38 3.25 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.744 1.217 . . . . 0.0 110.263 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.48 -58.2 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -163.78 174.74 11.22 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.958 -173.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.74 130.69 23.12 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.573 1.149 . . . . 0.0 108.926 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.2 mp -112.84 116.27 52.15 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.1 mtm-85 . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.909 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.645 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 23.6 m . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.539 ' HA ' HD11 ' A' ' 71' ' ' ILE . 3.2 p -159.01 122.59 3.81 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.735 0.814 . . . . 0.0 110.157 -175.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 46.4 m-85 -160.56 111.81 1.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.364 1.466 . . . . 0.0 107.927 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -166.63 136.0 3.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.964 0.906 . . . . 0.0 110.414 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.24 168.13 16.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.093 0.957 . . . . 0.0 110.329 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -57.32 -33.94 68.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.461 0.704 . . . . 0.0 112.312 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 m -65.8 -31.01 71.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.319 0.648 . . . . 0.0 112.284 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.2 14.16 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.693 0.797 . . . . 0.0 111.053 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.9 124.2 27.7 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.556 0.743 . . . . 0.0 109.883 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.36 -28.54 6.19 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.177 -174.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 74.7 mtp180 -75.63 -78.1 0.12 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 124.11 0.964 . . . . 0.0 109.189 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -84.26 119.92 25.61 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.628 0.771 . . . . 0.0 108.932 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -137.87 133.0 33.34 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 108.289 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.539 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -112.66 140.09 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.682 0.793 . . . . 0.0 110.081 -175.403 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -148.67 174.9 11.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.52 1.128 . . . . 0.0 109.527 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -152.01 150.29 29.82 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.571 0.748 . . . . 0.0 109.247 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.85 100.31 5.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.556 1.143 . . . . 0.0 108.173 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -69.94 -13.4 62.22 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.03 0.932 . . . . 0.0 111.498 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.31 70.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.22 . . . . 0.0 111.508 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.09 9.0 15.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.068 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m120 53.66 64.72 1.74 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.585 1.154 . . . . 0.0 111.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.8 m -138.7 130.69 28.11 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.711 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.42 131.68 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.929 0.891 . . . . 0.0 108.626 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.53 150.54 29.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.101 0.56 . . . . 0.0 111.849 -174.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 37.8 tp -132.74 97.92 4.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -81.11 109.39 15.63 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.699 ' HB3' HD21 ' A' ' 87' ' ' LEU . 28.4 mtm -100.58 97.43 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -91.81 162.78 14.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.895 0.878 . . . . 0.0 110.615 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.484 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 20.5 t 42.92 63.72 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.3 1.44 . . . . 0.0 111.912 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 84' ' ' MET . 50.7 mt -82.63 150.51 26.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.759 -168.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -106.2 153.07 40.56 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.117 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.15 -18.89 60.96 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.584 2.19 . . . . 0.0 112.922 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.48 -1.17 25.86 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -96.41 31.69 2.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.447 0.641 . . . . 0.0 110.377 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.6 m -82.81 98.96 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 164.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.58 156.18 25.31 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.976 0.417 . . . . 0.0 111.387 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.05 105.25 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 170.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.61 122.59 31.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 108.957 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.76 158.6 34.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.64 0.776 . . . . 0.0 110.012 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.81 159.24 17.37 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.235 1.014 . . . . 0.0 109.445 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -141.67 138.82 32.74 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.545 0.738 . . . . 0.0 109.782 -176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -114.1 124.63 52.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 0.0 110.081 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 C-N-CA 123.847 0.737 . . . . 0.0 111.536 176.507 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.537 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 73.2 Cg_endo . . . . . 0 CA--C 1.548 1.219 0 CA-C-O 121.176 0.407 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.24 -5.24 59.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.396 0.679 . . . . 0.0 111.351 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 89.9 m-85 -123.03 142.36 50.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.661 0.784 . . . . 0.0 109.414 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -132.09 150.71 52.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.995 1.318 . . . . 0.0 107.893 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.98 -142.09 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 123.212 0.32 . . . . 0.0 112.864 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -100.85 -29.88 11.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.904 0.882 . . . . 0.0 111.304 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.94 161.81 36.76 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.297 -173.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -144.62 126.03 14.88 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.054 0.454 . . . . 0.0 110.054 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -81.14 100.35 9.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 m -90.19 146.52 6.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 170.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 38.8 m -134.29 113.58 12.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.19 99.02 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.572 ' HB2' HD11 ' A' ' 12' ' ' LEU . 9.4 t -60.54 141.32 56.7 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.959 176.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.2 p -81.56 76.65 8.47 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.381 0.673 . . . . 0.0 109.822 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 125.232 1.413 . . . . 0.0 113.834 177.037 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 32' ' ' SER . 4.2 mm? . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.563 0.22 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.94 103.39 13.95 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 99' ' ' ALA . 86.9 mt -100.28 112.89 25.25 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.58 102.44 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.16 128.38 36.34 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.2 m -128.11 165.92 19.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.859 1.263 . . . . 0.0 109.194 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.61 8.16 40.83 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -76.55 103.24 1.71 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.752 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -178.99 32.65 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.2 tt -91.67 119.41 31.52 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.54 163.07 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.063 0.945 . . . . 0.0 108.656 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.62 154.73 23.59 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.736 0.814 . . . . 0.0 110.666 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -71.52 127.13 31.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 109.462 174.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.18 -14.12 44.16 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.99 -177.84 46.21 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.628 0.251 . . . . 0.0 113.132 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 p -119.37 131.09 55.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.651 0.781 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.9 tp -128.99 131.47 47.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.849 0.86 . . . . 0.0 108.964 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -112.63 132.41 55.17 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.8 0.84 . . . . 0.0 110.108 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.97 158.65 16.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.475 1.11 . . . . 0.0 109.851 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 p -140.25 122.39 15.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.705 0.802 . . . . 0.0 109.847 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -112.31 108.92 18.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.233 1.013 . . . . 0.0 108.851 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.96 121.62 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.49 108.67 19.94 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.711 0.805 . . . . 0.0 109.729 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 p 48.08 45.35 19.46 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.986 1.714 . . . . 0.0 113.067 172.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.61 -61.41 4.7 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 69.0 ttt180 -165.48 14.97 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.936 0.894 . . . . 0.0 110.606 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -106.12 154.64 20.39 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.321 0.648 . . . . 0.0 109.855 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -108.9 116.86 32.8 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -131.55 16.27 4.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.104 0.962 . . . . 0.0 109.717 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.418 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 38.2 t -139.55 147.72 41.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.747 0.819 . . . . 0.0 109.556 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -43.6 19.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.827 0.851 . . . . 0.0 109.336 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.33 152.39 46.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.907 0.483 . . . . 0.0 111.252 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 2.1 mpt? -133.14 118.48 18.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.67 135.35 10.09 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -93.28 129.23 39.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.111 0.964 . . . . 0.0 109.971 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.21 135.87 39.46 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 23.5 ptt180 -103.55 118.15 36.07 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.307 0.575 . . . . 0.0 109.946 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.492 ' HB3' HG13 ' A' ' 94' ' ' VAL . 49.7 tp60 -100.71 129.13 46.57 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -99.28 150.74 37.01 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 122.634 0.373 . . . . 0.0 110.408 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.21 98.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.688 2.259 . . . . 0.0 112.294 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.07 65.81 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.913 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.2 mmpt? -123.68 153.58 40.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.741 0.816 . . . . 0.0 110.182 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -68.39 172.65 5.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.174 0.989 . . . . 0.0 113.104 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.472 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.24 134.93 34.93 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.324 -177.11 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.0 142.86 29.19 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.069 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -71.05 122.02 19.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.979 0.912 . . . . 0.0 110.034 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.92 -53.47 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.97 173.6 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.807 0.443 . . . . 0.0 112.183 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.29 121.63 3.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.255 1.022 . . . . 0.0 110.313 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 52' ' ' ILE . 2.9 mp -115.14 115.47 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 . . . . . 0 N--CA 1.478 0.971 0 C-N-CA 122.582 0.353 . . . . 0.0 110.203 -179.1 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 p -170.01 145.64 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.105 1.762 . . . . 0.0 106.97 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.412 ' H ' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -165.78 130.12 2.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.718 0.807 . . . . 0.0 109.189 176.484 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -164.25 147.84 9.51 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.633 0.773 . . . . 0.0 110.576 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.33 164.29 13.57 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.054 0.941 . . . . 0.0 109.832 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.8 -21.37 66.04 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.387 0.675 . . . . 0.0 111.588 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 m -67.9 -38.38 82.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.388 0.675 . . . . 0.0 111.192 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -105.75 -6.28 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.671 0.788 . . . . 0.0 111.846 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -57.59 131.13 49.29 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.315 1.046 . . . . 0.0 112.359 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.28 -26.5 6.95 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.69 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.421 HH21 ' HE1' ' A' ' 69' ' ' PHE . 3.6 mtm180 -96.88 -59.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.421 ' HE1' HH21 ' A' ' 68' ' ' ARG . 1.2 m-85 -84.99 120.63 26.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -139.34 143.66 37.9 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.297 1.039 . . . . 0.0 108.491 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.441 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -126.5 146.16 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.764 0.826 . . . . 0.0 111.03 -175.312 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -151.75 140.49 20.86 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.344 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -107.96 123.48 48.7 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.68 131.0 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.907 170.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 -28.51 19.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.582 0.753 . . . . 0.0 111.177 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.19 -43.52 87.59 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.838 0.855 . . . . 0.0 112.141 -172.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -118.14 9.88 12.78 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.222 0.209 . . . . 0.0 111.506 172.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 47.48 67.35 0.82 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.886 1.274 . . . . 0.0 112.016 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.4 m -134.68 131.61 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.252 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.47 131.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.641 0.776 . . . . 0.0 109.267 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -111.87 137.76 49.4 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.506 0.722 . . . . 0.0 110.769 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.53 97.66 5.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -87.65 104.54 16.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.396 0.678 . . . . 0.0 109.548 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 35.4 mtm -103.09 103.21 13.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.752 0.821 . . . . 0.0 110.083 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -93.2 149.49 21.19 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.4 t 56.23 72.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.907 1.283 . . . . 0.0 110.968 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.4 mt -81.06 160.74 24.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.571 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 150.37 59.06 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.802 1.241 . . . . 0.0 108.358 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.43 -21.55 54.25 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.235 2.623 . . . . 0.0 114.18 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.74 -12.18 61.43 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.561 0.744 . . . . 0.0 112.43 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -79.11 13.82 1.67 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.206 0.602 . . . . 0.0 111.423 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 120' ' ' THR . 83.2 m -73.46 89.38 1.65 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.6 -178.6 3.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 -166.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -110.44 111.73 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 109.781 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -83.61 109.39 17.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.12 154.62 21.45 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.335 0.654 . . . . 0.0 110.159 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -108.55 158.0 17.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.331 1.052 . . . . 0.0 108.6 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -130.29 145.85 51.82 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.93 114.49 27.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.936 0 CA-C-O 121.23 0.35 . . . . 0.0 113.716 -167.903 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.519 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 12.1 Cg_exo . . . . . 0 CA--C 1.546 1.118 0 N-CA-C 110.176 -0.74 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.26 -37.27 74.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.015 0.926 . . . . 0.0 110.95 -173.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 67.8 m-85 -126.99 169.0 13.78 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.223 1.009 . . . . 0.0 109.238 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -133.94 164.35 27.49 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.49 1.116 . . . . 0.0 108.804 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -90.44 -172.99 44.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.236 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -75.27 -32.68 61.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.879 0.871 . . . . 0.0 110.128 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.2 124.96 1.67 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.627 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -97.96 118.52 34.73 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.493 0.663 . . . . 0.0 109.426 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.44 112.14 13.87 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.522 HG12 ' HA2' ' A' ' 10' ' ' GLY . 27.0 m -112.39 142.68 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.1 m -126.75 104.5 8.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.42 99.26 9.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -67.43 150.41 48.95 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.0 p -78.76 85.91 4.73 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.19 0.596 . . . . 0.0 110.291 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 15' ' ' ALA . 4.5 mm? . . . . . 0 N--CA 1.498 1.949 0 C-N-CA 125.223 1.409 . . . . 0.0 113.909 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -79.24 149.57 31.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.193 1.397 . . . . 0.0 110.567 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.7 mt -124.98 120.08 30.57 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.115 0.966 . . . . 0.0 108.738 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.47 101.45 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 23' ' ' CYS . 2.9 mp0 -90.56 153.04 20.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.442 0.697 . . . . 0.0 110.584 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.8 p -165.31 160.91 18.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.141 0.976 . . . . 0.0 109.582 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.87 -1.26 27.29 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 120.069 -0.295 . . . . 0.0 112.961 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -78.75 119.0 4.98 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.48 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.44 177.98 26.33 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.4 tt -82.52 117.1 22.28 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 m -118.22 160.18 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.006 0.922 . . . . 0.0 108.609 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.12 159.14 28.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.531 0.732 . . . . 0.0 110.791 174.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.55 133.38 52.23 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.549 0.74 . . . . 0.0 110.224 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.28 80.34 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.276 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.67 -178.26 43.84 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 120.88 0.156 . . . . 0.0 113.264 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -128.97 156.66 43.43 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -176.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -159.59 130.63 5.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.606 0.762 . . . . 0.0 109.354 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -105.57 132.85 51.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.682 0.393 . . . . 0.0 110.061 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 159.19 15.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.046 0.938 . . . . 0.0 109.693 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 p -143.53 130.89 20.94 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 109.284 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 43.1 t -131.95 110.64 10.91 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.9 t -86.58 132.37 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.56 100.24 12.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.077 0.551 . . . . 0.0 109.827 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 7.4 m 59.31 20.2 8.4 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.144 1.378 . . . . 0.0 113.391 176.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 68.64 1.57 Allowed Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -174.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.512 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 55.0 ttp180 62.26 51.95 3.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.856 1.262 . . . . 0.0 111.507 176.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 30.3 m -118.26 141.16 48.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.641 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -104.37 119.47 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -170.75 171.73 6.03 Favored 'General case' 0 C--O 1.248 0.988 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 m 71.01 121.1 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.61 1.164 . . . . 0.0 111.825 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -106.61 7.12 30.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.844 0.858 . . . . 0.0 110.717 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.51 122.37 27.5 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.7 mtt -138.79 152.75 48.17 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.282 0.633 . . . . 0.0 110.015 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -159.56 175.12 36.47 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.45 -178.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.8 131.97 34.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.537 1.135 . . . . 0.0 108.28 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.61 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 85.1 m-85 -134.37 137.32 44.02 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.58 1.152 . . . . 0.0 108.231 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -103.98 130.32 51.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -133.73 143.35 48.42 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.557 0.743 . . . . 0.0 109.058 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.15 160.99 31.85 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.711 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.93 105.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.306 2.671 . . . . 0.0 113.773 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.97 23.26 61.97 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.455 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 9.7 mmpt? -126.41 172.89 9.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.796 0.838 . . . . 0.0 110.492 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.68 168.19 17.49 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.101 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.61 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -102.03 117.87 35.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.225 174.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -93.19 139.92 30.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.032 0.933 . . . . 0.0 109.564 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.08 111.06 3.67 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.417 0.687 . . . . 0.0 110.051 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.96 -56.96 4.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.535 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -161.44 173.39 14.96 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.848 -171.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -163.37 162.8 25.16 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.194 0.997 . . . . 0.0 113.265 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mt -129.3 128.08 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 108.693 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 123.343 0.657 . . . . 0.0 110.143 175.983 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.776 0.322 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 p -158.84 119.23 3.22 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 17.1 m-85 -169.73 119.46 0.64 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 167.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.73 151.53 20.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.055 0.542 . . . . 0.0 110.764 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 159.76 30.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.503 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.6 -32.39 71.51 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.65 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.3 m -60.77 -37.65 82.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.14 0.976 . . . . 0.0 112.029 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.98 4.33 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.387 0.675 . . . . 0.0 111.896 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.77 111.26 3.62 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.148 0.979 . . . . 0.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.58 44.78 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.201 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 60.3 mtm180 -103.01 -40.24 6.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.299 0.64 . . . . 0.0 110.358 176.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.3 123.03 48.18 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.676 0.79 . . . . 0.0 109.459 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -139.35 152.26 47.03 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.121 0.968 . . . . 0.0 108.98 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.632 HD12 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -128.48 156.13 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.733 0.813 . . . . 0.0 110.497 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -154.54 134.17 12.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.371 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -110.85 120.07 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -90.89 104.63 17.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -62.75 -26.66 68.81 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.925 0.765 . . . . 0.0 110.966 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.39 -53.79 33.09 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.838 1.255 . . . . 0.0 112.263 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.512 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.37 11.17 11.4 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 45.07 67.81 0.66 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.943 1.297 . . . . 0.0 112.503 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 m -130.75 131.11 44.54 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.748 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.83 127.97 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.37 1.068 . . . . 0.0 109.503 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -110.83 150.88 28.51 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.991 0.916 . . . . 0.0 110.502 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 tp -132.36 99.32 4.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -82.76 102.3 11.48 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.646 ' HB3' HD21 ' A' ' 87' ' ' LEU . 34.4 mtm -95.53 132.61 40.46 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 83.7 m-20 -128.98 149.77 50.68 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.444 0.698 . . . . 0.0 109.775 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 t 47.59 68.74 0.61 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.95 1.3 . . . . 0.0 111.15 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.646 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -81.59 157.58 24.69 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.577 -170.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.43 149.72 36.94 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.896 0.878 . . . . 0.0 108.632 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -58.84 -23.16 65.88 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 122.626 2.217 . . . . 0.0 113.182 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.01 -14.36 62.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.216 1.006 . . . . 0.0 112.348 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 119' ' ' VAL . 30.0 m-20 -81.22 27.52 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.657 0.783 . . . . 0.0 111.85 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 93.7 m -81.49 92.05 6.42 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 165.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.83 9.25 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.446 0.699 . . . . 0.0 110.794 -170.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.96 114.52 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.335 0.588 . . . . 0.0 109.877 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -86.23 113.59 22.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.25 148.3 40.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.713 0.805 . . . . 0.0 109.857 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 31.7 p -96.05 155.2 16.86 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.23 13.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.26 166.38 11.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.825 0.85 . . . . 0.0 110.462 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 112.301 -0.319 . . . . 0.0 112.301 -179.219 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 CA--C 1.546 1.115 0 CA-C-O 121.204 0.418 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.54 -29.03 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.391 1.076 . . . . 0.0 110.192 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -117.99 128.03 54.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 0.0 109.131 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -110.13 128.88 55.71 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 166.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.39 -178.36 47.71 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 123.703 0.627 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.12 -27.09 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.135 0.574 . . . . 0.0 110.79 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.97 170.12 38.02 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.922 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.66 124.72 16.28 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.199 0.6 . . . . 0.0 109.528 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -78.63 101.45 7.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.615 0.766 . . . . 0.0 111.275 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.538 HG12 ' HA2' ' A' ' 10' ' ' GLY . 17.3 m -88.11 147.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 87.2 m -135.07 103.28 5.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.9 t -90.12 96.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.2 t -69.92 150.34 46.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.797 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.6 m -73.34 85.8 1.46 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.739 0.816 . . . . 0.0 111.133 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.491 1.587 0 C-N-CA 125.568 1.547 . . . . 0.0 112.991 -178.252 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 26' ' ' SER . 16.7 mt-30 -91.91 108.91 20.27 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.426 0.69 . . . . 0.0 109.447 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.753 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.9 mp -118.71 119.35 34.18 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.4 101.02 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -92.51 135.67 33.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.933 -174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 p -148.54 165.23 31.86 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.386 1.074 . . . . 0.0 109.72 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.84 -24.77 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.73 128.96 38.56 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.081 0.372 . . . . 0.0 113.175 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.84 -174.12 45.47 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.3 tp -78.03 116.98 18.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.06 0.544 . . . . 0.0 109.896 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 121' ' ' VAL . 4.8 m -129.42 163.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.414 1.086 . . . . 0.0 109.611 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.67 145.34 24.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.787 0.435 . . . . 0.0 111.399 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 127.17 30.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.341 1.057 . . . . 0.0 110.998 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.53 62.06 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 123.604 0.565 . . . . 0.0 112.304 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.04 -166.34 39.54 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -141.46 130.41 23.15 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.53 122.47 29.29 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.027 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -93.46 117.74 30.46 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.6 151.32 23.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.973 0.909 . . . . 0.0 109.175 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.4 p -136.59 126.22 25.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.624 0.77 . . . . 0.0 109.365 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 50.0 t -120.27 102.85 8.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.977 1.311 . . . . 0.0 109.372 -174.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -95.3 118.39 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.565 1.146 . . . . 0.0 109.639 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.53 99.69 11.86 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.945 -0.472 . . . . 0.0 110.643 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 27.3 t 49.6 39.39 17.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.568 1.547 . . . . 0.0 111.506 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.27 -89.96 1.11 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -168.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HG2' ' HB2' ' A' ' 77' ' ' LYS . 98.2 mtt180 -140.32 94.85 2.79 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 t -133.42 157.65 45.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.391 0.676 . . . . 0.0 110.013 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -112.42 119.76 39.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -154.38 -82.15 0.08 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.1 p -77.61 121.04 23.4 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.862 0.465 . . . . 0.0 111.275 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -92.84 10.36 31.35 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.267 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.57 122.79 15.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.653 1.181 . . . . 0.0 108.864 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.7 mtt -140.79 165.53 27.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.587 1.555 . . . . 0.0 108.546 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -166.36 156.17 27.88 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.612 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -108.14 133.67 52.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.387 1.075 . . . . 0.0 108.599 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -136.44 139.37 42.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.132 0.973 . . . . 0.0 108.829 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 33.4 ptt85 -103.68 137.98 40.97 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.492 0.717 . . . . 0.0 109.834 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.461 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 61.8 tt0 -143.83 130.72 20.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.059 0.544 . . . . 0.0 109.726 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.94 161.67 30.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.469 0.708 . . . . 0.0 109.563 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.35 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.59 2.193 . . . . 0.0 113.299 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.88 6.79 88.68 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -106.35 174.57 5.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.896 0.878 . . . . 0.0 110.549 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.45 166.37 22.07 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.833 0.853 . . . . 0.0 111.096 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -103.67 113.53 27.11 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 110.475 175.418 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -93.03 143.91 25.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.812 0.845 . . . . 0.0 110.382 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -62.76 118.12 7.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.751 0.821 . . . . 0.0 111.267 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -88.03 -47.16 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.15 176.47 8.45 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.785 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.591 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -156.98 127.24 6.43 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 123.886 0.874 . . . . 0.0 110.265 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.565 HD12 HG13 ' A' ' 80' ' ' VAL . 11.4 mt -118.92 118.06 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.35 1.06 . . . . 0.0 110.353 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 . . . . . 0 C--O 1.243 0.725 0 C-N-CA 124.218 1.007 . . . . 0.0 109.002 167.722 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 120.707 0.289 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -158.71 123.21 4.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.619 0.767 . . . . 0.0 110.031 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HB3' ' N ' ' A' ' 51' ' ' ALA . 4.4 t80 -171.36 141.82 1.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.476 0.71 . . . . 0.0 109.675 172.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -165.86 156.75 13.4 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.624 0.77 . . . . 0.0 110.383 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.68 167.28 11.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.754 0.822 . . . . 0.0 110.078 167.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.32 -29.11 69.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 112.036 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -68.22 -33.39 74.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.208 0.603 . . . . 0.0 111.42 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 69' ' ' PHE . 26.4 m -105.83 9.39 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.635 0.774 . . . . 0.0 111.098 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.07 119.19 8.44 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.391 1.076 . . . . 0.0 110.84 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.24 -16.67 15.99 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -98.51 -45.8 5.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.212 0.605 . . . . 0.0 109.384 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.457 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.8 m-85 -98.12 120.04 37.83 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.2 m -124.99 144.8 50.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.561 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -127.52 141.67 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.065 0.546 . . . . 0.0 110.826 -175.237 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -150.63 137.77 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.277 1.031 . . . . 0.0 109.694 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.51 ' HB2' HG21 ' A' ' 52' ' ' ILE . 22.1 ttp85 -124.6 130.16 51.92 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.27 110.01 22.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.886 1.274 . . . . 0.0 111.794 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.93 68.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.137 0.975 . . . . 0.0 111.712 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HE3' ' HB ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -120.23 -3.91 10.0 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.455 176.106 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 52.92 67.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.43 1.092 . . . . 0.0 111.451 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.453 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 92.3 m -127.15 132.83 50.45 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.682 173.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.565 HG13 HD12 ' A' ' 52' ' ' ILE . 23.3 t -101.6 151.16 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.773 1.229 . . . . 0.0 108.607 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -133.04 141.36 48.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.462 0.705 . . . . 0.0 109.59 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.45 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 66.3 tp -128.48 99.55 5.43 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -83.3 98.04 9.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.45 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 72.6 mtp -90.74 107.74 19.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.143 0.977 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.9 153.45 23.02 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.946 0.498 . . . . 0.0 110.156 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.5 t 60.07 62.17 1.69 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.562 1.145 . . . . 0.0 109.936 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.13 152.73 45.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.088 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -120.71 151.53 54.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.84 -15.2 45.61 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.15 1.9 . . . . 0.0 112.252 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.98 -25.1 66.16 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -82.2 24.15 0.68 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.661 0.784 . . . . 0.0 111.929 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 120' ' ' THR . 64.4 m -79.66 90.44 5.18 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 159.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.5 -174.31 2.48 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.446 -168.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.2 p -109.24 108.23 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.676 0.79 . . . . 0.0 109.807 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -85.04 116.3 23.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 167.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.462 HD13 ' HD1' ' A' ' 113' ' ' TRP . 2.5 pp -115.07 137.24 52.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 111.071 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.5 t -93.75 156.1 16.86 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.42 156.04 41.97 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.446 0.698 . . . . 0.0 109.713 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.64 158.61 37.33 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.906 0.482 . . . . 0.0 111.558 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.072 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 174.016 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.54 0.776 0 CA-C-O 120.847 0.27 . . . . 0.0 112.678 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.81 -40.23 6.65 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -121.94 164.35 17.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.162 0.985 . . . . 0.0 110.174 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.462 ' HD1' HD13 ' A' ' 96' ' ' LEU . 31.8 m-90 -119.7 157.53 28.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.695 1.198 . . . . 0.0 108.751 174.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -76.53 -76.43 0.83 Allowed Glycine 0 C--N 1.341 0.815 0 O-C-N 123.177 0.298 . . . . 0.0 112.987 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.92 -42.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 109.626 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.1 113.95 3.58 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.787 -172.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 t -96.41 108.67 21.25 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.832 0.825 . . . . 0.0 109.391 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -71.79 106.11 4.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.293 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.47 125.28 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 92' ' ' THR . 26.0 m -120.04 104.42 10.12 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 13' ' ' VAL . 57.8 t -89.23 105.79 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 121.862 -0.523 . . . . 0.0 110.365 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 m -58.74 139.27 56.44 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.46 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.9 m -72.54 91.14 1.38 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 125.668 1.587 . . . . 0.0 113.111 177.646 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.35 129.68 48.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.479 0.712 . . . . 0.0 109.667 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.45 HD22 ' SG ' ' A' ' 23' ' ' CYS . 89.7 mt -124.94 107.61 11.03 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.6 t -98.89 101.74 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 22' ' ' SER . 47.1 mt-10 -100.9 143.97 30.41 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.11 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.9 p -160.54 157.79 28.03 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.091 0.957 . . . . 0.0 109.792 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.443 ' O ' HD11 ' A' ' 19' ' ' LEU . . . 130.85 -32.27 3.05 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -59.09 127.96 46.43 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.27 -178.45 46.06 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 120' ' ' THR . 22.8 tp -88.18 109.51 19.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.86 0.464 . . . . 0.0 109.798 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 19' ' ' LEU . 18.5 m -126.68 151.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.089 0.956 . . . . 0.0 109.373 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -75.64 151.11 37.83 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.438 0.563 . . . . 0.0 111.259 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.11 125.09 23.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.156 0.982 . . . . 0.0 110.407 175.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.18 -20.26 26.22 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 123.814 0.721 . . . . 0.0 111.35 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.62 -166.94 9.88 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 121.598 0.554 . . . . 0.0 113.618 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.4 p -133.01 132.73 42.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.013 0.925 . . . . 0.0 109.395 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 13' ' ' VAL . 25.5 tp -134.95 118.76 17.22 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -97.65 120.8 38.69 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.128 0.571 . . . . 0.0 109.693 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.9 157.26 19.55 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.199 0.6 . . . . 0.0 109.394 172.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 18.6 p -145.92 126.11 13.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.845 0.858 . . . . 0.0 109.191 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 52.5 t -123.19 107.54 11.83 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.468 1.107 . . . . 0.0 108.901 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 21.2 t -89.24 115.22 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.642 0.777 . . . . 0.0 109.023 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.19 103.23 15.87 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p 54.66 36.74 26.79 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.707 1.603 . . . . 0.0 112.381 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.94 -107.94 2.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.69 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -118.79 10.98 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.009 0.924 . . . . 0.0 110.288 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -81.78 146.99 29.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -104.21 115.75 30.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -151.35 10.76 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.883 1.673 . . . . 0.0 108.847 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 p -86.99 88.52 7.72 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.224 1.01 . . . . 0.0 110.453 -174.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.74 -48.7 53.07 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.555 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.86 126.95 1.03 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.338 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.429 ' HE1' ' NH1' ' A' ' 73' ' ' ARG . 1.8 mpp? -125.44 119.76 29.15 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.657 1.183 . . . . 0.0 108.337 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -103.49 140.39 14.87 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -87.71 125.26 34.3 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.61 148.55 49.78 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -126.56 139.09 53.47 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.81 130.0 53.07 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.92 154.53 83.0 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -53.73 102.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.448 2.099 . . . . 0.0 112.41 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.99 23.21 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.931 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 6.9 mmpt? -133.44 170.41 15.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.83 0.824 . . . . 0.0 112.453 -174.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.24 176.46 6.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.982 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.48 37.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.61 125.65 40.61 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.36 110.26 4.02 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.18 -51.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.348 0.659 . . . . 0.0 109.64 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.69 170.04 22.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.212 0.605 . . . . 0.0 111.706 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -154.59 120.2 5.14 Favored 'General case' 0 C--O 1.25 1.126 0 C-N-CA 124.053 0.941 . . . . 0.0 110.131 173.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.645 HG23 ' HB3' ' A' ' 58' ' ' SER . 4.0 mp -122.65 116.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.392 1.077 . . . . 0.0 109.045 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.578 0 C-N-CA 123.091 0.556 . . . . 0.0 109.636 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.645 ' HB3' HG23 ' A' ' 52' ' ' ILE . 20.3 m . . . . . 0 CA--C 1.55 0.944 0 CA-C-O 121.457 0.646 . . . . 0.0 112.166 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -157.21 123.49 4.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.954 0.901 . . . . 0.0 109.883 -166.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 51' ' ' ALA . 25.8 m-85 -158.5 135.83 10.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.943 0.897 . . . . 0.0 109.167 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.55 153.9 11.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.554 1.542 . . . . 0.0 108.889 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.38 151.36 32.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.425 0.69 . . . . 0.0 109.789 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.2 -33.28 69.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.487 0.715 . . . . 0.0 111.498 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 m -66.82 -29.91 69.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.318 1.047 . . . . 0.0 112.208 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.48 -7.12 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.347 0.659 . . . . 0.0 111.869 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.05 122.48 17.49 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.603 0.761 . . . . 0.0 110.544 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.35 -28.54 14.05 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.666 0.604 . . . . 0.0 111.979 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 10.1 mtm180 -88.97 -52.89 4.85 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -91.39 131.6 36.77 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.722 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -140.9 150.21 42.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.458 1.103 . . . . 0.0 108.461 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.45 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -123.29 144.01 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.147 0.579 . . . . 0.0 110.491 178.057 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -144.13 134.4 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.101 0.96 . . . . 0.0 109.05 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.517 ' HB2' HG21 ' A' ' 52' ' ' ILE . 46.4 ttt180 -111.9 125.05 53.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.012 0.525 . . . . 0.0 110.363 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.523 ' HB3' ' HE3' ' A' ' 77' ' ' LYS . 60.6 m-20 -103.0 94.64 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.61 -26.07 67.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.824 0.85 . . . . 0.0 111.936 -173.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.58 73.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.678 0.791 . . . . 0.0 112.27 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.523 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -118.59 8.18 11.93 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.582 0.753 . . . . 0.0 110.528 176.229 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 55.82 30.73 16.32 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.843 1.257 . . . . 0.0 112.851 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.4 m -111.39 130.46 55.69 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.26 138.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 108.702 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -117.27 139.62 50.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.896 0.878 . . . . 0.0 110.055 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.1 tp -113.78 97.64 6.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -84.06 100.67 11.24 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 36.6 mtm -94.07 126.47 39.31 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -122.69 167.14 13.82 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 68' ' ' ARG . 13.5 m 57.65 40.2 26.82 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.622 0.769 . . . . 0.0 110.42 173.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.7 mt -56.85 142.99 38.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.653 -170.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.638 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -105.68 151.22 39.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.29 -14.19 40.48 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.199 1.933 . . . . 0.0 112.683 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.638 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.72 -22.02 66.58 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.453 0.701 . . . . 0.0 111.565 173.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -78.28 23.62 0.28 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.822 0.849 . . . . 0.0 111.647 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 120' ' ' THR . 99.0 m -82.79 92.54 7.26 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 163.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.02 -174.74 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.312 0.645 . . . . 0.0 111.106 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.93 112.04 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -85.45 108.73 18.02 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -112.18 138.45 48.84 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.977 0.911 . . . . 0.0 109.435 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 52.1 m -91.29 139.07 31.08 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.71 116.86 16.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.592 0.757 . . . . 0.0 109.136 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 35' ' ' MET . . . -111.87 152.96 27.35 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.104 0.562 . . . . 0.0 110.362 -173.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.573 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.831 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 CA--C 1.548 1.185 0 CA-C-O 121.016 0.34 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -97.22 -47.93 5.55 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.363 0.602 . . . . 0.0 109.705 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.07 144.17 40.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.73 1.212 . . . . 0.0 108.438 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -120.97 137.92 54.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.335 0.654 . . . . 0.0 109.247 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.03 -137.04 1.05 Allowed Glycine 0 C--N 1.346 1.117 0 O-C-N 123.338 0.399 . . . . 0.0 113.151 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -94.92 -30.89 13.92 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.073 0.549 . . . . 0.0 110.599 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.22 116.95 0.13 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.249 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -99.37 123.35 43.57 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 117.229 0.514 . . . . 0.0 110.489 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -77.39 101.48 6.38 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.261 1.024 . . . . 0.0 110.707 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.559 HG12 ' HA2' ' A' ' 10' ' ' GLY . 20.0 m -93.01 137.5 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 92' ' ' THR . 70.2 m -134.17 105.03 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.3 t -87.77 98.22 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 t -50.43 131.2 24.54 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.382 1.073 . . . . 0.0 111.742 172.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.6 p -76.4 82.52 3.13 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.057 0.543 . . . . 0.0 110.616 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.5 mm? . . . . . 0 N--CA 1.491 1.581 0 C-N-CA 125.007 1.323 . . . . 0.0 114.071 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -117.68 133.9 55.46 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.51 1.124 . . . . 0.0 108.812 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.648 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 94.3 mt -131.68 120.8 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.915 0.886 . . . . 0.0 109.381 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.2 t -98.42 104.88 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 108.537 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -104.66 151.08 24.12 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.369 0.668 . . . . 0.0 111.19 -168.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 p -157.15 170.75 21.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.658 0.783 . . . . 0.0 111.079 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.09 32.28 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.26 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.569 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -69.34 120.34 10.21 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 113.957 0.343 . . . . 0.0 113.957 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.76 179.48 48.78 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 120' ' ' THR . 10.2 tt -88.02 128.55 35.4 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.411 0.284 . . . . 0.0 110.288 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.58 152.53 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.25 150.99 35.31 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -59.7 127.6 32.82 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 0.0 110.552 174.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.15 18.13 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.2 -179.22 52.46 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 122.873 0.273 . . . . 0.0 113.292 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -121.0 164.64 16.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.042 0.937 . . . . 0.0 110.563 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.4 tp -159.47 123.65 3.87 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.579 0.752 . . . . 0.0 109.982 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -99.32 129.58 45.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.06 0.544 . . . . 0.0 109.576 173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -96.42 154.32 17.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.325 1.05 . . . . 0.0 109.007 171.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -143.54 128.74 18.74 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 30.8 t -137.74 104.61 5.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.46 0.704 . . . . 0.0 110.065 -172.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -84.75 145.28 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.812 . . . . 0.0 110.25 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.539 ' HA ' HD23 ' A' ' 5' ' ' LEU . . . -89.98 100.43 13.25 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.124 0.57 . . . . 0.0 110.063 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p 56.46 -75.38 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.85 2.06 . . . . 0.0 112.457 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.74 -64.38 0.06 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -161.66 39.32 0.13 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.06 0.933 . . . . 0.0 109.451 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -107.36 151.04 26.04 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -105.29 126.31 51.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.813 0.845 . . . . 0.0 108.878 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -150.66 146.68 26.64 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.832 0.853 . . . . 0.0 109.074 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t 66.07 115.34 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.212 1.405 . . . . 0.0 111.183 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -80.67 7.83 9.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.4 0.68 . . . . 0.0 111.299 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.86 119.92 21.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.561 0.744 . . . . 0.0 109.306 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.8 mtt -137.38 119.9 16.0 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -125.29 142.46 13.82 Favored Glycine 0 N--CA 1.468 0.832 0 CA-C-N 118.102 0.41 . . . . 0.0 112.92 -172.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.412 ' HE1' HG12 ' A' ' 80' ' ' VAL . 95.0 m95 -86.06 117.89 25.19 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -117.02 171.34 7.99 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.922 1.289 . . . . 0.0 108.595 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -150.83 130.93 13.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.924 0.49 . . . . 0.0 110.029 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -110.56 128.83 55.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.12 39.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.493 0.717 . . . . 0.0 109.658 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.74 107.72 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.778 2.318 . . . . 0.0 113.119 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.49 1.52 66.24 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.552 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.4 mmpt? -114.98 173.43 6.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.223 1.009 . . . . 0.0 110.203 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.59 176.48 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.024 0.93 . . . . 0.0 110.425 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 124.01 24.51 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.172 0.51 . . . . 0.0 111.141 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.15 134.63 36.39 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.358 1.063 . . . . 0.0 109.366 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -71.11 109.36 5.14 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.812 0.695 . . . . 0.0 109.305 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.57 -53.24 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.81 174.75 10.3 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.922 -172.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -159.85 142.07 13.31 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.15 0.976 . . . . 0.0 112.014 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 71' ' ' ILE . 4.0 mp -109.78 114.06 45.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.139 174.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 . . . . . 0 C--O 1.243 0.711 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 168.453 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 13.5 p . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -154.08 121.18 5.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.472 0.709 . . . . 0.0 110.021 -166.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.453 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 32.3 m-85 -158.25 154.58 27.44 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.764 1.626 . . . . 0.0 107.028 170.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -166.49 148.4 6.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.04 0.536 . . . . 0.0 110.368 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.01 25.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.6 -34.1 76.34 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -66.81 -18.44 65.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.696 0.798 . . . . 0.0 112.617 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.13 5.27 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.974 0.51 . . . . 0.0 111.662 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.19 131.68 51.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.544 0.738 . . . . 0.0 111.54 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 -28.32 4.57 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.167 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 88.9 mtm180 -92.67 -47.85 6.88 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.509 0.723 . . . . 0.0 110.158 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -87.84 122.62 31.7 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 m -124.99 133.54 52.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 108.446 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.548 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -120.77 146.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 122.766 0.426 . . . . 0.0 110.636 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 p -159.37 151.51 20.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.602 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.482 ' HB3' HG21 ' A' ' 52' ' ' ILE . 52.6 ttt180 -128.36 123.42 33.83 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -105.22 103.23 12.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -76.82 -11.83 59.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.218 0.607 . . . . 0.0 111.49 -173.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.59 92.34 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 122.549 0.34 . . . . 0.0 111.861 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -112.39 1.9 16.2 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 117.99 0.359 . . . . 0.0 110.905 169.708 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 43.8 m-80 58.56 66.66 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.843 1.257 . . . . 0.0 110.807 176.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.8 m -141.8 132.36 25.39 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.088 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.412 HG12 ' HE1' ' A' ' 37' ' ' TRP . 27.5 t -111.17 130.0 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.381 1.072 . . . . 0.0 108.965 -173.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -113.23 148.68 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.729 0.812 . . . . 0.0 111.308 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 65.5 tp -132.0 98.07 4.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -87.73 100.53 12.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.753 ' HB3' HD21 ' A' ' 87' ' ' LEU . 48.2 mtm -94.34 142.18 27.71 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.591 0.757 . . . . 0.0 108.99 175.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 18.1 m120 -136.81 150.15 48.16 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.45 0.7 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 t 52.31 59.91 4.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 173.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -79.66 161.08 26.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.4 -171.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.1 153.4 61.15 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 121' ' ' VAL . 37.7 Cg_endo -60.8 -15.66 39.31 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.862 2.375 . . . . 0.0 115.04 -168.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -72.56 -14.66 61.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.106 0.563 . . . . 0.0 111.983 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -82.15 19.52 1.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.403 0.681 . . . . 0.0 111.019 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 96.7 m -75.31 92.44 2.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 165.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.4 164.05 27.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.449 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.27 107.45 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.414 174.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -84.66 138.02 32.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 113' ' ' TRP . 1.7 pt? -150.2 139.75 21.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.935 0.494 . . . . 0.0 110.889 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.7 m -87.74 114.69 24.59 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -107.78 117.01 33.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 108.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.18 116.83 31.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.481 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.491 -174.659 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.583 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 2.6 Cg_exo . . . . . 0 CA--C 1.548 1.203 0 N-CA-C 110.433 -0.641 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -91.29 -47.01 7.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.432 0.693 . . . . 0.0 110.336 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -125.78 158.53 34.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.773 . . . . 0.0 109.945 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.418 ' HB3' HD12 ' A' ' 96' ' ' LEU . 22.7 m-90 -128.0 152.72 47.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.559 1.144 . . . . 0.0 108.534 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.21 46.52 3.4 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.965 -173.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 73.26 -45.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.633 1.573 . . . . 0.0 111.857 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . 98.36 112.06 3.13 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -97.75 123.16 41.57 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 121.885 0.85 . . . . 0.0 109.965 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -80.35 103.76 10.44 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.243 1.017 . . . . 0.0 110.567 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.569 HG12 ' HA2' ' A' ' 10' ' ' GLY . 3.5 m -105.26 150.56 7.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 89.8 m -134.85 114.6 12.75 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' PRO . 40.8 t -92.42 105.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 12' ' ' LEU . 15.0 t -73.72 158.02 35.43 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 120.667 0.27 . . . . 0.0 111.036 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.7 p -84.85 73.14 10.68 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.686 0.795 . . . . 0.0 110.667 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.9 mm? . . . . . 0 N--CA 1.49 1.571 0 C-N-CA 125.521 1.528 . . . . 0.0 113.765 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 32' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -112.19 127.83 56.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.653 0.781 . . . . 0.0 109.535 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.673 HD11 ' HG2' ' A' ' 35' ' ' MET . 96.4 mt -132.84 122.77 24.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.616 1.166 . . . . 0.0 109.703 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -106.48 102.29 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.02 145.1 27.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 p -160.88 168.09 25.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.852 0.861 . . . . 0.0 110.257 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.06 17.82 21.63 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.406 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -78.32 134.81 14.76 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.14 -178.54 47.67 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.6 tt -98.37 131.78 44.38 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.918 0.487 . . . . 0.0 109.889 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.68 170.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.926 1.291 . . . . 0.0 107.907 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -90.77 154.04 19.81 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.742 0.417 . . . . 0.0 109.964 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.45 124.97 24.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.761 0.824 . . . . 0.0 110.567 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.36 -23.35 24.97 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.03 174.81 48.79 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.774 0.338 . . . . 0.0 112.371 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.0 p -106.11 162.76 13.34 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.372 0.669 . . . . 0.0 110.566 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.6 tp -159.8 121.82 3.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.063 0.945 . . . . 0.0 108.613 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -98.53 122.41 41.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.062 0.458 . . . . 0.0 110.165 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.451 HD12 HG21 ' A' ' 117' ' ' THR . 3.8 mm? -94.82 145.32 24.97 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.071 0.949 . . . . 0.0 108.966 172.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 p -131.89 126.15 33.46 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.508 0.723 . . . . 0.0 109.15 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 43.2 t -122.73 108.94 13.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.619 1.167 . . . . 0.0 108.623 -177.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.24 129.69 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.135 0.974 . . . . 0.0 109.088 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -87.1 100.96 13.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.6 p 64.62 -75.51 0.04 OUTLIER 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.533 1.933 . . . . 0.0 111.713 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.06 -62.78 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -166.81 67.45 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -138.89 162.08 35.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.377 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -103.9 122.16 44.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.765 0.826 . . . . 0.0 109.227 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.22 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.531 ' HA ' HD21 ' A' ' 3' ' ' LEU . 5.5 m -71.84 85.03 0.94 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.565 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 73' ' ' ARG . 24.1 p-10 -93.59 -27.07 16.82 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.666 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.3 120.12 15.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.788 -171.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.673 ' HG2' HD11 ' A' ' 5' ' ' LEU . 4.5 mtm -150.82 141.84 23.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.222 1.409 . . . . 0.0 108.837 -175.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.64 136.44 11.06 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 76.2 m95 -86.72 130.12 34.6 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.532 0.666 . . . . 0.0 110.319 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -123.06 171.75 9.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.96 1.304 . . . . 0.0 108.261 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -143.23 131.37 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 168.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -102.5 130.9 49.46 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -115.99 149.56 43.55 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.007 0.523 . . . . 0.0 110.054 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.27 100.6 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.385 2.056 . . . . 0.0 111.367 172.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.78 5.66 56.5 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.964 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 7.4 mmpt? -138.76 137.89 37.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.723 0.809 . . . . 0.0 109.623 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.32 171.6 5.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.766 0.826 . . . . 0.0 111.555 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.04 124.88 21.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.289 0.566 . . . . 0.0 111.317 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -93.83 126.47 39.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -76.0 106.63 7.7 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -94.95 -48.63 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.541 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . . . -151.19 164.14 37.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -170.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -152.68 134.9 14.98 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.923 0.868 . . . . 0.0 111.442 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.51 118.33 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 123.258 0.623 . . . . 0.0 109.47 -177.973 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -156.86 124.3 5.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -165.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.423 ' H ' HD11 ' A' ' 71' ' ' ILE . 5.5 t80 -169.52 117.28 0.61 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 65' ' ' VAL . 4.8 p90 -164.87 151.92 11.0 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.935 0.894 . . . . 0.0 109.207 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.98 31.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.346 0.658 . . . . 0.0 110.885 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.58 -28.07 68.88 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.368 0.667 . . . . 0.0 110.439 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.8 p -68.32 -28.57 67.27 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.443 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 61' ' ' TYR . 29.3 m -116.37 19.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.615 0.766 . . . . 0.0 111.272 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -67.82 120.63 14.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.9 0.88 . . . . 0.0 110.483 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -20.83 26.27 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 68.6 mtp180 -85.68 -70.08 0.62 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 110.071 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -86.2 120.86 28.02 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 m -130.2 140.58 50.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.212 1.005 . . . . 0.0 108.615 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.438 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -122.53 147.06 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.535 0.734 . . . . 0.0 109.324 175.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -147.0 133.5 19.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.539 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 33' ' ' ASN . 51.2 ttt-85 -114.7 124.84 52.83 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -103.52 110.87 23.08 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -74.98 -20.18 59.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.556 0.742 . . . . 0.0 111.904 -175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.86 78.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.603 0.361 . . . . 0.0 111.727 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -118.93 -5.68 10.56 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.319 171.247 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 11.4 m-80 60.75 70.37 0.62 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.007 0.923 . . . . 0.0 110.524 -174.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.0 m -138.17 131.68 30.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.36 135.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.745 0.818 . . . . 0.0 109.594 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -121.0 115.01 22.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.836 0.854 . . . . 0.0 109.508 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 tp -92.35 97.79 11.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -85.17 100.94 12.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.45 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.624 ' SD ' HD21 ' A' ' 87' ' ' LEU . 56.6 mtt -84.23 126.59 33.29 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -129.41 137.31 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 t 58.76 73.11 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.593 0.711 . . . . 0.0 110.304 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.624 HD21 ' SD ' ' A' ' 84' ' ' MET . 22.6 mt -75.53 162.5 28.25 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.287 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -125.99 149.16 65.43 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.524 1.129 . . . . 0.0 108.458 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.47 -13.7 40.08 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.956 2.437 . . . . 0.0 112.739 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.43 -28.63 69.81 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.591 1.157 . . . . 0.0 111.891 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -74.92 14.97 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.418 0.687 . . . . 0.0 112.375 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 HG23 ' A' ' 120' ' ' THR . 92.5 m -73.33 89.41 1.59 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 158.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.96 173.37 3.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.722 1.209 . . . . 0.0 109.389 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.26 115.8 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -83.62 133.23 34.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.494 0.718 . . . . 0.0 109.227 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -139.81 120.9 14.71 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.461 0.704 . . . . 0.0 109.891 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.57 ' SG ' ' HB3' ' A' ' 35' ' ' MET . 46.8 t -89.37 116.14 27.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.75 158.67 23.49 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.13 0.972 . . . . 0.0 110.534 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -116.62 139.59 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.081 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.232 -178.466 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 N--CA 1.495 1.576 0 N-CA-C 114.028 0.742 . . . . 0.0 114.028 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.24 -47.95 22.06 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.201 0.524 . . . . 0.0 110.069 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 64.6 m-85 -111.84 147.24 36.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.27 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -126.13 146.23 50.02 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 167.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -70.42 -84.13 0.18 Allowed Glycine 0 C--N 1.339 0.744 0 O-C-N 123.664 0.602 . . . . 0.0 113.765 -176.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.26 -46.13 0.14 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -176.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.6 95.13 1.32 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.523 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.451 HG21 HD12 ' A' ' 21' ' ' LEU . 7.2 t -97.85 121.63 40.0 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.532 0.733 . . . . 0.0 110.409 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.36 117.88 20.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.845 0.858 . . . . 0.0 109.097 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.406 HG12 ' HA2' ' A' ' 10' ' ' GLY . 33.5 m -118.38 141.81 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.428 0.691 . . . . 0.0 109.23 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 33.6 m -129.23 104.34 7.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 87' ' ' LEU . 52.6 t -94.17 98.11 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.8 t -66.32 150.25 49.13 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.726 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.4 m -71.14 165.36 23.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.925 0.89 . . . . 0.0 111.463 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.334 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -119.89 108.38 14.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 99' ' ' ALA . 2.9 mm? -96.38 109.02 21.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.01 104.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -76.96 155.83 32.39 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.512 0.673 . . . . 0.0 111.209 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 p -155.33 154.06 31.46 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 108.695 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.52 -2.63 56.09 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -69.57 105.49 1.54 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.55 27.2 Favored Glycine 0 C--O 1.245 0.8 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 122' ' ' SER . 9.8 tt -88.31 137.09 32.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 m -136.37 168.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.694 1.198 . . . . 0.0 109.213 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -87.5 151.58 22.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.575 0.75 . . . . 0.0 110.724 177.38 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.25 141.55 52.43 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 123.32 0.648 . . . . 0.0 110.384 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.49 13.72 Favored Glycine 0 N--CA 1.464 0.545 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.09 -172.25 46.04 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 112.161 -0.375 . . . . 0.0 112.161 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 p -123.18 164.08 19.38 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.301 0.64 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.4 tp -148.25 127.75 13.19 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -108.28 113.2 26.12 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.532 0.733 . . . . 0.0 109.336 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -84.27 153.39 23.59 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.5 p -142.14 122.06 13.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.889 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.7 t -105.71 111.89 24.75 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.97 0.908 . . . . 0.0 109.486 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.65 118.96 32.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.51 99.44 12.44 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.497 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 22.7 t 59.53 39.45 21.6 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.903 1.281 . . . . 0.0 111.355 173.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.18 -69.69 2.2 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -162.23 87.13 0.62 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.33 1.052 . . . . 0.0 108.491 166.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 50.1 m -140.37 139.91 35.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 109.227 175.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -106.35 141.29 37.91 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -157.41 -49.06 0.07 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -98.39 133.8 42.28 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.909 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -97.78 -0.02 46.03 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.134 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.47 51.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.472 1.109 . . . . 0.0 108.472 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.635 ' SD ' ' HD2' ' A' ' 73' ' ' ARG . 47.2 mtt -150.68 168.32 24.69 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.515 1.526 . . . . 0.0 109.689 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.89 -171.99 32.73 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -132.86 133.28 43.11 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.72 155.24 35.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.382 1.073 . . . . 0.0 108.718 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -123.45 136.33 54.55 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.206 0.526 . . . . 0.0 110.407 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 94' ' ' VAL . 21.8 mm-40 -106.01 154.6 20.38 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.894 1.277 . . . . 0.0 108.254 172.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -141.79 154.78 66.14 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.568 0.747 . . . . 0.0 109.235 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.12 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.384 2.722 . . . . 0.0 114.102 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.9 20.2 78.08 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.649 -0.705 . . . . 0.0 114.288 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.5 mmpt? -129.87 145.32 51.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.951 0.901 . . . . 0.0 109.904 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.2 168.83 18.81 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.347 1.059 . . . . 0.0 111.854 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 143.1 46.7 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.28 139.11 51.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.158 0.583 . . . . 0.0 109.701 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.517 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 92.1 t80 -71.95 110.08 6.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.247 1.019 . . . . 0.0 109.61 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.27 -40.43 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.737 -174.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.58 160.28 40.22 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.517 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -143.24 125.14 15.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.33 1.052 . . . . 0.0 110.228 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.58 121.16 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.158 1.383 . . . . 0.0 108.11 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 N--CA 1.475 0.818 0 C-N-CA 123.54 0.736 . . . . 0.0 110.579 -177.807 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 p -152.86 131.44 12.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.958 0.503 . . . . 0.0 110.672 -169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' H ' HD11 ' A' ' 71' ' ' ILE . 11.0 t80 -160.7 132.82 6.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 168.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.42 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 20.1 p90 -159.57 157.88 30.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.178 0.991 . . . . 0.0 110.144 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.51 156.97 30.63 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.485 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.604 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 37.9 t70 -70.76 -20.82 62.58 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.731 0.301 . . . . 0.0 110.4 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.0 m -61.82 -36.7 81.91 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.528 0.731 . . . . 0.0 111.063 172.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.85 15.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.604 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -60.27 124.83 21.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.227 0.611 . . . . 0.0 109.83 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.77 -28.49 7.06 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 123.734 0.646 . . . . 0.0 112.597 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.588 HH21 ' HA ' ' A' ' 87' ' ' LEU . 66.3 mtp180 -76.36 -46.06 29.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.099 0.952 . . . . 0.0 109.326 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 61' ' ' TYR . 24.3 t80 -91.42 128.55 37.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.999 -166.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 42.1 m -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.35 1.06 . . . . 0.0 108.46 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.574 HD11 ' H ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -141.2 144.15 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.845 0.858 . . . . 0.0 109.131 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.9 m -151.97 142.07 22.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.617 0.767 . . . . 0.0 109.907 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.635 ' HD2' ' SD ' ' A' ' 35' ' ' MET . 18.2 ttt85 -110.17 127.45 54.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 170.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -103.08 132.39 49.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.472 0.709 . . . . 0.0 109.187 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.89 -27.05 21.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 112.69 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.89 94.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.705 0.802 . . . . 0.0 112.049 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.6 5.17 13.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.322 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 49.99 68.03 0.81 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.737 1.215 . . . . 0.0 111.67 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.1 m -136.16 133.44 37.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.129 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.44 147.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -126.99 141.19 51.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.023 0.529 . . . . 0.0 110.252 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.4 tp -127.25 96.28 4.54 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.499 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 24.9 tp60 -96.08 100.65 12.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.0 mtm -102.93 112.91 25.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.577 0.751 . . . . 0.0 109.017 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -102.79 165.58 10.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.128 0.971 . . . . 0.0 110.225 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 68' ' ' ARG . 10.6 m 54.17 45.0 28.32 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 124.158 0.911 . . . . 0.0 111.384 171.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.588 ' HA ' HH21 ' A' ' 68' ' ' ARG . 82.2 mt -63.59 146.1 54.39 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.701 -168.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.472 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 29.4 mmmt -96.27 141.62 23.38 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.917 1.287 . . . . 0.0 108.6 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.85 -23.92 61.52 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.37 2.046 . . . . 0.0 113.216 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -72.24 -7.69 50.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.899 0.88 . . . . 0.0 112.316 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -84.77 38.2 0.69 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.802 0.841 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.2 m -90.84 100.52 13.36 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 171.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.76 -171.39 3.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.643 0.777 . . . . 0.0 110.273 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 40' ' ' GLN . 1.5 p -123.77 106.03 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -90.98 146.84 23.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.626 0.77 . . . . 0.0 110.965 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD13 ' HB3' ' A' ' 113' ' ' TRP . 2.0 pp -144.28 153.72 42.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.236 1.014 . . . . 0.0 109.41 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.8 148.21 22.53 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.05 148.49 31.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.106 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB3' HD21 ' A' ' 5' ' ' LEU . . . -155.85 135.76 12.76 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.394 0.678 . . . . 0.0 109.685 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 O-C-N 123.876 0.735 . . . . 0.0 111.441 171.004 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 CA--C 1.546 1.11 0 CA-C-O 121.231 0.43 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.34 -42.68 99.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.296 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -142.01 125.68 16.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.693 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.444 ' HB3' HD13 ' A' ' 96' ' ' LEU . 5.7 m-90 -94.03 155.11 17.29 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.85 171.55 52.02 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.191 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -63.22 -21.14 66.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.934 0.894 . . . . 0.0 112.059 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.05 127.79 1.22 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.46 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 11.1 t -125.61 138.47 53.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.127 0.571 . . . . 0.0 110.254 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -80.44 101.69 9.2 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.614 0.766 . . . . 0.0 111.449 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.0 m -99.25 130.57 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 170.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 82.9 m -135.11 110.7 9.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.7 104.61 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.939 -0.476 . . . . 0.0 109.779 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.549 ' HB2' HD21 ' A' ' 12' ' ' LEU . 35.2 t -61.88 155.43 23.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.584 0.754 . . . . 0.0 112.045 168.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 t -85.47 71.45 10.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.162 0.585 . . . . 0.0 109.644 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 4.1 mm? . . . . . 0 N--CA 1.494 1.732 0 C-N-CA 125.068 1.347 . . . . 0.0 114.26 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -107.58 146.18 32.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.346 1.058 . . . . 0.0 108.968 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.575 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 94.5 mt -125.63 108.17 11.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.67 107.52 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -102.98 154.84 18.83 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.691 0.619 . . . . 0.0 111.72 -170.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -157.68 158.8 36.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.4 1.08 . . . . 0.0 109.133 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.12 -2.99 29.91 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.827 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -72.24 83.33 0.53 Allowed Glycine 0 C--N 1.35 1.322 0 CA-C-N 117.173 0.486 . . . . 0.0 112.725 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.86 177.03 17.19 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.0 tt -92.54 114.14 26.61 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 87' ' ' LEU . 35.9 m -113.34 171.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -94.4 158.07 15.73 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.15 0.58 . . . . 0.0 109.919 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.76 116.83 5.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.756 0.822 . . . . 0.0 110.571 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.43 22.8 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.602 0.564 . . . . 0.0 111.988 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.65 55.24 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 121.275 0.375 . . . . 0.0 113.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 p -109.4 165.7 11.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 110.685 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.7 tp -158.33 141.03 14.58 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -114.26 113.16 24.24 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.175 0.512 . . . . 0.0 110.15 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -87.72 149.17 24.39 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 109.332 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.2 p -145.22 126.79 15.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.798 0.839 . . . . 0.0 109.346 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 43.5 t -135.28 130.31 34.93 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 109.735 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.56 146.14 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.97 99.02 11.57 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t 53.37 40.65 31.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.297 1.439 . . . . 0.0 112.352 171.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.03 -61.08 4.36 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.027 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -168.54 33.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.03 1.332 . . . . 0.0 109.803 172.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -119.93 121.28 38.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.326 0.651 . . . . 0.0 109.945 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -133.43 150.67 51.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 110.371 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mtt85 -166.92 72.23 0.12 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 107.779 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.6 m -147.71 129.69 15.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.765 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.95 -43.71 21.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.88 0.472 . . . . 0.0 111.894 -171.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.39 169.5 9.26 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.569 0.347 . . . . 0.0 110.318 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 80' ' ' VAL . 58.2 mtt -148.98 165.39 31.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.533 1.133 . . . . 0.0 109.006 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -155.8 -174.82 26.08 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-O 119.993 -0.337 . . . . 0.0 112.264 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -143.6 118.87 10.18 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.659 1.184 . . . . 0.0 108.455 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.52 162.87 14.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.411 1.084 . . . . 0.0 108.824 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -121.61 133.98 54.99 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.524 ' HB3' HG13 ' A' ' 94' ' ' VAL . 9.9 tm0? -107.84 128.97 55.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -111.78 141.2 24.27 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.552 0.741 . . . . 0.0 109.015 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.82 114.1 2.01 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.597 2.198 . . . . 0.0 112.391 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.51 79.78 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.492 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -119.09 173.58 6.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.571 1.148 . . . . 0.0 108.943 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.49 166.46 15.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.843 0.354 . . . . 0.0 110.622 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.92 115.55 11.26 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.343 0.592 . . . . 0.0 109.746 170.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -92.63 141.57 28.34 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.082 0.953 . . . . 0.0 109.892 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -77.58 116.47 18.16 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.63 0.581 . . . . 0.0 109.535 -178.05 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.18 -59.59 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.584 0.754 . . . . 0.0 110.072 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.537 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -148.79 163.45 37.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.449 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -157.25 164.72 37.4 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.362 1.077 . . . . 0.0 112.226 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 73' ' ' ARG . 96.4 mt -109.2 116.77 52.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.31 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 . . . . . 0 C--N 1.351 0.653 0 O-C-N 124.19 0.931 . . . . 0.0 108.992 176.38 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 9.5 t . . . . . 0 CA--C 1.549 0.939 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.39 117.68 1.15 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.713 0.805 . . . . 0.0 109.573 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -171.02 128.21 0.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.206 2.202 . . . . 0.0 105.924 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.15 146.21 7.43 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.041 0.936 . . . . 0.0 109.708 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.95 156.43 38.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.682 0.793 . . . . 0.0 109.981 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -60.32 -26.73 66.79 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.474 0.71 . . . . 0.0 112.135 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.2 t -65.55 -39.02 91.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.764 0.826 . . . . 0.0 111.089 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.09 12.33 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.878 0.871 . . . . 0.0 111.268 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -66.78 120.75 14.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.144 0.978 . . . . 0.0 110.799 -173.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.63 5.49 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.305 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -77.51 -55.36 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.14 120.3 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.2 m -129.44 138.13 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.537 HD12 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -116.23 142.49 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.589 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -137.17 133.07 34.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.639 ' HB2' HD13 ' A' ' 52' ' ' ILE . 78.3 ttt180 -115.27 122.41 45.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.46 90.65 3.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -69.93 -13.26 62.16 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.01 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.61 77.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.343 1.057 . . . . 0.0 111.988 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.19 11.86 12.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.884 0.474 . . . . 0.0 110.794 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.28 28.62 15.78 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.833 1.253 . . . . 0.0 112.091 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.5 m -114.37 131.75 56.45 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.306 0.642 . . . . 0.0 110.287 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.48 HG21 ' SD ' ' A' ' 35' ' ' MET . 79.0 t -108.58 150.05 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.41 1.484 . . . . 0.0 108.946 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -131.02 151.62 51.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.643 0.777 . . . . 0.0 110.745 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 55.7 tp -132.22 101.36 5.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 108.521 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -85.97 101.14 12.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.487 ' SD ' HD21 ' A' ' 87' ' ' LEU . 39.9 mtt -83.33 139.58 32.95 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.109 0.964 . . . . 0.0 109.2 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -138.23 138.11 38.18 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 t 58.4 72.34 0.53 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.629 1.172 . . . . 0.0 110.451 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.487 HD21 ' SD ' ' A' ' 84' ' ' MET . 42.3 mt -82.62 144.8 30.06 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.574 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -87.18 150.29 49.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.734 0.814 . . . . 0.0 109.38 -176.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.83 -23.63 74.36 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 C-N-CA 121.726 1.617 . . . . 0.0 110.891 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.04 -31.73 69.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.696 1.598 . . . . 0.0 111.775 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.37 22.43 0.84 Allowed 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.607 0.717 . . . . 0.0 111.632 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -77.85 92.28 4.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 161.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.53 169.97 21.87 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.023 0.929 . . . . 0.0 109.694 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.524 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -97.69 107.82 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -82.06 150.81 27.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.401 0.681 . . . . 0.0 109.445 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.78 140.26 21.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.354 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 14.7 p -89.7 149.92 22.55 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -112.12 158.45 19.6 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.556 0.742 . . . . 0.0 109.71 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -139.33 137.71 36.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -176.839 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.565 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 17.4 Cg_exo . . . . . 0 CA--C 1.547 1.127 0 N-CA-C 111.318 -0.301 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -92.59 -12.05 32.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.312 0.645 . . . . 0.0 111.271 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 9.9 m-85 -128.55 149.25 50.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -138.92 163.98 30.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.623 0.769 . . . . 0.0 109.969 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -76.09 174.57 53.11 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.633 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -73.89 -28.11 61.39 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.987 0.515 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.06 100.81 2.66 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.378 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -96.2 106.81 19.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.078 0.942 . . . . 0.0 108.572 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -78.7 101.38 7.5 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.244 -172.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.521 HG12 ' HA2' ' A' ' 10' ' ' GLY . 19.8 m -91.04 137.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.0 m -124.46 102.98 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.32 94.73 4.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -64.43 142.43 58.42 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.0 p -70.48 88.58 0.67 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.75 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.492 1.657 0 C-N-CA 126.565 1.946 . . . . 0.0 113.361 174.57 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -75.39 144.4 42.28 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.126 0.571 . . . . 0.0 110.08 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.26 110.39 11.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.968 0.414 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.19 106.3 16.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 93.1 mt -93.42 105.6 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.865 0.466 . . . . 0.0 109.862 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t -98.75 104.19 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.14 146.78 24.38 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.338 0.655 . . . . 0.0 111.376 -171.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 p -149.82 158.01 43.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.213 1.005 . . . . 0.0 109.877 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.71 -0.75 42.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.237 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.95 118.68 9.86 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-O 120.241 -0.2 . . . . 0.0 112.662 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.36 -167.12 29.47 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.3 tt -105.21 124.28 49.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.821 0.449 . . . . 0.0 110.513 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 19' ' ' LEU . 28.0 m -118.67 163.03 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.345 1.058 . . . . 0.0 108.744 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 5.7 pm0 -88.89 155.55 19.46 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.065 0.546 . . . . 0.0 109.979 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.87 111.7 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.866 0.866 . . . . 0.0 110.745 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.02 -14.17 23.91 Favored Glycine 0 N--CA 1.474 1.181 0 O-C-N 123.273 0.358 . . . . 0.0 113.042 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.37 170.99 51.29 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 120.111 -0.272 . . . . 0.0 112.457 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -105.57 138.85 41.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.512 0.725 . . . . 0.0 110.626 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HB2' HG11 ' A' ' 13' ' ' VAL . 38.8 tp -132.51 130.94 41.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.683 1.193 . . . . 0.0 109.152 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -111.97 127.51 55.89 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.833 0.853 . . . . 0.0 109.573 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.7 mm? -99.61 149.31 23.41 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 108.957 170.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 p -138.26 124.05 19.9 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 49.2 t -116.77 101.96 9.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.895 0.878 . . . . 0.0 109.409 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.87 121.29 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.52 99.43 12.29 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.79 0.436 . . . . 0.0 110.374 -173.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 18.4 m 58.87 35.72 24.33 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.076 1.35 . . . . 0.0 112.108 173.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.79 -58.63 4.81 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.993 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 31.9 ttp-105 -173.47 77.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.668 1.187 . . . . 0.0 108.014 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.5 m -139.77 147.89 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.567 0.747 . . . . 0.0 110.293 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.471 ' HB3' HD21 ' A' ' 78' ' ' ASN . 11.6 p90 -128.18 136.95 51.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 0.0 110.103 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -169.67 12.93 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.0 0.92 . . . . 0.0 109.098 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 t -108.79 108.6 19.47 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.398 0.679 . . . . 0.0 109.992 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -88.83 -23.72 22.76 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.737 0.815 . . . . 0.0 110.66 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . . . -130.43 123.47 29.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.005 0.922 . . . . 0.0 109.04 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.0 mtm -132.28 166.18 22.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.233 1.013 . . . . 0.0 109.719 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -154.6 179.81 30.42 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.288 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 93.2 m95 -138.38 130.31 28.26 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 170.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.556 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 64.9 m-85 -135.48 152.63 51.54 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 109.262 -173.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 13.7 ptp180 -107.39 141.51 38.66 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -132.5 145.43 51.16 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -176.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -144.6 155.17 56.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.69 105.94 0.25 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.315 2.01 . . . . 0.0 111.83 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.05 -17.04 56.73 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.558 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 9.8 mmpt? -111.87 131.86 55.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.62 0.768 . . . . 0.0 110.326 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.68 170.64 14.09 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.009 0.924 . . . . 0.0 111.763 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -67.28 119.02 11.46 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.712 -177.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -103.68 136.85 42.61 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.961 0.904 . . . . 0.0 109.997 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -62.97 115.82 4.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.688 1.195 . . . . 0.0 111.539 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.4 t -102.46 -48.16 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.011 0.924 . . . . 0.0 109.281 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -153.11 168.45 25.89 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.434 0.694 . . . . 0.0 111.623 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.626 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -153.98 138.47 16.8 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.467 0.651 . . . . 0.0 111.423 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.658 HG21 ' HB2' ' A' ' 73' ' ' ARG . 72.3 mt -127.01 124.76 65.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.069 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.439 HH21 ' HA ' ' A' ' 108' ' ' ASP . 63.1 mtt180 -113.86 178.3 4.33 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 110.849 174.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.0 t90 -67.39 95.36 0.44 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.074 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.8 t 63.01 -173.25 0.16 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.395 1.078 . . . . 0.0 111.869 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.09 -19.54 53.61 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 122.278 -0.264 . . . . 0.0 113.745 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.38 -63.62 0.46 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB3' HG23 ' A' ' 52' ' ' ILE . 38.4 m 62.9 69.77 0.58 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.182 0.993 . . . . 0.0 112.114 170.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.499 ' HA ' HD11 ' A' ' 71' ' ' ILE . 12.4 p -163.9 122.54 1.92 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.45 1.1 . . . . 0.0 109.704 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.553 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 93.8 m-85 -150.15 147.84 28.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.482 1.113 . . . . 0.0 108.603 174.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' CD1' ' HA ' ' A' ' 66' ' ' LYS . 26.3 p90 -164.53 158.04 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.152 0.981 . . . . 0.0 109.649 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.0 157.63 28.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 110.631 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.43 -37.69 88.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.632 0.773 . . . . 0.0 110.985 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -70.2 -16.06 63.02 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.912 0.885 . . . . 0.0 112.635 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 62' ' ' ALA . 31.5 m -125.06 20.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.777 0.831 . . . . 0.0 110.551 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 4.3 ttmp? -48.92 113.55 0.81 Allowed 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.156 1.383 . . . . 0.0 113.072 -175.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.28 -28.91 4.97 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.275 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -71.49 -44.85 63.96 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.546 0.688 . . . . 0.0 109.546 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.62 121.88 28.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.563 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.2 m -134.94 149.8 50.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.388 1.475 . . . . 0.0 107.905 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.632 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.12 152.65 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.636 -177.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 t -151.47 145.23 25.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.608 0.763 . . . . 0.0 110.024 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.658 ' HB2' HG21 ' A' ' 52' ' ' ILE . 28.7 ttt180 -110.57 122.93 48.97 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.5 86.96 2.59 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -79.82 -11.91 59.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.341 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -35.95 73.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.817 0.847 . . . . 0.0 111.831 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.02 1.39 11.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.921 0.488 . . . . 0.0 111.212 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.471 HD21 ' HB3' ' A' ' 30' ' ' PHE . 19.3 m120 57.74 67.49 0.96 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.772 1.229 . . . . 0.0 110.885 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.3 m -139.04 131.76 29.03 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.898 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.4 HG12 ' HE1' ' A' ' 37' ' ' TRP . 20.6 t -108.82 125.02 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.29 134.13 48.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.791 0.436 . . . . 0.0 111.359 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 57.1 tp -115.64 97.14 5.97 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -92.6 98.5 11.48 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.498 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 75.9 mtm -98.25 111.56 23.85 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -100.4 138.37 37.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.6 t 58.56 72.04 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.308 1.043 . . . . 0.0 110.572 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.88 144.68 36.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.605 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -87.0 153.87 54.76 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.24 -18.45 64.94 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.944 1.763 . . . . 0.0 112.654 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.16 3.68 41.78 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.733 0.813 . . . . 0.0 112.134 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.85 26.38 1.82 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.557 0.743 . . . . 0.0 109.971 167.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.524 HG23 HG23 ' A' ' 120' ' ' THR . 95.9 m -83.25 94.0 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 166.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.93 -169.29 2.33 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.71 0.804 . . . . 0.0 110.047 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.0 p -114.84 110.7 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.441 0.697 . . . . 0.0 109.191 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -84.38 153.14 23.62 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.111 0.564 . . . . 0.0 109.683 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.41 147.5 31.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.368 0.667 . . . . 0.0 110.26 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.9 t -88.53 161.62 16.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.775 0.83 . . . . 0.0 109.244 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -122.7 158.22 30.57 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.045 0.538 . . . . 0.0 109.586 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -152.44 167.2 29.52 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.2 1.0 . . . . 0.0 109.515 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.52 -159.91 28.19 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.0 m -124.08 167.73 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.474 0.71 . . . . 0.0 110.221 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -83.31 144.05 29.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.068 0.547 . . . . 0.0 110.47 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HG3' ' H ' ' A' ' 105' ' ' SER . 19.2 tpt180 -90.35 143.01 27.16 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.411 0.684 . . . . 0.0 109.431 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 m -66.88 -20.26 65.88 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.307 0.643 . . . . 0.0 112.598 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.491 ' H ' ' HG3' ' A' ' 103' ' ' ARG . 47.3 t -71.17 -23.09 61.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.795 0.838 . . . . 0.0 111.381 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.28 -1.06 43.55 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.488 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -77.96 148.9 34.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.03 0.932 . . . . 0.0 110.286 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.439 ' HA ' HH21 ' A' ' 53' ' ' ARG . 23.2 t70 -95.07 123.32 38.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.077 0.551 . . . . 0.0 110.011 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.6 p -116.51 104.93 51.03 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 122.999 0.52 . . . . 0.0 110.515 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 15.7 Cg_exo -71.12 97.83 0.78 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.588 2.192 . . . . 0.0 110.198 164.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.47 -42.97 41.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.3 0.64 . . . . 0.0 110.075 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 96.8 m-85 -112.45 160.01 18.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.378 1.071 . . . . 0.0 110.453 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -137.1 165.36 26.24 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.562 1.145 . . . . 0.0 108.878 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -79.27 173.65 55.26 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.446 -175.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 11.7 mm100 -72.7 -19.55 61.38 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.244 0.618 . . . . 0.0 111.394 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.72 99.98 1.7 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 t -99.49 116.74 32.32 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.523 0.729 . . . . 0.0 110.104 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -72.27 112.27 8.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.901 0.881 . . . . 0.0 110.564 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.58 126.6 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.524 HG23 HG23 ' A' ' 92' ' ' THR . 57.1 m -120.5 104.37 9.92 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.69 98.08 7.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.7 t -71.29 146.46 48.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.826 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 m -71.92 86.41 0.99 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.158 0.583 . . . . 0.0 110.225 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 3.3 mm? 57.65 28.27 15.48 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.656 1.183 . . . . 0.0 112.252 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -126.23 165.72 18.41 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.825 0.85 . . . . 0.0 111.034 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -139.22 167.24 22.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.432 1.093 . . . . 0.0 108.808 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -131.69 128.6 39.32 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.117 0.567 . . . . 0.0 110.699 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -86.49 143.42 27.76 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.71 1.204 . . . . 0.0 109.668 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -139.44 99.92 3.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.445 0.698 . . . . 0.0 109.766 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -86.28 146.97 26.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.638 0.775 . . . . 0.0 110.381 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.8 m80 . . . . . 0 C--O 1.247 0.95 0 C-N-CA 123.522 0.729 . . . . 0.0 110.331 -176.95 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -81.78 82.38 7.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.467 0.707 . . . . 0.0 109.768 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.99 113.09 22.45 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -102.13 121.4 42.13 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.704 0.802 . . . . 0.0 110.322 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.691 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.4 mt -110.15 110.83 21.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.232 1.013 . . . . 0.0 109.878 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.3 104.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.691 0.797 . . . . 0.0 109.383 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.94 142.32 27.9 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.69 0.796 . . . . 0.0 111.427 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.8 m -154.62 145.85 22.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.401 1.48 . . . . 0.0 108.844 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.4 -32.91 2.28 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.958 -0.357 . . . . 0.0 112.4 175.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 127.05 43.94 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 123.977 0.457 . . . . 0.0 113.937 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.15 -175.78 36.16 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.302 0.477 . . . . 0.0 112.028 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 120' ' ' THR . 20.7 tp -91.46 120.11 32.01 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.956 0.503 . . . . 0.0 109.934 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 87' ' ' LEU . 27.5 m -125.24 158.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 109.156 170.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.45 152.91 31.88 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -60.82 133.61 56.27 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.507 0.723 . . . . 0.0 110.469 173.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.95 -15.12 64.07 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 123.306 0.379 . . . . 0.0 112.387 -170.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.29 -173.82 49.26 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-O 121.078 0.265 . . . . 0.0 113.657 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.6 p -127.12 154.27 44.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.137 0.975 . . . . 0.0 110.318 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.1 tp -154.82 122.94 5.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -98.14 117.29 32.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 110.505 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -88.77 155.18 19.72 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.12 0.968 . . . . 0.0 109.209 172.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.8 p -151.39 133.95 15.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.987 0.915 . . . . 0.0 109.006 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 46.2 t -131.52 101.96 5.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.624 0.77 . . . . 0.0 109.158 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 t -87.66 127.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 109.68 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.1 96.93 10.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t 43.85 53.44 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.02 1.728 . . . . 0.0 112.69 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.37 -79.03 1.24 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.392 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.565 ' HG2' ' HA ' ' A' ' 77' ' ' LYS . 61.8 mtm-85 -150.37 86.0 1.4 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.046 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 t -141.22 145.16 35.26 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.83 117.51 21.98 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mtp85 -143.01 1.46 1.27 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.73 1.212 . . . . 0.0 109.439 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 91.87 6.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.905 0.882 . . . . 0.0 110.216 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.668 ' HB2' ' HA ' ' A' ' 101' ' ' VAL . 34.0 m-80 -83.76 -26.24 29.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.31 1.044 . . . . 0.0 110.117 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.8 141.93 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.066 1.346 . . . . 0.0 108.076 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.487 ' HE3' HG22 ' A' ' 52' ' ' ILE . 20.9 mtm -151.89 162.06 41.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.121 0.968 . . . . 0.0 109.535 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -168.49 138.62 5.22 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.319 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -92.81 126.36 37.86 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -116.24 147.4 41.52 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 108.515 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.23 142.35 33.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.51 ' HB3' HG13 ' A' ' 94' ' ' VAL . 64.0 tt0 -141.41 128.38 20.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.83 160.78 31.85 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.391 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.73 112.39 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.095 2.53 . . . . 0.0 112.843 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.76 23.39 75.12 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.625 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -125.37 173.19 9.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.781 0.832 . . . . 0.0 110.679 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.18 163.8 26.72 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.481 1.112 . . . . 0.0 111.837 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -92.99 106.79 18.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.874 0.845 . . . . 0.0 109.024 170.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.73 135.84 33.76 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.346 1.059 . . . . 0.0 110.009 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -65.03 120.05 11.91 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.098 1.359 . . . . 0.0 111.31 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.96 -61.47 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.43 0.692 . . . . 0.0 109.162 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -146.65 159.36 43.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.958 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -132.19 141.41 49.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 0.0 111.021 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 73' ' ' ARG . 3.7 mp -112.6 121.3 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.5 mtp-105 -120.55 -175.42 3.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.393 1.077 . . . . 0.0 109.417 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -47.8 163.71 0.05 Allowed 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.48 0.712 . . . . 0.0 112.113 169.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -56.48 126.65 27.46 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.316 0.647 . . . . 0.0 110.202 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.32 -18.12 30.74 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.826 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.42 -128.88 6.01 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.547 -0.585 . . . . 0.0 111.926 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 40.8 m 62.06 52.6 3.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.068 0.947 . . . . 0.0 112.597 172.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.437 ' HA ' HD11 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -158.69 122.25 3.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.164 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 15.9 m-85 -159.16 125.62 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.599 1.56 . . . . 0.0 107.297 170.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -164.62 144.14 7.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.638 0.775 . . . . 0.0 109.649 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 158.46 28.63 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.332 165.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.41 -28.38 69.64 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.4 t -63.48 -34.69 78.32 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.04 0.936 . . . . 0.0 112.224 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 34.1 m -109.52 14.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.425 0.69 . . . . 0.0 111.035 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -71.25 134.31 46.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.868 0.867 . . . . 0.0 109.409 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.11 -0.14 63.82 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.697 0.623 . . . . 0.0 113.243 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 72.7 mtp180 -109.29 -73.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.525 1.13 . . . . 0.0 109.174 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.65 119.66 26.23 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -126.58 129.8 49.26 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.977 0.911 . . . . 0.0 108.801 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -113.37 138.82 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.272 0.558 . . . . 0.0 109.787 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -144.81 149.21 35.05 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.298 1.039 . . . . 0.0 108.775 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.599 ' HB2' HG21 ' A' ' 52' ' ' ILE . 57.7 ttp180 -124.6 129.29 50.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.15 130.01 45.44 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -87.44 -29.91 21.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 111.563 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.25 82.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.529 0.731 . . . . 0.0 112.064 -172.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.45 12.15 15.1 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.655 0.382 . . . . 0.0 111.839 175.083 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 53.76 56.85 6.66 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.093 0.957 . . . . 0.0 112.052 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -126.03 130.63 51.54 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.626 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.09 121.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.856 0.862 . . . . 0.0 109.127 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -102.25 145.38 29.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.622 0.769 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 53.1 tp -125.36 98.03 5.45 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -83.22 101.43 11.23 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.472 ' SD ' HD21 ' A' ' 87' ' ' LEU . 61.4 mtt -84.53 123.75 30.64 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -121.67 146.14 47.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.9 t 57.24 63.14 1.96 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.586 0.708 . . . . 0.0 110.935 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HB3' HG21 ' A' ' 121' ' ' VAL . 35.3 mt -79.66 140.04 37.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.839 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.6 mmmp? -99.15 157.89 33.26 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 108.729 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.67 -22.76 74.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.459 2.106 . . . . 0.0 112.72 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.42 -17.2 64.35 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.705 1.202 . . . . 0.0 112.452 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -81.87 37.84 0.5 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.745 0.818 . . . . 0.0 111.048 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 120' ' ' THR . 90.1 m -91.27 90.86 7.93 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 164.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.3 177.46 6.09 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.51 HG13 ' HB3' ' A' ' 40' ' ' GLN . 4.7 p -107.32 112.85 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.71 0.804 . . . . 0.0 110.173 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -92.01 133.23 35.91 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -122.47 141.51 51.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.058 0.543 . . . . 0.0 109.969 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -91.23 149.47 21.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.75 158.94 43.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.409 0.684 . . . . 0.0 109.566 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.76 169.35 17.77 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 109.811 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.11 -154.97 25.92 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.703 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.668 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 30.5 m -130.98 179.72 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.298 1.039 . . . . 0.0 110.079 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -58.48 149.24 25.73 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.903 0.881 . . . . 0.0 111.079 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -119.7 147.62 44.36 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.557 0.343 . . . . 0.0 110.161 -175.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.0 m -65.28 -20.15 66.28 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.164 0.586 . . . . 0.0 111.153 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.5 m -72.84 -25.33 61.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.043 0.937 . . . . 0.0 111.963 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.94 -23.18 30.3 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 113.832 0.293 . . . . 0.0 113.832 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -79.34 152.66 30.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.106 0.562 . . . . 0.0 110.209 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.57 122.26 17.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.2 m -122.68 127.3 25.83 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 122.785 0.434 . . . . 0.0 111.284 -171.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.83 103.88 1.78 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.77 2.313 . . . . 0.0 112.015 172.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.09 -30.55 55.43 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.36 0.6 . . . . 0.0 109.808 170.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -127.13 153.17 46.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.779 1.232 . . . . 0.0 108.567 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -131.38 157.64 42.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.7 -120.95 0.67 Allowed Glycine 0 C--N 1.336 0.57 0 O-C-N 123.244 0.34 . . . . 0.0 112.696 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -129.05 -15.14 4.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.8 109.97 0.14 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 123.332 0.395 . . . . 0.0 112.641 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.454 HG21 HD12 ' A' ' 21' ' ' LEU . 10.1 t -95.84 128.15 42.48 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.644 0.735 . . . . 0.0 110.798 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -79.36 108.86 13.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.47 136.27 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 92' ' ' THR . 31.3 m -133.9 129.34 36.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 87' ' ' LEU . 46.3 t -113.66 108.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 125' ' ' GLU . 20.8 m -60.88 141.64 56.98 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.939 0.495 . . . . 0.0 111.934 167.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 m -74.66 90.74 2.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.464 0.705 . . . . 0.0 110.964 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.8 mm? 61.16 15.44 6.33 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.486 1.114 . . . . 0.0 112.943 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.574 ' HB2' ' HB3' ' A' ' 122' ' ' SER . 44.6 mt-10 -82.19 -91.82 0.07 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 117.865 0.302 . . . . 0.0 111.555 -174.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -148.37 152.4 36.95 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.23 0.612 . . . . 0.0 111.09 -170.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -96.8 153.52 17.83 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 160.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -73.21 128.97 36.99 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -67.26 103.39 1.24 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.734 0.414 . . . . 0.0 110.282 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.6 m80 60.27 -159.91 0.3 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.877 1.271 . . . . 0.0 111.443 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 . . . . . 0 CA--C 1.556 1.192 0 CA-C-O 118.959 -0.543 . . . . 0.0 111.093 175.011 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 63.43 -163.42 0.27 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.646 1.178 . . . . 0.0 111.707 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.73 111.04 7.51 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -103.07 132.32 49.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.672 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 70.3 mt -121.86 120.22 33.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 52.4 t -95.76 99.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 51.9 mt-10 -95.34 123.92 39.11 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.678 -172.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 m -130.91 154.38 48.16 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.617 1.167 . . . . 0.0 109.769 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.23 11.67 35.87 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.015 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.57 74.65 1.5 Allowed Glycine 0 C--N 1.35 1.355 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.37 -164.17 13.68 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 120' ' ' THR . 6.5 tt -116.86 127.54 54.39 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.82 161.13 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.144 0.978 . . . . 0.0 109.007 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -80.67 158.27 25.66 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.212 0.605 . . . . 0.0 110.768 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.23 114.49 2.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.772 0.829 . . . . 0.0 110.539 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.99 -25.53 10.69 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.959 0.79 . . . . 0.0 112.01 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.67 164.63 54.82 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 113.725 0.25 . . . . 0.0 113.725 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.6 p -104.64 155.46 18.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.988 0.915 . . . . 0.0 110.38 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.2 tp -152.76 136.84 16.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.114 0.966 . . . . 0.0 108.464 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.062 0.545 . . . . 0.0 110.043 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -101.07 157.51 16.7 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.297 1.039 . . . . 0.0 108.899 174.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -144.89 127.27 15.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -127.79 105.37 8.39 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.542 0.737 . . . . 0.0 110.445 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.47 130.04 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.88 98.06 11.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.726 0.298 . . . . 0.0 110.374 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 5.6 m 56.9 29.12 15.66 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.329 1.451 . . . . 0.0 112.917 170.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.18 50.77 5.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -173.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 69.68 24.42 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.629 1.172 . . . . 0.0 113.092 171.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 32.7 p -87.8 153.24 21.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.889 0.476 . . . . 0.0 110.271 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -110.67 123.16 49.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.791 0.836 . . . . 0.0 109.76 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -145.95 -50.27 0.23 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.672 1.189 . . . . 0.0 108.168 167.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -73.52 103.72 4.24 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.942 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -88.97 -13.96 37.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.794 0.838 . . . . 0.0 110.033 167.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.58 43.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.784 1.234 . . . . 0.0 108.3 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtm -148.9 167.15 26.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.007 . . . . 0.0 109.157 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.61 148.79 8.91 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.715 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 95.4 m95 -89.51 136.25 33.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.25 164.78 18.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.42 1.088 . . . . 0.0 108.447 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -128.47 148.02 50.71 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.41 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 35.5 tt0 -155.07 144.67 21.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.546 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -108.82 152.56 42.38 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 171.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 110.71 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.706 2.27 . . . . 0.0 112.506 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.07 43.96 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.449 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 9.1 mmpt? -119.78 170.62 9.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.086 0.955 . . . . 0.0 110.57 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.28 163.44 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.655 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.499 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.56 123.36 31.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.6 137.59 32.71 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 0.0 109.673 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 80.7 t80 -69.09 119.72 13.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.13 0.972 . . . . 0.0 110.431 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.51 -54.68 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.293 0.637 . . . . 0.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . . . -139.9 164.9 28.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.588 -171.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . . . -145.09 131.86 20.04 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.377 0.671 . . . . 0.0 110.846 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -110.79 127.24 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.767 1.227 . . . . 0.0 109.375 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.47 ' HG3' ' HZ2' ' A' ' 102' ' ' TRP . 3.2 mpt_? -119.03 179.01 4.29 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.252 1.421 . . . . 0.0 109.408 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -66.02 -170.35 0.08 Allowed 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.994 0.918 . . . . 0.0 111.975 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.8 m -53.91 114.62 1.64 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.713 1.205 . . . . 0.0 112.439 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.48 16.78 28.4 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.465 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.6 -137.3 4.22 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.8 m 65.57 63.45 0.62 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.613 1.165 . . . . 0.0 112.236 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.467 ' HA ' HD11 ' A' ' 71' ' ' ILE . 2.5 p -150.59 122.2 8.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.261 1.025 . . . . 0.0 109.211 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.24 127.05 0.82 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -165.82 167.04 17.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.544 0.738 . . . . 0.0 110.086 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.34 145.56 33.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 168.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.77 -28.1 69.64 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.851 0.358 . . . . 0.0 110.966 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 m -70.92 -26.62 63.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.61 0.764 . . . . 0.0 112.214 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 62' ' ' ALA . 18.7 m -104.58 4.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 122.872 0.469 . . . . 0.0 111.43 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.76 116.05 3.2 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.463 1.105 . . . . 0.0 112.501 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.72 11.81 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.986 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -87.25 -57.24 3.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.516 0.726 . . . . 0.0 109.263 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -87.77 122.1 31.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -146.74 153.68 40.52 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.049 1.34 . . . . 0.0 108.63 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -124.92 156.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.59 0.756 . . . . 0.0 109.915 176.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -151.75 136.77 17.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.778 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.7 ttp85 -110.37 136.28 49.79 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -109.03 122.26 46.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -87.59 -23.85 24.18 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.053 0.541 . . . . 0.0 111.0 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.35 84.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.377 0.671 . . . . 0.0 111.875 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 17.1 12.53 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.51 0.324 . . . . 0.0 111.841 172.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 48.72 56.37 7.74 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.237 1.015 . . . . 0.0 112.191 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.1 m -130.07 130.72 45.24 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.422 HG12 ' HE1' ' A' ' 37' ' ' TRP . 86.9 t -109.65 125.53 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.901 0.88 . . . . 0.0 109.89 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -102.45 146.59 27.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.739 0.815 . . . . 0.0 110.388 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.3 tp -124.53 101.48 7.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.111 0.964 . . . . 0.0 108.685 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -91.55 101.18 13.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.369 0.668 . . . . 0.0 109.995 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.419 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 55.7 mtm -107.84 107.61 18.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.376 0.67 . . . . 0.0 110.118 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -106.91 147.94 29.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.303 0.641 . . . . 0.0 109.908 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.4 t 61.71 60.63 1.57 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.117 0.967 . . . . 0.0 110.067 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' A' ' 121' ' ' VAL . 42.9 mt -76.13 151.12 37.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.28 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -110.7 157.11 39.36 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.392 1.077 . . . . 0.0 109.046 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 27.3 Cg_endo -59.14 -26.14 80.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.56 2.174 . . . . 0.0 113.145 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.14 -17.3 64.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.002 0.921 . . . . 0.0 112.326 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.06 15.65 1.44 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.643 0.777 . . . . 0.0 111.193 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.52 HG23 HG23 ' A' ' 120' ' ' THR . 85.6 m -81.4 89.95 6.15 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 163.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.05 -166.07 0.77 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.491 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 p -115.23 112.93 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.195 0.598 . . . . 0.0 110.362 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -85.05 130.74 34.56 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 96' ' ' LEU . 1.6 pt? -130.3 125.04 33.77 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.504 0.721 . . . . 0.0 109.292 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.1 p -88.85 138.66 31.22 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -111.88 152.04 28.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.295 1.038 . . . . 0.0 109.823 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 5' ' ' LEU . . . -130.0 167.68 17.89 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.614 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.77 -168.88 39.85 Favored Glycine 0 C--O 1.236 0.274 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.6 145.74 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.602 0.761 . . . . 0.0 109.254 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.47 ' HZ2' ' HG3' ' A' ' 53' ' ' ARG . 83.1 m95 -59.61 117.03 4.45 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.618 0.767 . . . . 0.0 110.26 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.471 ' HD3' ' N ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -75.47 149.51 38.47 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 123.991 0.807 . . . . 0.0 108.943 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.471 ' N ' ' HD3' ' A' ' 103' ' ' ARG . 33.6 m -55.75 -19.92 12.89 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.539 1.135 . . . . 0.0 113.356 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.7 p -67.77 -24.2 65.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.305 1.042 . . . . 0.0 112.205 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.57 9.85 45.7 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.218 -174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -94.26 132.47 38.8 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.701 0.801 . . . . 0.0 110.531 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.41 92.25 2.81 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 166.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.9 p -95.48 107.05 30.53 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 123.286 0.634 . . . . 0.0 110.598 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 84.6 Cg_endo -81.52 86.68 1.55 Allowed 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.701 2.267 . . . . 0.0 110.054 170.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.2 -27.55 60.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.126 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -112.45 150.1 31.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 109.776 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -130.85 145.96 52.15 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -70.76 -79.39 0.37 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 123.527 0.517 . . . . 0.0 113.247 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -164.11 -40.31 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.771 0.828 . . . . 0.0 109.815 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.9 119.49 4.54 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.119 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 6.2 t -96.56 111.62 23.68 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.596 0.713 . . . . 0.0 109.622 174.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -70.45 98.56 1.45 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.513 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.02 132.79 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 10.8 m -128.1 106.21 8.91 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 87' ' ' LEU . 42.6 t -106.49 97.82 6.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 121.65 -0.656 . . . . 0.0 109.462 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.412 ' CB ' HD21 ' A' ' 12' ' ' LEU . 28.1 t -70.6 129.17 38.49 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.878 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 89' ' ' PRO . 43.8 t -59.93 98.23 0.05 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.499 0.72 . . . . 0.0 110.743 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 77.94 -43.24 0.38 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.83 1.652 . . . . 0.0 113.288 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.66 152.33 43.98 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.869 0.468 . . . . 0.0 110.995 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -92.11 -164.42 1.18 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.621 0.768 . . . . 0.0 110.345 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.49 ' HA ' HD22 ' A' ' 12' ' ' LEU . 57.8 t60 -47.5 -58.0 4.72 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.261 1.025 . . . . 0.0 113.673 -168.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 64.59 121.76 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.856 1.262 . . . . 0.0 112.329 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -78.23 155.23 30.42 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.823 0.449 . . . . 0.0 110.762 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -135.71 170.92 15.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.075 0.95 . . . . 0.0 109.286 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.7 t60 . . . . . 0 CA--C 1.562 1.411 0 C-N-CA 124.772 1.229 . . . . 0.0 110.578 -176.973 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtm . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -134.18 112.39 11.06 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.14 112.63 17.64 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 37.8 mt-30 -104.02 121.66 43.63 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.317 0.647 . . . . 0.0 109.568 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.582 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.6 mt -120.08 107.17 12.73 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.66 102.56 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.69 146.69 23.98 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.453 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 p -159.18 177.77 10.72 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.169 0.988 . . . . 0.0 109.788 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.8 -0.28 87.86 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.858 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 142.86 29.65 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.968 0.384 . . . . 0.0 112.478 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.66 -168.76 39.0 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.1 tt -99.73 130.3 45.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.348 0.659 . . . . 0.0 109.631 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.72 149.83 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.742 0.817 . . . . 0.0 109.258 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HB2' HD13 ' A' ' 124' ' ' LEU . 4.3 pm0 -70.17 146.92 50.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.827 0.451 . . . . 0.0 110.498 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.94 135.18 55.37 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.394 0.678 . . . . 0.0 110.868 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.08 6.2 72.06 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.068 -168.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.95 -169.83 27.36 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 122.896 0.284 . . . . 0.0 112.851 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 p -129.28 153.26 47.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.635 0.774 . . . . 0.0 110.57 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.5 tp -149.72 125.09 10.2 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -108.38 109.99 21.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.453 0.701 . . . . 0.0 110.216 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -87.55 153.8 21.12 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.209 1.004 . . . . 0.0 109.947 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 m -143.48 130.96 21.07 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.5 0.72 . . . . 0.0 109.407 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 47.8 t -124.78 105.93 9.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.19 0.996 . . . . 0.0 109.45 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.25 123.46 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.139 0.575 . . . . 0.0 109.464 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.44 97.39 11.15 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.026 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.454 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 21.4 t 55.7 33.36 21.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.827 1.251 . . . . 0.0 112.341 171.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.45 -88.92 0.61 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.436 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -125.81 -0.63 7.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.736 0.814 . . . . 0.0 111.532 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -77.3 126.09 30.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -105.32 124.87 50.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.066 0.946 . . . . 0.0 109.345 -170.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.1 mtt85 -165.11 175.55 9.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.116 0.967 . . . . 0.0 110.169 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t 66.25 104.89 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 O-C-N 125.176 1.547 . . . . 0.0 110.798 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.23 -28.98 67.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.708 0.803 . . . . 0.0 112.593 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB2' ' HG3' ' A' ' 53' ' ' ARG . . . -126.21 149.55 48.96 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.582 0.753 . . . . 0.0 109.592 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.0 mtt -144.9 122.38 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -118.18 -173.87 16.2 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 123.487 0.492 . . . . 0.0 113.222 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -132.87 143.75 49.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.116 0.967 . . . . 0.0 109.26 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.09 172.07 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.69 1.596 . . . . 0.0 107.65 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -139.35 123.73 18.16 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.056 0.455 . . . . 0.0 110.367 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.494 ' HB3' HG13 ' A' ' 94' ' ' VAL . 65.0 tp60 -101.58 135.23 43.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.624 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -122.58 137.83 28.43 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.048 0.939 . . . . 0.0 109.229 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -66.26 118.08 5.22 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.72 2.28 . . . . 0.0 111.717 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.73 0.4 59.11 Favored Glycine 0 N--CA 1.474 1.184 0 O-C-N 123.044 0.215 . . . . 0.0 112.656 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 5.5 mmpt? -135.61 172.89 12.36 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.155 . . . . 0.0 110.141 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.17 156.92 16.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.053 0.941 . . . . 0.0 109.922 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 125.92 28.16 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.456 0.646 . . . . 0.0 110.803 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -93.38 138.29 31.86 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.618 1.167 . . . . 0.0 109.29 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -69.18 115.24 8.24 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.742 0.652 . . . . 0.0 109.781 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.9 t -94.32 -53.1 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.409 0.683 . . . . 0.0 110.03 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -156.1 169.6 24.12 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -168.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.426 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -158.99 132.29 7.24 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 110.306 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -116.34 116.16 51.38 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HG3' ' HB2' ' A' ' 34' ' ' ALA . 28.7 ttt-85 -117.47 144.71 44.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -65.21 -13.66 58.79 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.624 0.769 . . . . 0.0 111.509 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 m -74.56 -2.61 26.66 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.7 0.8 . . . . 0.0 112.151 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.09 -16.89 32.49 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.694 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.26 72.54 1.65 Allowed Glycine 0 C--N 1.351 1.4 0 C-N-CA 122.885 0.278 . . . . 0.0 112.465 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 49.9 m -106.4 29.72 6.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.314 1.046 . . . . 0.0 111.97 -169.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.9 m -158.53 121.93 3.87 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.605 0.362 . . . . 0.0 111.274 -170.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.478 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 68.4 m-85 -156.52 135.53 11.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.876 1.67 . . . . 0.0 107.66 171.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -165.4 164.55 19.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.227 1.011 . . . . 0.0 110.263 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.16 160.89 30.58 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.705 0.402 . . . . 0.0 111.092 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.61 -36.05 81.66 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.425 0.69 . . . . 0.0 111.76 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.2 p -69.15 -36.09 77.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.294 0.638 . . . . 0.0 111.622 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.401 HG12 HH21 ' A' ' 68' ' ' ARG . 20.3 m -97.74 15.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.5 0.72 . . . . 0.0 111.634 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.15 114.23 2.51 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.325 1.05 . . . . 0.0 112.009 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.81 -19.75 35.85 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.588 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.401 HH21 HG12 ' A' ' 65' ' ' VAL . 15.1 mtm180 -80.84 -48.52 12.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -85.21 123.5 30.78 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.131 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -130.55 134.48 47.06 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.579 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -129.37 143.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 110.609 -176.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -150.05 169.5 21.08 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.279 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' HB3' HG21 ' A' ' 52' ' ' ILE . 77.0 ttt180 -147.76 131.44 16.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -122.47 106.14 10.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.293 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -72.51 -11.57 60.72 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.728 0.811 . . . . 0.0 110.844 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.18 79.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.419 1.087 . . . . 0.0 111.878 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.02 7.97 12.39 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.924 0.489 . . . . 0.0 111.406 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 53.59 67.28 1.03 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.448 1.099 . . . . 0.0 110.807 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -148.74 132.73 17.17 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.24 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 73' ' ' ARG . 21.5 t -103.68 136.13 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.518 1.127 . . . . 0.0 108.072 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.41 146.11 44.69 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.977 0.418 . . . . 0.0 111.34 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.7 tp -127.86 98.61 5.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.691 1.197 . . . . 0.0 108.081 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -93.21 100.14 12.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 109.187 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.436 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 56.7 mtm -104.25 103.24 12.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.896 0.478 . . . . 0.0 110.082 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -102.54 153.35 20.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.637 0.775 . . . . 0.0 109.581 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.5 t 58.13 48.96 12.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.172 0.989 . . . . 0.0 110.698 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 84' ' ' MET . 29.3 mt -68.99 133.49 48.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.114 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . 37.7 mtmt -92.06 157.24 41.35 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.104 0.962 . . . . 0.0 109.059 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.06 -23.77 78.07 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.11 1.873 . . . . 0.0 112.608 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.92 -11.4 60.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.276 1.03 . . . . 0.0 112.385 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -84.67 33.28 0.52 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.634 0.773 . . . . 0.0 110.656 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.7 m -88.1 98.19 11.4 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.59 -166.66 1.39 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.649 0.78 . . . . 0.0 109.322 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.8 p -117.05 109.52 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.66 131.39 35.21 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.25 143.06 47.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.117 0.567 . . . . 0.0 110.529 -173.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -89.04 158.16 18.09 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.781 0.833 . . . . 0.0 109.75 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.02 152.48 49.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.968 0.907 . . . . 0.0 109.255 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -118.36 120.59 38.06 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 110' ' ' PRO . . . -116.65 147.0 18.92 Favored Glycine 0 C--O 1.244 0.744 0 O-C-N 123.645 0.591 . . . . 0.0 111.918 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.0 m -136.99 140.16 43.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.749 1.219 . . . . 0.0 109.01 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -63.18 117.55 6.7 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.506 ' HD3' ' H ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -102.17 153.29 20.09 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.044 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.506 ' H ' ' HD3' ' A' ' 103' ' ' ARG . 54.6 p -65.99 -13.16 59.36 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.991 0.916 . . . . 0.0 111.984 174.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.7 m -67.19 -24.45 65.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.75 0.82 . . . . 0.0 111.075 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.07 -30.2 8.54 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.515 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 22.7 m-90 -83.81 146.4 28.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.082 0.553 . . . . 0.0 109.877 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.44 92.34 7.55 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 35.7 p -77.25 121.08 84.0 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.116 -170.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.438 ' HA ' ' HA2' ' A' ' 100' ' ' GLY . 1.9 Cg_endo -77.35 72.71 5.85 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.033 2.489 . . . . 0.0 109.301 175.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.35 -35.74 80.06 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.866 0.867 . . . . 0.0 111.661 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.557 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 80.8 m-85 -111.73 152.82 27.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.458 0.703 . . . . 0.0 110.131 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -134.13 160.05 38.97 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.342 1.057 . . . . 0.0 108.692 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.28 -151.97 6.6 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.877 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 6.72 28.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.235 0.614 . . . . 0.0 110.651 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.35 163.48 28.68 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 113.129 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 t -140.59 115.64 9.79 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -68.7 122.79 19.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.58 0.752 . . . . 0.0 111.011 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.93 136.16 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.9 m -134.04 103.58 5.86 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 87' ' ' LEU . 25.5 t -87.95 101.16 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.6 p -56.9 141.41 45.15 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.425 0.69 . . . . 0.0 111.413 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.3 p -85.11 59.27 5.53 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.459 0.704 . . . . 0.0 110.65 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 14' ' ' GLN . 3.2 mm? 58.59 34.82 24.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.316 1.046 . . . . 0.0 110.957 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -76.67 -87.52 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.154 0.582 . . . . 0.0 111.769 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -139.31 26.91 2.35 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.975 0.51 . . . . 0.0 111.368 -171.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -75.87 97.99 4.08 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -56.89 109.88 0.71 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.04 0.838 . . . . 0.0 111.195 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -82.92 168.89 16.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.777 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -141.48 140.26 33.5 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.534 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 175.077 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.6 mtp . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 121.168 0.509 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -107.78 125.22 51.15 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 113.69 15.24 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -103.95 142.44 34.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.182 0.993 . . . . 0.0 109.924 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.617 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 82.6 mt -132.36 129.08 38.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.231 1.013 . . . . 0.0 109.336 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 68.0 t -119.5 102.39 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.195 0.598 . . . . 0.0 109.689 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.66 151.31 25.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.42 0.688 . . . . 0.0 110.669 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 p -155.19 146.45 22.82 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.241 1.016 . . . . 0.0 109.308 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.01 0.59 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.709 0.671 . . . . 0.0 111.504 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.39 121.79 7.29 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.387 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.02 -178.24 48.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 122' ' ' SER . 19.3 tp -94.21 128.26 40.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.93 166.34 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.992 . . . . 0.0 108.949 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -85.84 151.94 23.4 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.918 0.487 . . . . 0.0 111.206 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.48 113.05 2.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.902 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.22 0.02 28.22 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -178.43 46.37 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 113.805 0.282 . . . . 0.0 113.805 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 m -108.68 159.99 16.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.495 1.118 . . . . 0.0 109.233 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 tp -160.69 116.84 2.3 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -99.49 109.18 21.75 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 117' ' ' THR . 3.1 mm? -86.91 140.71 29.35 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 p -140.37 125.45 18.53 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.795 0.838 . . . . 0.0 109.336 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -124.54 115.47 20.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.053 0.941 . . . . 0.0 109.421 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.07 129.56 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.05 103.23 15.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.167 0.987 . . . . 0.0 110.53 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 p 51.8 53.24 12.97 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.098 1.759 . . . . 0.0 112.93 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.86 -74.3 1.83 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.893 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -165.61 39.01 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 122.27 1.033 . . . . 0.0 108.471 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.0 m -103.95 147.52 27.25 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.297 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -105.84 121.41 44.0 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -167.31 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.609 0.764 . . . . 0.0 110.291 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -65.98 95.61 0.28 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.391 0.676 . . . . 0.0 109.756 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.52 -35.08 25.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.297 0.639 . . . . 0.0 110.212 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.67 121.68 31.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.7 0.8 . . . . 0.0 109.219 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.431 ' HG2' HG21 ' A' ' 80' ' ' VAL . 2.9 mpp? -123.75 163.18 21.67 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.397 1.479 . . . . 0.0 108.682 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -157.57 135.92 4.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.56 121.8 36.48 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.5 160.96 24.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -139.67 133.47 30.64 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -98.23 128.74 44.85 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -94.33 141.56 23.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 122.765 0.426 . . . . 0.0 110.219 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.42 101.73 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.651 2.234 . . . . 0.0 111.462 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.95 2.74 60.89 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.93 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 7.5 mmpt? -139.51 152.49 46.98 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.708 0.803 . . . . 0.0 110.276 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.19 163.27 10.51 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.418 1.087 . . . . 0.0 111.531 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.58 149.74 43.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.205 0.526 . . . . 0.0 111.373 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -120.18 134.44 55.26 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.184 0.994 . . . . 0.0 109.501 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -72.31 111.14 7.25 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.291 1.036 . . . . 0.0 109.055 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.6 t -88.57 -53.67 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.467 0.707 . . . . 0.0 110.002 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.88 165.23 37.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.677 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.419 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -150.4 127.61 11.29 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 124.096 0.959 . . . . 0.0 109.823 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.9 mp -110.22 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.31 127.81 53.55 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -72.82 82.46 1.18 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 t -162.77 21.14 0.09 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.34 1.056 . . . . 0.0 109.817 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.88 32.34 33.04 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.649 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.87 -91.56 0.78 Allowed Glycine 0 C--N 1.355 1.604 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 68.4 m 63.16 35.21 12.94 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.684 1.194 . . . . 0.0 113.999 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -157.91 122.02 4.16 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.3 0.64 . . . . 0.0 110.16 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -152.83 122.87 7.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.07 1.348 . . . . 0.0 108.194 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -164.73 161.75 20.8 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.656 1.182 . . . . 0.0 109.126 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -81.53 151.74 27.61 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.21 -28.9 69.1 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.075 0.464 . . . . 0.0 110.75 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 p -66.85 -25.62 66.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.246 1.018 . . . . 0.0 111.887 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.518 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 22.9 m -114.45 13.78 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.332 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 122.67 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.36 0.664 . . . . 0.0 110.476 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.17 -27.32 9.39 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.757 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.518 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 24.3 mtp180 -78.45 -52.67 8.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.78 1.232 . . . . 0.0 108.762 175.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -104.02 121.97 44.28 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.984 1.314 . . . . 0.0 107.787 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -135.72 151.39 50.11 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.442 1.097 . . . . 0.0 108.916 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.94 148.5 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.714 0.806 . . . . 0.0 110.206 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.8 m -153.03 172.2 17.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.13 0.972 . . . . 0.0 109.354 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -148.3 139.72 23.51 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.12 100.13 6.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.852 1.261 . . . . 0.0 108.585 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -71.1 -13.22 61.89 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.753 0.821 . . . . 0.0 111.167 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.35 64.56 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.409 1.084 . . . . 0.0 111.744 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -121.26 1.33 10.23 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.704 0.802 . . . . 0.0 111.513 173.032 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 60.75 68.94 0.71 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.649 1.18 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -142.26 133.33 25.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.642 0.777 . . . . 0.0 109.769 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.431 HG21 ' HG2' ' A' ' 35' ' ' MET . 23.2 t -101.18 133.65 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 108.327 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.78 148.41 34.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.52 0.728 . . . . 0.0 111.659 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 47.8 tp -132.91 99.57 4.63 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -84.19 99.5 10.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.744 ' HB3' HD21 ' A' ' 87' ' ' LEU . 74.1 mtp -87.56 136.41 32.96 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.86 160.59 41.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.767 0.827 . . . . 0.0 108.81 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.2 t 58.46 48.25 12.42 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.517 1.135 . . . . 0.0 109.016 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 84' ' ' MET . 70.4 mt -72.3 138.76 47.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.726 -166.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.494 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 14.1 mmmm -92.4 153.06 42.76 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 124.077 0.951 . . . . 0.0 108.904 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.494 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 19.5 Cg_endo -59.92 -20.79 61.67 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.644 2.229 . . . . 0.0 113.054 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -80.78 1.78 29.02 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.859 0.864 . . . . 0.0 112.151 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -87.98 24.95 1.66 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.631 0.772 . . . . 0.0 110.318 166.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 120' ' ' THR . 52.0 m -81.6 105.59 12.88 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 161.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.68 177.64 6.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.952 0.901 . . . . 0.0 110.494 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.08 107.05 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -83.89 115.22 22.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.372 0.669 . . . . 0.0 109.207 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.14 143.79 36.42 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -91.62 144.6 25.37 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 170.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -133.05 157.69 44.63 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.386 0.675 . . . . 0.0 109.445 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.55 12.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.529 0.731 . . . . 0.0 109.731 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.85 -151.13 5.43 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.94 146.85 14.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 C-N-CA 123.388 0.675 . . . . 0.0 110.044 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.476 ' HE3' ' HB2' ' A' ' 108' ' ' ASP . 42.7 t-105 -68.21 107.27 2.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -76.39 169.31 18.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.109 0.564 . . . . 0.0 111.922 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.5 m -65.77 -26.36 67.68 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.679 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.7 p -69.99 -15.17 62.99 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.056 0.942 . . . . 0.0 111.53 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.36 2.67 67.85 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.801 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -95.24 110.99 22.9 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.334 0.654 . . . . 0.0 110.183 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.476 ' HB2' ' HE3' ' A' ' 102' ' ' TRP . 27.6 t70 -79.43 105.6 10.86 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 168.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.4 p -136.67 139.03 28.02 Favored Pre-proline 0 C--O 1.244 0.775 0 C-N-CA 123.614 0.766 . . . . 0.0 110.064 -171.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.477 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 58.3 Cg_endo -69.72 128.78 16.55 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.802 2.335 . . . . 0.0 112.779 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.25 -34.26 14.33 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.034 0.934 . . . . 0.0 109.757 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -117.85 152.41 35.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.461 1.104 . . . . 0.0 109.339 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.09 157.35 47.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.22 1.008 . . . . 0.0 108.817 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.7 -147.73 15.39 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.829 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -94.05 -34.42 13.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.616 0.766 . . . . 0.0 111.541 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.22 116.04 1.27 Allowed Glycine 0 C--N 1.345 1.04 0 N-CA-C 111.879 -0.489 . . . . 0.0 111.879 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.525 HG21 HD12 ' A' ' 21' ' ' LEU . 7.0 t -99.79 118.39 36.16 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.632 0.773 . . . . 0.0 110.402 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.16 106.43 5.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.008 0.923 . . . . 0.0 110.514 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.91 139.89 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 92' ' ' THR . 43.5 m -135.25 118.58 16.72 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.0 103.4 14.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.571 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.5 t -66.37 140.8 58.1 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 123.293 0.371 . . . . 0.0 110.684 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -70.63 101.26 2.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 109.799 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 79.35 -51.87 0.42 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.785 1.634 . . . . 0.0 111.295 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -75.3 171.05 14.89 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.997 0.919 . . . . 0.0 111.808 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -168.16 42.38 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.223 1.409 . . . . 0.0 107.974 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -62.71 -44.89 95.06 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.448 -172.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -84.33 141.18 31.09 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 162.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -163.23 144.26 9.43 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.94 0.896 . . . . 0.0 108.855 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 58.48 41.85 22.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -167.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.556 1.185 0 C-N-CA 125.184 1.394 . . . . 0.0 109.834 -169.087 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 ttm . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -128.34 149.31 50.57 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.836 0.854 . . . . 0.0 109.121 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -75.59 109.94 9.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -102.96 143.42 32.56 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.68 1.192 . . . . 0.0 109.337 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.681 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.8 mt -130.46 113.98 14.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.097 0.959 . . . . 0.0 109.069 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.46 104.72 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' HG2' ' HB ' ' A' ' 117' ' ' THR . 78.2 tt0 -104.69 135.65 45.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.304 -166.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 p -163.2 -177.37 5.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.101 0.96 . . . . 0.0 110.264 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.0 5.74 57.25 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 112.547 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.38 148.23 21.97 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.714 0.257 . . . . 0.0 112.719 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.91 -174.04 45.44 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.7 tt -93.29 129.57 39.32 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.45 157.25 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.956 0.903 . . . . 0.0 108.787 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.619 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -81.33 149.59 28.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.09 0.556 . . . . 0.0 110.286 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.62 123.57 19.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.678 1.191 . . . . 0.0 111.47 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.35 -25.94 11.77 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -172.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.34 -166.77 32.65 Favored Glycine 0 C--N 1.35 1.321 0 C-N-CA 123.194 0.426 . . . . 0.0 114.13 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -134.97 160.32 38.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.065 0.946 . . . . 0.0 110.438 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -154.29 131.29 10.95 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.63 0.772 . . . . 0.0 109.208 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -102.49 127.11 49.68 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.106 0.562 . . . . 0.0 110.531 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -98.65 157.56 16.18 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.462 1.105 . . . . 0.0 109.207 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.8 p -148.83 126.88 11.99 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.47 0.708 . . . . 0.0 109.405 -175.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.2 t -128.05 106.13 8.86 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.81 0.844 . . . . 0.0 109.1 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.42 120.71 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.507 0.723 . . . . 0.0 109.301 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.08 100.76 13.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.937 0.495 . . . . 0.0 110.87 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.639 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 10.9 m 54.67 37.04 27.51 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.267 1.427 . . . . 0.0 112.183 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.66 -68.31 3.29 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.849 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 52.6 ttp180 -164.91 63.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 85.0 m -138.53 146.3 41.75 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.204 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -129.48 141.89 50.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 109.039 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -156.01 -50.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.926 0.89 . . . . 0.0 109.846 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -73.77 119.54 18.13 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.84 0.352 . . . . 0.0 110.101 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -78.63 -3.0 41.75 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.534 0.734 . . . . 0.0 111.028 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.98 41.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.383 0.673 . . . . 0.0 109.272 171.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 68.3 mtt -143.53 121.1 11.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.62 174.15 22.76 Favored Glycine 0 C--N 1.335 0.526 0 O-C-N 123.072 0.233 . . . . 0.0 113.341 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.505 ' HE1' HG12 ' A' ' 80' ' ' VAL . 85.7 m95 -110.98 133.68 53.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.857 0.863 . . . . 0.0 109.68 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -119.53 171.89 8.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.274 1.43 . . . . 0.0 107.486 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 40.1 ptt180 -143.42 127.76 17.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.044 0.449 . . . . 0.0 110.465 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -109.63 129.79 55.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -103.17 157.95 32.76 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.762 -0.637 . . . . 0.0 109.893 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.8 96.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.777 2.318 . . . . 0.0 113.326 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.69 -11.5 52.23 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.092 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 8.8 mmpt? -103.12 137.87 40.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.518 0.727 . . . . 0.0 109.496 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.25 149.92 23.04 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 146.27 22.09 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.38 1.072 . . . . 0.0 112.291 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -136.2 133.22 36.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 109.892 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.46 115.55 7.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.952 0.901 . . . . 0.0 110.781 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.54 -55.19 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.404 0.681 . . . . 0.0 109.417 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB3' HG21 ' A' ' 71' ' ' ILE . . . -167.42 173.91 8.39 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.097 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.53 158.95 27.24 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 122.267 1.032 . . . . 0.0 112.467 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -117.7 116.48 51.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 113.472 -1.694 . . . . 0.0 106.968 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.413 ' HG2' ' HE2' ' A' ' 60' ' ' TYR . 29.2 mmt180 -93.97 88.59 5.76 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 23.9 t90 63.95 -82.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.673 1.189 . . . . 0.0 110.478 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.2 p -165.29 166.29 18.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.286 1.034 . . . . 0.0 109.954 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.92 29.36 61.02 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.11 0.256 . . . . 0.0 113.599 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.04 -80.33 0.04 OUTLIER Glycine 0 C--N 1.348 1.197 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 22.8 t 60.2 40.74 17.72 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.386 1.074 . . . . 0.0 111.91 169.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.6 ' HA ' HD11 ' A' ' 71' ' ' ILE . 3.8 p -158.01 123.89 4.63 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.917 0.487 . . . . 0.0 111.034 -170.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HE2' ' HG2' ' A' ' 53' ' ' ARG . 69.6 m-85 -150.25 113.16 4.8 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 166.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.07 143.27 7.71 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.683 0.393 . . . . 0.0 110.71 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.28 159.0 31.0 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 168.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 31.2 t70 -60.9 -28.19 68.72 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.062 0.545 . . . . 0.0 111.147 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 m -65.98 -33.57 76.11 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.927 0.891 . . . . 0.0 112.087 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -109.22 -5.64 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.291 0.636 . . . . 0.0 111.877 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 25.5 ttpp -72.54 133.53 44.8 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 109.909 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.46 7.28 Favored Glycine 0 C--N 1.342 0.905 0 O-C-N 123.423 0.452 . . . . 0.0 112.053 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 69.7 mtp180 -80.64 -66.71 0.85 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -92.01 120.67 32.86 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.789 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 m -125.16 127.48 46.89 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.295 1.038 . . . . 0.0 108.213 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.6 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -125.07 140.97 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.122 0.569 . . . . 0.0 110.489 -174.345 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.444 ' HA ' ' OG ' ' A' ' 58' ' ' SER . 45.0 t -162.99 157.86 21.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.599 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -133.97 124.87 27.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.575 0.75 . . . . 0.0 109.364 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -103.37 122.02 43.98 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -76.8 -12.29 59.95 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.0 -48.78 67.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.618 1.167 . . . . 0.0 111.811 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 -0.06 11.0 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.13 175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 19.8 m120 53.37 68.12 0.89 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.396 1.079 . . . . 0.0 110.781 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.1 m -137.22 133.79 35.51 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.484 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.505 HG12 ' HE1' ' A' ' 37' ' ' TRP . 6.7 t -102.02 126.09 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -106.3 143.08 34.94 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.0 0.52 . . . . 0.0 110.82 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.6 tp -121.66 97.78 5.66 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 167.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -83.78 99.8 10.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.701 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.0 mtm -86.8 138.84 31.26 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -142.44 163.11 33.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.905 0.882 . . . . 0.0 109.068 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 26.9 t 54.3 42.24 31.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.014 0.926 . . . . 0.0 109.584 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.701 HD21 ' HB3' ' A' ' 84' ' ' MET . 51.6 mt -69.05 126.26 29.24 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.921 -171.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.1 mmmp? -87.83 149.99 47.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.661 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.61 -17.51 54.72 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.541 2.161 . . . . 0.0 113.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.8 pt-20 -69.46 -16.81 63.54 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.378 1.071 . . . . 0.0 112.029 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -84.43 32.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.962 0.905 . . . . 0.0 111.424 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.1 m -86.51 95.71 9.81 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -158.75 -174.25 4.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.422 0.689 . . . . 0.0 110.318 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -117.57 108.29 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 9.1 m-85 -82.28 137.02 34.94 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.416 HD13 ' HD1' ' A' ' 113' ' ' TRP . 4.1 pp -126.62 128.59 47.02 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -90.06 119.5 30.45 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.75 159.12 19.27 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.594 0.758 . . . . 0.0 109.821 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -130.97 169.07 16.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.052 0.941 . . . . 0.0 108.94 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -174.72 -178.76 44.85 Favored Glycine 0 CA--C 1.505 -0.559 0 C-N-CA 121.737 -0.268 . . . . 0.0 112.644 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.47 133.49 50.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -67.9 123.22 19.97 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -92.94 154.28 18.27 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.46 0.704 . . . . 0.0 110.788 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.0 p -69.41 -16.17 63.44 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.454 0.702 . . . . 0.0 111.754 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.2 p -67.91 -25.48 65.51 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.725 0.81 . . . . 0.0 110.919 170.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.53 -23.76 32.39 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 -173.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 35.6 t-105 -78.55 109.84 13.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.492 1.117 . . . . 0.0 108.427 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -86.49 147.67 25.87 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.021 0.529 . . . . 0.0 110.341 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 39.6 p -132.9 144.05 51.21 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.287 0.635 . . . . 0.0 110.155 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.87 91.81 0.62 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.073 1.849 . . . . 0.0 110.232 169.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -84.31 -16.09 44.25 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.482 0.713 . . . . 0.0 111.236 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 72.7 m-85 -134.26 154.09 51.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 107.92 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.416 ' HD1' HD13 ' A' ' 96' ' ' LEU . 29.6 m-90 -135.48 155.9 49.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.528 0.731 . . . . 0.0 109.428 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -78.54 -103.53 0.2 Allowed Glycine 0 C--N 1.345 1.039 0 O-C-N 123.437 0.46 . . . . 0.0 112.305 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -154.02 -14.82 0.13 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.218 0.607 . . . . 0.0 111.74 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.32 110.84 1.45 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.508 ' HB ' ' HG2' ' A' ' 7' ' ' GLU . 12.6 t -96.33 123.71 40.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.467 0.651 . . . . 0.0 109.696 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -81.18 116.49 21.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.297 0.639 . . . . 0.0 110.836 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.82 141.96 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.744 0.818 . . . . 0.0 108.968 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.4 m -134.38 105.2 6.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.86 97.78 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.2 t -73.61 147.66 43.6 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.428 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -75.68 77.27 2.65 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.509 0.724 . . . . 0.0 110.214 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER 75.58 -30.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.445 1.498 . . . . 0.0 112.338 178.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.38 109.21 2.21 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.323 1.049 . . . . 0.0 111.376 -171.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -83.99 171.93 12.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.45 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -65.95 87.71 0.1 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.077 0.941 . . . . 0.0 111.087 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -96.95 1.38 50.3 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.888 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -110.96 121.05 44.37 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 124.983 1.313 . . . . 0.0 108.568 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -74.86 152.34 38.92 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.387 0.43 . . . . 0.0 110.185 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 . . . . . 0 CA--C 1.563 1.443 0 C-N-CA 123.242 0.617 . . . . 0.0 110.01 175.924 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 62.32 -168.25 0.19 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.422 1.089 . . . . 0.0 111.643 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 3' ' ' LEU . 4.0 mm? -92.62 116.07 28.68 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 174.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 40.5 mt-30 -105.61 114.29 28.37 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 56.5 mt -105.08 118.29 36.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.82 102.81 14.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 23' ' ' CYS . 1.7 mp0 -84.66 150.03 25.42 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.049 0.94 . . . . 0.0 108.964 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 p -159.69 168.11 26.76 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.736 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.8 -5.46 61.9 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.95 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.83 146.83 45.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.679 0.24 . . . . 0.0 112.875 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.61 -176.73 47.4 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.6 tt -88.91 114.39 25.48 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 122.841 0.456 . . . . 0.0 110.148 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.76 163.31 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 165.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HB2' HD13 ' A' ' 124' ' ' LEU . 5.4 pm0 -84.59 160.44 20.44 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -65.63 113.6 4.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.549 0.74 . . . . 0.0 109.618 174.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.01 -1.72 27.08 Favored Glycine 0 C--N 1.34 0.755 0 O-C-N 123.818 0.699 . . . . 0.0 111.737 -171.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.36 -166.18 41.69 Favored Glycine 0 C--N 1.344 1.006 0 C-N-CA 123.041 0.353 . . . . 0.0 113.044 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -144.1 138.01 27.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.644 0.778 . . . . 0.0 109.687 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.7 tp -140.58 128.06 21.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.535 0.734 . . . . 0.0 109.69 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -103.04 139.82 38.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.225 0.61 . . . . 0.0 110.07 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -113.98 158.61 20.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.374 1.07 . . . . 0.0 109.419 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.8 m -146.7 127.54 14.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.626 ' SG ' ' HB ' ' A' ' 80' ' ' VAL . 27.1 p -124.8 115.72 21.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.248 0.619 . . . . 0.0 109.569 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.09 135.48 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.67 100.83 11.26 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.098 0.959 . . . . 0.0 109.992 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.598 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 20.2 m 64.32 33.02 11.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.684 1.594 . . . . 0.0 111.769 169.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.97 58.16 16.06 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.663 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 55.5 ttp180 62.67 68.63 0.64 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.277 1.031 . . . . 0.0 110.782 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.1 m -140.25 143.75 36.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.672 0.789 . . . . 0.0 109.133 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -105.45 120.82 42.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -145.9 -51.84 0.24 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.582 1.153 . . . . 0.0 108.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -83.53 163.72 20.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -146.95 9.35 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.509 1.124 . . . . 0.0 109.576 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.7 117.82 8.34 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.4 ttm -151.56 118.52 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -170.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -113.92 142.91 17.76 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.54 -173.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -88.41 135.57 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 92.7 m-85 -134.81 145.94 48.83 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.304 1.042 . . . . 0.0 109.063 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 12.9 ptp180 -104.14 145.24 30.48 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -151.02 129.08 11.79 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.92 0.782 . . . . 0.0 110.51 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -100.72 161.17 24.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.8 114.78 2.15 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.429 2.086 . . . . 0.0 111.598 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.288 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 9.3 mmpt? -128.02 153.93 46.21 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.285 1.034 . . . . 0.0 109.243 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.86 151.44 30.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.994 0.518 . . . . 0.0 110.664 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.07 113.42 13.57 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.647 0.592 . . . . 0.0 110.321 177.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -93.47 139.0 31.21 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.16 0.984 . . . . 0.0 110.104 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -64.94 110.24 2.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.23 1.412 . . . . 0.0 110.736 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.7 t -95.05 -48.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.318 0.647 . . . . 0.0 109.637 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.86 19.3 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.527 0.731 . . . . 0.0 110.815 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.475 ' H ' ' HB2' ' A' ' 60' ' ' TYR . . . -155.69 130.43 9.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 0.0 110.564 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.04 111.47 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -119.77 126.09 50.19 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.551 ' HA ' ' NH1' ' A' ' 73' ' ' ARG . 18.1 t90 -52.31 -55.13 23.45 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.332 1.02 . . . . 0.0 111.458 -165.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.0 p -112.91 118.35 34.63 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.891 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.42 23.42 7.27 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-O 119.676 -0.513 . . . . 0.0 114.125 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.22 -80.81 0.09 OUTLIER Glycine 0 C--N 1.348 1.208 0 CA-C-N 117.398 0.599 . . . . 0.0 112.598 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.9 m 63.48 9.87 4.48 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.013 1.325 . . . . 0.0 113.144 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 p -165.73 149.73 8.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.984 1.314 . . . . 0.0 108.756 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.475 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -154.47 118.23 4.64 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.244 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.7 140.35 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.812 0.845 . . . . 0.0 110.196 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.94 167.9 12.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.68 0.792 . . . . 0.0 109.459 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.03 -31.41 72.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.859 0.464 . . . . 0.0 110.869 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.5 p -64.01 -27.1 68.89 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.607 1.163 . . . . 0.0 112.539 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.94 5.62 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.409 0.684 . . . . 0.0 111.516 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -67.42 113.76 5.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.899 0.879 . . . . 0.0 109.785 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.81 -27.72 17.71 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.238 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.08 -70.88 0.47 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.959 0.904 . . . . 0.0 109.631 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -90.49 120.87 31.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.9 m -135.01 138.42 43.95 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.163 0.985 . . . . 0.0 109.188 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -119.2 143.05 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.134 0.974 . . . . 0.0 109.46 178.299 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.7 t -138.45 142.45 39.46 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.487 1.115 . . . . 0.0 108.136 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.551 ' NH1' ' HA ' ' A' ' 54' ' ' TRP . 42.4 ttp180 -115.91 123.48 48.19 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.84 129.59 49.56 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -86.85 -35.93 18.76 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.907 0.883 . . . . 0.0 110.178 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.13 78.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.425 1.09 . . . . 0.0 112.749 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -118.05 14.79 14.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.413 0.285 . . . . 0.0 111.233 175.029 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 18.5 m120 51.71 59.0 4.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.598 1.159 . . . . 0.0 111.488 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -126.67 129.27 48.13 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.63 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.626 ' HB ' ' SG ' ' A' ' 23' ' ' CYS . 47.7 t -103.14 125.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -101.95 150.58 23.06 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.668 0.787 . . . . 0.0 110.39 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 tp -133.0 99.18 4.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.964 0.905 . . . . 0.0 108.814 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -86.58 102.17 13.9 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.557 ' HB3' HD21 ' A' ' 87' ' ' LEU . 47.8 mtm -95.08 119.22 33.21 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.591 0.756 . . . . 0.0 109.182 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -116.21 151.38 35.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.743 0.817 . . . . 0.0 108.953 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t 59.96 69.07 0.73 Allowed 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.291 0.994 . . . . 0.0 110.02 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 84' ' ' MET . 62.4 mt -88.16 155.82 19.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.384 -176.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 11.0 mmmm -116.65 155.66 48.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.709 1.204 . . . . 0.0 109.677 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.441 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 30.5 Cg_endo -61.08 -22.58 75.13 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.631 2.221 . . . . 0.0 112.919 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.27 -21.68 65.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.118 0.967 . . . . 0.0 112.07 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.66 17.43 0.7 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.999 0.92 . . . . 0.0 111.766 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.0 m -80.36 94.12 6.09 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 164.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.84 -178.82 6.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.875 0.87 . . . . 0.0 110.149 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.4 p -100.09 114.95 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -85.83 109.96 19.05 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -115.15 145.81 42.0 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.493 0.717 . . . . 0.0 110.175 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 79.3 m -92.13 157.93 16.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -141.69 115.76 9.32 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.67 132.06 55.35 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.426 0.691 . . . . 0.0 110.618 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.97 -153.43 7.21 Favored Glycine 0 C--O 1.241 0.581 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.0 m -138.91 150.46 23.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 123.318 0.647 . . . . 0.0 110.088 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 108' ' ' ASP . 30.4 p-90 -74.11 80.95 1.75 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 164.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.454 ' HE ' ' HB2' ' A' ' 107' ' ' TRP . 28.3 ptt180 -65.42 165.13 12.49 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.167 -171.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.8 m -63.17 -17.21 62.14 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.218 1.007 . . . . 0.0 112.478 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.0 t -64.82 -24.9 67.69 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.06 0.944 . . . . 0.0 111.58 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.32 -18.56 23.11 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.144 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.454 ' HB2' ' HE ' ' A' ' 103' ' ' ARG . 74.8 m95 -85.16 132.56 34.28 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.613 0.765 . . . . 0.0 110.581 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 102' ' ' TRP . 25.7 t70 -86.85 95.33 9.83 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 168.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -108.05 114.51 59.72 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.627 0.771 . . . . 0.0 111.264 -171.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.55 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 67.8 Cg_endo -72.26 96.08 0.79 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.521 2.147 . . . . 0.0 109.774 167.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.31 -28.55 63.15 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.35 0.66 . . . . 0.0 111.23 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -119.41 146.61 45.21 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.865 0.866 . . . . 0.0 108.869 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -121.17 159.45 25.83 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.44 178.54 47.59 Favored Glycine 0 C--O 1.24 0.497 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.191 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -20.89 58.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.909 0.483 . . . . 0.0 111.174 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.91 125.03 0.64 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.844 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -99.52 121.16 40.77 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -74.63 112.25 10.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.055 0.542 . . . . 0.0 110.03 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.8 m -103.09 143.19 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 96.7 m -133.46 102.84 5.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.51 94.23 4.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -53.53 147.66 10.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.944 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.3 m -83.73 55.3 3.18 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.945 0.898 . . . . 0.0 110.207 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 14' ' ' GLN . 3.4 mm? 59.87 20.24 9.17 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.773 1.229 . . . . 0.0 112.136 -174.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -80.42 -64.45 1.19 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.209 0.604 . . . . 0.0 109.453 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.5 t60 71.78 -17.59 0.34 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.107 1.763 . . . . 0.0 113.656 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -71.56 171.6 11.12 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 123.796 0.839 . . . . 0.0 112.429 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -57.31 151.37 16.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.91 0.884 . . . . 0.0 111.732 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -153.7 129.21 9.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.293 1.037 . . . . 0.0 108.854 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -85.04 105.21 15.62 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.414 0.685 . . . . 0.0 109.346 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 . . . . . 0 C--O 1.251 1.174 0 C-N-CA 123.465 0.706 . . . . 0.0 109.179 174.724 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.1 mtp . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -113.69 117.99 33.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.539 0.736 . . . . 0.0 109.016 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.2 111.66 9.59 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -92.59 136.71 32.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.123 0.969 . . . . 0.0 109.437 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.462 HD13 ' SG ' ' A' ' 97' ' ' CYS . 49.1 mt -113.42 127.29 56.06 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.48 103.18 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.35 147.88 26.93 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.706 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.2 p -157.91 173.39 16.86 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.602 1.161 . . . . 0.0 109.093 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.67 -17.78 57.86 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.18 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -67.14 124.96 23.84 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 122.784 0.23 . . . . 0.0 112.686 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.86 -167.28 26.25 Favored Glycine 0 C--O 1.245 0.81 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -91.27 119.13 31.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.967 0.507 . . . . 0.0 110.258 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -124.88 169.75 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.327 1.051 . . . . 0.0 109.082 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -87.51 152.2 22.4 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.15 0.58 . . . . 0.0 111.04 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -66.36 119.06 10.93 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.338 1.055 . . . . 0.0 110.176 175.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.35 -16.14 38.39 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.771 0.669 . . . . 0.0 111.612 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.95 178.62 43.75 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.097 0.38 . . . . 0.0 113.825 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.9 p -107.92 162.66 13.81 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.042 0.937 . . . . 0.0 111.54 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.12 126.21 4.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 0.0 108.203 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -106.21 123.35 47.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -89.42 157.39 18.16 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.593 1.157 . . . . 0.0 109.559 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.6 m -139.15 124.42 19.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.727 0.811 . . . . 0.0 108.984 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 25.8 t -116.64 102.87 9.83 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.1 0.96 . . . . 0.0 109.425 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.6 t -91.51 126.54 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.553 0.741 . . . . 0.0 109.168 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.91 100.02 12.86 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m 55.85 33.33 21.34 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.14 1.376 . . . . 0.0 112.089 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.8 -84.76 1.1 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -141.58 95.86 2.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.611 0.764 . . . . 0.0 109.284 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 t -135.26 168.19 19.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.195 0.998 . . . . 0.0 108.453 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -140.25 120.37 13.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.389 0.676 . . . . 0.0 109.557 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -171.81 -72.95 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 0.0 108.999 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -84.32 129.24 34.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.314 0.646 . . . . 0.0 109.263 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.419 ' HB2' ' HD1' ' A' ' 54' ' ' TRP . 78.6 m-20 -121.3 16.14 11.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 109.876 176.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.96 118.4 32.82 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.019 0.928 . . . . 0.0 108.521 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -137.86 121.39 17.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.132 0.973 . . . . 0.0 109.104 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -99.27 136.14 12.52 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -86.94 132.11 33.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 109.921 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -132.97 171.71 13.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.044 1.338 . . . . 0.0 108.882 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -149.28 142.03 24.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.471 0.708 . . . . 0.0 109.848 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -133.27 131.95 40.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.98 0.512 . . . . 0.0 110.348 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.45 146.18 31.97 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 123.96 0.904 . . . . 0.0 109.101 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -54.9 118.71 5.44 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.957 2.438 . . . . 0.0 113.098 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.79 71.91 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 113.489 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -128.75 167.79 16.78 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 166.47 22.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.132 0.973 . . . . 0.0 110.037 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 122.92 31.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -93.5 142.13 27.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.9 0.88 . . . . 0.0 109.896 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -65.32 130.6 43.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.824 1.25 . . . . 0.0 110.336 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.38 -54.86 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.917 0.887 . . . . 0.0 108.774 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.46 170.39 20.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -160.98 128.61 4.27 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 121.284 0.564 . . . . 0.0 110.86 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.53 HD11 ' HB ' ' A' ' 71' ' ' ILE . 2.7 mp -110.59 113.49 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.538 ' H ' ' HA ' ' A' ' 58' ' ' SER . 73.2 mtp180 -94.12 175.27 6.77 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.709 0.404 . . . . 0.0 110.666 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.419 ' HD1' ' HB2' ' A' ' 33' ' ' ASN . 65.7 t90 -54.44 -44.34 72.39 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.885 0.741 . . . . 0.0 109.86 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.5 p -166.65 -178.96 4.6 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.418 1.087 . . . . 0.0 109.827 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.77 31.54 53.34 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.425 0.453 . . . . 0.0 113.722 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.56 -75.18 0.21 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.538 ' HA ' ' H ' ' A' ' 53' ' ' ARG . 77.5 p 54.92 24.7 6.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.239 1.416 . . . . 0.0 114.094 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.525 HG22 HD11 ' A' ' 71' ' ' ILE . 21.2 p -160.55 123.99 3.45 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.483 1.113 . . . . 0.0 108.986 -172.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 51' ' ' ALA . 59.7 m-85 -147.39 137.17 22.91 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -165.68 157.83 14.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.873 1.269 . . . . 0.0 109.808 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -85.59 149.63 25.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.15 -32.35 72.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.873 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 m -69.93 -38.0 76.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.165 0.586 . . . . 0.0 111.626 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 62' ' ' ALA . 14.6 m -96.71 -2.16 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.009 0.524 . . . . 0.0 111.593 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -61.69 128.69 37.44 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.65 0.78 . . . . 0.0 109.231 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.66 -26.55 17.65 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.629 0.581 . . . . 0.0 112.602 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -89.77 -54.9 3.85 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -84.73 121.05 27.12 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.351 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 132.39 51.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.539 1.136 . . . . 0.0 108.018 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.6 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -102.48 149.94 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.32 178.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 20.2 m -141.91 146.56 35.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 109.471 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.57 132.15 23.85 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.09 103.61 8.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.431 1.092 . . . . 0.0 108.42 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.43 -17.27 63.63 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.192 0.997 . . . . 0.0 111.962 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -46.39 75.07 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.964 0.905 . . . . 0.0 112.397 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -118.53 -0.74 11.32 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.62 0.768 . . . . 0.0 110.665 176.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 55.77 68.81 0.81 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.842 1.257 . . . . 0.0 111.32 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.449 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 98.7 m -132.71 131.58 41.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.396 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 125.8 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.418 1.087 . . . . 0.0 109.066 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 71.1 m-85 -106.52 155.57 19.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.56 0.744 . . . . 0.0 110.307 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 50.5 tp -133.92 98.43 4.15 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.47 0.708 . . . . 0.0 109.389 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.41 99.86 10.93 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.208 0.603 . . . . 0.0 109.423 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.76 ' HB3' HD21 ' A' ' 87' ' ' LEU . 75.0 mtp -100.66 101.06 11.86 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.753 0.821 . . . . 0.0 110.474 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.7 144.87 28.27 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.075 0.55 . . . . 0.0 111.082 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.1 t 60.97 72.95 0.5 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.854 1.261 . . . . 0.0 110.523 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' ' 84' ' ' MET . 67.5 mt -88.24 159.63 18.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.95 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -106.84 150.68 40.02 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.179 0.992 . . . . 0.0 108.657 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.98 -16.15 53.25 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.552 2.168 . . . . 0.0 112.958 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.77 -2.63 44.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.032 0.933 . . . . 0.0 112.142 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -90.76 37.38 0.92 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.604 0.762 . . . . 0.0 110.821 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.5 m -91.66 93.13 8.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.33 -177.23 5.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.759 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -104.55 109.83 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.031 0.532 . . . . 0.0 109.901 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.56 129.03 34.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.92 137.47 47.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 109.776 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.8 p -92.8 159.31 15.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 109.487 173.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -133.12 145.04 50.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.62 123.69 50.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.21 178.55 16.86 Favored Glycine 0 C--O 1.246 0.873 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.632 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.18 160.34 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.041 0.937 . . . . 0.0 110.019 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -74.86 85.11 2.21 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -74.48 150.77 39.72 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.445 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.9 m -59.39 -37.14 77.21 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.48 1.112 . . . . 0.0 112.15 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 t -64.18 -25.17 67.96 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.566 0.746 . . . . 0.0 111.635 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.55 -29.72 8.11 Favored Glycine 0 C--N 1.346 1.138 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -69.91 117.99 12.19 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.702 0.801 . . . . 0.0 108.944 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -76.25 139.69 41.25 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.4 p -128.69 125.27 23.0 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 123.505 0.722 . . . . 0.0 110.332 -173.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.587 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 36.2 Cg_exo -62.38 91.04 0.12 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.707 2.272 . . . . 0.0 111.819 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.1 -23.53 59.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.51 0.724 . . . . 0.0 110.983 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 79.8 m-85 -133.43 155.34 49.71 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.012 0.925 . . . . 0.0 109.079 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -127.28 158.86 36.08 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.97 -170.04 45.73 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.042 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -86.64 -21.1 26.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.558 0.743 . . . . 0.0 110.715 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 158.55 32.2 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.559 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.421 HG21 HD12 ' A' ' 21' ' ' LEU . 9.1 t -138.93 118.22 12.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.775 0.83 . . . . 0.0 108.809 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -78.22 103.48 8.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.486 0.714 . . . . 0.0 110.719 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.447 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -93.23 143.77 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 93.6 m -134.33 102.06 5.22 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.05 97.02 5.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 t -68.55 145.99 53.5 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.999 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -74.07 84.9 1.81 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.239 0.616 . . . . 0.0 110.155 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.9 mm? 70.24 -65.48 0.32 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.47 1.508 . . . . 0.0 112.327 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.45 106.11 2.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.015 0.926 . . . . 0.0 111.477 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -73.29 126.35 29.92 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -149.9 107.29 3.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.497 0.319 . . . . 0.0 110.188 -175.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -158.98 79.22 0.77 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.409 1.083 . . . . 0.0 108.677 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -97.61 109.08 21.9 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.949 -174.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -66.16 -36.25 82.62 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.996 0.918 . . . . 0.0 112.307 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.254 1.312 0 C-N-CA 123.598 0.759 . . . . 0.0 108.964 179.365 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -72.04 90.44 1.17 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.988 0.915 . . . . 0.0 109.994 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -94.0 114.62 26.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.707 0.803 . . . . 0.0 109.501 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.04 132.89 35.26 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.777 0.831 . . . . 0.0 110.155 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.5 mt -130.91 124.57 31.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.365 1.066 . . . . 0.0 108.579 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -121.32 101.25 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.209 0.604 . . . . 0.0 109.636 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.85 132.91 35.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.235 0.614 . . . . 0.0 109.635 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.3 m -144.35 163.77 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.147 0.979 . . . . 0.0 109.512 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.415 ' O ' HD11 ' A' ' 19' ' ' LEU . . . 117.73 -19.93 11.12 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.504 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.12 119.6 19.13 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 123.214 0.435 . . . . 0.0 112.871 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.23 -175.93 29.71 Favored Glycine 0 C--N 1.347 1.161 0 C-N-CA 123.431 0.538 . . . . 0.0 112.104 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 120' ' ' THR . 25.6 tp -89.85 114.46 26.21 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.354 0.662 . . . . 0.0 110.37 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.8 145.97 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 4.8 pm0 -75.22 154.65 37.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.126 0.421 . . . . 0.0 110.568 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . . . -58.14 113.68 2.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.559 0.744 . . . . 0.0 111.36 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.98 -4.41 25.66 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.122 0.867 . . . . 0.0 111.511 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.44 -165.68 39.83 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 123.345 0.498 . . . . 0.0 112.839 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -141.46 150.47 42.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.749 0.82 . . . . 0.0 111.129 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 9' ' ' GLY . 31.2 tp -147.33 122.91 10.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.661 0.784 . . . . 0.0 109.072 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -103.13 119.26 38.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.047 0.539 . . . . 0.0 110.139 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.47 157.46 19.19 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 m -143.22 127.34 17.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.941 0.896 . . . . 0.0 108.775 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.53 120.19 36.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.875 0.87 . . . . 0.0 109.81 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.66 115.18 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.541 0.736 . . . . 0.0 109.14 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.85 103.07 15.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.101 0.56 . . . . 0.0 110.633 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.1 p 52.75 57.68 6.13 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.999 1.72 . . . . 0.0 112.404 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.91 -82.84 0.4 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.407 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -160.54 41.79 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.594 1.187 . . . . 0.0 108.066 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -111.31 155.92 22.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.99 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -107.06 118.82 37.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -151.47 171.4 17.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.006 1.322 . . . . 0.0 107.759 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 t 65.69 114.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.807 1.243 . . . . 0.0 110.848 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 102' ' ' TRP . 2.2 p-10 -55.37 -32.36 62.52 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.887 0.875 . . . . 0.0 113.133 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.06 151.71 46.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 111.02 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 67.7 mtt -140.87 147.68 39.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 107.904 174.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.51 150.25 22.23 Favored Glycine 0 N--CA 1.467 0.723 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.858 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -91.23 149.4 21.78 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.2 152.14 49.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.222 1.409 . . . . 0.0 108.665 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -125.27 135.32 52.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.464 0.705 . . . . 0.0 109.181 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -147.56 130.95 16.62 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 123.313 0.645 . . . . 0.0 109.474 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -88.96 154.22 49.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -53.59 105.56 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.643 2.229 . . . . 0.0 112.888 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.2 31.53 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.509 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 6.6 mmpt? -126.33 174.5 8.53 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.966 0.907 . . . . 0.0 110.853 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -82.8 144.36 30.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.762 0.825 . . . . 0.0 110.208 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.29 116.34 24.4 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.046 0.45 . . . . 0.0 110.005 176.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -92.31 142.36 27.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.648 0.779 . . . . 0.0 109.904 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -73.61 107.77 6.07 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.717 0.807 . . . . 0.0 109.52 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -86.9 -54.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.714 0.806 . . . . 0.0 110.357 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -137.49 160.21 39.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -170.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.47 121.12 14.29 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 125.102 1.361 . . . . 0.0 108.873 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.5 mp -121.68 116.08 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -107.13 90.53 3.33 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.507 0.594 . . . . 0.0 110.022 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 63.85 -75.99 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.117 1.767 . . . . 0.0 111.726 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.8 p -163.25 145.3 9.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.244 1.017 . . . . 0.0 109.69 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.71 -19.26 34.09 Favored Glycine 0 N--CA 1.475 1.267 0 CA-C-O 120.081 -0.289 . . . . 0.0 113.815 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.62 44.72 1.28 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.1 m -101.99 60.73 0.86 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.961 0.905 . . . . 0.0 110.017 -175.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.442 ' HA ' HD11 ' A' ' 71' ' ' ILE . 17.8 p -146.57 120.84 9.56 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 12.3 t80 -171.38 131.94 0.77 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.56 134.99 9.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.06 150.47 33.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.923 0.489 . . . . 0.0 111.029 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.561 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 29.9 t70 -66.3 -18.86 65.61 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -72.97 -34.24 66.36 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.385 0.674 . . . . 0.0 111.219 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -106.96 15.97 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.788 0.835 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -65.93 121.17 14.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.36 1.064 . . . . 0.0 110.749 -176.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.52 -27.6 16.77 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.361 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 4.0 ptt180 -94.82 -28.08 15.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.394 0.597 . . . . 0.0 109.988 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -99.73 132.66 44.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.357 0.663 . . . . 0.0 109.282 173.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.9 m -137.99 145.23 41.67 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.889 1.276 . . . . 0.0 108.125 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -128.57 159.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.564 0.746 . . . . 0.0 109.884 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.8 t -156.78 139.69 15.29 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.74 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.546 ' HD2' HG21 ' A' ' 52' ' ' ILE . 50.2 ttt85 -115.19 120.54 40.06 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.77 107.67 18.75 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 109.303 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.34 -34.49 75.36 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.4 1.062 . . . . 0.0 111.283 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.54 -44.68 69.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.336 1.054 . . . . 0.0 112.963 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.77 7.6 11.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.074 0.55 . . . . 0.0 111.729 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.6 m120 53.66 38.37 28.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.488 1.115 . . . . 0.0 111.784 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 32.2 m -114.43 130.99 56.74 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.705 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 73' ' ' ARG . 39.8 t -104.63 121.31 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.749 0.82 . . . . 0.0 108.814 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -101.13 152.79 20.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.762 . . . . 0.0 111.261 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.7 tp -132.94 97.83 4.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.287 1.035 . . . . 0.0 108.374 171.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -80.51 101.35 9.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.624 ' HB3' HD21 ' A' ' 87' ' ' LEU . 34.3 mtm -92.71 135.63 33.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.49 170.09 16.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 t 58.61 33.45 23.1 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.859 0.864 . . . . 0.0 110.767 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -71.94 156.94 38.7 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.673 -173.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.608 ' HG2' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -132.06 158.3 75.89 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.848 1.259 . . . . 0.0 108.189 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' A' ' 15' ' ' ALA . 13.0 Cg_endo -53.68 -24.4 29.77 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 123.061 2.507 . . . . 0.0 114.522 -169.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.608 ' HG2' ' HG2' ' A' ' 88' ' ' LYS . 13.1 pt-20 -65.74 -18.76 65.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 0.0 112.589 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 121' ' ' VAL . 65.3 m-20 -82.36 30.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.493 0.717 . . . . 0.0 110.959 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.472 HG23 HG23 ' A' ' 120' ' ' THR . 95.9 m -83.14 93.56 7.66 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 164.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.6 27.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.431 0.692 . . . . 0.0 110.625 -172.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.53 120.89 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.009 0.524 . . . . 0.0 109.958 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -95.56 125.93 40.5 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -129.35 144.11 51.11 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 109.742 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -92.8 157.76 16.24 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.54 150.25 46.17 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.341 0.656 . . . . 0.0 109.518 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -113.4 132.03 55.77 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.71 178.84 16.43 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 121.353 0.418 . . . . 0.0 113.459 -172.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 p -139.47 115.74 9.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 124.035 0.934 . . . . 0.0 108.633 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.478 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 14.6 t90 -79.61 141.7 36.3 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.196 -171.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -105.52 153.84 21.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.567 1.147 . . . . 0.0 110.133 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 t -67.3 -21.09 65.7 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.878 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.5 p -68.66 -25.29 64.74 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.385 0.674 . . . . 0.0 110.634 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.59 -9.11 24.02 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 116.71 -0.223 . . . . 0.0 113.508 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -89.93 159.7 16.8 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.483 0.713 . . . . 0.0 109.897 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -116.35 141.69 47.83 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.8 p -116.84 109.51 43.06 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.146 0.578 . . . . 0.0 109.998 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.57 91.74 0.35 Allowed 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.738 2.292 . . . . 0.0 110.648 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -83.48 -22.59 32.49 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.115 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 21.9 m-85 -122.48 147.44 46.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.03 0.932 . . . . 0.0 108.525 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.8 m-90 -130.11 162.06 29.65 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 108.846 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.27 -142.93 7.78 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.438 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -102.34 -27.95 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 110.661 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.55 156.08 24.13 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.109 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.46 119.37 11.9 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -74.98 103.0 5.01 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -85.53 137.96 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 32.1 m -133.38 110.47 10.05 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 91' ' ' ASP . 48.0 t -91.89 103.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 35.5 t -45.35 143.0 1.9 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.387 1.075 . . . . 0.0 112.308 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.5 p -70.15 167.67 17.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.779 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.25 -41.22 88.25 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.919 0.488 . . . . 0.0 111.476 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -146.86 122.03 10.16 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 122.66 0.384 . . . . 0.0 110.438 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -147.6 107.61 4.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.945 0.898 . . . . 0.0 108.74 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -84.92 19.67 2.05 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.588 0.755 . . . . 0.0 111.637 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -122.16 166.58 14.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.632 0.773 . . . . 0.0 109.958 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -115.22 -77.54 0.57 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -179.19 -55.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.013 0.925 . . . . 0.0 111.085 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.0 m80 . . . . . 0 C--O 1.257 1.486 0 C-N-CA 124.523 1.129 . . . . 0.0 109.388 -160.962 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 62.25 -170.06 0.17 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.989 0.916 . . . . 0.0 111.709 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 26' ' ' SER . 2.0 tm? -75.35 115.89 15.48 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -103.12 150.32 23.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.571 1.149 . . . . 0.0 108.383 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.468 HD22 ' SG ' ' A' ' 23' ' ' CYS . 95.1 mt -131.27 108.76 9.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.092 0.557 . . . . 0.0 110.137 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.6 107.72 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.096 0.958 . . . . 0.0 108.821 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -99.22 155.24 17.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.1 m -153.56 155.63 36.52 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.836 1.654 . . . . 0.0 109.145 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.02 10.12 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 123.171 0.415 . . . . 0.0 112.887 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -71.05 90.13 0.41 Allowed Glycine 0 C--N 1.347 1.146 0 O-C-N 123.484 0.167 . . . . 0.0 113.206 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.31 -175.61 13.93 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -94.76 118.32 31.56 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.063 0.545 . . . . 0.0 110.041 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.63 167.36 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 109.271 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.24 152.83 23.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.797 0.839 . . . . 0.0 110.478 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -68.12 121.85 17.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.68 -22.39 14.92 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.077 0.846 . . . . 0.0 111.31 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.84 -166.99 38.41 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 121.225 0.347 . . . . 0.0 113.492 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 p -127.31 156.1 42.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.565 0.746 . . . . 0.0 110.891 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -152.66 133.24 13.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.006 0.922 . . . . 0.0 108.636 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -113.17 124.16 51.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.992 0.517 . . . . 0.0 109.706 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.37 157.12 19.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.906 0.882 . . . . 0.0 109.443 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.9 p -142.32 135.32 28.58 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.211 1.004 . . . . 0.0 108.725 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.468 ' SG ' HD22 ' A' ' 5' ' ' LEU . 53.8 t -140.06 116.83 10.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.24 0.616 . . . . 0.0 110.095 -177.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.53 122.86 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.58 102.57 15.31 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.037 0.935 . . . . 0.0 110.515 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.686 ' HB2' HD22 ' A' ' 3' ' ' LEU . 11.6 t 69.97 22.73 5.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.53 1.532 . . . . 0.0 111.906 168.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 56.97 10.24 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 86.6 mtm180 60.6 56.37 3.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.371 1.069 . . . . 0.0 110.948 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 47.2 m -137.3 150.33 47.7 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.817 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -103.14 127.42 50.43 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.589 ' HB3' HD23 ' A' ' 3' ' ' LEU . 44.3 ttm180 -170.51 -35.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.594 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 p -71.1 103.77 2.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.225 0.61 . . . . 0.0 110.52 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -79.32 -34.65 42.09 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.7 0.8 . . . . 0.0 109.415 174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.01 49.18 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.769 1.228 . . . . 0.0 108.948 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 50.2 mtm -150.54 168.43 24.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.932 1.693 . . . . 0.0 108.567 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.02 35.52 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 96.9 m95 -122.37 135.51 54.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 168.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -122.95 164.38 18.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.147 1.379 . . . . 0.0 108.326 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -138.11 151.18 47.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -153.94 150.41 28.29 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.42 145.34 30.61 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.95 104.53 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.371 2.714 . . . . 0.0 113.386 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.79 -12.58 50.02 Favored Glycine 0 C--N 1.352 1.469 0 C-N-CA 122.9 0.286 . . . . 0.0 113.349 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -97.99 173.53 7.01 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.0 0.92 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -78.13 170.06 17.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.909 0.883 . . . . 0.0 110.433 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -100.59 151.67 21.33 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.181 0.515 . . . . 0.0 110.681 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -115.75 139.53 50.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.668 1.587 . . . . 0.0 109.005 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 59.5 t80 -83.27 109.78 17.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.086 0.955 . . . . 0.0 109.155 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.7 t -90.09 -52.47 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.671 0.788 . . . . 0.0 110.288 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -148.83 169.83 19.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.112 -168.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -149.28 119.05 7.04 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.61 1.164 . . . . 0.0 109.512 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.0 mp -120.78 116.53 50.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 C-N-CA 123.801 0.84 . . . . 0.0 109.344 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HD3' ' H ' ' A' ' 58' ' ' SER . 2.5 mpt_? -95.74 177.63 5.72 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -80.43 -30.88 37.63 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 165.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 p -164.18 149.73 10.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.721 1.208 . . . . 0.0 109.693 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.09 -9.78 33.8 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.239 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.21 -81.36 0.05 OUTLIER Glycine 0 C--N 1.349 1.298 0 CA-C-N 117.903 0.852 . . . . 0.0 111.434 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.7 m 64.06 21.1 12.47 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.676 1.19 . . . . 0.0 113.617 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.522 ' HA ' HD11 ' A' ' 71' ' ' ILE . 19.3 p -151.33 126.11 9.66 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 6.0 t80 -166.47 130.2 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.73 150.73 12.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.616 1.566 . . . . 0.0 108.139 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.47 155.07 39.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.304 0.642 . . . . 0.0 110.729 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.88 -31.79 73.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.265 0.626 . . . . 0.0 111.42 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -69.37 -33.9 73.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.747 0.819 . . . . 0.0 111.77 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.528 ' HA ' HH21 ' A' ' 68' ' ' ARG . 31.1 m -102.53 -0.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.711 0.804 . . . . 0.0 111.722 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.16 134.94 56.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.052 1.341 . . . . 0.0 112.313 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.37 5.54 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.623 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.612 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 75.3 mtm180 -89.64 -51.78 5.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.008 0.908 . . . . 0.0 109.173 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -86.7 122.71 30.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.677 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -146.15 150.5 36.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.012 1.325 . . . . 0.0 108.037 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -121.42 155.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.959 0.904 . . . . 0.0 110.445 -177.04 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -146.78 134.07 20.63 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.957 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.61 ' HB2' HG21 ' A' ' 52' ' ' ILE . 32.3 ttt180 -112.21 130.8 55.8 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -116.42 116.06 26.98 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -87.51 -11.66 48.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.925 0.33 . . . . 0.0 111.642 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.33 94.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.135 0.574 . . . . 0.0 111.455 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -119.62 15.68 12.8 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 122.355 0.262 . . . . 0.0 110.957 169.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 16.9 m120 44.45 63.66 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.077 1.351 . . . . 0.0 111.982 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.5 m -131.29 132.61 44.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.394 0.677 . . . . 0.0 109.758 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.7 t -102.66 143.73 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.561 1.144 . . . . 0.0 108.623 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -125.78 142.22 51.62 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.585 0.754 . . . . 0.0 110.071 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.3 tp -126.85 96.8 4.75 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -89.98 107.75 19.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.6 mtm -107.96 119.08 38.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.959 0.904 . . . . 0.0 109.045 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -112.38 148.63 33.9 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.421 0.689 . . . . 0.0 110.229 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.612 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 41.6 t 56.47 68.86 0.8 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.434 1.093 . . . . 0.0 110.162 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -78.77 160.87 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.469 -1.242 . . . . 0.0 111.47 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -127.61 147.39 62.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.425 -169.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -57.96 -29.35 86.3 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.34 2.694 . . . . 0.0 114.098 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 pm0 -78.67 -2.88 41.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.323 0.649 . . . . 0.0 111.843 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -86.67 25.68 1.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.0 0.92 . . . . 0.0 110.733 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.44 HG23 ' HA ' ' A' ' 120' ' ' THR . 87.7 m -87.74 92.68 9.2 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.22 168.04 27.5 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.523 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.38 106.81 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-O 121.565 0.698 . . . . 0.0 109.765 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -89.9 114.41 26.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -111.74 146.97 36.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.175 0.59 . . . . 0.0 109.666 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -90.55 159.41 16.49 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.63 40.6 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.9 0.88 . . . . 0.0 109.089 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -152.97 170.0 21.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.607 0.763 . . . . 0.0 110.59 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.63 -154.8 25.83 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.96 140.01 46.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -66.51 148.85 51.3 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.388 0.43 . . . . 0.0 109.953 173.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.56 173.12 9.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.181 0.992 . . . . 0.0 112.279 -173.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -65.57 -24.34 67.07 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.623 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.2 t -70.46 -24.01 62.8 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.937 0.895 . . . . 0.0 111.164 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.58 -13.39 61.16 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.166 -174.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -66.42 114.81 5.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.911 0.884 . . . . 0.0 110.026 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.66 144.33 49.42 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 123.501 0.501 . . . . 0.0 109.843 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.8 t -146.79 131.96 9.06 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.187 0.595 . . . . 0.0 110.247 -172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.3 83.63 1.22 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.426 2.084 . . . . 0.0 111.305 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.97 -18.73 64.11 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.013 0.925 . . . . 0.0 111.012 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -134.76 151.63 51.12 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 125.14 1.376 . . . . 0.0 108.459 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -126.14 162.23 25.84 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.961 0.904 . . . . 0.0 109.255 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -94.14 177.23 36.49 Favored Glycine 0 C--O 1.241 0.552 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.927 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.7 -25.89 65.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.562 0.745 . . . . 0.0 111.221 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.36 110.81 0.23 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.753 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -99.02 118.92 36.89 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.458 0.647 . . . . 0.0 110.044 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -76.25 103.92 6.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.099 0.96 . . . . 0.0 111.135 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.553 HG12 ' HA2' ' A' ' 10' ' ' GLY . 9.0 m -90.05 152.0 3.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 85.3 m -132.72 106.61 7.87 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.54 0.736 . . . . 0.0 109.026 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.2 96.2 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 t -68.44 144.06 54.83 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.649 0.38 . . . . 0.0 110.766 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -67.65 92.51 0.33 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.127 0.971 . . . . 0.0 111.813 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 15' ' ' ALA . 4.3 mm? 61.56 13.16 4.96 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.565 1.146 . . . . 0.0 113.19 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -92.28 99.72 12.44 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 120.943 0.401 . . . . 0.0 110.312 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -76.57 78.79 3.25 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -70.33 -43.46 70.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.892 -173.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 61.52 94.02 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 O-C-N 124.621 1.201 . . . . 0.0 112.344 171.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -156.09 119.32 4.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.186 0.595 . . . . 0.0 109.398 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -95.51 120.63 36.11 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.49 0.716 . . . . 0.0 109.376 175.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 CA--C 1.562 1.422 0 C-N-CA 124.806 1.242 . . . . 0.0 111.433 -177.933 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -67.71 177.64 1.98 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.822 0.849 . . . . 0.0 112.967 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.4 117.11 5.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.799 0.839 . . . . 0.0 111.902 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 36.3 mt-30 -103.59 128.67 50.81 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.6 mp -127.12 122.88 35.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.2 t -114.39 101.87 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.94 144.59 26.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.408 0.683 . . . . 0.0 109.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -147.24 169.25 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 109.836 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.38 10.31 51.29 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.432 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.42 111.03 3.26 Favored Glycine 0 C--N 1.344 0.999 0 O-C-N 123.578 0.223 . . . . 0.0 112.649 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.85 -176.66 32.16 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.575 HD22 ' HB2' ' A' ' 129' ' ' HIS . 14.3 tp -92.07 125.87 36.93 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 19' ' ' LEU . 19.4 m -126.48 157.55 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -75.58 148.23 39.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.812 0.845 . . . . 0.0 110.358 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.56 111.9 2.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.345 0.658 . . . . 0.0 109.772 171.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.07 -21.7 17.4 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.561 0.538 . . . . 0.0 112.115 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.01 -178.53 34.94 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 116.555 0.178 . . . . 0.0 112.899 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 p -123.04 151.05 42.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.475 0.71 . . . . 0.0 110.553 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 13' ' ' VAL . 56.5 tp -151.82 133.65 14.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.355 1.062 . . . . 0.0 108.961 -177.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -109.42 126.0 53.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.408 0.683 . . . . 0.0 109.843 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -96.19 158.94 15.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 109.217 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.6 p -147.89 124.36 11.01 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.217 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.3 t -116.89 109.54 17.2 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.828 0.851 . . . . 0.0 109.429 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.4 t -86.17 126.11 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.79 100.61 13.38 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.537 0.735 . . . . 0.0 110.693 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.591 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 22.7 t 60.9 40.15 15.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.071 1.348 . . . . 0.0 111.83 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.73 -62.33 4.62 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.973 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 25.5 ttt180 -160.86 4.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.741 0.816 . . . . 0.0 110.445 173.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 m -77.57 145.13 37.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.401 0.681 . . . . 0.0 110.608 -170.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -105.97 123.57 48.19 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.416 ' H ' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -163.02 -18.11 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.519 1.128 . . . . 0.0 109.352 170.019 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 31' ' ' ARG . 17.9 m -63.76 108.19 1.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.872 0.869 . . . . 0.0 109.666 174.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -82.32 -36.93 26.47 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.858 0.837 . . . . 0.0 109.47 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.18 41.48 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.742 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 97.8 mtp -141.93 118.98 11.29 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.12 142.83 17.32 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.24 123.06 32.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-85 -120.17 133.91 55.38 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.401 1.08 . . . . 0.0 108.193 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -103.29 124.09 48.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.319 0.58 . . . . 0.0 109.934 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 128.68 53.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.6 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -125.36 155.15 72.05 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 122.889 0.475 . . . . 0.0 110.444 -170.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -52.5 96.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.027 2.484 . . . . 0.0 112.781 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.28 58.78 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.075 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.2 mmpt? -105.56 138.27 42.03 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.505 0.722 . . . . 0.0 109.998 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.48 163.79 10.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 0.0 112.6 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -58.56 122.15 12.69 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 168.552 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.3 tt0 -115.7 128.7 56.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.428 0.691 . . . . 0.0 109.51 -172.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 46.6 t80 -66.57 107.45 2.1 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 124.121 0.888 . . . . 0.0 109.714 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.05 -55.61 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.075 0.95 . . . . 0.0 109.954 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.65 32.29 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.865 -172.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -139.39 123.62 18.01 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.163 0.985 . . . . 0.0 109.92 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.761 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -108.68 119.36 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.454 HH22 ' HB2' ' A' ' 108' ' ' ASP . 16.1 tpp180 -120.19 107.69 13.31 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -68.58 -7.75 35.58 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.146 0.498 . . . . 0.0 111.205 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 m -68.49 -2.38 8.64 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.553 1.141 . . . . 0.0 112.825 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.74 17.18 9.95 Favored Glycine 0 C--N 1.353 1.484 0 C-N-CA 122.91 0.291 . . . . 0.0 112.402 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.17 -93.97 1.71 Allowed Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 50.6 m 61.68 39.36 14.42 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.378 1.071 . . . . 0.0 113.091 173.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 p -149.52 121.59 8.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.406 ' H ' HD11 ' A' ' 71' ' ' ILE . 12.3 t80 -170.59 126.83 0.76 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.405 ' HE2' ' HG3' ' A' ' 66' ' ' LYS . 25.1 p90 -163.66 144.07 8.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.154 0.982 . . . . 0.0 108.944 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -68.69 153.89 42.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.921 0.489 . . . . 0.0 110.378 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.45 -35.29 77.17 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.263 0.625 . . . . 0.0 110.54 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -63.41 -34.36 77.58 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 111.937 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 62' ' ' ALA . 34.4 m -108.23 19.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.953 0.901 . . . . 0.0 111.124 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' HG3' ' HE2' ' A' ' 61' ' ' TYR . 39.1 ttmt -57.34 116.84 3.56 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.169 0.988 . . . . 0.0 111.532 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.65 -27.91 6.81 Favored Glycine 0 C--N 1.342 0.876 0 O-C-N 123.733 0.646 . . . . 0.0 113.602 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -77.75 -60.25 2.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -84.69 122.11 28.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 p -143.58 153.82 42.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -130.28 154.39 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.747 0.819 . . . . 0.0 110.387 177.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.2 m -150.33 135.79 18.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.972 1.309 . . . . 0.0 107.932 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -110.05 123.42 49.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.02 128.32 36.79 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -87.25 -27.9 22.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.063 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.15 96.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.47 0.708 . . . . 0.0 112.403 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -116.34 4.28 13.41 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.135 0.425 . . . . 0.0 111.992 171.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 54.36 68.34 0.87 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.206 1.002 . . . . 0.0 111.183 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -134.99 130.67 36.11 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.25 120.43 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.031 0.932 . . . . 0.0 109.517 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.08 134.31 42.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.63 0.772 . . . . 0.0 110.297 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.5 tp -114.87 98.9 7.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -84.16 98.85 10.15 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.478 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 90.5 mtp -91.89 108.5 19.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 174.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -103.19 132.81 49.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t 61.17 70.33 0.61 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.203 1.001 . . . . 0.0 109.614 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 121' ' ' VAL . 5.5 mp -71.24 135.88 47.71 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.382 176.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.47 153.06 76.21 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.47 -19.7 68.31 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 121.946 1.764 . . . . 0.0 111.299 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -65.12 -20.51 66.5 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.861 2.064 . . . . 0.0 111.802 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.407 ' HB2' HG21 ' A' ' 121' ' ' VAL . 66.0 m-20 -84.9 31.61 0.54 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.814 0.846 . . . . 0.0 111.362 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 120' ' ' THR . 98.7 m -82.23 92.28 6.88 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 161.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.5 -175.35 4.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.818 -168.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.93 109.14 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -85.06 109.25 18.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.62 147.51 31.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 36.2 t -99.11 157.54 16.29 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 171.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -142.88 128.35 18.99 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.67 141.59 42.03 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.372 0.669 . . . . 0.0 110.345 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -159.75 -158.84 9.39 Favored Glycine 0 C--N 1.341 0.825 0 O-C-N 123.982 0.801 . . . . 0.0 113.127 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.9 m -119.25 -170.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.275 1.03 . . . . 0.0 110.746 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -97.2 123.77 41.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.686 0.794 . . . . 0.0 109.176 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -78.23 162.87 26.24 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.544 0.338 . . . . 0.0 111.165 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.7 m -72.25 -22.6 61.21 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.768 0.827 . . . . 0.0 110.946 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.9 t -73.81 -22.35 59.83 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.837 0.855 . . . . 0.0 110.506 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.55 -3.24 78.56 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.29 -174.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -79.1 151.95 31.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.119 0.968 . . . . 0.0 110.612 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.454 ' HB2' HH22 ' A' ' 53' ' ' ARG . 26.5 t70 -76.45 149.29 36.84 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.827 0.851 . . . . 0.0 110.408 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -138.94 113.71 8.39 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.209 0.604 . . . . 0.0 110.541 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.86 70.58 6.48 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.983 2.456 . . . . 0.0 111.762 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.76 -38.85 76.13 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.809 -176.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -136.86 123.92 21.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -87.25 162.91 17.17 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 109.668 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.34 -164.99 34.89 Favored Glycine 0 C--O 1.243 0.706 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.88 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -79.73 -37.53 35.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.431 0.692 . . . . 0.0 110.639 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.85 138.16 9.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.396 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.408 HG21 HD12 ' A' ' 21' ' ' LEU . 9.7 t -108.03 118.65 37.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.166 0.587 . . . . 0.0 109.51 173.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -79.12 107.44 11.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.795 0.838 . . . . 0.0 110.467 -177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.7 m -107.07 143.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.946 0.898 . . . . 0.0 109.501 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 92' ' ' THR . 61.7 m -132.92 120.92 22.1 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 87' ' ' LEU . 25.9 t -100.91 104.57 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 176.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.2 m -53.64 140.64 28.46 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.1 m -83.09 59.51 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.873 0.869 . . . . 0.0 110.255 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.7 mm? 69.3 23.36 6.27 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.306 1.442 . . . . 0.0 112.74 -171.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -86.0 87.04 7.35 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 166.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -75.6 84.4 2.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -146.95 114.61 6.41 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -169.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -73.07 90.02 1.5 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.113 0.482 . . . . 0.0 111.301 -172.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.575 ' HB2' HD22 ' A' ' 12' ' ' LEU . 26.7 m-70 -82.27 89.66 6.56 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.691 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -76.79 -17.4 59.06 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 165.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.3 m80 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.871 1.269 . . . . 0.0 108.262 166.019 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.728 0.299 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -68.18 141.76 55.9 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.515 0.726 . . . . 0.0 110.785 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.04 111.06 8.84 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -88.92 114.45 25.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.5 mt -112.04 122.32 47.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.02 100.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -87.21 118.8 26.86 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m -129.46 135.0 48.1 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.186 0.995 . . . . 0.0 109.186 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.78 9.21 0.73 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.074 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.3 89.99 0.61 Allowed Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.921 0.361 . . . . 0.0 112.749 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.22 172.78 23.32 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 112.268 -0.333 . . . . 0.0 112.268 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 122' ' ' SER . 15.9 tp -91.99 123.76 35.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.463 0.705 . . . . 0.0 109.132 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.1 m -126.81 151.15 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -77.89 153.75 32.35 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 122.574 0.35 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.7 114.15 2.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.672 0.789 . . . . 0.0 110.584 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.25 11.7 27.01 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.296 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.47 -167.01 24.61 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 122.555 0.121 . . . . 0.0 113.087 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -132.47 156.9 45.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.694 0.798 . . . . 0.0 110.011 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -159.32 119.71 3.13 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -100.18 126.45 46.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.994 0.518 . . . . 0.0 110.375 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.83 157.48 18.99 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.02 0.928 . . . . 0.0 109.865 170.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.3 p -141.12 148.81 40.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.66 1.184 . . . . 0.0 108.544 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.0 t -135.28 101.67 4.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.2 118.14 30.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.82 97.92 11.47 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m 51.97 49.35 20.89 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.334 1.453 . . . . 0.0 112.267 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.27 -78.1 2.04 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.333 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -172.28 85.1 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.406 1.082 . . . . 0.0 108.585 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -139.16 155.96 47.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.351 0.66 . . . . 0.0 110.222 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.17 117.87 35.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -173.08 160.91 4.26 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.757 1.223 . . . . 0.0 109.514 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m 64.95 177.52 0.19 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.422 1.089 . . . . 0.0 111.088 -171.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -147.33 19.68 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.807 0.443 . . . . 0.0 110.726 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.3 125.12 6.52 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.837 0.855 . . . . 0.0 109.78 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 65.9 mtt -139.91 119.86 13.55 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.31 177.13 16.85 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 123.125 0.393 . . . . 0.0 112.697 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -119.55 139.79 51.57 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.717 0.807 . . . . 0.0 110.656 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -127.28 166.86 16.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 107.527 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.24 139.22 19.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.316 0.246 . . . . 0.0 110.665 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -125.18 128.12 47.87 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.076 0.55 . . . . 0.0 109.697 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.33 158.69 31.77 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.393 0.677 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -55.08 115.68 2.61 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.919 2.413 . . . . 0.0 112.693 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -7.74 78.08 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 113.629 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 9.2 mmpt? -114.51 162.97 16.02 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.069 0.948 . . . . 0.0 110.596 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.24 175.18 9.09 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.668 0.787 . . . . 0.0 110.212 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 131.53 36.1 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -115.67 140.46 49.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 109.311 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.59 109.38 3.25 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.744 1.217 . . . . 0.0 110.263 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.48 -58.2 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -163.78 174.74 11.22 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.958 -173.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.74 130.69 23.12 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.573 1.149 . . . . 0.0 108.926 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.2 mp -112.84 116.27 52.15 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.1 mtm-85 -114.17 169.11 9.26 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -59.32 -39.09 81.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -158.99 146.27 17.42 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.521 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.41 30.95 32.0 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 114.129 0.412 . . . . 0.0 114.129 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.28 -124.52 0.74 Allowed Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.645 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 23.6 m 65.92 8.99 5.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 170.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.539 ' HA ' HD11 ' A' ' 71' ' ' ILE . 3.2 p -159.01 122.59 3.81 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.735 0.814 . . . . 0.0 110.157 -175.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 46.4 m-85 -160.56 111.81 1.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.364 1.466 . . . . 0.0 107.927 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -166.63 136.0 3.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.964 0.906 . . . . 0.0 110.414 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.24 168.13 16.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.093 0.957 . . . . 0.0 110.329 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -57.32 -33.94 68.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.461 0.704 . . . . 0.0 112.312 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 m -65.8 -31.01 71.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.319 0.648 . . . . 0.0 112.284 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.2 14.16 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.693 0.797 . . . . 0.0 111.053 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.9 124.2 27.7 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.556 0.743 . . . . 0.0 109.883 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.36 -28.54 6.19 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.177 -174.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 74.7 mtp180 -75.63 -78.1 0.12 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 124.11 0.964 . . . . 0.0 109.189 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -84.26 119.92 25.61 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.628 0.771 . . . . 0.0 108.932 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -137.87 133.0 33.34 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 108.289 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.539 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -112.66 140.09 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.682 0.793 . . . . 0.0 110.081 -175.403 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -148.67 174.9 11.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.52 1.128 . . . . 0.0 109.527 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -152.01 150.29 29.82 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.571 0.748 . . . . 0.0 109.247 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.85 100.31 5.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.556 1.143 . . . . 0.0 108.173 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -69.94 -13.4 62.22 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.03 0.932 . . . . 0.0 111.498 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.31 70.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.22 . . . . 0.0 111.508 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.09 9.0 15.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.068 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m120 53.66 64.72 1.74 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.585 1.154 . . . . 0.0 111.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.8 m -138.7 130.69 28.11 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.711 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.42 131.68 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.929 0.891 . . . . 0.0 108.626 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.53 150.54 29.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.101 0.56 . . . . 0.0 111.849 -174.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 37.8 tp -132.74 97.92 4.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -81.11 109.39 15.63 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.699 ' HB3' HD21 ' A' ' 87' ' ' LEU . 28.4 mtm -100.58 97.43 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -91.81 162.78 14.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.895 0.878 . . . . 0.0 110.615 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.484 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 20.5 t 42.92 63.72 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.3 1.44 . . . . 0.0 111.912 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 84' ' ' MET . 50.7 mt -82.63 150.51 26.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.759 -168.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -106.2 153.07 40.56 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.117 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.15 -18.89 60.96 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.584 2.19 . . . . 0.0 112.922 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.48 -1.17 25.86 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -96.41 31.69 2.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.447 0.641 . . . . 0.0 110.377 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.6 m -82.81 98.96 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 164.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.58 156.18 25.31 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.976 0.417 . . . . 0.0 111.387 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.05 105.25 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 170.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.61 122.59 31.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 108.957 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.76 158.6 34.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.64 0.776 . . . . 0.0 110.012 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.81 159.24 17.37 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.235 1.014 . . . . 0.0 109.445 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -141.67 138.82 32.74 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.545 0.738 . . . . 0.0 109.782 -176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -114.1 124.63 52.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 0.0 110.081 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.08 -172.7 12.94 Favored Glycine 0 C--O 1.248 0.974 0 C-N-CA 123.847 0.737 . . . . 0.0 111.536 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.57 158.91 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.02 0.928 . . . . 0.0 109.956 -176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -59.82 102.37 0.15 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 168.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -91.07 149.69 21.71 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.293 -172.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.6 m -68.89 -15.32 63.46 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.807 0.843 . . . . 0.0 112.441 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.8 p -69.03 -25.41 64.46 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.438 0.695 . . . . 0.0 110.967 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.56 -27.03 14.38 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.241 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -94.67 118.73 32.19 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.49 0.716 . . . . 0.0 110.45 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.48 120.35 12.14 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.3 p -123.74 126.08 25.81 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 123.334 0.654 . . . . 0.0 109.653 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.537 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 73.2 Cg_endo -74.23 95.76 0.93 Allowed 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.136 1.891 . . . . 0.0 111.302 173.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.24 -5.24 59.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.396 0.679 . . . . 0.0 111.351 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 89.9 m-85 -123.03 142.36 50.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.661 0.784 . . . . 0.0 109.414 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -132.09 150.71 52.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.995 1.318 . . . . 0.0 107.893 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.98 -142.09 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 123.212 0.32 . . . . 0.0 112.864 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -100.85 -29.88 11.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.904 0.882 . . . . 0.0 111.304 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.94 161.81 36.76 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.297 -173.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -144.62 126.03 14.88 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.054 0.454 . . . . 0.0 110.054 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -81.14 100.35 9.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 m -90.19 146.52 6.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 170.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 38.8 m -134.29 113.58 12.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.19 99.02 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.572 ' HB2' HD11 ' A' ' 12' ' ' LEU . 9.4 t -60.54 141.32 56.7 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.959 176.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.2 p -81.56 76.65 8.47 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.381 0.673 . . . . 0.0 109.822 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 71.44 -8.77 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.232 1.413 . . . . 0.0 113.834 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.491 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 7.1 tm-20 -75.71 140.45 42.47 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -154.32 96.9 1.97 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.283 0.633 . . . . 0.0 110.508 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -135.65 143.23 45.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.113 0.965 . . . . 0.0 109.615 173.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -81.0 84.47 6.46 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.921 0.867 . . . . 0.0 109.596 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -72.17 -28.23 63.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.309 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -109.01 117.56 34.53 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.393 1.077 . . . . 0.0 108.275 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 . . . . . 0 CA--C 1.559 1.291 0 C-N-CA 125.132 1.373 . . . . 0.0 110.97 -179.885 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mtm . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 119.006 -0.521 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 63.98 81.31 0.21 Allowed 'General case' 0 C--N 1.368 1.376 0 C-N-CA 124.591 1.156 . . . . 0.0 110.569 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 32' ' ' SER . 4.2 mm? -66.58 112.61 4.23 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.827 0.451 . . . . 0.0 110.901 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.94 103.39 13.95 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 99' ' ' ALA . 86.9 mt -100.28 112.89 25.25 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.58 102.44 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.16 128.38 36.34 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.2 m -128.11 165.92 19.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.859 1.263 . . . . 0.0 109.194 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.61 8.16 40.83 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -76.55 103.24 1.71 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.752 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -178.99 32.65 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.2 tt -91.67 119.41 31.52 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.54 163.07 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.063 0.945 . . . . 0.0 108.656 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.62 154.73 23.59 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.736 0.814 . . . . 0.0 110.666 177.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -71.52 127.13 31.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 109.462 174.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.18 -14.12 44.16 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.99 -177.84 46.21 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.628 0.251 . . . . 0.0 113.132 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 p -119.37 131.09 55.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.651 0.781 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.9 tp -128.99 131.47 47.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.849 0.86 . . . . 0.0 108.964 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -112.63 132.41 55.17 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.8 0.84 . . . . 0.0 110.108 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.97 158.65 16.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.475 1.11 . . . . 0.0 109.851 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 p -140.25 122.39 15.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.705 0.802 . . . . 0.0 109.847 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -112.31 108.92 18.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.233 1.013 . . . . 0.0 108.851 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.96 121.62 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.49 108.67 19.94 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.711 0.805 . . . . 0.0 109.729 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 p 48.08 45.35 19.46 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.986 1.714 . . . . 0.0 113.067 172.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.61 -61.41 4.7 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 69.0 ttt180 -165.48 14.97 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.936 0.894 . . . . 0.0 110.606 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -106.12 154.64 20.39 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.321 0.648 . . . . 0.0 109.855 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -108.9 116.86 32.8 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -131.55 16.27 4.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.104 0.962 . . . . 0.0 109.717 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.418 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 38.2 t -139.55 147.72 41.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.747 0.819 . . . . 0.0 109.556 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -43.6 19.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.827 0.851 . . . . 0.0 109.336 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.33 152.39 46.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.907 0.483 . . . . 0.0 111.252 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 2.1 mpt? -133.14 118.48 18.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.67 135.35 10.09 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -93.28 129.23 39.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.111 0.964 . . . . 0.0 109.971 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.21 135.87 39.46 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 23.5 ptt180 -103.55 118.15 36.07 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.307 0.575 . . . . 0.0 109.946 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.492 ' HB3' HG13 ' A' ' 94' ' ' VAL . 49.7 tp60 -100.71 129.13 46.57 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -99.28 150.74 37.01 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 122.634 0.373 . . . . 0.0 110.408 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.21 98.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.688 2.259 . . . . 0.0 112.294 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.07 65.81 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.913 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.2 mmpt? -123.68 153.58 40.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.741 0.816 . . . . 0.0 110.182 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -68.39 172.65 5.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.174 0.989 . . . . 0.0 113.104 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.472 ' NE ' ' H ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.24 134.93 34.93 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.324 -177.11 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.0 142.86 29.19 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.069 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -71.05 122.02 19.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.979 0.912 . . . . 0.0 110.034 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.92 -53.47 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.97 173.6 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.807 0.443 . . . . 0.0 112.183 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.29 121.63 3.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.255 1.022 . . . . 0.0 110.313 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 52' ' ' ILE . 2.9 mp -115.14 115.47 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -109.37 166.47 10.85 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.582 0.353 . . . . 0.0 110.203 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -60.08 -45.26 93.48 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.751 0.821 . . . . 0.0 109.273 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -151.82 162.17 41.47 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.823 170.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.47 32.72 41.36 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.39 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.61 -85.47 0.08 OUTLIER Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m 65.63 5.56 3.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.725 1.21 . . . . 0.0 113.504 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 p -170.01 145.64 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.105 1.762 . . . . 0.0 106.97 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.412 ' H ' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -165.78 130.12 2.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.718 0.807 . . . . 0.0 109.189 176.484 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -164.25 147.84 9.51 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.633 0.773 . . . . 0.0 110.576 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.33 164.29 13.57 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.054 0.941 . . . . 0.0 109.832 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.8 -21.37 66.04 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.387 0.675 . . . . 0.0 111.588 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 m -67.9 -38.38 82.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.388 0.675 . . . . 0.0 111.192 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -105.75 -6.28 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.671 0.788 . . . . 0.0 111.846 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -57.59 131.13 49.29 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.315 1.046 . . . . 0.0 112.359 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.28 -26.5 6.95 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.69 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.421 HH21 ' HE1' ' A' ' 69' ' ' PHE . 3.6 mtm180 -96.88 -59.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.421 ' HE1' HH21 ' A' ' 68' ' ' ARG . 1.2 m-85 -84.99 120.63 26.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -139.34 143.66 37.9 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.297 1.039 . . . . 0.0 108.491 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.441 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -126.5 146.16 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.764 0.826 . . . . 0.0 111.03 -175.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -151.75 140.49 20.86 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.344 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -107.96 123.48 48.7 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.68 131.0 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.907 170.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 -28.51 19.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.582 0.753 . . . . 0.0 111.177 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.19 -43.52 87.59 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.838 0.855 . . . . 0.0 112.141 -172.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -118.14 9.88 12.78 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.222 0.209 . . . . 0.0 111.506 172.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 47.48 67.35 0.82 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.886 1.274 . . . . 0.0 112.016 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.4 m -134.68 131.61 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.252 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.47 131.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.641 0.776 . . . . 0.0 109.267 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -111.87 137.76 49.4 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.506 0.722 . . . . 0.0 110.769 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.53 97.66 5.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -87.65 104.54 16.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.396 0.678 . . . . 0.0 109.548 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 35.4 mtm -103.09 103.21 13.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.752 0.821 . . . . 0.0 110.083 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -93.2 149.49 21.19 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.4 t 56.23 72.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.907 1.283 . . . . 0.0 110.968 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.4 mt -81.06 160.74 24.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.571 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 150.37 59.06 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.802 1.241 . . . . 0.0 108.358 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.43 -21.55 54.25 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.235 2.623 . . . . 0.0 114.18 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.74 -12.18 61.43 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.561 0.744 . . . . 0.0 112.43 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -79.11 13.82 1.67 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.206 0.602 . . . . 0.0 111.423 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 120' ' ' THR . 83.2 m -73.46 89.38 1.65 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.6 -178.6 3.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 -166.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -110.44 111.73 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 109.781 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -83.61 109.39 17.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.12 154.62 21.45 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.335 0.654 . . . . 0.0 110.159 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -108.55 158.0 17.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.331 1.052 . . . . 0.0 108.6 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -130.29 145.85 51.82 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.93 114.49 27.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.37 164.57 13.3 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 121.23 0.35 . . . . 0.0 113.716 -167.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.49 130.34 70.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 C-N-CA 125.187 1.395 . . . . 0.0 107.248 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 24.1 p-90 -69.28 139.23 54.36 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.579 0.55 . . . . 0.0 110.461 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -104.13 147.72 27.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 166.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.9 t -70.15 -17.22 63.17 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.013 0.525 . . . . 0.0 110.202 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.0 t -66.87 -19.42 65.73 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.442 1.097 . . . . 0.0 111.133 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.66 -28.88 11.27 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.88 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -73.77 109.96 7.69 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.333 0.653 . . . . 0.0 109.899 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.28 103.35 11.8 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.2 t -79.43 117.22 65.93 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 123.237 0.615 . . . . 0.0 111.287 -173.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.519 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 12.1 Cg_exo -69.5 95.53 0.53 Allowed 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.679 2.252 . . . . 0.0 110.176 176.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.26 -37.27 74.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.015 0.926 . . . . 0.0 110.95 -173.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 67.8 m-85 -126.99 169.0 13.78 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.223 1.009 . . . . 0.0 109.238 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -133.94 164.35 27.49 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.49 1.116 . . . . 0.0 108.804 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -90.44 -172.99 44.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.236 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -75.27 -32.68 61.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.879 0.871 . . . . 0.0 110.128 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.2 124.96 1.67 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.627 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -97.96 118.52 34.73 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.493 0.663 . . . . 0.0 109.426 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.44 112.14 13.87 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.522 HG12 ' HA2' ' A' ' 10' ' ' GLY . 27.0 m -112.39 142.68 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.1 m -126.75 104.5 8.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.42 99.26 9.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -67.43 150.41 48.95 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.0 p -78.76 85.91 4.73 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.19 0.596 . . . . 0.0 110.291 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 15' ' ' ALA . 4.5 mm? 69.44 -19.15 0.18 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.223 1.409 . . . . 0.0 113.909 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.93 127.48 32.61 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.094 0.558 . . . . 0.0 110.883 -170.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -97.17 89.09 4.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.234 1.014 . . . . 0.0 109.679 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -144.85 126.75 15.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.475 0.71 . . . . 0.0 110.012 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -77.65 109.58 11.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.107 0.963 . . . . 0.0 109.517 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -53.28 121.22 7.14 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.315 1.046 . . . . 0.0 111.272 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -81.89 102.39 10.85 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.806 0.843 . . . . 0.0 109.948 177.501 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -74.33 99.29 3.45 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.519 0.327 . . . . 0.0 110.201 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -71.13 108.13 4.51 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -79.24 149.57 31.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.193 1.397 . . . . 0.0 110.567 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.7 mt -124.98 120.08 30.57 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.115 0.966 . . . . 0.0 108.738 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.47 101.45 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 23' ' ' CYS . 2.9 mp0 -90.56 153.04 20.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.442 0.697 . . . . 0.0 110.584 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.8 p -165.31 160.91 18.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.141 0.976 . . . . 0.0 109.582 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.87 -1.26 27.29 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 120.069 -0.295 . . . . 0.0 112.961 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -78.75 119.0 4.98 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.48 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.44 177.98 26.33 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.4 tt -82.52 117.1 22.28 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 m -118.22 160.18 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.006 0.922 . . . . 0.0 108.609 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.12 159.14 28.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.531 0.732 . . . . 0.0 110.791 174.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.55 133.38 52.23 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.549 0.74 . . . . 0.0 110.224 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.28 80.34 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.276 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.67 -178.26 43.84 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 120.88 0.156 . . . . 0.0 113.264 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -128.97 156.66 43.43 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -176.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -159.59 130.63 5.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.606 0.762 . . . . 0.0 109.354 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -105.57 132.85 51.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.682 0.393 . . . . 0.0 110.061 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 159.19 15.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.046 0.938 . . . . 0.0 109.693 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 p -143.53 130.89 20.94 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 109.284 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 43.1 t -131.95 110.64 10.91 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.9 t -86.58 132.37 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.56 100.24 12.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.077 0.551 . . . . 0.0 109.827 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 7.4 m 59.31 20.2 8.4 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.144 1.378 . . . . 0.0 113.391 176.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 68.64 1.57 Allowed Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -174.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.512 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 55.0 ttp180 62.26 51.95 3.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.856 1.262 . . . . 0.0 111.507 176.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 30.3 m -118.26 141.16 48.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.641 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -104.37 119.47 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -170.75 171.73 6.03 Favored 'General case' 0 C--O 1.248 0.988 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 m 71.01 121.1 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.61 1.164 . . . . 0.0 111.825 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 102' ' ' TRP . 3.6 p-10 -106.61 7.12 30.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.844 0.858 . . . . 0.0 110.717 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.51 122.37 27.5 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.7 mtt -138.79 152.75 48.17 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.282 0.633 . . . . 0.0 110.015 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -159.56 175.12 36.47 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.45 -178.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.8 131.97 34.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.537 1.135 . . . . 0.0 108.28 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.61 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 85.1 m-85 -134.37 137.32 44.02 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.58 1.152 . . . . 0.0 108.231 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -103.98 130.32 51.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -133.73 143.35 48.42 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.557 0.743 . . . . 0.0 109.058 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.15 160.99 31.85 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.711 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.93 105.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.306 2.671 . . . . 0.0 113.773 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.97 23.26 61.97 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.455 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 9.7 mmpt? -126.41 172.89 9.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.796 0.838 . . . . 0.0 110.492 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.68 168.19 17.49 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.101 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.61 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -102.03 117.87 35.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.225 174.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -93.19 139.92 30.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.032 0.933 . . . . 0.0 109.564 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.08 111.06 3.67 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.417 0.687 . . . . 0.0 110.051 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.96 -56.96 4.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.535 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -161.44 173.39 14.96 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.848 -171.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -163.37 162.8 25.16 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.194 0.997 . . . . 0.0 113.265 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mt -129.3 128.08 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 108.693 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -98.78 123.41 43.0 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.343 0.657 . . . . 0.0 110.143 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 22.5 t90 59.62 -89.82 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.708 1.603 . . . . 0.0 110.767 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -171.55 130.82 0.71 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.73 -18.89 48.16 Favored Glycine 0 N--CA 1.471 1.031 0 N-CA-C 112.596 -0.201 . . . . 0.0 112.596 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.66 50.4 2.61 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 174.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.8 m -83.64 69.56 10.16 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.59 0.756 . . . . 0.0 111.085 -172.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 p -158.84 119.23 3.22 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 17.1 m-85 -169.73 119.46 0.64 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 167.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.73 151.53 20.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.055 0.542 . . . . 0.0 110.764 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 159.76 30.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.503 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.6 -32.39 71.51 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.65 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.3 m -60.77 -37.65 82.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.14 0.976 . . . . 0.0 112.029 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.98 4.33 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.387 0.675 . . . . 0.0 111.896 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.77 111.26 3.62 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.148 0.979 . . . . 0.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.58 44.78 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.201 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 60.3 mtm180 -103.01 -40.24 6.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.299 0.64 . . . . 0.0 110.358 176.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.3 123.03 48.18 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.676 0.79 . . . . 0.0 109.459 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -139.35 152.26 47.03 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.121 0.968 . . . . 0.0 108.98 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.632 HD12 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -128.48 156.13 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.733 0.813 . . . . 0.0 110.497 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -154.54 134.17 12.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.371 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -110.85 120.07 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -90.89 104.63 17.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -62.75 -26.66 68.81 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.925 0.765 . . . . 0.0 110.966 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.39 -53.79 33.09 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.838 1.255 . . . . 0.0 112.263 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.512 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.37 11.17 11.4 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 45.07 67.81 0.66 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.943 1.297 . . . . 0.0 112.503 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 m -130.75 131.11 44.54 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.748 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.83 127.97 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.37 1.068 . . . . 0.0 109.503 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -110.83 150.88 28.51 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.991 0.916 . . . . 0.0 110.502 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 tp -132.36 99.32 4.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -82.76 102.3 11.48 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.646 ' HB3' HD21 ' A' ' 87' ' ' LEU . 34.4 mtm -95.53 132.61 40.46 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 83.7 m-20 -128.98 149.77 50.68 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.444 0.698 . . . . 0.0 109.775 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 t 47.59 68.74 0.61 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.95 1.3 . . . . 0.0 111.15 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.646 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -81.59 157.58 24.69 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.577 -170.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.43 149.72 36.94 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.896 0.878 . . . . 0.0 108.632 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -58.84 -23.16 65.88 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 122.626 2.217 . . . . 0.0 113.182 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.01 -14.36 62.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.216 1.006 . . . . 0.0 112.348 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 119' ' ' VAL . 30.0 m-20 -81.22 27.52 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.657 0.783 . . . . 0.0 111.85 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 93.7 m -81.49 92.05 6.42 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 165.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.83 9.25 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.446 0.699 . . . . 0.0 110.794 -170.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.96 114.52 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.335 0.588 . . . . 0.0 109.877 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -86.23 113.59 22.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.25 148.3 40.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.713 0.805 . . . . 0.0 109.857 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 31.7 p -96.05 155.2 16.86 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.23 13.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.26 166.38 11.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.825 0.85 . . . . 0.0 110.462 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.83 -166.94 40.11 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 112.301 -0.319 . . . . 0.0 112.301 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.32 170.19 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.411 0.684 . . . . 0.0 111.465 -174.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.482 ' HB3' HD21 ' A' ' 33' ' ' ASN . 64.8 p-90 -66.04 155.81 35.62 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.944 0.897 . . . . 0.0 110.889 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 -134.8 142.34 46.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.422 0.689 . . . . 0.0 110.765 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.6 m -80.75 -11.64 59.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.07 0.948 . . . . 0.0 111.0 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 m -64.57 -23.41 67.26 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.564 0.746 . . . . 0.0 111.073 171.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.83 -30.55 9.16 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.405 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -76.94 117.99 19.09 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.998 0.519 . . . . 0.0 110.005 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.54 119.84 11.21 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.8 m -139.48 128.25 13.67 Favored Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -175.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.42 146.57 27.88 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.501 2.134 . . . . 0.0 112.109 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.54 -29.03 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.391 1.076 . . . . 0.0 110.192 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -117.99 128.03 54.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 0.0 109.131 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -110.13 128.88 55.71 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 166.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.39 -178.36 47.71 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 123.703 0.627 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.12 -27.09 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.135 0.574 . . . . 0.0 110.79 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.97 170.12 38.02 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.922 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.66 124.72 16.28 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.199 0.6 . . . . 0.0 109.528 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -78.63 101.45 7.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.615 0.766 . . . . 0.0 111.275 -174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.538 HG12 ' HA2' ' A' ' 10' ' ' GLY . 17.3 m -88.11 147.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 87.2 m -135.07 103.28 5.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.9 t -90.12 96.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.416 ' OG ' ' HB2' ' A' ' 125' ' ' GLU . 12.2 t -69.92 150.34 46.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.797 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.6 m -73.34 85.8 1.46 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.739 0.816 . . . . 0.0 111.133 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 67.45 2.13 2.79 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.568 1.547 . . . . 0.0 112.991 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.416 ' HB2' ' OG ' ' A' ' 122' ' ' SER . 9.8 mm-40 -90.36 89.38 7.58 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.026 0.531 . . . . 0.0 110.279 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -75.27 -18.74 60.0 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.427 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -78.4 116.93 19.16 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -160.5 173.14 16.0 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.045 0.938 . . . . 0.0 109.796 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.89 141.07 37.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -105.55 118.52 36.79 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.416 173.78 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -81.03 158.7 25.02 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.142 0.577 . . . . 0.0 109.768 169.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.45 116.7 14.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.168 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 26' ' ' SER . 16.7 mt-30 -91.91 108.91 20.27 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.426 0.69 . . . . 0.0 109.447 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.753 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.9 mp -118.71 119.35 34.18 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.4 101.02 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -92.51 135.67 33.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.933 -174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 p -148.54 165.23 31.86 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.386 1.074 . . . . 0.0 109.72 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.84 -24.77 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.73 128.96 38.56 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.081 0.372 . . . . 0.0 113.175 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.84 -174.12 45.47 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.3 tp -78.03 116.98 18.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.06 0.544 . . . . 0.0 109.896 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 121' ' ' VAL . 4.8 m -129.42 163.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.414 1.086 . . . . 0.0 109.611 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 145.34 24.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.787 0.435 . . . . 0.0 111.399 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 127.17 30.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.341 1.057 . . . . 0.0 110.998 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.53 62.06 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 123.604 0.565 . . . . 0.0 112.304 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.04 -166.34 39.54 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -141.46 130.41 23.15 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.53 122.47 29.29 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.027 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -93.46 117.74 30.46 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.6 151.32 23.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.973 0.909 . . . . 0.0 109.175 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.4 p -136.59 126.22 25.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.624 0.77 . . . . 0.0 109.365 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 50.0 t -120.27 102.85 8.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.977 1.311 . . . . 0.0 109.372 -174.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -95.3 118.39 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.565 1.146 . . . . 0.0 109.639 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.53 99.69 11.86 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.945 -0.472 . . . . 0.0 110.643 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 27.3 t 49.6 39.39 17.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.568 1.547 . . . . 0.0 111.506 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.27 -89.96 1.11 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -168.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HG2' ' HB2' ' A' ' 77' ' ' LYS . 98.2 mtt180 -140.32 94.85 2.79 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 t -133.42 157.65 45.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.391 0.676 . . . . 0.0 110.013 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -112.42 119.76 39.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -154.38 -82.15 0.08 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.1 p -77.61 121.04 23.4 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.862 0.465 . . . . 0.0 111.275 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.569 ' HB3' ' HD1' ' A' ' 54' ' ' TRP . 40.6 m-80 -92.84 10.36 31.35 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.267 173.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.57 122.79 15.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.653 1.181 . . . . 0.0 108.864 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.7 mtt -140.79 165.53 27.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.587 1.555 . . . . 0.0 108.546 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -166.36 156.17 27.88 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.612 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -108.14 133.67 52.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.387 1.075 . . . . 0.0 108.599 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -136.44 139.37 42.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.132 0.973 . . . . 0.0 108.829 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 33.4 ptt85 -103.68 137.98 40.97 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.492 0.717 . . . . 0.0 109.834 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.461 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 61.8 tt0 -143.83 130.72 20.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.059 0.544 . . . . 0.0 109.726 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.94 161.67 30.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.469 0.708 . . . . 0.0 109.563 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.35 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.59 2.193 . . . . 0.0 113.299 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.88 6.79 88.68 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -106.35 174.57 5.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.896 0.878 . . . . 0.0 110.549 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.45 166.37 22.07 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.833 0.853 . . . . 0.0 111.096 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -103.67 113.53 27.11 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 110.475 175.418 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -93.03 143.91 25.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.812 0.845 . . . . 0.0 110.382 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -62.76 118.12 7.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.751 0.821 . . . . 0.0 111.267 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -88.03 -47.16 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.15 176.47 8.45 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.785 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.591 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -156.98 127.24 6.43 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 123.886 0.874 . . . . 0.0 110.265 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.565 HD12 HG13 ' A' ' 80' ' ' VAL . 11.4 mt -118.92 118.06 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.35 1.06 . . . . 0.0 110.353 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -96.12 -175.84 3.5 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.218 1.007 . . . . 0.0 109.002 167.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.569 ' HD1' ' HB3' ' A' ' 33' ' ' ASN . 46.5 p-90 -43.61 160.29 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 123.426 0.69 . . . . 0.0 112.375 165.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -60.79 120.13 9.53 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.578 0.751 . . . . 0.0 111.639 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.51 -18.06 25.4 Favored Glycine 0 C--N 1.351 1.377 0 C-N-CA 123.434 0.54 . . . . 0.0 112.582 -172.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.94 12.3 8.18 Favored Glycine 0 N--CA 1.477 1.38 0 C-N-CA 123.248 0.451 . . . . 0.0 112.184 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 p -90.55 74.5 6.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.183 0.993 . . . . 0.0 110.362 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -158.71 123.21 4.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.619 0.767 . . . . 0.0 110.031 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HB3' ' N ' ' A' ' 51' ' ' ALA . 4.4 t80 -171.36 141.82 1.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.476 0.71 . . . . 0.0 109.675 172.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -165.86 156.75 13.4 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.624 0.77 . . . . 0.0 110.383 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.68 167.28 11.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.754 0.822 . . . . 0.0 110.078 167.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.32 -29.11 69.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 112.036 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -68.22 -33.39 74.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.208 0.603 . . . . 0.0 111.42 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 69' ' ' PHE . 26.4 m -105.83 9.39 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.635 0.774 . . . . 0.0 111.098 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.07 119.19 8.44 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.391 1.076 . . . . 0.0 110.84 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.24 -16.67 15.99 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -98.51 -45.8 5.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.212 0.605 . . . . 0.0 109.384 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.457 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.8 m-85 -98.12 120.04 37.83 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.2 m -124.99 144.8 50.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.561 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -127.52 141.67 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.065 0.546 . . . . 0.0 110.826 -175.237 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -150.63 137.77 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.277 1.031 . . . . 0.0 109.694 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.51 ' HB2' HG21 ' A' ' 52' ' ' ILE . 22.1 ttp85 -124.6 130.16 51.92 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.27 110.01 22.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.886 1.274 . . . . 0.0 111.794 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.93 68.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.137 0.975 . . . . 0.0 111.712 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HE3' ' HB ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -120.23 -3.91 10.0 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.455 176.106 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 52.92 67.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.43 1.092 . . . . 0.0 111.451 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.453 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 92.3 m -127.15 132.83 50.45 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.682 173.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.565 HG13 HD12 ' A' ' 52' ' ' ILE . 23.3 t -101.6 151.16 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.773 1.229 . . . . 0.0 108.607 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -133.04 141.36 48.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.462 0.705 . . . . 0.0 109.59 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.45 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 66.3 tp -128.48 99.55 5.43 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -83.3 98.04 9.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.45 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 72.6 mtp -90.74 107.74 19.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.143 0.977 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.9 153.45 23.02 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.946 0.498 . . . . 0.0 110.156 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.5 t 60.07 62.17 1.69 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.562 1.145 . . . . 0.0 109.936 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.13 152.73 45.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.088 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -120.71 151.53 54.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.84 -15.2 45.61 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.15 1.9 . . . . 0.0 112.252 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.98 -25.1 66.16 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -82.2 24.15 0.68 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.661 0.784 . . . . 0.0 111.929 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 120' ' ' THR . 64.4 m -79.66 90.44 5.18 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 159.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.5 -174.31 2.48 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.446 -168.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.2 p -109.24 108.23 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.676 0.79 . . . . 0.0 109.807 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -85.04 116.3 23.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 167.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.462 HD13 ' HD1' ' A' ' 113' ' ' TRP . 2.5 pp -115.07 137.24 52.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 111.071 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.5 t -93.75 156.1 16.86 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.42 156.04 41.97 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.446 0.698 . . . . 0.0 109.713 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.64 158.61 37.33 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.906 0.482 . . . . 0.0 111.558 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.96 149.15 5.26 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 t -111.45 19.34 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.062 0.934 . . . . 0.0 109.572 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -114.66 104.79 12.33 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -126.37 138.94 53.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.1 m -89.36 -41.85 11.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.486 0.714 . . . . 0.0 111.164 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.2 t -78.34 -24.95 46.3 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.001 0.92 . . . . 0.0 111.723 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.23 -28.77 11.69 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -174.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -67.37 143.35 56.38 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.49 0.716 . . . . 0.0 109.758 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.47 99.22 0.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 O-C-N 123.878 0.736 . . . . 0.0 110.478 -174.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.9 p -134.5 149.58 71.4 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.959 1.304 . . . . 0.0 109.389 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.14 154.63 29.09 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.441 2.094 . . . . 0.0 112.678 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.81 -40.23 6.65 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -121.94 164.35 17.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.162 0.985 . . . . 0.0 110.174 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.462 ' HD1' HD13 ' A' ' 96' ' ' LEU . 31.8 m-90 -119.7 157.53 28.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.695 1.198 . . . . 0.0 108.751 174.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -76.53 -76.43 0.83 Allowed Glycine 0 C--N 1.341 0.815 0 O-C-N 123.177 0.298 . . . . 0.0 112.987 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.92 -42.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 109.626 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.1 113.95 3.58 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.787 -172.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 t -96.41 108.67 21.25 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.832 0.825 . . . . 0.0 109.391 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -71.79 106.11 4.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.293 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.47 125.28 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 92' ' ' THR . 26.0 m -120.04 104.42 10.12 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 13' ' ' VAL . 57.8 t -89.23 105.79 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 121.862 -0.523 . . . . 0.0 110.365 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 m -58.74 139.27 56.44 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.46 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.9 m -72.54 91.14 1.38 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 73.81 -22.94 0.23 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.668 1.587 . . . . 0.0 113.111 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.58 145.39 36.88 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.123 0.969 . . . . 0.0 110.693 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -99.9 145.83 27.35 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.496 0.718 . . . . 0.0 110.657 -174.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -83.05 96.65 8.42 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.796 0.838 . . . . 0.0 110.159 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -76.15 111.1 11.21 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -68.78 133.82 48.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.688 0.795 . . . . 0.0 111.05 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -131.09 131.96 44.54 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.006 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 ttm . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -99.18 85.56 3.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.933 0.893 . . . . 0.0 109.152 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.33 111.64 9.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.35 129.68 48.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.479 0.712 . . . . 0.0 109.667 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.45 HD22 ' SG ' ' A' ' 23' ' ' CYS . 89.7 mt -124.94 107.61 11.03 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.6 t -98.89 101.74 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 22' ' ' SER . 47.1 mt-10 -100.9 143.97 30.41 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.11 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.9 p -160.54 157.79 28.03 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.091 0.957 . . . . 0.0 109.792 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.443 ' O ' HD11 ' A' ' 19' ' ' LEU . . . 130.85 -32.27 3.05 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -59.09 127.96 46.43 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.27 -178.45 46.06 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 120' ' ' THR . 22.8 tp -88.18 109.51 19.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.86 0.464 . . . . 0.0 109.798 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 19' ' ' LEU . 18.5 m -126.68 151.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.089 0.956 . . . . 0.0 109.373 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -75.64 151.11 37.83 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.438 0.563 . . . . 0.0 111.259 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.11 125.09 23.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.156 0.982 . . . . 0.0 110.407 175.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.18 -20.26 26.22 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 123.814 0.721 . . . . 0.0 111.35 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.62 -166.94 9.88 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 121.598 0.554 . . . . 0.0 113.618 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.4 p -133.01 132.73 42.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.013 0.925 . . . . 0.0 109.395 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 13' ' ' VAL . 25.5 tp -134.95 118.76 17.22 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -97.65 120.8 38.69 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.128 0.571 . . . . 0.0 109.693 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.9 157.26 19.55 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.199 0.6 . . . . 0.0 109.394 172.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 18.6 p -145.92 126.11 13.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.845 0.858 . . . . 0.0 109.191 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 52.5 t -123.19 107.54 11.83 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.468 1.107 . . . . 0.0 108.901 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 21.2 t -89.24 115.22 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.642 0.777 . . . . 0.0 109.023 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.19 103.23 15.87 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p 54.66 36.74 26.79 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.707 1.603 . . . . 0.0 112.381 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.94 -107.94 2.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.69 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -118.79 10.98 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.009 0.924 . . . . 0.0 110.288 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -81.78 146.99 29.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -104.21 115.75 30.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -151.35 10.76 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.883 1.673 . . . . 0.0 108.847 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 p -86.99 88.52 7.72 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.224 1.01 . . . . 0.0 110.453 -174.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -70.74 -48.7 53.07 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.555 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.86 126.95 1.03 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.338 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.429 ' HE1' ' NH1' ' A' ' 73' ' ' ARG . 1.8 mpp? -125.44 119.76 29.15 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.657 1.183 . . . . 0.0 108.337 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -103.49 140.39 14.87 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -87.71 125.26 34.3 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.61 148.55 49.78 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -126.56 139.09 53.47 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.81 130.0 53.07 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.92 154.53 83.0 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -53.73 102.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.448 2.099 . . . . 0.0 112.41 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.99 23.21 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.931 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 6.9 mmpt? -133.44 170.41 15.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.83 0.824 . . . . 0.0 112.453 -174.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.24 176.46 6.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.982 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.48 37.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.61 125.65 40.61 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.36 110.26 4.02 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.18 -51.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.348 0.659 . . . . 0.0 109.64 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.69 170.04 22.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.212 0.605 . . . . 0.0 111.706 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -154.59 120.2 5.14 Favored 'General case' 0 C--O 1.25 1.126 0 C-N-CA 124.053 0.941 . . . . 0.0 110.131 173.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.645 HG23 ' HB3' ' A' ' 58' ' ' SER . 4.0 mp -122.65 116.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.392 1.077 . . . . 0.0 109.045 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.87 178.33 5.47 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.091 0.556 . . . . 0.0 109.636 172.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.432 ' HE1' ' ND2' ' A' ' 75' ' ' ASN . 28.0 t90 -71.89 -28.45 63.53 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 120.982 0.42 . . . . 0.0 110.22 171.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.2 t -153.0 160.98 43.07 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.73 0.812 . . . . 0.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.93 11.7 25.7 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.848 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.83 -52.33 0.65 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.645 ' HB3' HG23 ' A' ' 52' ' ' ILE . 20.3 m 61.25 64.59 1.07 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.632 0.773 . . . . 0.0 112.166 168.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -157.21 123.49 4.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.954 0.901 . . . . 0.0 109.883 -166.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 51' ' ' ALA . 25.8 m-85 -158.5 135.83 10.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.943 0.897 . . . . 0.0 109.167 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.55 153.9 11.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.554 1.542 . . . . 0.0 108.889 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.38 151.36 32.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.425 0.69 . . . . 0.0 109.789 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.2 -33.28 69.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.487 0.715 . . . . 0.0 111.498 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 m -66.82 -29.91 69.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.318 1.047 . . . . 0.0 112.208 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.48 -7.12 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.347 0.659 . . . . 0.0 111.869 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.05 122.48 17.49 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.603 0.761 . . . . 0.0 110.544 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.35 -28.54 14.05 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.666 0.604 . . . . 0.0 111.979 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 10.1 mtm180 -88.97 -52.89 4.85 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -91.39 131.6 36.77 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.722 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -140.9 150.21 42.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.458 1.103 . . . . 0.0 108.461 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.45 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -123.29 144.01 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.147 0.579 . . . . 0.0 110.491 178.057 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -144.13 134.4 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.101 0.96 . . . . 0.0 109.05 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.517 ' HB2' HG21 ' A' ' 52' ' ' ILE . 46.4 ttt180 -111.9 125.05 53.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.012 0.525 . . . . 0.0 110.363 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.523 ' HB3' ' HE3' ' A' ' 77' ' ' LYS . 60.6 m-20 -103.0 94.64 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.432 ' ND2' ' HE1' ' A' ' 54' ' ' TRP . 63.9 t30 -65.61 -26.07 67.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.824 0.85 . . . . 0.0 111.936 -173.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.58 73.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.678 0.791 . . . . 0.0 112.27 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.523 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -118.59 8.18 11.93 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.582 0.753 . . . . 0.0 110.528 176.229 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 55.82 30.73 16.32 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.843 1.257 . . . . 0.0 112.851 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.4 m -111.39 130.46 55.69 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.26 138.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 108.702 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -117.27 139.62 50.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.896 0.878 . . . . 0.0 110.055 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.1 tp -113.78 97.64 6.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -84.06 100.67 11.24 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 36.6 mtm -94.07 126.47 39.31 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -122.69 167.14 13.82 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 68' ' ' ARG . 13.5 m 57.65 40.2 26.82 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.622 0.769 . . . . 0.0 110.42 173.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.7 mt -56.85 142.99 38.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.653 -170.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.638 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -105.68 151.22 39.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.29 -14.19 40.48 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.199 1.933 . . . . 0.0 112.683 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.638 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.72 -22.02 66.58 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.453 0.701 . . . . 0.0 111.565 173.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -78.28 23.62 0.28 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.822 0.849 . . . . 0.0 111.647 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 120' ' ' THR . 99.0 m -82.79 92.54 7.26 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 163.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.02 -174.74 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.312 0.645 . . . . 0.0 111.106 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.93 112.04 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -85.45 108.73 18.02 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -112.18 138.45 48.84 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.977 0.911 . . . . 0.0 109.435 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 52.1 m -91.29 139.07 31.08 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.71 116.86 16.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.592 0.757 . . . . 0.0 109.136 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 35' ' ' MET . . . -111.87 152.96 27.35 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.104 0.562 . . . . 0.0 110.362 -173.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -135.99 149.68 20.14 Favored Glycine 0 C--O 1.241 0.573 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.9 m -72.11 166.91 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.095 0.558 . . . . 0.0 110.267 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -53.85 133.75 42.65 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.8 0.84 . . . . 0.0 112.096 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.698 ' NH2' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -136.31 155.96 49.33 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.673 0.789 . . . . 0.0 110.347 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.5 m -77.2 -22.25 52.65 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.976 0.91 . . . . 0.0 111.257 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.2 p -74.04 -26.24 60.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.574 0.75 . . . . 0.0 112.232 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.14 -31.24 3.17 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.104 0.802 . . . . 0.0 115.104 173.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -73.94 153.57 39.73 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.071 0.935 . . . . 0.0 111.044 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.698 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 25.5 t70 -75.71 125.44 29.07 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.099 -174.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.9 t -125.15 114.9 26.06 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.699 -173.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.39 95.04 0.37 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.783 2.322 . . . . 0.0 111.441 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -97.22 -47.93 5.55 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.363 0.602 . . . . 0.0 109.705 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.07 144.17 40.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.73 1.212 . . . . 0.0 108.438 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -120.97 137.92 54.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.335 0.654 . . . . 0.0 109.247 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.03 -137.04 1.05 Allowed Glycine 0 C--N 1.346 1.117 0 O-C-N 123.338 0.399 . . . . 0.0 113.151 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -94.92 -30.89 13.92 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.073 0.549 . . . . 0.0 110.599 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.22 116.95 0.13 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.249 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -99.37 123.35 43.57 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 117.229 0.514 . . . . 0.0 110.489 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -77.39 101.48 6.38 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.261 1.024 . . . . 0.0 110.707 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.559 HG12 ' HA2' ' A' ' 10' ' ' GLY . 20.0 m -93.01 137.5 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 92' ' ' THR . 70.2 m -134.17 105.03 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.3 t -87.77 98.22 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 t -50.43 131.2 24.54 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.382 1.073 . . . . 0.0 111.742 172.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.6 p -76.4 82.52 3.13 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.057 0.543 . . . . 0.0 110.616 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.5 mm? 63.26 7.41 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.007 1.323 . . . . 0.0 114.071 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -88.55 143.34 27.02 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -85.38 109.1 18.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.745 0.818 . . . . 0.0 110.776 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -80.95 140.5 35.22 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -122.78 115.05 21.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -79.64 -27.24 40.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.18 0.992 . . . . 0.0 111.468 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 72.09 -77.44 0.06 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.626 1.17 . . . . 0.0 111.068 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.6 t60 . . . . . 0 C--O 1.246 0.911 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.333 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' N ' ' SD ' ' A' ' 1' ' ' MET . 96.6 mt-30 67.99 -175.22 0.2 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.221 1.008 . . . . 0.0 110.806 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.88 113.47 22.04 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 168.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -117.68 133.9 55.46 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.51 1.124 . . . . 0.0 108.812 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.648 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 94.3 mt -131.68 120.8 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.915 0.886 . . . . 0.0 109.381 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.2 t -98.42 104.88 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 108.537 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -104.66 151.08 24.12 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.369 0.668 . . . . 0.0 111.19 -168.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 p -157.15 170.75 21.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.658 0.783 . . . . 0.0 111.079 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.09 32.28 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.26 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.569 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -69.34 120.34 10.21 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 113.957 0.343 . . . . 0.0 113.957 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.76 179.48 48.78 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 120' ' ' THR . 10.2 tt -88.02 128.55 35.4 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.411 0.284 . . . . 0.0 110.288 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.58 152.53 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.25 150.99 35.31 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -59.7 127.6 32.82 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 0.0 110.552 174.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.15 18.13 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.2 -179.22 52.46 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 122.873 0.273 . . . . 0.0 113.292 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -121.0 164.64 16.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.042 0.937 . . . . 0.0 110.563 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.4 tp -159.47 123.65 3.87 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.579 0.752 . . . . 0.0 109.982 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -99.32 129.58 45.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.06 0.544 . . . . 0.0 109.576 173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -96.42 154.32 17.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.325 1.05 . . . . 0.0 109.007 171.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -143.54 128.74 18.74 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 30.8 t -137.74 104.61 5.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.46 0.704 . . . . 0.0 110.065 -172.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -84.75 145.28 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.812 . . . . 0.0 110.25 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.539 ' HA ' HD23 ' A' ' 5' ' ' LEU . . . -89.98 100.43 13.25 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.124 0.57 . . . . 0.0 110.063 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p 56.46 -75.38 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.85 2.06 . . . . 0.0 112.457 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.74 -64.38 0.06 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -161.66 39.32 0.13 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.06 0.933 . . . . 0.0 109.451 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -107.36 151.04 26.04 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -105.29 126.31 51.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.813 0.845 . . . . 0.0 108.878 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -150.66 146.68 26.64 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.832 0.853 . . . . 0.0 109.074 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t 66.07 115.34 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.212 1.405 . . . . 0.0 111.183 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -80.67 7.83 9.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.4 0.68 . . . . 0.0 111.299 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.86 119.92 21.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.561 0.744 . . . . 0.0 109.306 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.8 mtt -137.38 119.9 16.0 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -125.29 142.46 13.82 Favored Glycine 0 N--CA 1.468 0.832 0 CA-C-N 118.102 0.41 . . . . 0.0 112.92 -172.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.412 ' HE1' HG12 ' A' ' 80' ' ' VAL . 95.0 m95 -86.06 117.89 25.19 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -117.02 171.34 7.99 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.922 1.289 . . . . 0.0 108.595 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -150.83 130.93 13.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.924 0.49 . . . . 0.0 110.029 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -110.56 128.83 55.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.12 39.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.493 0.717 . . . . 0.0 109.658 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.74 107.72 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.778 2.318 . . . . 0.0 113.119 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.49 1.52 66.24 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.552 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.4 mmpt? -114.98 173.43 6.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.223 1.009 . . . . 0.0 110.203 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.59 176.48 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.024 0.93 . . . . 0.0 110.425 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 124.01 24.51 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.172 0.51 . . . . 0.0 111.141 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.15 134.63 36.39 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.358 1.063 . . . . 0.0 109.366 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -71.11 109.36 5.14 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.812 0.695 . . . . 0.0 109.305 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.57 -53.24 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.81 174.75 10.3 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.922 -172.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -159.85 142.07 13.31 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.15 0.976 . . . . 0.0 112.014 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 71' ' ' ILE . 4.0 mp -109.78 114.06 45.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.139 174.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -98.11 109.22 22.01 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 168.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -71.05 81.12 0.67 Allowed 'General case' 0 C--N 1.35 0.589 0 C-N-CA 123.386 0.674 . . . . 0.0 109.225 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.43 ' H ' ' H ' ' A' ' 56' ' ' GLY . 21.5 t 179.09 8.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.641 1.576 . . . . 0.0 109.924 -175.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 55' ' ' SER . . . 110.16 -18.44 28.35 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 119.928 -0.374 . . . . 0.0 113.218 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.87 44.65 2.69 Favored Glycine 0 N--CA 1.478 1.461 0 CA-C-N 117.387 0.593 . . . . 0.0 112.463 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 13.5 p -85.79 39.83 0.82 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.643 1.177 . . . . 0.0 112.445 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -154.08 121.18 5.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.472 0.709 . . . . 0.0 110.021 -166.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.453 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 32.3 m-85 -158.25 154.58 27.44 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.764 1.626 . . . . 0.0 107.028 170.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -166.49 148.4 6.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.04 0.536 . . . . 0.0 110.368 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.01 25.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.6 -34.1 76.34 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -66.81 -18.44 65.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.696 0.798 . . . . 0.0 112.617 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.13 5.27 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.974 0.51 . . . . 0.0 111.662 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.19 131.68 51.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.544 0.738 . . . . 0.0 111.54 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 -28.32 4.57 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.167 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 88.9 mtm180 -92.67 -47.85 6.88 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.509 0.723 . . . . 0.0 110.158 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -87.84 122.62 31.7 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 m -124.99 133.54 52.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 108.446 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.548 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -120.77 146.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 122.766 0.426 . . . . 0.0 110.636 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 p -159.37 151.51 20.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.602 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' HB3' HG21 ' A' ' 52' ' ' ILE . 52.6 ttt180 -128.36 123.42 33.83 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -105.22 103.23 12.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -76.82 -11.83 59.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.218 0.607 . . . . 0.0 111.49 -173.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.59 92.34 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 122.549 0.34 . . . . 0.0 111.861 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -112.39 1.9 16.2 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 117.99 0.359 . . . . 0.0 110.905 169.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 43.8 m-80 58.56 66.66 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.843 1.257 . . . . 0.0 110.807 176.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.8 m -141.8 132.36 25.39 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.088 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.412 HG12 ' HE1' ' A' ' 37' ' ' TRP . 27.5 t -111.17 130.0 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.381 1.072 . . . . 0.0 108.965 -173.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -113.23 148.68 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.729 0.812 . . . . 0.0 111.308 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 65.5 tp -132.0 98.07 4.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -87.73 100.53 12.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.753 ' HB3' HD21 ' A' ' 87' ' ' LEU . 48.2 mtm -94.34 142.18 27.71 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.591 0.757 . . . . 0.0 108.99 175.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 18.1 m120 -136.81 150.15 48.16 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.45 0.7 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 t 52.31 59.91 4.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 173.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -79.66 161.08 26.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.4 -171.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.1 153.4 61.15 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 121' ' ' VAL . 37.7 Cg_endo -60.8 -15.66 39.31 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.862 2.375 . . . . 0.0 115.04 -168.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -72.56 -14.66 61.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.106 0.563 . . . . 0.0 111.983 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -82.15 19.52 1.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.403 0.681 . . . . 0.0 111.019 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 96.7 m -75.31 92.44 2.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 165.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.4 164.05 27.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.449 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.27 107.45 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.414 174.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -84.66 138.02 32.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 113' ' ' TRP . 1.7 pt? -150.2 139.75 21.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.935 0.494 . . . . 0.0 110.889 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.7 m -87.74 114.69 24.59 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -107.78 117.01 33.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 108.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.18 116.83 31.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.29 159.29 29.31 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.491 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.24 118.66 43.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.579 ' HD1' ' HA ' ' A' ' 108' ' ' ASP . 6.3 m-90 -61.86 141.17 58.12 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -63.17 162.84 11.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.767 0.427 . . . . 0.0 111.55 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.0 t -65.81 -25.15 67.1 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.235 0.614 . . . . 0.0 110.745 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 p -73.13 -24.57 60.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.411 0.684 . . . . 0.0 111.051 172.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.18 -7.38 28.89 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.096 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -64.94 137.6 57.84 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.253 0.621 . . . . 0.0 110.481 -175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.579 ' HA ' ' HD1' ' A' ' 102' ' ' TRP . 21.9 t70 -72.21 126.87 30.88 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.238 0.615 . . . . 0.0 110.489 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.94 107.35 4.27 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.616 0.766 . . . . 0.0 111.006 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.583 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 2.6 Cg_exo -77.39 123.4 6.53 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.13 2.553 . . . . 0.0 110.433 167.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -91.29 -47.01 7.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.432 0.693 . . . . 0.0 110.336 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -125.78 158.53 34.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.773 . . . . 0.0 109.945 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.418 ' HB3' HD12 ' A' ' 96' ' ' LEU . 22.7 m-90 -128.0 152.72 47.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.559 1.144 . . . . 0.0 108.534 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.21 46.52 3.4 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.965 -173.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 73.26 -45.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.633 1.573 . . . . 0.0 111.857 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . 98.36 112.06 3.13 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -97.75 123.16 41.57 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 121.885 0.85 . . . . 0.0 109.965 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -80.35 103.76 10.44 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.243 1.017 . . . . 0.0 110.567 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.569 HG12 ' HA2' ' A' ' 10' ' ' GLY . 3.5 m -105.26 150.56 7.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 89.8 m -134.85 114.6 12.75 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' PRO . 40.8 t -92.42 105.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 12' ' ' LEU . 15.0 t -73.72 158.02 35.43 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 120.667 0.27 . . . . 0.0 111.036 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.7 p -84.85 73.14 10.68 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.686 0.795 . . . . 0.0 110.667 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.9 mm? 71.89 -14.67 0.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.521 1.528 . . . . 0.0 113.765 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.46 ' HB2' ' OG ' ' A' ' 122' ' ' SER . 2.4 mp0 -63.12 106.9 0.93 Allowed 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.97 0.805 . . . . 0.0 109.739 173.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -74.22 -10.32 59.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.944 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -63.9 98.62 0.21 Allowed 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.68 0.792 . . . . 0.0 108.924 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.512 ' HA ' HD22 ' A' ' 12' ' ' LEU . 92.8 m-70 -67.8 133.46 49.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.84 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.2 t60 58.57 87.55 0.07 Allowed 'General case' 0 CA--C 1.55 0.962 0 O-C-N 124.587 1.179 . . . . 0.0 108.652 -169.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -50.67 -40.25 53.1 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.518 1.127 . . . . 0.0 113.369 -165.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 . . . . . 0 C--O 1.244 0.784 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -63.85 144.61 56.92 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.081 0.552 . . . . 0.0 110.679 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -72.25 108.79 5.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -112.19 127.83 56.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.653 0.781 . . . . 0.0 109.535 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.673 HD11 ' HG2' ' A' ' 35' ' ' MET . 96.4 mt -132.84 122.77 24.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.616 1.166 . . . . 0.0 109.703 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -106.48 102.29 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.02 145.1 27.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 p -160.88 168.09 25.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.852 0.861 . . . . 0.0 110.257 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.06 17.82 21.63 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.406 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -78.32 134.81 14.76 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.14 -178.54 47.67 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.6 tt -98.37 131.78 44.38 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.918 0.487 . . . . 0.0 109.889 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.68 170.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.926 1.291 . . . . 0.0 107.907 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -90.77 154.04 19.81 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.742 0.417 . . . . 0.0 109.964 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.45 124.97 24.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.761 0.824 . . . . 0.0 110.567 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.36 -23.35 24.97 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.03 174.81 48.79 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.774 0.338 . . . . 0.0 112.371 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.0 p -106.11 162.76 13.34 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.372 0.669 . . . . 0.0 110.566 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.6 tp -159.8 121.82 3.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.063 0.945 . . . . 0.0 108.613 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -98.53 122.41 41.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.062 0.458 . . . . 0.0 110.165 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.451 HD12 HG21 ' A' ' 117' ' ' THR . 3.8 mm? -94.82 145.32 24.97 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.071 0.949 . . . . 0.0 108.966 172.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 p -131.89 126.15 33.46 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.508 0.723 . . . . 0.0 109.15 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 43.2 t -122.73 108.94 13.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.619 1.167 . . . . 0.0 108.623 -177.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.24 129.69 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.135 0.974 . . . . 0.0 109.088 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -87.1 100.96 13.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.6 p 64.62 -75.51 0.04 OUTLIER 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.533 1.933 . . . . 0.0 111.713 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.06 -62.78 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -166.81 67.45 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -138.89 162.08 35.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.377 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -103.9 122.16 44.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.765 0.826 . . . . 0.0 109.227 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.22 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.531 ' HA ' HD21 ' A' ' 3' ' ' LEU . 5.5 m -71.84 85.03 0.94 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.565 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 73' ' ' ARG . 24.1 p-10 -93.59 -27.07 16.82 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.666 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.3 120.12 15.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.788 -171.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.673 ' HG2' HD11 ' A' ' 5' ' ' LEU . 4.5 mtm -150.82 141.84 23.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.222 1.409 . . . . 0.0 108.837 -175.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.64 136.44 11.06 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 76.2 m95 -86.72 130.12 34.6 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.532 0.666 . . . . 0.0 110.319 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -123.06 171.75 9.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.96 1.304 . . . . 0.0 108.261 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -143.23 131.37 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 168.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -102.5 130.9 49.46 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -115.99 149.56 43.55 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.007 0.523 . . . . 0.0 110.054 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.27 100.6 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.385 2.056 . . . . 0.0 111.367 172.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.78 5.66 56.5 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.964 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 7.4 mmpt? -138.76 137.89 37.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.723 0.809 . . . . 0.0 109.623 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.32 171.6 5.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.766 0.826 . . . . 0.0 111.555 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.04 124.88 21.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.289 0.566 . . . . 0.0 111.317 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -93.83 126.47 39.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -76.0 106.63 7.7 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -94.95 -48.63 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.541 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . . . -151.19 164.14 37.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -170.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -152.68 134.9 14.98 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.923 0.868 . . . . 0.0 111.442 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.51 118.33 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -121.28 97.43 5.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.258 0.623 . . . . 0.0 109.47 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 67.98 -71.21 0.11 Allowed 'General case' 0 C--N 1.368 1.399 0 C-N-CA 125.278 1.431 . . . . 0.0 108.566 -172.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 t -146.45 -78.79 0.17 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 164.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.03 22.27 70.43 Favored Glycine 0 C--N 1.356 1.648 0 C-N-CA 123.12 0.391 . . . . 0.0 114.054 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.85 -20.58 41.44 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-O 119.334 -0.704 . . . . 0.0 112.797 -172.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.7 t 56.52 66.94 1.07 Allowed 'General case' 0 C--N 1.367 1.331 0 C-N-CA 124.468 1.107 . . . . 0.0 109.602 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -156.86 124.3 5.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -165.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.423 ' H ' HD11 ' A' ' 71' ' ' ILE . 5.5 t80 -169.52 117.28 0.61 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 65' ' ' VAL . 4.8 p90 -164.87 151.92 11.0 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.935 0.894 . . . . 0.0 109.207 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.98 31.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.346 0.658 . . . . 0.0 110.885 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.58 -28.07 68.88 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.368 0.667 . . . . 0.0 110.439 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.8 p -68.32 -28.57 67.27 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.443 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 61' ' ' TYR . 29.3 m -116.37 19.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.615 0.766 . . . . 0.0 111.272 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -67.82 120.63 14.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.9 0.88 . . . . 0.0 110.483 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -20.83 26.27 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 68.6 mtp180 -85.68 -70.08 0.62 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 110.071 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -86.2 120.86 28.02 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 m -130.2 140.58 50.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.212 1.005 . . . . 0.0 108.615 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.438 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -122.53 147.06 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.535 0.734 . . . . 0.0 109.324 175.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -147.0 133.5 19.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.539 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 33' ' ' ASN . 51.2 ttt-85 -114.7 124.84 52.83 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -103.52 110.87 23.08 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -74.98 -20.18 59.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.556 0.742 . . . . 0.0 111.904 -175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.86 78.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.603 0.361 . . . . 0.0 111.727 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -118.93 -5.68 10.56 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.319 171.247 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 11.4 m-80 60.75 70.37 0.62 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.007 0.923 . . . . 0.0 110.524 -174.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.0 m -138.17 131.68 30.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.36 135.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.745 0.818 . . . . 0.0 109.594 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -121.0 115.01 22.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.836 0.854 . . . . 0.0 109.508 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 tp -92.35 97.79 11.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -85.17 100.94 12.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.45 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.624 ' SD ' HD21 ' A' ' 87' ' ' LEU . 56.6 mtt -84.23 126.59 33.29 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -129.41 137.31 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 t 58.76 73.11 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.593 0.711 . . . . 0.0 110.304 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.624 HD21 ' SD ' ' A' ' 84' ' ' MET . 22.6 mt -75.53 162.5 28.25 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.287 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -125.99 149.16 65.43 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.524 1.129 . . . . 0.0 108.458 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.47 -13.7 40.08 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.956 2.437 . . . . 0.0 112.739 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.43 -28.63 69.81 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.591 1.157 . . . . 0.0 111.891 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -74.92 14.97 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.418 0.687 . . . . 0.0 112.375 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 HG23 ' A' ' 120' ' ' THR . 92.5 m -73.33 89.41 1.59 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 158.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.96 173.37 3.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.722 1.209 . . . . 0.0 109.389 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.26 115.8 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -83.62 133.23 34.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.494 0.718 . . . . 0.0 109.227 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -139.81 120.9 14.71 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.461 0.704 . . . . 0.0 109.891 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.57 ' SG ' ' HB3' ' A' ' 35' ' ' MET . 46.8 t -89.37 116.14 27.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.75 158.67 23.49 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.13 0.972 . . . . 0.0 110.534 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -116.62 139.59 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.4 -153.49 23.33 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.232 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 m -99.3 82.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-O 122.122 0.963 . . . . 0.0 109.896 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -69.48 117.33 10.96 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.101 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -136.77 159.03 43.05 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.6 m -85.17 -2.26 57.82 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.198 0.599 . . . . 0.0 111.671 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.3 t -80.99 14.3 2.31 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.956 0.903 . . . . 0.0 112.656 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.32 19.02 61.31 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.343 -0.698 . . . . 0.0 114.117 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -51.79 158.59 0.96 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.606 1.162 . . . . 0.0 113.79 -170.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.83 162.95 22.94 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.018 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 59.1 p -40.91 127.23 1.97 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 125.948 1.699 . . . . 0.0 113.661 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 109' ' ' THR . 48.1 Cg_exo -57.32 165.41 5.67 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.813 3.009 . . . . 0.0 114.028 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.24 -47.95 22.06 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.201 0.524 . . . . 0.0 110.069 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 64.6 m-85 -111.84 147.24 36.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.27 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.415 ' HZ2' ' HB ' ' A' ' 109' ' ' THR . 21.6 m-90 -126.13 146.23 50.02 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 167.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -70.42 -84.13 0.18 Allowed Glycine 0 C--N 1.339 0.744 0 O-C-N 123.664 0.602 . . . . 0.0 113.765 -176.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.26 -46.13 0.14 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -176.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.6 95.13 1.32 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.523 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.451 HG21 HD12 ' A' ' 21' ' ' LEU . 7.2 t -97.85 121.63 40.0 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.532 0.733 . . . . 0.0 110.409 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.36 117.88 20.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.845 0.858 . . . . 0.0 109.097 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.406 HG12 ' HA2' ' A' ' 10' ' ' GLY . 33.5 m -118.38 141.81 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.428 0.691 . . . . 0.0 109.23 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 33.6 m -129.23 104.34 7.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 87' ' ' LEU . 52.6 t -94.17 98.11 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.8 t -66.32 150.25 49.13 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.726 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.4 m -71.14 165.36 23.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.925 0.89 . . . . 0.0 111.463 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.55 -42.79 77.88 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -71.65 -92.97 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.136 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 176.54 107.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.892 0.877 . . . . 0.0 108.692 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -148.9 153.16 37.63 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.882 1.273 . . . . 0.0 110.034 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -159.81 138.23 10.44 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 62.18 -177.53 0.13 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.403 1.081 . . . . 0.0 111.932 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -122.23 115.94 23.26 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 17.1 p80 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 124.269 1.028 . . . . 0.0 111.47 -176.918 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 57.11 -156.49 0.3 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.104 0.962 . . . . 0.0 111.536 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.09 111.26 21.37 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -119.89 108.38 14.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 99' ' ' ALA . 2.9 mm? -96.38 109.02 21.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.01 104.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -76.96 155.83 32.39 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.512 0.673 . . . . 0.0 111.209 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 p -155.33 154.06 31.46 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 108.695 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.52 -2.63 56.09 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -69.57 105.49 1.54 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.55 27.2 Favored Glycine 0 C--O 1.245 0.8 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 122' ' ' SER . 9.8 tt -88.31 137.09 32.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 m -136.37 168.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.694 1.198 . . . . 0.0 109.213 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -87.5 151.58 22.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.575 0.75 . . . . 0.0 110.724 177.38 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.25 141.55 52.43 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 123.32 0.648 . . . . 0.0 110.384 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.49 13.72 Favored Glycine 0 N--CA 1.464 0.545 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.09 -172.25 46.04 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 112.161 -0.375 . . . . 0.0 112.161 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 p -123.18 164.08 19.38 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.301 0.64 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.4 tp -148.25 127.75 13.19 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -108.28 113.2 26.12 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.532 0.733 . . . . 0.0 109.336 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -84.27 153.39 23.59 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.5 p -142.14 122.06 13.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.889 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.7 t -105.71 111.89 24.75 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.97 0.908 . . . . 0.0 109.486 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.65 118.96 32.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.51 99.44 12.44 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.497 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 22.7 t 59.53 39.45 21.6 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.903 1.281 . . . . 0.0 111.355 173.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.18 -69.69 2.2 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -162.23 87.13 0.62 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.33 1.052 . . . . 0.0 108.491 166.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 50.1 m -140.37 139.91 35.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 109.227 175.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -106.35 141.29 37.91 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -157.41 -49.06 0.07 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -98.39 133.8 42.28 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.909 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -97.78 -0.02 46.03 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.134 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.47 51.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.472 1.109 . . . . 0.0 108.472 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.635 ' SD ' ' HD2' ' A' ' 73' ' ' ARG . 47.2 mtt -150.68 168.32 24.69 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.515 1.526 . . . . 0.0 109.689 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.89 -171.99 32.73 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -132.86 133.28 43.11 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.72 155.24 35.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.382 1.073 . . . . 0.0 108.718 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -123.45 136.33 54.55 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.206 0.526 . . . . 0.0 110.407 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 94' ' ' VAL . 21.8 mm-40 -106.01 154.6 20.38 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.894 1.277 . . . . 0.0 108.254 172.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -141.79 154.78 66.14 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.568 0.747 . . . . 0.0 109.235 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.12 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.384 2.722 . . . . 0.0 114.102 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.9 20.2 78.08 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.649 -0.705 . . . . 0.0 114.288 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.5 mmpt? -129.87 145.32 51.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.951 0.901 . . . . 0.0 109.904 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.2 168.83 18.81 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.347 1.059 . . . . 0.0 111.854 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 143.1 46.7 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.28 139.11 51.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.158 0.583 . . . . 0.0 109.701 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.517 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 92.1 t80 -71.95 110.08 6.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.247 1.019 . . . . 0.0 109.61 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.27 -40.43 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.737 -174.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.58 160.28 40.22 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.517 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -143.24 125.14 15.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.33 1.052 . . . . 0.0 110.228 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.58 121.16 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.158 1.383 . . . . 0.0 108.11 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -110.53 179.03 4.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.54 0.736 . . . . 0.0 110.579 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -59.48 162.9 4.48 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.081 0.952 . . . . 0.0 110.911 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -37.69 120.1 0.79 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.692 1.597 . . . . 0.0 112.691 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.2 32.05 3.13 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.188 -171.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.71 145.37 4.15 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.307 173.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 t -167.85 43.09 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.61 0.764 . . . . 0.0 109.331 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 p -152.86 131.44 12.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.958 0.503 . . . . 0.0 110.672 -169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' H ' HD11 ' A' ' 71' ' ' ILE . 11.0 t80 -160.7 132.82 6.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 168.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.42 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 20.1 p90 -159.57 157.88 30.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.178 0.991 . . . . 0.0 110.144 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.51 156.97 30.63 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.485 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.604 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 37.9 t70 -70.76 -20.82 62.58 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.731 0.301 . . . . 0.0 110.4 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.0 m -61.82 -36.7 81.91 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.528 0.731 . . . . 0.0 111.063 172.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.85 15.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.604 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -60.27 124.83 21.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.227 0.611 . . . . 0.0 109.83 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.77 -28.49 7.06 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 123.734 0.646 . . . . 0.0 112.597 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.588 HH21 ' HA ' ' A' ' 87' ' ' LEU . 66.3 mtp180 -76.36 -46.06 29.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.099 0.952 . . . . 0.0 109.326 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 61' ' ' TYR . 24.3 t80 -91.42 128.55 37.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.999 -166.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 42.1 m -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.35 1.06 . . . . 0.0 108.46 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.574 HD11 ' H ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -141.2 144.15 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.845 0.858 . . . . 0.0 109.131 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.9 m -151.97 142.07 22.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.617 0.767 . . . . 0.0 109.907 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.635 ' HD2' ' SD ' ' A' ' 35' ' ' MET . 18.2 ttt85 -110.17 127.45 54.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 170.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -103.08 132.39 49.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.472 0.709 . . . . 0.0 109.187 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.89 -27.05 21.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 112.69 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.89 94.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.705 0.802 . . . . 0.0 112.049 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.6 5.17 13.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.322 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 49.99 68.03 0.81 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.737 1.215 . . . . 0.0 111.67 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.1 m -136.16 133.44 37.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.129 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.44 147.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -126.99 141.19 51.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.023 0.529 . . . . 0.0 110.252 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.4 tp -127.25 96.28 4.54 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.499 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 24.9 tp60 -96.08 100.65 12.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.0 mtm -102.93 112.91 25.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.577 0.751 . . . . 0.0 109.017 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -102.79 165.58 10.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.128 0.971 . . . . 0.0 110.225 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 68' ' ' ARG . 10.6 m 54.17 45.0 28.32 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 124.158 0.911 . . . . 0.0 111.384 171.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.588 ' HA ' HH21 ' A' ' 68' ' ' ARG . 82.2 mt -63.59 146.1 54.39 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.701 -168.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.472 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 29.4 mmmt -96.27 141.62 23.38 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.917 1.287 . . . . 0.0 108.6 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.85 -23.92 61.52 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.37 2.046 . . . . 0.0 113.216 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -72.24 -7.69 50.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.899 0.88 . . . . 0.0 112.316 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -84.77 38.2 0.69 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.802 0.841 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.2 m -90.84 100.52 13.36 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 171.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.76 -171.39 3.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.643 0.777 . . . . 0.0 110.273 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 40' ' ' GLN . 1.5 p -123.77 106.03 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -90.98 146.84 23.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.626 0.77 . . . . 0.0 110.965 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD13 ' HB3' ' A' ' 113' ' ' TRP . 2.0 pp -144.28 153.72 42.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.236 1.014 . . . . 0.0 109.41 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.8 148.21 22.53 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.05 148.49 31.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.106 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB3' HD21 ' A' ' 5' ' ' LEU . . . -155.85 135.76 12.76 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.394 0.678 . . . . 0.0 109.685 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.05 166.59 34.11 Favored Glycine 0 N--CA 1.449 -0.447 0 O-C-N 123.876 0.735 . . . . 0.0 111.441 171.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 m -62.75 147.22 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 122.642 0.377 . . . . 0.0 111.57 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -57.59 108.83 0.6 Allowed 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.069 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.601 ' HD2' ' HB ' ' A' ' 109' ' ' THR . 66.8 ttt180 -73.7 150.89 40.93 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.354 -176.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.2 m -64.9 -22.57 67.02 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.695 0.798 . . . . 0.0 111.814 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 t -74.0 -17.4 60.99 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.699 0.8 . . . . 0.0 111.533 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.85 -28.68 14.87 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.652 -0.249 . . . . 0.0 112.833 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -78.81 161.26 26.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.692 0.797 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.88 125.82 27.88 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 171.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.601 ' HB ' ' HD2' ' A' ' 103' ' ' ARG . 8.1 t -96.13 109.5 47.37 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.85 88.59 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 121.91 1.74 . . . . 0.0 111.056 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.34 -42.68 99.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.296 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -142.01 125.68 16.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.693 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.444 ' HB3' HD13 ' A' ' 96' ' ' LEU . 5.7 m-90 -94.03 155.11 17.29 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.85 171.55 52.02 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.191 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -63.22 -21.14 66.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.934 0.894 . . . . 0.0 112.059 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.05 127.79 1.22 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.46 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 11.1 t -125.61 138.47 53.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.127 0.571 . . . . 0.0 110.254 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -80.44 101.69 9.2 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.614 0.766 . . . . 0.0 111.449 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.0 m -99.25 130.57 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 170.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 82.9 m -135.11 110.7 9.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.7 104.61 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.939 -0.476 . . . . 0.0 109.779 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.549 ' HB2' HD21 ' A' ' 12' ' ' LEU . 35.2 t -61.88 155.43 23.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.584 0.754 . . . . 0.0 112.045 168.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 t -85.47 71.45 10.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.162 0.585 . . . . 0.0 109.644 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 4.1 mm? 68.25 -2.04 1.66 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.068 1.347 . . . . 0.0 114.26 173.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -73.31 -57.52 3.95 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.495 0.589 . . . . 0.0 111.165 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -129.63 178.21 6.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.39 0.614 . . . . 0.0 110.837 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -144.35 42.47 1.39 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.417 1.487 . . . . 0.0 107.606 172.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.46 ' H ' HD22 ' A' ' 12' ' ' LEU . 69.0 t60 -62.09 113.05 2.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.875 -168.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -100.68 163.93 12.11 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -74.34 -48.81 25.82 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.098 0.475 . . . . 0.0 110.304 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 . . . . . 0 C--O 1.248 1.017 0 C-N-CA 123.972 0.909 . . . . 0.0 109.118 -176.589 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 mtm . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -87.37 71.84 9.87 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.837 0.855 . . . . 0.0 108.886 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -72.31 112.2 8.17 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -107.58 146.18 32.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.346 1.058 . . . . 0.0 108.968 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.575 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 94.5 mt -125.63 108.17 11.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.67 107.52 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -102.98 154.84 18.83 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.691 0.619 . . . . 0.0 111.72 -170.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -157.68 158.8 36.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.4 1.08 . . . . 0.0 109.133 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.12 -2.99 29.91 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.827 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -72.24 83.33 0.53 Allowed Glycine 0 C--N 1.35 1.322 0 CA-C-N 117.173 0.486 . . . . 0.0 112.725 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.86 177.03 17.19 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.0 tt -92.54 114.14 26.61 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 87' ' ' LEU . 35.9 m -113.34 171.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -94.4 158.07 15.73 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.15 0.58 . . . . 0.0 109.919 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.76 116.83 5.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.756 0.822 . . . . 0.0 110.571 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.43 22.8 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.602 0.564 . . . . 0.0 111.988 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.65 55.24 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 121.275 0.375 . . . . 0.0 113.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 p -109.4 165.7 11.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 110.685 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.7 tp -158.33 141.03 14.58 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -114.26 113.16 24.24 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.175 0.512 . . . . 0.0 110.15 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -87.72 149.17 24.39 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 109.332 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.2 p -145.22 126.79 15.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.798 0.839 . . . . 0.0 109.346 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HG ' ' HG ' ' A' ' 97' ' ' CYS . 43.5 t -135.28 130.31 34.93 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 109.735 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.56 146.14 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.97 99.02 11.57 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t 53.37 40.65 31.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.297 1.439 . . . . 0.0 112.352 171.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.03 -61.08 4.36 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.027 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -168.54 33.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.03 1.332 . . . . 0.0 109.803 172.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -119.93 121.28 38.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.326 0.651 . . . . 0.0 109.945 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -133.43 150.67 51.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 110.371 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mtt85 -166.92 72.23 0.12 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 107.779 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.6 m -147.71 129.69 15.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.765 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.424 ' HB3' ' NE1' ' A' ' 54' ' ' TRP . 18.5 m120 -79.95 -43.71 21.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.88 0.472 . . . . 0.0 111.894 -171.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' TRP . . . -116.39 169.5 9.26 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.569 0.347 . . . . 0.0 110.318 173.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 80' ' ' VAL . 58.2 mtt -148.98 165.39 31.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.533 1.133 . . . . 0.0 109.006 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -155.8 -174.82 26.08 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-O 119.993 -0.337 . . . . 0.0 112.264 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -143.6 118.87 10.18 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.659 1.184 . . . . 0.0 108.455 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.52 162.87 14.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.411 1.084 . . . . 0.0 108.824 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -121.61 133.98 54.99 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.524 ' HB3' HG13 ' A' ' 94' ' ' VAL . 9.9 tm0? -107.84 128.97 55.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -111.78 141.2 24.27 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.552 0.741 . . . . 0.0 109.015 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.82 114.1 2.01 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.597 2.198 . . . . 0.0 112.391 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.51 79.78 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.492 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -119.09 173.58 6.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.571 1.148 . . . . 0.0 108.943 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.49 166.46 15.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.843 0.354 . . . . 0.0 110.622 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.92 115.55 11.26 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.343 0.592 . . . . 0.0 109.746 170.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -92.63 141.57 28.34 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.082 0.953 . . . . 0.0 109.892 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -77.58 116.47 18.16 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.63 0.581 . . . . 0.0 109.535 -178.05 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.18 -59.59 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.584 0.754 . . . . 0.0 110.072 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.537 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -148.79 163.45 37.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.449 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -157.25 164.72 37.4 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.362 1.077 . . . . 0.0 112.226 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 73' ' ' ARG . 96.4 mt -109.2 116.77 52.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.31 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB3' ' HA3' ' A' ' 57' ' ' GLY . 16.5 tpt180 -63.28 95.0 0.08 Allowed 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.19 0.931 . . . . 0.0 108.992 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.451 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.6 t90 53.21 -100.63 0.1 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 125.446 1.498 . . . . 0.0 110.511 -176.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.0 t -151.89 106.78 3.25 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.77 -20.46 29.31 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.364 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 53' ' ' ARG . . . -72.77 -62.12 3.31 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 9.5 t 55.47 60.14 3.52 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.689 1.196 . . . . 0.0 113.501 167.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.39 117.68 1.15 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.713 0.805 . . . . 0.0 109.573 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -171.02 128.21 0.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.206 2.202 . . . . 0.0 105.924 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.15 146.21 7.43 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.041 0.936 . . . . 0.0 109.708 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.95 156.43 38.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.682 0.793 . . . . 0.0 109.981 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -60.32 -26.73 66.79 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.474 0.71 . . . . 0.0 112.135 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.2 t -65.55 -39.02 91.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.764 0.826 . . . . 0.0 111.089 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.09 12.33 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.878 0.871 . . . . 0.0 111.268 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -66.78 120.75 14.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.144 0.978 . . . . 0.0 110.799 -173.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.63 5.49 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.305 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -77.51 -55.36 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.14 120.3 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.2 m -129.44 138.13 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.537 HD12 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -116.23 142.49 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -137.17 133.07 34.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.639 ' HB2' HD13 ' A' ' 52' ' ' ILE . 78.3 ttt180 -115.27 122.41 45.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.46 90.65 3.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -69.93 -13.26 62.16 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.01 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.61 77.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.343 1.057 . . . . 0.0 111.988 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.19 11.86 12.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.884 0.474 . . . . 0.0 110.794 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.28 28.62 15.78 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.833 1.253 . . . . 0.0 112.091 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.5 m -114.37 131.75 56.45 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.306 0.642 . . . . 0.0 110.287 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG21 ' SD ' ' A' ' 35' ' ' MET . 79.0 t -108.58 150.05 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.41 1.484 . . . . 0.0 108.946 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -131.02 151.62 51.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.643 0.777 . . . . 0.0 110.745 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 55.7 tp -132.22 101.36 5.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 108.521 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -85.97 101.14 12.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.487 ' SD ' HD21 ' A' ' 87' ' ' LEU . 39.9 mtt -83.33 139.58 32.95 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.109 0.964 . . . . 0.0 109.2 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -138.23 138.11 38.18 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 t 58.4 72.34 0.53 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.629 1.172 . . . . 0.0 110.451 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.487 HD21 ' SD ' ' A' ' 84' ' ' MET . 42.3 mt -82.62 144.8 30.06 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.574 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -87.18 150.29 49.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.734 0.814 . . . . 0.0 109.38 -176.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.83 -23.63 74.36 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 C-N-CA 121.726 1.617 . . . . 0.0 110.891 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.04 -31.73 69.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.696 1.598 . . . . 0.0 111.775 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.37 22.43 0.84 Allowed 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.607 0.717 . . . . 0.0 111.632 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -77.85 92.28 4.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 161.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.53 169.97 21.87 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.023 0.929 . . . . 0.0 109.694 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.524 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -97.69 107.82 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -82.06 150.81 27.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.401 0.681 . . . . 0.0 109.445 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.78 140.26 21.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.354 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.661 ' HG ' ' HG ' ' A' ' 23' ' ' CYS . 14.7 p -89.7 149.92 22.55 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -112.12 158.45 19.6 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.556 0.742 . . . . 0.0 109.71 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -139.33 137.71 36.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.31 157.83 25.16 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.5 m -114.23 149.54 16.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 123.459 0.703 . . . . 0.0 109.98 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -69.7 84.96 0.46 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -70.94 152.6 43.47 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.116 -167.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.6 m -66.73 -17.58 64.93 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.252 0.621 . . . . 0.0 111.821 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.1 t -67.05 -22.87 65.84 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.988 0.915 . . . . 0.0 111.421 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.58 -29.37 11.53 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -88.0 117.69 27.04 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.564 0.745 . . . . 0.0 110.024 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -76.24 101.4 5.41 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.1 t -110.67 142.68 26.64 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 123.327 0.651 . . . . 0.0 110.577 -171.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.565 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 17.4 Cg_exo -64.66 99.82 0.32 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.68 2.253 . . . . 0.0 111.318 177.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -92.59 -12.05 32.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.312 0.645 . . . . 0.0 111.271 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 9.9 m-85 -128.55 149.25 50.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -138.92 163.98 30.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.623 0.769 . . . . 0.0 109.969 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -76.09 174.57 53.11 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.633 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -73.89 -28.11 61.39 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.987 0.515 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.06 100.81 2.66 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.378 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -96.2 106.81 19.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.078 0.942 . . . . 0.0 108.572 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -78.7 101.38 7.5 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.244 -172.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.521 HG12 ' HA2' ' A' ' 10' ' ' GLY . 19.8 m -91.04 137.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.0 m -124.46 102.98 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.32 94.73 4.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -64.43 142.43 58.42 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.0 p -70.48 88.58 0.67 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.75 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 73.98 -46.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.565 1.946 . . . . 0.0 113.361 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.77 110.61 5.66 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.107 0.963 . . . . 0.0 110.344 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -77.82 81.75 4.23 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -71.77 152.79 42.44 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.199 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 45.7 m170 -111.73 -167.04 1.13 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.283 1.033 . . . . 0.0 109.104 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -150.86 176.19 11.31 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.047 0.939 . . . . 0.0 109.218 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -69.76 113.08 6.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.958 0.503 . . . . 0.0 109.882 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 . . . . . 0 C--O 1.247 0.969 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.609 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.968 0.414 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.19 106.3 16.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 93.1 mt -93.42 105.6 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.865 0.466 . . . . 0.0 109.862 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t -98.75 104.19 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.14 146.78 24.38 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.338 0.655 . . . . 0.0 111.376 -171.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 p -149.82 158.01 43.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.213 1.005 . . . . 0.0 109.877 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.71 -0.75 42.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.237 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.95 118.68 9.86 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-O 120.241 -0.2 . . . . 0.0 112.662 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.36 -167.12 29.47 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.3 tt -105.21 124.28 49.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.821 0.449 . . . . 0.0 110.513 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 19' ' ' LEU . 28.0 m -118.67 163.03 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.345 1.058 . . . . 0.0 108.744 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 5.7 pm0 -88.89 155.55 19.46 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.065 0.546 . . . . 0.0 109.979 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.87 111.7 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.866 0.866 . . . . 0.0 110.745 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.02 -14.17 23.91 Favored Glycine 0 N--CA 1.474 1.181 0 O-C-N 123.273 0.358 . . . . 0.0 113.042 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.37 170.99 51.29 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 120.111 -0.272 . . . . 0.0 112.457 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -105.57 138.85 41.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.512 0.725 . . . . 0.0 110.626 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HB2' HG11 ' A' ' 13' ' ' VAL . 38.8 tp -132.51 130.94 41.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.683 1.193 . . . . 0.0 109.152 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -111.97 127.51 55.89 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.833 0.853 . . . . 0.0 109.573 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.7 mm? -99.61 149.31 23.41 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 108.957 170.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 p -138.26 124.05 19.9 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 49.2 t -116.77 101.96 9.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.895 0.878 . . . . 0.0 109.409 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.87 121.29 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.52 99.43 12.29 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.79 0.436 . . . . 0.0 110.374 -173.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 18.4 m 58.87 35.72 24.33 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.076 1.35 . . . . 0.0 112.108 173.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.79 -58.63 4.81 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.993 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 31.9 ttp-105 -173.47 77.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.668 1.187 . . . . 0.0 108.014 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.5 m -139.77 147.89 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.567 0.747 . . . . 0.0 110.293 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.471 ' HB3' HD21 ' A' ' 78' ' ' ASN . 11.6 p90 -128.18 136.95 51.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 0.0 110.103 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -169.67 12.93 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.0 0.92 . . . . 0.0 109.098 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 t -108.79 108.6 19.47 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.398 0.679 . . . . 0.0 109.992 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -88.83 -23.72 22.76 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.737 0.815 . . . . 0.0 110.66 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . . . -130.43 123.47 29.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.005 0.922 . . . . 0.0 109.04 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.0 mtm -132.28 166.18 22.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.233 1.013 . . . . 0.0 109.719 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -154.6 179.81 30.42 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.288 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 93.2 m95 -138.38 130.31 28.26 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 170.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.556 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 64.9 m-85 -135.48 152.63 51.54 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 109.262 -173.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 13.7 ptp180 -107.39 141.51 38.66 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -132.5 145.43 51.16 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -176.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -144.6 155.17 56.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.69 105.94 0.25 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.315 2.01 . . . . 0.0 111.83 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.05 -17.04 56.73 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.558 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 9.8 mmpt? -111.87 131.86 55.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.62 0.768 . . . . 0.0 110.326 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.68 170.64 14.09 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.009 0.924 . . . . 0.0 111.763 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -67.28 119.02 11.46 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.712 -177.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -103.68 136.85 42.61 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.961 0.904 . . . . 0.0 109.997 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -62.97 115.82 4.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.688 1.195 . . . . 0.0 111.539 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.4 t -102.46 -48.16 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.011 0.924 . . . . 0.0 109.281 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -153.11 168.45 25.89 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.434 0.694 . . . . 0.0 111.623 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.626 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -153.98 138.47 16.8 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.467 0.651 . . . . 0.0 111.423 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.658 HG21 ' HB2' ' A' ' 73' ' ' ARG . 72.3 mt -127.01 124.76 65.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.069 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 34' ' ' ALA . 63.1 mtt180 . . . . . 0 C--O 1.243 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 110.849 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB3' HG23 ' A' ' 52' ' ' ILE . 38.4 m . . . . . 0 CA--C 1.549 0.913 0 CA-C-O 121.271 0.557 . . . . 0.0 112.114 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.499 ' HA ' HD11 ' A' ' 71' ' ' ILE . 12.4 p -163.9 122.54 1.92 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.45 1.1 . . . . 0.0 109.704 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.553 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 93.8 m-85 -150.15 147.84 28.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.482 1.113 . . . . 0.0 108.603 174.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' CD1' ' HA ' ' A' ' 66' ' ' LYS . 26.3 p90 -164.53 158.04 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.152 0.981 . . . . 0.0 109.649 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.0 157.63 28.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 110.631 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.43 -37.69 88.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.632 0.773 . . . . 0.0 110.985 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -70.2 -16.06 63.02 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.912 0.885 . . . . 0.0 112.635 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 62' ' ' ALA . 31.5 m -125.06 20.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.777 0.831 . . . . 0.0 110.551 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 4.3 ttmp? -48.92 113.55 0.81 Allowed 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.156 1.383 . . . . 0.0 113.072 -175.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.28 -28.91 4.97 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.275 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -71.49 -44.85 63.96 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.546 0.688 . . . . 0.0 109.546 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.62 121.88 28.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.563 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.2 m -134.94 149.8 50.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.388 1.475 . . . . 0.0 107.905 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.632 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.12 152.65 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.636 -177.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 t -151.47 145.23 25.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.608 0.763 . . . . 0.0 110.024 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.658 ' HB2' HG21 ' A' ' 52' ' ' ILE . 28.7 ttt180 -110.57 122.93 48.97 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.5 86.96 2.59 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -79.82 -11.91 59.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.341 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -35.95 73.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.817 0.847 . . . . 0.0 111.831 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.02 1.39 11.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.921 0.488 . . . . 0.0 111.212 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.471 HD21 ' HB3' ' A' ' 30' ' ' PHE . 19.3 m120 57.74 67.49 0.96 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.772 1.229 . . . . 0.0 110.885 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.3 m -139.04 131.76 29.03 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.898 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.4 HG12 ' HE1' ' A' ' 37' ' ' TRP . 20.6 t -108.82 125.02 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.29 134.13 48.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.791 0.436 . . . . 0.0 111.359 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 57.1 tp -115.64 97.14 5.97 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -92.6 98.5 11.48 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.498 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 75.9 mtm -98.25 111.56 23.85 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -100.4 138.37 37.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.6 t 58.56 72.04 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.308 1.043 . . . . 0.0 110.572 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.88 144.68 36.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.605 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -87.0 153.87 54.76 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.24 -18.45 64.94 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.944 1.763 . . . . 0.0 112.654 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.16 3.68 41.78 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.733 0.813 . . . . 0.0 112.134 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.85 26.38 1.82 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.557 0.743 . . . . 0.0 109.971 167.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.524 HG23 HG23 ' A' ' 120' ' ' THR . 95.9 m -83.25 94.0 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 166.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.93 -169.29 2.33 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.71 0.804 . . . . 0.0 110.047 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.0 p -114.84 110.7 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.441 0.697 . . . . 0.0 109.191 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -84.38 153.14 23.62 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.111 0.564 . . . . 0.0 109.683 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.41 147.5 31.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.368 0.667 . . . . 0.0 110.26 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.9 t -88.53 161.62 16.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.775 0.83 . . . . 0.0 109.244 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -122.7 158.22 30.57 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.045 0.538 . . . . 0.0 109.586 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -152.44 167.2 29.52 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.2 1.0 . . . . 0.0 109.515 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.516 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.468 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 15.7 Cg_exo . . . . . 0 CA--C 1.545 1.029 0 N-CA-C 110.198 -0.732 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.47 -42.97 41.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.3 0.64 . . . . 0.0 110.075 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 96.8 m-85 -112.45 160.01 18.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.378 1.071 . . . . 0.0 110.453 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -137.1 165.36 26.24 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.562 1.145 . . . . 0.0 108.878 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -79.27 173.65 55.26 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.446 -175.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 11.7 mm100 -72.7 -19.55 61.38 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.244 0.618 . . . . 0.0 111.394 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.72 99.98 1.7 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 t -99.49 116.74 32.32 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.523 0.729 . . . . 0.0 110.104 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 112.27 8.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.901 0.881 . . . . 0.0 110.564 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.58 126.6 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.524 HG23 HG23 ' A' ' 92' ' ' THR . 57.1 m -120.5 104.37 9.92 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.69 98.08 7.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.7 t -71.29 146.46 48.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.826 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 m -71.92 86.41 0.99 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.158 0.583 . . . . 0.0 110.225 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 3.3 mm? . . . . . 0 N--CA 1.482 1.152 0 C-N-CA 124.656 1.183 . . . . 0.0 112.252 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -102.13 121.4 42.13 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.704 0.802 . . . . 0.0 110.322 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.691 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.4 mt -110.15 110.83 21.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.232 1.013 . . . . 0.0 109.878 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.3 104.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.691 0.797 . . . . 0.0 109.383 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.94 142.32 27.9 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.69 0.796 . . . . 0.0 111.427 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.8 m -154.62 145.85 22.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.401 1.48 . . . . 0.0 108.844 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.4 -32.91 2.28 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.958 -0.357 . . . . 0.0 112.4 175.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 127.05 43.94 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 123.977 0.457 . . . . 0.0 113.937 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.15 -175.78 36.16 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.302 0.477 . . . . 0.0 112.028 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 120' ' ' THR . 20.7 tp -91.46 120.11 32.01 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.956 0.503 . . . . 0.0 109.934 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 87' ' ' LEU . 27.5 m -125.24 158.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 109.156 170.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.438 HE21 ' HA3' ' A' ' 17' ' ' GLY . 0.7 OUTLIER -78.45 152.91 31.88 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -60.82 133.61 56.27 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.507 0.723 . . . . 0.0 110.469 173.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.95 -15.12 64.07 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 123.306 0.379 . . . . 0.0 112.387 -170.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA3' HE21 ' A' ' 14' ' ' GLN . . . -82.29 -173.82 49.26 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-O 121.078 0.265 . . . . 0.0 113.657 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.6 p -127.12 154.27 44.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.137 0.975 . . . . 0.0 110.318 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.1 tp -154.82 122.94 5.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -98.14 117.29 32.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 110.505 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -88.77 155.18 19.72 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.12 0.968 . . . . 0.0 109.209 172.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.8 p -151.39 133.95 15.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.987 0.915 . . . . 0.0 109.006 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 46.2 t -131.52 101.96 5.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.624 0.77 . . . . 0.0 109.158 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 t -87.66 127.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 109.68 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.1 96.93 10.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t 43.85 53.44 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.02 1.728 . . . . 0.0 112.69 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.37 -79.03 1.24 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.392 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.565 ' HG2' ' HA ' ' A' ' 77' ' ' LYS . 61.8 mtm-85 -150.37 86.0 1.4 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.046 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 t -141.22 145.16 35.26 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.83 117.51 21.98 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mtp85 -143.01 1.46 1.27 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.73 1.212 . . . . 0.0 109.439 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 91.87 6.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.905 0.882 . . . . 0.0 110.216 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -83.76 -26.24 29.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.31 1.044 . . . . 0.0 110.117 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.8 141.93 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.066 1.346 . . . . 0.0 108.076 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.487 ' HE3' HG22 ' A' ' 52' ' ' ILE . 20.9 mtm -151.89 162.06 41.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.121 0.968 . . . . 0.0 109.535 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -168.49 138.62 5.22 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.319 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -92.81 126.36 37.86 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -116.24 147.4 41.52 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 108.515 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.23 142.35 33.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.51 ' HB3' HG13 ' A' ' 94' ' ' VAL . 64.0 tt0 -141.41 128.38 20.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.83 160.78 31.85 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.391 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.73 112.39 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.095 2.53 . . . . 0.0 112.843 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.76 23.39 75.12 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.625 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -125.37 173.19 9.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.781 0.832 . . . . 0.0 110.679 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.18 163.8 26.72 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.481 1.112 . . . . 0.0 111.837 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -92.99 106.79 18.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.874 0.845 . . . . 0.0 109.024 170.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.73 135.84 33.76 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.346 1.059 . . . . 0.0 110.009 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -65.03 120.05 11.91 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.098 1.359 . . . . 0.0 111.31 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.96 -61.47 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.43 0.692 . . . . 0.0 109.162 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -146.65 159.36 43.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.958 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -132.19 141.41 49.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 0.0 111.021 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 73' ' ' ARG . 3.7 mp -112.6 121.3 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.5 mtp-105 . . . . . 0 N--CA 1.472 0.644 0 C-N-CA 124.393 1.077 . . . . 0.0 109.417 -174.495 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 40.8 m . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.437 ' HA ' HD11 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -158.69 122.25 3.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.164 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 15.9 m-85 -159.16 125.62 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.599 1.56 . . . . 0.0 107.297 170.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -164.62 144.14 7.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.638 0.775 . . . . 0.0 109.649 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 158.46 28.63 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.332 165.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.41 -28.38 69.64 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.4 t -63.48 -34.69 78.32 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.04 0.936 . . . . 0.0 112.224 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 34.1 m -109.52 14.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.425 0.69 . . . . 0.0 111.035 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -71.25 134.31 46.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.868 0.867 . . . . 0.0 109.409 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.11 -0.14 63.82 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.697 0.623 . . . . 0.0 113.243 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 72.7 mtp180 -109.29 -73.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.525 1.13 . . . . 0.0 109.174 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.65 119.66 26.23 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -126.58 129.8 49.26 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.977 0.911 . . . . 0.0 108.801 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -113.37 138.82 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.272 0.558 . . . . 0.0 109.787 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -144.81 149.21 35.05 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.298 1.039 . . . . 0.0 108.775 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.599 ' HB2' HG21 ' A' ' 52' ' ' ILE . 57.7 ttp180 -124.6 129.29 50.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.15 130.01 45.44 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -87.44 -29.91 21.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 111.563 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.25 82.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.529 0.731 . . . . 0.0 112.064 -172.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.45 12.15 15.1 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.655 0.382 . . . . 0.0 111.839 175.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.7 m120 53.76 56.85 6.66 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.093 0.957 . . . . 0.0 112.052 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -126.03 130.63 51.54 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.626 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.09 121.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.856 0.862 . . . . 0.0 109.127 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -102.25 145.38 29.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.622 0.769 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 53.1 tp -125.36 98.03 5.45 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -83.22 101.43 11.23 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.472 ' SD ' HD21 ' A' ' 87' ' ' LEU . 61.4 mtt -84.53 123.75 30.64 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -121.67 146.14 47.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.9 t 57.24 63.14 1.96 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.586 0.708 . . . . 0.0 110.935 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HB3' HG21 ' A' ' 121' ' ' VAL . 35.3 mt -79.66 140.04 37.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.839 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.6 mmmp? -99.15 157.89 33.26 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 108.729 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.67 -22.76 74.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.459 2.106 . . . . 0.0 112.72 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.42 -17.2 64.35 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.705 1.202 . . . . 0.0 112.452 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -81.87 37.84 0.5 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.745 0.818 . . . . 0.0 111.048 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 120' ' ' THR . 90.1 m -91.27 90.86 7.93 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 164.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.3 177.46 6.09 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.51 HG13 ' HB3' ' A' ' 40' ' ' GLN . 4.7 p -107.32 112.85 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.71 0.804 . . . . 0.0 110.173 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -92.01 133.23 35.91 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -122.47 141.51 51.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.058 0.543 . . . . 0.0 109.969 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -91.23 149.47 21.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.75 158.94 43.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.409 0.684 . . . . 0.0 109.566 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.76 169.35 17.77 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 109.811 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.437 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.703 176.756 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 CA--C 1.546 1.102 0 CA-C-O 121.221 0.425 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.09 -30.55 55.43 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.36 0.6 . . . . 0.0 109.808 170.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -127.13 153.17 46.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.779 1.232 . . . . 0.0 108.567 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -131.38 157.64 42.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.7 -120.95 0.67 Allowed Glycine 0 C--N 1.336 0.57 0 O-C-N 123.244 0.34 . . . . 0.0 112.696 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -129.05 -15.14 4.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.8 109.97 0.14 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 123.332 0.395 . . . . 0.0 112.641 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.454 HG21 HD12 ' A' ' 21' ' ' LEU . 10.1 t -95.84 128.15 42.48 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.644 0.735 . . . . 0.0 110.798 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.462 HE21 ' HB ' ' A' ' 94' ' ' VAL . 8.4 mm-40 -79.36 108.86 13.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.47 136.27 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 92' ' ' THR . 31.3 m -133.9 129.34 36.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 87' ' ' LEU . 46.3 t -113.66 108.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.8 m -60.88 141.64 56.98 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.939 0.495 . . . . 0.0 111.934 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 m -74.66 90.74 2.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.464 0.705 . . . . 0.0 110.964 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.8 mm? . . . . . 0 N--CA 1.491 1.579 0 C-N-CA 124.486 1.114 . . . . 0.0 112.943 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -103.07 132.32 49.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.672 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 70.3 mt -121.86 120.22 33.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 52.4 t -95.76 99.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 51.9 mt-10 -95.34 123.92 39.11 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.678 -172.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 m -130.91 154.38 48.16 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.617 1.167 . . . . 0.0 109.769 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.23 11.67 35.87 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.015 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.57 74.65 1.5 Allowed Glycine 0 C--N 1.35 1.355 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.37 -164.17 13.68 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 120' ' ' THR . 6.5 tt -116.86 127.54 54.39 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.82 161.13 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.144 0.978 . . . . 0.0 109.007 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -80.67 158.27 25.66 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.212 0.605 . . . . 0.0 110.768 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.23 114.49 2.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.772 0.829 . . . . 0.0 110.539 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.99 -25.53 10.69 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.959 0.79 . . . . 0.0 112.01 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.67 164.63 54.82 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 113.725 0.25 . . . . 0.0 113.725 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.6 p -104.64 155.46 18.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.988 0.915 . . . . 0.0 110.38 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.2 tp -152.76 136.84 16.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.114 0.966 . . . . 0.0 108.464 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.062 0.545 . . . . 0.0 110.043 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -101.07 157.51 16.7 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.297 1.039 . . . . 0.0 108.899 174.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -144.89 127.27 15.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -127.79 105.37 8.39 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.542 0.737 . . . . 0.0 110.445 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.47 130.04 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.88 98.06 11.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.726 0.298 . . . . 0.0 110.374 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 5.6 m 56.9 29.12 15.66 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.329 1.451 . . . . 0.0 112.917 170.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.18 50.77 5.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -173.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 69.68 24.42 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.629 1.172 . . . . 0.0 113.092 171.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 32.7 p -87.8 153.24 21.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.889 0.476 . . . . 0.0 110.271 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -110.67 123.16 49.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.791 0.836 . . . . 0.0 109.76 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -145.95 -50.27 0.23 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.672 1.189 . . . . 0.0 108.168 167.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -73.52 103.72 4.24 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.942 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -88.97 -13.96 37.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.794 0.838 . . . . 0.0 110.033 167.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.58 43.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.784 1.234 . . . . 0.0 108.3 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtm -148.9 167.15 26.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.007 . . . . 0.0 109.157 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.61 148.79 8.91 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.715 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 95.4 m95 -89.51 136.25 33.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.25 164.78 18.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.42 1.088 . . . . 0.0 108.447 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -128.47 148.02 50.71 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.41 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 35.5 tt0 -155.07 144.67 21.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.546 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -108.82 152.56 42.38 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 171.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 110.71 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.706 2.27 . . . . 0.0 112.506 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.07 43.96 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.449 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 9.1 mmpt? -119.78 170.62 9.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.086 0.955 . . . . 0.0 110.57 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.28 163.44 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.655 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.499 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.56 123.36 31.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.6 137.59 32.71 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 0.0 109.673 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 80.7 t80 -69.09 119.72 13.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.13 0.972 . . . . 0.0 110.431 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.51 -54.68 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.293 0.637 . . . . 0.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . . . -139.9 164.9 28.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.588 -171.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . . . -145.09 131.86 20.04 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.377 0.671 . . . . 0.0 110.846 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -110.79 127.24 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.767 1.227 . . . . 0.0 109.375 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.41 ' CZ ' ' HB1' ' A' ' 51' ' ' ALA . 3.2 mpt_? . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 125.252 1.421 . . . . 0.0 109.408 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.8 m . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 121.323 0.583 . . . . 0.0 112.236 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.467 ' HA ' HD11 ' A' ' 71' ' ' ILE . 2.5 p -150.59 122.2 8.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.261 1.025 . . . . 0.0 109.211 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.24 127.05 0.82 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -165.82 167.04 17.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.544 0.738 . . . . 0.0 110.086 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.34 145.56 33.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 168.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.77 -28.1 69.64 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.851 0.358 . . . . 0.0 110.966 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 m -70.92 -26.62 63.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.61 0.764 . . . . 0.0 112.214 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 62' ' ' ALA . 18.7 m -104.58 4.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 122.872 0.469 . . . . 0.0 111.43 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.76 116.05 3.2 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.463 1.105 . . . . 0.0 112.501 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.72 11.81 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.986 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -87.25 -57.24 3.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.516 0.726 . . . . 0.0 109.263 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -87.77 122.1 31.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -146.74 153.68 40.52 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.049 1.34 . . . . 0.0 108.63 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -124.92 156.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.59 0.756 . . . . 0.0 109.915 176.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -151.75 136.77 17.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.778 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.7 ttp85 -110.37 136.28 49.79 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -109.03 122.26 46.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -87.59 -23.85 24.18 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.053 0.541 . . . . 0.0 111.0 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.35 84.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.377 0.671 . . . . 0.0 111.875 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 17.1 12.53 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.51 0.324 . . . . 0.0 111.841 172.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.6 m120 48.72 56.37 7.74 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.237 1.015 . . . . 0.0 112.191 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.1 m -130.07 130.72 45.24 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.422 HG12 ' HE1' ' A' ' 37' ' ' TRP . 86.9 t -109.65 125.53 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.901 0.88 . . . . 0.0 109.89 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -102.45 146.59 27.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.739 0.815 . . . . 0.0 110.388 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.3 tp -124.53 101.48 7.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.111 0.964 . . . . 0.0 108.685 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -91.55 101.18 13.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.369 0.668 . . . . 0.0 109.995 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.419 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 55.7 mtm -107.84 107.61 18.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.376 0.67 . . . . 0.0 110.118 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -106.91 147.94 29.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.303 0.641 . . . . 0.0 109.908 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.4 t 61.71 60.63 1.57 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.117 0.967 . . . . 0.0 110.067 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' A' ' 121' ' ' VAL . 42.9 mt -76.13 151.12 37.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.28 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -110.7 157.11 39.36 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.392 1.077 . . . . 0.0 109.046 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 27.3 Cg_endo -59.14 -26.14 80.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.56 2.174 . . . . 0.0 113.145 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.14 -17.3 64.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.002 0.921 . . . . 0.0 112.326 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.06 15.65 1.44 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.643 0.777 . . . . 0.0 111.193 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.52 HG23 HG23 ' A' ' 120' ' ' THR . 85.6 m -81.4 89.95 6.15 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 163.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.05 -166.07 0.77 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.491 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 p -115.23 112.93 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.195 0.598 . . . . 0.0 110.362 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -85.05 130.74 34.56 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.6 pt? -130.3 125.04 33.77 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.504 0.721 . . . . 0.0 109.292 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.1 p -88.85 138.66 31.22 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -111.88 152.04 28.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.295 1.038 . . . . 0.0 109.823 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 5' ' ' LEU . . . -130.0 167.68 17.89 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.614 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.274 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.604 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 84.6 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 N-CA-C 110.054 -0.787 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.2 -27.55 60.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.126 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -112.45 150.1 31.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 109.776 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -130.85 145.96 52.15 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -70.76 -79.39 0.37 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 123.527 0.517 . . . . 0.0 113.247 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -164.11 -40.31 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.771 0.828 . . . . 0.0 109.815 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.9 119.49 4.54 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.119 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 6.2 t -96.56 111.62 23.68 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.596 0.713 . . . . 0.0 109.622 174.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.45 98.56 1.45 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.513 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.02 132.79 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 10.8 m -128.1 106.21 8.91 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 87' ' ' LEU . 42.6 t -106.49 97.82 6.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 121.65 -0.656 . . . . 0.0 109.462 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.412 ' CB ' HD21 ' A' ' 12' ' ' LEU . 28.1 t -70.6 129.17 38.49 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.878 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 89' ' ' PRO . 43.8 t -59.93 98.23 0.05 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.499 0.72 . . . . 0.0 110.743 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.486 1.361 0 C-N-CA 125.83 1.652 . . . . 0.0 113.288 177.319 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 37.8 mt-30 -104.02 121.66 43.63 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.317 0.647 . . . . 0.0 109.568 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.582 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.6 mt -120.08 107.17 12.73 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.66 102.56 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.69 146.69 23.98 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.453 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 p -159.18 177.77 10.72 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.169 0.988 . . . . 0.0 109.788 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.8 -0.28 87.86 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.858 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 142.86 29.65 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.968 0.384 . . . . 0.0 112.478 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.66 -168.76 39.0 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.1 tt -99.73 130.3 45.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.348 0.659 . . . . 0.0 109.631 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.72 149.83 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.742 0.817 . . . . 0.0 109.258 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HB2' HD13 ' A' ' 124' ' ' LEU . 4.3 pm0 -70.17 146.92 50.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.827 0.451 . . . . 0.0 110.498 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.94 135.18 55.37 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.394 0.678 . . . . 0.0 110.868 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.08 6.2 72.06 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.068 -168.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.95 -169.83 27.36 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 122.896 0.284 . . . . 0.0 112.851 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 p -129.28 153.26 47.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.635 0.774 . . . . 0.0 110.57 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.5 tp -149.72 125.09 10.2 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -108.38 109.99 21.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.453 0.701 . . . . 0.0 110.216 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -87.55 153.8 21.12 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.209 1.004 . . . . 0.0 109.947 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 m -143.48 130.96 21.07 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.5 0.72 . . . . 0.0 109.407 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 47.8 t -124.78 105.93 9.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.19 0.996 . . . . 0.0 109.45 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.25 123.46 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.139 0.575 . . . . 0.0 109.464 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.44 97.39 11.15 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.026 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.454 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 21.4 t 55.7 33.36 21.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.827 1.251 . . . . 0.0 112.341 171.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.45 -88.92 0.61 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.436 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -125.81 -0.63 7.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.736 0.814 . . . . 0.0 111.532 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -77.3 126.09 30.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -105.32 124.87 50.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.066 0.946 . . . . 0.0 109.345 -170.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.1 mtt85 -165.11 175.55 9.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.116 0.967 . . . . 0.0 110.169 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t 66.25 104.89 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 O-C-N 125.176 1.547 . . . . 0.0 110.798 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.23 -28.98 67.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.708 0.803 . . . . 0.0 112.593 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB2' ' HG3' ' A' ' 53' ' ' ARG . . . -126.21 149.55 48.96 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.582 0.753 . . . . 0.0 109.592 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.0 mtt -144.9 122.38 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -118.18 -173.87 16.2 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 123.487 0.492 . . . . 0.0 113.222 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -132.87 143.75 49.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.116 0.967 . . . . 0.0 109.26 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.09 172.07 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.69 1.596 . . . . 0.0 107.65 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -139.35 123.73 18.16 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.056 0.455 . . . . 0.0 110.367 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.494 ' HB3' HG13 ' A' ' 94' ' ' VAL . 65.0 tp60 -101.58 135.23 43.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.624 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -122.58 137.83 28.43 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.048 0.939 . . . . 0.0 109.229 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -66.26 118.08 5.22 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.72 2.28 . . . . 0.0 111.717 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.73 0.4 59.11 Favored Glycine 0 N--CA 1.474 1.184 0 O-C-N 123.044 0.215 . . . . 0.0 112.656 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 5.5 mmpt? -135.61 172.89 12.36 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.155 . . . . 0.0 110.141 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.17 156.92 16.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.053 0.941 . . . . 0.0 109.922 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 125.92 28.16 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.456 0.646 . . . . 0.0 110.803 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -93.38 138.29 31.86 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.618 1.167 . . . . 0.0 109.29 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -69.18 115.24 8.24 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.742 0.652 . . . . 0.0 109.781 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.9 t -94.32 -53.1 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.409 0.683 . . . . 0.0 110.03 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -156.1 169.6 24.12 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -168.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.426 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -158.99 132.29 7.24 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 110.306 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -116.34 116.16 51.38 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HG3' ' HB2' ' A' ' 34' ' ' ALA . 28.7 ttt-85 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 49.9 m . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.9 m -158.53 121.93 3.87 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.605 0.362 . . . . 0.0 111.274 -170.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.478 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 68.4 m-85 -156.52 135.53 11.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.876 1.67 . . . . 0.0 107.66 171.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -165.4 164.55 19.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.227 1.011 . . . . 0.0 110.263 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.16 160.89 30.58 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.705 0.402 . . . . 0.0 111.092 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.61 -36.05 81.66 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.425 0.69 . . . . 0.0 111.76 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.2 p -69.15 -36.09 77.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.294 0.638 . . . . 0.0 111.622 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.401 HG12 HH21 ' A' ' 68' ' ' ARG . 20.3 m -97.74 15.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.5 0.72 . . . . 0.0 111.634 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.15 114.23 2.51 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.325 1.05 . . . . 0.0 112.009 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.81 -19.75 35.85 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.588 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.401 HH21 HG12 ' A' ' 65' ' ' VAL . 15.1 mtm180 -80.84 -48.52 12.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -85.21 123.5 30.78 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.131 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -130.55 134.48 47.06 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.579 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -129.37 143.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 110.609 -176.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -150.05 169.5 21.08 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.279 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.482 ' HB3' HG21 ' A' ' 52' ' ' ILE . 77.0 ttt180 -147.76 131.44 16.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -122.47 106.14 10.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.293 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -72.51 -11.57 60.72 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.728 0.811 . . . . 0.0 110.844 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.18 79.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.419 1.087 . . . . 0.0 111.878 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.02 7.97 12.39 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.924 0.489 . . . . 0.0 111.406 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 53.59 67.28 1.03 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.448 1.099 . . . . 0.0 110.807 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -148.74 132.73 17.17 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.24 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 73' ' ' ARG . 21.5 t -103.68 136.13 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.518 1.127 . . . . 0.0 108.072 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.41 146.11 44.69 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.977 0.418 . . . . 0.0 111.34 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.7 tp -127.86 98.61 5.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.691 1.197 . . . . 0.0 108.081 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -93.21 100.14 12.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 109.187 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.436 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 56.7 mtm -104.25 103.24 12.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.896 0.478 . . . . 0.0 110.082 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -102.54 153.35 20.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.637 0.775 . . . . 0.0 109.581 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.5 t 58.13 48.96 12.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.172 0.989 . . . . 0.0 110.698 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 84' ' ' MET . 29.3 mt -68.99 133.49 48.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.114 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . 37.7 mtmt -92.06 157.24 41.35 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.104 0.962 . . . . 0.0 109.059 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.06 -23.77 78.07 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.11 1.873 . . . . 0.0 112.608 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.92 -11.4 60.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.276 1.03 . . . . 0.0 112.385 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -84.67 33.28 0.52 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.634 0.773 . . . . 0.0 110.656 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.7 m -88.1 98.19 11.4 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.59 -166.66 1.39 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.649 0.78 . . . . 0.0 109.322 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.8 p -117.05 109.52 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.66 131.39 35.21 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.25 143.06 47.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.117 0.567 . . . . 0.0 110.529 -173.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -89.04 158.16 18.09 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.781 0.833 . . . . 0.0 109.75 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.02 152.48 49.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.968 0.907 . . . . 0.0 109.255 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -118.36 120.59 38.06 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 110' ' ' PRO . . . . . . . . 0 C--O 1.244 0.744 0 O-C-N 123.645 0.591 . . . . 0.0 111.918 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.438 ' HA ' ' HA2' ' A' ' 100' ' ' GLY . 1.9 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 N-CA-C 109.301 -1.077 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.35 -35.74 80.06 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.866 0.867 . . . . 0.0 111.661 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.557 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 80.8 m-85 -111.73 152.82 27.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.458 0.703 . . . . 0.0 110.131 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -134.13 160.05 38.97 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.342 1.057 . . . . 0.0 108.692 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.28 -151.97 6.6 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.877 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 6.72 28.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.235 0.614 . . . . 0.0 110.651 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.35 163.48 28.68 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 113.129 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 t -140.59 115.64 9.79 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -68.7 122.79 19.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.58 0.752 . . . . 0.0 111.011 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.93 136.16 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.9 m -134.04 103.58 5.86 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 87' ' ' LEU . 25.5 t -87.95 101.16 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.6 p -56.9 141.41 45.15 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.425 0.69 . . . . 0.0 111.413 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.3 p -85.11 59.27 5.53 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.459 0.704 . . . . 0.0 110.65 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 14' ' ' GLN . 3.2 mm? . . . . . 0 N--CA 1.489 1.509 0 C-N-CA 124.316 1.046 . . . . 0.0 110.957 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -103.95 142.44 34.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.182 0.993 . . . . 0.0 109.924 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.617 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 82.6 mt -132.36 129.08 38.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.231 1.013 . . . . 0.0 109.336 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.481 ' HA ' HE21 ' A' ' 115' ' ' GLN . 68.0 t -119.5 102.39 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.195 0.598 . . . . 0.0 109.689 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.66 151.31 25.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.42 0.688 . . . . 0.0 110.669 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 p -155.19 146.45 22.82 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.241 1.016 . . . . 0.0 109.308 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.01 0.59 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.709 0.671 . . . . 0.0 111.504 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.39 121.79 7.29 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.387 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.02 -178.24 48.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 122' ' ' SER . 19.3 tp -94.21 128.26 40.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.93 166.34 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.992 . . . . 0.0 108.949 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -85.84 151.94 23.4 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.918 0.487 . . . . 0.0 111.206 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.48 113.05 2.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.902 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.22 0.02 28.22 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -178.43 46.37 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 113.805 0.282 . . . . 0.0 113.805 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 m -108.68 159.99 16.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.495 1.118 . . . . 0.0 109.233 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 tp -160.69 116.84 2.3 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -99.49 109.18 21.75 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 117' ' ' THR . 3.1 mm? -86.91 140.71 29.35 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 p -140.37 125.45 18.53 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.795 0.838 . . . . 0.0 109.336 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -124.54 115.47 20.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.053 0.941 . . . . 0.0 109.421 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.07 129.56 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.05 103.23 15.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.167 0.987 . . . . 0.0 110.53 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 p 51.8 53.24 12.97 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.098 1.759 . . . . 0.0 112.93 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.86 -74.3 1.83 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.893 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -165.61 39.01 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 122.27 1.033 . . . . 0.0 108.471 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.0 m -103.95 147.52 27.25 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.297 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -105.84 121.41 44.0 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -167.31 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.609 0.764 . . . . 0.0 110.291 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -65.98 95.61 0.28 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.391 0.676 . . . . 0.0 109.756 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.52 -35.08 25.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.297 0.639 . . . . 0.0 110.212 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.67 121.68 31.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.7 0.8 . . . . 0.0 109.219 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.431 ' HG2' HG21 ' A' ' 80' ' ' VAL . 2.9 mpp? -123.75 163.18 21.67 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.397 1.479 . . . . 0.0 108.682 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -157.57 135.92 4.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.56 121.8 36.48 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.5 160.96 24.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -139.67 133.47 30.64 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -98.23 128.74 44.85 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -94.33 141.56 23.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 122.765 0.426 . . . . 0.0 110.219 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.42 101.73 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.651 2.234 . . . . 0.0 111.462 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.95 2.74 60.89 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.93 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 7.5 mmpt? -139.51 152.49 46.98 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.708 0.803 . . . . 0.0 110.276 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.19 163.27 10.51 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.418 1.087 . . . . 0.0 111.531 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.58 149.74 43.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.205 0.526 . . . . 0.0 111.373 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -120.18 134.44 55.26 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.184 0.994 . . . . 0.0 109.501 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -72.31 111.14 7.25 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.291 1.036 . . . . 0.0 109.055 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.6 t -88.57 -53.67 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.467 0.707 . . . . 0.0 110.002 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.88 165.23 37.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.677 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.419 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -150.4 127.61 11.29 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 124.096 0.959 . . . . 0.0 109.823 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.9 mp -110.22 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 68.4 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -157.91 122.02 4.16 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.3 0.64 . . . . 0.0 110.16 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -152.83 122.87 7.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.07 1.348 . . . . 0.0 108.194 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -164.73 161.75 20.8 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.656 1.182 . . . . 0.0 109.126 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -81.53 151.74 27.61 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.21 -28.9 69.1 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.075 0.464 . . . . 0.0 110.75 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 p -66.85 -25.62 66.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.246 1.018 . . . . 0.0 111.887 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.518 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 22.9 m -114.45 13.78 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.332 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 122.67 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.36 0.664 . . . . 0.0 110.476 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.17 -27.32 9.39 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.757 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.518 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 24.3 mtp180 -78.45 -52.67 8.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.78 1.232 . . . . 0.0 108.762 175.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -104.02 121.97 44.28 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.984 1.314 . . . . 0.0 107.787 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -135.72 151.39 50.11 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.442 1.097 . . . . 0.0 108.916 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.94 148.5 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.714 0.806 . . . . 0.0 110.206 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.8 m -153.03 172.2 17.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.13 0.972 . . . . 0.0 109.354 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -148.3 139.72 23.51 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.12 100.13 6.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.852 1.261 . . . . 0.0 108.585 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -71.1 -13.22 61.89 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.753 0.821 . . . . 0.0 111.167 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.35 64.56 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.409 1.084 . . . . 0.0 111.744 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -121.26 1.33 10.23 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.704 0.802 . . . . 0.0 111.513 173.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m120 60.75 68.94 0.71 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.649 1.18 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -142.26 133.33 25.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.642 0.777 . . . . 0.0 109.769 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.431 HG21 ' HG2' ' A' ' 35' ' ' MET . 23.2 t -101.18 133.65 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 108.327 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.78 148.41 34.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.52 0.728 . . . . 0.0 111.659 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 47.8 tp -132.91 99.57 4.63 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -84.19 99.5 10.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.744 ' HB3' HD21 ' A' ' 87' ' ' LEU . 74.1 mtp -87.56 136.41 32.96 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.86 160.59 41.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.767 0.827 . . . . 0.0 108.81 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.2 t 58.46 48.25 12.42 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.517 1.135 . . . . 0.0 109.016 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 84' ' ' MET . 70.4 mt -72.3 138.76 47.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.726 -166.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.494 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 14.1 mmmm -92.4 153.06 42.76 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 124.077 0.951 . . . . 0.0 108.904 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.494 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 19.5 Cg_endo -59.92 -20.79 61.67 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.644 2.229 . . . . 0.0 113.054 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -80.78 1.78 29.02 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.859 0.864 . . . . 0.0 112.151 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -87.98 24.95 1.66 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.631 0.772 . . . . 0.0 110.318 166.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 120' ' ' THR . 52.0 m -81.6 105.59 12.88 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 161.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.68 177.64 6.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.952 0.901 . . . . 0.0 110.494 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.425 ' HB ' ' NE2' ' A' ' 118' ' ' GLN . 3.1 p -110.08 107.05 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -83.89 115.22 22.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.372 0.669 . . . . 0.0 109.207 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.14 143.79 36.42 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -91.62 144.6 25.37 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 170.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -133.05 157.69 44.63 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.386 0.675 . . . . 0.0 109.445 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.55 12.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.529 0.731 . . . . 0.0 109.731 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.647 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -176.086 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.477 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 58.3 Cg_endo . . . . . 0 CA--C 1.545 1.057 0 CA-C-O 121.089 0.371 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.25 -34.26 14.33 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.034 0.934 . . . . 0.0 109.757 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -117.85 152.41 35.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.461 1.104 . . . . 0.0 109.339 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.09 157.35 47.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.22 1.008 . . . . 0.0 108.817 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.7 -147.73 15.39 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.829 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.481 HE21 ' HA ' ' A' ' 6' ' ' VAL . 48.1 mt-30 -94.05 -34.42 13.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.616 0.766 . . . . 0.0 111.541 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.22 116.04 1.27 Allowed Glycine 0 C--N 1.345 1.04 0 N-CA-C 111.879 -0.489 . . . . 0.0 111.879 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.525 HG21 HD12 ' A' ' 21' ' ' LEU . 7.0 t -99.79 118.39 36.16 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.632 0.773 . . . . 0.0 110.402 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.425 ' NE2' ' HB ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -74.16 106.43 5.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.008 0.923 . . . . 0.0 110.514 178.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.91 139.89 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 92' ' ' THR . 43.5 m -135.25 118.58 16.72 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.0 103.4 14.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.571 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.5 t -66.37 140.8 58.1 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 123.293 0.371 . . . . 0.0 110.684 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -70.63 101.26 2.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 109.799 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 125.785 1.634 . . . . 0.0 111.295 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -102.96 143.42 32.56 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.68 1.192 . . . . 0.0 109.337 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.681 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.8 mt -130.46 113.98 14.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.097 0.959 . . . . 0.0 109.069 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.46 104.72 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' HG2' ' HB ' ' A' ' 117' ' ' THR . 78.2 tt0 -104.69 135.65 45.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.304 -166.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 p -163.2 -177.37 5.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.101 0.96 . . . . 0.0 110.264 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.0 5.74 57.25 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 112.547 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.38 148.23 21.97 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.714 0.257 . . . . 0.0 112.719 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.91 -174.04 45.44 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.7 tt -93.29 129.57 39.32 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.45 157.25 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.956 0.903 . . . . 0.0 108.787 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.619 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -81.33 149.59 28.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.09 0.556 . . . . 0.0 110.286 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.62 123.57 19.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.678 1.191 . . . . 0.0 111.47 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.35 -25.94 11.77 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -172.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.34 -166.77 32.65 Favored Glycine 0 C--N 1.35 1.321 0 C-N-CA 123.194 0.426 . . . . 0.0 114.13 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -134.97 160.32 38.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.065 0.946 . . . . 0.0 110.438 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -154.29 131.29 10.95 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.63 0.772 . . . . 0.0 109.208 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -102.49 127.11 49.68 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.106 0.562 . . . . 0.0 110.531 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -98.65 157.56 16.18 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.462 1.105 . . . . 0.0 109.207 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.8 p -148.83 126.88 11.99 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.47 0.708 . . . . 0.0 109.405 -175.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.2 t -128.05 106.13 8.86 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.81 0.844 . . . . 0.0 109.1 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.42 120.71 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.507 0.723 . . . . 0.0 109.301 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.08 100.76 13.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.937 0.495 . . . . 0.0 110.87 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.639 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 10.9 m 54.67 37.04 27.51 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.267 1.427 . . . . 0.0 112.183 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.66 -68.31 3.29 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.849 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 52.6 ttp180 -164.91 63.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 85.0 m -138.53 146.3 41.75 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.204 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -129.48 141.89 50.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 109.039 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -156.01 -50.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.926 0.89 . . . . 0.0 109.846 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -73.77 119.54 18.13 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.84 0.352 . . . . 0.0 110.101 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -78.63 -3.0 41.75 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.534 0.734 . . . . 0.0 111.028 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.98 41.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.383 0.673 . . . . 0.0 109.272 171.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 68.3 mtt -143.53 121.1 11.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.62 174.15 22.76 Favored Glycine 0 C--N 1.335 0.526 0 O-C-N 123.072 0.233 . . . . 0.0 113.341 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.505 ' HE1' HG12 ' A' ' 80' ' ' VAL . 85.7 m95 -110.98 133.68 53.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.857 0.863 . . . . 0.0 109.68 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -119.53 171.89 8.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.274 1.43 . . . . 0.0 107.486 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 40.1 ptt180 -143.42 127.76 17.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.044 0.449 . . . . 0.0 110.465 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -109.63 129.79 55.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -103.17 157.95 32.76 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.762 -0.637 . . . . 0.0 109.893 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.8 96.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.777 2.318 . . . . 0.0 113.326 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.69 -11.5 52.23 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.092 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 8.8 mmpt? -103.12 137.87 40.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.518 0.727 . . . . 0.0 109.496 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.25 149.92 23.04 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 146.27 22.09 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.38 1.072 . . . . 0.0 112.291 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -136.2 133.22 36.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 109.892 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.46 115.55 7.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.952 0.901 . . . . 0.0 110.781 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.54 -55.19 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.404 0.681 . . . . 0.0 109.417 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB3' HG21 ' A' ' 71' ' ' ILE . . . -167.42 173.91 8.39 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.097 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.53 158.95 27.24 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 122.267 1.032 . . . . 0.0 112.467 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -117.7 116.48 51.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 113.472 -1.694 . . . . 0.0 106.968 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.413 ' HG2' ' HE2' ' A' ' 60' ' ' TYR . 29.2 mmt180 . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 22.8 t . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.6 ' HA ' HD11 ' A' ' 71' ' ' ILE . 3.8 p -158.01 123.89 4.63 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.917 0.487 . . . . 0.0 111.034 -170.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HE2' ' HG2' ' A' ' 53' ' ' ARG . 69.6 m-85 -150.25 113.16 4.8 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 166.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.07 143.27 7.71 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.683 0.393 . . . . 0.0 110.71 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.28 159.0 31.0 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 168.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 31.2 t70 -60.9 -28.19 68.72 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.062 0.545 . . . . 0.0 111.147 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 m -65.98 -33.57 76.11 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.927 0.891 . . . . 0.0 112.087 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -109.22 -5.64 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.291 0.636 . . . . 0.0 111.877 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 25.5 ttpp -72.54 133.53 44.8 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 109.909 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.46 7.28 Favored Glycine 0 C--N 1.342 0.905 0 O-C-N 123.423 0.452 . . . . 0.0 112.053 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 69.7 mtp180 -80.64 -66.71 0.85 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -92.01 120.67 32.86 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.789 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 m -125.16 127.48 46.89 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.295 1.038 . . . . 0.0 108.213 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.6 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -125.07 140.97 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.122 0.569 . . . . 0.0 110.489 -174.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.444 ' HA ' ' OG ' ' A' ' 58' ' ' SER . 45.0 t -162.99 157.86 21.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.599 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -133.97 124.87 27.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.575 0.75 . . . . 0.0 109.364 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -103.37 122.02 43.98 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -76.8 -12.29 59.95 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.0 -48.78 67.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.618 1.167 . . . . 0.0 111.811 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 -0.06 11.0 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.13 175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 19.8 m120 53.37 68.12 0.89 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.396 1.079 . . . . 0.0 110.781 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.1 m -137.22 133.79 35.51 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.484 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.505 HG12 ' HE1' ' A' ' 37' ' ' TRP . 6.7 t -102.02 126.09 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -106.3 143.08 34.94 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.0 0.52 . . . . 0.0 110.82 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.6 tp -121.66 97.78 5.66 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 167.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -83.78 99.8 10.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.701 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.0 mtm -86.8 138.84 31.26 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -142.44 163.11 33.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.905 0.882 . . . . 0.0 109.068 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 26.9 t 54.3 42.24 31.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.014 0.926 . . . . 0.0 109.584 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.701 HD21 ' HB3' ' A' ' 84' ' ' MET . 51.6 mt -69.05 126.26 29.24 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.921 -171.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.1 mmmp? -87.83 149.99 47.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.661 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.61 -17.51 54.72 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.541 2.161 . . . . 0.0 113.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.8 pt-20 -69.46 -16.81 63.54 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.378 1.071 . . . . 0.0 112.029 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -84.43 32.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.962 0.905 . . . . 0.0 111.424 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.1 m -86.51 95.71 9.81 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -158.75 -174.25 4.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.422 0.689 . . . . 0.0 110.318 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -117.57 108.29 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 9.1 m-85 -82.28 137.02 34.94 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.416 HD13 ' HD1' ' A' ' 113' ' ' TRP . 4.1 pp -126.62 128.59 47.02 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -90.06 119.5 30.45 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.75 159.12 19.27 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.594 0.758 . . . . 0.0 109.821 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -130.97 169.07 16.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.052 0.941 . . . . 0.0 108.94 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.559 0 C-N-CA 121.737 -0.268 . . . . 0.0 112.644 178.35 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.546 1.095 0 N-CA-C 110.232 -0.718 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -84.31 -16.09 44.25 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.482 0.713 . . . . 0.0 111.236 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 72.7 m-85 -134.26 154.09 51.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 107.92 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.416 ' HD1' HD13 ' A' ' 96' ' ' LEU . 29.6 m-90 -135.48 155.9 49.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.528 0.731 . . . . 0.0 109.428 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -78.54 -103.53 0.2 Allowed Glycine 0 C--N 1.345 1.039 0 O-C-N 123.437 0.46 . . . . 0.0 112.305 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -154.02 -14.82 0.13 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.218 0.607 . . . . 0.0 111.74 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.32 110.84 1.45 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.508 ' HB ' ' HG2' ' A' ' 7' ' ' GLU . 12.6 t -96.33 123.71 40.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.467 0.651 . . . . 0.0 109.696 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.18 116.49 21.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.297 0.639 . . . . 0.0 110.836 -177.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.82 141.96 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.744 0.818 . . . . 0.0 108.968 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.4 m -134.38 105.2 6.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.86 97.78 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.2 t -73.61 147.66 43.6 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.428 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -75.68 77.27 2.65 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.509 0.724 . . . . 0.0 110.214 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 C-N-CA 125.445 1.498 . . . . 0.0 112.338 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 3' ' ' LEU . 4.0 mm? . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 40.5 mt-30 -105.61 114.29 28.37 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 56.5 mt -105.08 118.29 36.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.82 102.81 14.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 23' ' ' CYS . 1.7 mp0 -84.66 150.03 25.42 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.049 0.94 . . . . 0.0 108.964 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 p -159.69 168.11 26.76 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.736 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.8 -5.46 61.9 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.95 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.83 146.83 45.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.679 0.24 . . . . 0.0 112.875 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.61 -176.73 47.4 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.6 tt -88.91 114.39 25.48 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 122.841 0.456 . . . . 0.0 110.148 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.76 163.31 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 165.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HB2' HD13 ' A' ' 124' ' ' LEU . 5.4 pm0 -84.59 160.44 20.44 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -65.63 113.6 4.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.549 0.74 . . . . 0.0 109.618 174.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.01 -1.72 27.08 Favored Glycine 0 C--N 1.34 0.755 0 O-C-N 123.818 0.699 . . . . 0.0 111.737 -171.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.36 -166.18 41.69 Favored Glycine 0 C--N 1.344 1.006 0 C-N-CA 123.041 0.353 . . . . 0.0 113.044 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -144.1 138.01 27.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.644 0.778 . . . . 0.0 109.687 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.7 tp -140.58 128.06 21.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.535 0.734 . . . . 0.0 109.69 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -103.04 139.82 38.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.225 0.61 . . . . 0.0 110.07 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -113.98 158.61 20.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.374 1.07 . . . . 0.0 109.419 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.8 m -146.7 127.54 14.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.626 ' SG ' ' HB ' ' A' ' 80' ' ' VAL . 27.1 p -124.8 115.72 21.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.248 0.619 . . . . 0.0 109.569 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.09 135.48 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.67 100.83 11.26 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.098 0.959 . . . . 0.0 109.992 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.598 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 20.2 m 64.32 33.02 11.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.684 1.594 . . . . 0.0 111.769 169.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.97 58.16 16.06 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.663 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 55.5 ttp180 62.67 68.63 0.64 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.277 1.031 . . . . 0.0 110.782 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.1 m -140.25 143.75 36.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.672 0.789 . . . . 0.0 109.133 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -105.45 120.82 42.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -145.9 -51.84 0.24 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.582 1.153 . . . . 0.0 108.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -83.53 163.72 20.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -146.95 9.35 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.509 1.124 . . . . 0.0 109.576 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.7 117.82 8.34 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.4 ttm -151.56 118.52 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -170.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -113.92 142.91 17.76 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.54 -173.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -88.41 135.57 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 92.7 m-85 -134.81 145.94 48.83 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.304 1.042 . . . . 0.0 109.063 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 12.9 ptp180 -104.14 145.24 30.48 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -151.02 129.08 11.79 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.92 0.782 . . . . 0.0 110.51 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -100.72 161.17 24.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.8 114.78 2.15 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.429 2.086 . . . . 0.0 111.598 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.288 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 9.3 mmpt? -128.02 153.93 46.21 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.285 1.034 . . . . 0.0 109.243 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.86 151.44 30.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.994 0.518 . . . . 0.0 110.664 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.07 113.42 13.57 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.647 0.592 . . . . 0.0 110.321 177.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -93.47 139.0 31.21 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.16 0.984 . . . . 0.0 110.104 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -64.94 110.24 2.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.23 1.412 . . . . 0.0 110.736 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.7 t -95.05 -48.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.318 0.647 . . . . 0.0 109.637 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.86 19.3 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.527 0.731 . . . . 0.0 110.815 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.475 ' H ' ' HB2' ' A' ' 60' ' ' TYR . . . -155.69 130.43 9.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 0.0 110.564 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.04 111.47 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.335 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 p -165.73 149.73 8.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.984 1.314 . . . . 0.0 108.756 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.475 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -154.47 118.23 4.64 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.7 140.35 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.812 0.845 . . . . 0.0 110.196 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.94 167.9 12.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.68 0.792 . . . . 0.0 109.459 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.03 -31.41 72.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.859 0.464 . . . . 0.0 110.869 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.5 p -64.01 -27.1 68.89 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.607 1.163 . . . . 0.0 112.539 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.94 5.62 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.409 0.684 . . . . 0.0 111.516 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -67.42 113.76 5.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.899 0.879 . . . . 0.0 109.785 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.81 -27.72 17.71 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.238 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.08 -70.88 0.47 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.959 0.904 . . . . 0.0 109.631 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -90.49 120.87 31.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.9 m -135.01 138.42 43.95 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.163 0.985 . . . . 0.0 109.188 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -119.2 143.05 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.134 0.974 . . . . 0.0 109.46 178.299 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.7 t -138.45 142.45 39.46 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.487 1.115 . . . . 0.0 108.136 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -115.91 123.48 48.19 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.84 129.59 49.56 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -86.85 -35.93 18.76 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.907 0.883 . . . . 0.0 110.178 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.13 78.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.425 1.09 . . . . 0.0 112.749 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -118.05 14.79 14.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.413 0.285 . . . . 0.0 111.233 175.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 18.5 m120 51.71 59.0 4.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.598 1.159 . . . . 0.0 111.488 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -126.67 129.27 48.13 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.63 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.626 ' HB ' ' SG ' ' A' ' 23' ' ' CYS . 47.7 t -103.14 125.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -101.95 150.58 23.06 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.668 0.787 . . . . 0.0 110.39 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 tp -133.0 99.18 4.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.964 0.905 . . . . 0.0 108.814 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -86.58 102.17 13.9 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.557 ' HB3' HD21 ' A' ' 87' ' ' LEU . 47.8 mtm -95.08 119.22 33.21 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.591 0.756 . . . . 0.0 109.182 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -116.21 151.38 35.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.743 0.817 . . . . 0.0 108.953 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t 59.96 69.07 0.73 Allowed 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.291 0.994 . . . . 0.0 110.02 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 84' ' ' MET . 62.4 mt -88.16 155.82 19.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.384 -176.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 11.0 mmmm -116.65 155.66 48.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.709 1.204 . . . . 0.0 109.677 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.441 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 30.5 Cg_endo -61.08 -22.58 75.13 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.631 2.221 . . . . 0.0 112.919 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.27 -21.68 65.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.118 0.967 . . . . 0.0 112.07 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.66 17.43 0.7 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.999 0.92 . . . . 0.0 111.766 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.0 m -80.36 94.12 6.09 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 164.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.84 -178.82 6.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.875 0.87 . . . . 0.0 110.149 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.4 p -100.09 114.95 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -85.83 109.96 19.05 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -115.15 145.81 42.0 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.493 0.717 . . . . 0.0 110.175 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 79.3 m -92.13 157.93 16.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -141.69 115.76 9.32 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.67 132.06 55.35 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.426 0.691 . . . . 0.0 110.618 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.581 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.529 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.55 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 67.8 Cg_endo . . . . . 0 CA--C 1.547 1.15 0 N-CA-C 109.774 -0.894 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.31 -28.55 63.15 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.35 0.66 . . . . 0.0 111.23 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -119.41 146.61 45.21 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.865 0.866 . . . . 0.0 108.869 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -121.17 159.45 25.83 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.44 178.54 47.59 Favored Glycine 0 C--O 1.24 0.497 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.191 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -20.89 58.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.909 0.483 . . . . 0.0 111.174 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.91 125.03 0.64 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.844 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -99.52 121.16 40.77 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.63 112.25 10.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.055 0.542 . . . . 0.0 110.03 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.8 m -103.09 143.19 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 96.7 m -133.46 102.84 5.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.51 94.23 4.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -53.53 147.66 10.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.944 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.3 m -83.73 55.3 3.18 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.945 0.898 . . . . 0.0 110.207 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 14' ' ' GLN . 3.4 mm? . . . . . 0 N--CA 1.491 1.592 0 C-N-CA 124.773 1.229 . . . . 0.0 112.136 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -92.59 136.71 32.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.123 0.969 . . . . 0.0 109.437 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.462 HD13 ' SG ' ' A' ' 97' ' ' CYS . 49.1 mt -113.42 127.29 56.06 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 59.5 t -115.48 103.18 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.35 147.88 26.93 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.706 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.2 p -157.91 173.39 16.86 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.602 1.161 . . . . 0.0 109.093 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.67 -17.78 57.86 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.18 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -67.14 124.96 23.84 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 122.784 0.23 . . . . 0.0 112.686 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.86 -167.28 26.25 Favored Glycine 0 C--O 1.245 0.81 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -91.27 119.13 31.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.967 0.507 . . . . 0.0 110.258 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -124.88 169.75 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.327 1.051 . . . . 0.0 109.082 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -87.51 152.2 22.4 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.15 0.58 . . . . 0.0 111.04 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -66.36 119.06 10.93 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.338 1.055 . . . . 0.0 110.176 175.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.35 -16.14 38.39 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.771 0.669 . . . . 0.0 111.612 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.95 178.62 43.75 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.097 0.38 . . . . 0.0 113.825 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.9 p -107.92 162.66 13.81 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.042 0.937 . . . . 0.0 111.54 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.12 126.21 4.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 0.0 108.203 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -106.21 123.35 47.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -89.42 157.39 18.16 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.593 1.157 . . . . 0.0 109.559 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.6 m -139.15 124.42 19.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.727 0.811 . . . . 0.0 108.984 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 25.8 t -116.64 102.87 9.83 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.1 0.96 . . . . 0.0 109.425 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.6 t -91.51 126.54 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.553 0.741 . . . . 0.0 109.168 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.91 100.02 12.86 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m 55.85 33.33 21.34 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.14 1.376 . . . . 0.0 112.089 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.8 -84.76 1.1 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -141.58 95.86 2.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.611 0.764 . . . . 0.0 109.284 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 t -135.26 168.19 19.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.195 0.998 . . . . 0.0 108.453 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -140.25 120.37 13.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.389 0.676 . . . . 0.0 109.557 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -171.81 -72.95 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 0.0 108.999 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -84.32 129.24 34.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.314 0.646 . . . . 0.0 109.263 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -121.3 16.14 11.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 109.876 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.96 118.4 32.82 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.019 0.928 . . . . 0.0 108.521 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -137.86 121.39 17.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.132 0.973 . . . . 0.0 109.104 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -99.27 136.14 12.52 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -86.94 132.11 33.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 109.921 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -132.97 171.71 13.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.044 1.338 . . . . 0.0 108.882 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -149.28 142.03 24.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.471 0.708 . . . . 0.0 109.848 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -133.27 131.95 40.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.98 0.512 . . . . 0.0 110.348 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.45 146.18 31.97 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 123.96 0.904 . . . . 0.0 109.101 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -54.9 118.71 5.44 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.957 2.438 . . . . 0.0 113.098 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.79 71.91 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 113.489 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -128.75 167.79 16.78 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 166.47 22.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.132 0.973 . . . . 0.0 110.037 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 122.92 31.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -93.5 142.13 27.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.9 0.88 . . . . 0.0 109.896 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -65.32 130.6 43.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.824 1.25 . . . . 0.0 110.336 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.38 -54.86 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.917 0.887 . . . . 0.0 108.774 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.46 170.39 20.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -160.98 128.61 4.27 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 121.284 0.564 . . . . 0.0 110.86 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.53 HD11 ' HB ' ' A' ' 71' ' ' ILE . 2.7 mp -110.59 113.49 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.538 ' H ' ' HA ' ' A' ' 58' ' ' SER . 73.2 mtp180 . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 122.709 0.404 . . . . 0.0 110.666 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.538 ' HA ' ' H ' ' A' ' 53' ' ' ARG . 77.5 p . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.525 HG22 HD11 ' A' ' 71' ' ' ILE . 21.2 p -160.55 123.99 3.45 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.483 1.113 . . . . 0.0 108.986 -172.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 51' ' ' ALA . 59.7 m-85 -147.39 137.17 22.91 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -165.68 157.83 14.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.873 1.269 . . . . 0.0 109.808 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -85.59 149.63 25.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.15 -32.35 72.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.873 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 m -69.93 -38.0 76.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.165 0.586 . . . . 0.0 111.626 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 62' ' ' ALA . 14.6 m -96.71 -2.16 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.009 0.524 . . . . 0.0 111.593 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -61.69 128.69 37.44 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.65 0.78 . . . . 0.0 109.231 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.66 -26.55 17.65 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.629 0.581 . . . . 0.0 112.602 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -89.77 -54.9 3.85 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -84.73 121.05 27.12 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.351 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 132.39 51.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.539 1.136 . . . . 0.0 108.018 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.6 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -102.48 149.94 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.32 178.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 20.2 m -141.91 146.56 35.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 109.471 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.57 132.15 23.85 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.09 103.61 8.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.431 1.092 . . . . 0.0 108.42 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.43 -17.27 63.63 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.192 0.997 . . . . 0.0 111.962 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -46.39 75.07 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.964 0.905 . . . . 0.0 112.397 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -118.53 -0.74 11.32 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.62 0.768 . . . . 0.0 110.665 176.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 55.77 68.81 0.81 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.842 1.257 . . . . 0.0 111.32 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.449 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 98.7 m -132.71 131.58 41.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.396 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 125.8 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.418 1.087 . . . . 0.0 109.066 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 71.1 m-85 -106.52 155.57 19.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.56 0.744 . . . . 0.0 110.307 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 50.5 tp -133.92 98.43 4.15 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.47 0.708 . . . . 0.0 109.389 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.41 99.86 10.93 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.208 0.603 . . . . 0.0 109.423 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.76 ' HB3' HD21 ' A' ' 87' ' ' LEU . 75.0 mtp -100.66 101.06 11.86 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.753 0.821 . . . . 0.0 110.474 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.7 144.87 28.27 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.075 0.55 . . . . 0.0 111.082 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.1 t 60.97 72.95 0.5 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.854 1.261 . . . . 0.0 110.523 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' ' 84' ' ' MET . 67.5 mt -88.24 159.63 18.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.95 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -106.84 150.68 40.02 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.179 0.992 . . . . 0.0 108.657 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.98 -16.15 53.25 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.552 2.168 . . . . 0.0 112.958 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.77 -2.63 44.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.032 0.933 . . . . 0.0 112.142 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -90.76 37.38 0.92 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.604 0.762 . . . . 0.0 110.821 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.5 m -91.66 93.13 8.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.33 -177.23 5.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.759 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -104.55 109.83 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.031 0.532 . . . . 0.0 109.901 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.56 129.03 34.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.92 137.47 47.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 109.776 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.8 p -92.8 159.31 15.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 109.487 173.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -133.12 145.04 50.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.62 123.69 50.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.873 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.632 179.421 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.587 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 36.2 Cg_exo . . . . . 0 CA--C 1.549 1.227 0 CA-C-O 120.778 0.241 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.1 -23.53 59.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.51 0.724 . . . . 0.0 110.983 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 79.8 m-85 -133.43 155.34 49.71 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.012 0.925 . . . . 0.0 109.079 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -127.28 158.86 36.08 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.97 -170.04 45.73 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.042 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.413 ' NE2' ' HA ' ' A' ' 6' ' ' VAL . 9.8 pt20 -86.64 -21.1 26.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.558 0.743 . . . . 0.0 110.715 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 158.55 32.2 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.559 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.421 HG21 HD12 ' A' ' 21' ' ' LEU . 9.1 t -138.93 118.22 12.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.775 0.83 . . . . 0.0 108.809 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.22 103.48 8.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.486 0.714 . . . . 0.0 110.719 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.447 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -93.23 143.77 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 93.6 m -134.33 102.06 5.22 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.05 97.02 5.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 t -68.55 145.99 53.5 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.999 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -74.07 84.9 1.81 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.239 0.616 . . . . 0.0 110.155 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.9 mm? . . . . . 0 N--CA 1.486 1.355 0 C-N-CA 125.47 1.508 . . . . 0.0 112.327 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 CA--C 1.548 0.876 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.04 132.89 35.26 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.777 0.831 . . . . 0.0 110.155 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.5 mt -130.91 124.57 31.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.365 1.066 . . . . 0.0 108.579 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -121.32 101.25 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.209 0.604 . . . . 0.0 109.636 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.85 132.91 35.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.235 0.614 . . . . 0.0 109.635 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.3 m -144.35 163.77 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.147 0.979 . . . . 0.0 109.512 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.415 ' O ' HD11 ' A' ' 19' ' ' LEU . . . 117.73 -19.93 11.12 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.504 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.12 119.6 19.13 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 123.214 0.435 . . . . 0.0 112.871 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.23 -175.93 29.71 Favored Glycine 0 C--N 1.347 1.161 0 C-N-CA 123.431 0.538 . . . . 0.0 112.104 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 120' ' ' THR . 25.6 tp -89.85 114.46 26.21 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.354 0.662 . . . . 0.0 110.37 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.8 145.97 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 4.8 pm0 -75.22 154.65 37.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.126 0.421 . . . . 0.0 110.568 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . . . -58.14 113.68 2.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.559 0.744 . . . . 0.0 111.36 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.98 -4.41 25.66 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.122 0.867 . . . . 0.0 111.511 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.44 -165.68 39.83 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 123.345 0.498 . . . . 0.0 112.839 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -141.46 150.47 42.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.749 0.82 . . . . 0.0 111.129 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 9' ' ' GLY . 31.2 tp -147.33 122.91 10.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.661 0.784 . . . . 0.0 109.072 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -103.13 119.26 38.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.047 0.539 . . . . 0.0 110.139 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.47 157.46 19.19 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 m -143.22 127.34 17.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.941 0.896 . . . . 0.0 108.775 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.53 120.19 36.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.875 0.87 . . . . 0.0 109.81 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.66 115.18 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.541 0.736 . . . . 0.0 109.14 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.85 103.07 15.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.101 0.56 . . . . 0.0 110.633 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.1 p 52.75 57.68 6.13 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.999 1.72 . . . . 0.0 112.404 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.91 -82.84 0.4 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.407 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -160.54 41.79 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.594 1.187 . . . . 0.0 108.066 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -111.31 155.92 22.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.99 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -107.06 118.82 37.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -151.47 171.4 17.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.006 1.322 . . . . 0.0 107.759 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 t 65.69 114.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.807 1.243 . . . . 0.0 110.848 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -55.37 -32.36 62.52 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.887 0.875 . . . . 0.0 113.133 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.06 151.71 46.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 111.02 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 67.7 mtt -140.87 147.68 39.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 107.904 174.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.51 150.25 22.23 Favored Glycine 0 N--CA 1.467 0.723 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.858 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -91.23 149.4 21.78 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.2 152.14 49.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.222 1.409 . . . . 0.0 108.665 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -125.27 135.32 52.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.464 0.705 . . . . 0.0 109.181 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -147.56 130.95 16.62 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 123.313 0.645 . . . . 0.0 109.474 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -88.96 154.22 49.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -53.59 105.56 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.643 2.229 . . . . 0.0 112.888 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.2 31.53 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.509 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 6.6 mmpt? -126.33 174.5 8.53 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.966 0.907 . . . . 0.0 110.853 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -82.8 144.36 30.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.762 0.825 . . . . 0.0 110.208 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.29 116.34 24.4 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.046 0.45 . . . . 0.0 110.005 176.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -92.31 142.36 27.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.648 0.779 . . . . 0.0 109.904 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -73.61 107.77 6.07 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.717 0.807 . . . . 0.0 109.52 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -86.9 -54.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.714 0.806 . . . . 0.0 110.357 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -137.49 160.21 39.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -170.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.47 121.12 14.29 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 125.102 1.361 . . . . 0.0 108.873 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.5 mp -121.68 116.08 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 . . . . . 0 N--CA 1.48 1.031 0 CA-C-N 118.507 0.594 . . . . 0.0 110.022 175.585 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.1 m . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.442 ' HA ' HD11 ' A' ' 71' ' ' ILE . 17.8 p -146.57 120.84 9.56 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 12.3 t80 -171.38 131.94 0.77 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.56 134.99 9.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.06 150.47 33.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.923 0.489 . . . . 0.0 111.029 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.561 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 29.9 t70 -66.3 -18.86 65.61 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -72.97 -34.24 66.36 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.385 0.674 . . . . 0.0 111.219 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -106.96 15.97 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.788 0.835 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -65.93 121.17 14.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.36 1.064 . . . . 0.0 110.749 -176.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.52 -27.6 16.77 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.361 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 4.0 ptt180 -94.82 -28.08 15.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.394 0.597 . . . . 0.0 109.988 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -99.73 132.66 44.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.357 0.663 . . . . 0.0 109.282 173.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.9 m -137.99 145.23 41.67 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.889 1.276 . . . . 0.0 108.125 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -128.57 159.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.564 0.746 . . . . 0.0 109.884 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.8 t -156.78 139.69 15.29 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.74 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.546 ' HD2' HG21 ' A' ' 52' ' ' ILE . 50.2 ttt85 -115.19 120.54 40.06 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.77 107.67 18.75 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 109.303 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.34 -34.49 75.36 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.4 1.062 . . . . 0.0 111.283 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.54 -44.68 69.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.336 1.054 . . . . 0.0 112.963 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.77 7.6 11.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.074 0.55 . . . . 0.0 111.729 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.6 m120 53.66 38.37 28.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.488 1.115 . . . . 0.0 111.784 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 32.2 m -114.43 130.99 56.74 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.705 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 73' ' ' ARG . 39.8 t -104.63 121.31 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.749 0.82 . . . . 0.0 108.814 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -101.13 152.79 20.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.762 . . . . 0.0 111.261 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.7 tp -132.94 97.83 4.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.287 1.035 . . . . 0.0 108.374 171.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -80.51 101.35 9.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.624 ' HB3' HD21 ' A' ' 87' ' ' LEU . 34.3 mtm -92.71 135.63 33.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.49 170.09 16.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 t 58.61 33.45 23.1 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.859 0.864 . . . . 0.0 110.767 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -71.94 156.94 38.7 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.673 -173.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.608 ' HG2' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -132.06 158.3 75.89 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.848 1.259 . . . . 0.0 108.189 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' A' ' 15' ' ' ALA . 13.0 Cg_endo -53.68 -24.4 29.77 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 123.061 2.507 . . . . 0.0 114.522 -169.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.608 ' HG2' ' HG2' ' A' ' 88' ' ' LYS . 13.1 pt-20 -65.74 -18.76 65.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 0.0 112.589 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 121' ' ' VAL . 65.3 m-20 -82.36 30.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.493 0.717 . . . . 0.0 110.959 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.472 HG23 HG23 ' A' ' 120' ' ' THR . 95.9 m -83.14 93.56 7.66 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 164.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.6 27.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.431 0.692 . . . . 0.0 110.625 -172.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.53 120.89 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.009 0.524 . . . . 0.0 109.958 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -95.56 125.93 40.5 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -129.35 144.11 51.11 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 109.742 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -92.8 157.76 16.24 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.54 150.25 46.17 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.341 0.656 . . . . 0.0 109.518 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -113.4 132.03 55.77 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.661 0 CA-C-O 121.353 0.418 . . . . 0.0 113.459 -172.089 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.543 0.933 0 N-CA-C 110.648 -0.558 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -83.48 -22.59 32.49 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.115 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 21.9 m-85 -122.48 147.44 46.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.03 0.932 . . . . 0.0 108.525 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.8 m-90 -130.11 162.06 29.65 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 108.846 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.27 -142.93 7.78 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.438 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -102.34 -27.95 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 110.661 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.55 156.08 24.13 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.109 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.46 119.37 11.9 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.98 103.0 5.01 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -85.53 137.96 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 32.1 m -133.38 110.47 10.05 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 91' ' ' ASP . 48.0 t -91.89 103.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 35.5 t -45.35 143.0 1.9 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.387 1.075 . . . . 0.0 112.308 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.5 p -70.15 167.67 17.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.779 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 122.919 0.488 . . . . 0.0 111.476 -179.106 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 26' ' ' SER . 2.0 tm? . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -103.12 150.32 23.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.571 1.149 . . . . 0.0 108.383 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.468 HD22 ' SG ' ' A' ' 23' ' ' CYS . 95.1 mt -131.27 108.76 9.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.092 0.557 . . . . 0.0 110.137 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.6 107.72 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.096 0.958 . . . . 0.0 108.821 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -99.22 155.24 17.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.1 m -153.56 155.63 36.52 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.836 1.654 . . . . 0.0 109.145 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.02 10.12 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 123.171 0.415 . . . . 0.0 112.887 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -71.05 90.13 0.41 Allowed Glycine 0 C--N 1.347 1.146 0 O-C-N 123.484 0.167 . . . . 0.0 113.206 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.31 -175.61 13.93 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -94.76 118.32 31.56 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.063 0.545 . . . . 0.0 110.041 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.63 167.36 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 109.271 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.47 ' NE2' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -84.24 152.83 23.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.797 0.839 . . . . 0.0 110.478 175.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -68.12 121.85 17.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.68 -22.39 14.92 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.077 0.846 . . . . 0.0 111.31 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.47 ' HA3' ' NE2' ' A' ' 14' ' ' GLN . . . -81.84 -166.99 38.41 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 121.225 0.347 . . . . 0.0 113.492 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 p -127.31 156.1 42.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.565 0.746 . . . . 0.0 110.891 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -152.66 133.24 13.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.006 0.922 . . . . 0.0 108.636 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -113.17 124.16 51.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.992 0.517 . . . . 0.0 109.706 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.37 157.12 19.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.906 0.882 . . . . 0.0 109.443 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.9 p -142.32 135.32 28.58 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.211 1.004 . . . . 0.0 108.725 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' SG ' HD22 ' A' ' 5' ' ' LEU . 53.8 t -140.06 116.83 10.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.24 0.616 . . . . 0.0 110.095 -177.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.53 122.86 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.58 102.57 15.31 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.037 0.935 . . . . 0.0 110.515 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.686 ' HB2' HD22 ' A' ' 3' ' ' LEU . 11.6 t 69.97 22.73 5.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.53 1.532 . . . . 0.0 111.906 168.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 56.97 10.24 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 86.6 mtm180 60.6 56.37 3.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.371 1.069 . . . . 0.0 110.948 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 47.2 m -137.3 150.33 47.7 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.817 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -103.14 127.42 50.43 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.589 ' HB3' HD23 ' A' ' 3' ' ' LEU . 44.3 ttm180 -170.51 -35.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.594 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 p -71.1 103.77 2.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.225 0.61 . . . . 0.0 110.52 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -79.32 -34.65 42.09 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.7 0.8 . . . . 0.0 109.415 174.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.01 49.18 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.769 1.228 . . . . 0.0 108.948 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 50.2 mtm -150.54 168.43 24.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.932 1.693 . . . . 0.0 108.567 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.02 35.52 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 96.9 m95 -122.37 135.51 54.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 168.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -122.95 164.38 18.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.147 1.379 . . . . 0.0 108.326 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -138.11 151.18 47.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -153.94 150.41 28.29 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.42 145.34 30.61 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.95 104.53 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.371 2.714 . . . . 0.0 113.386 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.79 -12.58 50.02 Favored Glycine 0 C--N 1.352 1.469 0 C-N-CA 122.9 0.286 . . . . 0.0 113.349 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -97.99 173.53 7.01 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.0 0.92 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -78.13 170.06 17.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.909 0.883 . . . . 0.0 110.433 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' H ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -100.59 151.67 21.33 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.181 0.515 . . . . 0.0 110.681 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -115.75 139.53 50.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.668 1.587 . . . . 0.0 109.005 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 59.5 t80 -83.27 109.78 17.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.086 0.955 . . . . 0.0 109.155 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.7 t -90.09 -52.47 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.671 0.788 . . . . 0.0 110.288 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -148.83 169.83 19.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.112 -168.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -149.28 119.05 7.04 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.61 1.164 . . . . 0.0 109.512 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.0 mp -120.78 116.53 50.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 C-N-CA 123.801 0.84 . . . . 0.0 109.344 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.438 ' H ' ' HA ' ' A' ' 58' ' ' SER . 2.5 mpt_? . . . . . 0 C--O 1.244 0.782 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.7 m . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.522 ' HA ' HD11 ' A' ' 71' ' ' ILE . 19.3 p -151.33 126.11 9.66 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 6.0 t80 -166.47 130.2 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.73 150.73 12.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.616 1.566 . . . . 0.0 108.139 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.47 155.07 39.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.304 0.642 . . . . 0.0 110.729 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.88 -31.79 73.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.265 0.626 . . . . 0.0 111.42 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -69.37 -33.9 73.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.747 0.819 . . . . 0.0 111.77 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.528 ' HA ' HH21 ' A' ' 68' ' ' ARG . 31.1 m -102.53 -0.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.711 0.804 . . . . 0.0 111.722 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.16 134.94 56.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.052 1.341 . . . . 0.0 112.313 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.37 5.54 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.623 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.612 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 75.3 mtm180 -89.64 -51.78 5.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.008 0.908 . . . . 0.0 109.173 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -86.7 122.71 30.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.677 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -146.15 150.5 36.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.012 1.325 . . . . 0.0 108.037 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -121.42 155.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.959 0.904 . . . . 0.0 110.445 -177.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -146.78 134.07 20.63 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.957 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.61 ' HB2' HG21 ' A' ' 52' ' ' ILE . 32.3 ttt180 -112.21 130.8 55.8 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -116.42 116.06 26.98 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -87.51 -11.66 48.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.925 0.33 . . . . 0.0 111.642 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.33 94.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.135 0.574 . . . . 0.0 111.455 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -119.62 15.68 12.8 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 122.355 0.262 . . . . 0.0 110.957 169.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 16.9 m120 44.45 63.66 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.077 1.351 . . . . 0.0 111.982 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.5 m -131.29 132.61 44.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.394 0.677 . . . . 0.0 109.758 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.7 t -102.66 143.73 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.561 1.144 . . . . 0.0 108.623 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -125.78 142.22 51.62 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.585 0.754 . . . . 0.0 110.071 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.3 tp -126.85 96.8 4.75 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -89.98 107.75 19.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.6 mtm -107.96 119.08 38.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.959 0.904 . . . . 0.0 109.045 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -112.38 148.63 33.9 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.421 0.689 . . . . 0.0 110.229 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.612 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 41.6 t 56.47 68.86 0.8 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.434 1.093 . . . . 0.0 110.162 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -78.77 160.87 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.469 -1.242 . . . . 0.0 111.47 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -127.61 147.39 62.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.425 -169.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -57.96 -29.35 86.3 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.34 2.694 . . . . 0.0 114.098 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 pm0 -78.67 -2.88 41.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.323 0.649 . . . . 0.0 111.843 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -86.67 25.68 1.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.0 0.92 . . . . 0.0 110.733 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.44 HG23 ' HA ' ' A' ' 120' ' ' THR . 87.7 m -87.74 92.68 9.2 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.22 168.04 27.5 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.523 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.38 106.81 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-O 121.565 0.698 . . . . 0.0 109.765 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -89.9 114.41 26.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -111.74 146.97 36.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.175 0.59 . . . . 0.0 109.666 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -90.55 159.41 16.49 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.63 40.6 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.9 0.88 . . . . 0.0 109.089 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -152.97 170.0 21.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.607 0.763 . . . . 0.0 110.59 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.697 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 176.679 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 CA--C 1.552 1.419 0 CA-C-O 121.297 0.457 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.97 -18.73 64.11 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.013 0.925 . . . . 0.0 111.012 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -134.76 151.63 51.12 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 125.14 1.376 . . . . 0.0 108.459 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -126.14 162.23 25.84 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.961 0.904 . . . . 0.0 109.255 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -94.14 177.23 36.49 Favored Glycine 0 C--O 1.241 0.552 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.927 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.7 -25.89 65.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.562 0.745 . . . . 0.0 111.221 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.36 110.81 0.23 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.753 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -99.02 118.92 36.89 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.458 0.647 . . . . 0.0 110.044 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.25 103.92 6.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.099 0.96 . . . . 0.0 111.135 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.553 HG12 ' HA2' ' A' ' 10' ' ' GLY . 9.0 m -90.05 152.0 3.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 85.3 m -132.72 106.61 7.87 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.54 0.736 . . . . 0.0 109.026 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.2 96.2 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 t -68.44 144.06 54.83 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.649 0.38 . . . . 0.0 110.766 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -67.65 92.51 0.33 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.127 0.971 . . . . 0.0 111.813 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 15' ' ' ALA . 4.3 mm? . . . . . 0 N--CA 1.494 1.748 0 C-N-CA 124.565 1.146 . . . . 0.0 113.19 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.912 0.387 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 36.3 mt-30 -103.59 128.67 50.81 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.6 mp -127.12 122.88 35.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.2 t -114.39 101.87 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.94 144.59 26.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.408 0.683 . . . . 0.0 109.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -147.24 169.25 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 109.836 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.38 10.31 51.29 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.432 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.42 111.03 3.26 Favored Glycine 0 C--N 1.344 0.999 0 O-C-N 123.578 0.223 . . . . 0.0 112.649 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.85 -176.66 32.16 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 120' ' ' THR . 14.3 tp -92.07 125.87 36.93 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 19' ' ' LEU . 19.4 m -126.48 157.55 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -75.58 148.23 39.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.812 0.845 . . . . 0.0 110.358 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.56 111.9 2.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.345 0.658 . . . . 0.0 109.772 171.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.07 -21.7 17.4 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.561 0.538 . . . . 0.0 112.115 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.01 -178.53 34.94 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 116.555 0.178 . . . . 0.0 112.899 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 p -123.04 151.05 42.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.475 0.71 . . . . 0.0 110.553 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 13' ' ' VAL . 56.5 tp -151.82 133.65 14.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.355 1.062 . . . . 0.0 108.961 -177.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -109.42 126.0 53.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.408 0.683 . . . . 0.0 109.843 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -96.19 158.94 15.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 109.217 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.6 p -147.89 124.36 11.01 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.217 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.3 t -116.89 109.54 17.2 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.828 0.851 . . . . 0.0 109.429 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.4 t -86.17 126.11 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.79 100.61 13.38 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.537 0.735 . . . . 0.0 110.693 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.591 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 22.7 t 60.9 40.15 15.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.071 1.348 . . . . 0.0 111.83 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.73 -62.33 4.62 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.973 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 25.5 ttt180 -160.86 4.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.741 0.816 . . . . 0.0 110.445 173.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 m -77.57 145.13 37.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.401 0.681 . . . . 0.0 110.608 -170.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -105.97 123.57 48.19 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.416 ' H ' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -163.02 -18.11 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.519 1.128 . . . . 0.0 109.352 170.019 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 31' ' ' ARG . 17.9 m -63.76 108.19 1.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.872 0.869 . . . . 0.0 109.666 174.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -82.32 -36.93 26.47 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.858 0.837 . . . . 0.0 109.47 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.18 41.48 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.742 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 97.8 mtp -141.93 118.98 11.29 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.12 142.83 17.32 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.24 123.06 32.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-85 -120.17 133.91 55.38 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.401 1.08 . . . . 0.0 108.193 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -103.29 124.09 48.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.319 0.58 . . . . 0.0 109.934 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 128.68 53.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.6 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -125.36 155.15 72.05 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 122.889 0.475 . . . . 0.0 110.444 -170.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -52.5 96.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.027 2.484 . . . . 0.0 112.781 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.28 58.78 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.075 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.2 mmpt? -105.56 138.27 42.03 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.505 0.722 . . . . 0.0 109.998 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.48 163.79 10.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 0.0 112.6 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -58.56 122.15 12.69 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 168.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.3 tt0 -115.7 128.7 56.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.428 0.691 . . . . 0.0 109.51 -172.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 46.6 t80 -66.57 107.45 2.1 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 124.121 0.888 . . . . 0.0 109.714 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.05 -55.61 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.075 0.95 . . . . 0.0 109.954 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.65 32.29 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.865 -172.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -139.39 123.62 18.01 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.163 0.985 . . . . 0.0 109.92 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.761 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -108.68 119.36 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 . . . . . 0 C--O 1.238 0.497 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.678 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 50.6 m . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 p -149.52 121.59 8.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.406 ' H ' HD11 ' A' ' 71' ' ' ILE . 12.3 t80 -170.59 126.83 0.76 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.405 ' HE2' ' HG3' ' A' ' 66' ' ' LYS . 25.1 p90 -163.66 144.07 8.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.154 0.982 . . . . 0.0 108.944 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -68.69 153.89 42.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.921 0.489 . . . . 0.0 110.378 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.45 -35.29 77.17 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.263 0.625 . . . . 0.0 110.54 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -63.41 -34.36 77.58 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 111.937 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 62' ' ' ALA . 34.4 m -108.23 19.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.953 0.901 . . . . 0.0 111.124 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.405 ' HG3' ' HE2' ' A' ' 61' ' ' TYR . 39.1 ttmt -57.34 116.84 3.56 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.169 0.988 . . . . 0.0 111.532 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.65 -27.91 6.81 Favored Glycine 0 C--N 1.342 0.876 0 O-C-N 123.733 0.646 . . . . 0.0 113.602 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -77.75 -60.25 2.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -84.69 122.11 28.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 p -143.58 153.82 42.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -130.28 154.39 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.747 0.819 . . . . 0.0 110.387 177.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.2 m -150.33 135.79 18.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.972 1.309 . . . . 0.0 107.932 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -110.05 123.42 49.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.02 128.32 36.79 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -87.25 -27.9 22.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.063 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.15 96.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.47 0.708 . . . . 0.0 112.403 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -116.34 4.28 13.41 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.135 0.425 . . . . 0.0 111.992 171.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 54.36 68.34 0.87 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.206 1.002 . . . . 0.0 111.183 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -134.99 130.67 36.11 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.25 120.43 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.031 0.932 . . . . 0.0 109.517 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.08 134.31 42.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.63 0.772 . . . . 0.0 110.297 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.5 tp -114.87 98.9 7.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -84.16 98.85 10.15 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.478 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 90.5 mtp -91.89 108.5 19.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 174.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -103.19 132.81 49.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t 61.17 70.33 0.61 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.203 1.001 . . . . 0.0 109.614 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 121' ' ' VAL . 5.5 mp -71.24 135.88 47.71 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.382 176.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.47 153.06 76.21 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.47 -19.7 68.31 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 121.946 1.764 . . . . 0.0 111.299 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -65.12 -20.51 66.5 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.861 2.064 . . . . 0.0 111.802 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.407 ' HB2' HG21 ' A' ' 121' ' ' VAL . 66.0 m-20 -84.9 31.61 0.54 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.814 0.846 . . . . 0.0 111.362 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 120' ' ' THR . 98.7 m -82.23 92.28 6.88 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 161.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.5 -175.35 4.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.818 -168.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.93 109.14 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -85.06 109.25 18.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.62 147.51 31.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 36.2 t -99.11 157.54 16.29 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 171.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -142.88 128.35 18.99 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.67 141.59 42.03 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.372 0.669 . . . . 0.0 110.345 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.825 0 O-C-N 123.982 0.801 . . . . 0.0 113.127 -177.841 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 CA--C 1.553 1.442 0 CA-C-O 120.565 0.152 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.76 -38.85 76.13 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.809 -176.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -136.86 123.92 21.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -87.25 162.91 17.17 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 109.668 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.34 -164.99 34.89 Favored Glycine 0 C--O 1.243 0.706 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.88 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -79.73 -37.53 35.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.431 0.692 . . . . 0.0 110.639 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.85 138.16 9.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.396 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.408 HG21 HD12 ' A' ' 21' ' ' LEU . 9.7 t -108.03 118.65 37.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.166 0.587 . . . . 0.0 109.51 173.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.12 107.44 11.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.795 0.838 . . . . 0.0 110.467 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.7 m -107.07 143.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.946 0.898 . . . . 0.0 109.501 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 92' ' ' THR . 61.7 m -132.92 120.92 22.1 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 87' ' ' LEU . 25.9 t -100.91 104.57 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 176.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.2 m -53.64 140.64 28.46 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.1 m -83.09 59.51 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.873 0.869 . . . . 0.0 110.255 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.485 1.32 0 C-N-CA 125.306 1.442 . . . . 0.0 112.74 -171.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -88.92 114.45 25.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.5 mt -112.04 122.32 47.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.02 100.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -87.21 118.8 26.86 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m -129.46 135.0 48.1 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.186 0.995 . . . . 0.0 109.186 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.78 9.21 0.73 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.074 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.3 89.99 0.61 Allowed Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.921 0.361 . . . . 0.0 112.749 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.22 172.78 23.32 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 112.268 -0.333 . . . . 0.0 112.268 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 122' ' ' SER . 15.9 tp -91.99 123.76 35.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.463 0.705 . . . . 0.0 109.132 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.1 m -126.81 151.15 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -77.89 153.75 32.35 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 122.574 0.35 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.7 114.15 2.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.672 0.789 . . . . 0.0 110.584 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.25 11.7 27.01 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.296 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.47 -167.01 24.61 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 122.555 0.121 . . . . 0.0 113.087 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -132.47 156.9 45.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.694 0.798 . . . . 0.0 110.011 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -159.32 119.71 3.13 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -100.18 126.45 46.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.994 0.518 . . . . 0.0 110.375 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.83 157.48 18.99 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.02 0.928 . . . . 0.0 109.865 170.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.3 p -141.12 148.81 40.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.66 1.184 . . . . 0.0 108.544 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.0 t -135.28 101.67 4.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.2 118.14 30.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.82 97.92 11.47 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m 51.97 49.35 20.89 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.334 1.453 . . . . 0.0 112.267 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.27 -78.1 2.04 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.333 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -172.28 85.1 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.406 1.082 . . . . 0.0 108.585 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -139.16 155.96 47.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.351 0.66 . . . . 0.0 110.222 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.17 117.87 35.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -173.08 160.91 4.26 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.757 1.223 . . . . 0.0 109.514 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m 64.95 177.52 0.19 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.422 1.089 . . . . 0.0 111.088 -171.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -147.33 19.68 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.807 0.443 . . . . 0.0 110.726 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.3 125.12 6.52 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.837 0.855 . . . . 0.0 109.78 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 65.9 mtt -139.91 119.86 13.55 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.31 177.13 16.85 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 123.125 0.393 . . . . 0.0 112.697 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -119.55 139.79 51.57 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.717 0.807 . . . . 0.0 110.656 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -127.28 166.86 16.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 107.527 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.24 139.22 19.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.316 0.246 . . . . 0.0 110.665 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -125.18 128.12 47.87 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.076 0.55 . . . . 0.0 109.697 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.33 158.69 31.77 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.393 0.677 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -55.08 115.68 2.61 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.919 2.413 . . . . 0.0 112.693 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -7.74 78.08 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 113.629 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.2 mmpt? -114.51 162.97 16.02 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.069 0.948 . . . . 0.0 110.596 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.24 175.18 9.09 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.668 0.787 . . . . 0.0 110.212 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 131.53 36.1 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -115.67 140.46 49.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 109.311 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.59 109.38 3.25 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.744 1.217 . . . . 0.0 110.263 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.48 -58.2 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -163.78 174.74 11.22 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.958 -173.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.74 130.69 23.12 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.573 1.149 . . . . 0.0 108.926 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.2 mp -112.84 116.27 52.15 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.1 mtm-85 . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.909 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.645 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 23.6 m . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.539 ' HA ' HD11 ' A' ' 71' ' ' ILE . 3.2 p -159.01 122.59 3.81 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.735 0.814 . . . . 0.0 110.157 -175.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 46.4 m-85 -160.56 111.81 1.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.364 1.466 . . . . 0.0 107.927 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -166.63 136.0 3.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.964 0.906 . . . . 0.0 110.414 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.24 168.13 16.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.093 0.957 . . . . 0.0 110.329 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -57.32 -33.94 68.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.461 0.704 . . . . 0.0 112.312 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 m -65.8 -31.01 71.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.319 0.648 . . . . 0.0 112.284 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.2 14.16 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.693 0.797 . . . . 0.0 111.053 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.9 124.2 27.7 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.556 0.743 . . . . 0.0 109.883 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.36 -28.54 6.19 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.177 -174.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 74.7 mtp180 -75.63 -78.1 0.12 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 124.11 0.964 . . . . 0.0 109.189 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -84.26 119.92 25.61 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.628 0.771 . . . . 0.0 108.932 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -137.87 133.0 33.34 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 108.289 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.539 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -112.66 140.09 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.682 0.793 . . . . 0.0 110.081 -175.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -148.67 174.9 11.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.52 1.128 . . . . 0.0 109.527 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -152.01 150.29 29.82 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.571 0.748 . . . . 0.0 109.247 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.85 100.31 5.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.556 1.143 . . . . 0.0 108.173 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -69.94 -13.4 62.22 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.03 0.932 . . . . 0.0 111.498 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.31 70.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.22 . . . . 0.0 111.508 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.09 9.0 15.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.068 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m120 53.66 64.72 1.74 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.585 1.154 . . . . 0.0 111.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.8 m -138.7 130.69 28.11 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.711 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.42 131.68 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.929 0.891 . . . . 0.0 108.626 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.53 150.54 29.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.101 0.56 . . . . 0.0 111.849 -174.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 37.8 tp -132.74 97.92 4.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -81.11 109.39 15.63 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.699 ' HB3' HD21 ' A' ' 87' ' ' LEU . 28.4 mtm -100.58 97.43 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -91.81 162.78 14.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.895 0.878 . . . . 0.0 110.615 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.484 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 20.5 t 42.92 63.72 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.3 1.44 . . . . 0.0 111.912 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 84' ' ' MET . 50.7 mt -82.63 150.51 26.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.759 -168.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -106.2 153.07 40.56 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.117 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.15 -18.89 60.96 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.584 2.19 . . . . 0.0 112.922 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.48 -1.17 25.86 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -96.41 31.69 2.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.447 0.641 . . . . 0.0 110.377 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.6 m -82.81 98.96 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 164.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.58 156.18 25.31 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.976 0.417 . . . . 0.0 111.387 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.05 105.25 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 170.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.61 122.59 31.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 108.957 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.76 158.6 34.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.64 0.776 . . . . 0.0 110.012 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.81 159.24 17.37 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.235 1.014 . . . . 0.0 109.445 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -141.67 138.82 32.74 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.545 0.738 . . . . 0.0 109.782 -176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -114.1 124.63 52.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 0.0 110.081 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 C-N-CA 123.847 0.737 . . . . 0.0 111.536 176.507 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.537 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 73.2 Cg_endo . . . . . 0 CA--C 1.548 1.219 0 CA-C-O 121.176 0.407 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.24 -5.24 59.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.396 0.679 . . . . 0.0 111.351 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 89.9 m-85 -123.03 142.36 50.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.661 0.784 . . . . 0.0 109.414 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -132.09 150.71 52.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.995 1.318 . . . . 0.0 107.893 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.98 -142.09 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 123.212 0.32 . . . . 0.0 112.864 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -100.85 -29.88 11.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.904 0.882 . . . . 0.0 111.304 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.94 161.81 36.76 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.297 -173.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -144.62 126.03 14.88 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.054 0.454 . . . . 0.0 110.054 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 100.35 9.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 -175.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 m -90.19 146.52 6.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 170.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 38.8 m -134.29 113.58 12.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.19 99.02 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.572 ' HB2' HD11 ' A' ' 12' ' ' LEU . 9.4 t -60.54 141.32 56.7 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.959 176.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.2 p -81.56 76.65 8.47 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.381 0.673 . . . . 0.0 109.822 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 125.232 1.413 . . . . 0.0 113.834 177.037 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 32' ' ' SER . 4.2 mm? . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.563 0.22 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.94 103.39 13.95 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 99' ' ' ALA . 86.9 mt -100.28 112.89 25.25 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.58 102.44 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.16 128.38 36.34 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.2 m -128.11 165.92 19.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.859 1.263 . . . . 0.0 109.194 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.61 8.16 40.83 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -76.55 103.24 1.71 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.752 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -178.99 32.65 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.2 tt -91.67 119.41 31.52 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.54 163.07 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.063 0.945 . . . . 0.0 108.656 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' NE2' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -83.62 154.73 23.59 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.736 0.814 . . . . 0.0 110.666 177.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -71.52 127.13 31.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 109.462 174.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.18 -14.12 44.16 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.45 ' HA3' ' NE2' ' A' ' 14' ' ' GLN . . . -88.99 -177.84 46.21 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.628 0.251 . . . . 0.0 113.132 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 p -119.37 131.09 55.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.651 0.781 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.9 tp -128.99 131.47 47.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.849 0.86 . . . . 0.0 108.964 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -112.63 132.41 55.17 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.8 0.84 . . . . 0.0 110.108 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.97 158.65 16.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.475 1.11 . . . . 0.0 109.851 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 p -140.25 122.39 15.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.705 0.802 . . . . 0.0 109.847 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -112.31 108.92 18.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.233 1.013 . . . . 0.0 108.851 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.96 121.62 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.49 108.67 19.94 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.711 0.805 . . . . 0.0 109.729 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 p 48.08 45.35 19.46 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.986 1.714 . . . . 0.0 113.067 172.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.61 -61.41 4.7 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 69.0 ttt180 -165.48 14.97 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.936 0.894 . . . . 0.0 110.606 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -106.12 154.64 20.39 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.321 0.648 . . . . 0.0 109.855 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -108.9 116.86 32.8 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -131.55 16.27 4.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.104 0.962 . . . . 0.0 109.717 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.418 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 38.2 t -139.55 147.72 41.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.747 0.819 . . . . 0.0 109.556 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -43.6 19.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.827 0.851 . . . . 0.0 109.336 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.33 152.39 46.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.907 0.483 . . . . 0.0 111.252 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 2.1 mpt? -133.14 118.48 18.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.67 135.35 10.09 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -93.28 129.23 39.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.111 0.964 . . . . 0.0 109.971 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.21 135.87 39.46 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 23.5 ptt180 -103.55 118.15 36.07 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.307 0.575 . . . . 0.0 109.946 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.492 ' HB3' HG13 ' A' ' 94' ' ' VAL . 49.7 tp60 -100.71 129.13 46.57 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -99.28 150.74 37.01 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 122.634 0.373 . . . . 0.0 110.408 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.21 98.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.688 2.259 . . . . 0.0 112.294 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.07 65.81 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.913 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.2 mmpt? -123.68 153.58 40.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.741 0.816 . . . . 0.0 110.182 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -68.39 172.65 5.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.174 0.989 . . . . 0.0 113.104 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.472 ' H ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.24 134.93 34.93 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.324 -177.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.0 142.86 29.19 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.069 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -71.05 122.02 19.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.979 0.912 . . . . 0.0 110.034 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.92 -53.47 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.97 173.6 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.807 0.443 . . . . 0.0 112.183 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.29 121.63 3.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.255 1.022 . . . . 0.0 110.313 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 52' ' ' ILE . 2.9 mp -115.14 115.47 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 . . . . . 0 N--CA 1.478 0.971 0 C-N-CA 122.582 0.353 . . . . 0.0 110.203 -179.1 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 p -170.01 145.64 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.105 1.762 . . . . 0.0 106.97 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.412 ' H ' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -165.78 130.12 2.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.718 0.807 . . . . 0.0 109.189 176.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -164.25 147.84 9.51 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.633 0.773 . . . . 0.0 110.576 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.33 164.29 13.57 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.054 0.941 . . . . 0.0 109.832 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.8 -21.37 66.04 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.387 0.675 . . . . 0.0 111.588 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 m -67.9 -38.38 82.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.388 0.675 . . . . 0.0 111.192 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -105.75 -6.28 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.671 0.788 . . . . 0.0 111.846 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -57.59 131.13 49.29 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.315 1.046 . . . . 0.0 112.359 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.28 -26.5 6.95 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.69 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.421 HH21 ' HE1' ' A' ' 69' ' ' PHE . 3.6 mtm180 -96.88 -59.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.421 ' HE1' HH21 ' A' ' 68' ' ' ARG . 1.2 m-85 -84.99 120.63 26.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -139.34 143.66 37.9 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.297 1.039 . . . . 0.0 108.491 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.441 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -126.5 146.16 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.764 0.826 . . . . 0.0 111.03 -175.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -151.75 140.49 20.86 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.344 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -107.96 123.48 48.7 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.68 131.0 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.907 170.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 -28.51 19.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.582 0.753 . . . . 0.0 111.177 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.19 -43.52 87.59 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.838 0.855 . . . . 0.0 112.141 -172.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -118.14 9.88 12.78 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.222 0.209 . . . . 0.0 111.506 172.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 47.48 67.35 0.82 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.886 1.274 . . . . 0.0 112.016 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.4 m -134.68 131.61 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.252 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.47 131.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.641 0.776 . . . . 0.0 109.267 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -111.87 137.76 49.4 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.506 0.722 . . . . 0.0 110.769 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.53 97.66 5.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -87.65 104.54 16.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.396 0.678 . . . . 0.0 109.548 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 35.4 mtm -103.09 103.21 13.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.752 0.821 . . . . 0.0 110.083 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -93.2 149.49 21.19 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.4 t 56.23 72.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.907 1.283 . . . . 0.0 110.968 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.4 mt -81.06 160.74 24.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.571 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 150.37 59.06 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.802 1.241 . . . . 0.0 108.358 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.43 -21.55 54.25 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.235 2.623 . . . . 0.0 114.18 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.74 -12.18 61.43 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.561 0.744 . . . . 0.0 112.43 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -79.11 13.82 1.67 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.206 0.602 . . . . 0.0 111.423 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 120' ' ' THR . 83.2 m -73.46 89.38 1.65 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.6 -178.6 3.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 -166.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -110.44 111.73 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 109.781 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -83.61 109.39 17.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.12 154.62 21.45 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.335 0.654 . . . . 0.0 110.159 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -108.55 158.0 17.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.331 1.052 . . . . 0.0 108.6 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -130.29 145.85 51.82 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.93 114.49 27.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.936 0 CA-C-O 121.23 0.35 . . . . 0.0 113.716 -167.903 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.519 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 12.1 Cg_exo . . . . . 0 CA--C 1.546 1.118 0 N-CA-C 110.176 -0.74 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.26 -37.27 74.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.015 0.926 . . . . 0.0 110.95 -173.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 67.8 m-85 -126.99 169.0 13.78 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.223 1.009 . . . . 0.0 109.238 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -133.94 164.35 27.49 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.49 1.116 . . . . 0.0 108.804 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -90.44 -172.99 44.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.236 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -75.27 -32.68 61.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.879 0.871 . . . . 0.0 110.128 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.2 124.96 1.67 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.627 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -97.96 118.52 34.73 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.493 0.663 . . . . 0.0 109.426 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.44 112.14 13.87 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.522 HG12 ' HA2' ' A' ' 10' ' ' GLY . 27.0 m -112.39 142.68 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.1 m -126.75 104.5 8.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.42 99.26 9.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -67.43 150.41 48.95 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.0 p -78.76 85.91 4.73 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.19 0.596 . . . . 0.0 110.291 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 15' ' ' ALA . 4.5 mm? . . . . . 0 N--CA 1.498 1.949 0 C-N-CA 125.223 1.409 . . . . 0.0 113.909 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -79.24 149.57 31.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.193 1.397 . . . . 0.0 110.567 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.7 mt -124.98 120.08 30.57 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.115 0.966 . . . . 0.0 108.738 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.47 101.45 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 23' ' ' CYS . 2.9 mp0 -90.56 153.04 20.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.442 0.697 . . . . 0.0 110.584 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.8 p -165.31 160.91 18.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.141 0.976 . . . . 0.0 109.582 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.87 -1.26 27.29 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 120.069 -0.295 . . . . 0.0 112.961 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -78.75 119.0 4.98 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.48 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.44 177.98 26.33 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.4 tt -82.52 117.1 22.28 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 m -118.22 160.18 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.006 0.922 . . . . 0.0 108.609 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.48 HE21 ' HA3' ' A' ' 17' ' ' GLY . 0.4 OUTLIER -78.12 159.14 28.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.531 0.732 . . . . 0.0 110.791 174.035 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.55 133.38 52.23 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.549 0.74 . . . . 0.0 110.224 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.28 80.34 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.276 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.48 ' HA3' HE21 ' A' ' 14' ' ' GLN . . . -90.67 -178.26 43.84 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 120.88 0.156 . . . . 0.0 113.264 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -128.97 156.66 43.43 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -176.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -159.59 130.63 5.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.606 0.762 . . . . 0.0 109.354 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -105.57 132.85 51.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.682 0.393 . . . . 0.0 110.061 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 159.19 15.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.046 0.938 . . . . 0.0 109.693 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 p -143.53 130.89 20.94 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 109.284 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 43.1 t -131.95 110.64 10.91 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.9 t -86.58 132.37 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.56 100.24 12.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.077 0.551 . . . . 0.0 109.827 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 7.4 m 59.31 20.2 8.4 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.144 1.378 . . . . 0.0 113.391 176.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 68.64 1.57 Allowed Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -174.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.512 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 55.0 ttp180 62.26 51.95 3.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.856 1.262 . . . . 0.0 111.507 176.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 30.3 m -118.26 141.16 48.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.641 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -104.37 119.47 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -170.75 171.73 6.03 Favored 'General case' 0 C--O 1.248 0.988 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 m 71.01 121.1 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.61 1.164 . . . . 0.0 111.825 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -106.61 7.12 30.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.844 0.858 . . . . 0.0 110.717 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.51 122.37 27.5 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.7 mtt -138.79 152.75 48.17 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.282 0.633 . . . . 0.0 110.015 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -159.56 175.12 36.47 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.45 -178.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.8 131.97 34.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.537 1.135 . . . . 0.0 108.28 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.61 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 85.1 m-85 -134.37 137.32 44.02 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.58 1.152 . . . . 0.0 108.231 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -103.98 130.32 51.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -133.73 143.35 48.42 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.557 0.743 . . . . 0.0 109.058 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.15 160.99 31.85 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.711 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.93 105.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.306 2.671 . . . . 0.0 113.773 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.97 23.26 61.97 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.455 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.7 mmpt? -126.41 172.89 9.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.796 0.838 . . . . 0.0 110.492 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.68 168.19 17.49 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.101 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.61 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -102.03 117.87 35.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.225 174.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -93.19 139.92 30.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.032 0.933 . . . . 0.0 109.564 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.08 111.06 3.67 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.417 0.687 . . . . 0.0 110.051 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.96 -56.96 4.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.535 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -161.44 173.39 14.96 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.848 -171.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -163.37 162.8 25.16 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.194 0.997 . . . . 0.0 113.265 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mt -129.3 128.08 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 108.693 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 123.343 0.657 . . . . 0.0 110.143 175.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.776 0.322 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 p -158.84 119.23 3.22 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 17.1 m-85 -169.73 119.46 0.64 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 167.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.73 151.53 20.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.055 0.542 . . . . 0.0 110.764 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 159.76 30.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.503 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.6 -32.39 71.51 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.65 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.3 m -60.77 -37.65 82.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.14 0.976 . . . . 0.0 112.029 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.98 4.33 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.387 0.675 . . . . 0.0 111.896 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.77 111.26 3.62 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.148 0.979 . . . . 0.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.58 44.78 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.201 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 60.3 mtm180 -103.01 -40.24 6.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.299 0.64 . . . . 0.0 110.358 176.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.3 123.03 48.18 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.676 0.79 . . . . 0.0 109.459 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -139.35 152.26 47.03 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.121 0.968 . . . . 0.0 108.98 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.632 HD12 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -128.48 156.13 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.733 0.813 . . . . 0.0 110.497 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -154.54 134.17 12.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.371 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -110.85 120.07 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -90.89 104.63 17.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -62.75 -26.66 68.81 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.925 0.765 . . . . 0.0 110.966 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.39 -53.79 33.09 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.838 1.255 . . . . 0.0 112.263 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.512 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.37 11.17 11.4 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 45.07 67.81 0.66 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.943 1.297 . . . . 0.0 112.503 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 m -130.75 131.11 44.54 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.748 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.83 127.97 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.37 1.068 . . . . 0.0 109.503 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -110.83 150.88 28.51 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.991 0.916 . . . . 0.0 110.502 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 tp -132.36 99.32 4.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -82.76 102.3 11.48 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.646 ' HB3' HD21 ' A' ' 87' ' ' LEU . 34.4 mtm -95.53 132.61 40.46 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 83.7 m-20 -128.98 149.77 50.68 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.444 0.698 . . . . 0.0 109.775 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 t 47.59 68.74 0.61 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.95 1.3 . . . . 0.0 111.15 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.646 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -81.59 157.58 24.69 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.577 -170.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.43 149.72 36.94 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.896 0.878 . . . . 0.0 108.632 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -58.84 -23.16 65.88 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 122.626 2.217 . . . . 0.0 113.182 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.01 -14.36 62.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.216 1.006 . . . . 0.0 112.348 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 119' ' ' VAL . 30.0 m-20 -81.22 27.52 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.657 0.783 . . . . 0.0 111.85 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 93.7 m -81.49 92.05 6.42 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 165.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.83 9.25 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.446 0.699 . . . . 0.0 110.794 -170.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.96 114.52 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.335 0.588 . . . . 0.0 109.877 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -86.23 113.59 22.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.25 148.3 40.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.713 0.805 . . . . 0.0 109.857 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 31.7 p -96.05 155.2 16.86 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.23 13.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.26 166.38 11.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.825 0.85 . . . . 0.0 110.462 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 112.301 -0.319 . . . . 0.0 112.301 -179.219 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 CA--C 1.546 1.115 0 CA-C-O 121.204 0.418 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.54 -29.03 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.391 1.076 . . . . 0.0 110.192 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -117.99 128.03 54.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 0.0 109.131 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -110.13 128.88 55.71 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 166.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.39 -178.36 47.71 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 123.703 0.627 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.12 -27.09 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.135 0.574 . . . . 0.0 110.79 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.97 170.12 38.02 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.922 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.66 124.72 16.28 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.199 0.6 . . . . 0.0 109.528 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 101.45 7.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.615 0.766 . . . . 0.0 111.275 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.538 HG12 ' HA2' ' A' ' 10' ' ' GLY . 17.3 m -88.11 147.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 87.2 m -135.07 103.28 5.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.9 t -90.12 96.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.2 t -69.92 150.34 46.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.797 176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.6 m -73.34 85.8 1.46 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.739 0.816 . . . . 0.0 111.133 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.491 1.587 0 C-N-CA 125.568 1.547 . . . . 0.0 112.991 -178.252 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 26' ' ' SER . 16.7 mt-30 -91.91 108.91 20.27 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.426 0.69 . . . . 0.0 109.447 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.753 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.9 mp -118.71 119.35 34.18 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.4 101.02 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -92.51 135.67 33.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.933 -174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 p -148.54 165.23 31.86 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.386 1.074 . . . . 0.0 109.72 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.84 -24.77 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.73 128.96 38.56 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.081 0.372 . . . . 0.0 113.175 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.84 -174.12 45.47 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.3 tp -78.03 116.98 18.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.06 0.544 . . . . 0.0 109.896 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 121' ' ' VAL . 4.8 m -129.42 163.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.414 1.086 . . . . 0.0 109.611 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 145.34 24.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.787 0.435 . . . . 0.0 111.399 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 127.17 30.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.341 1.057 . . . . 0.0 110.998 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.53 62.06 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 123.604 0.565 . . . . 0.0 112.304 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.04 -166.34 39.54 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -141.46 130.41 23.15 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.53 122.47 29.29 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.027 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -93.46 117.74 30.46 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.6 151.32 23.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.973 0.909 . . . . 0.0 109.175 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.4 p -136.59 126.22 25.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.624 0.77 . . . . 0.0 109.365 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 50.0 t -120.27 102.85 8.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.977 1.311 . . . . 0.0 109.372 -174.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -95.3 118.39 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.565 1.146 . . . . 0.0 109.639 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.53 99.69 11.86 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.945 -0.472 . . . . 0.0 110.643 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 27.3 t 49.6 39.39 17.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.568 1.547 . . . . 0.0 111.506 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.27 -89.96 1.11 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -168.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HG2' ' HB2' ' A' ' 77' ' ' LYS . 98.2 mtt180 -140.32 94.85 2.79 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 t -133.42 157.65 45.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.391 0.676 . . . . 0.0 110.013 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -112.42 119.76 39.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -154.38 -82.15 0.08 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.1 p -77.61 121.04 23.4 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.862 0.465 . . . . 0.0 111.275 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -92.84 10.36 31.35 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.267 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.57 122.79 15.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.653 1.181 . . . . 0.0 108.864 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.7 mtt -140.79 165.53 27.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.587 1.555 . . . . 0.0 108.546 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -166.36 156.17 27.88 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.612 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -108.14 133.67 52.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.387 1.075 . . . . 0.0 108.599 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -136.44 139.37 42.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.132 0.973 . . . . 0.0 108.829 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 33.4 ptt85 -103.68 137.98 40.97 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.492 0.717 . . . . 0.0 109.834 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.461 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 61.8 tt0 -143.83 130.72 20.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.059 0.544 . . . . 0.0 109.726 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.94 161.67 30.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.469 0.708 . . . . 0.0 109.563 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.35 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.59 2.193 . . . . 0.0 113.299 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.88 6.79 88.68 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -106.35 174.57 5.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.896 0.878 . . . . 0.0 110.549 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.45 166.37 22.07 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.833 0.853 . . . . 0.0 111.096 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -103.67 113.53 27.11 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 110.475 175.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -93.03 143.91 25.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.812 0.845 . . . . 0.0 110.382 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -62.76 118.12 7.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.751 0.821 . . . . 0.0 111.267 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -88.03 -47.16 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.15 176.47 8.45 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.785 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.591 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -156.98 127.24 6.43 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 123.886 0.874 . . . . 0.0 110.265 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.565 HD12 HG13 ' A' ' 80' ' ' VAL . 11.4 mt -118.92 118.06 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.35 1.06 . . . . 0.0 110.353 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 . . . . . 0 C--O 1.243 0.725 0 C-N-CA 124.218 1.007 . . . . 0.0 109.002 167.722 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 120.707 0.289 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -158.71 123.21 4.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.619 0.767 . . . . 0.0 110.031 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HB3' ' N ' ' A' ' 51' ' ' ALA . 4.4 t80 -171.36 141.82 1.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.476 0.71 . . . . 0.0 109.675 172.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -165.86 156.75 13.4 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.624 0.77 . . . . 0.0 110.383 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.68 167.28 11.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.754 0.822 . . . . 0.0 110.078 167.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.32 -29.11 69.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 112.036 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -68.22 -33.39 74.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.208 0.603 . . . . 0.0 111.42 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 69' ' ' PHE . 26.4 m -105.83 9.39 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.635 0.774 . . . . 0.0 111.098 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.07 119.19 8.44 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.391 1.076 . . . . 0.0 110.84 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.24 -16.67 15.99 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -98.51 -45.8 5.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.212 0.605 . . . . 0.0 109.384 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.457 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.8 m-85 -98.12 120.04 37.83 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.2 m -124.99 144.8 50.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.561 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -127.52 141.67 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.065 0.546 . . . . 0.0 110.826 -175.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -150.63 137.77 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.277 1.031 . . . . 0.0 109.694 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.51 ' HB2' HG21 ' A' ' 52' ' ' ILE . 22.1 ttp85 -124.6 130.16 51.92 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.27 110.01 22.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.886 1.274 . . . . 0.0 111.794 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.93 68.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.137 0.975 . . . . 0.0 111.712 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HE3' ' HB ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -120.23 -3.91 10.0 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.455 176.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 52.92 67.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.43 1.092 . . . . 0.0 111.451 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.453 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 92.3 m -127.15 132.83 50.45 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.682 173.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.565 HG13 HD12 ' A' ' 52' ' ' ILE . 23.3 t -101.6 151.16 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.773 1.229 . . . . 0.0 108.607 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -133.04 141.36 48.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.462 0.705 . . . . 0.0 109.59 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.45 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 66.3 tp -128.48 99.55 5.43 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -83.3 98.04 9.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.45 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 72.6 mtp -90.74 107.74 19.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.143 0.977 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.9 153.45 23.02 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.946 0.498 . . . . 0.0 110.156 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.5 t 60.07 62.17 1.69 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.562 1.145 . . . . 0.0 109.936 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.13 152.73 45.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.088 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -120.71 151.53 54.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.84 -15.2 45.61 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.15 1.9 . . . . 0.0 112.252 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.98 -25.1 66.16 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -82.2 24.15 0.68 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.661 0.784 . . . . 0.0 111.929 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 120' ' ' THR . 64.4 m -79.66 90.44 5.18 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 159.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.5 -174.31 2.48 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.446 -168.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.2 p -109.24 108.23 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.676 0.79 . . . . 0.0 109.807 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -85.04 116.3 23.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 167.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.462 HD13 ' HD1' ' A' ' 113' ' ' TRP . 2.5 pp -115.07 137.24 52.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 111.071 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.5 t -93.75 156.1 16.86 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.42 156.04 41.97 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.446 0.698 . . . . 0.0 109.713 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.64 158.61 37.33 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.906 0.482 . . . . 0.0 111.558 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.072 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 174.016 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 CA--C 1.54 0.776 0 CA-C-O 120.847 0.27 . . . . 0.0 112.678 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.81 -40.23 6.65 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -121.94 164.35 17.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.162 0.985 . . . . 0.0 110.174 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.462 ' HD1' HD13 ' A' ' 96' ' ' LEU . 31.8 m-90 -119.7 157.53 28.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.695 1.198 . . . . 0.0 108.751 174.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -76.53 -76.43 0.83 Allowed Glycine 0 C--N 1.341 0.815 0 O-C-N 123.177 0.298 . . . . 0.0 112.987 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.92 -42.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 109.626 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.1 113.95 3.58 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.787 -172.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 t -96.41 108.67 21.25 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.832 0.825 . . . . 0.0 109.391 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 106.11 4.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.293 -175.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.47 125.28 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 92' ' ' THR . 26.0 m -120.04 104.42 10.12 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 13' ' ' VAL . 57.8 t -89.23 105.79 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 121.862 -0.523 . . . . 0.0 110.365 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 m -58.74 139.27 56.44 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.46 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.9 m -72.54 91.14 1.38 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 125.668 1.587 . . . . 0.0 113.111 177.646 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.35 129.68 48.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.479 0.712 . . . . 0.0 109.667 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.45 HD22 ' SG ' ' A' ' 23' ' ' CYS . 89.7 mt -124.94 107.61 11.03 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.6 t -98.89 101.74 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 22' ' ' SER . 47.1 mt-10 -100.9 143.97 30.41 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.11 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.9 p -160.54 157.79 28.03 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.091 0.957 . . . . 0.0 109.792 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.443 ' O ' HD11 ' A' ' 19' ' ' LEU . . . 130.85 -32.27 3.05 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -59.09 127.96 46.43 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.27 -178.45 46.06 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 120' ' ' THR . 22.8 tp -88.18 109.51 19.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.86 0.464 . . . . 0.0 109.798 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 19' ' ' LEU . 18.5 m -126.68 151.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.089 0.956 . . . . 0.0 109.373 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -75.64 151.11 37.83 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.438 0.563 . . . . 0.0 111.259 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.11 125.09 23.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.156 0.982 . . . . 0.0 110.407 175.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.18 -20.26 26.22 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 123.814 0.721 . . . . 0.0 111.35 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.62 -166.94 9.88 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 121.598 0.554 . . . . 0.0 113.618 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.4 p -133.01 132.73 42.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.013 0.925 . . . . 0.0 109.395 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 13' ' ' VAL . 25.5 tp -134.95 118.76 17.22 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -97.65 120.8 38.69 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.128 0.571 . . . . 0.0 109.693 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.9 157.26 19.55 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.199 0.6 . . . . 0.0 109.394 172.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 18.6 p -145.92 126.11 13.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.845 0.858 . . . . 0.0 109.191 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 52.5 t -123.19 107.54 11.83 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.468 1.107 . . . . 0.0 108.901 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 21.2 t -89.24 115.22 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.642 0.777 . . . . 0.0 109.023 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.19 103.23 15.87 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p 54.66 36.74 26.79 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.707 1.603 . . . . 0.0 112.381 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.94 -107.94 2.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.69 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -118.79 10.98 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.009 0.924 . . . . 0.0 110.288 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -81.78 146.99 29.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -104.21 115.75 30.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -151.35 10.76 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.883 1.673 . . . . 0.0 108.847 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 p -86.99 88.52 7.72 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.224 1.01 . . . . 0.0 110.453 -174.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.74 -48.7 53.07 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.555 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.86 126.95 1.03 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.338 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.429 ' HE1' ' NH1' ' A' ' 73' ' ' ARG . 1.8 mpp? -125.44 119.76 29.15 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.657 1.183 . . . . 0.0 108.337 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -103.49 140.39 14.87 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -87.71 125.26 34.3 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.61 148.55 49.78 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -126.56 139.09 53.47 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.81 130.0 53.07 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.92 154.53 83.0 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -53.73 102.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.448 2.099 . . . . 0.0 112.41 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.99 23.21 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.931 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 6.9 mmpt? -133.44 170.41 15.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.83 0.824 . . . . 0.0 112.453 -174.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.24 176.46 6.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.982 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.48 37.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.61 125.65 40.61 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.36 110.26 4.02 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.18 -51.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.348 0.659 . . . . 0.0 109.64 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.69 170.04 22.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.212 0.605 . . . . 0.0 111.706 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -154.59 120.2 5.14 Favored 'General case' 0 C--O 1.25 1.126 0 C-N-CA 124.053 0.941 . . . . 0.0 110.131 173.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.645 HG23 ' HB3' ' A' ' 58' ' ' SER . 4.0 mp -122.65 116.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.392 1.077 . . . . 0.0 109.045 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.578 0 C-N-CA 123.091 0.556 . . . . 0.0 109.636 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.645 ' HB3' HG23 ' A' ' 52' ' ' ILE . 20.3 m . . . . . 0 CA--C 1.55 0.944 0 CA-C-O 121.457 0.646 . . . . 0.0 112.166 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -157.21 123.49 4.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.954 0.901 . . . . 0.0 109.883 -166.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 51' ' ' ALA . 25.8 m-85 -158.5 135.83 10.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.943 0.897 . . . . 0.0 109.167 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.55 153.9 11.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.554 1.542 . . . . 0.0 108.889 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.38 151.36 32.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.425 0.69 . . . . 0.0 109.789 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.2 -33.28 69.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.487 0.715 . . . . 0.0 111.498 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 m -66.82 -29.91 69.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.318 1.047 . . . . 0.0 112.208 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.48 -7.12 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.347 0.659 . . . . 0.0 111.869 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.05 122.48 17.49 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.603 0.761 . . . . 0.0 110.544 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.35 -28.54 14.05 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.666 0.604 . . . . 0.0 111.979 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 10.1 mtm180 -88.97 -52.89 4.85 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -91.39 131.6 36.77 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.722 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -140.9 150.21 42.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.458 1.103 . . . . 0.0 108.461 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.45 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -123.29 144.01 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.147 0.579 . . . . 0.0 110.491 178.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -144.13 134.4 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.101 0.96 . . . . 0.0 109.05 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.517 ' HB2' HG21 ' A' ' 52' ' ' ILE . 46.4 ttt180 -111.9 125.05 53.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.012 0.525 . . . . 0.0 110.363 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.523 ' HB3' ' HE3' ' A' ' 77' ' ' LYS . 60.6 m-20 -103.0 94.64 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -65.61 -26.07 67.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.824 0.85 . . . . 0.0 111.936 -173.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.58 73.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.678 0.791 . . . . 0.0 112.27 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.523 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -118.59 8.18 11.93 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.582 0.753 . . . . 0.0 110.528 176.229 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 55.82 30.73 16.32 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.843 1.257 . . . . 0.0 112.851 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.4 m -111.39 130.46 55.69 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.26 138.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 108.702 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -117.27 139.62 50.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.896 0.878 . . . . 0.0 110.055 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.1 tp -113.78 97.64 6.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -84.06 100.67 11.24 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 36.6 mtm -94.07 126.47 39.31 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -122.69 167.14 13.82 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 68' ' ' ARG . 13.5 m 57.65 40.2 26.82 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.622 0.769 . . . . 0.0 110.42 173.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.7 mt -56.85 142.99 38.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.653 -170.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.638 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -105.68 151.22 39.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.29 -14.19 40.48 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.199 1.933 . . . . 0.0 112.683 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.638 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.72 -22.02 66.58 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.453 0.701 . . . . 0.0 111.565 173.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -78.28 23.62 0.28 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.822 0.849 . . . . 0.0 111.647 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 120' ' ' THR . 99.0 m -82.79 92.54 7.26 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 163.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.02 -174.74 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.312 0.645 . . . . 0.0 111.106 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.447 ' HB ' HE21 ' A' ' 118' ' ' GLN . 3.6 p -107.93 112.04 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -85.45 108.73 18.02 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -112.18 138.45 48.84 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.977 0.911 . . . . 0.0 109.435 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 52.1 m -91.29 139.07 31.08 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.71 116.86 16.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.592 0.757 . . . . 0.0 109.136 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 35' ' ' MET . . . -111.87 152.96 27.35 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.104 0.562 . . . . 0.0 110.362 -173.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.573 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.831 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 CA--C 1.548 1.185 0 CA-C-O 121.016 0.34 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -97.22 -47.93 5.55 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.363 0.602 . . . . 0.0 109.705 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.07 144.17 40.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.73 1.212 . . . . 0.0 108.438 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -120.97 137.92 54.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.335 0.654 . . . . 0.0 109.247 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.03 -137.04 1.05 Allowed Glycine 0 C--N 1.346 1.117 0 O-C-N 123.338 0.399 . . . . 0.0 113.151 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -94.92 -30.89 13.92 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.073 0.549 . . . . 0.0 110.599 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.22 116.95 0.13 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.249 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -99.37 123.35 43.57 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 117.229 0.514 . . . . 0.0 110.489 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.447 HE21 ' HB ' ' A' ' 94' ' ' VAL . 3.7 mm-40 -77.39 101.48 6.38 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.261 1.024 . . . . 0.0 110.707 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.559 HG12 ' HA2' ' A' ' 10' ' ' GLY . 20.0 m -93.01 137.5 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 92' ' ' THR . 70.2 m -134.17 105.03 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.3 t -87.77 98.22 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 t -50.43 131.2 24.54 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.382 1.073 . . . . 0.0 111.742 172.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.6 p -76.4 82.52 3.13 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.057 0.543 . . . . 0.0 110.616 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.5 mm? . . . . . 0 N--CA 1.491 1.581 0 C-N-CA 125.007 1.323 . . . . 0.0 114.071 174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -117.68 133.9 55.46 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.51 1.124 . . . . 0.0 108.812 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.648 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 94.3 mt -131.68 120.8 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.915 0.886 . . . . 0.0 109.381 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.469 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 23.2 t -98.42 104.88 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 108.537 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -104.66 151.08 24.12 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.369 0.668 . . . . 0.0 111.19 -168.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 p -157.15 170.75 21.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.658 0.783 . . . . 0.0 111.079 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.09 32.28 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.26 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.569 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -69.34 120.34 10.21 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 113.957 0.343 . . . . 0.0 113.957 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.76 179.48 48.78 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 120' ' ' THR . 10.2 tt -88.02 128.55 35.4 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.411 0.284 . . . . 0.0 110.288 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.58 152.53 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.25 150.99 35.31 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -59.7 127.6 32.82 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 0.0 110.552 174.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.15 18.13 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.2 -179.22 52.46 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 122.873 0.273 . . . . 0.0 113.292 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -121.0 164.64 16.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.042 0.937 . . . . 0.0 110.563 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.4 tp -159.47 123.65 3.87 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.579 0.752 . . . . 0.0 109.982 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -99.32 129.58 45.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.06 0.544 . . . . 0.0 109.576 173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -96.42 154.32 17.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.325 1.05 . . . . 0.0 109.007 171.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -143.54 128.74 18.74 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 30.8 t -137.74 104.61 5.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.46 0.704 . . . . 0.0 110.065 -172.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -84.75 145.28 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.812 . . . . 0.0 110.25 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.539 ' HA ' HD23 ' A' ' 5' ' ' LEU . . . -89.98 100.43 13.25 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.124 0.57 . . . . 0.0 110.063 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p 56.46 -75.38 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.85 2.06 . . . . 0.0 112.457 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.74 -64.38 0.06 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -161.66 39.32 0.13 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.06 0.933 . . . . 0.0 109.451 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -107.36 151.04 26.04 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.53 ' HB3' HD21 ' A' ' 78' ' ' ASN . 19.5 p90 -105.29 126.31 51.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.813 0.845 . . . . 0.0 108.878 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -150.66 146.68 26.64 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.832 0.853 . . . . 0.0 109.074 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t 66.07 115.34 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.212 1.405 . . . . 0.0 111.183 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -80.67 7.83 9.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.4 0.68 . . . . 0.0 111.299 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.86 119.92 21.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.561 0.744 . . . . 0.0 109.306 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.8 mtt -137.38 119.9 16.0 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -125.29 142.46 13.82 Favored Glycine 0 N--CA 1.468 0.832 0 CA-C-N 118.102 0.41 . . . . 0.0 112.92 -172.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.412 ' HE1' HG12 ' A' ' 80' ' ' VAL . 95.0 m95 -86.06 117.89 25.19 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -117.02 171.34 7.99 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.922 1.289 . . . . 0.0 108.595 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -150.83 130.93 13.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.924 0.49 . . . . 0.0 110.029 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -110.56 128.83 55.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.12 39.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.493 0.717 . . . . 0.0 109.658 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.74 107.72 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.778 2.318 . . . . 0.0 113.119 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.49 1.52 66.24 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.552 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.4 mmpt? -114.98 173.43 6.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.223 1.009 . . . . 0.0 110.203 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.59 176.48 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.024 0.93 . . . . 0.0 110.425 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 124.01 24.51 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.172 0.51 . . . . 0.0 111.141 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.15 134.63 36.39 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.358 1.063 . . . . 0.0 109.366 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -71.11 109.36 5.14 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.812 0.695 . . . . 0.0 109.305 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.57 -53.24 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.81 174.75 10.3 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.922 -172.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -159.85 142.07 13.31 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.15 0.976 . . . . 0.0 112.014 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 71' ' ' ILE . 4.0 mp -109.78 114.06 45.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.139 174.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 . . . . . 0 C--O 1.243 0.711 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 168.453 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 13.5 p . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -154.08 121.18 5.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.472 0.709 . . . . 0.0 110.021 -166.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.453 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 32.3 m-85 -158.25 154.58 27.44 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.764 1.626 . . . . 0.0 107.028 170.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -166.49 148.4 6.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.04 0.536 . . . . 0.0 110.368 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.01 25.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.6 -34.1 76.34 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -66.81 -18.44 65.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.696 0.798 . . . . 0.0 112.617 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.13 5.27 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.974 0.51 . . . . 0.0 111.662 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.19 131.68 51.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.544 0.738 . . . . 0.0 111.54 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 -28.32 4.57 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.167 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 88.9 mtm180 -92.67 -47.85 6.88 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.509 0.723 . . . . 0.0 110.158 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -87.84 122.62 31.7 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 m -124.99 133.54 52.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 108.446 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.548 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -120.77 146.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 122.766 0.426 . . . . 0.0 110.636 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 p -159.37 151.51 20.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.602 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.482 ' HB3' HG21 ' A' ' 52' ' ' ILE . 52.6 ttt180 -128.36 123.42 33.83 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -105.22 103.23 12.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -76.82 -11.83 59.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.218 0.607 . . . . 0.0 111.49 -173.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.59 92.34 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 122.549 0.34 . . . . 0.0 111.861 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -112.39 1.9 16.2 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 117.99 0.359 . . . . 0.0 110.905 169.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.53 HD21 ' HB3' ' A' ' 30' ' ' PHE . 18.5 m120 58.56 66.66 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.843 1.257 . . . . 0.0 110.807 176.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.8 m -141.8 132.36 25.39 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.088 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.412 HG12 ' HE1' ' A' ' 37' ' ' TRP . 27.5 t -111.17 130.0 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.381 1.072 . . . . 0.0 108.965 -173.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -113.23 148.68 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.729 0.812 . . . . 0.0 111.308 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 65.5 tp -132.0 98.07 4.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -87.73 100.53 12.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.753 ' HB3' HD21 ' A' ' 87' ' ' LEU . 48.2 mtm -94.34 142.18 27.71 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.591 0.757 . . . . 0.0 108.99 175.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 18.1 m120 -136.81 150.15 48.16 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.45 0.7 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 t 52.31 59.91 4.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 173.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -79.66 161.08 26.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.4 -171.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.1 153.4 61.15 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 121' ' ' VAL . 37.7 Cg_endo -60.8 -15.66 39.31 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.862 2.375 . . . . 0.0 115.04 -168.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -72.56 -14.66 61.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.106 0.563 . . . . 0.0 111.983 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -82.15 19.52 1.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.403 0.681 . . . . 0.0 111.019 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 96.7 m -75.31 92.44 2.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 165.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.4 164.05 27.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.449 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.41 ' HB ' HE21 ' A' ' 118' ' ' GLN . 6.0 p -88.27 107.45 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.414 174.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -84.66 138.02 32.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 113' ' ' TRP . 1.7 pt? -150.2 139.75 21.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.935 0.494 . . . . 0.0 110.889 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.7 m -87.74 114.69 24.59 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -107.78 117.01 33.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 108.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.18 116.83 31.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.481 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.491 -174.659 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.583 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 2.6 Cg_exo . . . . . 0 CA--C 1.548 1.203 0 N-CA-C 110.433 -0.641 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -91.29 -47.01 7.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.432 0.693 . . . . 0.0 110.336 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -125.78 158.53 34.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.773 . . . . 0.0 109.945 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.418 ' HB3' HD12 ' A' ' 96' ' ' LEU . 22.7 m-90 -128.0 152.72 47.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.559 1.144 . . . . 0.0 108.534 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.21 46.52 3.4 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.965 -173.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 6' ' ' VAL . 46.2 mt-30 73.26 -45.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.633 1.573 . . . . 0.0 111.857 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . 98.36 112.06 3.13 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -97.75 123.16 41.57 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 121.885 0.85 . . . . 0.0 109.965 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.41 HE21 ' HB ' ' A' ' 94' ' ' VAL . 4.0 mm-40 -80.35 103.76 10.44 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.243 1.017 . . . . 0.0 110.567 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.569 HG12 ' HA2' ' A' ' 10' ' ' GLY . 3.5 m -105.26 150.56 7.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 89.8 m -134.85 114.6 12.75 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' PRO . 40.8 t -92.42 105.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 12' ' ' LEU . 15.0 t -73.72 158.02 35.43 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 120.667 0.27 . . . . 0.0 111.036 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.7 p -84.85 73.14 10.68 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.686 0.795 . . . . 0.0 110.667 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.9 mm? . . . . . 0 N--CA 1.49 1.571 0 C-N-CA 125.521 1.528 . . . . 0.0 113.765 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 32' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -112.19 127.83 56.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.653 0.781 . . . . 0.0 109.535 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.673 HD11 ' HG2' ' A' ' 35' ' ' MET . 96.4 mt -132.84 122.77 24.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.616 1.166 . . . . 0.0 109.703 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -106.48 102.29 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.02 145.1 27.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 p -160.88 168.09 25.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.852 0.861 . . . . 0.0 110.257 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.06 17.82 21.63 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.406 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -78.32 134.81 14.76 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.14 -178.54 47.67 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.6 tt -98.37 131.78 44.38 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.918 0.487 . . . . 0.0 109.889 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.68 170.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.926 1.291 . . . . 0.0 107.907 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -90.77 154.04 19.81 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.742 0.417 . . . . 0.0 109.964 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.45 124.97 24.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.761 0.824 . . . . 0.0 110.567 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.36 -23.35 24.97 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.03 174.81 48.79 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.774 0.338 . . . . 0.0 112.371 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.0 p -106.11 162.76 13.34 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.372 0.669 . . . . 0.0 110.566 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.6 tp -159.8 121.82 3.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.063 0.945 . . . . 0.0 108.613 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -98.53 122.41 41.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.062 0.458 . . . . 0.0 110.165 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.451 HD12 HG21 ' A' ' 117' ' ' THR . 3.8 mm? -94.82 145.32 24.97 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.071 0.949 . . . . 0.0 108.966 172.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 p -131.89 126.15 33.46 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.508 0.723 . . . . 0.0 109.15 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 43.2 t -122.73 108.94 13.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.619 1.167 . . . . 0.0 108.623 -177.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.24 129.69 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.135 0.974 . . . . 0.0 109.088 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -87.1 100.96 13.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.6 p 64.62 -75.51 0.04 OUTLIER 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.533 1.933 . . . . 0.0 111.713 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.06 -62.78 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -166.81 67.45 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -138.89 162.08 35.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.377 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -103.9 122.16 44.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.765 0.826 . . . . 0.0 109.227 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.22 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.531 ' HA ' HD21 ' A' ' 3' ' ' LEU . 5.5 m -71.84 85.03 0.94 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.565 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 73' ' ' ARG . 24.1 p-10 -93.59 -27.07 16.82 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.666 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.3 120.12 15.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.788 -171.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.673 ' HG2' HD11 ' A' ' 5' ' ' LEU . 4.5 mtm -150.82 141.84 23.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.222 1.409 . . . . 0.0 108.837 -175.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.64 136.44 11.06 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 76.2 m95 -86.72 130.12 34.6 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.532 0.666 . . . . 0.0 110.319 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -123.06 171.75 9.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.96 1.304 . . . . 0.0 108.261 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -143.23 131.37 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 168.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -102.5 130.9 49.46 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -115.99 149.56 43.55 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.007 0.523 . . . . 0.0 110.054 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.27 100.6 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.385 2.056 . . . . 0.0 111.367 172.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.78 5.66 56.5 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.964 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 7.4 mmpt? -138.76 137.89 37.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.723 0.809 . . . . 0.0 109.623 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.32 171.6 5.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.766 0.826 . . . . 0.0 111.555 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.04 124.88 21.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.289 0.566 . . . . 0.0 111.317 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -93.83 126.47 39.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -76.0 106.63 7.7 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -94.95 -48.63 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.541 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . . . -151.19 164.14 37.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -170.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -152.68 134.9 14.98 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.923 0.868 . . . . 0.0 111.442 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.51 118.33 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 123.258 0.623 . . . . 0.0 109.47 -177.973 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -156.86 124.3 5.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -165.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.423 ' H ' HD11 ' A' ' 71' ' ' ILE . 5.5 t80 -169.52 117.28 0.61 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 65' ' ' VAL . 4.8 p90 -164.87 151.92 11.0 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.935 0.894 . . . . 0.0 109.207 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.98 31.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.346 0.658 . . . . 0.0 110.885 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.58 -28.07 68.88 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.368 0.667 . . . . 0.0 110.439 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.8 p -68.32 -28.57 67.27 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.443 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 61' ' ' TYR . 29.3 m -116.37 19.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.615 0.766 . . . . 0.0 111.272 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -67.82 120.63 14.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.9 0.88 . . . . 0.0 110.483 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -20.83 26.27 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 68.6 mtp180 -85.68 -70.08 0.62 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 110.071 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -86.2 120.86 28.02 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 m -130.2 140.58 50.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.212 1.005 . . . . 0.0 108.615 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.438 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -122.53 147.06 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.535 0.734 . . . . 0.0 109.324 175.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -147.0 133.5 19.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.539 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 33' ' ' ASN . 51.2 ttt-85 -114.7 124.84 52.83 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -103.52 110.87 23.08 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -74.98 -20.18 59.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.556 0.742 . . . . 0.0 111.904 -175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.86 78.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.603 0.361 . . . . 0.0 111.727 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -118.93 -5.68 10.56 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.319 171.247 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 11.4 m-80 60.75 70.37 0.62 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.007 0.923 . . . . 0.0 110.524 -174.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.0 m -138.17 131.68 30.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.36 135.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.745 0.818 . . . . 0.0 109.594 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -121.0 115.01 22.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.836 0.854 . . . . 0.0 109.508 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 tp -92.35 97.79 11.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -85.17 100.94 12.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.45 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.624 ' SD ' HD21 ' A' ' 87' ' ' LEU . 56.6 mtt -84.23 126.59 33.29 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -129.41 137.31 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 t 58.76 73.11 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.593 0.711 . . . . 0.0 110.304 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.624 HD21 ' SD ' ' A' ' 84' ' ' MET . 22.6 mt -75.53 162.5 28.25 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.287 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -125.99 149.16 65.43 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.524 1.129 . . . . 0.0 108.458 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.47 -13.7 40.08 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.956 2.437 . . . . 0.0 112.739 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.43 -28.63 69.81 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.591 1.157 . . . . 0.0 111.891 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -74.92 14.97 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.418 0.687 . . . . 0.0 112.375 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 HG23 ' A' ' 120' ' ' THR . 92.5 m -73.33 89.41 1.59 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 158.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.96 173.37 3.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.722 1.209 . . . . 0.0 109.389 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.26 115.8 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -83.62 133.23 34.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.494 0.718 . . . . 0.0 109.227 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -139.81 120.9 14.71 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.461 0.704 . . . . 0.0 109.891 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.57 ' SG ' ' HB3' ' A' ' 35' ' ' MET . 46.8 t -89.37 116.14 27.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.75 158.67 23.49 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.13 0.972 . . . . 0.0 110.534 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -116.62 139.59 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.081 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.232 -178.466 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 N--CA 1.495 1.576 0 N-CA-C 114.028 0.742 . . . . 0.0 114.028 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.24 -47.95 22.06 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.201 0.524 . . . . 0.0 110.069 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 64.6 m-85 -111.84 147.24 36.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.27 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -126.13 146.23 50.02 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 167.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -70.42 -84.13 0.18 Allowed Glycine 0 C--N 1.339 0.744 0 O-C-N 123.664 0.602 . . . . 0.0 113.765 -176.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.26 -46.13 0.14 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -176.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.6 95.13 1.32 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.523 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.451 HG21 HD12 ' A' ' 21' ' ' LEU . 7.2 t -97.85 121.63 40.0 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.532 0.733 . . . . 0.0 110.409 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.36 117.88 20.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.845 0.858 . . . . 0.0 109.097 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.406 HG12 ' HA2' ' A' ' 10' ' ' GLY . 33.5 m -118.38 141.81 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.428 0.691 . . . . 0.0 109.23 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 33.6 m -129.23 104.34 7.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 87' ' ' LEU . 52.6 t -94.17 98.11 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.8 t -66.32 150.25 49.13 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.726 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.4 m -71.14 165.36 23.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.925 0.89 . . . . 0.0 111.463 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.334 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -119.89 108.38 14.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 99' ' ' ALA . 2.9 mm? -96.38 109.02 21.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.01 104.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -76.96 155.83 32.39 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.512 0.673 . . . . 0.0 111.209 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 p -155.33 154.06 31.46 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 108.695 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.52 -2.63 56.09 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -69.57 105.49 1.54 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.55 27.2 Favored Glycine 0 C--O 1.245 0.8 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 122' ' ' SER . 9.8 tt -88.31 137.09 32.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 m -136.37 168.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.694 1.198 . . . . 0.0 109.213 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -87.5 151.58 22.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.575 0.75 . . . . 0.0 110.724 177.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.25 141.55 52.43 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 123.32 0.648 . . . . 0.0 110.384 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.49 13.72 Favored Glycine 0 N--CA 1.464 0.545 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.09 -172.25 46.04 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 112.161 -0.375 . . . . 0.0 112.161 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 p -123.18 164.08 19.38 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.301 0.64 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.4 tp -148.25 127.75 13.19 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -108.28 113.2 26.12 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.532 0.733 . . . . 0.0 109.336 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -84.27 153.39 23.59 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.5 p -142.14 122.06 13.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.889 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.7 t -105.71 111.89 24.75 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.97 0.908 . . . . 0.0 109.486 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.65 118.96 32.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.51 99.44 12.44 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.497 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 22.7 t 59.53 39.45 21.6 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.903 1.281 . . . . 0.0 111.355 173.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.18 -69.69 2.2 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -162.23 87.13 0.62 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.33 1.052 . . . . 0.0 108.491 166.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 50.1 m -140.37 139.91 35.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 109.227 175.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -106.35 141.29 37.91 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -157.41 -49.06 0.07 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -98.39 133.8 42.28 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.909 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -97.78 -0.02 46.03 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.134 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.47 51.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.472 1.109 . . . . 0.0 108.472 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.635 ' SD ' ' HD2' ' A' ' 73' ' ' ARG . 47.2 mtt -150.68 168.32 24.69 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.515 1.526 . . . . 0.0 109.689 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.89 -171.99 32.73 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -132.86 133.28 43.11 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.72 155.24 35.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.382 1.073 . . . . 0.0 108.718 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -123.45 136.33 54.55 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.206 0.526 . . . . 0.0 110.407 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 94' ' ' VAL . 21.8 mm-40 -106.01 154.6 20.38 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.894 1.277 . . . . 0.0 108.254 172.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -141.79 154.78 66.14 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.568 0.747 . . . . 0.0 109.235 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.12 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.384 2.722 . . . . 0.0 114.102 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.9 20.2 78.08 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.649 -0.705 . . . . 0.0 114.288 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.5 mmpt? -129.87 145.32 51.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.951 0.901 . . . . 0.0 109.904 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.2 168.83 18.81 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.347 1.059 . . . . 0.0 111.854 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 143.1 46.7 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.28 139.11 51.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.158 0.583 . . . . 0.0 109.701 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.517 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 92.1 t80 -71.95 110.08 6.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.247 1.019 . . . . 0.0 109.61 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.27 -40.43 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.737 -174.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.58 160.28 40.22 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.517 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -143.24 125.14 15.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.33 1.052 . . . . 0.0 110.228 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.58 121.16 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.158 1.383 . . . . 0.0 108.11 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 N--CA 1.475 0.818 0 C-N-CA 123.54 0.736 . . . . 0.0 110.579 -177.807 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 p -152.86 131.44 12.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.958 0.503 . . . . 0.0 110.672 -169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' H ' HD11 ' A' ' 71' ' ' ILE . 11.0 t80 -160.7 132.82 6.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 168.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.42 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 20.1 p90 -159.57 157.88 30.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.178 0.991 . . . . 0.0 110.144 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.51 156.97 30.63 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.485 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.604 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 37.9 t70 -70.76 -20.82 62.58 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.731 0.301 . . . . 0.0 110.4 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.0 m -61.82 -36.7 81.91 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.528 0.731 . . . . 0.0 111.063 172.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.85 15.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.604 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -60.27 124.83 21.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.227 0.611 . . . . 0.0 109.83 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.77 -28.49 7.06 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 123.734 0.646 . . . . 0.0 112.597 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.588 HH21 ' HA ' ' A' ' 87' ' ' LEU . 66.3 mtp180 -76.36 -46.06 29.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.099 0.952 . . . . 0.0 109.326 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 61' ' ' TYR . 24.3 t80 -91.42 128.55 37.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.999 -166.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 42.1 m -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.35 1.06 . . . . 0.0 108.46 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.574 HD11 ' H ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -141.2 144.15 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.845 0.858 . . . . 0.0 109.131 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.9 m -151.97 142.07 22.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.617 0.767 . . . . 0.0 109.907 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.635 ' HD2' ' SD ' ' A' ' 35' ' ' MET . 18.2 ttt85 -110.17 127.45 54.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 170.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -103.08 132.39 49.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.472 0.709 . . . . 0.0 109.187 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.89 -27.05 21.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 112.69 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.89 94.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.705 0.802 . . . . 0.0 112.049 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.6 5.17 13.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.322 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 49.99 68.03 0.81 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.737 1.215 . . . . 0.0 111.67 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.1 m -136.16 133.44 37.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.129 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.44 147.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -126.99 141.19 51.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.023 0.529 . . . . 0.0 110.252 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.4 tp -127.25 96.28 4.54 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.499 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 24.9 tp60 -96.08 100.65 12.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.0 mtm -102.93 112.91 25.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.577 0.751 . . . . 0.0 109.017 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.439 HD21 ' HG3' ' A' ' 83' ' ' GLN . 40.2 m-80 -102.79 165.58 10.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.128 0.971 . . . . 0.0 110.225 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 68' ' ' ARG . 10.6 m 54.17 45.0 28.32 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 124.158 0.911 . . . . 0.0 111.384 171.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.588 ' HA ' HH21 ' A' ' 68' ' ' ARG . 82.2 mt -63.59 146.1 54.39 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.701 -168.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.472 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 29.4 mmmt -96.27 141.62 23.38 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.917 1.287 . . . . 0.0 108.6 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.85 -23.92 61.52 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.37 2.046 . . . . 0.0 113.216 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -72.24 -7.69 50.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.899 0.88 . . . . 0.0 112.316 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -84.77 38.2 0.69 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.802 0.841 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.2 m -90.84 100.52 13.36 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 171.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.76 -171.39 3.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.643 0.777 . . . . 0.0 110.273 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 40' ' ' GLN . 1.5 p -123.77 106.03 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -90.98 146.84 23.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.626 0.77 . . . . 0.0 110.965 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD13 ' HB3' ' A' ' 113' ' ' TRP . 2.0 pp -144.28 153.72 42.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.236 1.014 . . . . 0.0 109.41 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.8 148.21 22.53 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.05 148.49 31.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.106 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB3' HD21 ' A' ' 5' ' ' LEU . . . -155.85 135.76 12.76 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.394 0.678 . . . . 0.0 109.685 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 O-C-N 123.876 0.735 . . . . 0.0 111.441 171.004 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 CA--C 1.546 1.11 0 CA-C-O 121.231 0.43 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.34 -42.68 99.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.296 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -142.01 125.68 16.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.693 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.444 ' HB3' HD13 ' A' ' 96' ' ' LEU . 5.7 m-90 -94.03 155.11 17.29 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.85 171.55 52.02 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.191 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.22 -21.14 66.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.934 0.894 . . . . 0.0 112.059 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.05 127.79 1.22 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.46 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 11.1 t -125.61 138.47 53.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.127 0.571 . . . . 0.0 110.254 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.555 HE21 ' HB ' ' A' ' 94' ' ' VAL . 6.9 mm-40 -80.44 101.69 9.2 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.614 0.766 . . . . 0.0 111.449 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.0 m -99.25 130.57 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 170.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 82.9 m -135.11 110.7 9.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.7 104.61 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.939 -0.476 . . . . 0.0 109.779 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.549 ' HB2' HD21 ' A' ' 12' ' ' LEU . 35.2 t -61.88 155.43 23.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.584 0.754 . . . . 0.0 112.045 168.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 t -85.47 71.45 10.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.162 0.585 . . . . 0.0 109.644 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 4.1 mm? . . . . . 0 N--CA 1.494 1.732 0 C-N-CA 125.068 1.347 . . . . 0.0 114.26 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -107.58 146.18 32.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.346 1.058 . . . . 0.0 108.968 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.575 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 94.5 mt -125.63 108.17 11.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.67 107.52 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -102.98 154.84 18.83 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.691 0.619 . . . . 0.0 111.72 -170.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -157.68 158.8 36.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.4 1.08 . . . . 0.0 109.133 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.12 -2.99 29.91 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.827 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -72.24 83.33 0.53 Allowed Glycine 0 C--N 1.35 1.322 0 CA-C-N 117.173 0.486 . . . . 0.0 112.725 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.86 177.03 17.19 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.0 tt -92.54 114.14 26.61 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 87' ' ' LEU . 35.9 m -113.34 171.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -94.4 158.07 15.73 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.15 0.58 . . . . 0.0 109.919 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.76 116.83 5.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.756 0.822 . . . . 0.0 110.571 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.43 22.8 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.602 0.564 . . . . 0.0 111.988 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.65 55.24 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 121.275 0.375 . . . . 0.0 113.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 p -109.4 165.7 11.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 110.685 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.7 tp -158.33 141.03 14.58 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -114.26 113.16 24.24 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.175 0.512 . . . . 0.0 110.15 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -87.72 149.17 24.39 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 109.332 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.2 p -145.22 126.79 15.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.798 0.839 . . . . 0.0 109.346 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 43.5 t -135.28 130.31 34.93 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 109.735 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.56 146.14 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.97 99.02 11.57 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t 53.37 40.65 31.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.297 1.439 . . . . 0.0 112.352 171.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.03 -61.08 4.36 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.027 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -168.54 33.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.03 1.332 . . . . 0.0 109.803 172.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -119.93 121.28 38.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.326 0.651 . . . . 0.0 109.945 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -133.43 150.67 51.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 110.371 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mtt85 -166.92 72.23 0.12 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 107.779 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.6 m -147.71 129.69 15.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.765 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.95 -43.71 21.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.88 0.472 . . . . 0.0 111.894 -171.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.39 169.5 9.26 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.569 0.347 . . . . 0.0 110.318 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 80' ' ' VAL . 58.2 mtt -148.98 165.39 31.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.533 1.133 . . . . 0.0 109.006 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -155.8 -174.82 26.08 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-O 119.993 -0.337 . . . . 0.0 112.264 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -143.6 118.87 10.18 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.659 1.184 . . . . 0.0 108.455 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.52 162.87 14.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.411 1.084 . . . . 0.0 108.824 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -121.61 133.98 54.99 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.524 ' HB3' HG13 ' A' ' 94' ' ' VAL . 9.9 tm0? -107.84 128.97 55.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -111.78 141.2 24.27 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.552 0.741 . . . . 0.0 109.015 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.82 114.1 2.01 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.597 2.198 . . . . 0.0 112.391 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.51 79.78 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.492 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -119.09 173.58 6.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.571 1.148 . . . . 0.0 108.943 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.49 166.46 15.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.843 0.354 . . . . 0.0 110.622 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.92 115.55 11.26 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.343 0.592 . . . . 0.0 109.746 170.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -92.63 141.57 28.34 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.082 0.953 . . . . 0.0 109.892 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -77.58 116.47 18.16 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.63 0.581 . . . . 0.0 109.535 -178.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.18 -59.59 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.584 0.754 . . . . 0.0 110.072 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.537 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -148.79 163.45 37.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.449 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -157.25 164.72 37.4 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.362 1.077 . . . . 0.0 112.226 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 73' ' ' ARG . 96.4 mt -109.2 116.77 52.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.31 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 . . . . . 0 C--N 1.351 0.653 0 O-C-N 124.19 0.931 . . . . 0.0 108.992 176.38 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 9.5 t . . . . . 0 CA--C 1.549 0.939 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.39 117.68 1.15 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.713 0.805 . . . . 0.0 109.573 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -171.02 128.21 0.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.206 2.202 . . . . 0.0 105.924 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.15 146.21 7.43 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.041 0.936 . . . . 0.0 109.708 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.95 156.43 38.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.682 0.793 . . . . 0.0 109.981 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -60.32 -26.73 66.79 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.474 0.71 . . . . 0.0 112.135 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.2 t -65.55 -39.02 91.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.764 0.826 . . . . 0.0 111.089 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.09 12.33 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.878 0.871 . . . . 0.0 111.268 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -66.78 120.75 14.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.144 0.978 . . . . 0.0 110.799 -173.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.63 5.49 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.305 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -77.51 -55.36 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.14 120.3 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.2 m -129.44 138.13 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.537 HD12 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -116.23 142.49 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -137.17 133.07 34.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.639 ' HB2' HD13 ' A' ' 52' ' ' ILE . 78.3 ttt180 -115.27 122.41 45.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.46 90.65 3.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -69.93 -13.26 62.16 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.01 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.61 77.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.343 1.057 . . . . 0.0 111.988 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.19 11.86 12.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.884 0.474 . . . . 0.0 110.794 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.28 28.62 15.78 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.833 1.253 . . . . 0.0 112.091 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.5 m -114.37 131.75 56.45 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.306 0.642 . . . . 0.0 110.287 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.48 HG21 ' SD ' ' A' ' 35' ' ' MET . 79.0 t -108.58 150.05 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.41 1.484 . . . . 0.0 108.946 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -131.02 151.62 51.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.643 0.777 . . . . 0.0 110.745 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 55.7 tp -132.22 101.36 5.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 108.521 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -85.97 101.14 12.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.487 ' SD ' HD21 ' A' ' 87' ' ' LEU . 39.9 mtt -83.33 139.58 32.95 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.109 0.964 . . . . 0.0 109.2 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -138.23 138.11 38.18 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 t 58.4 72.34 0.53 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.629 1.172 . . . . 0.0 110.451 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.487 HD21 ' SD ' ' A' ' 84' ' ' MET . 42.3 mt -82.62 144.8 30.06 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.574 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -87.18 150.29 49.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.734 0.814 . . . . 0.0 109.38 -176.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.83 -23.63 74.36 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 C-N-CA 121.726 1.617 . . . . 0.0 110.891 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.04 -31.73 69.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.696 1.598 . . . . 0.0 111.775 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.37 22.43 0.84 Allowed 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.607 0.717 . . . . 0.0 111.632 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -77.85 92.28 4.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 161.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.53 169.97 21.87 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.023 0.929 . . . . 0.0 109.694 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.524 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -97.69 107.82 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -82.06 150.81 27.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.401 0.681 . . . . 0.0 109.445 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.78 140.26 21.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.354 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 14.7 p -89.7 149.92 22.55 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -112.12 158.45 19.6 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.556 0.742 . . . . 0.0 109.71 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -139.33 137.71 36.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -176.839 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.565 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 17.4 Cg_exo . . . . . 0 CA--C 1.547 1.127 0 N-CA-C 111.318 -0.301 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -92.59 -12.05 32.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.312 0.645 . . . . 0.0 111.271 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 9.9 m-85 -128.55 149.25 50.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -138.92 163.98 30.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.623 0.769 . . . . 0.0 109.969 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -76.09 174.57 53.11 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.633 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -73.89 -28.11 61.39 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.987 0.515 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.06 100.81 2.66 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.378 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -96.2 106.81 19.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.078 0.942 . . . . 0.0 108.572 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -78.7 101.38 7.5 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.244 -172.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.521 HG12 ' HA2' ' A' ' 10' ' ' GLY . 19.8 m -91.04 137.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.0 m -124.46 102.98 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.32 94.73 4.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -64.43 142.43 58.42 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.0 p -70.48 88.58 0.67 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.75 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.492 1.657 0 C-N-CA 126.565 1.946 . . . . 0.0 113.361 174.57 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -75.39 144.4 42.28 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.126 0.571 . . . . 0.0 110.08 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.26 110.39 11.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.968 0.414 . . . . 0.0 109.997 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -108.19 106.3 16.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 93.1 mt -93.42 105.6 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.865 0.466 . . . . 0.0 109.862 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.6 t -98.75 104.19 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.14 146.78 24.38 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.338 0.655 . . . . 0.0 111.376 -171.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 p -149.82 158.01 43.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.213 1.005 . . . . 0.0 109.877 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.71 -0.75 42.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.237 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.95 118.68 9.86 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-O 120.241 -0.2 . . . . 0.0 112.662 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -169.36 -167.12 29.47 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.3 tt -105.21 124.28 49.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.821 0.449 . . . . 0.0 110.513 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 19' ' ' LEU . 28.0 m -118.67 163.03 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.345 1.058 . . . . 0.0 108.744 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 5.7 pm0 -88.89 155.55 19.46 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.065 0.546 . . . . 0.0 109.979 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.87 111.7 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.866 0.866 . . . . 0.0 110.745 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.02 -14.17 23.91 Favored Glycine 0 N--CA 1.474 1.181 0 O-C-N 123.273 0.358 . . . . 0.0 113.042 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.37 170.99 51.29 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-O 120.111 -0.272 . . . . 0.0 112.457 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -105.57 138.85 41.08 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.512 0.725 . . . . 0.0 110.626 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HB2' HG11 ' A' ' 13' ' ' VAL . 38.8 tp -132.51 130.94 41.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.683 1.193 . . . . 0.0 109.152 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -111.97 127.51 55.89 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.833 0.853 . . . . 0.0 109.573 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.7 mm? -99.61 149.31 23.41 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.655 0.782 . . . . 0.0 108.957 170.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 p -138.26 124.05 19.9 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 49.2 t -116.77 101.96 9.0 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.895 0.878 . . . . 0.0 109.409 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.87 121.29 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.52 99.43 12.29 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.79 0.436 . . . . 0.0 110.374 -173.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 18.4 m 58.87 35.72 24.33 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.076 1.35 . . . . 0.0 112.108 173.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.79 -58.63 4.81 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.993 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 31.9 ttp-105 -173.47 77.65 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.668 1.187 . . . . 0.0 108.014 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.5 m -139.77 147.89 41.45 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.567 0.747 . . . . 0.0 110.293 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.471 ' HB3' HD21 ' A' ' 78' ' ' ASN . 11.6 p90 -128.18 136.95 51.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.505 1.122 . . . . 0.0 110.103 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -169.67 12.93 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.0 0.92 . . . . 0.0 109.098 166.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 t -108.79 108.6 19.47 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.398 0.679 . . . . 0.0 109.992 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -88.83 -23.72 22.76 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.737 0.815 . . . . 0.0 110.66 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . . . -130.43 123.47 29.88 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.005 0.922 . . . . 0.0 109.04 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.0 mtm -132.28 166.18 22.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.233 1.013 . . . . 0.0 109.719 -177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -154.6 179.81 30.42 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.288 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 93.2 m95 -138.38 130.31 28.26 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 170.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.556 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 64.9 m-85 -135.48 152.63 51.54 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.022 0.929 . . . . 0.0 109.262 -173.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 13.7 ptp180 -107.39 141.51 38.66 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.423 ' HB3' HG13 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -132.5 145.43 51.16 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -176.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -144.6 155.17 56.82 Favored Pre-proline 0 N--CA 1.478 0.956 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.69 105.94 0.25 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.315 2.01 . . . . 0.0 111.83 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.05 -17.04 56.73 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.558 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 9.8 mmpt? -111.87 131.86 55.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.62 0.768 . . . . 0.0 110.326 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.68 170.64 14.09 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.009 0.924 . . . . 0.0 111.763 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -67.28 119.02 11.46 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.712 -177.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -103.68 136.85 42.61 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.961 0.904 . . . . 0.0 109.997 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -62.97 115.82 4.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.688 1.195 . . . . 0.0 111.539 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.4 t -102.46 -48.16 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.011 0.924 . . . . 0.0 109.281 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -153.11 168.45 25.89 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.434 0.694 . . . . 0.0 111.623 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.626 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -153.98 138.47 16.8 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.467 0.651 . . . . 0.0 111.423 172.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.658 HG21 ' HB2' ' A' ' 73' ' ' ARG . 72.3 mt -127.01 124.76 65.23 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.069 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.439 HH21 ' HA ' ' A' ' 108' ' ' ASP . 63.1 mtt180 -113.86 178.3 4.33 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 110.849 174.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.0 t90 -67.39 95.36 0.44 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.074 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.8 t 63.01 -173.25 0.16 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.395 1.078 . . . . 0.0 111.869 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.09 -19.54 53.61 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 122.278 -0.264 . . . . 0.0 113.745 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.38 -63.62 0.46 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB3' HG23 ' A' ' 52' ' ' ILE . 38.4 m 62.9 69.77 0.58 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.182 0.993 . . . . 0.0 112.114 170.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.499 ' HA ' HD11 ' A' ' 71' ' ' ILE . 12.4 p -163.9 122.54 1.92 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.45 1.1 . . . . 0.0 109.704 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.553 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 93.8 m-85 -150.15 147.84 28.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.482 1.113 . . . . 0.0 108.603 174.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' CD1' ' HA ' ' A' ' 66' ' ' LYS . 26.3 p90 -164.53 158.04 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.152 0.981 . . . . 0.0 109.649 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.0 157.63 28.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.363 0.665 . . . . 0.0 110.631 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.43 -37.69 88.27 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.632 0.773 . . . . 0.0 110.985 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.8 m -70.2 -16.06 63.02 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.912 0.885 . . . . 0.0 112.635 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 62' ' ' ALA . 31.5 m -125.06 20.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.777 0.831 . . . . 0.0 110.551 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 61' ' ' TYR . 4.3 ttmp? -48.92 113.55 0.81 Allowed 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.156 1.383 . . . . 0.0 113.072 -175.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.28 -28.91 4.97 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.275 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -71.49 -44.85 63.96 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.546 0.688 . . . . 0.0 109.546 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.62 121.88 28.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.563 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.2 m -134.94 149.8 50.3 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.388 1.475 . . . . 0.0 107.905 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.632 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.12 152.65 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.333 0.653 . . . . 0.0 110.636 -177.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 t -151.47 145.23 25.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.608 0.763 . . . . 0.0 110.024 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.658 ' HB2' HG21 ' A' ' 52' ' ' ILE . 28.7 ttt180 -110.57 122.93 48.97 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.5 86.96 2.59 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -79.82 -11.91 59.8 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.341 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.89 -35.95 73.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.817 0.847 . . . . 0.0 111.831 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.02 1.39 11.43 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.921 0.488 . . . . 0.0 111.212 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.471 HD21 ' HB3' ' A' ' 30' ' ' PHE . 19.3 m120 57.74 67.49 0.96 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.772 1.229 . . . . 0.0 110.885 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.3 m -139.04 131.76 29.03 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.898 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.4 HG12 ' HE1' ' A' ' 37' ' ' TRP . 20.6 t -108.82 125.02 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.29 134.13 48.9 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.791 0.436 . . . . 0.0 111.359 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 57.1 tp -115.64 97.14 5.97 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -92.6 98.5 11.48 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.498 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 75.9 mtm -98.25 111.56 23.85 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -100.4 138.37 37.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.6 t 58.56 72.04 0.55 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.308 1.043 . . . . 0.0 110.572 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.88 144.68 36.75 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.605 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -87.0 153.87 54.76 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.24 -18.45 64.94 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.944 1.763 . . . . 0.0 112.654 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.16 3.68 41.78 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.733 0.813 . . . . 0.0 112.134 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.85 26.38 1.82 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.557 0.743 . . . . 0.0 109.971 167.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.524 HG23 HG23 ' A' ' 120' ' ' THR . 95.9 m -83.25 94.0 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 166.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.93 -169.29 2.33 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.71 0.804 . . . . 0.0 110.047 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.0 p -114.84 110.7 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.441 0.697 . . . . 0.0 109.191 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -84.38 153.14 23.62 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.111 0.564 . . . . 0.0 109.683 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 pp -146.41 147.5 31.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.368 0.667 . . . . 0.0 110.26 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.9 t -88.53 161.62 16.87 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.775 0.83 . . . . 0.0 109.244 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -122.7 158.22 30.57 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.045 0.538 . . . . 0.0 109.586 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -152.44 167.2 29.52 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.2 1.0 . . . . 0.0 109.515 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.52 -159.91 28.19 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.0 m -124.08 167.73 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.474 0.71 . . . . 0.0 110.221 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -83.31 144.05 29.96 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.068 0.547 . . . . 0.0 110.47 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HG3' ' H ' ' A' ' 105' ' ' SER . 19.2 tpt180 -90.35 143.01 27.16 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.411 0.684 . . . . 0.0 109.431 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 m -66.88 -20.26 65.88 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.307 0.643 . . . . 0.0 112.598 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.491 ' H ' ' HG3' ' A' ' 103' ' ' ARG . 47.3 t -71.17 -23.09 61.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.795 0.838 . . . . 0.0 111.381 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.28 -1.06 43.55 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 116.39 -0.368 . . . . 0.0 112.488 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -77.96 148.9 34.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.03 0.932 . . . . 0.0 110.286 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.439 ' HA ' HH21 ' A' ' 53' ' ' ARG . 23.2 t70 -95.07 123.32 38.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.077 0.551 . . . . 0.0 110.011 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.6 p -116.51 104.93 51.03 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 122.999 0.52 . . . . 0.0 110.515 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 15.7 Cg_exo -71.12 97.83 0.78 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.588 2.192 . . . . 0.0 110.198 164.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.47 -42.97 41.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.3 0.64 . . . . 0.0 110.075 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 96.8 m-85 -112.45 160.01 18.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.378 1.071 . . . . 0.0 110.453 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -137.1 165.36 26.24 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.562 1.145 . . . . 0.0 108.878 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -79.27 173.65 55.26 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.446 -175.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 11.7 mm100 -72.7 -19.55 61.38 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.244 0.618 . . . . 0.0 111.394 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.72 99.98 1.7 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.3 t -99.49 116.74 32.32 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.523 0.729 . . . . 0.0 110.104 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 112.27 8.19 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.901 0.881 . . . . 0.0 110.564 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.58 126.6 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 172.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.524 HG23 HG23 ' A' ' 92' ' ' THR . 57.1 m -120.5 104.37 9.92 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.69 98.08 7.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.7 t -71.29 146.46 48.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.826 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 m -71.92 86.41 0.99 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.158 0.583 . . . . 0.0 110.225 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 3.3 mm? 57.65 28.27 15.48 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.656 1.183 . . . . 0.0 112.252 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -126.23 165.72 18.41 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.825 0.85 . . . . 0.0 111.034 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -139.22 167.24 22.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.432 1.093 . . . . 0.0 108.808 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -131.69 128.6 39.32 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.117 0.567 . . . . 0.0 110.699 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -86.49 143.42 27.76 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.71 1.204 . . . . 0.0 109.668 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -139.44 99.92 3.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.445 0.698 . . . . 0.0 109.766 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -86.28 146.97 26.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.638 0.775 . . . . 0.0 110.381 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.8 m80 . . . . . 0 C--O 1.247 0.95 0 C-N-CA 123.522 0.729 . . . . 0.0 110.331 -176.95 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -81.78 82.38 7.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.467 0.707 . . . . 0.0 109.768 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.99 113.09 22.45 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -102.13 121.4 42.13 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.704 0.802 . . . . 0.0 110.322 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.691 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.4 mt -110.15 110.83 21.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.232 1.013 . . . . 0.0 109.878 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.3 104.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.691 0.797 . . . . 0.0 109.383 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -90.94 142.32 27.9 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.69 0.796 . . . . 0.0 111.427 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.8 m -154.62 145.85 22.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.401 1.48 . . . . 0.0 108.844 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.4 -32.91 2.28 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.958 -0.357 . . . . 0.0 112.4 175.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 127.05 43.94 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 123.977 0.457 . . . . 0.0 113.937 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.15 -175.78 36.16 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 123.302 0.477 . . . . 0.0 112.028 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 120' ' ' THR . 20.7 tp -91.46 120.11 32.01 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 122.956 0.503 . . . . 0.0 109.934 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 87' ' ' LEU . 27.5 m -125.24 158.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 109.156 170.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.438 HE21 ' HA3' ' A' ' 17' ' ' GLY . 0.7 OUTLIER -78.45 152.91 31.88 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -60.82 133.61 56.27 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.507 0.723 . . . . 0.0 110.469 173.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.95 -15.12 64.07 Favored Glycine 0 C--N 1.34 0.759 0 O-C-N 123.306 0.379 . . . . 0.0 112.387 -170.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA3' HE21 ' A' ' 14' ' ' GLN . . . -82.29 -173.82 49.26 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-O 121.078 0.265 . . . . 0.0 113.657 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.6 p -127.12 154.27 44.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.137 0.975 . . . . 0.0 110.318 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.1 tp -154.82 122.94 5.9 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -98.14 117.29 32.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 110.505 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -88.77 155.18 19.72 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.12 0.968 . . . . 0.0 109.209 172.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.8 p -151.39 133.95 15.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.987 0.915 . . . . 0.0 109.006 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 46.2 t -131.52 101.96 5.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.624 0.77 . . . . 0.0 109.158 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.9 t -87.66 127.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 109.68 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.1 96.93 10.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.3 t 43.85 53.44 6.19 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.02 1.728 . . . . 0.0 112.69 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.37 -79.03 1.24 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.392 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.565 ' HG2' ' HA ' ' A' ' 77' ' ' LYS . 61.8 mtm-85 -150.37 86.0 1.4 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.562 1.145 . . . . 0.0 109.046 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.9 t -141.22 145.16 35.26 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 168.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.83 117.51 21.98 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mtp85 -143.01 1.46 1.27 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.73 1.212 . . . . 0.0 109.439 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 91.87 6.46 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.905 0.882 . . . . 0.0 110.216 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.668 ' HB2' ' HA ' ' A' ' 101' ' ' VAL . 34.0 m-80 -83.76 -26.24 29.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.31 1.044 . . . . 0.0 110.117 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.8 141.93 51.69 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.066 1.346 . . . . 0.0 108.076 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.487 ' HE3' HG22 ' A' ' 52' ' ' ILE . 20.9 mtm -151.89 162.06 41.65 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.121 0.968 . . . . 0.0 109.535 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -168.49 138.62 5.22 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 121.353 -0.451 . . . . 0.0 113.319 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -92.81 126.36 37.86 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -116.24 147.4 41.52 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 108.515 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.23 142.35 33.62 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.51 ' HB3' HG13 ' A' ' 94' ' ' VAL . 64.0 tt0 -141.41 128.38 20.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.83 160.78 31.85 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.391 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.73 112.39 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.095 2.53 . . . . 0.0 112.843 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.76 23.39 75.12 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.625 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -125.37 173.19 9.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.781 0.832 . . . . 0.0 110.679 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.18 163.8 26.72 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.481 1.112 . . . . 0.0 111.837 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -92.99 106.79 18.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.874 0.845 . . . . 0.0 109.024 170.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -92.73 135.84 33.76 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.346 1.059 . . . . 0.0 110.009 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -65.03 120.05 11.91 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.098 1.359 . . . . 0.0 111.31 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.96 -61.47 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.43 0.692 . . . . 0.0 109.162 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -146.65 159.36 43.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.958 -172.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -132.19 141.41 49.07 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.319 0.648 . . . . 0.0 111.021 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.599 HG21 ' HB2' ' A' ' 73' ' ' ARG . 3.7 mp -112.6 121.3 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.5 mtp-105 -120.55 -175.42 3.01 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.393 1.077 . . . . 0.0 109.417 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -47.8 163.71 0.05 Allowed 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.48 0.712 . . . . 0.0 112.113 169.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -56.48 126.65 27.46 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.316 0.647 . . . . 0.0 110.202 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.32 -18.12 30.74 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.826 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.42 -128.88 6.01 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.547 -0.585 . . . . 0.0 111.926 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 40.8 m 62.06 52.6 3.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.068 0.947 . . . . 0.0 112.597 172.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.437 ' HA ' HD11 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -158.69 122.25 3.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.164 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 15.9 m-85 -159.16 125.62 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.599 1.56 . . . . 0.0 107.297 170.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -164.62 144.14 7.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.638 0.775 . . . . 0.0 109.649 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 158.46 28.63 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.332 165.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.41 -28.38 69.64 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.4 t -63.48 -34.69 78.32 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.04 0.936 . . . . 0.0 112.224 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 34.1 m -109.52 14.84 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.425 0.69 . . . . 0.0 111.035 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -71.25 134.31 46.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.868 0.867 . . . . 0.0 109.409 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.11 -0.14 63.82 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.697 0.623 . . . . 0.0 113.243 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 72.7 mtp180 -109.29 -73.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.525 1.13 . . . . 0.0 109.174 -175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.65 119.66 26.23 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -126.58 129.8 49.26 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.977 0.911 . . . . 0.0 108.801 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -113.37 138.82 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.272 0.558 . . . . 0.0 109.787 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -144.81 149.21 35.05 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.298 1.039 . . . . 0.0 108.775 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.599 ' HB2' HG21 ' A' ' 52' ' ' ILE . 57.7 ttp180 -124.6 129.29 50.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 171.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -99.15 130.01 45.44 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -87.44 -29.91 21.08 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.415 0.686 . . . . 0.0 111.563 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.25 82.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.529 0.731 . . . . 0.0 112.064 -172.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -116.45 12.15 15.1 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.655 0.382 . . . . 0.0 111.839 175.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.7 m120 53.76 56.85 6.66 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.093 0.957 . . . . 0.0 112.052 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -126.03 130.63 51.54 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.626 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.2 t -103.09 121.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.856 0.862 . . . . 0.0 109.127 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -102.25 145.38 29.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.622 0.769 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 53.1 tp -125.36 98.03 5.45 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -83.22 101.43 11.23 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.472 ' SD ' HD21 ' A' ' 87' ' ' LEU . 61.4 mtt -84.53 123.75 30.64 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -121.67 146.14 47.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.9 t 57.24 63.14 1.96 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.586 0.708 . . . . 0.0 110.935 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HB3' HG21 ' A' ' 121' ' ' VAL . 35.3 mt -79.66 140.04 37.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.839 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.6 mmmp? -99.15 157.89 33.26 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.95 0.9 . . . . 0.0 108.729 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.67 -22.76 74.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.459 2.106 . . . . 0.0 112.72 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.42 -17.2 64.35 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.705 1.202 . . . . 0.0 112.452 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -81.87 37.84 0.5 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.745 0.818 . . . . 0.0 111.048 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 120' ' ' THR . 90.1 m -91.27 90.86 7.93 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 164.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.3 177.46 6.09 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -168.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.51 HG13 ' HB3' ' A' ' 40' ' ' GLN . 4.7 p -107.32 112.85 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.71 0.804 . . . . 0.0 110.173 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -92.01 133.23 35.91 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 170.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -122.47 141.51 51.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.058 0.543 . . . . 0.0 109.969 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -91.23 149.47 21.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.75 158.94 43.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.409 0.684 . . . . 0.0 109.566 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.76 169.35 17.77 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 109.811 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.11 -154.97 25.92 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.703 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.668 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 30.5 m -130.98 179.72 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.298 1.039 . . . . 0.0 110.079 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -58.48 149.24 25.73 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.903 0.881 . . . . 0.0 111.079 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -119.7 147.62 44.36 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.557 0.343 . . . . 0.0 110.161 -175.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.0 m -65.28 -20.15 66.28 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.164 0.586 . . . . 0.0 111.153 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.5 m -72.84 -25.33 61.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.043 0.937 . . . . 0.0 111.963 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.94 -23.18 30.3 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 113.832 0.293 . . . . 0.0 113.832 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 20.8 m-90 -79.34 152.66 30.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.106 0.562 . . . . 0.0 110.209 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.57 122.26 17.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.2 m -122.68 127.3 25.83 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 122.785 0.434 . . . . 0.0 111.284 -171.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.83 103.88 1.78 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.77 2.313 . . . . 0.0 112.015 172.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.09 -30.55 55.43 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.36 0.6 . . . . 0.0 109.808 170.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -127.13 153.17 46.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.779 1.232 . . . . 0.0 108.567 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -131.38 157.64 42.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.7 -120.95 0.67 Allowed Glycine 0 C--N 1.336 0.57 0 O-C-N 123.244 0.34 . . . . 0.0 112.696 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -129.05 -15.14 4.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.737 0.815 . . . . 0.0 111.075 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.8 109.97 0.14 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 123.332 0.395 . . . . 0.0 112.641 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.454 HG21 HD12 ' A' ' 21' ' ' LEU . 10.1 t -95.84 128.15 42.48 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-O 121.644 0.735 . . . . 0.0 110.798 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.462 HE21 ' HB ' ' A' ' 94' ' ' VAL . 8.4 mm-40 -79.36 108.86 13.2 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.6 m -101.47 136.27 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 92' ' ' THR . 31.3 m -133.9 129.34 36.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 87' ' ' LEU . 46.3 t -113.66 108.72 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 125' ' ' GLU . 20.8 m -60.88 141.64 56.98 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.939 0.495 . . . . 0.0 111.934 167.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 m -74.66 90.74 2.31 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.464 0.705 . . . . 0.0 110.964 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.8 mm? 61.16 15.44 6.33 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.486 1.114 . . . . 0.0 112.943 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.574 ' HB2' ' HB3' ' A' ' 122' ' ' SER . 44.6 mt-10 -82.19 -91.82 0.07 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 117.865 0.302 . . . . 0.0 111.555 -174.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -148.37 152.4 36.95 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.23 0.612 . . . . 0.0 111.09 -170.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -96.8 153.52 17.83 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 160.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -73.21 128.97 36.99 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -67.26 103.39 1.24 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.734 0.414 . . . . 0.0 110.282 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.6 m80 60.27 -159.91 0.3 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.877 1.271 . . . . 0.0 111.443 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 . . . . . 0 CA--C 1.556 1.192 0 CA-C-O 118.959 -0.543 . . . . 0.0 111.093 175.011 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 63.43 -163.42 0.27 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.646 1.178 . . . . 0.0 111.707 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.73 111.04 7.51 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -103.07 132.32 49.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.672 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 70.3 mt -121.86 120.22 33.9 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 52.4 t -95.76 99.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 51.9 mt-10 -95.34 123.92 39.11 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.678 -172.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 m -130.91 154.38 48.16 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.617 1.167 . . . . 0.0 109.769 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.23 11.67 35.87 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.015 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.57 74.65 1.5 Allowed Glycine 0 C--N 1.35 1.355 0 N-CA-C 112.185 -0.366 . . . . 0.0 112.185 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.37 -164.17 13.68 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 120' ' ' THR . 6.5 tt -116.86 127.54 54.39 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.82 161.13 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.144 0.978 . . . . 0.0 109.007 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -80.67 158.27 25.66 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.212 0.605 . . . . 0.0 110.768 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.23 114.49 2.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.772 0.829 . . . . 0.0 110.539 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.99 -25.53 10.69 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.959 0.79 . . . . 0.0 112.01 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.67 164.63 54.82 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 113.725 0.25 . . . . 0.0 113.725 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.6 p -104.64 155.46 18.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.988 0.915 . . . . 0.0 110.38 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.2 tp -152.76 136.84 16.42 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.114 0.966 . . . . 0.0 108.464 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.062 0.545 . . . . 0.0 110.043 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -101.07 157.51 16.7 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.297 1.039 . . . . 0.0 108.899 174.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -144.89 127.27 15.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -127.79 105.37 8.39 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.542 0.737 . . . . 0.0 110.445 -174.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.47 130.04 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.88 98.06 11.28 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.726 0.298 . . . . 0.0 110.374 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 5.6 m 56.9 29.12 15.66 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.329 1.451 . . . . 0.0 112.917 170.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.18 50.77 5.64 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -173.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 69.68 24.42 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.629 1.172 . . . . 0.0 113.092 171.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 32.7 p -87.8 153.24 21.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.889 0.476 . . . . 0.0 110.271 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -110.67 123.16 49.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.791 0.836 . . . . 0.0 109.76 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -145.95 -50.27 0.23 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.672 1.189 . . . . 0.0 108.168 167.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 p -73.52 103.72 4.24 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.942 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -88.97 -13.96 37.69 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.794 0.838 . . . . 0.0 110.033 167.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.58 43.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.784 1.234 . . . . 0.0 108.3 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtm -148.9 167.15 26.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.007 . . . . 0.0 109.157 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.61 148.79 8.91 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.715 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 95.4 m95 -89.51 136.25 33.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -123.25 164.78 18.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.42 1.088 . . . . 0.0 108.447 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -128.47 148.02 50.71 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.41 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 35.5 tt0 -155.07 144.67 21.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.546 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -108.82 152.56 42.38 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 171.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.05 110.71 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.706 2.27 . . . . 0.0 112.506 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.08 13.07 43.96 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.327 -0.397 . . . . 0.0 113.449 -177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 9.1 mmpt? -119.78 170.62 9.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.086 0.955 . . . . 0.0 110.57 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.28 163.44 19.64 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.655 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.499 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.56 123.36 31.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.6 137.59 32.71 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 0.0 109.673 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 80.7 t80 -69.09 119.72 13.81 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.13 0.972 . . . . 0.0 110.431 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.51 -54.68 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.293 0.637 . . . . 0.0 110.075 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . . . -139.9 164.9 28.77 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.588 -171.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . . . -145.09 131.86 20.04 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.377 0.671 . . . . 0.0 110.846 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -110.79 127.24 68.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.767 1.227 . . . . 0.0 109.375 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.47 ' HG3' ' HZ2' ' A' ' 102' ' ' TRP . 3.2 mpt_? -119.03 179.01 4.29 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.252 1.421 . . . . 0.0 109.408 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -66.02 -170.35 0.08 Allowed 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.994 0.918 . . . . 0.0 111.975 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.8 m -53.91 114.62 1.64 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.713 1.205 . . . . 0.0 112.439 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.48 16.78 28.4 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.465 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.6 -137.3 4.22 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.8 m 65.57 63.45 0.62 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.613 1.165 . . . . 0.0 112.236 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.467 ' HA ' HD11 ' A' ' 71' ' ' ILE . 2.5 p -150.59 122.2 8.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.261 1.025 . . . . 0.0 109.211 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.24 127.05 0.82 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -165.82 167.04 17.25 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.544 0.738 . . . . 0.0 110.086 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.34 145.56 33.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 168.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.77 -28.1 69.64 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 120.851 0.358 . . . . 0.0 110.966 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 m -70.92 -26.62 63.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.61 0.764 . . . . 0.0 112.214 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 62' ' ' ALA . 18.7 m -104.58 4.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 122.872 0.469 . . . . 0.0 111.43 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -57.76 116.05 3.2 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.463 1.105 . . . . 0.0 112.501 -175.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.72 11.81 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.986 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -87.25 -57.24 3.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.516 0.726 . . . . 0.0 109.263 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -87.77 122.1 31.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -146.74 153.68 40.52 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.049 1.34 . . . . 0.0 108.63 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -124.92 156.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.59 0.756 . . . . 0.0 109.915 176.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -151.75 136.77 17.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.778 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.7 ttp85 -110.37 136.28 49.79 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -109.03 122.26 46.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -87.59 -23.85 24.18 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.053 0.541 . . . . 0.0 111.0 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.35 84.85 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.377 0.671 . . . . 0.0 111.875 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 17.1 12.53 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.51 0.324 . . . . 0.0 111.841 172.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.6 m120 48.72 56.37 7.74 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.237 1.015 . . . . 0.0 112.191 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.1 m -130.07 130.72 45.24 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.04 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.422 HG12 ' HE1' ' A' ' 37' ' ' TRP . 86.9 t -109.65 125.53 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.901 0.88 . . . . 0.0 109.89 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -102.45 146.59 27.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.739 0.815 . . . . 0.0 110.388 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.3 tp -124.53 101.48 7.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.111 0.964 . . . . 0.0 108.685 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -91.55 101.18 13.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.369 0.668 . . . . 0.0 109.995 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.419 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 55.7 mtm -107.84 107.61 18.43 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.376 0.67 . . . . 0.0 110.118 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -106.91 147.94 29.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.303 0.641 . . . . 0.0 109.908 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.4 t 61.71 60.63 1.57 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.117 0.967 . . . . 0.0 110.067 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' A' ' 121' ' ' VAL . 42.9 mt -76.13 151.12 37.08 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.28 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -110.7 157.11 39.36 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.392 1.077 . . . . 0.0 109.046 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HB3' ' HB2' ' A' ' 123' ' ' SER . 27.3 Cg_endo -59.14 -26.14 80.63 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.56 2.174 . . . . 0.0 113.145 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.14 -17.3 64.79 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.002 0.921 . . . . 0.0 112.326 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.06 15.65 1.44 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.643 0.777 . . . . 0.0 111.193 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.52 HG23 HG23 ' A' ' 120' ' ' THR . 85.6 m -81.4 89.95 6.15 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 163.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.05 -166.07 0.77 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.491 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.3 p -115.23 112.93 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.195 0.598 . . . . 0.0 110.362 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -85.05 130.74 34.56 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.6 pt? -130.3 125.04 33.77 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.504 0.721 . . . . 0.0 109.292 -175.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.1 p -88.85 138.66 31.22 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -111.88 152.04 28.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.295 1.038 . . . . 0.0 109.823 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 5' ' ' LEU . . . -130.0 167.68 17.89 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.614 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.77 -168.88 39.85 Favored Glycine 0 C--O 1.236 0.274 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.6 145.74 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.602 0.761 . . . . 0.0 109.254 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.47 ' HZ2' ' HG3' ' A' ' 53' ' ' ARG . 83.1 m95 -59.61 117.03 4.45 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.618 0.767 . . . . 0.0 110.26 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.471 ' HD3' ' N ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -75.47 149.51 38.47 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 123.991 0.807 . . . . 0.0 108.943 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.471 ' N ' ' HD3' ' A' ' 103' ' ' ARG . 33.6 m -55.75 -19.92 12.89 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.539 1.135 . . . . 0.0 113.356 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.7 p -67.77 -24.2 65.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.305 1.042 . . . . 0.0 112.205 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.57 9.85 45.7 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.218 -174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -94.26 132.47 38.8 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.701 0.801 . . . . 0.0 110.531 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.41 92.25 2.81 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 166.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.9 p -95.48 107.05 30.53 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 123.286 0.634 . . . . 0.0 110.598 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 84.6 Cg_endo -81.52 86.68 1.55 Allowed 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.701 2.267 . . . . 0.0 110.054 170.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.2 -27.55 60.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.126 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -112.45 150.1 31.66 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 109.776 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -130.85 145.96 52.15 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -70.76 -79.39 0.37 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 123.527 0.517 . . . . 0.0 113.247 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -164.11 -40.31 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.771 0.828 . . . . 0.0 109.815 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.9 119.49 4.54 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.119 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 6.2 t -96.56 111.62 23.68 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.596 0.713 . . . . 0.0 109.622 174.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.45 98.56 1.45 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.513 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.02 132.79 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 10.8 m -128.1 106.21 8.91 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 87' ' ' LEU . 42.6 t -106.49 97.82 6.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 121.65 -0.656 . . . . 0.0 109.462 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.412 ' CB ' HD21 ' A' ' 12' ' ' LEU . 28.1 t -70.6 129.17 38.49 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.878 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 89' ' ' PRO . 43.8 t -59.93 98.23 0.05 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.499 0.72 . . . . 0.0 110.743 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 77.94 -43.24 0.38 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.83 1.652 . . . . 0.0 113.288 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.66 152.33 43.98 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.869 0.468 . . . . 0.0 110.995 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -92.11 -164.42 1.18 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.621 0.768 . . . . 0.0 110.345 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.49 ' HA ' HD22 ' A' ' 12' ' ' LEU . 57.8 t60 -47.5 -58.0 4.72 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.261 1.025 . . . . 0.0 113.673 -168.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 64.59 121.76 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.856 1.262 . . . . 0.0 112.329 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -78.23 155.23 30.42 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.823 0.449 . . . . 0.0 110.762 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -135.71 170.92 15.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.075 0.95 . . . . 0.0 109.286 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 50.7 t60 . . . . . 0 CA--C 1.562 1.411 0 C-N-CA 124.772 1.229 . . . . 0.0 110.578 -176.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtm . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -134.18 112.39 11.06 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.14 112.63 17.64 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 37.8 mt-30 -104.02 121.66 43.63 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.317 0.647 . . . . 0.0 109.568 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.582 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.6 mt -120.08 107.17 12.73 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 173.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.66 102.56 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.69 146.69 23.98 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.453 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 p -159.18 177.77 10.72 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.169 0.988 . . . . 0.0 109.788 -172.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.8 -0.28 87.86 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.858 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.49 142.86 29.65 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 116.968 0.384 . . . . 0.0 112.478 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.66 -168.76 39.0 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.1 tt -99.73 130.3 45.93 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.348 0.659 . . . . 0.0 109.631 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.72 149.83 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.742 0.817 . . . . 0.0 109.258 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HB2' HD13 ' A' ' 124' ' ' LEU . 4.3 pm0 -70.17 146.92 50.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.827 0.451 . . . . 0.0 110.498 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.94 135.18 55.37 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.394 0.678 . . . . 0.0 110.868 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.08 6.2 72.06 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.068 -168.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.95 -169.83 27.36 Favored Glycine 0 C--N 1.351 1.415 0 C-N-CA 122.896 0.284 . . . . 0.0 112.851 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 p -129.28 153.26 47.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.635 0.774 . . . . 0.0 110.57 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.5 tp -149.72 125.09 10.2 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -108.38 109.99 21.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.453 0.701 . . . . 0.0 110.216 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -87.55 153.8 21.12 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.209 1.004 . . . . 0.0 109.947 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 m -143.48 130.96 21.07 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.5 0.72 . . . . 0.0 109.407 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 47.8 t -124.78 105.93 9.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.19 0.996 . . . . 0.0 109.45 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.25 123.46 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.139 0.575 . . . . 0.0 109.464 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.44 97.39 11.15 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.026 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.454 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 21.4 t 55.7 33.36 21.19 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.827 1.251 . . . . 0.0 112.341 171.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.45 -88.92 0.61 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.436 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -125.81 -0.63 7.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.736 0.814 . . . . 0.0 111.532 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.8 m -77.3 126.09 30.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -105.32 124.87 50.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.066 0.946 . . . . 0.0 109.345 -170.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.1 mtt85 -165.11 175.55 9.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.116 0.967 . . . . 0.0 110.169 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t 66.25 104.89 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.874 0 O-C-N 125.176 1.547 . . . . 0.0 110.798 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -59.23 -28.98 67.18 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.708 0.803 . . . . 0.0 112.593 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' HB2' ' HG3' ' A' ' 53' ' ' ARG . . . -126.21 149.55 48.96 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.582 0.753 . . . . 0.0 109.592 176.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.0 mtt -144.9 122.38 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -118.18 -173.87 16.2 Favored Glycine 0 C--N 1.34 0.77 0 O-C-N 123.487 0.492 . . . . 0.0 113.222 -172.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -132.87 143.75 49.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.116 0.967 . . . . 0.0 109.26 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.09 172.07 13.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.69 1.596 . . . . 0.0 107.65 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -139.35 123.73 18.16 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.056 0.455 . . . . 0.0 110.367 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.494 ' HB3' HG13 ' A' ' 94' ' ' VAL . 65.0 tp60 -101.58 135.23 43.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.624 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -122.58 137.83 28.43 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.048 0.939 . . . . 0.0 109.229 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -66.26 118.08 5.22 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.72 2.28 . . . . 0.0 111.717 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.73 0.4 59.11 Favored Glycine 0 N--CA 1.474 1.184 0 O-C-N 123.044 0.215 . . . . 0.0 112.656 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 5.5 mmpt? -135.61 172.89 12.36 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.155 . . . . 0.0 110.141 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.17 156.92 16.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.053 0.941 . . . . 0.0 109.922 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.23 125.92 28.16 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.456 0.646 . . . . 0.0 110.803 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -93.38 138.29 31.86 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.618 1.167 . . . . 0.0 109.29 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -69.18 115.24 8.24 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.742 0.652 . . . . 0.0 109.781 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.9 t -94.32 -53.1 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.409 0.683 . . . . 0.0 110.03 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -156.1 169.6 24.12 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -168.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.426 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -158.99 132.29 7.24 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 124.32 1.048 . . . . 0.0 110.306 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -116.34 116.16 51.38 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HG3' ' HB2' ' A' ' 34' ' ' ALA . 28.7 ttt-85 -117.47 144.71 44.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -65.21 -13.66 58.79 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.624 0.769 . . . . 0.0 111.509 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 m -74.56 -2.61 26.66 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.7 0.8 . . . . 0.0 112.151 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.09 -16.89 32.49 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.694 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.26 72.54 1.65 Allowed Glycine 0 C--N 1.351 1.4 0 C-N-CA 122.885 0.278 . . . . 0.0 112.465 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 49.9 m -106.4 29.72 6.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.314 1.046 . . . . 0.0 111.97 -169.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.9 m -158.53 121.93 3.87 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.605 0.362 . . . . 0.0 111.274 -170.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.478 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 68.4 m-85 -156.52 135.53 11.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.876 1.67 . . . . 0.0 107.66 171.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -165.4 164.55 19.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.227 1.011 . . . . 0.0 110.263 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.16 160.89 30.58 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.705 0.402 . . . . 0.0 111.092 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.61 -36.05 81.66 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.425 0.69 . . . . 0.0 111.76 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.2 p -69.15 -36.09 77.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.294 0.638 . . . . 0.0 111.622 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.401 HG12 HH21 ' A' ' 68' ' ' ARG . 20.3 m -97.74 15.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.5 0.72 . . . . 0.0 111.634 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -59.15 114.23 2.51 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.325 1.05 . . . . 0.0 112.009 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.81 -19.75 35.85 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.588 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.401 HH21 HG12 ' A' ' 65' ' ' VAL . 15.1 mtm180 -80.84 -48.52 12.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -85.21 123.5 30.78 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.131 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.0 m -130.55 134.48 47.06 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.579 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -129.37 143.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 110.609 -176.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -150.05 169.5 21.08 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.279 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' HB3' HG21 ' A' ' 52' ' ' ILE . 77.0 ttt180 -147.76 131.44 16.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -122.47 106.14 10.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.293 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -72.51 -11.57 60.72 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.728 0.811 . . . . 0.0 110.844 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.18 79.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.419 1.087 . . . . 0.0 111.878 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.02 7.97 12.39 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.924 0.489 . . . . 0.0 111.406 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 53.59 67.28 1.03 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.448 1.099 . . . . 0.0 110.807 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -148.74 132.73 17.17 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.24 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 73' ' ' ARG . 21.5 t -103.68 136.13 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.518 1.127 . . . . 0.0 108.072 176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -118.41 146.11 44.69 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.977 0.418 . . . . 0.0 111.34 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 61.7 tp -127.86 98.61 5.22 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.691 1.197 . . . . 0.0 108.081 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -93.21 100.14 12.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 109.187 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.436 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 56.7 mtm -104.25 103.24 12.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.896 0.478 . . . . 0.0 110.082 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -102.54 153.35 20.17 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.637 0.775 . . . . 0.0 109.581 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.5 t 58.13 48.96 12.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.172 0.989 . . . . 0.0 110.698 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 84' ' ' MET . 29.3 mt -68.99 133.49 48.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.114 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . 37.7 mtmt -92.06 157.24 41.35 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.104 0.962 . . . . 0.0 109.059 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.06 -23.77 78.07 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.11 1.873 . . . . 0.0 112.608 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.92 -11.4 60.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.276 1.03 . . . . 0.0 112.385 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -84.67 33.28 0.52 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.634 0.773 . . . . 0.0 110.656 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 97.7 m -88.1 98.19 11.4 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.59 -166.66 1.39 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.649 0.78 . . . . 0.0 109.322 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.8 p -117.05 109.52 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.66 131.39 35.21 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.25 143.06 47.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.117 0.567 . . . . 0.0 110.529 -173.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -89.04 158.16 18.09 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.781 0.833 . . . . 0.0 109.75 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -130.02 152.48 49.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.968 0.907 . . . . 0.0 109.255 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -118.36 120.59 38.06 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 110' ' ' PRO . . . -116.65 147.0 18.92 Favored Glycine 0 C--O 1.244 0.744 0 O-C-N 123.645 0.591 . . . . 0.0 111.918 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.0 m -136.99 140.16 43.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 124.749 1.219 . . . . 0.0 109.01 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -63.18 117.55 6.7 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.506 ' HD3' ' H ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -102.17 153.29 20.09 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.044 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.506 ' H ' ' HD3' ' A' ' 103' ' ' ARG . 54.6 p -65.99 -13.16 59.36 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.991 0.916 . . . . 0.0 111.984 174.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.7 m -67.19 -24.45 65.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.75 0.82 . . . . 0.0 111.075 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.07 -30.2 8.54 Favored Glycine 0 N--CA 1.471 1.025 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.515 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 22.7 m-90 -83.81 146.4 28.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.082 0.553 . . . . 0.0 109.877 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.44 92.34 7.55 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 35.7 p -77.25 121.08 84.0 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.116 -170.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.438 ' HA ' ' HA2' ' A' ' 100' ' ' GLY . 1.9 Cg_endo -77.35 72.71 5.85 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.033 2.489 . . . . 0.0 109.301 175.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.35 -35.74 80.06 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.866 0.867 . . . . 0.0 111.661 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.557 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 80.8 m-85 -111.73 152.82 27.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.458 0.703 . . . . 0.0 110.131 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.0 m-90 -134.13 160.05 38.97 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.342 1.057 . . . . 0.0 108.692 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.28 -151.97 6.6 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.877 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.46 6.72 28.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.235 0.614 . . . . 0.0 110.651 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.35 163.48 28.68 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 113.129 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.8 t -140.59 115.64 9.79 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -68.7 122.79 19.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.58 0.752 . . . . 0.0 111.011 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.93 136.16 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.9 m -134.04 103.58 5.86 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 87' ' ' LEU . 25.5 t -87.95 101.16 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.6 p -56.9 141.41 45.15 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.425 0.69 . . . . 0.0 111.413 171.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.3 p -85.11 59.27 5.53 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.459 0.704 . . . . 0.0 110.65 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' A' ' 14' ' ' GLN . 3.2 mm? 58.59 34.82 24.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.316 1.046 . . . . 0.0 110.957 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -76.67 -87.52 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.154 0.582 . . . . 0.0 111.769 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -139.31 26.91 2.35 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.975 0.51 . . . . 0.0 111.368 -171.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -75.87 97.99 4.08 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -56.89 109.88 0.71 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.04 0.838 . . . . 0.0 111.195 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -82.92 168.89 16.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.777 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -141.48 140.26 33.5 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.534 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 175.077 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.6 mtp . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 121.168 0.509 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -107.78 125.22 51.15 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 113.69 15.24 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -103.95 142.44 34.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.182 0.993 . . . . 0.0 109.924 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.617 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 82.6 mt -132.36 129.08 38.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.231 1.013 . . . . 0.0 109.336 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.481 ' HA ' HE21 ' A' ' 115' ' ' GLN . 68.0 t -119.5 102.39 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.195 0.598 . . . . 0.0 109.689 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.66 151.31 25.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.42 0.688 . . . . 0.0 110.669 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 p -155.19 146.45 22.82 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.241 1.016 . . . . 0.0 109.308 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.01 0.59 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 123.709 0.671 . . . . 0.0 111.504 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.39 121.79 7.29 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 119.941 -0.366 . . . . 0.0 112.387 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.02 -178.24 48.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 122' ' ' SER . 19.3 tp -94.21 128.26 40.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.93 166.34 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.992 . . . . 0.0 108.949 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -85.84 151.94 23.4 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.918 0.487 . . . . 0.0 111.206 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.48 113.05 2.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.902 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.22 0.02 28.22 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 -175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -178.43 46.37 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 113.805 0.282 . . . . 0.0 113.805 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.1 m -108.68 159.99 16.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.495 1.118 . . . . 0.0 109.233 172.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.3 tp -160.69 116.84 2.3 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -99.49 109.18 21.75 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 117' ' ' THR . 3.1 mm? -86.91 140.71 29.35 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 p -140.37 125.45 18.53 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.795 0.838 . . . . 0.0 109.336 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 40.9 t -124.54 115.47 20.9 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.053 0.941 . . . . 0.0 109.421 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.07 129.56 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.05 103.23 15.92 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.167 0.987 . . . . 0.0 110.53 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 p 51.8 53.24 12.97 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.098 1.759 . . . . 0.0 112.93 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.86 -74.3 1.83 Allowed Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.893 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -165.61 39.01 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 122.27 1.033 . . . . 0.0 108.471 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.0 m -103.95 147.52 27.25 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.297 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -105.84 121.41 44.0 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -167.31 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.609 0.764 . . . . 0.0 110.291 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 m -65.98 95.61 0.28 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.391 0.676 . . . . 0.0 109.756 174.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -83.52 -35.08 25.1 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.297 0.639 . . . . 0.0 110.212 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.67 121.68 31.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.7 0.8 . . . . 0.0 109.219 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.431 ' HG2' HG21 ' A' ' 80' ' ' VAL . 2.9 mpp? -123.75 163.18 21.67 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.397 1.479 . . . . 0.0 108.682 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -157.57 135.92 4.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -94.56 121.8 36.48 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.5 160.96 24.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -139.67 133.47 30.64 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -98.23 128.74 44.85 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -94.33 141.56 23.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 122.765 0.426 . . . . 0.0 110.219 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.42 101.73 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.651 2.234 . . . . 0.0 111.462 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.95 2.74 60.89 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.863 -0.608 . . . . 0.0 113.93 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 7.5 mmpt? -139.51 152.49 46.98 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.708 0.803 . . . . 0.0 110.276 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.19 163.27 10.51 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.418 1.087 . . . . 0.0 111.531 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.58 149.74 43.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.205 0.526 . . . . 0.0 111.373 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -120.18 134.44 55.26 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.184 0.994 . . . . 0.0 109.501 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -72.31 111.14 7.25 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.291 1.036 . . . . 0.0 109.055 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.6 t -88.57 -53.67 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.467 0.707 . . . . 0.0 110.002 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.88 165.23 37.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.677 -173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.419 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -150.4 127.61 11.29 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 124.096 0.959 . . . . 0.0 109.823 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.9 mp -110.22 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.31 127.81 53.55 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 172.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -72.82 82.46 1.18 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 t -162.77 21.14 0.09 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.34 1.056 . . . . 0.0 109.817 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.88 32.34 33.04 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.649 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.87 -91.56 0.78 Allowed Glycine 0 C--N 1.355 1.604 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 68.4 m 63.16 35.21 12.94 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.684 1.194 . . . . 0.0 113.999 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -157.91 122.02 4.16 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.3 0.64 . . . . 0.0 110.16 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -152.83 122.87 7.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.07 1.348 . . . . 0.0 108.194 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -164.73 161.75 20.8 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.656 1.182 . . . . 0.0 109.126 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -81.53 151.74 27.61 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.21 -28.9 69.1 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.075 0.464 . . . . 0.0 110.75 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 p -66.85 -25.62 66.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.246 1.018 . . . . 0.0 111.887 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.518 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 22.9 m -114.45 13.78 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.332 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 122.67 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.36 0.664 . . . . 0.0 110.476 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.17 -27.32 9.39 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.757 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.518 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 24.3 mtp180 -78.45 -52.67 8.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.78 1.232 . . . . 0.0 108.762 175.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -104.02 121.97 44.28 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.984 1.314 . . . . 0.0 107.787 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 p -135.72 151.39 50.11 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.442 1.097 . . . . 0.0 108.916 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.94 148.5 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.714 0.806 . . . . 0.0 110.206 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.8 m -153.03 172.2 17.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.13 0.972 . . . . 0.0 109.354 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -148.3 139.72 23.51 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.12 100.13 6.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.852 1.261 . . . . 0.0 108.585 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -71.1 -13.22 61.89 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.753 0.821 . . . . 0.0 111.167 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.35 64.56 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.409 1.084 . . . . 0.0 111.744 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -121.26 1.33 10.23 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.704 0.802 . . . . 0.0 111.513 173.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m120 60.75 68.94 0.71 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.649 1.18 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -142.26 133.33 25.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.642 0.777 . . . . 0.0 109.769 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.431 HG21 ' HG2' ' A' ' 35' ' ' MET . 23.2 t -101.18 133.65 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.352 1.061 . . . . 0.0 108.327 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.78 148.41 34.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.52 0.728 . . . . 0.0 111.659 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 47.8 tp -132.91 99.57 4.63 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -84.19 99.5 10.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.744 ' HB3' HD21 ' A' ' 87' ' ' LEU . 74.1 mtp -87.56 136.41 32.96 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -154.86 160.59 41.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.767 0.827 . . . . 0.0 108.81 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.2 t 58.46 48.25 12.42 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.517 1.135 . . . . 0.0 109.016 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 84' ' ' MET . 70.4 mt -72.3 138.76 47.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.726 -166.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.494 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 14.1 mmmm -92.4 153.06 42.76 Favored Pre-proline 0 C--N 1.321 -0.65 0 C-N-CA 124.077 0.951 . . . . 0.0 108.904 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.494 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 19.5 Cg_endo -59.92 -20.79 61.67 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.644 2.229 . . . . 0.0 113.054 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -80.78 1.78 29.02 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.859 0.864 . . . . 0.0 112.151 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -87.98 24.95 1.66 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.631 0.772 . . . . 0.0 110.318 166.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 120' ' ' THR . 52.0 m -81.6 105.59 12.88 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 161.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.68 177.64 6.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.952 0.901 . . . . 0.0 110.494 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.425 ' HB ' ' NE2' ' A' ' 118' ' ' GLN . 3.1 p -110.08 107.05 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -83.89 115.22 22.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.372 0.669 . . . . 0.0 109.207 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.14 143.79 36.42 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -91.62 144.6 25.37 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 170.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -133.05 157.69 44.63 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.386 0.675 . . . . 0.0 109.445 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.55 12.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.529 0.731 . . . . 0.0 109.731 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.85 -151.13 5.43 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.0 p -153.94 146.85 14.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 C-N-CA 123.388 0.675 . . . . 0.0 110.044 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.476 ' HE3' ' HB2' ' A' ' 108' ' ' ASP . 42.7 t-105 -68.21 107.27 2.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -76.39 169.31 18.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.109 0.564 . . . . 0.0 111.922 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.5 m -65.77 -26.36 67.68 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.679 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.7 p -69.99 -15.17 62.99 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.056 0.942 . . . . 0.0 111.53 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.36 2.67 67.85 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.801 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -95.24 110.99 22.9 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.334 0.654 . . . . 0.0 110.183 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.476 ' HB2' ' HE3' ' A' ' 102' ' ' TRP . 27.6 t70 -79.43 105.6 10.86 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 168.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.4 p -136.67 139.03 28.02 Favored Pre-proline 0 C--O 1.244 0.775 0 C-N-CA 123.614 0.766 . . . . 0.0 110.064 -171.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.477 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 58.3 Cg_endo -69.72 128.78 16.55 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.802 2.335 . . . . 0.0 112.779 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.25 -34.26 14.33 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.034 0.934 . . . . 0.0 109.757 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -117.85 152.41 35.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.461 1.104 . . . . 0.0 109.339 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.09 157.35 47.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.22 1.008 . . . . 0.0 108.817 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.7 -147.73 15.39 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.829 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.481 HE21 ' HA ' ' A' ' 6' ' ' VAL . 48.1 mt-30 -94.05 -34.42 13.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.616 0.766 . . . . 0.0 111.541 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.22 116.04 1.27 Allowed Glycine 0 C--N 1.345 1.04 0 N-CA-C 111.879 -0.489 . . . . 0.0 111.879 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.525 HG21 HD12 ' A' ' 21' ' ' LEU . 7.0 t -99.79 118.39 36.16 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.632 0.773 . . . . 0.0 110.402 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.425 ' NE2' ' HB ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -74.16 106.43 5.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.008 0.923 . . . . 0.0 110.514 178.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.91 139.89 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.419 HG23 HG23 ' A' ' 92' ' ' THR . 43.5 m -135.25 118.58 16.72 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.9 t -96.0 103.4 14.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.571 ' HB2' HD11 ' A' ' 12' ' ' LEU . 40.5 t -66.37 140.8 58.1 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 123.293 0.371 . . . . 0.0 110.684 172.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -70.63 101.26 2.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 109.799 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 79.35 -51.87 0.42 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.785 1.634 . . . . 0.0 111.295 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -75.3 171.05 14.89 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.997 0.919 . . . . 0.0 111.808 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -168.16 42.38 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.223 1.409 . . . . 0.0 107.974 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -62.71 -44.89 95.06 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.448 -172.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -84.33 141.18 31.09 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 162.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -163.23 144.26 9.43 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.94 0.896 . . . . 0.0 108.855 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 58.48 41.85 22.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -167.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.556 1.185 0 C-N-CA 125.184 1.394 . . . . 0.0 109.834 -169.087 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 ttm . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -128.34 149.31 50.57 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.836 0.854 . . . . 0.0 109.121 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -75.59 109.94 9.58 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -102.96 143.42 32.56 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.68 1.192 . . . . 0.0 109.337 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.681 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 97.8 mt -130.46 113.98 14.96 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.097 0.959 . . . . 0.0 109.069 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.46 104.72 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' HG2' ' HB ' ' A' ' 117' ' ' THR . 78.2 tt0 -104.69 135.65 45.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.304 -166.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 p -163.2 -177.37 5.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.101 0.96 . . . . 0.0 110.264 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.0 5.74 57.25 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 112.547 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.38 148.23 21.97 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.714 0.257 . . . . 0.0 112.719 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.91 -174.04 45.44 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.7 tt -93.29 129.57 39.32 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.45 157.25 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.956 0.903 . . . . 0.0 108.787 170.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.619 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -81.33 149.59 28.85 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.09 0.556 . . . . 0.0 110.286 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.62 123.57 19.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.678 1.191 . . . . 0.0 111.47 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.35 -25.94 11.77 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -172.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.34 -166.77 32.65 Favored Glycine 0 C--N 1.35 1.321 0 C-N-CA 123.194 0.426 . . . . 0.0 114.13 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.3 p -134.97 160.32 38.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.065 0.946 . . . . 0.0 110.438 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -154.29 131.29 10.95 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.63 0.772 . . . . 0.0 109.208 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -102.49 127.11 49.68 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.106 0.562 . . . . 0.0 110.531 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.7 mm? -98.65 157.56 16.18 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.462 1.105 . . . . 0.0 109.207 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.8 p -148.83 126.88 11.99 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.47 0.708 . . . . 0.0 109.405 -175.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.2 t -128.05 106.13 8.86 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.81 0.844 . . . . 0.0 109.1 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.42 120.71 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.507 0.723 . . . . 0.0 109.301 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.08 100.76 13.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.937 0.495 . . . . 0.0 110.87 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.639 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 10.9 m 54.67 37.04 27.51 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.267 1.427 . . . . 0.0 112.183 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.66 -68.31 3.29 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.849 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 52.6 ttp180 -164.91 63.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 173.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 85.0 m -138.53 146.3 41.75 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.204 -176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -129.48 141.89 50.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 109.039 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 mtt85 -156.01 -50.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.926 0.89 . . . . 0.0 109.846 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -73.77 119.54 18.13 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.84 0.352 . . . . 0.0 110.101 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -78.63 -3.0 41.75 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.534 0.734 . . . . 0.0 111.028 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.98 41.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.383 0.673 . . . . 0.0 109.272 171.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 68.3 mtt -143.53 121.1 11.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.62 174.15 22.76 Favored Glycine 0 C--N 1.335 0.526 0 O-C-N 123.072 0.233 . . . . 0.0 113.341 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.505 ' HE1' HG12 ' A' ' 80' ' ' VAL . 85.7 m95 -110.98 133.68 53.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.857 0.863 . . . . 0.0 109.68 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -119.53 171.89 8.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.274 1.43 . . . . 0.0 107.486 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 40.1 ptt180 -143.42 127.76 17.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.044 0.449 . . . . 0.0 110.465 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -109.63 129.79 55.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -103.17 157.95 32.76 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.762 -0.637 . . . . 0.0 109.893 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.8 96.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 122.777 2.318 . . . . 0.0 113.326 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.69 -11.5 52.23 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.092 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 8.8 mmpt? -103.12 137.87 40.71 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.518 0.727 . . . . 0.0 109.496 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.25 149.92 23.04 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 146.27 22.09 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.38 1.072 . . . . 0.0 112.291 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -136.2 133.22 36.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.197 0.999 . . . . 0.0 109.892 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -67.46 115.55 7.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.952 0.901 . . . . 0.0 110.781 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.54 -55.19 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.404 0.681 . . . . 0.0 109.417 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB3' HG21 ' A' ' 71' ' ' ILE . . . -167.42 173.91 8.39 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.097 -170.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.53 158.95 27.24 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 122.267 1.032 . . . . 0.0 112.467 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 4.0 mp -117.7 116.48 51.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 113.472 -1.694 . . . . 0.0 106.968 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.413 ' HG2' ' HE2' ' A' ' 60' ' ' TYR . 29.2 mmt180 -93.97 88.59 5.76 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 23.9 t90 63.95 -82.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.673 1.189 . . . . 0.0 110.478 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.2 p -165.29 166.29 18.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.286 1.034 . . . . 0.0 109.954 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.92 29.36 61.02 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.11 0.256 . . . . 0.0 113.599 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.04 -80.33 0.04 OUTLIER Glycine 0 C--N 1.348 1.197 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 22.8 t 60.2 40.74 17.72 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.386 1.074 . . . . 0.0 111.91 169.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.6 ' HA ' HD11 ' A' ' 71' ' ' ILE . 3.8 p -158.01 123.89 4.63 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.917 0.487 . . . . 0.0 111.034 -170.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HE2' ' HG2' ' A' ' 53' ' ' ARG . 69.6 m-85 -150.25 113.16 4.8 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 166.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.07 143.27 7.71 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.683 0.393 . . . . 0.0 110.71 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.28 159.0 31.0 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 168.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 31.2 t70 -60.9 -28.19 68.72 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.062 0.545 . . . . 0.0 111.147 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.7 m -65.98 -33.57 76.11 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.927 0.891 . . . . 0.0 112.087 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -109.22 -5.64 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.291 0.636 . . . . 0.0 111.877 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 63' ' ' ASP . 25.5 ttpp -72.54 133.53 44.8 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.126 0.57 . . . . 0.0 109.909 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.61 -29.46 7.28 Favored Glycine 0 C--N 1.342 0.905 0 O-C-N 123.423 0.452 . . . . 0.0 112.053 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 69.7 mtp180 -80.64 -66.71 0.85 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -92.01 120.67 32.86 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.789 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 m -125.16 127.48 46.89 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.295 1.038 . . . . 0.0 108.213 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.6 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -125.07 140.97 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.122 0.569 . . . . 0.0 110.489 -174.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.444 ' HA ' ' OG ' ' A' ' 58' ' ' SER . 45.0 t -162.99 157.86 21.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.599 176.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -133.97 124.87 27.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.575 0.75 . . . . 0.0 109.364 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -103.37 122.02 43.98 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -76.8 -12.29 59.95 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.0 -48.78 67.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.618 1.167 . . . . 0.0 111.811 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.39 -0.06 11.0 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.13 175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 19.8 m120 53.37 68.12 0.89 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.396 1.079 . . . . 0.0 110.781 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 65.1 m -137.22 133.79 35.51 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.484 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.505 HG12 ' HE1' ' A' ' 37' ' ' TRP . 6.7 t -102.02 126.09 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -106.3 143.08 34.94 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.0 0.52 . . . . 0.0 110.82 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.6 tp -121.66 97.78 5.66 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 167.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -83.78 99.8 10.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.701 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.0 mtm -86.8 138.84 31.26 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -142.44 163.11 33.74 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.905 0.882 . . . . 0.0 109.068 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 26.9 t 54.3 42.24 31.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.014 0.926 . . . . 0.0 109.584 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.701 HD21 ' HB3' ' A' ' 84' ' ' MET . 51.6 mt -69.05 126.26 29.24 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.921 -171.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 1.1 mmmp? -87.83 149.99 47.05 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.661 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.61 -17.51 54.72 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.541 2.161 . . . . 0.0 113.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.8 pt-20 -69.46 -16.81 63.54 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.378 1.071 . . . . 0.0 112.029 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -84.43 32.09 0.51 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.962 0.905 . . . . 0.0 111.424 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.1 m -86.51 95.71 9.81 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -158.75 -174.25 4.67 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.422 0.689 . . . . 0.0 110.318 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -117.57 108.29 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 9.1 m-85 -82.28 137.02 34.94 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.416 HD13 ' HD1' ' A' ' 113' ' ' TRP . 4.1 pp -126.62 128.59 47.02 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.6 t -90.06 119.5 30.45 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.75 159.12 19.27 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.594 0.758 . . . . 0.0 109.821 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -130.97 169.07 16.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.052 0.941 . . . . 0.0 108.94 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -174.72 -178.76 44.85 Favored Glycine 0 CA--C 1.505 -0.559 0 C-N-CA 121.737 -0.268 . . . . 0.0 112.644 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.47 133.49 50.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -67.9 123.22 19.97 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -92.94 154.28 18.27 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.46 0.704 . . . . 0.0 110.788 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.0 p -69.41 -16.17 63.44 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.454 0.702 . . . . 0.0 111.754 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.2 p -67.91 -25.48 65.51 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.725 0.81 . . . . 0.0 110.919 170.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.53 -23.76 32.39 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 -173.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 35.6 t-105 -78.55 109.84 13.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.492 1.117 . . . . 0.0 108.427 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -86.49 147.67 25.87 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.021 0.529 . . . . 0.0 110.341 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 39.6 p -132.9 144.05 51.21 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.287 0.635 . . . . 0.0 110.155 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.87 91.81 0.62 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.073 1.849 . . . . 0.0 110.232 169.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -84.31 -16.09 44.25 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.482 0.713 . . . . 0.0 111.236 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 72.7 m-85 -134.26 154.09 51.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 107.92 177.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.416 ' HD1' HD13 ' A' ' 96' ' ' LEU . 29.6 m-90 -135.48 155.9 49.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.528 0.731 . . . . 0.0 109.428 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -78.54 -103.53 0.2 Allowed Glycine 0 C--N 1.345 1.039 0 O-C-N 123.437 0.46 . . . . 0.0 112.305 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -154.02 -14.82 0.13 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.218 0.607 . . . . 0.0 111.74 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.32 110.84 1.45 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.508 ' HB ' ' HG2' ' A' ' 7' ' ' GLU . 12.6 t -96.33 123.71 40.06 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.467 0.651 . . . . 0.0 109.696 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.18 116.49 21.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.297 0.639 . . . . 0.0 110.836 -177.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.82 141.96 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.744 0.818 . . . . 0.0 108.968 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.4 m -134.38 105.2 6.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.86 97.78 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.2 t -73.61 147.66 43.6 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.428 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -75.68 77.27 2.65 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.509 0.724 . . . . 0.0 110.214 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 0.4 OUTLIER 75.58 -30.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.445 1.498 . . . . 0.0 112.338 178.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.38 109.21 2.21 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.323 1.049 . . . . 0.0 111.376 -171.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -83.99 171.93 12.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.45 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -65.95 87.71 0.1 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.077 0.941 . . . . 0.0 111.087 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -96.95 1.38 50.3 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.888 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -110.96 121.05 44.37 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 124.983 1.313 . . . . 0.0 108.568 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -74.86 152.34 38.92 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 123.387 0.43 . . . . 0.0 110.185 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 . . . . . 0 CA--C 1.563 1.443 0 C-N-CA 123.242 0.617 . . . . 0.0 110.01 175.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 62.32 -168.25 0.19 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.422 1.089 . . . . 0.0 111.643 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 3' ' ' LEU . 4.0 mm? -92.62 116.07 28.68 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 174.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 40.5 mt-30 -105.61 114.29 28.37 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 56.5 mt -105.08 118.29 36.17 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.82 102.81 14.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 23' ' ' CYS . 1.7 mp0 -84.66 150.03 25.42 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.049 0.94 . . . . 0.0 108.964 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 p -159.69 168.11 26.76 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.736 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.8 -5.46 61.9 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.95 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.83 146.83 45.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.679 0.24 . . . . 0.0 112.875 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.61 -176.73 47.4 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.6 tt -88.91 114.39 25.48 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 122.841 0.456 . . . . 0.0 110.148 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.76 163.31 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 165.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HB2' HD13 ' A' ' 124' ' ' LEU . 5.4 pm0 -84.59 160.44 20.44 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -65.63 113.6 4.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.549 0.74 . . . . 0.0 109.618 174.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.01 -1.72 27.08 Favored Glycine 0 C--N 1.34 0.755 0 O-C-N 123.818 0.699 . . . . 0.0 111.737 -171.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.36 -166.18 41.69 Favored Glycine 0 C--N 1.344 1.006 0 C-N-CA 123.041 0.353 . . . . 0.0 113.044 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.4 p -144.1 138.01 27.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.644 0.778 . . . . 0.0 109.687 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.7 tp -140.58 128.06 21.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.535 0.734 . . . . 0.0 109.69 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -103.04 139.82 38.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.225 0.61 . . . . 0.0 110.07 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -113.98 158.61 20.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.374 1.07 . . . . 0.0 109.419 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.8 m -146.7 127.54 14.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.626 ' SG ' ' HB ' ' A' ' 80' ' ' VAL . 27.1 p -124.8 115.72 21.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.248 0.619 . . . . 0.0 109.569 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.09 135.48 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -101.67 100.83 11.26 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.098 0.959 . . . . 0.0 109.992 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.598 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 20.2 m 64.32 33.02 11.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.684 1.594 . . . . 0.0 111.769 169.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.97 58.16 16.06 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.663 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HA ' ' HB2' ' A' ' 78' ' ' ASN . 55.5 ttp180 62.67 68.63 0.64 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.277 1.031 . . . . 0.0 110.782 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 24.1 m -140.25 143.75 36.13 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.672 0.789 . . . . 0.0 109.133 173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -105.45 120.82 42.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -145.9 -51.84 0.24 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.582 1.153 . . . . 0.0 108.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -83.53 163.72 20.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.639 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -146.95 9.35 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.509 1.124 . . . . 0.0 109.576 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.7 117.82 8.34 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.4 ttm -151.56 118.52 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -170.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -113.92 142.91 17.76 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.54 -173.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -88.41 135.57 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 92.7 m-85 -134.81 145.94 48.83 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.304 1.042 . . . . 0.0 109.063 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 12.9 ptp180 -104.14 145.24 30.48 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 171.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -151.02 129.08 11.79 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.92 0.782 . . . . 0.0 110.51 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.506 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -100.72 161.17 24.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.8 114.78 2.15 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.429 2.086 . . . . 0.0 111.598 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.288 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 9.3 mmpt? -128.02 153.93 46.21 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.285 1.034 . . . . 0.0 109.243 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.86 151.44 30.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.994 0.518 . . . . 0.0 110.664 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.07 113.42 13.57 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.647 0.592 . . . . 0.0 110.321 177.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -93.47 139.0 31.21 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 124.16 0.984 . . . . 0.0 110.104 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -64.94 110.24 2.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.23 1.412 . . . . 0.0 110.736 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.7 t -95.05 -48.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.318 0.647 . . . . 0.0 109.637 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.86 19.3 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.527 0.731 . . . . 0.0 110.815 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.475 ' H ' ' HB2' ' A' ' 60' ' ' TYR . . . -155.69 130.43 9.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 0.0 110.564 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.04 111.47 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -119.77 126.09 50.19 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.551 ' HA ' ' NH1' ' A' ' 73' ' ' ARG . 18.1 t90 -52.31 -55.13 23.45 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.332 1.02 . . . . 0.0 111.458 -165.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.0 p -112.91 118.35 34.63 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.891 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.42 23.42 7.27 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-O 119.676 -0.513 . . . . 0.0 114.125 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.22 -80.81 0.09 OUTLIER Glycine 0 C--N 1.348 1.208 0 CA-C-N 117.398 0.599 . . . . 0.0 112.598 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.9 m 63.48 9.87 4.48 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.013 1.325 . . . . 0.0 113.144 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.5 p -165.73 149.73 8.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.984 1.314 . . . . 0.0 108.756 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.475 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -154.47 118.23 4.64 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -159.7 140.35 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.812 0.845 . . . . 0.0 110.196 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.94 167.9 12.82 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.68 0.792 . . . . 0.0 109.459 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.03 -31.41 72.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.859 0.464 . . . . 0.0 110.869 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.5 p -64.01 -27.1 68.89 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.607 1.163 . . . . 0.0 112.539 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.94 5.62 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.409 0.684 . . . . 0.0 111.516 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -67.42 113.76 5.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.899 0.879 . . . . 0.0 109.785 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.81 -27.72 17.71 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.238 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -79.08 -70.88 0.47 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.959 0.904 . . . . 0.0 109.631 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -90.49 120.87 31.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.9 m -135.01 138.42 43.95 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.163 0.985 . . . . 0.0 109.188 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -119.2 143.05 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.134 0.974 . . . . 0.0 109.46 178.299 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.7 t -138.45 142.45 39.46 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.487 1.115 . . . . 0.0 108.136 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.551 ' NH1' ' HA ' ' A' ' 54' ' ' TRP . 42.4 ttp180 -115.91 123.48 48.19 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.84 129.59 49.56 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -86.85 -35.93 18.76 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.907 0.883 . . . . 0.0 110.178 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.13 78.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.425 1.09 . . . . 0.0 112.749 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -118.05 14.79 14.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.413 0.285 . . . . 0.0 111.233 175.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 18.5 m120 51.71 59.0 4.87 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.598 1.159 . . . . 0.0 111.488 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -126.67 129.27 48.13 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.63 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.626 ' HB ' ' SG ' ' A' ' 23' ' ' CYS . 47.7 t -103.14 125.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -101.95 150.58 23.06 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.668 0.787 . . . . 0.0 110.39 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.2 tp -133.0 99.18 4.5 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.964 0.905 . . . . 0.0 108.814 172.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -86.58 102.17 13.9 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.557 ' HB3' HD21 ' A' ' 87' ' ' LEU . 47.8 mtm -95.08 119.22 33.21 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.591 0.756 . . . . 0.0 109.182 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -116.21 151.38 35.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.743 0.817 . . . . 0.0 108.953 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 t 59.96 69.07 0.73 Allowed 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.291 0.994 . . . . 0.0 110.02 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 84' ' ' MET . 62.4 mt -88.16 155.82 19.57 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.384 -176.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HE2' ' HD2' ' A' ' 89' ' ' PRO . 11.0 mmmm -116.65 155.66 48.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.709 1.204 . . . . 0.0 109.677 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.441 ' HD2' ' HE2' ' A' ' 88' ' ' LYS . 30.5 Cg_endo -61.08 -22.58 75.13 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.631 2.221 . . . . 0.0 112.919 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.27 -21.68 65.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.118 0.967 . . . . 0.0 112.07 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.66 17.43 0.7 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.999 0.92 . . . . 0.0 111.766 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.0 m -80.36 94.12 6.09 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 164.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.84 -178.82 6.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.875 0.87 . . . . 0.0 110.149 -173.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.4 p -100.09 114.95 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -85.83 109.96 19.05 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -115.15 145.81 42.0 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.493 0.717 . . . . 0.0 110.175 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 79.3 m -92.13 157.93 16.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -141.69 115.76 9.32 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.67 132.06 55.35 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.426 0.691 . . . . 0.0 110.618 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.97 -153.43 7.21 Favored Glycine 0 C--O 1.241 0.581 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.0 m -138.91 150.46 23.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 123.318 0.647 . . . . 0.0 110.088 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 108' ' ' ASP . 30.4 p-90 -74.11 80.95 1.75 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 164.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.454 ' HE ' ' HB2' ' A' ' 107' ' ' TRP . 28.3 ptt180 -65.42 165.13 12.49 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.167 -171.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.8 m -63.17 -17.21 62.14 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.218 1.007 . . . . 0.0 112.478 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.0 t -64.82 -24.9 67.69 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.06 0.944 . . . . 0.0 111.58 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.32 -18.56 23.11 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.144 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.454 ' HB2' ' HE ' ' A' ' 103' ' ' ARG . 74.8 m95 -85.16 132.56 34.28 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.613 0.765 . . . . 0.0 110.581 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 102' ' ' TRP . 25.7 t70 -86.85 95.33 9.83 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 168.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -108.05 114.51 59.72 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.627 0.771 . . . . 0.0 111.264 -171.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.55 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 67.8 Cg_endo -72.26 96.08 0.79 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.521 2.147 . . . . 0.0 109.774 167.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.31 -28.55 63.15 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.35 0.66 . . . . 0.0 111.23 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -119.41 146.61 45.21 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.865 0.866 . . . . 0.0 108.869 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -121.17 159.45 25.83 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.44 178.54 47.59 Favored Glycine 0 C--O 1.24 0.497 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.191 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -20.89 58.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.909 0.483 . . . . 0.0 111.174 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.91 125.03 0.64 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.844 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -99.52 121.16 40.77 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.63 112.25 10.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.055 0.542 . . . . 0.0 110.03 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.8 m -103.09 143.19 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 96.7 m -133.46 102.84 5.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.51 94.23 4.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -53.53 147.66 10.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.944 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.3 m -83.73 55.3 3.18 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.945 0.898 . . . . 0.0 110.207 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 14' ' ' GLN . 3.4 mm? 59.87 20.24 9.17 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.773 1.229 . . . . 0.0 112.136 -174.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -80.42 -64.45 1.19 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.209 0.604 . . . . 0.0 109.453 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.5 t60 71.78 -17.59 0.34 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.107 1.763 . . . . 0.0 113.656 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -71.56 171.6 11.12 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 123.796 0.839 . . . . 0.0 112.429 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -57.31 151.37 16.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.91 0.884 . . . . 0.0 111.732 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -153.7 129.21 9.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.293 1.037 . . . . 0.0 108.854 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -85.04 105.21 15.62 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.414 0.685 . . . . 0.0 109.346 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 . . . . . 0 C--O 1.251 1.174 0 C-N-CA 123.465 0.706 . . . . 0.0 109.179 174.724 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.1 mtp . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -113.69 117.99 33.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.539 0.736 . . . . 0.0 109.016 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.2 111.66 9.59 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -92.59 136.71 32.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.123 0.969 . . . . 0.0 109.437 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.462 HD13 ' SG ' ' A' ' 97' ' ' CYS . 49.1 mt -113.42 127.29 56.06 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 59.5 t -115.48 103.18 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.35 147.88 26.93 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.706 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.2 p -157.91 173.39 16.86 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.602 1.161 . . . . 0.0 109.093 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.67 -17.78 57.86 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.18 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -67.14 124.96 23.84 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 122.784 0.23 . . . . 0.0 112.686 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.86 -167.28 26.25 Favored Glycine 0 C--O 1.245 0.81 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -91.27 119.13 31.07 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.967 0.507 . . . . 0.0 110.258 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 m -124.88 169.75 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.327 1.051 . . . . 0.0 109.082 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -87.51 152.2 22.4 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.15 0.58 . . . . 0.0 111.04 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -66.36 119.06 10.93 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.338 1.055 . . . . 0.0 110.176 175.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.35 -16.14 38.39 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 123.771 0.669 . . . . 0.0 111.612 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.95 178.62 43.75 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.097 0.38 . . . . 0.0 113.825 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.9 p -107.92 162.66 13.81 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.042 0.937 . . . . 0.0 111.54 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.12 126.21 4.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 0.0 108.203 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -106.21 123.35 47.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -89.42 157.39 18.16 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.593 1.157 . . . . 0.0 109.559 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.6 m -139.15 124.42 19.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.727 0.811 . . . . 0.0 108.984 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 25.8 t -116.64 102.87 9.83 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.1 0.96 . . . . 0.0 109.425 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.6 t -91.51 126.54 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.553 0.741 . . . . 0.0 109.168 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.91 100.02 12.86 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 m 55.85 33.33 21.34 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.14 1.376 . . . . 0.0 112.089 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.8 -84.76 1.1 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -141.58 95.86 2.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.611 0.764 . . . . 0.0 109.284 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.5 t -135.26 168.19 19.64 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.195 0.998 . . . . 0.0 108.453 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -140.25 120.37 13.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.389 0.676 . . . . 0.0 109.557 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -171.81 -72.95 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.142 0.977 . . . . 0.0 108.999 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.5 m -84.32 129.24 34.89 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.314 0.646 . . . . 0.0 109.263 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.419 ' HB2' ' HD1' ' A' ' 54' ' ' TRP . 13.6 m120 -121.3 16.14 11.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.838 0.855 . . . . 0.0 109.876 176.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.96 118.4 32.82 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.019 0.928 . . . . 0.0 108.521 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -137.86 121.39 17.25 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.132 0.973 . . . . 0.0 109.104 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -99.27 136.14 12.52 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -86.94 132.11 33.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.588 0.755 . . . . 0.0 109.921 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -132.97 171.71 13.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.044 1.338 . . . . 0.0 108.882 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -149.28 142.03 24.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.471 0.708 . . . . 0.0 109.848 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -133.27 131.95 40.83 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.98 0.512 . . . . 0.0 110.348 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.45 146.18 31.97 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 123.96 0.904 . . . . 0.0 109.101 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -54.9 118.71 5.44 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.957 2.438 . . . . 0.0 113.098 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.82 14.79 71.91 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 113.489 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -128.75 167.79 16.78 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 166.47 22.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.132 0.973 . . . . 0.0 110.037 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 122.92 31.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -93.5 142.13 27.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.9 0.88 . . . . 0.0 109.896 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -65.32 130.6 43.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.824 1.25 . . . . 0.0 110.336 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.38 -54.86 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.917 0.887 . . . . 0.0 108.774 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.46 170.39 20.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.499 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -160.98 128.61 4.27 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-O 121.284 0.564 . . . . 0.0 110.86 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.53 HD11 ' HB ' ' A' ' 71' ' ' ILE . 2.7 mp -110.59 113.49 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.538 ' H ' ' HA ' ' A' ' 58' ' ' SER . 73.2 mtp180 -94.12 175.27 6.77 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.709 0.404 . . . . 0.0 110.666 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.419 ' HD1' ' HB2' ' A' ' 33' ' ' ASN . 65.7 t90 -54.44 -44.34 72.39 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.885 0.741 . . . . 0.0 109.86 174.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.5 p -166.65 -178.96 4.6 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.418 1.087 . . . . 0.0 109.827 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.77 31.54 53.34 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.425 0.453 . . . . 0.0 113.722 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.56 -75.18 0.21 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.538 ' HA ' ' H ' ' A' ' 53' ' ' ARG . 77.5 p 54.92 24.7 6.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.239 1.416 . . . . 0.0 114.094 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.525 HG22 HD11 ' A' ' 71' ' ' ILE . 21.2 p -160.55 123.99 3.45 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.483 1.113 . . . . 0.0 108.986 -172.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 51' ' ' ALA . 59.7 m-85 -147.39 137.17 22.91 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -165.68 157.83 14.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.873 1.269 . . . . 0.0 109.808 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -85.59 149.63 25.21 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.15 -32.35 72.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.781 0.832 . . . . 0.0 111.873 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 m -69.93 -38.0 76.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.165 0.586 . . . . 0.0 111.626 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 62' ' ' ALA . 14.6 m -96.71 -2.16 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.009 0.524 . . . . 0.0 111.593 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -61.69 128.69 37.44 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.65 0.78 . . . . 0.0 109.231 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.66 -26.55 17.65 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.629 0.581 . . . . 0.0 112.602 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -89.77 -54.9 3.85 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -84.73 121.05 27.12 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.351 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 132.39 51.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.539 1.136 . . . . 0.0 108.018 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.6 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -102.48 149.94 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.396 0.678 . . . . 0.0 109.32 178.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 20.2 m -141.91 146.56 35.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.568 0.747 . . . . 0.0 109.471 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.57 132.15 23.85 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.09 103.61 8.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.431 1.092 . . . . 0.0 108.42 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.43 -17.27 63.63 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.192 0.997 . . . . 0.0 111.962 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.97 -46.39 75.07 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.964 0.905 . . . . 0.0 112.397 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -118.53 -0.74 11.32 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.62 0.768 . . . . 0.0 110.665 176.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 55.77 68.81 0.81 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.842 1.257 . . . . 0.0 111.32 -175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.449 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 98.7 m -132.71 131.58 41.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.396 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 125.8 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.418 1.087 . . . . 0.0 109.066 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 71.1 m-85 -106.52 155.57 19.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.56 0.744 . . . . 0.0 110.307 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 50.5 tp -133.92 98.43 4.15 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.47 0.708 . . . . 0.0 109.389 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.41 99.86 10.93 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.208 0.603 . . . . 0.0 109.423 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.76 ' HB3' HD21 ' A' ' 87' ' ' LEU . 75.0 mtp -100.66 101.06 11.86 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.753 0.821 . . . . 0.0 110.474 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.7 144.87 28.27 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.075 0.55 . . . . 0.0 111.082 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.1 t 60.97 72.95 0.5 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.854 1.261 . . . . 0.0 110.523 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' ' 84' ' ' MET . 67.5 mt -88.24 159.63 18.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.95 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -106.84 150.68 40.02 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.179 0.992 . . . . 0.0 108.657 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.98 -16.15 53.25 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.552 2.168 . . . . 0.0 112.958 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.77 -2.63 44.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.032 0.933 . . . . 0.0 112.142 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -90.76 37.38 0.92 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.604 0.762 . . . . 0.0 110.821 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.5 m -91.66 93.13 8.76 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 168.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.33 -177.23 5.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.759 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -104.55 109.83 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.031 0.532 . . . . 0.0 109.901 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.56 129.03 34.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.92 137.47 47.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 109.776 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 29.8 p -92.8 159.31 15.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.225 0.61 . . . . 0.0 109.487 173.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -133.12 145.04 50.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.62 123.69 50.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -118.21 178.55 16.86 Favored Glycine 0 C--O 1.246 0.873 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.632 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.18 160.34 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.041 0.937 . . . . 0.0 110.019 -176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -74.86 85.11 2.21 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -74.48 150.77 39.72 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.445 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.9 m -59.39 -37.14 77.21 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.48 1.112 . . . . 0.0 112.15 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 t -64.18 -25.17 67.96 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.566 0.746 . . . . 0.0 111.635 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.55 -29.72 8.11 Favored Glycine 0 C--N 1.346 1.138 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -69.91 117.99 12.19 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.702 0.801 . . . . 0.0 108.944 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -76.25 139.69 41.25 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.4 p -128.69 125.27 23.0 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 123.505 0.722 . . . . 0.0 110.332 -173.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.587 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 36.2 Cg_exo -62.38 91.04 0.12 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.707 2.272 . . . . 0.0 111.819 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.1 -23.53 59.34 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.51 0.724 . . . . 0.0 110.983 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 79.8 m-85 -133.43 155.34 49.71 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.012 0.925 . . . . 0.0 109.079 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -127.28 158.86 36.08 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -87.97 -170.04 45.73 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.042 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.413 ' NE2' ' HA ' ' A' ' 6' ' ' VAL . 9.8 pt20 -86.64 -21.1 26.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.558 0.743 . . . . 0.0 110.715 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 158.55 32.2 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.559 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.421 HG21 HD12 ' A' ' 21' ' ' LEU . 9.1 t -138.93 118.22 12.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.775 0.83 . . . . 0.0 108.809 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.22 103.48 8.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.486 0.714 . . . . 0.0 110.719 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.447 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -93.23 143.77 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 93.6 m -134.33 102.06 5.22 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.6 t -87.05 97.02 5.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.3 t -68.55 145.99 53.5 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.999 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.1 t -74.07 84.9 1.81 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.239 0.616 . . . . 0.0 110.155 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.9 mm? 70.24 -65.48 0.32 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.47 1.508 . . . . 0.0 112.327 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.45 106.11 2.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.015 0.926 . . . . 0.0 111.477 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -73.29 126.35 29.92 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -149.9 107.29 3.62 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.497 0.319 . . . . 0.0 110.188 -175.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -158.98 79.22 0.77 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.409 1.083 . . . . 0.0 108.677 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -97.61 109.08 21.9 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.949 -174.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -66.16 -36.25 82.62 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.996 0.918 . . . . 0.0 112.307 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.254 1.312 0 C-N-CA 123.598 0.759 . . . . 0.0 108.964 179.365 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HB2' ' OH ' ' A' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -72.04 90.44 1.17 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.988 0.915 . . . . 0.0 109.994 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -94.0 114.62 26.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.707 0.803 . . . . 0.0 109.501 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.04 132.89 35.26 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.777 0.831 . . . . 0.0 110.155 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.5 mt -130.91 124.57 31.42 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.365 1.066 . . . . 0.0 108.579 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -121.32 101.25 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.209 0.604 . . . . 0.0 109.636 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -90.85 132.91 35.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.235 0.614 . . . . 0.0 109.635 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.3 m -144.35 163.77 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.147 0.979 . . . . 0.0 109.512 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.415 ' O ' HD11 ' A' ' 19' ' ' LEU . . . 117.73 -19.93 11.12 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.504 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.12 119.6 19.13 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 123.214 0.435 . . . . 0.0 112.871 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.23 -175.93 29.71 Favored Glycine 0 C--N 1.347 1.161 0 C-N-CA 123.431 0.538 . . . . 0.0 112.104 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 120' ' ' THR . 25.6 tp -89.85 114.46 26.21 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.354 0.662 . . . . 0.0 110.37 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.8 145.97 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 4.8 pm0 -75.22 154.65 37.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.126 0.421 . . . . 0.0 110.568 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . . . -58.14 113.68 2.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.559 0.744 . . . . 0.0 111.36 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.98 -4.41 25.66 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.122 0.867 . . . . 0.0 111.511 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.44 -165.68 39.83 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 123.345 0.498 . . . . 0.0 112.839 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.1 p -141.46 150.47 42.3 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.749 0.82 . . . . 0.0 111.129 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 9' ' ' GLY . 31.2 tp -147.33 122.91 10.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.661 0.784 . . . . 0.0 109.072 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -103.13 119.26 38.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.047 0.539 . . . . 0.0 110.139 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.47 157.46 19.19 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.853 0.861 . . . . 0.0 110.153 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 m -143.22 127.34 17.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.941 0.896 . . . . 0.0 108.775 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.9 t -118.53 120.19 36.77 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.875 0.87 . . . . 0.0 109.81 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -84.66 115.18 26.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.541 0.736 . . . . 0.0 109.14 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.85 103.07 15.82 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.101 0.56 . . . . 0.0 110.633 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.1 p 52.75 57.68 6.13 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.999 1.72 . . . . 0.0 112.404 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.91 -82.84 0.4 Allowed Glycine 0 C--N 1.349 1.296 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.407 -176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -160.54 41.79 0.18 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.594 1.187 . . . . 0.0 108.066 173.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 m -111.31 155.92 22.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.99 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -107.06 118.82 37.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -151.47 171.4 17.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.006 1.322 . . . . 0.0 107.759 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.9 t 65.69 114.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.807 1.243 . . . . 0.0 110.848 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 102' ' ' TRP . 2.2 p-10 -55.37 -32.36 62.52 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.887 0.875 . . . . 0.0 113.133 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.06 151.71 46.98 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 111.02 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 67.7 mtt -140.87 147.68 39.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 107.904 174.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.51 150.25 22.23 Favored Glycine 0 N--CA 1.467 0.723 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.858 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -91.23 149.4 21.78 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.2 152.14 49.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.222 1.409 . . . . 0.0 108.665 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -125.27 135.32 52.4 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.464 0.705 . . . . 0.0 109.181 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -147.56 130.95 16.62 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 123.313 0.645 . . . . 0.0 109.474 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' HG3' ' A' ' 44' ' ' LYS . . . -88.96 154.22 49.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 170.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -53.59 105.56 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.643 2.229 . . . . 0.0 112.888 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.54 24.2 31.53 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.509 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 6.6 mmpt? -126.33 174.5 8.53 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.966 0.907 . . . . 0.0 110.853 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -82.8 144.36 30.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.762 0.825 . . . . 0.0 110.208 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.29 116.34 24.4 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.046 0.45 . . . . 0.0 110.005 176.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -92.31 142.36 27.55 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.648 0.779 . . . . 0.0 109.904 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -73.61 107.77 6.07 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.717 0.807 . . . . 0.0 109.52 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.5 t -86.9 -54.1 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.714 0.806 . . . . 0.0 110.357 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -137.49 160.21 39.76 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -170.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.47 121.12 14.29 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 125.102 1.361 . . . . 0.0 108.873 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.5 mp -121.68 116.08 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -107.13 90.53 3.33 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.507 0.594 . . . . 0.0 110.022 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 63.85 -75.99 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.117 1.767 . . . . 0.0 111.726 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.8 p -163.25 145.3 9.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.244 1.017 . . . . 0.0 109.69 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.71 -19.26 34.09 Favored Glycine 0 N--CA 1.475 1.267 0 CA-C-O 120.081 -0.289 . . . . 0.0 113.815 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.62 44.72 1.28 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 16.1 m -101.99 60.73 0.86 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.961 0.905 . . . . 0.0 110.017 -175.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.442 ' HA ' HD11 ' A' ' 71' ' ' ILE . 17.8 p -146.57 120.84 9.56 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -175.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 12.3 t80 -171.38 131.94 0.77 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -158.56 134.99 9.36 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.06 150.47 33.74 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.923 0.489 . . . . 0.0 111.029 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.561 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 29.9 t70 -66.3 -18.86 65.61 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 111.563 0.208 . . . . 0.0 111.563 -176.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -72.97 -34.24 66.36 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.385 0.674 . . . . 0.0 111.219 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -106.96 15.97 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.788 0.835 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -65.93 121.17 14.48 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.36 1.064 . . . . 0.0 110.749 -176.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.52 -27.6 16.77 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.361 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 4.0 ptt180 -94.82 -28.08 15.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.394 0.597 . . . . 0.0 109.988 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -99.73 132.66 44.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.357 0.663 . . . . 0.0 109.282 173.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.9 m -137.99 145.23 41.67 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.889 1.276 . . . . 0.0 108.125 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.493 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -128.57 159.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.564 0.746 . . . . 0.0 109.884 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.8 t -156.78 139.69 15.29 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.74 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.546 ' HD2' HG21 ' A' ' 52' ' ' ILE . 50.2 ttt85 -115.19 120.54 40.06 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 169.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.77 107.67 18.75 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 109.303 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.34 -34.49 75.36 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.4 1.062 . . . . 0.0 111.283 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.54 -44.68 69.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.336 1.054 . . . . 0.0 112.963 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.77 7.6 11.03 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.074 0.55 . . . . 0.0 111.729 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.6 m120 53.66 38.37 28.19 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.488 1.115 . . . . 0.0 111.784 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 32.2 m -114.43 130.99 56.74 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.705 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 73' ' ' ARG . 39.8 t -104.63 121.31 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.749 0.82 . . . . 0.0 108.814 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -101.13 152.79 20.2 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.762 . . . . 0.0 111.261 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.7 tp -132.94 97.83 4.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.287 1.035 . . . . 0.0 108.374 171.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -80.51 101.35 9.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.624 ' HB3' HD21 ' A' ' 87' ' ' LEU . 34.3 mtm -92.71 135.63 33.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.49 170.09 16.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.2 t 58.61 33.45 23.1 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.859 0.864 . . . . 0.0 110.767 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -71.94 156.94 38.7 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.673 -173.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.608 ' HG2' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -132.06 158.3 75.89 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.848 1.259 . . . . 0.0 108.189 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' A' ' 15' ' ' ALA . 13.0 Cg_endo -53.68 -24.4 29.77 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 123.061 2.507 . . . . 0.0 114.522 -169.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.608 ' HG2' ' HG2' ' A' ' 88' ' ' LYS . 13.1 pt-20 -65.74 -18.76 65.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.173 0.589 . . . . 0.0 112.589 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' HG21 ' A' ' 121' ' ' VAL . 65.3 m-20 -82.36 30.33 0.41 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.493 0.717 . . . . 0.0 110.959 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.472 HG23 HG23 ' A' ' 120' ' ' THR . 95.9 m -83.14 93.56 7.66 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 164.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.6 27.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.431 0.692 . . . . 0.0 110.625 -172.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.53 120.89 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.009 0.524 . . . . 0.0 109.958 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -95.56 125.93 40.5 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -129.35 144.11 51.11 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.022 0.929 . . . . 0.0 109.742 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -92.8 157.76 16.24 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -138.54 150.25 46.17 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.341 0.656 . . . . 0.0 109.518 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -113.4 132.03 55.77 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.71 178.84 16.43 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 121.353 0.418 . . . . 0.0 113.459 -172.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 p -139.47 115.74 9.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 124.035 0.934 . . . . 0.0 108.633 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.478 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 14.6 t90 -79.61 141.7 36.3 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.196 -171.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -105.52 153.84 21.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.567 1.147 . . . . 0.0 110.133 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 t -67.3 -21.09 65.7 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.878 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.5 p -68.66 -25.29 64.74 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.385 0.674 . . . . 0.0 110.634 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.59 -9.11 24.02 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 116.71 -0.223 . . . . 0.0 113.508 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -89.93 159.7 16.8 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.483 0.713 . . . . 0.0 109.897 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -116.35 141.69 47.83 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.8 p -116.84 109.51 43.06 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.146 0.578 . . . . 0.0 109.998 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.57 91.74 0.35 Allowed 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.738 2.292 . . . . 0.0 110.648 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -83.48 -22.59 32.49 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.115 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 21.9 m-85 -122.48 147.44 46.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.03 0.932 . . . . 0.0 108.525 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.8 m-90 -130.11 162.06 29.65 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 108.846 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.27 -142.93 7.78 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.438 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -102.34 -27.95 12.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.182 0.593 . . . . 0.0 110.661 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.55 156.08 24.13 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.109 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.46 119.37 11.9 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.98 103.0 5.01 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -85.53 137.96 19.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 32.1 m -133.38 110.47 10.05 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 91' ' ' ASP . 48.0 t -91.89 103.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 35.5 t -45.35 143.0 1.9 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.387 1.075 . . . . 0.0 112.308 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.5 p -70.15 167.67 17.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.779 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.25 -41.22 88.25 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.919 0.488 . . . . 0.0 111.476 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -146.86 122.03 10.16 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 122.66 0.384 . . . . 0.0 110.438 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -147.6 107.61 4.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.945 0.898 . . . . 0.0 108.74 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -84.92 19.67 2.05 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.588 0.755 . . . . 0.0 111.637 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -122.16 166.58 14.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.632 0.773 . . . . 0.0 109.958 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -115.22 -77.54 0.57 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -179.19 -55.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.013 0.925 . . . . 0.0 111.085 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.0 m80 . . . . . 0 C--O 1.257 1.486 0 C-N-CA 124.523 1.129 . . . . 0.0 109.388 -160.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 62.25 -170.06 0.17 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.989 0.916 . . . . 0.0 111.709 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 26' ' ' SER . 2.0 tm? -75.35 115.89 15.48 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -103.12 150.32 23.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.571 1.149 . . . . 0.0 108.383 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.468 HD22 ' SG ' ' A' ' 23' ' ' CYS . 95.1 mt -131.27 108.76 9.9 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.092 0.557 . . . . 0.0 110.137 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.4 t -108.6 107.72 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.096 0.958 . . . . 0.0 108.821 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -99.22 155.24 17.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.062 0.945 . . . . 0.0 111.88 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.1 m -153.56 155.63 36.52 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.836 1.654 . . . . 0.0 109.145 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.47 -9.02 10.12 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 123.171 0.415 . . . . 0.0 112.887 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -71.05 90.13 0.41 Allowed Glycine 0 C--N 1.347 1.146 0 O-C-N 123.484 0.167 . . . . 0.0 113.206 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.31 -175.61 13.93 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.4 tt -94.76 118.32 31.56 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.063 0.545 . . . . 0.0 110.041 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.63 167.36 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 109.271 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.47 ' NE2' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -84.24 152.83 23.96 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.797 0.839 . . . . 0.0 110.478 175.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -68.12 121.85 17.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 171.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.68 -22.39 14.92 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.077 0.846 . . . . 0.0 111.31 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.47 ' HA3' ' NE2' ' A' ' 14' ' ' GLN . . . -81.84 -166.99 38.41 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 121.225 0.347 . . . . 0.0 113.492 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 p -127.31 156.1 42.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.565 0.746 . . . . 0.0 110.891 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -152.66 133.24 13.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.006 0.922 . . . . 0.0 108.636 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -113.17 124.16 51.9 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.992 0.517 . . . . 0.0 109.706 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.37 157.12 19.32 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.906 0.882 . . . . 0.0 109.443 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.9 p -142.32 135.32 28.58 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.211 1.004 . . . . 0.0 108.725 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.468 ' SG ' HD22 ' A' ' 5' ' ' LEU . 53.8 t -140.06 116.83 10.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.24 0.616 . . . . 0.0 110.095 -177.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 t -83.53 122.86 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.58 102.57 15.31 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.037 0.935 . . . . 0.0 110.515 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.686 ' HB2' HD22 ' A' ' 3' ' ' LEU . 11.6 t 69.97 22.73 5.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.53 1.532 . . . . 0.0 111.906 168.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.08 56.97 10.24 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 86.6 mtm180 60.6 56.37 3.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.371 1.069 . . . . 0.0 110.948 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 47.2 m -137.3 150.33 47.7 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.817 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -103.14 127.42 50.43 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.589 ' HB3' HD23 ' A' ' 3' ' ' LEU . 44.3 ttm180 -170.51 -35.39 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.594 -173.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 p -71.1 103.77 2.84 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.225 0.61 . . . . 0.0 110.52 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -79.32 -34.65 42.09 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.7 0.8 . . . . 0.0 109.415 174.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.01 49.18 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.769 1.228 . . . . 0.0 108.948 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 50.2 mtm -150.54 168.43 24.27 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.932 1.693 . . . . 0.0 108.567 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.02 35.52 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 96.9 m95 -122.37 135.51 54.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 168.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -122.95 164.38 18.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.147 1.379 . . . . 0.0 108.326 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -138.11 151.18 47.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -153.94 150.41 28.29 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.42 145.34 30.61 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.95 104.53 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.371 2.714 . . . . 0.0 113.386 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.79 -12.58 50.02 Favored Glycine 0 C--N 1.352 1.469 0 C-N-CA 122.9 0.286 . . . . 0.0 113.349 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -97.99 173.53 7.01 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.0 0.92 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -78.13 170.06 17.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.909 0.883 . . . . 0.0 110.433 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' H ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -100.59 151.67 21.33 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.181 0.515 . . . . 0.0 110.681 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -115.75 139.53 50.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.668 1.587 . . . . 0.0 109.005 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 59.5 t80 -83.27 109.78 17.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.086 0.955 . . . . 0.0 109.155 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 67.7 t -90.09 -52.47 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.671 0.788 . . . . 0.0 110.288 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 60' ' ' TYR . . . -148.83 169.83 19.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.112 -168.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -149.28 119.05 7.04 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.61 1.164 . . . . 0.0 109.512 175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.0 mp -120.78 116.53 50.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 C-N-CA 123.801 0.84 . . . . 0.0 109.344 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HD3' ' H ' ' A' ' 58' ' ' SER . 2.5 mpt_? -95.74 177.63 5.72 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -80.43 -30.88 37.63 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 165.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.9 p -164.18 149.73 10.63 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.721 1.208 . . . . 0.0 109.693 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.09 -9.78 33.8 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.239 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.21 -81.36 0.05 OUTLIER Glycine 0 C--N 1.349 1.298 0 CA-C-N 117.903 0.852 . . . . 0.0 111.434 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 27.7 m 64.06 21.1 12.47 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.676 1.19 . . . . 0.0 113.617 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.522 ' HA ' HD11 ' A' ' 71' ' ' ILE . 19.3 p -151.33 126.11 9.66 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 6.0 t80 -166.47 130.2 2.03 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.73 150.73 12.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.616 1.566 . . . . 0.0 108.139 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.47 155.07 39.92 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.304 0.642 . . . . 0.0 110.729 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.88 -31.79 73.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.265 0.626 . . . . 0.0 111.42 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -69.37 -33.9 73.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.747 0.819 . . . . 0.0 111.77 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.528 ' HA ' HH21 ' A' ' 68' ' ' ARG . 31.1 m -102.53 -0.73 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.711 0.804 . . . . 0.0 111.722 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.16 134.94 56.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.052 1.341 . . . . 0.0 112.313 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.97 -29.37 5.54 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.623 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.612 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 75.3 mtm180 -89.64 -51.78 5.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 122.008 0.908 . . . . 0.0 109.173 176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -86.7 122.71 30.98 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.677 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -146.15 150.5 36.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.012 1.325 . . . . 0.0 108.037 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -121.42 155.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.959 0.904 . . . . 0.0 110.445 -177.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -146.78 134.07 20.63 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.957 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.61 ' HB2' HG21 ' A' ' 52' ' ' ILE . 32.3 ttt180 -112.21 130.8 55.8 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -116.42 116.06 26.98 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -87.51 -11.66 48.23 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.925 0.33 . . . . 0.0 111.642 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.19 -41.33 94.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.135 0.574 . . . . 0.0 111.455 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -119.62 15.68 12.8 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 122.355 0.262 . . . . 0.0 110.957 169.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 28' ' ' ARG . 16.9 m120 44.45 63.66 1.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.077 1.351 . . . . 0.0 111.982 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.5 m -131.29 132.61 44.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.394 0.677 . . . . 0.0 109.758 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.7 t -102.66 143.73 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.561 1.144 . . . . 0.0 108.623 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -125.78 142.22 51.62 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.585 0.754 . . . . 0.0 110.071 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.3 tp -126.85 96.8 4.75 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -89.98 107.75 19.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.6 mtm -107.96 119.08 38.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.959 0.904 . . . . 0.0 109.045 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -112.38 148.63 33.9 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.421 0.689 . . . . 0.0 110.229 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.612 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 41.6 t 56.47 68.86 0.8 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.434 1.093 . . . . 0.0 110.162 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -78.77 160.87 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.469 -1.242 . . . . 0.0 111.47 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -127.61 147.39 62.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.425 -169.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -57.96 -29.35 86.3 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.34 2.694 . . . . 0.0 114.098 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.3 pm0 -78.67 -2.88 41.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.323 0.649 . . . . 0.0 111.843 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -86.67 25.68 1.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.0 0.92 . . . . 0.0 110.733 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.44 HG23 ' HA ' ' A' ' 120' ' ' THR . 87.7 m -87.74 92.68 9.2 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.22 168.04 27.5 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.523 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.38 106.81 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-O 121.565 0.698 . . . . 0.0 109.765 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -89.9 114.41 26.2 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -111.74 146.97 36.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.175 0.59 . . . . 0.0 109.666 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -90.55 159.41 16.49 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.63 40.6 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.9 0.88 . . . . 0.0 109.089 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -152.97 170.0 21.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.607 0.763 . . . . 0.0 110.59 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.63 -154.8 25.83 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.96 140.01 46.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -66.51 148.85 51.3 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.388 0.43 . . . . 0.0 109.953 173.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.56 173.12 9.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.181 0.992 . . . . 0.0 112.279 -173.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 m -65.57 -24.34 67.07 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.623 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.2 t -70.46 -24.01 62.8 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.937 0.895 . . . . 0.0 111.164 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.58 -13.39 61.16 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.166 -174.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -66.42 114.81 5.72 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.911 0.884 . . . . 0.0 110.026 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.66 144.33 49.42 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 123.501 0.501 . . . . 0.0 109.843 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.8 t -146.79 131.96 9.06 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.187 0.595 . . . . 0.0 110.247 -172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.3 83.63 1.22 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.426 2.084 . . . . 0.0 111.305 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.97 -18.73 64.11 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.013 0.925 . . . . 0.0 111.012 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -134.76 151.63 51.12 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 125.14 1.376 . . . . 0.0 108.459 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -126.14 162.23 25.84 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.961 0.904 . . . . 0.0 109.255 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -94.14 177.23 36.49 Favored Glycine 0 C--O 1.241 0.552 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.927 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -67.7 -25.89 65.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.562 0.745 . . . . 0.0 111.221 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.36 110.81 0.23 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.753 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -99.02 118.92 36.89 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 121.458 0.647 . . . . 0.0 110.044 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.25 103.92 6.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.099 0.96 . . . . 0.0 111.135 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.553 HG12 ' HA2' ' A' ' 10' ' ' GLY . 9.0 m -90.05 152.0 3.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 85.3 m -132.72 106.61 7.87 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.54 0.736 . . . . 0.0 109.026 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.2 96.2 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 t -68.44 144.06 54.83 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.649 0.38 . . . . 0.0 110.766 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -67.65 92.51 0.33 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.127 0.971 . . . . 0.0 111.813 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 15' ' ' ALA . 4.3 mm? 61.56 13.16 4.96 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.565 1.146 . . . . 0.0 113.19 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -92.28 99.72 12.44 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 120.943 0.401 . . . . 0.0 110.312 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -76.57 78.79 3.25 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -70.33 -43.46 70.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.892 -173.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 61.52 94.02 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 O-C-N 124.621 1.201 . . . . 0.0 112.344 171.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -156.09 119.32 4.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.186 0.595 . . . . 0.0 109.398 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -95.51 120.63 36.11 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.49 0.716 . . . . 0.0 109.376 175.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 CA--C 1.562 1.422 0 C-N-CA 124.806 1.242 . . . . 0.0 111.433 -177.933 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -67.71 177.64 1.98 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.822 0.849 . . . . 0.0 112.967 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.4 117.11 5.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.799 0.839 . . . . 0.0 111.902 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 36.3 mt-30 -103.59 128.67 50.81 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.6 mp -127.12 122.88 35.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.2 t -114.39 101.87 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.94 144.59 26.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.408 0.683 . . . . 0.0 109.502 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -147.24 169.25 19.76 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 109.836 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.38 10.31 51.29 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.432 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.42 111.03 3.26 Favored Glycine 0 C--N 1.344 0.999 0 O-C-N 123.578 0.223 . . . . 0.0 112.649 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.85 -176.66 32.16 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.575 HD22 ' HB2' ' A' ' 129' ' ' HIS . 14.3 tp -92.07 125.87 36.93 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 19' ' ' LEU . 19.4 m -126.48 157.55 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -75.58 148.23 39.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.812 0.845 . . . . 0.0 110.358 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.56 111.9 2.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.345 0.658 . . . . 0.0 109.772 171.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.07 -21.7 17.4 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.561 0.538 . . . . 0.0 112.115 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.01 -178.53 34.94 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 116.555 0.178 . . . . 0.0 112.899 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 p -123.04 151.05 42.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.475 0.71 . . . . 0.0 110.553 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 13' ' ' VAL . 56.5 tp -151.82 133.65 14.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.355 1.062 . . . . 0.0 108.961 -177.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -109.42 126.0 53.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.408 0.683 . . . . 0.0 109.843 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -96.19 158.94 15.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.827 1.251 . . . . 0.0 109.217 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.6 p -147.89 124.36 11.01 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.217 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 51.3 t -116.89 109.54 17.2 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.828 0.851 . . . . 0.0 109.429 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.4 t -86.17 126.11 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.79 100.61 13.38 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.537 0.735 . . . . 0.0 110.693 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.591 ' HA ' ' HB2' ' A' ' 4' ' ' GLN . 22.7 t 60.9 40.15 15.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.071 1.348 . . . . 0.0 111.83 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.73 -62.33 4.62 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.973 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 25.5 ttt180 -160.86 4.17 0.07 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.741 0.816 . . . . 0.0 110.445 173.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 m -77.57 145.13 37.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.401 0.681 . . . . 0.0 110.608 -170.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -105.97 123.57 48.19 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.416 ' H ' ' H ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -163.02 -18.11 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.519 1.128 . . . . 0.0 109.352 170.019 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 31' ' ' ARG . 17.9 m -63.76 108.19 1.38 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.872 0.869 . . . . 0.0 109.666 174.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -82.32 -36.93 26.47 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.858 0.837 . . . . 0.0 109.47 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.18 41.48 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.147 -1.388 . . . . 0.0 108.742 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 97.8 mtp -141.93 118.98 11.29 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.12 142.83 17.32 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.24 123.06 32.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-85 -120.17 133.91 55.38 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.401 1.08 . . . . 0.0 108.193 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -103.29 124.09 48.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.319 0.58 . . . . 0.0 109.934 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.91 128.68 53.25 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.6 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -125.36 155.15 72.05 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 122.889 0.475 . . . . 0.0 110.444 -170.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -52.5 96.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.027 2.484 . . . . 0.0 112.781 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.43 -17.28 58.78 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.075 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.2 mmpt? -105.56 138.27 42.03 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.505 0.722 . . . . 0.0 109.998 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.48 163.79 10.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 0.0 112.6 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' H ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -58.56 122.15 12.69 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 168.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.3 tt0 -115.7 128.7 56.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.428 0.691 . . . . 0.0 109.51 -172.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 46.6 t80 -66.57 107.45 2.1 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 124.121 0.888 . . . . 0.0 109.714 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.05 -55.61 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.075 0.95 . . . . 0.0 109.954 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.65 32.29 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.865 -172.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -139.39 123.62 18.01 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.163 0.985 . . . . 0.0 109.92 -177.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.761 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 2.9 mp -108.68 119.36 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.454 HH22 ' HB2' ' A' ' 108' ' ' ASP . 16.1 tpp180 -120.19 107.69 13.31 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -175.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -68.58 -7.75 35.58 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.146 0.498 . . . . 0.0 111.205 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 m -68.49 -2.38 8.64 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.553 1.141 . . . . 0.0 112.825 173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.74 17.18 9.95 Favored Glycine 0 C--N 1.353 1.484 0 C-N-CA 122.91 0.291 . . . . 0.0 112.402 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.17 -93.97 1.71 Allowed Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 50.6 m 61.68 39.36 14.42 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.378 1.071 . . . . 0.0 113.091 173.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 p -149.52 121.59 8.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.406 ' H ' HD11 ' A' ' 71' ' ' ILE . 12.3 t80 -170.59 126.83 0.76 Allowed 'General case' 0 C--N 1.343 0.312 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.405 ' HE2' ' HG3' ' A' ' 66' ' ' LYS . 25.1 p90 -163.66 144.07 8.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.154 0.982 . . . . 0.0 108.944 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -68.69 153.89 42.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.921 0.489 . . . . 0.0 110.378 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.45 -35.29 77.17 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.263 0.625 . . . . 0.0 110.54 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -63.41 -34.36 77.58 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.978 0.911 . . . . 0.0 111.937 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 62' ' ' ALA . 34.4 m -108.23 19.12 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.953 0.901 . . . . 0.0 111.124 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.405 ' HG3' ' HE2' ' A' ' 61' ' ' TYR . 39.1 ttmt -57.34 116.84 3.56 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.169 0.988 . . . . 0.0 111.532 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.65 -27.91 6.81 Favored Glycine 0 C--N 1.342 0.876 0 O-C-N 123.733 0.646 . . . . 0.0 113.602 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -77.75 -60.25 2.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -84.69 122.11 28.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 p -143.58 153.82 42.95 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -130.28 154.39 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.747 0.819 . . . . 0.0 110.387 177.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.2 m -150.33 135.79 18.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.972 1.309 . . . . 0.0 107.932 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -110.05 123.42 49.65 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.02 128.32 36.79 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -87.25 -27.9 22.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.063 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.15 96.88 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.47 0.708 . . . . 0.0 112.403 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -116.34 4.28 13.41 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.135 0.425 . . . . 0.0 111.992 171.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 54.36 68.34 0.87 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.206 1.002 . . . . 0.0 111.183 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.4 m -134.99 130.67 36.11 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.9 t -106.25 120.43 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.031 0.932 . . . . 0.0 109.517 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.08 134.31 42.11 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.63 0.772 . . . . 0.0 110.297 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 49.5 tp -114.87 98.9 7.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -84.16 98.85 10.15 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.478 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 90.5 mtp -91.89 108.5 19.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 174.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -103.19 132.81 49.17 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t 61.17 70.33 0.61 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.203 1.001 . . . . 0.0 109.614 -175.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 121' ' ' VAL . 5.5 mp -71.24 135.88 47.71 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.382 176.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.47 153.06 76.21 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.47 -19.7 68.31 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 121.946 1.764 . . . . 0.0 111.299 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -65.12 -20.51 66.5 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.861 2.064 . . . . 0.0 111.802 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.407 ' HB2' HG21 ' A' ' 121' ' ' VAL . 66.0 m-20 -84.9 31.61 0.54 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.814 0.846 . . . . 0.0 111.362 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 120' ' ' THR . 98.7 m -82.23 92.28 6.88 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 161.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.5 -175.35 4.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.818 -168.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -113.93 109.14 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -85.06 109.25 18.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.62 147.51 31.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 36.2 t -99.11 157.54 16.29 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 171.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -142.88 128.35 18.99 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.67 141.59 42.03 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.372 0.669 . . . . 0.0 110.345 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -159.75 -158.84 9.39 Favored Glycine 0 C--N 1.341 0.825 0 O-C-N 123.982 0.801 . . . . 0.0 113.127 -177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.9 m -119.25 -170.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.275 1.03 . . . . 0.0 110.746 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -97.2 123.77 41.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.686 0.794 . . . . 0.0 109.176 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -78.23 162.87 26.24 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.544 0.338 . . . . 0.0 111.165 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.7 m -72.25 -22.6 61.21 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.768 0.827 . . . . 0.0 110.946 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.9 t -73.81 -22.35 59.83 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.837 0.855 . . . . 0.0 110.506 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.55 -3.24 78.56 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.29 -174.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -79.1 151.95 31.09 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.119 0.968 . . . . 0.0 110.612 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.454 ' HB2' HH22 ' A' ' 53' ' ' ARG . 26.5 t70 -76.45 149.29 36.84 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.827 0.851 . . . . 0.0 110.408 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.8 t -138.94 113.71 8.39 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.209 0.604 . . . . 0.0 110.541 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.86 70.58 6.48 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.983 2.456 . . . . 0.0 111.762 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.76 -38.85 76.13 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 111.809 -176.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -136.86 123.92 21.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -87.25 162.91 17.17 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.217 0.607 . . . . 0.0 109.668 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -95.34 -164.99 34.89 Favored Glycine 0 C--O 1.243 0.706 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.88 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -79.73 -37.53 35.36 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.431 0.692 . . . . 0.0 110.639 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.85 138.16 9.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.396 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.408 HG21 HD12 ' A' ' 21' ' ' LEU . 9.7 t -108.03 118.65 37.31 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.166 0.587 . . . . 0.0 109.51 173.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.12 107.44 11.88 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.795 0.838 . . . . 0.0 110.467 -177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.7 m -107.07 143.73 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.946 0.898 . . . . 0.0 109.501 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.493 HG23 HG23 ' A' ' 92' ' ' THR . 61.7 m -132.92 120.92 22.1 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 87' ' ' LEU . 25.9 t -100.91 104.57 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 176.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.2 m -53.64 140.64 28.46 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.1 m -83.09 59.51 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.873 0.869 . . . . 0.0 110.255 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.7 mm? 69.3 23.36 6.27 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.306 1.442 . . . . 0.0 112.74 -171.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -86.0 87.04 7.35 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 166.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -75.6 84.4 2.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -146.95 114.61 6.41 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -169.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -73.07 90.02 1.5 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.113 0.482 . . . . 0.0 111.301 -172.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.575 ' HB2' HD22 ' A' ' 12' ' ' LEU . 26.7 m-70 -82.27 89.66 6.56 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.691 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -76.79 -17.4 59.06 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 165.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.3 m80 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.871 1.269 . . . . 0.0 108.262 166.019 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 120.728 0.299 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -68.18 141.76 55.9 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.515 0.726 . . . . 0.0 110.785 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.04 111.06 8.84 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -88.92 114.45 25.55 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.5 mt -112.04 122.32 47.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.02 100.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -87.21 118.8 26.86 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m -129.46 135.0 48.1 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.186 0.995 . . . . 0.0 109.186 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.78 9.21 0.73 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-O 119.939 -0.367 . . . . 0.0 113.074 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.3 89.99 0.61 Allowed Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.921 0.361 . . . . 0.0 112.749 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.22 172.78 23.32 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 112.268 -0.333 . . . . 0.0 112.268 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 122' ' ' SER . 15.9 tp -91.99 123.76 35.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.463 0.705 . . . . 0.0 109.132 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.1 m -126.81 151.15 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -77.89 153.75 32.35 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 122.574 0.35 . . . . 0.0 110.526 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.7 114.15 2.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.672 0.789 . . . . 0.0 110.584 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.25 11.7 27.01 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.296 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.47 -167.01 24.61 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 122.555 0.121 . . . . 0.0 113.087 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -132.47 156.9 45.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.694 0.798 . . . . 0.0 110.011 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -159.32 119.71 3.13 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -100.18 126.45 46.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.994 0.518 . . . . 0.0 110.375 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -87.83 157.48 18.99 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.02 0.928 . . . . 0.0 109.865 170.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.3 p -141.12 148.81 40.69 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.66 1.184 . . . . 0.0 108.544 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.0 t -135.28 101.67 4.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.2 118.14 30.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.82 97.92 11.47 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.636 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m 51.97 49.35 20.89 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.334 1.453 . . . . 0.0 112.267 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.27 -78.1 2.04 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.333 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -172.28 85.1 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.406 1.082 . . . . 0.0 108.585 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -139.16 155.96 47.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.351 0.66 . . . . 0.0 110.222 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.17 117.87 35.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -173.08 160.91 4.26 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.757 1.223 . . . . 0.0 109.514 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m 64.95 177.52 0.19 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.422 1.089 . . . . 0.0 111.088 -171.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -147.33 19.68 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.807 0.443 . . . . 0.0 110.726 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.3 125.12 6.52 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.837 0.855 . . . . 0.0 109.78 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.437 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 65.9 mtt -139.91 119.86 13.55 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.31 177.13 16.85 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 123.125 0.393 . . . . 0.0 112.697 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -119.55 139.79 51.57 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.717 0.807 . . . . 0.0 110.656 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -127.28 166.86 16.97 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.358 1.463 . . . . 0.0 107.527 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.24 139.22 19.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.316 0.246 . . . . 0.0 110.665 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -125.18 128.12 47.87 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.076 0.55 . . . . 0.0 109.697 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.33 158.69 31.77 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.393 0.677 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -55.08 115.68 2.61 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.919 2.413 . . . . 0.0 112.693 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.22 -7.74 78.08 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 113.629 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.2 mmpt? -114.51 162.97 16.02 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.069 0.948 . . . . 0.0 110.596 -176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.24 175.18 9.09 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.668 0.787 . . . . 0.0 110.212 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 131.53 36.1 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -115.67 140.46 49.17 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.703 1.201 . . . . 0.0 109.311 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -67.59 109.38 3.25 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.744 1.217 . . . . 0.0 110.263 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.48 -58.2 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HA ' ' HB2' ' A' ' 60' ' ' TYR . . . -163.78 174.74 11.22 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.958 -173.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.74 130.69 23.12 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.573 1.149 . . . . 0.0 108.926 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.2 mp -112.84 116.27 52.15 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.1 mtm-85 -114.17 169.11 9.26 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.113 0.482 . . . . 0.0 110.798 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -59.32 -39.09 81.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -158.99 146.27 17.42 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.521 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.41 30.95 32.0 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 114.129 0.412 . . . . 0.0 114.129 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.28 -124.52 0.74 Allowed Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.645 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 23.6 m 65.92 8.99 5.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 170.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.539 ' HA ' HD11 ' A' ' 71' ' ' ILE . 3.2 p -159.01 122.59 3.81 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.735 0.814 . . . . 0.0 110.157 -175.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 46.4 m-85 -160.56 111.81 1.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.364 1.466 . . . . 0.0 107.927 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -166.63 136.0 3.01 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.964 0.906 . . . . 0.0 110.414 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.24 168.13 16.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.093 0.957 . . . . 0.0 110.329 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -57.32 -33.94 68.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.461 0.704 . . . . 0.0 112.312 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 m -65.8 -31.01 71.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.319 0.648 . . . . 0.0 112.284 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.2 14.16 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.693 0.797 . . . . 0.0 111.053 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.9 124.2 27.7 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.556 0.743 . . . . 0.0 109.883 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.36 -28.54 6.19 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.177 -174.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 74.7 mtp180 -75.63 -78.1 0.12 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 124.11 0.964 . . . . 0.0 109.189 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -84.26 119.92 25.61 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.628 0.771 . . . . 0.0 108.932 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -137.87 133.0 33.34 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 108.289 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.539 HD11 ' HA ' ' A' ' 59' ' ' THR . 0.2 OUTLIER -112.66 140.09 34.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.682 0.793 . . . . 0.0 110.081 -175.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -148.67 174.9 11.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.52 1.128 . . . . 0.0 109.527 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -152.01 150.29 29.82 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.571 0.748 . . . . 0.0 109.247 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -128.85 100.31 5.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.556 1.143 . . . . 0.0 108.173 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -69.94 -13.4 62.22 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.03 0.932 . . . . 0.0 111.498 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.31 70.64 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.22 . . . . 0.0 111.508 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.09 9.0 15.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.068 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.0 m120 53.66 64.72 1.74 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.585 1.154 . . . . 0.0 111.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.8 m -138.7 130.69 28.11 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.711 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.42 131.68 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.929 0.891 . . . . 0.0 108.626 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.53 150.54 29.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.101 0.56 . . . . 0.0 111.849 -174.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 37.8 tp -132.74 97.92 4.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -81.11 109.39 15.63 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.699 ' HB3' HD21 ' A' ' 87' ' ' LEU . 28.4 mtm -100.58 97.43 8.12 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -91.81 162.78 14.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.895 0.878 . . . . 0.0 110.615 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.484 ' HB3' ' HG2' ' A' ' 68' ' ' ARG . 20.5 t 42.92 63.72 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.3 1.44 . . . . 0.0 111.912 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 84' ' ' MET . 50.7 mt -82.63 150.51 26.79 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.759 -168.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -106.2 153.07 40.56 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 114.426 -1.261 . . . . 0.0 108.117 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.15 -18.89 60.96 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.584 2.19 . . . . 0.0 112.922 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.48 -1.17 25.86 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -96.41 31.69 2.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.447 0.641 . . . . 0.0 110.377 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.6 m -82.81 98.96 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 164.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.58 156.18 25.31 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.976 0.417 . . . . 0.0 111.387 -172.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.05 105.25 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 170.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -87.61 122.59 31.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.707 0.803 . . . . 0.0 108.957 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.76 158.6 34.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.64 0.776 . . . . 0.0 110.012 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -109.81 159.24 17.37 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.235 1.014 . . . . 0.0 109.445 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 110' ' ' PRO . . . -141.67 138.82 32.74 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.545 0.738 . . . . 0.0 109.782 -176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -114.1 124.63 52.56 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.223 0.609 . . . . 0.0 110.081 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.08 -172.7 12.94 Favored Glycine 0 C--O 1.248 0.974 0 C-N-CA 123.847 0.737 . . . . 0.0 111.536 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.57 158.91 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.02 0.928 . . . . 0.0 109.956 -176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 63.7 t90 -59.82 102.37 0.15 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 168.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -91.07 149.69 21.71 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.293 -172.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.6 m -68.89 -15.32 63.46 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.807 0.843 . . . . 0.0 112.441 -176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.8 p -69.03 -25.41 64.46 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.438 0.695 . . . . 0.0 110.967 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.56 -27.03 14.38 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.241 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -94.67 118.73 32.19 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.49 0.716 . . . . 0.0 110.45 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.48 120.35 12.14 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.3 p -123.74 126.08 25.81 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 123.334 0.654 . . . . 0.0 109.653 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.537 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . 73.2 Cg_endo -74.23 95.76 0.93 Allowed 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.136 1.891 . . . . 0.0 111.302 173.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -84.24 -5.24 59.23 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.396 0.679 . . . . 0.0 111.351 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 89.9 m-85 -123.03 142.36 50.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.661 0.784 . . . . 0.0 109.414 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -132.09 150.71 52.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.995 1.318 . . . . 0.0 107.893 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.98 -142.09 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 123.212 0.32 . . . . 0.0 112.864 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -100.85 -29.88 11.99 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.904 0.882 . . . . 0.0 111.304 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.94 161.81 36.76 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.297 -173.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -144.62 126.03 14.88 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.054 0.454 . . . . 0.0 110.054 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 100.35 9.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 -175.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 m -90.19 146.52 6.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 170.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 38.8 m -134.29 113.58 12.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.1 t -88.19 99.02 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.572 ' HB2' HD11 ' A' ' 12' ' ' LEU . 9.4 t -60.54 141.32 56.7 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.959 176.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.2 p -81.56 76.65 8.47 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.381 0.673 . . . . 0.0 109.822 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 71.44 -8.77 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.232 1.413 . . . . 0.0 113.834 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.491 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 7.1 tm-20 -75.71 140.45 42.47 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -154.32 96.9 1.97 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.283 0.633 . . . . 0.0 110.508 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -135.65 143.23 45.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.113 0.965 . . . . 0.0 109.615 173.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -81.0 84.47 6.46 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.921 0.867 . . . . 0.0 109.596 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -72.17 -28.23 63.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.309 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -109.01 117.56 34.53 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.393 1.077 . . . . 0.0 108.275 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 . . . . . 0 CA--C 1.559 1.291 0 C-N-CA 125.132 1.373 . . . . 0.0 110.97 -179.885 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mtm . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 119.006 -0.521 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 63.98 81.31 0.21 Allowed 'General case' 0 C--N 1.368 1.376 0 C-N-CA 124.591 1.156 . . . . 0.0 110.569 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 32' ' ' SER . 4.2 mm? -66.58 112.61 4.23 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.827 0.451 . . . . 0.0 110.901 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.94 103.39 13.95 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 99' ' ' ALA . 86.9 mt -100.28 112.89 25.25 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.58 102.44 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.16 128.38 36.34 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.2 m -128.11 165.92 19.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.859 1.263 . . . . 0.0 109.194 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.61 8.16 40.83 Favored Glycine 0 N--CA 1.474 1.175 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -76.55 103.24 1.71 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.752 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -178.99 32.65 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.2 tt -91.67 119.41 31.52 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.54 163.07 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.063 0.945 . . . . 0.0 108.656 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' NE2' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -83.62 154.73 23.59 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.736 0.814 . . . . 0.0 110.666 177.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -71.52 127.13 31.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.708 0.803 . . . . 0.0 109.462 174.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.18 -14.12 44.16 Favored Glycine 0 N--CA 1.468 0.769 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.45 ' HA3' ' NE2' ' A' ' 14' ' ' GLN . . . -88.99 -177.84 46.21 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.628 0.251 . . . . 0.0 113.132 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.1 p -119.37 131.09 55.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.651 0.781 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.9 tp -128.99 131.47 47.43 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.849 0.86 . . . . 0.0 108.964 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -112.63 132.41 55.17 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.8 0.84 . . . . 0.0 110.108 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.97 158.65 16.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.475 1.11 . . . . 0.0 109.851 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 p -140.25 122.39 15.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.705 0.802 . . . . 0.0 109.847 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -112.31 108.92 18.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.233 1.013 . . . . 0.0 108.851 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.96 121.62 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.49 108.67 19.94 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.711 0.805 . . . . 0.0 109.729 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.5 p 48.08 45.35 19.46 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.986 1.714 . . . . 0.0 113.067 172.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.61 -61.41 4.7 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 69.0 ttt180 -165.48 14.97 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.936 0.894 . . . . 0.0 110.606 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -106.12 154.64 20.39 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.321 0.648 . . . . 0.0 109.855 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -108.9 116.86 32.8 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -131.55 16.27 4.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.104 0.962 . . . . 0.0 109.717 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.418 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 38.2 t -139.55 147.72 41.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.747 0.819 . . . . 0.0 109.556 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.21 -43.6 19.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.827 0.851 . . . . 0.0 109.336 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.33 152.39 46.29 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.907 0.483 . . . . 0.0 111.252 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 2.1 mpt? -133.14 118.48 18.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.67 135.35 10.09 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -172.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -93.28 129.23 39.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.111 0.964 . . . . 0.0 109.971 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.21 135.87 39.46 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 23.5 ptt180 -103.55 118.15 36.07 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.307 0.575 . . . . 0.0 109.946 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.492 ' HB3' HG13 ' A' ' 94' ' ' VAL . 49.7 tp60 -100.71 129.13 46.57 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -99.28 150.74 37.01 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 122.634 0.373 . . . . 0.0 110.408 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.21 98.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.688 2.259 . . . . 0.0 112.294 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.07 65.81 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.913 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.632 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.2 mmpt? -123.68 153.58 40.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.741 0.816 . . . . 0.0 110.182 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -68.39 172.65 5.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.174 0.989 . . . . 0.0 113.104 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.472 ' H ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.24 134.93 34.93 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.324 -177.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.0 142.86 29.19 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.069 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -71.05 122.02 19.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.979 0.912 . . . . 0.0 110.034 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.92 -53.47 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.97 173.6 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.807 0.443 . . . . 0.0 112.183 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.29 121.63 3.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.255 1.022 . . . . 0.0 110.313 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 52' ' ' ILE . 2.9 mp -115.14 115.47 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -109.37 166.47 10.85 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.582 0.353 . . . . 0.0 110.203 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -60.08 -45.26 93.48 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.751 0.821 . . . . 0.0 109.273 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -151.82 162.17 41.47 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.823 170.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.47 32.72 41.36 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.39 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.61 -85.47 0.08 OUTLIER Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.6 m 65.63 5.56 3.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.725 1.21 . . . . 0.0 113.504 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 p -170.01 145.64 2.93 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.105 1.762 . . . . 0.0 106.97 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.412 ' H ' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -165.78 130.12 2.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.718 0.807 . . . . 0.0 109.189 176.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -164.25 147.84 9.51 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.633 0.773 . . . . 0.0 110.576 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.33 164.29 13.57 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.054 0.941 . . . . 0.0 109.832 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -66.8 -21.37 66.04 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.387 0.675 . . . . 0.0 111.588 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 m -67.9 -38.38 82.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.388 0.675 . . . . 0.0 111.192 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -105.75 -6.28 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.671 0.788 . . . . 0.0 111.846 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -57.59 131.13 49.29 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.315 1.046 . . . . 0.0 112.359 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.28 -26.5 6.95 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.69 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.421 HH21 ' HE1' ' A' ' 69' ' ' PHE . 3.6 mtm180 -96.88 -59.64 1.76 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.421 ' HE1' HH21 ' A' ' 68' ' ' ARG . 1.2 m-85 -84.99 120.63 26.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -139.34 143.66 37.9 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.297 1.039 . . . . 0.0 108.491 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.441 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -126.5 146.16 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.764 0.826 . . . . 0.0 111.03 -175.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -151.75 140.49 20.86 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.344 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -107.96 123.48 48.7 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.68 131.0 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.907 170.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 -28.51 19.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.582 0.753 . . . . 0.0 111.177 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.19 -43.52 87.59 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.838 0.855 . . . . 0.0 112.141 -172.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -118.14 9.88 12.78 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.222 0.209 . . . . 0.0 111.506 172.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 47.48 67.35 0.82 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.886 1.274 . . . . 0.0 112.016 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.4 m -134.68 131.61 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.252 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.1 t -103.47 131.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.641 0.776 . . . . 0.0 109.267 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -111.87 137.76 49.4 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.506 0.722 . . . . 0.0 110.769 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.53 97.66 5.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -87.65 104.54 16.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.396 0.678 . . . . 0.0 109.548 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 35.4 mtm -103.09 103.21 13.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.752 0.821 . . . . 0.0 110.083 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -93.2 149.49 21.19 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.779 0.431 . . . . 0.0 110.327 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.4 t 56.23 72.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.907 1.283 . . . . 0.0 110.968 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.4 mt -81.06 160.74 24.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.571 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 150.37 59.06 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.802 1.241 . . . . 0.0 108.358 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.43 -21.55 54.25 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.235 2.623 . . . . 0.0 114.18 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.74 -12.18 61.43 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.561 0.744 . . . . 0.0 112.43 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -79.11 13.82 1.67 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.206 0.602 . . . . 0.0 111.423 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 120' ' ' THR . 83.2 m -73.46 89.38 1.65 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 161.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.6 -178.6 3.52 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 -166.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -110.44 111.73 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 109.781 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -83.61 109.39 17.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -108.12 154.62 21.45 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.335 0.654 . . . . 0.0 110.159 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -108.55 158.0 17.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.331 1.052 . . . . 0.0 108.6 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -130.29 145.85 51.82 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -110.93 114.49 27.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.37 164.57 13.3 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 121.23 0.35 . . . . 0.0 113.716 -167.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.49 130.34 70.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 C-N-CA 125.187 1.395 . . . . 0.0 107.248 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 24.1 p-90 -69.28 139.23 54.36 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.579 0.55 . . . . 0.0 110.461 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -104.13 147.72 27.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 166.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.9 t -70.15 -17.22 63.17 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.013 0.525 . . . . 0.0 110.202 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.0 t -66.87 -19.42 65.73 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.442 1.097 . . . . 0.0 111.133 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.66 -28.88 11.27 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.88 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -73.77 109.96 7.69 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.333 0.653 . . . . 0.0 109.899 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.28 103.35 11.8 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.2 t -79.43 117.22 65.93 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 123.237 0.615 . . . . 0.0 111.287 -173.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.519 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 12.1 Cg_exo -69.5 95.53 0.53 Allowed 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.679 2.252 . . . . 0.0 110.176 176.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.26 -37.27 74.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.015 0.926 . . . . 0.0 110.95 -173.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 67.8 m-85 -126.99 169.0 13.78 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.223 1.009 . . . . 0.0 109.238 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -133.94 164.35 27.49 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.49 1.116 . . . . 0.0 108.804 172.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -90.44 -172.99 44.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.236 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -75.27 -32.68 61.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.879 0.871 . . . . 0.0 110.128 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.2 124.96 1.67 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.627 -175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.9 t -97.96 118.52 34.73 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.493 0.663 . . . . 0.0 109.426 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.44 112.14 13.87 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.522 HG12 ' HA2' ' A' ' 10' ' ' GLY . 27.0 m -112.39 142.68 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 91.1 m -126.75 104.5 8.1 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.42 99.26 9.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -67.43 150.41 48.95 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.0 p -78.76 85.91 4.73 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.19 0.596 . . . . 0.0 110.291 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 15' ' ' ALA . 4.5 mm? 69.44 -19.15 0.18 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 125.223 1.409 . . . . 0.0 113.909 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.93 127.48 32.61 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.094 0.558 . . . . 0.0 110.883 -170.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -97.17 89.09 4.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.234 1.014 . . . . 0.0 109.679 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -144.85 126.75 15.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.475 0.71 . . . . 0.0 110.012 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -77.65 109.58 11.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.107 0.963 . . . . 0.0 109.517 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -53.28 121.22 7.14 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.315 1.046 . . . . 0.0 111.272 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -81.89 102.39 10.85 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.806 0.843 . . . . 0.0 109.948 177.501 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -74.33 99.29 3.45 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.519 0.327 . . . . 0.0 110.201 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -71.13 108.13 4.51 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -79.24 149.57 31.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.193 1.397 . . . . 0.0 110.567 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.7 mt -124.98 120.08 30.57 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.115 0.966 . . . . 0.0 108.738 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.47 101.45 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 23' ' ' CYS . 2.9 mp0 -90.56 153.04 20.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.442 0.697 . . . . 0.0 110.584 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.8 p -165.31 160.91 18.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.141 0.976 . . . . 0.0 109.582 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.87 -1.26 27.29 Favored Glycine 0 N--CA 1.473 1.141 0 CA-C-O 120.069 -0.295 . . . . 0.0 112.961 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -78.75 119.0 4.98 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.48 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.44 177.98 26.33 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.4 tt -82.52 117.1 22.28 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 m -118.22 160.18 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.006 0.922 . . . . 0.0 108.609 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.48 HE21 ' HA3' ' A' ' 17' ' ' GLY . 0.4 OUTLIER -78.12 159.14 28.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.531 0.732 . . . . 0.0 110.791 174.035 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.55 133.38 52.23 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.549 0.74 . . . . 0.0 110.224 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.31 -4.28 80.34 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.276 -174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.48 ' HA3' HE21 ' A' ' 14' ' ' GLN . . . -90.67 -178.26 43.84 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-O 120.88 0.156 . . . . 0.0 113.264 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -128.97 156.66 43.43 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -176.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -159.59 130.63 5.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.606 0.762 . . . . 0.0 109.354 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -105.57 132.85 51.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.682 0.393 . . . . 0.0 110.061 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 159.19 15.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.046 0.938 . . . . 0.0 109.693 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 p -143.53 130.89 20.94 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.207 1.003 . . . . 0.0 109.284 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 43.1 t -131.95 110.64 10.91 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.781 0.832 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.9 t -86.58 132.37 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.56 100.24 12.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.077 0.551 . . . . 0.0 109.827 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 29' ' ' THR . 7.4 m 59.31 20.2 8.4 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.144 1.378 . . . . 0.0 113.391 176.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.8 68.64 1.57 Allowed Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -174.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.512 ' HG3' ' HA ' ' A' ' 77' ' ' LYS . 55.0 ttp180 62.26 51.95 3.3 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.856 1.262 . . . . 0.0 111.507 176.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 30.3 m -118.26 141.16 48.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.641 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -104.37 119.47 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -170.75 171.73 6.03 Favored 'General case' 0 C--O 1.248 0.988 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 m 71.01 121.1 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.61 1.164 . . . . 0.0 111.825 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 102' ' ' TRP . 3.6 p-10 -106.61 7.12 30.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.844 0.858 . . . . 0.0 110.717 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.51 122.37 27.5 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.7 mtt -138.79 152.75 48.17 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.282 0.633 . . . . 0.0 110.015 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -159.56 175.12 36.47 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.45 -178.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -136.8 131.97 34.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.537 1.135 . . . . 0.0 108.28 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.61 ' HB3' ' HB2' ' A' ' 46' ' ' ARG . 85.1 m-85 -134.37 137.32 44.02 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.58 1.152 . . . . 0.0 108.231 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -103.98 130.32 51.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -133.73 143.35 48.42 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.557 0.743 . . . . 0.0 109.058 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.15 160.99 31.85 Favored Pre-proline 0 N--CA 1.48 1.051 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.711 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.93 105.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.306 2.671 . . . . 0.0 113.773 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.97 23.26 61.97 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.455 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.7 mmpt? -126.41 172.89 9.78 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.796 0.838 . . . . 0.0 110.492 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.68 168.19 17.49 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.101 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.61 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -102.03 117.87 35.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.225 174.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -93.19 139.92 30.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.032 0.933 . . . . 0.0 109.564 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.08 111.06 3.67 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.417 0.687 . . . . 0.0 110.051 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.96 -56.96 4.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.535 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -161.44 173.39 14.96 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.848 -171.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -163.37 162.8 25.16 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 122.194 0.997 . . . . 0.0 113.265 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mt -129.3 128.08 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 108.693 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -98.78 123.41 43.0 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.343 0.657 . . . . 0.0 110.143 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 22.5 t90 59.62 -89.82 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.708 1.603 . . . . 0.0 110.767 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -171.55 130.82 0.71 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.73 -18.89 48.16 Favored Glycine 0 N--CA 1.471 1.031 0 N-CA-C 112.596 -0.201 . . . . 0.0 112.596 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.66 50.4 2.61 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 174.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.8 m -83.64 69.56 10.16 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.59 0.756 . . . . 0.0 111.085 -172.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 p -158.84 119.23 3.22 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 17.1 m-85 -169.73 119.46 0.64 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 167.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.73 151.53 20.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.055 0.542 . . . . 0.0 110.764 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.51 159.76 30.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.503 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.6 -32.39 71.51 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.414 0.686 . . . . 0.0 110.65 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.3 m -60.77 -37.65 82.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.14 0.976 . . . . 0.0 112.029 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.98 4.33 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.387 0.675 . . . . 0.0 111.896 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.77 111.26 3.62 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.148 0.979 . . . . 0.0 111.231 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.58 44.78 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.201 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 60.3 mtm180 -103.01 -40.24 6.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.299 0.64 . . . . 0.0 110.358 176.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -108.3 123.03 48.18 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.676 0.79 . . . . 0.0 109.459 -176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -139.35 152.26 47.03 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.121 0.968 . . . . 0.0 108.98 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.632 HD12 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -128.48 156.13 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.733 0.813 . . . . 0.0 110.497 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 t -154.54 134.17 12.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.371 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -110.85 120.07 41.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -90.89 104.63 17.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -62.75 -26.66 68.81 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.925 0.765 . . . . 0.0 110.966 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.39 -53.79 33.09 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 124.838 1.255 . . . . 0.0 112.263 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.512 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.37 11.17 11.4 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 45.07 67.81 0.66 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.943 1.297 . . . . 0.0 112.503 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 m -130.75 131.11 44.54 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.748 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.83 127.97 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.37 1.068 . . . . 0.0 109.503 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -110.83 150.88 28.51 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.991 0.916 . . . . 0.0 110.502 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 tp -132.36 99.32 4.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -82.76 102.3 11.48 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.646 ' HB3' HD21 ' A' ' 87' ' ' LEU . 34.4 mtm -95.53 132.61 40.46 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 83.7 m-20 -128.98 149.77 50.68 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.444 0.698 . . . . 0.0 109.775 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 t 47.59 68.74 0.61 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.95 1.3 . . . . 0.0 111.15 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.646 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -81.59 157.58 24.69 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.577 -170.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.43 149.72 36.94 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.896 0.878 . . . . 0.0 108.632 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -58.84 -23.16 65.88 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 122.626 2.217 . . . . 0.0 113.182 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.01 -14.36 62.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.216 1.006 . . . . 0.0 112.348 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 119' ' ' VAL . 30.0 m-20 -81.22 27.52 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.657 0.783 . . . . 0.0 111.85 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 93.7 m -81.49 92.05 6.42 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 165.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.83 9.25 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.446 0.699 . . . . 0.0 110.794 -170.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.96 114.52 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.335 0.588 . . . . 0.0 109.877 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -86.23 113.59 22.36 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.25 148.3 40.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.713 0.805 . . . . 0.0 109.857 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 31.7 p -96.05 155.2 16.86 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.23 13.53 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.26 166.38 11.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.825 0.85 . . . . 0.0 110.462 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.83 -166.94 40.11 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 112.301 -0.319 . . . . 0.0 112.301 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.32 170.19 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.411 0.684 . . . . 0.0 111.465 -174.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.482 ' HB3' HD21 ' A' ' 33' ' ' ASN . 64.8 p-90 -66.04 155.81 35.62 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.944 0.897 . . . . 0.0 110.889 173.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 -134.8 142.34 46.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.422 0.689 . . . . 0.0 110.765 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 33.6 m -80.75 -11.64 59.58 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.07 0.948 . . . . 0.0 111.0 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 m -64.57 -23.41 67.26 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.564 0.746 . . . . 0.0 111.073 171.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.83 -30.55 9.16 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.405 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -76.94 117.99 19.09 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.998 0.519 . . . . 0.0 110.005 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.54 119.84 11.21 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.8 m -139.48 128.25 13.67 Favored Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.42 146.57 27.88 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.501 2.134 . . . . 0.0 112.109 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.54 -29.03 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.391 1.076 . . . . 0.0 110.192 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -117.99 128.03 54.39 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 0.0 109.131 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -110.13 128.88 55.71 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 166.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.39 -178.36 47.71 Favored Glycine 0 C--N 1.339 0.718 0 O-C-N 123.703 0.627 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.12 -27.09 63.33 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.135 0.574 . . . . 0.0 110.79 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.97 170.12 38.02 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.922 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.9 t -141.66 124.72 16.28 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.199 0.6 . . . . 0.0 109.528 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.63 101.45 7.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.615 0.766 . . . . 0.0 111.275 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.538 HG12 ' HA2' ' A' ' 10' ' ' GLY . 17.3 m -88.11 147.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 169.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 87.2 m -135.07 103.28 5.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.9 t -90.12 96.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.416 ' OG ' ' HB2' ' A' ' 125' ' ' GLU . 12.2 t -69.92 150.34 46.85 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.797 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.6 m -73.34 85.8 1.46 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.739 0.816 . . . . 0.0 111.133 -172.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 67.45 2.13 2.79 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.568 1.547 . . . . 0.0 112.991 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.416 ' HB2' ' OG ' ' A' ' 122' ' ' SER . 9.8 mm-40 -90.36 89.38 7.58 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.026 0.531 . . . . 0.0 110.279 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -75.27 -18.74 60.0 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.427 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -78.4 116.93 19.16 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -160.5 173.14 16.0 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.045 0.938 . . . . 0.0 109.796 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.89 141.07 37.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -105.55 118.52 36.79 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.416 173.78 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -81.03 158.7 25.02 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.142 0.577 . . . . 0.0 109.768 169.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.45 116.7 14.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.168 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 26' ' ' SER . 16.7 mt-30 -91.91 108.91 20.27 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.426 0.69 . . . . 0.0 109.447 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.753 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 4.9 mp -118.71 119.35 34.18 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.4 101.02 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -92.51 135.67 33.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.933 -174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 p -148.54 165.23 31.86 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.386 1.074 . . . . 0.0 109.72 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.84 -24.77 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.73 128.96 38.56 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.081 0.372 . . . . 0.0 113.175 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.84 -174.12 45.47 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.3 tp -78.03 116.98 18.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.06 0.544 . . . . 0.0 109.896 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 121' ' ' VAL . 4.8 m -129.42 163.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.414 1.086 . . . . 0.0 109.611 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 145.34 24.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.787 0.435 . . . . 0.0 111.399 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 127.17 30.35 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.341 1.057 . . . . 0.0 110.998 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.53 62.06 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 123.604 0.565 . . . . 0.0 112.304 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.04 -166.34 39.54 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -141.46 130.41 23.15 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.0 tp -129.53 122.47 29.29 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.027 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -93.46 117.74 30.46 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.6 151.32 23.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.973 0.909 . . . . 0.0 109.175 172.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.4 p -136.59 126.22 25.39 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.624 0.77 . . . . 0.0 109.365 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 50.0 t -120.27 102.85 8.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.977 1.311 . . . . 0.0 109.372 -174.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -95.3 118.39 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 124.565 1.146 . . . . 0.0 109.639 -170.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.53 99.69 11.86 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.945 -0.472 . . . . 0.0 110.643 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 27.3 t 49.6 39.39 17.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.568 1.547 . . . . 0.0 111.506 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.27 -89.96 1.11 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -168.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HG2' ' HB2' ' A' ' 77' ' ' LYS . 98.2 mtt180 -140.32 94.85 2.79 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 t -133.42 157.65 45.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.391 0.676 . . . . 0.0 110.013 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -112.42 119.76 39.34 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -154.38 -82.15 0.08 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.1 p -77.61 121.04 23.4 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 122.862 0.465 . . . . 0.0 111.275 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.569 ' HB3' ' HD1' ' A' ' 54' ' ' TRP . 40.6 m-80 -92.84 10.36 31.35 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.267 173.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.57 122.79 15.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.653 1.181 . . . . 0.0 108.864 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.7 mtt -140.79 165.53 27.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.587 1.555 . . . . 0.0 108.546 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -166.36 156.17 27.88 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.612 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -108.14 133.67 52.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.387 1.075 . . . . 0.0 108.599 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -136.44 139.37 42.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.132 0.973 . . . . 0.0 108.829 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 46' ' ' ARG . 33.4 ptt85 -103.68 137.98 40.97 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.492 0.717 . . . . 0.0 109.834 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.461 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 61.8 tt0 -143.83 130.72 20.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.059 0.544 . . . . 0.0 109.726 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.94 161.67 30.86 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.469 0.708 . . . . 0.0 109.563 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.35 110.45 0.49 Allowed 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.59 2.193 . . . . 0.0 113.299 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.88 6.79 88.68 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -106.35 174.57 5.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.896 0.878 . . . . 0.0 110.549 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.45 166.37 22.07 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.833 0.853 . . . . 0.0 111.096 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -103.67 113.53 27.11 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 110.475 175.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -93.03 143.91 25.77 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.812 0.845 . . . . 0.0 110.382 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -62.76 118.12 7.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.751 0.821 . . . . 0.0 111.267 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -88.03 -47.16 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.15 176.47 8.45 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.785 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.591 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -156.98 127.24 6.43 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 123.886 0.874 . . . . 0.0 110.265 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.565 HD12 HG13 ' A' ' 80' ' ' VAL . 11.4 mt -118.92 118.06 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.35 1.06 . . . . 0.0 110.353 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -96.12 -175.84 3.5 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.218 1.007 . . . . 0.0 109.002 167.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.569 ' HD1' ' HB3' ' A' ' 33' ' ' ASN . 46.5 p-90 -43.61 160.29 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 123.426 0.69 . . . . 0.0 112.375 165.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -60.79 120.13 9.53 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.578 0.751 . . . . 0.0 111.639 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.51 -18.06 25.4 Favored Glycine 0 C--N 1.351 1.377 0 C-N-CA 123.434 0.54 . . . . 0.0 112.582 -172.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.94 12.3 8.18 Favored Glycine 0 N--CA 1.477 1.38 0 C-N-CA 123.248 0.451 . . . . 0.0 112.184 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 p -90.55 74.5 6.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.183 0.993 . . . . 0.0 110.362 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -158.71 123.21 4.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.619 0.767 . . . . 0.0 110.031 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HB3' ' N ' ' A' ' 51' ' ' ALA . 4.4 t80 -171.36 141.82 1.61 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.476 0.71 . . . . 0.0 109.675 172.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -165.86 156.75 13.4 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.624 0.77 . . . . 0.0 110.383 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.68 167.28 11.56 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.754 0.822 . . . . 0.0 110.078 167.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.32 -29.11 69.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.733 0.813 . . . . 0.0 112.036 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -68.22 -33.39 74.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.208 0.603 . . . . 0.0 111.42 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 69' ' ' PHE . 26.4 m -105.83 9.39 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.635 0.774 . . . . 0.0 111.098 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.07 119.19 8.44 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.391 1.076 . . . . 0.0 110.84 -177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.24 -16.67 15.99 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -98.51 -45.8 5.98 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.212 0.605 . . . . 0.0 109.384 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.457 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.8 m-85 -98.12 120.04 37.83 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.2 m -124.99 144.8 50.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.561 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -127.52 141.67 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.065 0.546 . . . . 0.0 110.826 -175.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -150.63 137.77 19.34 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.277 1.031 . . . . 0.0 109.694 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.51 ' HB2' HG21 ' A' ' 52' ' ' ILE . 22.1 ttp85 -124.6 130.16 51.92 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -105.27 110.01 22.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.886 1.274 . . . . 0.0 111.794 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.93 68.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.137 0.975 . . . . 0.0 111.712 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HE3' ' HB ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -120.23 -3.91 10.0 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.455 176.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 52.92 67.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.43 1.092 . . . . 0.0 111.451 -171.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.453 ' HB ' ' HE3' ' A' ' 77' ' ' LYS . 92.3 m -127.15 132.83 50.45 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.682 173.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.565 HG13 HD12 ' A' ' 52' ' ' ILE . 23.3 t -101.6 151.16 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.773 1.229 . . . . 0.0 108.607 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -133.04 141.36 48.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.462 0.705 . . . . 0.0 109.59 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.45 ' HG ' ' HG3' ' A' ' 84' ' ' MET . 66.3 tp -128.48 99.55 5.43 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -83.3 98.04 9.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.45 ' HG3' ' HG ' ' A' ' 82' ' ' LEU . 72.6 mtp -90.74 107.74 19.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.143 0.977 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.9 153.45 23.02 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.946 0.498 . . . . 0.0 110.156 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.5 t 60.07 62.17 1.69 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.562 1.145 . . . . 0.0 109.936 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.8 mt -67.13 152.73 45.22 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.088 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -120.71 151.53 54.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.84 -15.2 45.61 Favored 'Trans proline' 0 CA--C 1.563 1.931 0 C-N-CA 122.15 1.9 . . . . 0.0 112.252 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.98 -25.1 66.16 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.597 1.159 . . . . 0.0 111.756 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -82.2 24.15 0.68 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.661 0.784 . . . . 0.0 111.929 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 120' ' ' THR . 64.4 m -79.66 90.44 5.18 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 159.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 40' ' ' GLN . . . -167.5 -174.31 2.48 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.446 -168.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.2 p -109.24 108.23 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.676 0.79 . . . . 0.0 109.807 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -85.04 116.3 23.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 167.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.462 HD13 ' HD1' ' A' ' 113' ' ' TRP . 2.5 pp -115.07 137.24 52.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 111.071 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.5 t -93.75 156.1 16.86 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.42 156.04 41.97 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.446 0.698 . . . . 0.0 109.713 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.64 158.61 37.33 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.906 0.482 . . . . 0.0 111.558 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.96 149.15 5.26 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 t -111.45 19.34 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.062 0.934 . . . . 0.0 109.572 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -114.66 104.79 12.33 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -126.37 138.94 53.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.1 m -89.36 -41.85 11.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.486 0.714 . . . . 0.0 111.164 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.2 t -78.34 -24.95 46.3 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.001 0.92 . . . . 0.0 111.723 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.23 -28.77 11.69 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -174.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -67.37 143.35 56.38 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.49 0.716 . . . . 0.0 109.758 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.47 99.22 0.55 Allowed 'General case' 0 N--CA 1.476 0.869 0 O-C-N 123.878 0.736 . . . . 0.0 110.478 -174.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 24.9 p -134.5 149.58 71.4 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.959 1.304 . . . . 0.0 109.389 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.14 154.63 29.09 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.441 2.094 . . . . 0.0 112.678 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.81 -40.23 6.65 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -121.94 164.35 17.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.162 0.985 . . . . 0.0 110.174 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.462 ' HD1' HD13 ' A' ' 96' ' ' LEU . 31.8 m-90 -119.7 157.53 28.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.695 1.198 . . . . 0.0 108.751 174.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -76.53 -76.43 0.83 Allowed Glycine 0 C--N 1.341 0.815 0 O-C-N 123.177 0.298 . . . . 0.0 112.987 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.92 -42.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 109.626 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.1 113.95 3.58 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.787 -172.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 t -96.41 108.67 21.25 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.832 0.825 . . . . 0.0 109.391 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 106.11 4.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.293 -175.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.47 125.28 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.588 HG23 HG23 ' A' ' 92' ' ' THR . 26.0 m -120.04 104.42 10.12 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 13' ' ' VAL . 57.8 t -89.23 105.79 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 O-C-N 121.862 -0.523 . . . . 0.0 110.365 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.2 m -58.74 139.27 56.44 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.46 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.9 m -72.54 91.14 1.38 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 73.81 -22.94 0.23 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.668 1.587 . . . . 0.0 113.111 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -77.58 145.39 36.88 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.123 0.969 . . . . 0.0 110.693 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -99.9 145.83 27.35 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.496 0.718 . . . . 0.0 110.657 -174.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -83.05 96.65 8.42 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.796 0.838 . . . . 0.0 110.159 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -76.15 111.1 11.21 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -68.78 133.82 48.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.688 0.795 . . . . 0.0 111.05 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -131.09 131.96 44.54 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 171.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.006 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 ttm . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -99.18 85.56 3.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.933 0.893 . . . . 0.0 109.152 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.33 111.64 9.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.35 129.68 48.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.479 0.712 . . . . 0.0 109.667 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.45 HD22 ' SG ' ' A' ' 23' ' ' CYS . 89.7 mt -124.94 107.61 11.03 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.6 t -98.89 101.74 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 22' ' ' SER . 47.1 mt-10 -100.9 143.97 30.41 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.11 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.9 p -160.54 157.79 28.03 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.091 0.957 . . . . 0.0 109.792 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.443 ' O ' HD11 ' A' ' 19' ' ' LEU . . . 130.85 -32.27 3.05 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -59.09 127.96 46.43 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.261 0.464 . . . . 0.0 114.261 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.27 -178.45 46.06 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 120' ' ' THR . 22.8 tp -88.18 109.51 19.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.86 0.464 . . . . 0.0 109.798 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 19' ' ' LEU . 18.5 m -126.68 151.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.089 0.956 . . . . 0.0 109.373 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -75.64 151.11 37.83 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.438 0.563 . . . . 0.0 111.259 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -64.11 125.09 23.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.156 0.982 . . . . 0.0 110.407 175.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.18 -20.26 26.22 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 123.814 0.721 . . . . 0.0 111.35 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.62 -166.94 9.88 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 121.598 0.554 . . . . 0.0 113.618 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.4 p -133.01 132.73 42.21 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.013 0.925 . . . . 0.0 109.395 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 13' ' ' VAL . 25.5 tp -134.95 118.76 17.22 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -97.65 120.8 38.69 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.128 0.571 . . . . 0.0 109.693 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.9 157.26 19.55 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.199 0.6 . . . . 0.0 109.394 172.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 18.6 p -145.92 126.11 13.84 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.845 0.858 . . . . 0.0 109.191 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 52.5 t -123.19 107.54 11.83 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.468 1.107 . . . . 0.0 108.901 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 21.2 t -89.24 115.22 28.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.642 0.777 . . . . 0.0 109.023 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.19 103.23 15.87 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -174.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p 54.66 36.74 26.79 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.707 1.603 . . . . 0.0 112.381 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.94 -107.94 2.41 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.69 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -118.79 10.98 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.009 0.924 . . . . 0.0 110.288 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -81.78 146.99 29.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -104.21 115.75 30.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -151.35 10.76 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.883 1.673 . . . . 0.0 108.847 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 p -86.99 88.52 7.72 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.224 1.01 . . . . 0.0 110.453 -174.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.74 -48.7 53.07 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.555 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.86 126.95 1.03 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.338 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.429 ' HE1' ' NH1' ' A' ' 73' ' ' ARG . 1.8 mpp? -125.44 119.76 29.15 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.657 1.183 . . . . 0.0 108.337 175.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -103.49 140.39 14.87 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 174.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -87.71 125.26 34.3 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -126.61 148.55 49.78 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -126.56 139.09 53.47 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -121.81 130.0 53.07 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.92 154.53 83.0 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -53.73 102.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.448 2.099 . . . . 0.0 112.41 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.52 20.99 23.21 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.931 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 6.9 mmpt? -133.44 170.41 15.52 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.83 0.824 . . . . 0.0 112.453 -174.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.24 176.46 6.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.982 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.26 157.48 37.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -127.61 125.65 40.61 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 167.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.36 110.26 4.02 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.18 -51.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.348 0.659 . . . . 0.0 109.64 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.69 170.04 22.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.212 0.605 . . . . 0.0 111.706 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -154.59 120.2 5.14 Favored 'General case' 0 C--O 1.25 1.126 0 C-N-CA 124.053 0.941 . . . . 0.0 110.131 173.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.645 HG23 ' HB3' ' A' ' 58' ' ' SER . 4.0 mp -122.65 116.51 49.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.392 1.077 . . . . 0.0 109.045 -175.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.87 178.33 5.47 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.091 0.556 . . . . 0.0 109.636 172.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.432 ' HE1' ' ND2' ' A' ' 75' ' ' ASN . 28.0 t90 -71.89 -28.45 63.53 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 120.982 0.42 . . . . 0.0 110.22 171.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.2 t -153.0 160.98 43.07 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.73 0.812 . . . . 0.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.93 11.7 25.7 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.848 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.83 -52.33 0.65 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.645 ' HB3' HG23 ' A' ' 52' ' ' ILE . 20.3 m 61.25 64.59 1.07 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.632 0.773 . . . . 0.0 112.166 168.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -157.21 123.49 4.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.954 0.901 . . . . 0.0 109.883 -166.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 51' ' ' ALA . 25.8 m-85 -158.5 135.83 10.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.943 0.897 . . . . 0.0 109.167 175.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.55 153.9 11.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.554 1.542 . . . . 0.0 108.889 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.38 151.36 32.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.425 0.69 . . . . 0.0 109.789 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -58.2 -33.28 69.11 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.487 0.715 . . . . 0.0 111.498 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 m -66.82 -29.91 69.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.318 1.047 . . . . 0.0 112.208 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.48 -7.12 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.347 0.659 . . . . 0.0 111.869 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.05 122.48 17.49 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.603 0.761 . . . . 0.0 110.544 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.35 -28.54 14.05 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.666 0.604 . . . . 0.0 111.979 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 10.1 mtm180 -88.97 -52.89 4.85 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -91.39 131.6 36.77 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.722 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -140.9 150.21 42.89 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.458 1.103 . . . . 0.0 108.461 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.45 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -123.29 144.01 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.147 0.579 . . . . 0.0 110.491 178.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -144.13 134.4 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.101 0.96 . . . . 0.0 109.05 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.517 ' HB2' HG21 ' A' ' 52' ' ' ILE . 46.4 ttt180 -111.9 125.05 53.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.012 0.525 . . . . 0.0 110.363 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.523 ' HB3' ' HE3' ' A' ' 77' ' ' LYS . 60.6 m-20 -103.0 94.64 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.432 ' ND2' ' HE1' ' A' ' 54' ' ' TRP . 63.9 t30 -65.61 -26.07 67.67 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.824 0.85 . . . . 0.0 111.936 -173.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.58 73.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.678 0.791 . . . . 0.0 112.27 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.523 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -118.59 8.18 11.93 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.582 0.753 . . . . 0.0 110.528 176.229 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 55.82 30.73 16.32 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.843 1.257 . . . . 0.0 112.851 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.4 m -111.39 130.46 55.69 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.26 138.99 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 108.702 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -117.27 139.62 50.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.896 0.878 . . . . 0.0 110.055 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.1 tp -113.78 97.64 6.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -84.06 100.67 11.24 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 36.6 mtm -94.07 126.47 39.31 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -122.69 167.14 13.82 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 68' ' ' ARG . 13.5 m 57.65 40.2 26.82 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.622 0.769 . . . . 0.0 110.42 173.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.7 mt -56.85 142.99 38.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.653 -170.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.638 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -105.68 151.22 39.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.29 -14.19 40.48 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.199 1.933 . . . . 0.0 112.683 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.638 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.5 pt-20 -65.72 -22.02 66.58 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.453 0.701 . . . . 0.0 111.565 173.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -78.28 23.62 0.28 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.822 0.849 . . . . 0.0 111.647 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 120' ' ' THR . 99.0 m -82.79 92.54 7.26 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 163.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.02 -174.74 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.312 0.645 . . . . 0.0 111.106 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.447 ' HB ' HE21 ' A' ' 118' ' ' GLN . 3.6 p -107.93 112.04 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -85.45 108.73 18.02 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -112.18 138.45 48.84 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.977 0.911 . . . . 0.0 109.435 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 23' ' ' CYS . 52.1 m -91.29 139.07 31.08 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.71 116.86 16.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.592 0.757 . . . . 0.0 109.136 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 35' ' ' MET . . . -111.87 152.96 27.35 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.104 0.562 . . . . 0.0 110.362 -173.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -135.99 149.68 20.14 Favored Glycine 0 C--O 1.241 0.573 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.9 m -72.11 166.91 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.095 0.558 . . . . 0.0 110.267 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -53.85 133.75 42.65 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.8 0.84 . . . . 0.0 112.096 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.698 ' NH2' ' HA ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -136.31 155.96 49.33 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.673 0.789 . . . . 0.0 110.347 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.5 m -77.2 -22.25 52.65 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.976 0.91 . . . . 0.0 111.257 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.2 p -74.04 -26.24 60.3 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.574 0.75 . . . . 0.0 112.232 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.14 -31.24 3.17 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 115.104 0.802 . . . . 0.0 115.104 173.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -73.94 153.57 39.73 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.071 0.935 . . . . 0.0 111.044 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.698 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 25.5 t70 -75.71 125.44 29.07 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.099 -174.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.9 t -125.15 114.9 26.06 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.699 -173.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.39 95.04 0.37 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.783 2.322 . . . . 0.0 111.441 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -97.22 -47.93 5.55 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.363 0.602 . . . . 0.0 109.705 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -111.07 144.17 40.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.73 1.212 . . . . 0.0 108.438 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -120.97 137.92 54.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.335 0.654 . . . . 0.0 109.247 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.03 -137.04 1.05 Allowed Glycine 0 C--N 1.346 1.117 0 O-C-N 123.338 0.399 . . . . 0.0 113.151 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -94.92 -30.89 13.92 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.073 0.549 . . . . 0.0 110.599 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.22 116.95 0.13 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.249 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -99.37 123.35 43.57 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 117.229 0.514 . . . . 0.0 110.489 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.447 HE21 ' HB ' ' A' ' 94' ' ' VAL . 3.7 mm-40 -77.39 101.48 6.38 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.261 1.024 . . . . 0.0 110.707 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.559 HG12 ' HA2' ' A' ' 10' ' ' GLY . 20.0 m -93.01 137.5 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.562 HG23 HG23 ' A' ' 92' ' ' THR . 70.2 m -134.17 105.03 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 91.3 t -87.77 98.22 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.4 t -50.43 131.2 24.54 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.382 1.073 . . . . 0.0 111.742 172.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.6 p -76.4 82.52 3.13 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.057 0.543 . . . . 0.0 110.616 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.5 mm? 63.26 7.41 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.007 1.323 . . . . 0.0 114.071 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -88.55 143.34 27.02 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -85.38 109.1 18.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.745 0.818 . . . . 0.0 110.776 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -80.95 140.5 35.22 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -122.78 115.05 21.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -79.64 -27.24 40.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.18 0.992 . . . . 0.0 111.468 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 72.09 -77.44 0.06 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.626 1.17 . . . . 0.0 111.068 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.6 t60 . . . . . 0 C--O 1.246 0.911 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.333 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' N ' ' SD ' ' A' ' 1' ' ' MET . 96.6 mt-30 67.99 -175.22 0.2 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.221 1.008 . . . . 0.0 110.806 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.88 113.47 22.04 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 168.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -117.68 133.9 55.46 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.51 1.124 . . . . 0.0 108.812 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.648 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 94.3 mt -131.68 120.8 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.915 0.886 . . . . 0.0 109.381 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.469 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 23.2 t -98.42 104.88 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 108.537 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -104.66 151.08 24.12 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.369 0.668 . . . . 0.0 111.19 -168.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 p -157.15 170.75 21.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.658 0.783 . . . . 0.0 111.079 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.64 -2.09 32.28 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.26 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.569 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -69.34 120.34 10.21 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 113.957 0.343 . . . . 0.0 113.957 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.76 179.48 48.78 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 120' ' ' THR . 10.2 tt -88.02 128.55 35.4 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.411 0.284 . . . . 0.0 110.288 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -120.58 152.53 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.25 150.99 35.31 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.502 ' HB3' HD22 ' A' ' 124' ' ' LEU . . . -59.7 127.6 32.82 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.55 0.74 . . . . 0.0 110.552 174.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.06 -26.15 18.13 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.2 -179.22 52.46 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 122.873 0.273 . . . . 0.0 113.292 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -121.0 164.64 16.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.042 0.937 . . . . 0.0 110.563 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.4 tp -159.47 123.65 3.87 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.579 0.752 . . . . 0.0 109.982 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -99.32 129.58 45.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.06 0.544 . . . . 0.0 109.576 173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -96.42 154.32 17.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.325 1.05 . . . . 0.0 109.007 171.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -143.54 128.74 18.74 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 30.8 t -137.74 104.61 5.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.46 0.704 . . . . 0.0 110.065 -172.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -84.75 145.28 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.812 . . . . 0.0 110.25 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.539 ' HA ' HD23 ' A' ' 5' ' ' LEU . . . -89.98 100.43 13.25 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.124 0.57 . . . . 0.0 110.063 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p 56.46 -75.38 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.85 2.06 . . . . 0.0 112.457 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.74 -64.38 0.06 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -161.66 39.32 0.13 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.06 0.933 . . . . 0.0 109.451 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -107.36 151.04 26.04 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.53 ' HB3' HD21 ' A' ' 78' ' ' ASN . 19.5 p90 -105.29 126.31 51.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.813 0.845 . . . . 0.0 108.878 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -150.66 146.68 26.64 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.832 0.853 . . . . 0.0 109.074 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t 66.07 115.34 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.212 1.405 . . . . 0.0 111.183 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -80.67 7.83 9.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.4 0.68 . . . . 0.0 111.299 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.86 119.92 21.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.561 0.744 . . . . 0.0 109.306 172.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.8 mtt -137.38 119.9 16.0 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -125.29 142.46 13.82 Favored Glycine 0 N--CA 1.468 0.832 0 CA-C-N 118.102 0.41 . . . . 0.0 112.92 -172.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.412 ' HE1' HG12 ' A' ' 80' ' ' VAL . 95.0 m95 -86.06 117.89 25.19 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -117.02 171.34 7.99 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.922 1.289 . . . . 0.0 108.595 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -150.83 130.93 13.47 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.924 0.49 . . . . 0.0 110.029 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -110.56 128.83 55.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.12 39.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.493 0.717 . . . . 0.0 109.658 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.74 107.72 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.778 2.318 . . . . 0.0 113.119 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.49 1.52 66.24 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.552 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.4 mmpt? -114.98 173.43 6.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.223 1.009 . . . . 0.0 110.203 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.59 176.48 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.024 0.93 . . . . 0.0 110.425 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.82 124.01 24.51 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.172 0.51 . . . . 0.0 111.141 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.15 134.63 36.39 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.358 1.063 . . . . 0.0 109.366 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -71.11 109.36 5.14 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.812 0.695 . . . . 0.0 109.305 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.57 -53.24 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.81 174.75 10.3 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.922 -172.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -159.85 142.07 13.31 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 122.15 0.976 . . . . 0.0 112.014 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 71' ' ' ILE . 4.0 mp -109.78 114.06 45.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.139 174.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -98.11 109.22 22.01 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 168.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -71.05 81.12 0.67 Allowed 'General case' 0 C--N 1.35 0.589 0 C-N-CA 123.386 0.674 . . . . 0.0 109.225 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.43 ' H ' ' H ' ' A' ' 56' ' ' GLY . 21.5 t 179.09 8.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.641 1.576 . . . . 0.0 109.924 -175.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 55' ' ' SER . . . 110.16 -18.44 28.35 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 119.928 -0.374 . . . . 0.0 113.218 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.87 44.65 2.69 Favored Glycine 0 N--CA 1.478 1.461 0 CA-C-N 117.387 0.593 . . . . 0.0 112.463 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 13.5 p -85.79 39.83 0.82 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.643 1.177 . . . . 0.0 112.445 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -154.08 121.18 5.68 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.472 0.709 . . . . 0.0 110.021 -166.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.453 ' HB2' ' H ' ' A' ' 51' ' ' ALA . 32.3 m-85 -158.25 154.58 27.44 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.764 1.626 . . . . 0.0 107.028 170.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -166.49 148.4 6.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.04 0.536 . . . . 0.0 110.368 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.01 25.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.6 -34.1 76.34 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -66.81 -18.44 65.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.696 0.798 . . . . 0.0 112.617 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.13 5.27 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 122.974 0.51 . . . . 0.0 111.662 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -60.19 131.68 51.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.544 0.738 . . . . 0.0 111.54 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.91 -28.32 4.57 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.167 173.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 88.9 mtm180 -92.67 -47.85 6.88 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.509 0.723 . . . . 0.0 110.158 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -87.84 122.62 31.7 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.3 m -124.99 133.54 52.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.378 1.071 . . . . 0.0 108.446 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.548 ' HB ' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -120.77 146.8 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 122.766 0.426 . . . . 0.0 110.636 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 p -159.37 151.51 20.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.602 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' HB3' HG21 ' A' ' 52' ' ' ILE . 52.6 ttt180 -128.36 123.42 33.83 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -105.22 103.23 12.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -76.82 -11.83 59.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.218 0.607 . . . . 0.0 111.49 -173.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.73 -40.59 92.34 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 122.549 0.34 . . . . 0.0 111.861 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -112.39 1.9 16.2 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 117.99 0.359 . . . . 0.0 110.905 169.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.53 HD21 ' HB3' ' A' ' 30' ' ' PHE . 18.5 m120 58.56 66.66 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.843 1.257 . . . . 0.0 110.807 176.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.8 m -141.8 132.36 25.39 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.088 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.412 HG12 ' HE1' ' A' ' 37' ' ' TRP . 27.5 t -111.17 130.0 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.381 1.072 . . . . 0.0 108.965 -173.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -113.23 148.68 35.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.729 0.812 . . . . 0.0 111.308 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 65.5 tp -132.0 98.07 4.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -87.73 100.53 12.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.753 ' HB3' HD21 ' A' ' 87' ' ' LEU . 48.2 mtm -94.34 142.18 27.71 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.591 0.757 . . . . 0.0 108.99 175.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 18.1 m120 -136.81 150.15 48.16 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.45 0.7 . . . . 0.0 110.016 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 t 52.31 59.91 4.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.361 1.064 . . . . 0.0 111.704 173.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.753 HD21 ' HB3' ' A' ' 84' ' ' MET . 93.1 mt -79.66 161.08 26.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.4 -171.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.1 153.4 61.15 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.276 1.03 . . . . 0.0 108.62 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 121' ' ' VAL . 37.7 Cg_endo -60.8 -15.66 39.31 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.862 2.375 . . . . 0.0 115.04 -168.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -72.56 -14.66 61.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.106 0.563 . . . . 0.0 111.983 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -82.15 19.52 1.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.403 0.681 . . . . 0.0 111.019 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 96.7 m -75.31 92.44 2.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 165.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -162.4 164.05 27.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.449 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.41 ' HB ' HE21 ' A' ' 118' ' ' GLN . 6.0 p -88.27 107.45 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.414 174.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -84.66 138.02 32.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 113' ' ' TRP . 1.7 pt? -150.2 139.75 21.56 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.935 0.494 . . . . 0.0 110.889 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.7 m -87.74 114.69 24.59 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -107.78 117.01 33.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 108.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.18 116.83 31.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.29 159.29 29.31 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.491 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.24 118.66 43.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.579 ' HD1' ' HA ' ' A' ' 108' ' ' ASP . 6.3 m-90 -61.86 141.17 58.12 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -63.17 162.84 11.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.767 0.427 . . . . 0.0 111.55 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.0 t -65.81 -25.15 67.1 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.235 0.614 . . . . 0.0 110.745 175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 p -73.13 -24.57 60.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.411 0.684 . . . . 0.0 111.051 172.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.18 -7.38 28.89 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.096 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -64.94 137.6 57.84 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.253 0.621 . . . . 0.0 110.481 -175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.579 ' HA ' ' HD1' ' A' ' 102' ' ' TRP . 21.9 t70 -72.21 126.87 30.88 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.238 0.615 . . . . 0.0 110.489 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.94 107.35 4.27 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.616 0.766 . . . . 0.0 111.006 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.583 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 2.6 Cg_exo -77.39 123.4 6.53 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.13 2.553 . . . . 0.0 110.433 167.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -91.29 -47.01 7.73 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.432 0.693 . . . . 0.0 110.336 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -125.78 158.53 34.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.773 . . . . 0.0 109.945 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.418 ' HB3' HD12 ' A' ' 96' ' ' LEU . 22.7 m-90 -128.0 152.72 47.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.559 1.144 . . . . 0.0 108.534 178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.21 46.52 3.4 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.965 -173.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 6' ' ' VAL . 46.2 mt-30 73.26 -45.81 0.63 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.633 1.573 . . . . 0.0 111.857 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . 98.36 112.06 3.13 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -97.75 123.16 41.57 Favored 'General case' 0 CA--C 1.559 1.299 0 CA-C-O 121.885 0.85 . . . . 0.0 109.965 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.41 HE21 ' HB ' ' A' ' 94' ' ' VAL . 4.0 mm-40 -80.35 103.76 10.44 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.243 1.017 . . . . 0.0 110.567 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.569 HG12 ' HA2' ' A' ' 10' ' ' GLY . 3.5 m -105.26 150.56 7.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 89.8 m -134.85 114.6 12.75 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' PRO . 40.8 t -92.42 105.2 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 12' ' ' LEU . 15.0 t -73.72 158.02 35.43 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 120.667 0.27 . . . . 0.0 111.036 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.7 p -84.85 73.14 10.68 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.686 0.795 . . . . 0.0 110.667 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 15' ' ' ALA . 3.9 mm? 71.89 -14.67 0.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.521 1.528 . . . . 0.0 113.765 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.46 ' HB2' ' OG ' ' A' ' 122' ' ' SER . 2.4 mp0 -63.12 106.9 0.93 Allowed 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.97 0.805 . . . . 0.0 109.739 173.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -74.22 -10.32 59.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.944 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -63.9 98.62 0.21 Allowed 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.68 0.792 . . . . 0.0 108.924 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.512 ' HA ' HD22 ' A' ' 12' ' ' LEU . 57.6 m80 -67.8 133.46 49.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.84 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.2 t60 58.57 87.55 0.07 Allowed 'General case' 0 CA--C 1.55 0.962 0 O-C-N 124.587 1.179 . . . . 0.0 108.652 -169.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -50.67 -40.25 53.1 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.518 1.127 . . . . 0.0 113.369 -165.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 . . . . . 0 C--O 1.244 0.784 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -63.85 144.61 56.92 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.081 0.552 . . . . 0.0 110.679 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -72.25 108.79 5.58 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -112.19 127.83 56.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.653 0.781 . . . . 0.0 109.535 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.673 HD11 ' HG2' ' A' ' 35' ' ' MET . 96.4 mt -132.84 122.77 24.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.616 1.166 . . . . 0.0 109.703 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -106.48 102.29 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.02 145.1 27.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 p -160.88 168.09 25.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.852 0.861 . . . . 0.0 110.257 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.06 17.82 21.63 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.406 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -78.32 134.81 14.76 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.14 -178.54 47.67 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 120' ' ' THR . 8.6 tt -98.37 131.78 44.38 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.918 0.487 . . . . 0.0 109.889 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.68 170.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.926 1.291 . . . . 0.0 107.907 171.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -90.77 154.04 19.81 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 122.742 0.417 . . . . 0.0 109.964 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.45 124.97 24.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.761 0.824 . . . . 0.0 110.567 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.36 -23.35 24.97 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.03 174.81 48.79 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.774 0.338 . . . . 0.0 112.371 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.0 p -106.11 162.76 13.34 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.372 0.669 . . . . 0.0 110.566 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.6 tp -159.8 121.82 3.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.063 0.945 . . . . 0.0 108.613 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -98.53 122.41 41.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.062 0.458 . . . . 0.0 110.165 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.451 HD12 HG21 ' A' ' 117' ' ' THR . 3.8 mm? -94.82 145.32 24.97 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.071 0.949 . . . . 0.0 108.966 172.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 p -131.89 126.15 33.46 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.508 0.723 . . . . 0.0 109.15 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 43.2 t -122.73 108.94 13.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.619 1.167 . . . . 0.0 108.623 -177.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.24 129.69 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.135 0.974 . . . . 0.0 109.088 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -87.1 100.96 13.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.6 p 64.62 -75.51 0.04 OUTLIER 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.533 1.933 . . . . 0.0 111.713 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.06 -62.78 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -166.81 67.45 0.1 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -138.89 162.08 35.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.377 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -103.9 122.16 44.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.765 0.826 . . . . 0.0 109.227 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.22 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.531 ' HA ' HD21 ' A' ' 3' ' ' LEU . 5.5 m -71.84 85.03 0.94 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.565 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 73' ' ' ARG . 24.1 p-10 -93.59 -27.07 16.82 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.666 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.3 120.12 15.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.788 -171.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.673 ' HG2' HD11 ' A' ' 5' ' ' LEU . 4.5 mtm -150.82 141.84 23.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.222 1.409 . . . . 0.0 108.837 -175.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.64 136.44 11.06 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 76.2 m95 -86.72 130.12 34.6 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.532 0.666 . . . . 0.0 110.319 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -123.06 171.75 9.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.96 1.304 . . . . 0.0 108.261 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -143.23 131.37 21.88 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 168.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -102.5 130.9 49.46 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -115.99 149.56 43.55 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.007 0.523 . . . . 0.0 110.054 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.27 100.6 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.385 2.056 . . . . 0.0 111.367 172.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.78 5.66 56.5 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.964 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 7.4 mmpt? -138.76 137.89 37.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.723 0.809 . . . . 0.0 109.623 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.32 171.6 5.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.766 0.826 . . . . 0.0 111.555 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.04 124.88 21.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.289 0.566 . . . . 0.0 111.317 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -93.83 126.47 39.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -76.0 106.63 7.7 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -94.95 -48.63 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.541 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . . . -151.19 164.14 37.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -170.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -152.68 134.9 14.98 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.923 0.868 . . . . 0.0 111.442 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.51 118.33 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -121.28 97.43 5.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.258 0.623 . . . . 0.0 109.47 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 67.98 -71.21 0.11 Allowed 'General case' 0 C--N 1.368 1.399 0 C-N-CA 125.278 1.431 . . . . 0.0 108.566 -172.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 t -146.45 -78.79 0.17 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 164.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.03 22.27 70.43 Favored Glycine 0 C--N 1.356 1.648 0 C-N-CA 123.12 0.391 . . . . 0.0 114.054 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.85 -20.58 41.44 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-O 119.334 -0.704 . . . . 0.0 112.797 -172.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.7 t 56.52 66.94 1.07 Allowed 'General case' 0 C--N 1.367 1.331 0 C-N-CA 124.468 1.107 . . . . 0.0 109.602 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -156.86 124.3 5.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -165.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.423 ' H ' HD11 ' A' ' 71' ' ' ILE . 5.5 t80 -169.52 117.28 0.61 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 65' ' ' VAL . 4.8 p90 -164.87 151.92 11.0 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.935 0.894 . . . . 0.0 109.207 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.98 31.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.346 0.658 . . . . 0.0 110.885 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.58 -28.07 68.88 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.368 0.667 . . . . 0.0 110.439 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.8 p -68.32 -28.57 67.27 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.443 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 61' ' ' TYR . 29.3 m -116.37 19.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.615 0.766 . . . . 0.0 111.272 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -67.82 120.63 14.45 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.9 0.88 . . . . 0.0 110.483 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -20.83 26.27 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 65' ' ' VAL . 68.6 mtp180 -85.68 -70.08 0.62 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.15 0.98 . . . . 0.0 110.071 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -86.2 120.86 28.02 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 m -130.2 140.58 50.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.212 1.005 . . . . 0.0 108.615 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.438 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -122.53 147.06 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.535 0.734 . . . . 0.0 109.324 175.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -147.0 133.5 19.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.539 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 33' ' ' ASN . 51.2 ttt-85 -114.7 124.84 52.83 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -103.52 110.87 23.08 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -74.98 -20.18 59.77 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.556 0.742 . . . . 0.0 111.904 -175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.1 -36.86 78.37 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.603 0.361 . . . . 0.0 111.727 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -118.93 -5.68 10.56 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.319 171.247 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 11.4 m-80 60.75 70.37 0.62 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.007 0.923 . . . . 0.0 110.524 -174.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.0 m -138.17 131.68 30.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.36 135.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.745 0.818 . . . . 0.0 109.594 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -121.0 115.01 22.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.836 0.854 . . . . 0.0 109.508 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 tp -92.35 97.79 11.09 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -85.17 100.94 12.08 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.45 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.624 ' SD ' HD21 ' A' ' 87' ' ' LEU . 56.6 mtt -84.23 126.59 33.29 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -129.41 137.31 50.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 t 58.76 73.11 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.593 0.711 . . . . 0.0 110.304 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.624 HD21 ' SD ' ' A' ' 84' ' ' MET . 22.6 mt -75.53 162.5 28.25 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.287 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -125.99 149.16 65.43 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.524 1.129 . . . . 0.0 108.458 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.47 -13.7 40.08 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.956 2.437 . . . . 0.0 112.739 -174.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.43 -28.63 69.81 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.591 1.157 . . . . 0.0 111.891 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -74.92 14.97 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.418 0.687 . . . . 0.0 112.375 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 HG23 ' A' ' 120' ' ' THR . 92.5 m -73.33 89.41 1.59 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 158.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.96 173.37 3.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.722 1.209 . . . . 0.0 109.389 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.26 115.8 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -83.62 133.23 34.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.494 0.718 . . . . 0.0 109.227 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -139.81 120.9 14.71 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.461 0.704 . . . . 0.0 109.891 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.57 ' SG ' ' HB3' ' A' ' 35' ' ' MET . 46.8 t -89.37 116.14 27.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.75 158.67 23.49 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.13 0.972 . . . . 0.0 110.534 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -116.62 139.59 50.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 166.4 -153.49 23.33 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.232 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 m -99.3 82.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-O 122.122 0.963 . . . . 0.0 109.896 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -69.48 117.33 10.96 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.101 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -136.77 159.03 43.05 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.6 m -85.17 -2.26 57.82 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.198 0.599 . . . . 0.0 111.671 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.3 t -80.99 14.3 2.31 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.956 0.903 . . . . 0.0 112.656 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.32 19.02 61.31 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.343 -0.698 . . . . 0.0 114.117 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -51.79 158.59 0.96 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.606 1.162 . . . . 0.0 113.79 -170.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.83 162.95 22.94 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.018 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 59.1 p -40.91 127.23 1.97 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 125.948 1.699 . . . . 0.0 113.661 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 109' ' ' THR . 48.1 Cg_exo -57.32 165.41 5.67 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.813 3.009 . . . . 0.0 114.028 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.24 -47.95 22.06 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.201 0.524 . . . . 0.0 110.069 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 64.6 m-85 -111.84 147.24 36.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.27 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.415 ' HZ2' ' HB ' ' A' ' 109' ' ' THR . 21.6 m-90 -126.13 146.23 50.02 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.735 1.214 . . . . 0.0 107.959 167.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -70.42 -84.13 0.18 Allowed Glycine 0 C--N 1.339 0.744 0 O-C-N 123.664 0.602 . . . . 0.0 113.765 -176.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.26 -46.13 0.14 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -176.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.6 95.13 1.32 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.523 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.451 HG21 HD12 ' A' ' 21' ' ' LEU . 7.2 t -97.85 121.63 40.0 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.532 0.733 . . . . 0.0 110.409 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.36 117.88 20.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.845 0.858 . . . . 0.0 109.097 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.406 HG12 ' HA2' ' A' ' 10' ' ' GLY . 33.5 m -118.38 141.81 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.428 0.691 . . . . 0.0 109.23 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 33.6 m -129.23 104.34 7.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 87' ' ' LEU . 52.6 t -94.17 98.11 7.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.8 t -66.32 150.25 49.13 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.726 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.4 m -71.14 165.36 23.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.925 0.89 . . . . 0.0 111.463 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.55 -42.79 77.88 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -71.65 -92.97 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.136 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 176.54 107.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.892 0.877 . . . . 0.0 108.692 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -148.9 153.16 37.63 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.882 1.273 . . . . 0.0 110.034 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -159.81 138.23 10.44 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 62.18 -177.53 0.13 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.403 1.081 . . . . 0.0 111.932 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -122.23 115.94 23.26 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 17.1 p80 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 124.269 1.028 . . . . 0.0 111.47 -176.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 57.11 -156.49 0.3 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.104 0.962 . . . . 0.0 111.536 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.09 111.26 21.37 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -119.89 108.38 14.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 99' ' ' ALA . 2.9 mm? -96.38 109.02 21.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.01 104.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -76.96 155.83 32.39 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.512 0.673 . . . . 0.0 111.209 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 p -155.33 154.06 31.46 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 108.695 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.52 -2.63 56.09 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -69.57 105.49 1.54 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.08 -175.55 27.2 Favored Glycine 0 C--O 1.245 0.8 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 122' ' ' SER . 9.8 tt -88.31 137.09 32.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 m -136.37 168.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.694 1.198 . . . . 0.0 109.213 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -87.5 151.58 22.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.575 0.75 . . . . 0.0 110.724 177.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.25 141.55 52.43 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 123.32 0.648 . . . . 0.0 110.384 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.52 -26.49 13.72 Favored Glycine 0 N--CA 1.464 0.545 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.09 -172.25 46.04 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 112.161 -0.375 . . . . 0.0 112.161 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.4 p -123.18 164.08 19.38 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.301 0.64 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.4 tp -148.25 127.75 13.19 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -108.28 113.2 26.12 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.532 0.733 . . . . 0.0 109.336 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -84.27 153.39 23.59 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.5 p -142.14 122.06 13.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.889 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.7 t -105.71 111.89 24.75 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.97 0.908 . . . . 0.0 109.486 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.65 118.96 32.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.51 99.44 12.44 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.497 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 22.7 t 59.53 39.45 21.6 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.903 1.281 . . . . 0.0 111.355 173.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.18 -69.69 2.2 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -162.23 87.13 0.62 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.33 1.052 . . . . 0.0 108.491 166.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 26' ' ' SER . 50.1 m -140.37 139.91 35.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.813 0.845 . . . . 0.0 109.227 175.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -106.35 141.29 37.91 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -157.41 -49.06 0.07 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.9 p -98.39 133.8 42.28 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.909 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -97.78 -0.02 46.03 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.134 164.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.47 51.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.472 1.109 . . . . 0.0 108.472 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.635 ' SD ' ' HD2' ' A' ' 73' ' ' ARG . 47.2 mtt -150.68 168.32 24.69 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.515 1.526 . . . . 0.0 109.689 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.89 -171.99 32.73 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -132.86 133.28 43.11 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 171.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.72 155.24 35.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.382 1.073 . . . . 0.0 108.718 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -123.45 136.33 54.55 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.206 0.526 . . . . 0.0 110.407 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.572 ' HB2' HG13 ' A' ' 94' ' ' VAL . 21.8 mm-40 -106.01 154.6 20.38 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.894 1.277 . . . . 0.0 108.254 172.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -141.79 154.78 66.14 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 123.568 0.747 . . . . 0.0 109.235 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.12 104.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.384 2.722 . . . . 0.0 114.102 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.9 20.2 78.08 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.649 -0.705 . . . . 0.0 114.288 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 10.5 mmpt? -129.87 145.32 51.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.951 0.901 . . . . 0.0 109.904 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.2 168.83 18.81 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.347 1.059 . . . . 0.0 111.854 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 143.1 46.7 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -118.28 139.11 51.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.158 0.583 . . . . 0.0 109.701 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.517 ' HZ ' ' HB2' ' A' ' 51' ' ' ALA . 92.1 t80 -71.95 110.08 6.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.247 1.019 . . . . 0.0 109.61 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.27 -40.43 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.737 -174.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.58 160.28 40.22 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.081 0.552 . . . . 0.0 111.917 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.517 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . . . -143.24 125.14 15.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.33 1.052 . . . . 0.0 110.228 176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.58 121.16 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.158 1.383 . . . . 0.0 108.11 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -110.53 179.03 4.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.54 0.736 . . . . 0.0 110.579 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -59.48 162.9 4.48 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.081 0.952 . . . . 0.0 110.911 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -37.69 120.1 0.79 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.692 1.597 . . . . 0.0 112.691 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.2 32.05 3.13 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.188 -171.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.71 145.37 4.15 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.307 173.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 t -167.85 43.09 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.61 0.764 . . . . 0.0 109.331 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 p -152.86 131.44 12.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.958 0.503 . . . . 0.0 110.672 -169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' H ' HD11 ' A' ' 71' ' ' ILE . 11.0 t80 -160.7 132.82 6.01 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 168.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.42 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 20.1 p90 -159.57 157.88 30.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.178 0.991 . . . . 0.0 110.144 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.51 156.97 30.63 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.485 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.604 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 37.9 t70 -70.76 -20.82 62.58 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.731 0.301 . . . . 0.0 110.4 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.0 m -61.82 -36.7 81.91 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.528 0.731 . . . . 0.0 111.063 172.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.85 15.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.383 0.673 . . . . 0.0 111.41 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.604 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . 4.6 tmmm? -60.27 124.83 21.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.227 0.611 . . . . 0.0 109.83 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.77 -28.49 7.06 Favored Glycine 0 N--CA 1.478 1.49 0 O-C-N 123.734 0.646 . . . . 0.0 112.597 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.588 HH21 ' HA ' ' A' ' 87' ' ' LEU . 66.3 mtp180 -76.36 -46.06 29.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.099 0.952 . . . . 0.0 109.326 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 61' ' ' TYR . 24.3 t80 -91.42 128.55 37.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.999 -166.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 42.1 m -141.19 139.39 33.83 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.35 1.06 . . . . 0.0 108.46 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.574 HD11 ' H ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -141.2 144.15 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.845 0.858 . . . . 0.0 109.131 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.9 m -151.97 142.07 22.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.617 0.767 . . . . 0.0 109.907 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.635 ' HD2' ' SD ' ' A' ' 35' ' ' MET . 18.2 ttt85 -110.17 127.45 54.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 170.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -103.08 132.39 49.38 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.472 0.709 . . . . 0.0 109.187 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -88.89 -27.05 21.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 112.69 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.89 94.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.705 0.802 . . . . 0.0 112.049 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.6 5.17 13.23 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.322 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 49.99 68.03 0.81 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.737 1.215 . . . . 0.0 111.67 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.1 m -136.16 133.44 37.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.129 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.44 147.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -126.99 141.19 51.85 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.023 0.529 . . . . 0.0 110.252 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.4 tp -127.25 96.28 4.54 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.499 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 24.9 tp60 -96.08 100.65 12.29 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 59.0 mtm -102.93 112.91 25.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.577 0.751 . . . . 0.0 109.017 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.439 HD21 ' HG3' ' A' ' 83' ' ' GLN . 40.2 m-80 -102.79 165.58 10.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.128 0.971 . . . . 0.0 110.225 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 68' ' ' ARG . 10.6 m 54.17 45.0 28.32 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 124.158 0.911 . . . . 0.0 111.384 171.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.588 ' HA ' HH21 ' A' ' 68' ' ' ARG . 82.2 mt -63.59 146.1 54.39 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.701 -168.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.472 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 29.4 mmmt -96.27 141.62 23.38 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.917 1.287 . . . . 0.0 108.6 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.85 -23.92 61.52 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.37 2.046 . . . . 0.0 113.216 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 12.9 pt-20 -72.24 -7.69 50.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.899 0.88 . . . . 0.0 112.316 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -84.77 38.2 0.69 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.802 0.841 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.2 m -90.84 100.52 13.36 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 171.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.76 -171.39 3.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.643 0.777 . . . . 0.0 110.273 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 40' ' ' GLN . 1.5 p -123.77 106.03 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -90.98 146.84 23.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.626 0.77 . . . . 0.0 110.965 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD13 ' HB3' ' A' ' 113' ' ' TRP . 2.0 pp -144.28 153.72 42.32 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.236 1.014 . . . . 0.0 109.41 175.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -94.8 148.21 22.53 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.05 148.49 31.6 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.106 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB3' HD21 ' A' ' 5' ' ' LEU . . . -155.85 135.76 12.76 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.394 0.678 . . . . 0.0 109.685 172.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.05 166.59 34.11 Favored Glycine 0 N--CA 1.449 -0.447 0 O-C-N 123.876 0.735 . . . . 0.0 111.441 171.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 m -62.75 147.22 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 122.642 0.377 . . . . 0.0 111.57 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -57.59 108.83 0.6 Allowed 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.069 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.601 ' HD2' ' HB ' ' A' ' 109' ' ' THR . 66.8 ttt180 -73.7 150.89 40.93 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.354 -176.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.2 m -64.9 -22.57 67.02 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.695 0.798 . . . . 0.0 111.814 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 t -74.0 -17.4 60.99 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.699 0.8 . . . . 0.0 111.533 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.85 -28.68 14.87 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.652 -0.249 . . . . 0.0 112.833 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -78.81 161.26 26.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.692 0.797 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.88 125.82 27.88 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 171.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.601 ' HB ' ' HD2' ' A' ' 103' ' ' ARG . 8.1 t -96.13 109.5 47.37 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.85 88.59 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 121.91 1.74 . . . . 0.0 111.056 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.34 -42.68 99.09 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.296 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -142.01 125.68 16.91 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.693 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.444 ' HB3' HD13 ' A' ' 96' ' ' LEU . 5.7 m-90 -94.03 155.11 17.29 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.85 171.55 52.02 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.191 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -63.22 -21.14 66.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.934 0.894 . . . . 0.0 112.059 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.05 127.79 1.22 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.46 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 11.1 t -125.61 138.47 53.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.127 0.571 . . . . 0.0 110.254 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.555 HE21 ' HB ' ' A' ' 94' ' ' VAL . 6.9 mm-40 -80.44 101.69 9.2 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.614 0.766 . . . . 0.0 111.449 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.0 m -99.25 130.57 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 170.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 82.9 m -135.11 110.7 9.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.8 t -92.7 104.61 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.939 -0.476 . . . . 0.0 109.779 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.549 ' HB2' HD21 ' A' ' 12' ' ' LEU . 35.2 t -61.88 155.43 23.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.584 0.754 . . . . 0.0 112.045 168.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 t -85.47 71.45 10.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.162 0.585 . . . . 0.0 109.644 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 14' ' ' GLN . 4.1 mm? 68.25 -2.04 1.66 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.068 1.347 . . . . 0.0 114.26 173.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -73.31 -57.52 3.95 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.495 0.589 . . . . 0.0 111.165 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -129.63 178.21 6.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.39 0.614 . . . . 0.0 110.837 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -144.35 42.47 1.39 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.417 1.487 . . . . 0.0 107.606 172.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.46 ' H ' HD22 ' A' ' 12' ' ' LEU . 69.0 t60 -62.09 113.05 2.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.875 -168.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -100.68 163.93 12.11 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -74.34 -48.81 25.82 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.098 0.475 . . . . 0.0 110.304 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 . . . . . 0 C--O 1.248 1.017 0 C-N-CA 123.972 0.909 . . . . 0.0 109.118 -176.589 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 mtm . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -87.37 71.84 9.87 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.837 0.855 . . . . 0.0 108.886 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -72.31 112.2 8.17 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -107.58 146.18 32.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.346 1.058 . . . . 0.0 108.968 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.575 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 94.5 mt -125.63 108.17 11.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.67 107.52 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -102.98 154.84 18.83 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.691 0.619 . . . . 0.0 111.72 -170.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -157.68 158.8 36.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.4 1.08 . . . . 0.0 109.133 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.12 -2.99 29.91 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.827 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -72.24 83.33 0.53 Allowed Glycine 0 C--N 1.35 1.322 0 CA-C-N 117.173 0.486 . . . . 0.0 112.725 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.86 177.03 17.19 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 112.243 -0.343 . . . . 0.0 112.243 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 120' ' ' THR . 9.0 tt -92.54 114.14 26.61 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 87' ' ' LEU . 35.9 m -113.34 171.27 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -94.4 158.07 15.73 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.15 0.58 . . . . 0.0 109.919 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.76 116.83 5.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.756 0.822 . . . . 0.0 110.571 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.43 22.8 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.602 0.564 . . . . 0.0 111.988 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.65 55.24 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 121.275 0.375 . . . . 0.0 113.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 p -109.4 165.7 11.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.113 0.965 . . . . 0.0 110.685 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 41.7 tp -158.33 141.03 14.58 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -114.26 113.16 24.24 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.175 0.512 . . . . 0.0 110.15 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.6 mm? -87.72 149.17 24.39 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 109.332 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.2 p -145.22 126.79 15.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.798 0.839 . . . . 0.0 109.346 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HG ' ' HG ' ' A' ' 97' ' ' CYS . 43.5 t -135.28 130.31 34.93 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 109.735 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.56 146.14 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.97 99.02 11.57 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t 53.37 40.65 31.65 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.297 1.439 . . . . 0.0 112.352 171.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.03 -61.08 4.36 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.027 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -168.54 33.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.03 1.332 . . . . 0.0 109.803 172.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -119.93 121.28 38.64 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.326 0.651 . . . . 0.0 109.945 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -133.43 150.67 51.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.712 0.805 . . . . 0.0 110.371 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mtt85 -166.92 72.23 0.12 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 107.779 164.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.6 m -147.71 129.69 15.37 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.765 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.424 ' HB3' ' NE1' ' A' ' 54' ' ' TRP . 18.5 m120 -79.95 -43.71 21.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.88 0.472 . . . . 0.0 111.894 -171.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' TRP . . . -116.39 169.5 9.26 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.569 0.347 . . . . 0.0 110.318 173.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 80' ' ' VAL . 58.2 mtt -148.98 165.39 31.77 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.533 1.133 . . . . 0.0 109.006 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 51' ' ' ALA . . . -155.8 -174.82 26.08 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-O 119.993 -0.337 . . . . 0.0 112.264 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -143.6 118.87 10.18 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.659 1.184 . . . . 0.0 108.455 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -111.52 162.87 14.66 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.411 1.084 . . . . 0.0 108.824 174.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -121.61 133.98 54.99 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.524 ' HB3' HG13 ' A' ' 94' ' ' VAL . 9.9 tm0? -107.84 128.97 55.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -111.78 141.2 24.27 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.552 0.741 . . . . 0.0 109.015 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.82 114.1 2.01 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.597 2.198 . . . . 0.0 112.391 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.51 79.78 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.492 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.9 mmpt? -119.09 173.58 6.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.571 1.148 . . . . 0.0 108.943 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.49 166.46 15.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.843 0.354 . . . . 0.0 110.622 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.92 115.55 11.26 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.343 0.592 . . . . 0.0 109.746 170.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -92.63 141.57 28.34 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.082 0.953 . . . . 0.0 109.892 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -77.58 116.47 18.16 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.63 0.581 . . . . 0.0 109.535 -178.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.18 -59.59 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.584 0.754 . . . . 0.0 110.072 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.537 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -148.79 163.45 37.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.449 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . . . -157.25 164.72 37.4 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 122.362 1.077 . . . . 0.0 112.226 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.639 HD13 ' HB2' ' A' ' 73' ' ' ARG . 96.4 mt -109.2 116.77 52.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.31 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB3' ' HA3' ' A' ' 57' ' ' GLY . 16.5 tpt180 -63.28 95.0 0.08 Allowed 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.19 0.931 . . . . 0.0 108.992 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.451 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 13.6 t90 53.21 -100.63 0.1 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 125.446 1.498 . . . . 0.0 110.511 -176.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.0 t -151.89 106.78 3.25 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.77 -20.46 29.31 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.364 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 53' ' ' ARG . . . -72.77 -62.12 3.31 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 9.5 t 55.47 60.14 3.52 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.689 1.196 . . . . 0.0 113.501 167.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.39 117.68 1.15 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.713 0.805 . . . . 0.0 109.573 -176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -171.02 128.21 0.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.206 2.202 . . . . 0.0 105.924 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.15 146.21 7.43 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.041 0.936 . . . . 0.0 109.708 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.95 156.43 38.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.682 0.793 . . . . 0.0 109.981 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -60.32 -26.73 66.79 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.474 0.71 . . . . 0.0 112.135 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.2 t -65.55 -39.02 91.25 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.764 0.826 . . . . 0.0 111.089 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.09 12.33 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.878 0.871 . . . . 0.0 111.268 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -66.78 120.75 14.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.144 0.978 . . . . 0.0 110.799 -173.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.08 -28.63 5.49 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.305 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -77.51 -55.36 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.14 120.3 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.2 m -129.44 138.13 51.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -176.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.537 HD12 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -116.23 142.49 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.3 m -137.17 133.07 34.83 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.639 ' HB2' HD13 ' A' ' 52' ' ' ILE . 78.3 ttt180 -115.27 122.41 45.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.46 90.65 3.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -69.93 -13.26 62.16 Favored 'General case' 0 CA--C 1.559 1.321 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.01 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.83 -43.61 77.16 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.343 1.057 . . . . 0.0 111.988 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.19 11.86 12.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.884 0.474 . . . . 0.0 110.794 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.28 28.62 15.78 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.833 1.253 . . . . 0.0 112.091 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.5 m -114.37 131.75 56.45 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.306 0.642 . . . . 0.0 110.287 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG21 ' SD ' ' A' ' 35' ' ' MET . 79.0 t -108.58 150.05 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.41 1.484 . . . . 0.0 108.946 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -131.02 151.62 51.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.643 0.777 . . . . 0.0 110.745 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 55.7 tp -132.22 101.36 5.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.314 1.046 . . . . 0.0 108.521 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -85.97 101.14 12.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.487 ' SD ' HD21 ' A' ' 87' ' ' LEU . 39.9 mtt -83.33 139.58 32.95 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.109 0.964 . . . . 0.0 109.2 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -138.23 138.11 38.18 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 t 58.4 72.34 0.53 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.629 1.172 . . . . 0.0 110.451 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.487 HD21 ' SD ' ' A' ' 84' ' ' MET . 42.3 mt -82.62 144.8 30.06 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.574 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -87.18 150.29 49.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 123.734 0.814 . . . . 0.0 109.38 -176.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.83 -23.63 74.36 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 C-N-CA 121.726 1.617 . . . . 0.0 110.891 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.04 -31.73 69.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.696 1.598 . . . . 0.0 111.775 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.37 22.43 0.84 Allowed 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.607 0.717 . . . . 0.0 111.632 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.9 m -77.85 92.28 4.22 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 161.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -160.53 169.97 21.87 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.023 0.929 . . . . 0.0 109.694 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.524 HG13 ' HB3' ' A' ' 40' ' ' GLN . 3.6 p -97.69 107.82 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -82.06 150.81 27.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.401 0.681 . . . . 0.0 109.445 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 pp -150.78 140.26 21.49 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.354 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.661 ' HG ' ' HG ' ' A' ' 23' ' ' CYS . 14.7 p -89.7 149.92 22.55 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -112.12 158.45 19.6 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.556 0.742 . . . . 0.0 109.71 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -139.33 137.71 36.03 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.31 157.83 25.16 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.5 m -114.23 149.54 16.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 123.459 0.703 . . . . 0.0 109.98 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -69.7 84.96 0.46 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -70.94 152.6 43.47 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.116 -167.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.6 m -66.73 -17.58 64.93 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.252 0.621 . . . . 0.0 111.821 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.1 t -67.05 -22.87 65.84 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.988 0.915 . . . . 0.0 111.421 172.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.58 -29.37 11.53 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -88.0 117.69 27.04 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.564 0.745 . . . . 0.0 110.024 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -76.24 101.4 5.41 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.1 t -110.67 142.68 26.64 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 123.327 0.651 . . . . 0.0 110.577 -171.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.565 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 17.4 Cg_exo -64.66 99.82 0.32 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.68 2.253 . . . . 0.0 111.318 177.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -92.59 -12.05 32.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.312 0.645 . . . . 0.0 111.271 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 9.9 m-85 -128.55 149.25 50.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -138.92 163.98 30.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.623 0.769 . . . . 0.0 109.969 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -76.09 174.57 53.11 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.327 -0.851 . . . . 0.0 113.633 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -73.89 -28.11 61.39 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.987 0.515 . . . . 0.0 111.236 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.06 100.81 2.66 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.378 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -96.2 106.81 19.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.078 0.942 . . . . 0.0 108.572 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -78.7 101.38 7.5 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.244 -172.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.521 HG12 ' HA2' ' A' ' 10' ' ' GLY . 19.8 m -91.04 137.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 94.0 m -124.46 102.98 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.32 94.73 4.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 t -64.43 142.43 58.42 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.7 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.0 p -70.48 88.58 0.67 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.676 0.79 . . . . 0.0 111.75 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 73.98 -46.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.565 1.946 . . . . 0.0 113.361 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.77 110.61 5.66 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.107 0.963 . . . . 0.0 110.344 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -77.82 81.75 4.23 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -71.77 152.79 42.44 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.199 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 45.7 m170 -111.73 -167.04 1.13 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.283 1.033 . . . . 0.0 109.104 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -150.86 176.19 11.31 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.047 0.939 . . . . 0.0 109.218 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -69.76 113.08 6.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.958 0.503 . . . . 0.0 109.882 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 . . . . . 0 C--O 1.247 0.969 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.609 . . . . . . . . 0 0 . 1 stop_ save_